Citrus Sinensis ID: 015138

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410--
Protein Sequence
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHccccccEEEEEcccccccEEEEEcccccccccccccEEEEEccccccccHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEcccccccEEEEEEccccccHHHHHHHHHHHHHHHHHHccccccEEEEcccccEEEEccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHEEEccccccccHHHHHccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHcccccccEEEcccccccEEEEEEEccccccccEEEccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccccEEcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHcccccEEEEEEccccccEEEEEEccccHcccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHccccccHEcccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEcccEEEEEEEEccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEcHHHHHHHHHcccHHccccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccHHEcHHHcEccccEEEEcc
Coil and Loop (DISEMBL)
mepsscrdCINVARKNLtslcpnkvtaiggyddrgynncmlryanydifglmenapyFFVYAESNISENLIEFNQTRQRLLERLFSeaaarpspnkyatgkeAVSDIVTMYALVQctpdlseadckeCLHDTTKLMskccdrrqggrvinpscsfryetnkffkpsiagppgspdpvtpeppprkknhtILITVIVSVVASVILITGICIFLRvgklkledeNVEETIAKSLQFDFETIRVAtdnfsdanklgqggfgaVYKGMLSNGETIAVKRLSknskqgeiEFKNEVLLLARLQHRNLVRLLGFCLERKERILvyefvpnasldhfifdpinrehmTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNilldsemnpkisdfGMARLFEMdqthsdtnrvvgtl
Flexible Loop (DISEMBL)
MEPSSCRDCINVArknltslcpnkvtaiggyddrgynNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSeaaarpspnkyatgkEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKlmskccdrrqggrvinpscsFRYETNKFfkpsiagppgsPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEfvpnasldhfifdPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKasnilldsemnpKISDFGMARLFEmdqthsdtnrvvgtl
Low Complexity Region (SEG)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPRKKNHtilitvivsvvasvilitGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL
Disordered region (IsUnstruct)
******RDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLF*************TGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFF************************HTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRL******GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS*******DFGM********************
Disordered Region (DISOPRED)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPS*************************ITVIVSVVASVILITGICIFLRV******************QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL
Disordered Region (DISEMBL)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGP*************RKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS*********
Disordered Region (DISPRO)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPS*******************KNHTILITVIVSVVASVILITGICIFLRVGKL***********AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	412	2.2.26 [Sep-21-2011]
Q9M0X5	675	Cysteine-rich receptor-li	yes	no	0.968	0.591	0.496	1e-111
Q8H199	658	Cysteine-rich receptor-li	no	no	0.987	0.618	0.457	1e-104
Q8S9L6	679	Cysteine-rich receptor-li	no	no	0.973	0.590	0.468	1e-101
Q9T0J1	665	Cysteine-rich receptor-li	no	no	0.966	0.598	0.468	1e-100
O65405	683	Cysteine-rich receptor-li	no	no	0.973	0.587	0.464	1e-98
Q9ZP16	667	Cysteine-rich receptor-li	no	no	0.975	0.602	0.443	7e-98
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.968	0.636	0.444	2e-97
O49564	642	Cysteine-rich receptor-li	no	no	0.953	0.612	0.474	3e-97
Q9C5S8	659	Cysteine-rich receptor-li	no	no	0.975	0.610	0.48	4e-97
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.958	0.590	0.459	9e-97

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  401 bits (1031), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 210/423 (49%), Positives = 276/423 (65%), Gaps = 24/423 (5%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           CRDC+  A       CP +  A+  YD+     CM+RY+N  I G M   P  F+  + N
Sbjct: 97  CRDCVAFAANETLQRCPREKVAVIWYDE-----CMVRYSNQSIVGQMRIRPGVFLTNKQN 151

Query: 66  ISENLIE-FNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEAD 124
           I+EN +  FN++   LL  +  +AA   S  K+AT K   +   T+Y+LVQCTPDL+  D
Sbjct: 152 ITENQVSRFNESLPALLIDVAVKAAL--SSRKFATEKANFTVFQTIYSLVQCTPDLTNQD 209

Query: 125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSI---------AGPPGSPD 175
           C+ CL      + +CCDR  GGRVI PSCSFRYE   F+  +I         +    +P 
Sbjct: 210 CESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTAPP 269

Query: 176 PVTPEPPPRKKNHTILITVI-VSVVASVILITGICIFL---RVGKLKLEDENVEE---TI 228
              P    + KN T+++T I V V   V+L+  +C  L   R  KL  E E+++E   T 
Sbjct: 270 LNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDLDEDGITS 329

Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK 288
            ++LQF F  I  AT+ FS++NKLG GGFG VYKG L  GET+A+KRLS+ S QG  EFK
Sbjct: 330 TETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFK 389

Query: 289 NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
           NEV ++A+LQHRNL +LLG+CL+ +E+ILVYEFVPN SLD+F+FD   R  + W++RYKI
Sbjct: 390 NEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKI 449

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
           IEGIARG+LYLH DSRL IIHRDLKASNILLD++M+PKISDFGMAR+F +DQT ++T R+
Sbjct: 450 IEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRI 509

Query: 409 VGT 411
           VGT
Sbjct: 510 VGT 512

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2

 Score =  377 bits (969), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 194/424 (45%), Positives = 268/424 (63%), Gaps = 17/424 (4%)

Query: 2   EPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVY 61
           EP  C DCI  A   L   C N+   +   + R    CM+RY+N   FG ++  P+F+++
Sbjct: 81  EPDVCSDCIEYASNLLLDTCLNQTEGLAWPEKRIL--CMVRYSNSSFFGSLKAEPHFYIH 138

Query: 62  AESNISENLIEFNQTRQRLLERLFSEAAARPSPNKY-ATGKEAVSDIVTMYALVQCTPDL 120
              +I+ NL EF+Q  + L  R+ +   +  S  KY A    A++    +YAL+QCTPDL
Sbjct: 139 NVDDITSNLTEFDQVWEELARRMIASTTSPSSKRKYYAADVAALTAFQIIYALMQCTPDL 198

Query: 121 SEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYE----TNKFFKPSIAGPPGSPDP 176
           S  DC  CL  +      CC+ +QGG V   SC FR+E    +  F + S+A PP SP  
Sbjct: 199 SLEDCHICLRQSVGDYETCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAF 258

Query: 177 VTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKL---------EDENVEET 227
            T             IT+ + +V ++I+ T I +FL +  L           +  + + T
Sbjct: 259 PTLPAVTNTATKKGSITISIGIVWAIIIPTVIVVFLVLLALGFVVYRRRKSYQGSSTDIT 318

Query: 228 IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEF 287
           I  SLQFDF+ I  AT+ FS++N +G+GGFG V+ G+L NG  +A+KRLSK S+QG  EF
Sbjct: 319 ITHSLQFDFKAIEDATNKFSESNIIGRGGFGEVFMGVL-NGTEVAIKRLSKASRQGAREF 377

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           KNEV+++A+L HRNLV+LLGFCLE +E+ILVYEFVPN SLD+F+FDP  +  + W KRY 
Sbjct: 378 KNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLFDPTKQGQLDWTKRYN 437

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           II GI RG+LYLH+DSRL IIHRDLKASNILLD++MNPKI+DFGMAR+F +DQ+ ++T +
Sbjct: 438 IIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGIDQSGANTKK 497

Query: 408 VVGT 411
           + GT
Sbjct: 498 IAGT 501

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  369 bits (947), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 203/433 (46%), Positives = 263/433 (60%), Gaps = 32/433 (7%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C  CI  A +NLT  CP    A+       Y +CM RY+N  I+G  E  P     A   
Sbjct: 97  CVSCIQTAARNLTKQCPLTKQAV-----VWYTHCMFRYSNRTIYGRKETNPTKAFIAGEE 151

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGK-EAVSDIVTMYALVQCTPDLSEAD 124
           IS N  +F + ++ LL+RL   AAA     KYA G   A +     Y  VQCTPDLSE D
Sbjct: 152 ISANRDDFERLQRGLLDRLKGIAAAGGPNRKYAQGNGSASAGYRRFYGTVQCTPDLSEQD 211

Query: 125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFK--------PSIAGPPGSPDP 176
           C +CL    + +  CCD   G R  +PSC+FR+ET +F++        P    P  SP  
Sbjct: 212 CNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRFETWRFYEFDADLEPDPPAIQPADSPQS 271

Query: 177 V--TPEPPPRKKNHTILITVIVSVVASVILITGICIFLR------------VGKLKLEDE 222
              T      K    ++I +++ ++   +L   +C+ L+            +GK  L   
Sbjct: 272 AARTERTGKGKGGSKVIIAIVIPILLVALLAICLCLVLKWRKNKSGYKNKVLGKSPLSGS 331

Query: 223 NVEETIA--KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
             E+  +  +SL   FET++ ATDNFS  N+LG+GGFG+VYKG+   G+ IAVKRLS NS
Sbjct: 332 IAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNS 391

Query: 281 KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM 340
            QG+ EFKNE+LLLA+LQHRNLVRL+GFC++ +ER+LVYEF+ NASLD FIFD   R+ +
Sbjct: 392 GQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLL 451

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            W  RYK+I GIARGLLYLHEDSR RIIHRDLKASNILLD EMNPKI+DFG+A+LF+  Q
Sbjct: 452 DWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQ 511

Query: 401 --THSDTNRVVGT 411
             TH  T+R+ GT
Sbjct: 512 TMTHRFTSRIAGT 524

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1

 Score =  365 bits (937), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 201/429 (46%), Positives = 267/429 (62%), Gaps = 31/429 (7%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C +CI +A K L +LCP +  AI  YD      C  RY+N  IF  +E +P+  +    N
Sbjct: 92  CINCIAMAGKRLVTLCPVQKEAIIWYD-----KCTFRYSNRTIFNRLEISPHTSITGTRN 146

Query: 66  ISENLIEFNQTRQRLLERLFSEAAA-RPSPNKYATGKEAVSDIVTMYALVQCTPDLSEAD 124
            + +   + ++ + LLE L + A+    S   +  G+ +     T++ LVQCTPD+SE D
Sbjct: 147 FTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGETSGPSFQTLFGLVQCTPDISEED 206

Query: 125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPR 184
           C  CL      +  CCD + G  V++PSC   Y   +F+ P     P S  P TP  PP+
Sbjct: 207 CSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYDPVDTDDPSSV-PATPSRPPK 265

Query: 185 KKNHTI------------LITVIVSVVASVILITGICIF--------LRVGKLKLEDENV 224
            +  ++            LI    SV   V+ I  + +F        +R  + K E+EN+
Sbjct: 266 NETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSENKHENENI 325

Query: 225 EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGE 284
                 S++FDF  ++ AT +FS  NKLG+GGFGAVYKG+LS+G+ IAVKRLSKN++QGE
Sbjct: 326 S---TDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGE 382

Query: 285 IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK 344
            EFKNE LL+A+LQHRNLV+LLG+ +E  ER+LVYEF+P+ SLD FIFDPI    + WE 
Sbjct: 383 TEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEI 442

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ-THS 403
           RYKII G+ARGLLYLH+DSRLRIIHRDLKASNILLD EM PKI+DFGMARLF++D  T  
Sbjct: 443 RYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQR 502

Query: 404 DTNRVVGTL 412
            TNR+VGT 
Sbjct: 503 YTNRIVGTF 511

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2

 Score =  360 bits (923), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 202/435 (46%), Positives = 265/435 (60%), Gaps = 34/435 (7%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C  CI +A +NL   CP    A+       Y +CM RY+N  I+G  E  P     A  N
Sbjct: 99  CLSCIQIAARNLIEQCPLTNQAV-----VWYTHCMFRYSNMIIYGRKETTPTLSFQAGKN 153

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGK-EAVSDIVTMYALVQCTPDLSEAD 124
           IS N  EF++ +  LL+RL   AAA     KYA G    V+     Y    CTPDLSE D
Sbjct: 154 ISANRDEFDRLQIELLDRLKGIAAAGGPNRKYAQGSGSGVAGYPQFYGSAHCTPDLSEQD 213

Query: 125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFK--------PSIAGPPGSPDP 176
           C +CL    + +  CC  + G R   PSCS+R+ET +F++        P    P  SP  
Sbjct: 214 CNDCLVFGFEKIPGCCAGQVGLRWFFPSCSYRFETWRFYEFDADLEPDPPAIQPADSPTS 273

Query: 177 V--TPEPPPRKKNHTILITVIVSVVASVILITGICIFLR------VGKLKLEDENV---- 224
              T      K    +++ +++ +V   +    +C+ L+      VG++K    N+    
Sbjct: 274 AARTERTGKGKGGSKVIVAIVIPIVFVALFAICLCLLLKWKKNKSVGRVKGNKHNLLLLV 333

Query: 225 ------EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSK 278
                 ++  + SL  DFET++ ATDNFS  N+LG+GGFG+VYKG+ S G+ IAVKRLS 
Sbjct: 334 IVILLQKDEFSDSLVVDFETLKAATDNFSPENELGRGGFGSVYKGVFSGGQEIAVKRLSC 393

Query: 279 NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE 338
            S QG+ EFKNE+LLLA+LQHRNLVRLLGFC+E +ERILVYEF+ NASLD+FIFD   R+
Sbjct: 394 TSGQGDSEFKNEILLLAKLQHRNLVRLLGFCIEGQERILVYEFIKNASLDNFIFDLKKRQ 453

Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            + W  RYK+I G+ARGLLYLHEDSR RIIHRDLKASNILLD EMNPKI+DFG+A+L++ 
Sbjct: 454 LLDWGVRYKMIGGVARGLLYLHEDSRYRIIHRDLKASNILLDQEMNPKIADFGLAKLYDT 513

Query: 399 DQ--THSDTNRVVGT 411
           DQ  TH  T+++ GT
Sbjct: 514 DQTSTHRFTSKIAGT 528

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2

 Score =  357 bits (917), Expect = 7e-98,   Method: Compositional matrix adjust.
 Identities = 191/431 (44%), Positives = 266/431 (61%), Gaps = 29/431 (6%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNN-CMLRYANYDIFGLMENAPYFFVYAES 64
           C DCI    +     CPN+  A   Y   G    C +RY+N    G  +  P  ++    
Sbjct: 89  CSDCIKKESEFFLKNCPNQTEA---YSWPGEPTLCYVRYSNTSFSGSADLNPRNWLTNTG 145

Query: 65  NISENLIEFNQTRQRLLERLFSEAA-ARPSP----NKYATGKEAVSDIVTMYALVQCTPD 119
           ++  NL EF +  + L+ R+ S A+ A+ +P    N Y+     ++ ++ +YAL+QCTPD
Sbjct: 146 DLDSNLTEFTKIWEGLMGRMISAASTAKSTPSSSDNHYSADSAVLTPLLNIYALMQCTPD 205

Query: 120 LSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYE----TNKFFKPSIAGP----- 170
           LS  DC+ CL  +      CC +++GG V+ PSC  R++    +N F   ++A P     
Sbjct: 206 LSSGDCENCLRQSAIDYQSCCSQKRGGVVMRPSCFLRWDLYTYSNAFDNLTVASPPPEPP 265

Query: 171 ------PGSPD-PVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLR---VGKLKLE 220
                  G  D P   +         + ITV   +   ++L+ G  +F R     + K E
Sbjct: 266 VTVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVIAILILLVLGFVLFRRRKSYQRTKTE 325

Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
            E+ + +   SL +DF+TI  AT+ FS +NKLG+GGFGAVYKG LSNG  +AVKRLSK S
Sbjct: 326 SES-DISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKS 384

Query: 281 KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM 340
            QG  EF+NE +L+ +LQHRNLVRLLGFCLER+E+IL+YEFV N SLD+F+FDP  +  +
Sbjct: 385 GQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQL 444

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            W +RYKII GIARG+LYLH+DSRL+IIHRDLKASNILLD++MNPKI+DFG+A +F ++Q
Sbjct: 445 DWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQ 504

Query: 401 THSDTNRVVGT 411
           T  +TNR+ GT
Sbjct: 505 TQGNTNRIAGT 515

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  356 bits (913), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 191/430 (44%), Positives = 270/430 (62%), Gaps = 31/430 (7%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           + P+ CR+C+  +  +    CP++  ++  YD+     CMLRY++ +I   +     + +
Sbjct: 87  VSPAVCRNCVAFSINDTLVQCPSERKSVFYYDE-----CMLRYSDQNILSTLAYDGAW-I 140

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAA--ARPSPNKYATGKEAVSDIVTMYALVQCTP 118
               NIS +  + N+ +   +    ++AA  A  SP K+ T K   + + T+Y LVQCTP
Sbjct: 141 RMNGNISIDQNQMNRFKD-FVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTP 199

Query: 119 DLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDP-- 176
           DL+  DC  CL  + KLM      + GGR +  SC+ RYE   F+  +      +P P  
Sbjct: 200 DLTRQDCFSCLESSIKLMPL---YKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLP 256

Query: 177 -------VTPEPPPRKKNHTILITVIV--SVVASVILITGICIFLRVGKLKLEDENV--- 224
                   +P  P +  N  +L+  IV   +VA+++LI G C   RV   K   +N    
Sbjct: 257 PSSTPLVTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRV---KNSSDNAPAF 313

Query: 225 --EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ 282
             ++   +SLQ D+  IR AT+ FS+ NK+GQGGFG VYKG  SNG  +AVKRLSK+S Q
Sbjct: 314 DGDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQ 373

Query: 283 GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW 342
           G+ EFKNEV+++A+LQHRNLVRLLGF +   ERILVYE++PN SLD+F+FDP  +  + W
Sbjct: 374 GDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDW 433

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
            +RYK+I GIARG+LYLH+DSRL IIHRDLKASNILLD++MNPK++DFG+AR+F MDQT 
Sbjct: 434 TRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQ 493

Query: 403 SDTNRVVGTL 412
            +T+R+VGT 
Sbjct: 494 ENTSRIVGTF 503

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2

 Score =  355 bits (911), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 199/419 (47%), Positives = 252/419 (60%), Gaps = 26/419 (6%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C  CI  A K L   CPN + A     +     CM RY +  I G ME  P  F Y  SN
Sbjct: 93  CISCITTAAKQLVESCPNIIEA-----NIWLEKCMFRYTSRIILGQMEPVP--FSYTSSN 145

Query: 66  ISENLIE-FNQTRQRLLERLFS--EAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSE 122
           +S    E F++    LL+ L +  +AA      K+A G +      T+YAL QCTPDLSE
Sbjct: 146 VSVTDKEGFSKGLGDLLDSLGAKIDAANETKEVKFAAGVKG-----TIYALAQCTPDLSE 200

Query: 123 ADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSP------DP 176
           +DC+ CL      +  CCD + GG   NPSC FR+E   FF  S+      P      + 
Sbjct: 201 SDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQKQPLSSHNNNT 260

Query: 177 VTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVG----KLKLEDENVEETIAKSL 232
              +    K     LI  +V +VA ++ +  + I+L+       LK   EN  E+   SL
Sbjct: 261 RRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKKTLKENAENEFES-TDSL 319

Query: 233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVL 292
            FDFETIRVATD+FS  NK+G+GGFG VYKG L +G  IAVKRLS +S QG  EFK EVL
Sbjct: 320 HFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEFKTEVL 379

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           L+ +LQH+NLV+L GF ++  ER+LVYEF+PN SLD F+FDPI ++ + WEKRY II G+
Sbjct: 380 LMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYNIIVGV 439

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +RGLLYLHE S   IIHRDLK+SN+LLD +M PKISDFGMAR F+ D T + T RVVGT
Sbjct: 440 SRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRRVVGT 498

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1

 Score =  355 bits (910), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 204/425 (48%), Positives = 264/425 (62%), Gaps = 23/425 (5%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           + P SCR+C+  A K+  S CP     +  YD+     CML Y++ +IF           
Sbjct: 90  LSPESCRECVIFAAKDTRSRCPGGKEFLIQYDE-----CMLGYSDRNIFMDTVTTTTIIT 144

Query: 61  YAESNISENLIE-FNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPD 119
           +    ++ +  + FN     L+++  +E AA  +  K+A  K   S   ++YA VQC PD
Sbjct: 145 WNTQKVTADQSDRFNDAVLSLMKKS-AEEAANSTSKKFAVKKSDFSSSQSLYASVQCIPD 203

Query: 120 LSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPV-- 177
           L+  DC  CL  + K +      + GGR + PSC+ RYE   F+K +I G    P     
Sbjct: 204 LTSEDCVMCLQQSIKELYF---NKVGGRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSAP 260

Query: 178 ------TPE-PPPRKKNHTILITVIVSVVA-SVILITGICIFLRVGKLKLEDENVEE--- 226
                 TP  PP + KN T++I  IV  VA SV++   +  F    + K   +  EE   
Sbjct: 261 PLPLVSTPSFPPGKGKNSTVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYDTPEEDDI 320

Query: 227 TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE 286
           T A SLQFDF+ I  ATD FS  NKLGQGGFG VYKG L NG  +AVKRLSK S QGE E
Sbjct: 321 TTAGSLQFDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKRLSKTSGQGEKE 380

Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           FKNEV+++A+LQHRNLV+LLGFCLER+E+ILVYEFV N SLD+F+FD   +  + W  RY
Sbjct: 381 FKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSRMQSQLDWTTRY 440

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           KII GIARG+LYLH+DSRL IIHRDLKA NILLD++MNPK++DFGMAR+FE+DQT + T 
Sbjct: 441 KIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFEIDQTEAHTR 500

Query: 407 RVVGT 411
           RVVGT
Sbjct: 501 RVVGT 505

Involved in multiple distinct defense responses. May function as a disease resistance (R) protein.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  354 bits (908), Expect = 9e-97,   Method: Compositional matrix adjust.
 Identities = 193/420 (45%), Positives = 267/420 (63%), Gaps = 25/420 (5%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           CR C++ A  +  + CPN+  A   YD+     C+LRY+N +I   +       +    N
Sbjct: 105 CRRCVSFAVNDTLTRCPNQKEATLYYDE-----CVLRYSNQNILSTLITTGGVILVNTRN 159

Query: 66  ISENLIEFNQTRQRLLERLFSEAA--ARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEA 123
           ++ N ++       L+    ++AA  A  S  K+ T K   + + + Y LVQCTPDL+  
Sbjct: 160 VTSNQLDL---LSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQ 216

Query: 124 DCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPE--- 180
           DC  CL     ++++    R G R+INPSC+ RYE   F+  S   PP  P  ++     
Sbjct: 217 DCSRCLQ---LVINQIPTDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVS 273

Query: 181 PPPRK-----KNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENV----EETIAKS 231
            PPR          ++  V+  +VA ++ I G C   R  +      +     + T A S
Sbjct: 274 APPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSYYTPSAFAGDDITTADS 333

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEV 291
           LQ D+ TI+ ATD+F ++NK+GQGGFG VYKG LS+G  +AVKRLSK+S QGE+EFKNEV
Sbjct: 334 LQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEV 393

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           +L+A+LQHRNLVRLLGFCL+ +ER+LVYE+VPN SLD+F+FDP  +  + W +RYKII G
Sbjct: 394 VLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGG 453

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +ARG+LYLH+DSRL IIHRDLKASNILLD++MNPKI+DFGMAR+F +DQT  +T+R+VGT
Sbjct: 454 VARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	412
224076544	652	predicted protein [Populus trichocarpa]	0.983	0.621	0.583	1e-130
255555051	1390	serine-threonine protein kinase, plant-t	0.970	0.287	0.566	1e-128
224116124	630	predicted protein [Populus trichocarpa]	0.987	0.646	0.573	1e-125
147811956	839	hypothetical protein VITISV_019620 [Viti	0.975	0.479	0.553	1e-124
358347946	552	Cysteine-rich receptor-like protein kina	0.980	0.731	0.551	1e-124
358347848	671	Cysteine-rich receptor-like protein kina	0.980	0.602	0.551	1e-124
224114251	647	predicted protein [Populus trichocarpa]	0.985	0.627	0.579	1e-123
224113941	637	predicted protein [Populus trichocarpa]	0.966	0.624	0.552	1e-123
359496752	751	PREDICTED: cysteine-rich receptor-like p	0.978	0.536	0.545	1e-122
356574368	656	PREDICTED: cysteine-rich receptor-like p	0.961	0.603	0.531	1e-121

>gi|224076544|ref|XP_002304959.1| predicted protein [Populus trichocarpa] gi|222847923|gb|EEE85470.1| predicted protein [Populus trichocarpa]

 Score =  473 bits (1216), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 244/418 (58%), Positives = 310/418 (74%), Gaps = 13/418 (3%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           ++P +CRDC+N + + LT+LCP +  AI G+D     +C+LRYA+  IFGL E APYFFV
Sbjct: 74  VKPDACRDCLNYSSRVLTALCPTQKEAIIGFD-----SCILRYASRSIFGLNEVAPYFFV 128

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDL 120
           Y+ +N+S+    FN++   LL+ L  EAAA  S  KYAT K +  +  T+YAL QCTPDL
Sbjct: 129 YSLTNVSDEK-GFNRSLNSLLDSLQDEAAAGDSRRKYATRKISAPNFQTIYALSQCTPDL 187

Query: 121 SEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIA------GPPGSP 174
           S+ +C  CL + +  + +CC  RQGGRVI PSC+FRYE N+F++  I            P
Sbjct: 188 SQTECSSCLRNASARVGQCCQERQGGRVIYPSCNFRYEINQFYEIPIGEDPSPPPSKVPP 247

Query: 175 DPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETI-AKSLQ 233
            P   E   R    TI+I V+ +V   +++I+ IC++LR+ K + + E VEE I A+SLQ
Sbjct: 248 PPPPAEGKKRNNARTIIIIVVSTVSVVILMISCICLYLRIRKPEEKVETVEEMITAESLQ 307

Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           FDF TIR ATDNFS+ NKLGQGGFG+VYKG LSNG+ +AVKRLSK+S QG++EFKNEVLL
Sbjct: 308 FDFSTIRAATDNFSEENKLGQGGFGSVYKGTLSNGQEVAVKRLSKDSGQGDLEFKNEVLL 367

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +A+LQHRNLVRL GFCL+  ER+L+YEFVPNASLDHFIF+   R  + WE+RYKII GIA
Sbjct: 368 VAKLQHRNLVRLQGFCLQGIERLLIYEFVPNASLDHFIFNQARRAQLDWERRYKIIGGIA 427

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           RGLLYLHEDSRLRIIHRDLKASNILLD++MNPKISDFGMARLF MD+T  +T+R+VGT
Sbjct: 428 RGLLYLHEDSRLRIIHRDLKASNILLDADMNPKISDFGMARLFVMDETQGNTSRIVGT 485

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555051|ref|XP_002518563.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223542408|gb|EEF43950.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  463 bits (1191), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 234/413 (56%), Positives = 301/413 (72%), Gaps = 13/413 (3%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           CR CI  + + +T  CPN+   +G YD     +CM RY+N  IFG+ME  P   +  E N
Sbjct: 62  CRGCIRNSTREITQHCPNQKEVLGFYD-----SCMFRYSNRSIFGVMETQPTIHMKNEEN 116

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADC 125
           +++ + +FNQ  Q LL RL S+AAA  S  K+ATG E+ +   T++ L+QCTPD++E DC
Sbjct: 117 VTD-VNQFNQALQTLLSRLRSKAAAGNSTRKFATGNES-AGFETIFGLMQCTPDITEQDC 174

Query: 126 KECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSI---AGPPGSP-DPVTPEP 181
            +C+   T+ +  CC+ + GGRVI PSC+FRYE  +F++P+    A  P  P DP    P
Sbjct: 175 NDCIVAATRDIPICCNGKLGGRVIKPSCNFRYENYRFYQPTSDDDATHPSLPVDPSVSPP 234

Query: 182 PPRKKNHTILITVIVSVVASVI-LITGICIFLRVGKLKLEDENVEETI-AKSLQFDFETI 239
            P++ N+   I +IV +  S++ LI  + IF++V K +   E  EE +  +SLQFDFETI
Sbjct: 235 APKEGNNRRNIIIIVVLTVSIVSLIICVGIFIKVRKARKRIETAEEIMNVESLQFDFETI 294

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH 299
           R+ TD+FS+ NKLG+GGFG+VYKG L  G+ IAVKRLS  SKQG++EFKNEVLL+A+LQH
Sbjct: 295 RICTDDFSEENKLGEGGFGSVYKGTLPMGQDIAVKRLSNGSKQGDLEFKNEVLLVAKLQH 354

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           RNLVRLLGFCL+  ER+L+YEFVPNASLD +IFDP+    + WEKRYKII GIARGLLYL
Sbjct: 355 RNLVRLLGFCLQGIERLLIYEFVPNASLDQYIFDPVRCVQLDWEKRYKIIGGIARGLLYL 414

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           HEDSRLRIIHRDLKASNILLDS+MNPKISDFGMARLF MDQTHS+T+R+VGT 
Sbjct: 415 HEDSRLRIIHRDLKASNILLDSDMNPKISDFGMARLFIMDQTHSNTSRIVGTF 467

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116124|ref|XP_002317217.1| predicted protein [Populus trichocarpa] gi|222860282|gb|EEE97829.1| predicted protein [Populus trichocarpa]

 Score =  454 bits (1169), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 245/427 (57%), Positives = 297/427 (69%), Gaps = 20/427 (4%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           + P  CR CI  A   L  LCPN V AIGG D     NCM+RY N  IF  ME  PYF+V
Sbjct: 61  ISPDVCRVCIRNASDFLVRLCPNFVEAIGGLD-----NCMVRYTNRSIFNRMEKGPYFWV 115

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAV-SDIVTMYALVQCTPD 119
           Y +     +++ FNQ+R  LL RL  +AAA  S  KYA  +  V  +   +YALVQCTPD
Sbjct: 116 YDDRVNVSDVVGFNQSRMTLLGRLSDQAAAGDSRYKYAMDQIDVPKNFQKIYALVQCTPD 175

Query: 120 LSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVT- 178
           LS ++C++CL++ + L+ +CCD RQGGRVI PSC+FRYE ++F+ P     P  PD  + 
Sbjct: 176 LSASECRDCLYNASGLIPQCCDARQGGRVIYPSCNFRYEIDRFYDPPTNSIPPPPDSTSN 235

Query: 179 ---PEPPPR-------KKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDEN---VE 225
              P PP         KK + I+ITVIV +  SVILI  +CIFLR  K K E+E     E
Sbjct: 236 NTVPSPPASTSQGKKGKKRNVIIITVIVPIAVSVILIVCVCIFLRARKQKEEEEVKDLYE 295

Query: 226 ETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI 285
               +  Q DF T+R AT NFS+ NKLGQGGFG VYKG L+NG+ IAVKRLS+ S QGE+
Sbjct: 296 MEDVELFQLDFGTVREATGNFSEDNKLGQGGFGTVYKGTLANGQDIAVKRLSRTSGQGEL 355

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR 345
           EFKNEV+L+A+LQHRNLVRLLGFC E++ERILVYEF+PN+SL++ IFDP+ R  + WE  
Sbjct: 356 EFKNEVMLVAKLQHRNLVRLLGFCFEKEERILVYEFLPNSSLNNLIFDPVKRVLLDWETL 415

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           YKIIEGIARGLLYLHEDSRLRIIHRDLKA+NILLD  MNPKISDFGMAR+F MDQ    T
Sbjct: 416 YKIIEGIARGLLYLHEDSRLRIIHRDLKAANILLDENMNPKISDFGMARMFVMDQAQDST 475

Query: 406 NRVVGTL 412
           +RVVGT 
Sbjct: 476 SRVVGTF 482

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147811956|emb|CAN74851.1| hypothetical protein VITISV_019620 [Vitis vinifera]

 Score =  451 bits (1161), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 236/426 (55%), Positives = 299/426 (70%), Gaps = 24/426 (5%)

Query: 3   PSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYA 62
           P++CR CIN +R  LT LCPN+  AIG YD     NCMLRY+N  IFG  +++PYF++  
Sbjct: 255 PTACRSCINDSRIQLTQLCPNQKEAIGWYD-----NCMLRYSNDSIFGTQQSSPYFYMRN 309

Query: 63  ESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSE 122
             N S+ + EFNQ    ++  L S+AA+     K+ATG+  V+   ++Y L+QCTPDLSE
Sbjct: 310 SKNASD-VEEFNQVLGNMMASLRSKAASGDWRRKFATGEANVTSFQSIYGLMQCTPDLSE 368

Query: 123 ADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGS--------- 173
             C  CL   T  +  CCD R+GGRV+ PSC+ RYET +F+  + A  P           
Sbjct: 369 LSCSNCLEGATNEIPTCCDSRKGGRVVKPSCNLRYETYRFYDFTAANAPPPSPPSADLSP 428

Query: 174 ---PDPVTPEPPPRKKNHTILITVIVSVVASVILITG-ICIFLR----VGKLKLEDENVE 225
               +  + +      + TI++ ++ SV+  +I++ G IC F R    + KL+  DE+ E
Sbjct: 429 PPLANTTSTQETRSNSSRTIILIIVPSVIILIIILVGFICFFSRKRSSMEKLETHDED-E 487

Query: 226 ETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI 285
            T  +SL FDF+TIRVAT+NFSD+NKLGQGGFG VYKG LSNG+ +AVKRLS  S QGE+
Sbjct: 488 ITNVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYKGKLSNGQYVAVKRLSSGSAQGEL 547

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR 345
           EFKNE +L+A+LQHRNLVRLLGFCL+  ER+L+YEFVPN SLDHFIFD I R  + WE+R
Sbjct: 548 EFKNEAVLVAKLQHRNLVRLLGFCLDGAERLLIYEFVPNTSLDHFIFDLIRRAQLDWERR 607

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           YKII GIARGLLYLHEDSRLRIIHRDLKASNILLD+EMNPKISDFGMARLF +DQT   T
Sbjct: 608 YKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARLFLVDQTQGST 667

Query: 406 NRVVGT 411
           +R+VGT
Sbjct: 668 SRIVGT 673

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358347946|ref|XP_003638011.1| Cysteine-rich receptor-like protein kinase, partial [Medicago truncatula] gi|355503946|gb|AES85149.1| Cysteine-rich receptor-like protein kinase, partial [Medicago truncatula]

 Score =  451 bits (1160), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 231/419 (55%), Positives = 298/419 (71%), Gaps = 15/419 (3%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           ++P  CR C+N +R  LT LCPN+  AIG YD     NCMLRY+N  IFG+ME +P F++
Sbjct: 92  VKPDVCRSCLNDSRVLLTKLCPNQKEAIGWYD-----NCMLRYSNRSIFGVMEGSPKFYM 146

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYAT--GKEAVSDIVTMYALVQCTP 118
           +   N++E + +FNQ    L+ +L  +AA+  S  K+AT    +   +  T+Y LVQCTP
Sbjct: 147 WNIYNVTE-VDQFNQVLGNLMRKLKEKAASSDSRRKFATDNATDVNLNFQTIYGLVQCTP 205

Query: 119 DLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVT 178
           DLSE DC  CL      +  CC+ + GGRV+ PSC+ RYET+ F+ P+ A  PG   P +
Sbjct: 206 DLSEQDCNNCLDGAISDIPSCCNNKIGGRVLKPSCNIRYETSSFYDPTPAIDPGETSP-S 264

Query: 179 PEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLE------DENVEETIAKSL 232
            E   +  + TI I V   VV    L+  ICI LR  K ++       D+N +  +A+SL
Sbjct: 265 EEEKSKSSHTTIAIVVPTVVVVVAALLIFICICLRKRKARINLEEIEEDDNDDIDMAESL 324

Query: 233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVL 292
           QF+FET++VAT NFS+ANKLG GGFG VY G+L+ G+ IAVKRLS NS QG++EFKNEVL
Sbjct: 325 QFNFETLQVATSNFSEANKLGHGGFGVVYHGILAGGQVIAVKRLSTNSGQGDVEFKNEVL 384

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           L+A+LQHRNLVRLLGFCLE +ER+LVYE+VPN SLD+FIFDPI +  + WE+RYKII GI
Sbjct: 385 LVAKLQHRNLVRLLGFCLEGRERLLVYEYVPNKSLDYFIFDPIKKAQLDWERRYKIIGGI 444

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           ARGLLYLHEDS+LRIIHRDLKASNILLD ++NPKISDFGMARL  +D+T  +TN++VGT
Sbjct: 445 ARGLLYLHEDSQLRIIHRDLKASNILLDEKLNPKISDFGMARLLLVDETQVNTNKIVGT 503

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358347848|ref|XP_003637963.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503898|gb|AES85101.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  450 bits (1158), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 231/419 (55%), Positives = 298/419 (71%), Gaps = 15/419 (3%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           ++P  CR C+N +R  LT LCPN+  AIG YD     NCMLRY+N  IFG+ME +P F++
Sbjct: 92  VKPDVCRSCLNDSRVLLTKLCPNQKEAIGWYD-----NCMLRYSNRSIFGVMEGSPKFYM 146

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYAT--GKEAVSDIVTMYALVQCTP 118
           +   N++E + +FNQ    L+ +L  +AA+  S  K+AT    +   +  T+Y LVQCTP
Sbjct: 147 WNIYNVTE-VDQFNQVLGNLMRKLKEKAASSDSRRKFATDNATDVNLNFQTIYGLVQCTP 205

Query: 119 DLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVT 178
           DLSE DC  CL      +  CC+ + GGRV+ PSC+ RYET+ F+ P+ A  PG   P +
Sbjct: 206 DLSEQDCNNCLDGAISDIPSCCNNKIGGRVLKPSCNIRYETSSFYDPTPAIDPGETSP-S 264

Query: 179 PEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLE------DENVEETIAKSL 232
            E   +  + TI I V   VV    L+  ICI LR  K ++       D+N +  +A+SL
Sbjct: 265 EEEKSKSSHTTIAIVVPTVVVVVAALLIFICICLRKRKARINLEEIEEDDNDDIDMAESL 324

Query: 233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVL 292
           QF+FET++VAT NFS+ANKLG GGFG VY G+L+ G+ IAVKRLS NS QG++EFKNEVL
Sbjct: 325 QFNFETLQVATSNFSEANKLGHGGFGVVYHGILAGGQVIAVKRLSTNSGQGDVEFKNEVL 384

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           L+A+LQHRNLVRLLGFCLE +ER+LVYE+VPN SLD+FIFDPI +  + WE+RYKII GI
Sbjct: 385 LVAKLQHRNLVRLLGFCLEGRERLLVYEYVPNKSLDYFIFDPIKKAQLDWERRYKIIGGI 444

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           ARGLLYLHEDS+LRIIHRDLKASNILLD ++NPKISDFGMARL  +D+T  +TN++VGT
Sbjct: 445 ARGLLYLHEDSQLRIIHRDLKASNILLDEKLNPKISDFGMARLLLVDETQVNTNKIVGT 503

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114251|ref|XP_002316708.1| predicted protein [Populus trichocarpa] gi|222859773|gb|EEE97320.1| predicted protein [Populus trichocarpa]

 Score =  448 bits (1153), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 241/416 (57%), Positives = 293/416 (70%), Gaps = 10/416 (2%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           + P  CR CI  A   L  LCPN V AIGG D     NCM+RY N  IF  ME  PYF+V
Sbjct: 90  ISPDVCRVCIRNASDFLVRLCPNFVEAIGGLD-----NCMVRYTNRSIFNRMEKGPYFWV 144

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAV-SDIVTMYALVQCTPD 119
           Y +     +++ FNQ+R  LL RL  +AAA  S  KYA  +  V  +   +YALVQCTPD
Sbjct: 145 YDDRVNVSDVVGFNQSRMTLLGRLSDQAAAGDSRYKYAMDQIDVPKNFQKIYALVQCTPD 204

Query: 120 LSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTP 179
           LS ++C++CL++ + L+ +CCD RQGGRVI PSC+FRYE ++F+ P     P  PD  + 
Sbjct: 205 LSASECRDCLYNASGLIPQCCDARQGGRVIYPSCNFRYEIDRFYDPPTNSIPPPPDSTSN 264

Query: 180 EPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDEN---VEETIAKSLQFDF 236
               +K+N  I I VIV +  SVILI  +CIFLR  K K E+E     E    +  Q DF
Sbjct: 265 NTKGKKRNVII-IIVIVPIAVSVILIVCVCIFLRARKQKEEEEVKDLYEMEDVELFQLDF 323

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
            T+R AT NFS+ NKLGQGGFG VYKG L+NG+ IAVKRLS+ S QGE+EFKNEV+L+A+
Sbjct: 324 GTVREATGNFSEDNKLGQGGFGTVYKGTLANGQDIAVKRLSRTSGQGELEFKNEVMLVAK 383

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQHRNLVRLLGFC E++ERILVYEF+PN+SL++ IFDP+ R  + WE  YKIIEGIARGL
Sbjct: 384 LQHRNLVRLLGFCFEKEERILVYEFLPNSSLNNLIFDPVKRVLLDWETLYKIIEGIARGL 443

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           LYLHEDSRLRIIHRDLKA+NILLD  MNPKISDFGMAR+F MDQ    T+RVVGT 
Sbjct: 444 LYLHEDSRLRIIHRDLKAANILLDENMNPKISDFGMARMFVMDQAQDSTSRVVGTF 499

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113941|ref|XP_002316621.1| predicted protein [Populus trichocarpa] gi|222859686|gb|EEE97233.1| predicted protein [Populus trichocarpa]

 Score =  446 bits (1148), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 233/422 (55%), Positives = 295/422 (69%), Gaps = 24/422 (5%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           CR C+N +   +  +CPNK+ A G Y+      CM+RY+N  IFG++   PY +     N
Sbjct: 58  CRSCVNDSTHKILEVCPNKMEAFGVYEL-----CMIRYSNRSIFGVVNEEPYIYRANRKN 112

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADC 125
           + +  + FNQ  Q L  RL ++AA+  S  K+ATG ++ + + T+YA+VQCTPDLSE  C
Sbjct: 113 VLDVTL-FNQALQTLFARLQAKAASGNSLKKFATGNQS-AGVETVYAIVQCTPDLSEGQC 170

Query: 126 KECLHDTTKLMSKCCDR----RQGGRVINPSCSFRYETNKFFKPSI------AGPPGSPD 175
             CL D  +++  CCD     + G R+I PSC+ R+E  KFF  ++        P  S  
Sbjct: 171 SSCLLDVFRMIPNCCDGNVQGKIGVRLIKPSCNLRWEIGKFFNGTLEILPSPPPPQISSP 230

Query: 176 PVTPEPPPRKKNHT--ILITVIVSVVASVILITGICIFLRVGKLKLEDENVEET----IA 229
              P P   KK++T  I++  +V  V  +IL+  IC+F+R  K + E E VE       A
Sbjct: 231 TSLPAPAQGKKSNTARIIVITVVPAVGVMILVICICLFIRTRKQR-EKERVETVDEIESA 289

Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKN 289
           +SLQF F TIR AT++FS+ NKLGQGGFGAVYKG L +G+ IAVKRLSK+S QG++EFKN
Sbjct: 290 ESLQFAFSTIRDATEDFSEKNKLGQGGFGAVYKGALPSGQEIAVKRLSKDSGQGDLEFKN 349

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           EVLL+ARLQHRNLVRLLGFCL+  ER+L+YEFVPNASLDHFIFDPI R H+ WE+RYKII
Sbjct: 350 EVLLVARLQHRNLVRLLGFCLQGIERLLIYEFVPNASLDHFIFDPIKRVHLNWERRYKII 409

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
            GIARGLLYLHEDSRLRIIHRDLKASNILLD EMNPKISDFGMARLF +DQT  +T+R+V
Sbjct: 410 GGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMNPKISDFGMARLFVVDQTQGNTSRIV 469

Query: 410 GT 411
           GT
Sbjct: 470 GT 471

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496752|ref|XP_003635322.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  443 bits (1139), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 235/431 (54%), Positives = 298/431 (69%), Gaps = 28/431 (6%)

Query: 3   PSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYA 62
           P++CR CIN +R  LT LCPN+  AIG YD      CMLRY+N  IFG  + +P F ++ 
Sbjct: 161 PTACRSCINDSRIQLTRLCPNQKEAIGWYD-----GCMLRYSNDSIFGKAQTSPSFTMWN 215

Query: 63  ESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSE 122
             N+S N+ +FNQ    L+  L S+AA+     K+AT +  V+   ++Y L+QCTPDLSE
Sbjct: 216 LQNVS-NVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTSFQSIYGLMQCTPDLSE 274

Query: 123 ADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPG---------- 172
             C  CL      +  CC+RR+ GRV+ PSC+ RY T +F+  + A  P           
Sbjct: 275 LSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYGTYRFYYFTAANAPPPTATPQPSPP 334

Query: 173 ----SPDPV----TPEPPPRKKNHTILITVIVSVVASVILITG-ICIFLR--VGKLKLED 221
               SP P+    + +      + TI++ ++ SV+  +I++ G IC F R      KLE 
Sbjct: 335 SADLSPQPLANTTSTQETRSNSSRTIILIIVPSVIILIIILVGFICFFSRKRSSMEKLET 394

Query: 222 ENVEETI-AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
            + ++ I  +SL FDF+TIRVAT+NFSD+NKLGQGGFG VYKG LSNG+ IAVKRLS  S
Sbjct: 395 NDEDDIINVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYKGKLSNGQDIAVKRLSSGS 454

Query: 281 KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM 340
            QGE+EFKNEV+L+A+LQHRNLVRLLGFCL+  ER+L+YEFVPN SLDHFIFDPI R  +
Sbjct: 455 GQGELEFKNEVVLVAKLQHRNLVRLLGFCLDGAERLLIYEFVPNTSLDHFIFDPIRRAQL 514

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            WE+RYKII GIARGLLYLHEDSRLRIIHRDLKASNILLD+EMNPKISDFGMARLF +DQ
Sbjct: 515 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARLFLVDQ 574

Query: 401 THSDTNRVVGT 411
           T  +T+R+VGT
Sbjct: 575 TQGNTSRIVGT 585

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574368|ref|XP_003555320.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like [Glycine max]

 Score =  442 bits (1137), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 218/410 (53%), Positives = 284/410 (69%), Gaps = 14/410 (3%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C  C++ AR N T LCPN+  AI  +D      CMLRY+N  IFG+MEN P+       N
Sbjct: 90  CLACLDDARANFTQLCPNQKEAIN-WD----GECMLRYSNRSIFGIMENEPFVETVLTMN 144

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADC 125
           ++  + +FN+  Q L+  L S AA+  S  KY T      +  T+Y   QCTPDLS  DC
Sbjct: 145 VTGPVDQFNEALQSLMRNLTSTAASGDSRRKYGTASTHAPNFQTIYGYAQCTPDLSLEDC 204

Query: 126 KECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPRK 185
             CL +    + +CC  + GG V+ PSC  R++   FF P+I  P  SP+        + 
Sbjct: 205 TNCLGEAIAEIPRCCSGKAGGNVLKPSCRIRFDPYNFFGPTIPLPSPSPNS-----QGKS 259

Query: 186 KNHTILITVIVSVVASVILITGICIFLRVGK--LKLEDENVEE--TIAKSLQFDFETIRV 241
           K    +I ++V   + V++++  CI+LR  K   K+E ++ E+  T A+SLQF+F+TIR 
Sbjct: 260 KTSRTIIAIVVPAASVVLVVSLFCIYLRARKPRKKIEKDSHEDEITFAESLQFNFDTIRA 319

Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
           AT+ F+D+NKLGQGGFGAVY+G LSNG+ IAVKRLS++S QG +EFKNEVLL+A+LQHRN
Sbjct: 320 ATNEFADSNKLGQGGFGAVYRGQLSNGQEIAVKRLSRDSGQGNMEFKNEVLLVAKLQHRN 379

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           LV+LLGFCLE +ER+L+YEFVPN SLD+FIFDPI +  + W++RY II GIARG+LYLHE
Sbjct: 380 LVKLLGFCLEGRERLLIYEFVPNKSLDYFIFDPIKKAQLDWQRRYNIIGGIARGILYLHE 439

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           DSRLRIIHRDLKASNILLD EMNPKISDFGMARL  MD+T  +T+R+VGT
Sbjct: 440 DSRLRIIHRDLKASNILLDEEMNPKISDFGMARLVHMDETQGNTSRIVGT 489

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	412
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.968	0.591	0.498	1.5e-99
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.609	0.376	0.531	1.6e-92
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.480	0.291	0.638	1.1e-91
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.961	0.591	0.455	3.1e-90
TAIR|locus:2123126	666	CRK31 "cysteine-rich RLK (RECE	0.980	0.606	0.460	1.8e-87
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.975	0.610	0.450	3.7e-87
TAIR|locus:2127323	642	CRK27 "cysteine-rich RLK (RECE	0.968	0.621	0.464	1.4e-85
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.468	0.285	0.673	5e-85
TAIR|locus:2137144	646	CRK37 "cysteine-rich RLK (RECE	0.992	0.633	0.454	1.2e-83
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.970	0.591	0.434	1.5e-83

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
 Identities = 211/423 (49%), Positives = 270/423 (63%)

Query:     6 CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
             CRDC+  A       CP +  A+  YD+     CM+RY+N  I G M   P  F+  + N
Sbjct:    97 CRDCVAFAANETLQRCPREKVAVIWYDE-----CMVRYSNQSIVGQMRIRPGVFLTNKQN 151

Query:    66 ISENLIE-FNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEAD 124
             I+EN +  FN++   LL  +  +AA   S  K+AT K   +   T+Y+LVQCTPDL+  D
Sbjct:   152 ITENQVSRFNESLPALLIDVAVKAAL--SSRKFATEKANFTVFQTIYSLVQCTPDLTNQD 209

Query:   125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDP---VTPEP 181
             C+ CL      + +CCDR  GGRVI PSCSFRYE   F+  +IA  P +P P   VT  P
Sbjct:   210 CESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTAPP 269

Query:   182 ---PPRK---KNHXXXXXXXXXXXXXXXXXXG-ICIFL---RVGKLKLEDENVEE---TI 228
                P  K   KN                   G +C  L   R  KL  E E+++E   T 
Sbjct:   270 LNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDLDEDGITS 329

Query:   229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK 288
              ++LQF F  I  AT+ FS++NKLG GGFG VYKG L  GET+A+KRLS+ S QG  EFK
Sbjct:   330 TETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFK 389

Query:   289 NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
             NEV ++A+LQHRNL +LLG+CL+ +E+ILVYEFVPN SLD+F+FD   R  + W++RYKI
Sbjct:   390 NEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKI 449

Query:   349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
             IEGIARG+LYLH DSRL IIHRDLKASNILLD++M+PKISDFGMAR+F +DQT ++T R+
Sbjct:   450 IEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRI 509

Query:   409 VGT 411
             VGT
Sbjct:   510 VGT 512

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 1.6e-92, Sum P(2) = 1.6e-92
 Identities = 143/269 (53%), Positives = 181/269 (67%)

Query:   159 TNKFFKPSIAGPPGSPDPVT-PEPPPRK----KNHXXXXXXXXXXXXXXXXXXGICIFLR 213
             +N F   ++A PP  P PVT P+P   +     N                    I I L 
Sbjct:   249 SNAFDNLTVASPPPEP-PVTVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVIAILILLV 307

Query:   214 VG-----------KLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYK 262
             +G           + K E E+   T   SL +DF+TI  AT+ FS +NKLG+GGFGAVYK
Sbjct:   308 LGFVLFRRRKSYQRTKTESESDIST-TDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYK 366

Query:   263 GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV 322
             G LSNG  +AVKRLSK S QG  EF+NE +L+ +LQHRNLVRLLGFCLER+E+IL+YEFV
Sbjct:   367 GKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFV 426

Query:   323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE 382
              N SLD+F+FDP  +  + W +RYKII GIARG+LYLH+DSRL+IIHRDLKASNILLD++
Sbjct:   427 HNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDAD 486

Query:   383 MNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             MNPKI+DFG+A +F ++QT  +TNR+ GT
Sbjct:   487 MNPKIADFGLATIFGVEQTQGNTNRIAGT 515

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 653 (234.9 bits), Expect = 1.1e-91, Sum P(2) = 1.1e-91
 Identities = 129/202 (63%), Positives = 158/202 (78%)

Query:   214 VGKLKLEDENVEETIA--KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI 271
             +GK  L     E+  +  +SL   FET++ ATDNFS  N+LG+GGFG+VYKG+   G+ I
Sbjct:   323 LGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEI 382

Query:   272 AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
             AVKRLS NS QG+ EFKNE+LLLA+LQHRNLVRL+GFC++ +ER+LVYEF+ NASLD FI
Sbjct:   383 AVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFI 442

Query:   332 FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
             FD   R+ + W  RYK+I GIARGLLYLHEDSR RIIHRDLKASNILLD EMNPKI+DFG
Sbjct:   443 FDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFG 502

Query:   392 MARLFEMDQT--HSDTNRVVGT 411
             +A+LF+  QT  H  T+R+ GT
Sbjct:   503 LAKLFDSGQTMTHRFTSRIAGT 524

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
 Identities = 191/419 (45%), Positives = 258/419 (61%)

Query:     6 CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
             CR C++ A  +  + CPN+  A   YD+     C+LRY+N +I   +       +    N
Sbjct:   105 CRRCVSFAVNDTLTRCPNQKEATLYYDE-----CVLRYSNQNILSTLITTGGVILVNTRN 159

Query:    66 ISENLIEFNQTRQRLLERLFSEAA-ARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEAD 124
             ++ N ++       +L  L   A  A  S  K+ T K   + + + Y LVQCTPDL+  D
Sbjct:   160 VTSNQLDL--LSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQD 217

Query:   125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEP--- 181
             C  CL     ++++    R G R+INPSC+ RYE   F+  S   PP  P  ++  P   
Sbjct:   218 CSRCLQ---LVINQIPTDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVSA 274

Query:   182 PPR--KKNHXXXXXXXXXX---XXXXXXXXGICIFLRVGKLKLEDENV----EETIAKSL 232
             PPR  K  +                     G C   R  +      +     + T A SL
Sbjct:   275 PPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSYYTPSAFAGDDITTADSL 334

Query:   233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVL 292
             Q D+ TI+ ATD+F ++NK+GQGGFG VYKG LS+G  +AVKRLSK+S QGE+EFKNEV+
Sbjct:   335 QLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVV 394

Query:   293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
             L+A+LQHRNLVRLLGFCL+ +ER+LVYE+VPN SLD+F+FDP  +  + W +RYKII G+
Sbjct:   395 LVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGV 454

Query:   353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             ARG+LYLH+DSRL IIHRDLKASNILLD++MNPKI+DFGMAR+F +DQT  +T+R+VGT
Sbjct:   455 ARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)]

 Score = 874 (312.7 bits), Expect = 1.8e-87, P = 1.8e-87
 Identities = 197/428 (46%), Positives = 248/428 (57%)

Query:     2 EPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNN-CMLRYANYDIFGLMENAPYFFV 60
             +P  C DCI +A + L   CPN+  +     D      C +RY+N   F  M   P   V
Sbjct:    83 DPRVCSDCIQLASQGLLQTCPNQTDSFYWTGDNADKTLCFVRYSNNSFFNKMALEPTHAV 142

Query:    61 YAESNISENLIEFNQTRQRLLERLFSEAA-----ARPSPNKYATGKEAVS-DIVTMYALV 114
             Y       NL  + +T    +  +F+        A  SP      +E +S D++  YAL+
Sbjct:   143 YNTMRFQGNLTAYTRTWDAFMNFMFTRVGQTRYLADISPR---INQEPLSPDLI--YALM 197

Query:   115 QCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKF---FKPSIAGPP 171
             QC P +S  DC+ CL         CC+   GG V  P C FR++  K+   F       P
Sbjct:   198 QCIPGISSEDCETCLGKCVDDYQSCCNGFIGGVVNKPVCYFRWDGYKYYGAFGDEAPSQP 257

Query:   172 GSPDPVTPEPPPR----KK--NHXXXXXXXXXXXXXXXXXXGICIFLRVGKLKLEDENVE 225
              +P P+ P PPPR    KK                      G+ I+ R    K    + +
Sbjct:   258 PTPLPLPP-PPPRDPDGKKISTGVIVAIVVSAVIFVVLVALGLVIWKRRQSYKTLKYHTD 316

Query:   226 E--TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
             +  T  +SLQFDF TI VATDNFS  NKLGQGGFG VYKGML N   IAVKRLS NS QG
Sbjct:   317 DDMTSPQSLQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQG 376

Query:   284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
               EFKNEV+++A+LQH+NLVRLLGFC+ER E+ILVYEFV N SLD+F+FDP  +  + W+
Sbjct:   377 TQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWK 436

Query:   344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
             +RY II G+ RGLLYLH+DSRL IIHRD+KASNILLD++MNPKI+DFGMAR F +DQT  
Sbjct:   437 RRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTED 496

Query:   404 DTNRVVGT 411
              T RVVGT
Sbjct:   497 QTGRVVGT 504

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 871 (311.7 bits), Expect = 3.7e-87, P = 3.7e-87
 Identities = 190/422 (45%), Positives = 258/422 (61%)

Query:     1 MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGL-MENAPYFF 59
             + P  CR+C+  A  N  S CPN+  A+  Y++     C+LRY++ +I    + N   F 
Sbjct:    89 VSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEE-----CILRYSHKNILSTAITNEGEFI 143

Query:    60 VYAESNISENLIEFNQTRQRLLERLFSEAA-ARPSPNKYATGKEAVSDIVTMYALVQCTP 118
             +   ++IS    + NQ    +L  +   A  A  +P K++T K  ++ + T Y LVQCTP
Sbjct:   144 LRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGLVQCTP 203

Query:   119 DLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVT 178
             DLS  +C  CL   T  +++    R G R   PSC+ RYE   F+  +  G P  P P  
Sbjct:   204 DLSRQNCMNCL---TSSINRMPFSRIGARQFWPSCNSRYELYDFYNETAIGTPPPPLPPL 260

Query:   179 PEPPPRKK----NHXXXXXXXXXXXXXXXXXXGICIFLR-----VGKLKLEDENVEETIA 229
               P    K    N                   G C F +      G     DE+ + TI 
Sbjct:   261 ASPSLSDKSGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPALDEDDKTTI- 319

Query:   230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKN 289
             +SLQ D+  I+ AT++FS+ NK+G+GGFG VYKG  SNG  +AVKRLSK S+QG+ EFKN
Sbjct:   320 ESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKN 379

Query:   290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             EV+++A L+H+NLVR+LGF +ER+ERILVYE+V N SLD+F+FDP  +  + W +RY II
Sbjct:   380 EVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHII 439

Query:   350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
              GIARG+LYLH+DSRL IIHRDLKASNILLD++MNPKI+DFGMAR+F MDQT  +T+R+V
Sbjct:   440 GGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIV 499

Query:   410 GT 411
             GT
Sbjct:   500 GT 501

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)]

 Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
 Identities = 197/424 (46%), Positives = 246/424 (58%)

Query:     1 MEPSS-CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFF 59
             ++P+  C  CI  A K L   CPN + A     +     CM RY +  I G ME  P  F
Sbjct:    87 VKPNQDCISCITTAAKQLVESCPNIIEA-----NIWLEKCMFRYTSRIILGQMEPVP--F 139

Query:    60 VYAESNISENLIE-FNQTRQRLLERLFS--EAAARPSPNKYATGKEAVSDIVTMYALVQC 116
              Y  SN+S    E F++    LL+ L +  +AA      K+A G +      T+YAL QC
Sbjct:   140 SYTSSNVSVTDKEGFSKGLGDLLDSLGAKIDAANETKEVKFAAGVKG-----TIYALAQC 194

Query:   117 TPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAG----PPG 172
             TPDLSE+DC+ CL      +  CCD + GG   NPSC FR+E   FF  S+      P  
Sbjct:   195 TPDLSESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQKQPLS 254

Query:   173 SPDPVTPEPPPRKKNHXXXXXXXXXXXXXXXXXXGICIFL---RVGKLKLEDENVEETIA 229
             S +  T      K                      + +F+   R  K K   EN E    
Sbjct:   255 SHNNNTRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKKTLKENAENEFE 314

Query:   230 K--SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEF 287
                SL FDFETIRVATD+FS  NK+G+GGFG VYKG L +G  IAVKRLS +S QG  EF
Sbjct:   315 STDSLHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEF 374

Query:   288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
             K EVLL+ +LQH+NLV+L GF ++  ER+LVYEF+PN SLD F+FDPI ++ + WEKRY 
Sbjct:   375 KTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYN 434

Query:   348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
             II G++RGLLYLHE S   IIHRDLK+SN+LLD +M PKISDFGMAR F+ D T + T R
Sbjct:   435 IIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRR 494

Query:   408 VVGT 411
             VVGT
Sbjct:   495 VVGT 498

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 670 (240.9 bits), Expect = 5.0e-85, Sum P(2) = 5.0e-85
 Identities = 130/193 (67%), Positives = 155/193 (80%)

Query:   219 LEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSK 278
             L +E+ + T A SLQFDF+ I  AT+ F + NKLGQGGFG VYKG+  +G  +AVKRLSK
Sbjct:   324 LTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSK 383

Query:   279 NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE 338
              S QGE EF NEV+++A+LQHRNLVRLLGFCLER ERILVYEFVPN SLD+FIFD   + 
Sbjct:   384 TSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQS 443

Query:   339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
              + W +RYKII GIARG+LYLH+DSRL IIHRDLKA NILL  +MN KI+DFGMAR+F M
Sbjct:   444 LLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGM 503

Query:   399 DQTHSDTNRVVGT 411
             DQT ++T R+VGT
Sbjct:   504 DQTEANTRRIVGT 516

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2137144 CRK37 "cysteine-rich RLK (RECEPTOR-like protein kinase) 37" [Arabidopsis thaliana (taxid:3702)]

 Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
 Identities = 194/427 (45%), Positives = 251/427 (58%)

Query:     2 EPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYN-NCMLRYANYDIFGLMENAPYFFV 60
             E  +C+ C+    ++  S CP +  +     D   + +C LRY N+   G +E  P    
Sbjct:    85 EKQACKTCLEHVIEDTKSKCPRQKESFSWVTDEFDDVSCSLRYTNHSTLGKLELLPNTIN 144

Query:    61 YAESNISE---NLIEFNQTRQRLLERLFSEA--AARPSPNKY--ATGKEAVSDIVTMYAL 113
                ++I     N+  F+Q    ++ R    A  A   S  KY  AT  E  + I  +YAL
Sbjct:   145 PNPNSIDSKFNNMAMFSQEWIAMVNRTLEAASTAENSSVLKYYSATRTE-FTQISDVYAL 203

Query:   114 VQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKP--SI---- 167
             +QC PDLS  +CK CL +      K    RQGG V  PSC FR++   +++   ++    
Sbjct:   204 MQCVPDLSPGNCKRCLRECVNDFQKQFWGRQGGGVSRPSCYFRWDLYPYYRAFDNVVRVP 263

Query:   168 AGPPGSPDPVTPEPPPRKKNHXXXXXXXXXXXXXXXXXXGICIFL--RVGKLKLEDENVE 225
             A PP +   +       K                      + IF   R     + ++  +
Sbjct:   264 APPPQASSTIIDYGRDEKSFQGSNIAIIVVPSVINLIIFVVLIFSWKRKQSHTIINDVFD 323

Query:   226 ETIAKS-LQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGE 284
                 +S L+FD   I  AT+NFS  NKLGQGGFG+VYKG+L +G+ IAVKRL K S QG 
Sbjct:   324 SNNGQSMLRFDLRMIVTATNNFSLENKLGQGGFGSVYKGILPSGQEIAVKRLRKGSGQGG 383

Query:   285 IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK 344
             +EFKNEVLLL RLQHRNLV+LLGFC E+ E ILVYEFVPN+SLDHFIFD   R  +TW+ 
Sbjct:   384 MEFKNEVLLLTRLQHRNLVKLLGFCNEKDEEILVYEFVPNSSLDHFIFDEEKRRVLTWDV 443

Query:   345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
             RY IIEG+ARGLLYLHEDS+LRIIHRDLKASNILLD+EMNPK++DFGMARLF+MD+T   
Sbjct:   444 RYTIIEGVARGLLYLHEDSQLRIIHRDLKASNILLDAEMNPKVADFGMARLFDMDETRGQ 503

Query:   405 TNRVVGT 411
             T+RVVGT
Sbjct:   504 TSRVVGT 510

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
 Identities = 187/430 (43%), Positives = 259/430 (60%)

Query:     1 MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
             + P  C +C+  +     + CPN+  A+  Y++     C+LRY++ +    +       +
Sbjct:   100 LSPEVCSNCVAFSVNESLTRCPNQREAVFYYEE-----CILRYSHKNFLSTVTYEGELIM 154

Query:    61 YAESNISENLIEFNQTRQ--RLLERLFSEAA--ARPSPNKYATGKEAVSDIVTMYALVQC 116
                +NIS   I+ NQ  Q   L++   ++AA  A  S  K++T K  ++ + T+Y LVQC
Sbjct:   155 RNPNNISS--IQ-NQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQC 211

Query:   117 TPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDP 176
             TPDL+  DC  CL  +   M      R G R   PSC+ RYE   F+  +  G P SP P
Sbjct:   212 TPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTP-SPPP 268

Query:   177 VTP--EPP------PRKKNHXXXXXXXXXXXXXXXXXX--GICIFLRVGKLKLEDENVEE 226
             + P   PP      P K  +                    G C   +  K   +  +  E
Sbjct:   269 LFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASASE 328

Query:   227 T-----IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK 281
                    A SLQ D+ TI+ AT++F+++NK+G+GGFG VYKG  SNG+ +AVKRLSKNS+
Sbjct:   329 VGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSR 388

Query:   282 QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMT 341
             QGE EFK EV+++A+LQHRNLVRLLGF L+ +ERILVYE++PN SLD  +FDP  +  + 
Sbjct:   389 QGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLD 448

Query:   342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
             W +RY II GIARG+LYLH+DSRL IIHRDLKASNILLD+++NPKI+DFGMAR+F +DQT
Sbjct:   449 WMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQT 508

Query:   402 HSDTNRVVGT 411
               +T+R+VGT
Sbjct:   509 QDNTSRIVGT 518

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_LG_IV000044 hypothetical protein (652 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	412
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-41
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-23
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	2e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-23
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-19
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-11
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-06
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	4e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-04
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	8e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
pfam01163	186	pfam01163, RIO1, RIO1 family	0.002
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.002
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.002
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.002
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  148 bits (376), Expect = 4e-42
 Identities = 54/150 (36%), Positives = 79/150 (52%), Gaps = 11/150 (7%)

Query: 251 KLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
           KLG+G FG VYKG L          +AVK L +++ + +I EF  E  ++ +L H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           LLG C E +   +V E++    L  ++    NR  ++          IARG+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IHRDL A N L+   +  KISDFG++R
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  146 bits (370), Expect = 3e-41
 Identities = 59/165 (35%), Positives = 81/165 (49%), Gaps = 11/165 (6%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           KLG G FG VYK      G+ +AVK L K     + +   + E+ +L RL H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
              ++    LV E+     L  ++        ++ ++  KI   I RGL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           IHRDLK  NILLD     KI+DFG+A+      +   T   VGT 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTP 162

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  143 bits (363), Expect = 3e-40
 Identities = 54/150 (36%), Positives = 81/150 (54%), Gaps = 10/150 (6%)

Query: 251 KLGQGGFGAVYKGMLSNG-----ETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
           KLG+G FG VYKG L          +AVK L +++ + +I EF  E  ++ +L H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           LLG C E +  ++V E++P   L  ++     +E ++          IARG+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE---S 121

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IHRDL A N L+   +  KISDFG++R
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  140 bits (354), Expect = 2e-39
 Identities = 56/164 (34%), Positives = 83/164 (50%), Gaps = 10/164 (6%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLGFC 309
           LG+GGFG VY       G+ +A+K + K      +E    E+ +L +L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +     LV E+    SL   + +  N   ++ ++  +I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 370 RDLKASNILLDS-EMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           RDLK  NILLDS     K++DFG+++L       S    +VGT 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTP 157

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  140 bits (356), Expect = 4e-39
 Identities = 56/163 (34%), Positives = 85/163 (52%), Gaps = 12/163 (7%)

Query: 251 KLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
           KLG+G FG VYKG L          +AVK L + + + E  EF  E  ++ +L H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           LLG C + +   +V E++P   L  F+    + E +T +   ++   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTN 406
              +HRDL A N L+   +  KISDFG++R ++E D       
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  137 bits (347), Expect = 6e-38
 Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 13/170 (7%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLV 303
           +    KLG+G FG VY       G+ +A+K + K   + + E    E+ +L +L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIEGIARGLLYLHED 362
           RL     +  +  LV E+     L   +     R  ++ E   +  +  I   L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLS-EDEARFYLRQILSALEYLHS- 115

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
               I+HRDLK  NILLD + + K++DFG+AR  +  +  +     VGT 
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTP 160

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  135 bits (343), Expect = 3e-37
 Identities = 54/172 (31%), Positives = 87/172 (50%), Gaps = 15/172 (8%)

Query: 250 NKLGQGGFGAVYKGMLSNGETI----AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
            KLG+G FG VYKG L   +      AVK L ++ S++   +F  E  ++ +L H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLY 358
           LLG C E +   LV E++    L  ++      F    +  ++ +        IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVV 409
           L      + +HRDL A N L+  ++  KISDFG++R +++ D     T   +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 2e-32
 Identities = 57/172 (33%), Positives = 90/172 (52%), Gaps = 15/172 (8%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRN 301
           N+   + +G+G FG VYKG+ L  G+ +A+K++S    + E       E+ LL  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYL 359
           +V+ +G         ++ E+  N SL   I  F P   E +     Y  +  + +GL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLV--AVY--VYQVLQGLAYL 115

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           HE     +IHRD+KA+NIL   +   K++DFG+A   +++    D   VVGT
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  118 bits (299), Expect = 6e-31
 Identities = 58/171 (33%), Positives = 94/171 (54%), Gaps = 19/171 (11%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
             LG+G FG+VY  +    GE +AVK   LS +S++     + E+ +L+ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 307 GFCLERKER-ILVY-EFVPNASLDHFI--FDPINREHMTWEKRY--KIIEGIARGLLYLH 360
           G   + ++  + ++ E+V   SL   +  F  +  E +   ++Y  +I+EG+A    YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVI--RKYTRQILEGLA----YLH 118

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
                 I+HRD+K +NIL+DS+   K++DFG A+     +T   T  V GT
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (276), Expect = 1e-27
 Identities = 52/158 (32%), Positives = 84/158 (53%), Gaps = 13/158 (8%)

Query: 250 NKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLV 303
            +LG+G FG V            GE +AVK L+ + ++    +F+ E+ +L  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 304 RLLGFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +  G C +   R   L+ E++P+ SL  ++    +R+ +  ++       I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
               R IHRDL A NIL++SE   KISDFG+A++   D
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 53/173 (30%), Positives = 92/173 (53%), Gaps = 22/173 (12%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQHRNLVRLL 306
            ++G+G +G VYK      GE +A+K++  +N K+G  I    E+ LL +L+H N+VRL 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 307 GFCLERKER--ILVYEFVPN--ASLDH---FIFDPINREHMTWEKRYKIIEGIARGLLYL 359
                + +    +V+E++ +    L       F     +        +++EG+     YL
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM----KQLLEGLQ----YL 116

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H +    I+HRD+K SNIL++++   K++DFG+AR +    +   TNRV+ TL
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 5e-25
 Identities = 53/150 (35%), Positives = 76/150 (50%), Gaps = 12/150 (8%)

Query: 250 NKLGQGGFGAVYKG---MLSNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG G FG+V KG   M S  E  +AVK L +     G+ EF  E  ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L+G C   +  +LV E  P   L  ++     R  +      ++   +A G+ YL     
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK-- 114

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +HRDL A N+LL +    KISDFGM+R
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 1e-24
 Identities = 52/161 (32%), Positives = 89/161 (55%), Gaps = 20/161 (12%)

Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ +  GE +    A+K L + +      E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDP---INREHM-TWEKRYKIIEGIARGLLYLHE 361
           LG CL   +  L+ + +P   L  ++ +    I  +++  W  +      IA+G+ YL E
Sbjct: 75  LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
               R++HRDL A N+L+ +  + KI+DFG+A+L ++D+  
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 3e-24
 Identities = 50/151 (33%), Positives = 86/151 (56%), Gaps = 10/151 (6%)

Query: 252 LGQGGFGAVYKGMLS-NGE---TIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V +G L   G+    +A+K L + +S +  ++F  E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + +  +++ E++ N SLD F+ +  N    T  +   ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            +HRDL A NIL++S +  K+SDFG++R  E
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =   99 bits (250), Expect = 4e-24
 Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 13/169 (7%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           F    K+G+GGFG VYK      G+ +A+K +   SK+ + +  NE+ +L + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY--KIIEGIARGLLYLHED 362
             G  L++ E  +V EF    SL     D +   + T  +     + + + +GL YLH  
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLK----DLLKSTNQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
               IIHRD+KA+NILL S+   K+ DFG++            N +VGT
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGT 160

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 5/162 (3%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           F+   KLG G FG V++G+  N   +A+K L  +    + +F+ EV  L RL+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
              C   +   ++ E +   SL  F+  P  +  +       +   +A G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMD-QTHSDTN 406
             IHRDL A NIL+  ++  K++DFG+ARL + D    SD  
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 93.3 bits (232), Expect = 2e-23
 Identities = 34/101 (33%), Positives = 45/101 (44%), Gaps = 2/101 (1%)

Query: 62  AESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLS 121
              N +     F      LL  L S AA+       A    A  D  T+Y L QC  DLS
Sbjct: 8   TSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPD--TVYGLAQCRGDLS 65

Query: 122 EADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKF 162
            +DC+ CL      + +CC  ++GGR+   SC  RYE+  F
Sbjct: 66  ASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 97.9 bits (245), Expect = 4e-23
 Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 31/175 (17%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQHRNLVRLL 306
           KLG+G +G VYK      GE +A+K++ +   + E        E+ LL  L+H N+V+LL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG---------IARGLL 357
                 ++  LV+E+     L  ++           +KR   +           + RGL 
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYL-----------DKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           Y H  S  RI+HRDLK  NIL++ +   K++DFG+AR F +    + T+ VV TL
Sbjct: 113 YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV-TL 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 58/161 (36%), Positives = 98/161 (60%), Gaps = 12/161 (7%)

Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ +  GET+    A+K L++ +  +  +EF +E L++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG CL    + LV + +P+  L  ++ +  +++++  +        IA+G++YL E    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           R++HRDL A N+L+ S  + KI+DFG+ARL E D+   + +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 96.7 bits (239), Expect = 4e-22
 Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 14/171 (8%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQH-RNLVRLL 306
           KLG+G FG VY     + + +A+K L+K   +  +    F  E+ +LA L H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            F  +     LV E+V   SL+  +     +  ++  +   I+  I   L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 367 IIHRDLKASNILLDSEMN-PKISDFGMARLFEMDQTHS----DTNRVVGTL 412
           IIHRD+K  NILLD +    K+ DFG+A+L     + S      +  VGT 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 94.2 bits (235), Expect = 7e-22
 Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 17/174 (9%)

Query: 243 TDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            + + +  K+G+G  G VYK      G+ +A+K++    +  E+   NE+L++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL-IINEILIMKDCKHPN 76

Query: 302 LVRLLGFCLERKERILVYEFVPNASL----DHFIFDPINREHMTWEKRYKIIEGIARGLL 357
           +V      L   E  +V E++   SL           +N   + +     +   + +GL 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAY-----VCREVLQGLE 130

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           YLH      +IHRD+K+ NILL  + + K++DFG A   ++ +  S  N VVGT
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAA--QLTKEKSKRNSVVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 52/152 (34%), Positives = 75/152 (49%), Gaps = 11/152 (7%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLG 307
           KLG G FG V+ G  +    +AVK L    K G +    F  E  ++ +L+H  LV+L  
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
            C E +   +V E++   SL  F+     +  +   +   +   IA G+ YL        
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SRNY 124

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           IHRDL A NIL+   +  KI+DFG+ARL E D
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 53/183 (28%), Positives = 80/183 (43%), Gaps = 35/183 (19%)

Query: 252 LGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+G FG V+ G   + E       +AVK L +  S     +F+ E  LL   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI----------------FDPINREHMTWEKRYKI 348
             G C E    I+V+E++ +  L+ F+                   +    +       I
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ-----I 127

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D   +D  RV
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRV 180

Query: 409 VGT 411
            G 
Sbjct: 181 GGH 183

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 19/171 (11%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEF-KNEVLLLARLQHRNLVRLL 306
            ++G+G FG VY     S+G+   +K +   N  + E E   NEV +L +L H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 307 GFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLYLH 360
               E+ +  +V E+     L   I        P   E             +   L YLH
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF-PEEQIL----DWFVQLCLALKYLH 120

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
                +I+HRD+K  NI L S    K+ DFG++++       + T  VVGT
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 12/156 (7%)

Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           LG+G FG+V    Y  +  N GE +AVK+L  ++ +   +F+ E+ +L  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 307 GFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           G C    R+   LV E++P  SL  ++    +RE +   K       I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            R +HRDL   NIL++SE   KI DFG+ ++   D+
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 2e-21
 Identities = 46/143 (32%), Positives = 75/143 (52%), Gaps = 6/143 (4%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G+ +AVK L  +S   +  F  E  ++  L+H NLV+LLG  L+
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
                +V E++   SL  ++     R  +T  ++      +  G+ YL E      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 372 LKASNILLDSEMNPKISDFGMAR 394
           L A N+L+  ++  K+SDFG+A+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 19/169 (11%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS--NGET----IAVKRLSKN-SKQGEIEFKNEVLL 293
           V  D+ +    LG G FG VY+G+    +G+     +AVK L ++ S+Q E +F  E L+
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VRL+G   ER  R ++ E +    L  F+ +    P     +T +      
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMAR 394
             +A+G  YL E+     IHRD+ A N LL  +  P    KI+DFGMAR
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 51/156 (32%), Positives = 84/156 (53%), Gaps = 26/156 (16%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLS-----KNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG+VY+G+ L +G+  AVK +S     +  ++   + + E+ LL++LQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 306 LGFCLERKERILVY-EFVPNASLDHFI--FDPINREHMTWEKRYKII----EGIARGLLY 358
           LG   E ++ + ++ E VP  SL   +  +               +I      I  GL Y
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSF---------PEPVIRLYTRQILLGLEY 117

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           LH+      +HRD+K +NIL+D+    K++DFGMA+
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 54/166 (32%), Positives = 88/166 (53%), Gaps = 16/166 (9%)

Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQGEIEF-KNEVLLLARLQHRNLVRLLG 307
           LG+G FG V      +   + A+K L K    K+ E+E    E  +L+R+ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRL 365
           +  + +E++ LV E+ P   L    F  +++E    E+R +     I   L YLH    L
Sbjct: 60  YAFQTEEKLYLVLEYAPGGEL----FSHLSKEGRFSEERARFYAAEIVLALEYLH---SL 112

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            II+RDLK  NILLD++ + K++DFG+A+    + + ++T    GT
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 58/168 (34%), Positives = 93/168 (55%), Gaps = 19/168 (11%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQ 298
              ++    KLG+G FG VYK   +  G  +A+K+ L  N K G  I    E+ +L +L+
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 299 HRNLVRLLGFCLER-----KERILVYEFVP--NASLDHFIFDPINREHMTWEKRY--KII 349
           H N+V L+   +ER     ++R  VY   P  +  L   + +P  +   +  K Y  +++
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           EGI     YLHE+    I+HRD+KA+NIL+D++   KI+DFG+AR ++
Sbjct: 126 EGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 14/164 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           KLG+G +G+VYK +    G+ +A+K +       EI    E+ +L +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVKYYGSY 67

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKII-EGIARGLLYLHEDSRLRI 367
            +  +  +V E+    S    + D +   + T  E+    I     +GL YLH     + 
Sbjct: 68  FKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKK 120

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           IHRD+KA NILL+ E   K++DFG++   ++  T +  N V+GT
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGT 162

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 6/155 (3%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           ++G G FG V+ G       +A+K + + +   E +F  E  ++ +L H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           ER    LV+EF+ +  L  ++     R   + E    +   +  G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           DL A N L+      K+SDFGM R    DQ  S T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 23/164 (14%)

Query: 252 LGQGGFGAVYKGML---SNGE---TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+G FG VYKG L   +      ++A+K L +N   + + EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIF--DPINREHMTWEKR-----------YKIIEG 351
           LLG C + +   +++E++ +  L  F+    P +                      I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R 
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.8 bits (220), Expect = 4e-20
 Identities = 57/167 (34%), Positives = 88/167 (52%), Gaps = 21/167 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRL---SKNSKQGEIEFKN---EVLLLARLQHRNLV 303
             LG+G +G VY G+ + G+ IAVK++   + N    E E++    EV LL  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYK-IIEGIARGLLYLH 360
           + LG CL+     +  EFVP  S+   +  F P+      + K  K I++G+A    YLH
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL--PEPVFCKYTKQILDGVA----YLH 119

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSD 404
            +    ++HRD+K +N++L      K+ DFG AR         THS+
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 12/152 (7%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           LG G FG V+ G       +A+K + + +   E +F  E  ++ +L H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---GIARGLLYLHEDSRLRII 368
           ++   +V E++ N  L +++     RE         +++    +   + YL  +     I
Sbjct: 71  QRPIFIVTEYMANGCLLNYL-----RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           HRDL A N L+  +   K+SDFG+AR    DQ
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 5e-20
 Identities = 55/145 (37%), Positives = 81/145 (55%), Gaps = 6/145 (4%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G FG VYKG+L     +AVK   S      + +F  E  +L +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           ++++   +V E VP  SL  F+    NR  +T +K  ++    A G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 370 RDLKASNILLDSEMNPKISDFGMAR 394
           RDL A N L+      KISDFGM+R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 88.5 bits (219), Expect = 6e-20
 Identities = 47/153 (30%), Positives = 87/153 (56%), Gaps = 10/153 (6%)

Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V++G+L         +A+K L    +++   +F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  +++ E++ N +LD ++ D  +    +  +   ++ GIA G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            +HRDL A NIL++S +  K+SDFG++R+ E D
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 47/164 (28%), Positives = 87/164 (53%), Gaps = 13/164 (7%)

Query: 251 KLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRNLVRLLG 307
           ++G+G  G V+K      GET+A+K+++    +G I  +   E+  L   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 308 FCLERKERILVYEFVPN--ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
                   +LV E++P+  + +      P+    +   K Y  +  + +G+ Y+H     
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQV---KSYMRM--LLKGVAYMHA---N 118

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
            I+HRDLK +N+L+ ++   KI+DFG+ARLF  ++    +++V 
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 88.0 bits (218), Expect = 9e-20
 Identities = 56/154 (36%), Positives = 85/154 (55%), Gaps = 14/154 (9%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLG 307
           KLG G FG V+ G  +    +A+K L    KQG +    F  E  L+ +LQH  LVRL  
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRL-- 66

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           + +  +E I ++ E++ N SL  F+  P   + +T  K   +   IA G+ ++    R  
Sbjct: 67  YAVVTQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKN 122

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            IHRDL+A+NIL+   +  KI+DFG+ARL E ++
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 31/185 (16%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVL 292
           D E ++V          LGQG  G VYK      G+  A+K++  +   +   +   E+ 
Sbjct: 2   DLERVKV----------LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK 51

Query: 293 LLARLQHRNLVRLLG-FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
            L   +   +V+  G F   ++  I +V E++   SL   +     ++     +   ++ 
Sbjct: 52  TLRSCESPYVVKCYGAFY--KEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLA 102

Query: 351 GIAR----GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            IAR    GL YLH  ++  IIHRD+K SN+L++S+   KI+DFG++++  ++ T    N
Sbjct: 103 YIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCN 158

Query: 407 RVVGT 411
             VGT
Sbjct: 159 TFVGT 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 11/148 (7%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           NK+G G FG VY  + L  GE +AVK  R+  N  +   E  +E+ +L  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 307 GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G  + R++  +  E+    +L+  +    I  EH+   + Y +   +  GL YLH     
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI--RVYTL--QLLEGLAYLHSH--- 118

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMA 393
            I+HRD+K +NI LD     K+ DFG A
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCA 146

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 58/185 (31%), Positives = 98/185 (52%), Gaps = 25/185 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHR 300
             +    K+GQG FG V+K       + +A+K+ L +N K+G  I    E+ +L  L+H 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 301 NLVRLLGFCLERKER--------ILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIE 350
           N+V L+  C  +            LV+EF      +H +   ++ ++   T  +  K+++
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMK 126

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNR 407
            +  GL Y+H   R +I+HRD+KA+NIL+  +   K++DFG+AR F   +  + +  TNR
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183

Query: 408 VVGTL 412
           VV TL
Sbjct: 184 VV-TL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 56/155 (36%), Positives = 71/155 (45%), Gaps = 22/155 (14%)

Query: 251 KLGQGGFGAVYKG--MLSNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           KLG G FG V +G    S G+ I  AVK L  +     + +F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 306 LGFCLERKERILVYEFVPNASL------DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            G  L     ++V E  P  SL      D      I+         Y +   IA G+ YL
Sbjct: 62  YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLC-----DYAV--QIANGMRYL 113

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                 R IHRDL A NILL S+   KI DFG+ R
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 31/161 (19%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--------SKQGEI--EFKNEVLLLARLQHR 300
           +G+G +G VY  + ++ GE +AVK++           S+Q ++    ++E+  L  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 301 NLVRLLGFCLERKERIL--VYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
           N+V+ LGF  E  E  L    E+VP  S+   +     F+       T        E + 
Sbjct: 69  NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT--------EQVL 118

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            GL YLH      I+HRDLKA N+L+D++   KISDFG+++
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 85.8 bits (212), Expect = 6e-19
 Identities = 58/165 (35%), Positives = 95/165 (57%), Gaps = 14/165 (8%)

Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ + +GE +    A+K L +N S +   E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG CL    + LV + +P   L  ++ +  N++ +  +        IA+G+ YL E   +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEE---V 128

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRV 408
           R++HRDL A N+L+ S  + KI+DFG+ARL ++D+T  H+D  +V
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 8e-19
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 18/158 (11%)

Query: 252 LGQGGFGAVYKGMLSNGET----IAVKRLS-KNSKQGEIE-FKNEVLLLARLQHRNLVRL 305
           LG+G FG+V +G LS  +     +AVK +        EIE F +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 306 LGFCLERKER------ILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGL 356
           +G C E          +++  F+ +  L  F+         E +  +   K +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            YL   S    IHRDL A N +L  +M   ++DFG+++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 85.3 bits (211), Expect = 8e-19
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)

Query: 250 NKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 9/153 (5%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARLQHRNLVRLLG 307
           K+G+G +G VYK      GE +A+K++    +   I      E+ LL  L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
               + +  LV+EF+ +  L   I D   +  +        +  + +GL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           +HRDLK  N+L+++E   K++DFG+AR F    
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 54/164 (32%), Positives = 80/164 (48%), Gaps = 23/164 (14%)

Query: 244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEF-KNEVLLLARL-Q 298
           D+F     +G+G F  V         +  A+K L K    K+ ++++ K E  +L RL  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 299 HRNLVRLLGFCLERKERI-LVYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGI 352
           H  +++L  +  + +E +  V E+ PN  L  +I      D    E  T   R+   E I
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD----EKCT---RFYAAE-I 111

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
              L YLH      IIHRDLK  NILLD +M+ KI+DFG A++ 
Sbjct: 112 LLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 60/171 (35%), Positives = 94/171 (54%), Gaps = 28/171 (16%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRL--------SKNSKQGEIE-FKNEVLLLARLQHRN 301
           +G G FG+VY GM  S+GE +AVK++        SK+ K+  ++    E+ LL  LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 302 LVRLLGFCLERKERILVYEFVPNAS----LDHF--IFDPINREHMTWEKRYKIIEGIARG 355
           +V+ LG  L+     +  E+VP  S    L+++    + + R           +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKG 118

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           L YLH  +R  IIHRD+K +NIL+D++   KISDFG+++  E +   + TN
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 51/144 (35%), Positives = 77/144 (53%), Gaps = 6/144 (4%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCL 310
           LG+G FG V+KG L +   +AVK   ++  Q  +I+F +E  +L +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           +R+   +V E VP    D   F    ++ +  ++  K     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 371 DLKASNILLDSEMNPKISDFGMAR 394
           DL A N L+      KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 51/152 (33%), Positives = 81/152 (53%), Gaps = 18/152 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKR-----LSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG VY    +  G  +AVK+      S  +K+     + E+ LL  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 306 LGFCLERKERILVY-EFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHED 362
            G CL   E + ++ E++P  S+   +  +  +  E +T +   +I+EG+     YLH +
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALT-ETVTRKYTRQILEGVE----YLHSN 123

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               I+HRD+K +NIL DS  N K+ DFG ++
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 10/155 (6%)

Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V +G L         +A+K L S  +++   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + +  +++ EF+ N +LD F+    N    T  +   ++ GIA G+ YL E   + 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
            +HRDL A NIL++S +  K+SDFG++R  E D +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 60/187 (32%), Positives = 98/187 (52%), Gaps = 37/187 (19%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQ---H 299
           + +  ++G+G +G VYK   L+ G  +A+K++    S++G  +    E+ LL +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 300 RNLVRLLGFC----LERKERI-LVYEFVPNASLDHFI-------FDPINREHMTWEKRYK 347
            N+VRLL  C     +R+ ++ LV+E V +  L  ++         P   + +  +    
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ---- 115

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL--FEMDQTHSDT 405
               + RG+ +LH     RI+HRDLK  NIL+ S+   KI+DFG+AR+  FEM  T    
Sbjct: 116 ----LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT---- 164

Query: 406 NRVVGTL 412
             VV TL
Sbjct: 165 -SVVVTL 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 8e-18
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 28/168 (16%)

Query: 252 LGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVR 304
           LGQG FG VY+G+            +A+K +++N+   E IEF NE  ++      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI------------FDPINREHMTWEKRYKIIEGI 352
           LLG     +  ++V E +    L  ++              P   +        ++   I
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-----IQMAAEI 128

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           A G+ YL      + +HRDL A N ++  ++  KI DFGM R ++E D
Sbjct: 129 ADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 52/152 (34%), Positives = 78/152 (51%), Gaps = 14/152 (9%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           K+G+G +G VYK      GE +A+K  RL    +        E+ LL  L H N+VRLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 308 FCLERKERILVYEFVP---NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                 +  LV+EF+       +D      ++   +     Y++++GIA    Y H  S 
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPP-LIKSYLYQLLQGIA----YCH--SH 118

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            R++HRDLK  N+L+D E   K++DFG+AR F
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 5/149 (3%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLG G FG V++G+ +N   +AVK L   +   + +F  E  ++ +L+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
             +   +V E +   SL  ++     R  +   +   +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMD 399
           DL A N+L+      K++DFG+AR+ + D
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKED 156

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 6/150 (4%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +LG G FG V+ G       +A+K +++ +   E +F  E  ++ +L H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           ++K   +V EF+ N  L +++     +  ++ +    + + +  G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           DL A N L+ S    K+SDFGM R    D+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 53/151 (35%), Positives = 78/151 (51%), Gaps = 15/151 (9%)

Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V  Y    +N   GE +AVK L  +  +Q    +K E+ +L  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 306 LGFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C E+  +   L+ E+VP  SL     D + +  +   +     + I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               IHRDL A N+LLD++   KI DFG+A+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 57/157 (36%), Positives = 84/157 (53%), Gaps = 13/157 (8%)

Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           LG+G FG V    Y     N GE +AVK L   S    I + K E+ +L  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 306 LGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C E       L+ EF+P+ SL  ++  P N+  +  +++ K    I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           R + +HRDL A N+L++SE   KI DFG+ +  E D+
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 35/183 (19%)

Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREH-----------------MTWEKRYK 347
             G C E +  ++V+E++ +  L+ F+     R H                 +T  +   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFL-----RSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I   IA G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D   +D  R
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR 179

Query: 408 VVG 410
           V G
Sbjct: 180 VGG 182

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 6/157 (3%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +  ++     KLG G FG V+ G  +    +AVK L   +   E  F  E  ++ +L+H 
Sbjct: 3   IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHD 61

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LV+L     E    I V E++   SL  F+ D   R  +       +   +A G+ Y+ 
Sbjct: 62  KLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE 119

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
              R+  IHRDL+++NIL+   +  KI+DFG+ARL E
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 50/170 (29%), Positives = 91/170 (53%), Gaps = 9/170 (5%)

Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKR--LSKNSKQGEIEFKNEVLLLARLQHRN 301
           +F   NK+G+G FG V+K +  ++    A+K+  LSK +++   E  +E  +LA+L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++R     L++ +  +V E+  N  L   +     R  +  ++ ++    I  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP-LPEDQVWRFFIQILLGLAHLHS 119

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
               +I+HRD+K+ N+ LD+  N KI D G+A+L   +   ++T  +VGT
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 33/184 (17%)

Query: 251 KLGQGGFGAVYKGMLSNGET---IAVKRLSKNSKQGE-IEFKN--EVLLLARLQHRNLVR 304
            +G+G +G VYK    NG+     A+K+   + +Q   I      E+ LL  L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 305 LLGFCLERKERI--LVYEFVPNASLD--HFIFDPINREHMTWEKRY-------KIIEGIA 353
           L+   LE  ++   L++++   A  D    I     + H   ++          ++  I 
Sbjct: 67  LVEVFLEHADKSVYLLFDY---AEHDLWQII-----KFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLF-EMDQTHSDTNRV 408
            G+ YLH +    ++HRDLK +NIL+  E       KI D G+ARLF    +  +D + V
Sbjct: 119 NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 409 VGTL 412
           V T+
Sbjct: 176 VVTI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 7/155 (4%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRN 301
           +++   K+G+G +G VYKG     G+ +A+K++   S++  +      E+ LL  LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V L    ++     L++EF+ +  L  ++      ++M  E     +  I +G+L+ H 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               R++HRDLK  N+L+D++   K++DFG+AR F
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 29/170 (17%)

Query: 251 KLGQGGFGAVY----------------KGMLSNGET-IAVKRLSKN-SKQGEIEFKNEVL 292
           KLG+G FG V+                +   ++    +AVK L  + S     +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--------FDPINREHMTWEK 344
           +L+RL   N+ RLLG C       ++ E++ N  L+ F+            N + +++  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +   IA G+ YL     L  +HRDL   N L+      KI+DFGM+R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.9 bits (197), Expect = 8e-17
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 29/169 (17%)

Query: 252 LGQGGFGAVYK----GMLSNGE--TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
           +GQG FG V++    G+L       +AVK L +  S   + +F+ E  L+A   H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFD-------------------PINREHMTWEKR 345
           LLG C   K   L++E++    L+ F+                      +N   ++  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             I + +A G+ YL E    + +HRDL   N L+   M  KI+DFG++R
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 57/186 (30%), Positives = 99/186 (53%), Gaps = 33/186 (17%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQHR 300
           D F    ++G+G +G VYK    + GE +A+K++   N K+G  I    E+ +L +L HR
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 301 NLVRL----------LGFCLERKERILVYEFVPN-------ASLDHFIFDPINREHMTWE 343
           N+V L          L F  ++    LV+E++ +       + L HF     + +H+   
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF-----SEDHIK-- 119

Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
                ++ +  GL Y H+ + L   HRD+K SNILL+++   K++DFG+ARL+  +++  
Sbjct: 120 ---SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 404 DTNRVV 409
            TN+V+
Sbjct: 174 YTNKVI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.9 bits (197), Expect = 9e-17
 Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 14/158 (8%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           NF    K+G+G +G VYK      GE +A+K  RL   ++        E+ LL  L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY--KIIEGIARGLLY 358
           +V+LL       +  LV+EF+ +  L  F+   P++   +   K Y  ++++G+A    +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 57/170 (33%), Positives = 86/170 (50%), Gaps = 16/170 (9%)

Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           F+D  ++G G FGAVY        E +A+K++S + KQ   ++++   EV  L +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            +   G  L      LV E+   ++ D  I + ++++ +   +   I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILE-VHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             R   IHRD+KA NILL      K++DFG A L       S  N  VGT
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLV------SPANSFVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 12/153 (7%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN-----EVLLLARLQHRNLV 303
            KLG+G +  VYK      G  +A+K++    ++   +  N     E+ LL  L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            LL     +    LV+EF+    L+  I D          K Y ++    RGL YLH   
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM--TLRGLEYLH--- 119

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
              I+HRDLK +N+L+ S+   K++DFG+AR F
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 10/161 (6%)

Query: 252 LGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L      E  +A+K L    +++   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  ++V E++ N SLD F+    +    T  +   ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 20/175 (11%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
             +G+G FG V K    S+G+ +  K +     +++ + +  +EV +L  L+H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 307 GFCLER-KERI-LVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLY 358
              ++R  + + +V E+     L   I         I  E   W    +I+  +   L  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE-EEFIW----RILTQLLLALYE 120

Query: 359 LH--EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            H   D    ++HRDLK +NI LD+  N K+ DFG+A++  +    S     VGT
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 52/171 (30%), Positives = 93/171 (54%), Gaps = 14/171 (8%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRV 408
            E    R++HRDL A N+L+ +  + KI+DFG+A+L   D+   H++  +V
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 13/169 (7%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNLV 303
           F+    +G+G FG VYK +     + +A+K +     + EIE    E+  L++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E+    S    +    ++  ++ +     I+  +  GL YLHE+
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-----ILREVLLGLEYLHEE 117

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
                IHRD+KA+NILL  E + K++DFG++   ++  T S  N  VGT
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGT 161

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 57/176 (32%), Positives = 84/176 (47%), Gaps = 24/176 (13%)

Query: 252 LGQGGFGAVYKGML------SNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLV 303
           LG G FG VY+G         +G   +AVK L K +   E  EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREH----MTWEKRYKIIEGIARGLLYL 359
           +LLG CL  + + ++ E +    L  ++ D          +T ++   I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 360 HEDSRLRIIHRDLKASNILL-----DSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
               ++  IHRDL A N L+     D++   KI DFG+AR    D   SD  R  G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEG 171

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 20/173 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLS----KNSKQGEI--EFKNEVLLLARLQHRNLVR 304
           LG G F + Y+   +  G  +AVK+++     +S+Q E+    + E+ L+ARL H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +LG   E     L  E++   S+ H +  +    +E +         E + RGL YLHE+
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAF-KEAVI----INYTEQLLRGLSYLHEN 122

Query: 363 SRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSD--TNRVVGTL 412
              +IIHRD+K +N+L+DS     +I+DFG A       T +     +++GT+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 24/185 (12%)

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNE 290
           L++++E      D   +   LG+G +G VY    LS    IA+K + +   +       E
Sbjct: 1   LEYEYEY-----DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEE 55

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---FDPI--NREHMTWEKR 345
           + L + L+HRN+V+ LG   E     +  E VP  SL   +   + P+  N + + +  +
Sbjct: 56  IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFG----MARLFEMDQ 400
            +I+E    GL YLH+    +I+HRD+K  N+L+++     KISDFG    +A +    +
Sbjct: 116 -QILE----GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167

Query: 401 THSDT 405
           T + T
Sbjct: 168 TFTGT 172

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 60/173 (34%), Positives = 93/173 (53%), Gaps = 18/173 (10%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQHRN 301
            F   N++G+G +G VY+    ++GE +A+K++   N + G  I    E+ LL  L+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 302 LVRLLGFCLERK-ERI-LVYEFVPN--ASLDHFIFDPINREHMTWEKRYK-IIEGIARGL 356
           +V L    + +  + I LV E+     ASL   +  P +      E + K ++  + RGL
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS------ESQVKCLMLQLLRGL 121

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
            YLHE+    IIHRDLK SN+LL  +   KI+DFG+AR + +      T +VV
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 5/150 (3%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLG G FG V+ G  +N   +AVK L   +   +  F  E  L+  LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           + +   ++ E++   SL  F+      + +   K       IA G+ Y+    R   IHR
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           DL+A+N+L+   +  KI+DFG+AR+ E ++
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE 157

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 16/156 (10%)

Query: 252 LGQGGFGAVYKGML-----SNGET-IAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVR 304
           LG+G FG V+           GET + VK L K   +  + EF+ E+ +  +L H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLY 358
           LLG C E +   ++ E+     L  F+       + +    ++ +++  +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           L   S  R +HRDL A N L+ S+   K+S   +++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 14/166 (8%)

Query: 250 NKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
            ++G G +G VYK   ++ GE +A+K +           + E+ +L   +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 309 CLERKERILVYEFVPNASLD---HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            L R +  +V E+    SL         P++   + +  R  +     +GL YLHE    
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---T 120

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             IHRD+K +NILL  + + K++DFG++   ++  T +     +GT
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGT 164

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 57/166 (34%), Positives = 86/166 (51%), Gaps = 27/166 (16%)

Query: 244 DNFSDANKLGQGGFGAVYKGM--LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQH 299
           D +    K+G+G +G VYK    ++N ETIA+K  RL +  +        E+ LL  +QH
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM----TWEKRYKIIEG---- 351
            N+VRL       K   LV+E++    LD        ++HM     + K  ++I+     
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYL---DLDL-------KKHMDSSPDFAKNPRLIKTYLYQ 110

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLF 396
           I RG+ Y H     R++HRDLK  N+L+D   N  K++DFG+AR F
Sbjct: 111 ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153

Length = 294

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 77.1 bits (189), Expect = 1e-15
 Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 16/170 (9%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           F+D  ++G G FGAVY    +   E +A+K++S + KQ   ++++   EV  L R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            +   G  L      LV E+   ++ D      ++++ +   +   I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   +IHRD+KA NILL      K++DFG A +       S  N  VGT
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGT 184

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 43/175 (24%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVLLLARLQHRN 301
           +G G +G V   +    G  +A+K++S         F +         E+ LL  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 302 LVRLL---------GFCLERKERILVYEFVPNASLDHFIF---DPINREHMTWEKRYKII 349
           ++ LL          F     +  +V E +    L H +     P+  +H+    +Y  +
Sbjct: 61  IIGLLDILRPPSPEDF----NDVYIVTELME-TDL-HKVIKSPQPLTDDHI----QY-FL 109

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
             I RGL YLH  +   +IHRDLK SNIL++S  + KI DFG+AR  + D+    
Sbjct: 110 YQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 48/162 (29%), Positives = 85/162 (52%), Gaps = 22/162 (13%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNL 302
           NF    KLG+G +  VYKG   + GE +A+K +  ++++G       E+ L+  L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFI--------FDPINREHMTWEKRYKIIEGIAR 354
           VRL        + +LV+E++    L  ++         DP   +  T++        + +
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           G+ + HE+   R++HRDLK  N+L++     K++DFG+AR F
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 28/183 (15%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS----KNSKQGEIEFKNEVLLLARL 297
             NF    K+G+G F  VYK + L +G  +A+K++      ++K  +   K E+ LL +L
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-------YKIIE 350
            H N+++ L   +E  E  +V E      L   I      +H   +KR       +K   
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMI------KHFKKQKRLIPERTIWKYFV 113

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRV 408
            +   L ++H     RI+HRD+K +N+ + +    K+ D G+ R F    T  HS    +
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----L 166

Query: 409 VGT 411
           VGT
Sbjct: 167 VGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 51/147 (34%), Positives = 78/147 (53%), Gaps = 6/147 (4%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V EF+   SL  F+ +  + +++   +   +   IA G+ Y+    R+  IHR
Sbjct: 72  EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  KI+DFG+ARL E
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 53/184 (28%), Positives = 80/184 (43%), Gaps = 25/184 (13%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QH 299
            T  F     +G+G +G VYK      G+ +A+K +    +  E E K E  +L +   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNH 62

Query: 300 RNLVRLLGFCLERKERI------LVYEFVPNASLDHFIFDPINREHMTWEKRYK------ 347
            N+    G  +++          LV E     S    + D +        KR K      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGLRKK-GKRLKEEWIAY 117

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I+    RGL YLHE+   ++IHRD+K  NILL      K+ DFG++   ++D T    N 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNT 172

Query: 408 VVGT 411
            +GT
Sbjct: 173 FIGT 176

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 6/153 (3%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +LG G FG V  G       +A+K + + S   E EF  E  ++ +L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           +++   +V E++ N  L +++ +  + +     +  ++ + +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
           DL A N L+D +   K+SDFG++R    D+  S
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 11/148 (7%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK---NEVLLLARLQHRNLVRLL 306
            +G+G +G V K    + GE +A+K+  K S+  E   K    EV +L +L+H N+V L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
                +    LV+E+V    L+       +   +  +     I  + + + Y H      
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SHN 120

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMAR 394
           IIHRD+K  NIL+      K+ DFG AR
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 16/170 (9%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           FSD  ++G G FGAVY    + N E +A+K++S + KQ   ++++   EV  L +L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            ++  G  L      LV E+   ++ D      ++++ +   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   +IHRD+KA NILL      K+ DFG A +       +  N  VGT
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 13/169 (7%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNG-ETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLV 303
           F+   ++G+G FG VYKG+ +   E +A+K +     + EIE  + E+ +L++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           R  G  L+  +  ++ E++   S LD     P+   ++       I+  I +GL YLH +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
              R IHRD+KA+N+LL  + + K++DFG+A   ++  T    N  VGT
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGT 164

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 55/181 (30%), Positives = 82/181 (45%), Gaps = 33/181 (18%)

Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L   S     +F  E  LL  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREH---------------MTWEKRYKII 349
             G C+E    I+V+E++ +  L+ F+     R H               +T  +   I 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFL-----RAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           + IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D   +D  RV 
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVG 179

Query: 410 G 410
           G
Sbjct: 180 G 180

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 10/148 (6%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQ-HRNLVRLL 306
           +LG G FG+VY       GE +A+K++ K   S +  +  + EV  L +L  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLK 64

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
               E  E   V+E++   +L   + D   +   +      II  I +GL ++H   +  
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQLMKDRKGK-PFSESVIRSIIYQILQGLAHIH---KHG 119

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMAR 394
             HRDLK  N+L+      KI+DFG+AR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 49/150 (32%), Positives = 79/150 (52%), Gaps = 12/150 (8%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---GIARGLLYLHEDSRLRI 367
           E    I V E++   SL  F+      E   + +  ++++    IA G+ Y+    R+  
Sbjct: 72  EEPIYI-VTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 123

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFE 397
           +HRDL+A+NIL+   +  K++DFG+ARL E
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 19/153 (12%)

Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  S+G+ I  AVK L++ +   E+E F  E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG----IARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI    +   +      K + G    +A+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV------KDLIGFGLQVAKGMEYLAS 116

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               + +HRDL A N +LD     K++DFG+AR
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.1 bits (183), Expect = 7e-15
 Identities = 59/175 (33%), Positives = 80/175 (45%), Gaps = 42/175 (24%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIE-F 287
           DFE I+           LG G FG V   ML     +G+  A+K LSK    K  ++E  
Sbjct: 2   DFEFIKT----------LGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHV 48

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NE  +L  ++H  LV L G   +     LV E+VP   L    F  + +         +
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSG-------R 97

Query: 348 IIEGIAR--------GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             E +AR         L YLH    L I++RDLK  N+LLDS+   KI+DFG A+
Sbjct: 98  FPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 13/152 (8%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIA---VKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRL 305
           +++G G FG V  G    G + A   VK L  ++    ++ F  EV     L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE----GIARGLLYLHE 361
           LG C+E    +LV EF P   L +++    NR  +    +  +++     +A GLL+LH 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRS--NRGMVAQMAQKDVLQRMACEVASGLLWLH- 117

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
             +   IH DL   N  L ++++ KI D+G+A
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.5 bits (184), Expect = 1e-14
 Identities = 55/166 (33%), Positives = 93/166 (56%), Gaps = 23/166 (13%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS---KNSKQGEIEFKNEVLLLARL-QHRNLVR 304
            KLG+G +G V+K +     E +A+K++    +N+   +  F+ E++ L  L  H N+V+
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 305 LLG-FCLERKERI-LVYEFVP---NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           LL     E  + I LV+E++    +A +   I + +   H    KRY I+  + + L Y+
Sbjct: 72  LLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV---H----KRY-IMYQLLKALKYI 123

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-EMDQTHSD 404
           H  S   +IHRDLK SNILL+S+   K++DFG+AR   E+++   +
Sbjct: 124 H--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 53/177 (29%), Positives = 91/177 (51%), Gaps = 27/177 (15%)

Query: 239 IRVATDNFSDANKLGQGGFGAVYKGML---SNGE---TIAVKRLSKNSKQGEI--EFKNE 290
           I ++T  F +  +LG+  FG VYKG L   + GE    +A+K L K+  +G +  EFK+E
Sbjct: 2   INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHE 58

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------------DPINR 337
            ++ +RLQH N+V LLG   + +   +++ +  ++ L  F+              D   +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             +       I+  IA G+ +L   S   ++H+DL   N+L+  ++N KISD G+ R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 56/178 (31%), Positives = 88/178 (49%), Gaps = 21/178 (11%)

Query: 242 ATDNFSD---ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-EIEFKNEVLLLAR 296
           A  + S+    N++G G  G VYK +    G   A+K +  N +     +   E+ +L  
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLD--HFIFDPINREHMTWEKRYKIIEGIAR 354
           + H N+V+         E  ++ EF+   SL+  H     I  E    +   +I+ GIA 
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIA- 182

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              YLH   R  I+HRD+K SN+L++S  N KI+DFG++R+  + QT    N  VGT+
Sbjct: 183 ---YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTI 232

Length = 353

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 7/166 (4%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF-KNEVLLLARLQHRNLVRLLG 307
             +G G    VY  + L N E +A+KR+     Q  ++  + EV  +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
             +   E  LV  ++   SL   +     R  +       +++ + +GL YLH + +   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 368 IHRDLKASNILLDSEMNPKISDFGM-ARLFE-MDQTHSDTNRVVGT 411
           IHRD+KA NILL  + + KI+DFG+ A L +  D+T       VGT
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 12/154 (7%)

Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG V+KG+ +  G++I    A+K +  ++ +Q   E  + +L +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG C     + LV +  P  SL   +    +R+ +  ++       IA+G+ YL E    
Sbjct: 75  LGICPGASLQ-LVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           R++HR+L A NILL S+   +I+DFG+A L   D
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 49/157 (31%), Positives = 86/157 (54%), Gaps = 12/157 (7%)

Query: 251 KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRL 305
           +LG G FG V KG   M  + +T+AVK L  ++    +  E   E  ++ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           +G C E +  +LV E      L+ F+    N+ H+T +   +++  ++ G+ YL E +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQK--NK-HVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
             +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 55/170 (32%), Positives = 86/170 (50%), Gaps = 16/170 (9%)

Query: 246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           F   +++G G FGAVY    S+  E +AVK++S + KQ   ++++   EV  L +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            +   G  L+     LV E+   ++ D      ++++ +   +   I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   +IHRD+KA NILL      K++DFG A         S  N  VGT
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGT 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 9/149 (6%)

Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLS-KNSKQGEIEFK-NEVLLLARLQHRNLVRLLG 307
           K+G+G +G V+K       E +A+KR+   +  +G       E+ LL  L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                K+  LV+E+  +  L  + FD  N + +  E     +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLF 396
           +HRDLK  N+L++     K++DFG+AR F
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 15/150 (10%)

Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRL--SKNSKQ-GEIEFKNEVLLLARLQHRNLVRLL 306
            +G+G +G V K      G+ +A+K+   S++ K   +I  + E+ +L +L+H NLV L+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINR-EHMTWEKRY-KIIEGIARGLLYLHEDSR 364
                +K   LV+EFV     DH + D + +  +   E R  K +  I RG+ + H  + 
Sbjct: 67  EVFRRKKRLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRD+K  NIL+      K+ DFG AR
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 23/160 (14%)

Query: 252 LGQGGFGAVYKGMLSNGETI---AVKRLS-KNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           LG+G FG+V +G L+  ++I   AVK +      + E+E F +E + +    H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 307 GFCLERKER------ILVYEFVPNASLDHFIF------DPINREHMTWEKRYKIIEGIAR 354
           G CL+  E       +++  F+ +  L  F+        P    ++  +   K +  IA 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ---YLPTQMLVKFMTDIAS 123

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           G+ YL   S    IHRDL A N +L+  MN  ++DFG+++
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 32/177 (18%)

Query: 252 LGQGGFGAVYKGM------LSNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
           LG+G FG V K         +   T+AVK L +N+   E+ +  +E  LL ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI---------------------FDPINREHMTWE 343
           L G C +    +L+ E+    SL  F+                      D  +   +T  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
                   I+RG+ YL E   ++++HRDL A N+L+      KISDFG++R ++E D
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 18/159 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGML--SNGETIAVKRL---SKNSKQGEIEFKNEVLLLARLQ 298
           D+     +LG G  G V K +L    G+ +AVK +      + Q +I  + ++L   +  
Sbjct: 1   DDLEYLGELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH--KCN 57

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHF---IFDPINREHMTWEKRYKIIEGIARG 355
              +V   G      +  +  E++   SLD     +   I    +      KI   + +G
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKG 112

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           L YLHE    +IIHRD+K SNIL++S    K+ DFG++ 
Sbjct: 113 LTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 9/151 (5%)

Query: 251 KLGQGGFGAVYKGMLSNGET---IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           ++G G FG V  G +++G T   + VK L  + S Q +++F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR--YKIIEGIARGLLYLHEDSR 364
           G C E    +LV EF P   L  ++      E MT +     ++   IA GLL+LH+++ 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARL 395
              IH DL   N LL +++  KI D+G++  
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 8/153 (5%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           +   + ++LG+G  G+V K  L N   I   +        ++  +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 302 LVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIARGLLY 358
           +V+  G  L+     +    E+    SLD        R     EK   KI E + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           LH     +IIHRD+K SNILL  +   K+ DFG
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 49/145 (33%), Positives = 79/145 (54%), Gaps = 10/145 (6%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +G+G FGAV +G  + G+ +AVK +  + + Q    F  E  ++ +L H+NLVRLLG  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           L     I V E +   +L +F+     R  ++  +  +    +A G+ YL      +++H
Sbjct: 69  LHNGLYI-VMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 370 RDLKASNILLDSEMNPKISDFGMAR 394
           RDL A NIL+  +   K+SDFG+AR
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 48/166 (28%), Positives = 90/166 (54%), Gaps = 16/166 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQH---RNLVRLL 306
           +G+G +GAVY+G  +  G  +A+K ++ ++   ++ + + EV LL++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 307 GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G  L+     ++ E+    S+   +   PI  ++++      II  +   L Y+H+    
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS-----VIIREVLVALKYIHKVG-- 121

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +IHRD+KA+NIL+ +  N K+ DFG+A L   +Q  S  +  VGT
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 11/164 (6%)

Query: 239 IRVATDNFSDANKLGQGGFGAVYKG--MLSNGETI--AVKRLSKNSKQGEIE-FKNEVLL 293
             +  ++ +    +G+G FG VY+G  M    E I  AVK     +     E F  E  +
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           + +  H ++V+L+G   E    I V E  P   L  ++   +N+  +           ++
Sbjct: 61  MRQFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
             L YL      R +HRD+ A N+L+ S    K+ DFG++R  E
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 28/169 (16%)

Query: 251 KLGQGGFGAV----------YKGMLSNGET-----IAVKRLSKN-SKQGEIEFKNEVLLL 294
           KLG+G FG V          + G  +         +AVK L  + +K    +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---- 350
           +RL++ N++RLLG C+      ++ E++ N  L+ F+         T       +     
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 351 -----GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                 IA G+ YL   + L  +HRDL   N L+ +    KI+DFGM+R
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.1 bits (175), Expect = 9e-14
 Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 33/184 (17%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQH 299
           D +   N++ +G +G VY+      GE +A+K+L K  K+ E   I    E+ +L +LQH
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQH 63

Query: 300 RNLVRL----LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---- 350
            N+V +    +G      ++I +V E+V     +H +   +  E M   + +   E    
Sbjct: 64  PNIVTVKEVVVG---SNLDKIYMVMEYV-----EHDLKSLM--ETMK--QPFLQSEVKCL 111

Query: 351 --GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              +  G+ +LH++    I+HRDLK SN+LL++    KI DFG+AR +        T  V
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLV 167

Query: 409 VGTL 412
           V TL
Sbjct: 168 V-TL 170

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.4 bits (172), Expect = 9e-14
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 10/156 (6%)

Query: 251 KLGQGGFGAVYKG---MLSNGETIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +LG G FG V KG   M      +A+K L ++N K    E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C E +  +LV E      L+ F+     ++ +T     +++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
            +HRDL A N+LL ++   KISDFG+++    D ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 23/164 (14%)

Query: 251 KLGQGGFGAVYKGML-----SNGETIAVKRLSK-NSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+  FG +YKG L      + + +A+K L   N+ Q   EF+ E  L+A L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIF--------------DPINREHMTWEKRYKIIE 350
           LLG   + +   +++E++    L  F+               D   +  +       I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            IA G+ YL   S    +H+DL A NIL+  +++ KISD G++R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 23/163 (14%)

Query: 245 NFSDANKLGQGGFGAVYK-GMLSNGETIAVKR-----LSKNSKQGEIEFKNEVLLLARLQ 298
           +F    KLG+G +G+VYK   LS+ +  A+K      +S+  ++  +   NE+ +LA + 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV---NEIRILASVN 57

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGI 352
           H N++      L+  +  +V E+ P   L   I         I  E   W  R  I   +
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLI-PEQEIW--RIFI--QL 112

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
            RGL  LHE    +I+HRDLK++NILL +    KI D G++++
Sbjct: 113 LRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV 152

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 53/177 (29%), Positives = 89/177 (50%), Gaps = 21/177 (11%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EV 291
            +T+    D + + + +G G +G V     +  G  +A+K+LS+   Q  I  K    E+
Sbjct: 7   NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYREL 65

Query: 292 LLLARLQHRNLVRLLG-FC----LERKERI-LVYEFVPNASLDHFI-FDPINREHMTWEK 344
            LL  + H N++ LL  F     LE  + + LV   +  A L++ +    ++ +H+ +  
Sbjct: 66  RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQF-- 122

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
              ++  I RGL Y+H      IIHRDLK SNI ++ +   KI DFG+AR  + + T
Sbjct: 123 ---LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT 173

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 18/172 (10%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNL 302
              +  K+G+G  G V      S G  +AVK++    +Q  E+ F NEV+++   QH N+
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNI 78

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           V +    L   E  +V EF+   +L     D +    M  E+   +   + + L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGT 411
               +IHRD+K+ +ILL S+   K+SDFG        Q   +  R   +VGT
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 19/175 (10%)

Query: 252 LGQGGFGAVYKGMLSNG--ETIAVKRLS-------KNSKQGEIEFKNEV----LLLARLQ 298
           LG G FG VYK    N     +A+K ++       K+ ++ +    + V    ++  +L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLL 357
           H N+VR     LE     +V + +  A L +HF      ++  T E+ + I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           YLH++ R  I+HRDL  +NI+L  +    I+DFG+A+     Q  S    VVGT+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTI 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 9/164 (5%)

Query: 243 TDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            D +    +LG G FG VYK      G   A K +   S++   +F  E+ +L+  +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 302 LVRLL-GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           +V L   +  E K  IL+ EF    +LD  I   + R     + RY +   +   L +LH
Sbjct: 64  IVGLYEAYFYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH 120

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGM-ARLFEMDQTHS 403
                ++IHRDLKA NILL  + + K++DFG+ A+     Q   
Sbjct: 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 8/148 (5%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLG G FG V+    +    +AVK +   S   E  F  E  ++  LQH  LV+L    +
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VV 70

Query: 311 ERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            ++   ++ EF+   SL  F+  D  +++ +   K       IA G+ ++ + +    IH
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 125

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFE 397
           RDL+A+NIL+ + +  KI+DFG+AR+ E
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIE 153

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 16/157 (10%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQ---HRNLVR 304
           ++G G +G VYK     +G  +A+K  R+  N     +    EV LL RL+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 305 LLGFC----LERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           L+  C     +R+ ++ LV+E V +  L  ++ D +    +  E    ++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H +    I+HRDLK  NIL+ S    K++DFG+AR++
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 8/157 (5%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHRNLVRLLGF 308
           ++G+G FG V+ G L    T    +  + +   +++  F  E  +L +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C +++   +V E V     D   F       +  ++  +++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           HRDL A N L+  +   KISDFGM+R  E D  ++ T
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYAST 152

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 51/147 (34%), Positives = 84/147 (57%), Gaps = 12/147 (8%)

Query: 251 KLGQGGFGAVYKGMLSNGET--IAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           +LG G FG VYK    N ET  +A  ++ +   + E+E +  E+ +LA   H  +V+LLG
Sbjct: 19  ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 308 -FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            F  + K  I++ EF P  ++D  + + ++R  +T  +   I   +   L YLH    ++
Sbjct: 77  AFYWDGKLWIMI-EFCPGGAVDAIMLE-LDR-GLTEPQIQVICRQMLEALQYLHS---MK 130

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMA 393
           IIHRDLKA N+LL  + + K++DFG++
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 21/161 (13%)

Query: 252 LGQGGFGAVYKGMLS---NGETIAVKRLSK-NSKQGEIEFKNEVLLLARL-QHRNLVRLL 306
           +G+G FG V + M+         A+K L +  S+    +F  E+ +L +L  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDP-INREH-----MTWEKRYKIIEGIA 353
           G C  R    +  E+ P  +L  F+        DP   +EH     +T ++  +    +A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            G+ YL E    + IHRDL A N+L+   +  KI+DFG++R
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 26/179 (14%)

Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L   +     +F+ E  LL  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 305 LLGFCLERKERILVYEFVPNASLDHF----------IFDPINRE---HMTWEKRYKIIEG 351
             G C +    I+V+E++ +  L+ F          + D   R+    +   +   I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           IA G++YL   +    +HRDL   N L+ + +  KI DFGM+R    D   +D  RV G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGG 183

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 18/174 (10%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN---GET---IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G   +   GE    +AVK +++++   E IEF NE  +
Sbjct: 3   VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------DPINREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++        +   R   T ++  
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 21/161 (13%)

Query: 252 LGQGGFGAVYKGML-SNGETI--AVKRLSK-NSKQGEIEFKNEVLLLARL-QHRNLVRLL 306
           +G+G FG V K  +  +G  +  A+KR+ +  SK    +F  E+ +L +L  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 307 GFCLERKERILVYEFVPNASLDHFI-----------FDPINREHMTW--EKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+           F   N    T   ++       +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           RG+ YL   S+ + IHRDL A NIL+      KI+DFG++R
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 20/161 (12%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           A  ++ +  KLG+G +  VYKG+   NG+ +A+K +S  +++G + F    E  LL  L+
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLK 61

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
           H N+V L      ++    V+E++      + I       P N     ++        + 
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ--------LL 113

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           RGL Y+H      I+HRDLK  N+L+      K++DFG+AR
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.6 bits (167), Expect = 5e-13
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 13/169 (7%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +     + EIE  + E+ +L++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 120

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 16/152 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-----FKNEVLLLARLQHRNLVRL 305
           LGQG FG VY       G  +AVK++  + +  E        + E+ LL  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 306 LGFCLERKERIL--VYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
            G   +  ER L    E +P  S+ D         E++T +   +I+EG+     YLH +
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV----SYLHSN 125

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               I+HRD+K +NIL DS  N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 37/178 (20%)

Query: 251 KLGQGGFGAVYKGMLSNGET-----------------IAVKRLSKN-SKQGEIEFKNEVL 292
           KLG+G FG V+   + N +                  +AVK L  + +K    +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI------------FDPINREH- 339
           +L+RL+  N++RLLG C++     ++ E++ N  L+ F+             D +   H 
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 340 ---MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +++     +   IA G+ YL   S L  +HRDL   N L+   +  KI+DFGM+R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 48/146 (32%), Positives = 77/146 (52%), Gaps = 10/146 (6%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GF 308
           +LG G FG VYK        +A  ++     + E+E +  E+ +LA   H N+V+LL  F
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLHEDSRLRI 367
             E    IL+ EF    ++D  + +    E    E + +++ +     L YLHE+   +I
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 368 IHRDLKASNILLDSEMNPKISDFGMA 393
           IHRDLKA NIL   + + K++DFG++
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)

Query: 181 PPPRKKNHT----ILITVIVSVVASVILITGICIFLRVGKLKLEDENVE-ETIAKSLQFD 235
           PP ++   T      IT  +     + L+    +F+R G+  LE + VE E     LQF 
Sbjct: 617 PPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIR-GRNNLELKRVENEDGTWELQF- 674

Query: 236 FE-------TIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEF 287
           F+       TI     +  + N + +G  GA YKG  + NG    VK ++  +     E 
Sbjct: 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            +    + +LQH N+V+L+G C   K   L++E++   +L   +       +++WE+R K
Sbjct: 735 AD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRK 784

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           I  GIA+ L +LH      ++  +L    I++D +  P +    +  L   D  
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837

Length = 968

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 47/169 (27%), Positives = 90/169 (53%), Gaps = 13/169 (7%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLV 303
           F+   ++G+G FG V+KG+ +  + + A+K +     + EIE  + E+ +L++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P +   +       +++ I +GL YLH +
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHSE 120

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   IHRD+KA+N+LL  + + K++DFG+A   ++  T    N  VGT
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 52/162 (32%), Positives = 85/162 (52%), Gaps = 9/162 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVRLLG 307
           +KLG+G +  VYKG     +  +A+K +    ++G       EV LL  L+H N+V L  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                K   LV+E++ +  L  ++ D  N  +M   K +  +  + RGL Y H   R ++
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRKV 125

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           +HRDLK  N+L++     K++DFG+AR   +  T + +N VV
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV 166

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 18/174 (10%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-----NGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 3   VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM-------TWEKRY 346
           +      ++VRLLG   + +  +++ E +    L  ++                + +K  
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 32/179 (17%)

Query: 252 LGQGGFGAVY---KGMLSNGETIAVKRLSKNSKQGEIEF---KNEVLLLARLQHRNLVRL 305
           + +G +G V+   K   S G+  A+K + K     + +      E  +L++ Q   +V+L
Sbjct: 1   ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIARGLLYL 359
             +  + K+ + LV E++P   L   +      D    E +    R  I E I   L YL
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLD----EDVA---RIYIAE-IVLALEYL 109

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFG------MARLFEMDQTHSDTNRVVGTL 412
           H      IIHRDLK  NIL+DS  + K++DFG      + R   ++    +  R+VGT 
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 55/170 (32%), Positives = 85/170 (50%), Gaps = 17/170 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-----FKNEVLLLARLQHRNLVRL 305
           LGQG FG VY    +  G  +A K++  + +  E        + E+ LL  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 306 LGFCLERKERILV--YEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
            G   +R E+ L    E++P  S+ D         E +T +   +I+EG++    YLH +
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS----YLHSN 125

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGT 411
               I+HRD+K +NIL DS  N K+ DFG + RL  +  + +    V GT
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 27/183 (14%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVY--KGMLSNGETI----AVKRLSKNSKQGEIEFKN 289
           +E IRV          +G+G FG V+  +        I     V++++K+ +      +N
Sbjct: 2   YEKIRV----------VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QN 48

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           E  +L  L H N++      LE K  ++V E+ P  +L  +I        +  E    I+
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDED--TIL 104

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEMDQTHSDTNRV 408
               + LL LH      I+HRDLK  NILLD  +M  KI DFG++++     + S    V
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTV 161

Query: 409 VGT 411
           VGT
Sbjct: 162 VGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 14/157 (8%)

Query: 245 NFSDANKLGQGGFGAVY--KGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            +    K+G+G FG +Y  K    +    I    L+K   + +   K EV+LLA+++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---GIARGLLY 358
           +V       E     +V E+     L       INR+        +I+     I+ GL +
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDL----MKRINRQRGVLFSEDQILSWFVQISLGLKH 116

Query: 359 LHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMAR 394
           +H+    +I+HRD+K+ NI L    M  K+ DFG+AR
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.3 bits (161), Expect = 4e-12
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 21/174 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRN 301
           D++    KLG+G +  VYKG    NG+ +A+K +    ++G       E  LL  L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARG 355
           +V L      ++   LV+E+V +  L  ++        P N +   ++        + RG
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ--------LLRG 115

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           L Y+H+     I+HRDLK  N+L+      K++DFG+AR   +  +H+ +N VV
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV 165

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 11/157 (7%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   ++F    ++G G +G VYK   ++ GE  A+K +     +     + E++++   +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLD--HFIFDPINREHMTWEKRYKIIEGIARGL 356
           H N+V   G  L R +  +  EF    SL   + +  P++   + +  R  +     +GL
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGL 119

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            YLH   +   +HRD+K +NILL    + K++DFG++
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 65.5 bits (159), Expect = 6e-12
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 21/161 (13%)

Query: 252 LGQGGFGAVYKGMLSNG---ETIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRNLVRLL 306
           +G+G FG V K  +         A+KR+ + + + +  +F  E+ +L +L  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDP-INREH-----MTWEKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+        DP     +     ++ ++       +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           RG+ YL +    + IHRDL A NIL+      KI+DFG++R
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 46/167 (27%), Positives = 85/167 (50%), Gaps = 10/167 (5%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  + ++ G+ +A+K+++   +  +    NE+L++   +H N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 134

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++IHRD+K+ NILL  + + K++DFG       +Q+   T  +VGT
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 14/149 (9%)

Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKNS--KQGEI-EFKNEVLLLARLQHRNLVRLL 306
           ++GQGG+G V+     + GE +A+KR+ K+   K  E+     E  +L   +   LV+LL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            +  +  E + L  E+VP       + +  +  E      R+ + E     +  LH    
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFE-AVDALH---E 119

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMA 393
           L  IHRDLK  N L+D+  + K++DFG++
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 22/169 (13%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAV--YKGMLSNGETIAVKRLSK------NSKQGEIEF 287
           F T+   T+ + D   +G G FG V   +  L+ G+ +A+K++ K       +K+   E 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYREL 60

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           K    LL  L+H N++ L    +   E I  V E +           P+ ++ + +    
Sbjct: 61  K----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY---- 112

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
             +  I RGL Y+H      ++HRDLK SNIL++   + KI DFG+AR+
Sbjct: 113 -FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.9 bits (158), Expect = 9e-12
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 29/170 (17%)

Query: 251 KLGQGGFGAVY----KGMLSNGET-------------IAVKRLSKNS-KQGEIEFKNEVL 292
           KLG+G FG V+    +GM    +              +AVK L +++ K    +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF------DPINREHMT--WEK 344
           +++RL+  N++RLL  C+      ++ E++ N  L+ F+            + +T  +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +   IA G+ YL   S L  +HRDL   N L+      KI+DFGM+R
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 21/171 (12%)

Query: 226 ETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE 284
           + + ++ Q D+E I+          ++G G +G VYK   L  GE  AVK +        
Sbjct: 1   DILRRNPQHDYELIQ----------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF 50

Query: 285 IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD--HFIFDPINREHMTW 342
              + E+ ++   +H N+V   G  L R++  +  E+    SL   + +  P++   + +
Sbjct: 51  SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
             R  +     +GL YLH   ++   HRD+K +NILL    + K++DFG+A
Sbjct: 111 VCRETL-----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 54/174 (31%), Positives = 91/174 (52%), Gaps = 20/174 (11%)

Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQ---HRNLV 303
           ++G+G +G V+K   + + G  +A+KR+  +  ++G  +    EV +L  L+   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 304 RLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           RL   C + R +R     LV+E V +  L  ++ D +    +  E    ++  + RGL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           LH     R++HRDLK  NIL+ S    K++DFG+AR++           VV TL
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 28/166 (16%)

Query: 252 LGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRNLV 303
           LG+G FG V K         +   T+AVK L  ++ + +  +  +E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------------- 350
            LLG C +     +V E+  + +L  F+     R    +                     
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRA--RRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 351 --GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +ARG+ +L      + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 25/156 (16%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK---NEVLLLARLQHRNLVRLL 306
           K+G+G +G V+K      G+ +A+K+  ++     I+ K    E+ +L +L+H NLV L+
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALREIRMLKQLKHPNLVNLI 66

Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDPINR------EHMTWEKRYKIIEGIARGLLYL 359
                RK ++ LV+E+      DH + + + +      EH+      KII    + + + 
Sbjct: 67  E-VFRRKRKLHLVFEYC-----DHTVLNELEKNPRGVPEHLI----KKIIWQTLQAVNFC 116

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
           H   +   IHRD+K  NIL+  +   K+ DFG AR+
Sbjct: 117 H---KHNCIHRDVKPENILITKQGQIKLCDFGFARI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 51/174 (29%), Positives = 87/174 (50%), Gaps = 26/174 (14%)

Query: 244 DNFSDANKLGQGGFGAVYK----GMLSNGE----TIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V +    G+  +      T+AVK L  N+   ++ +  +E+ L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FD--PINREHM 340
             + +H+N++ LLG C +     ++ E+    +L  F+           FD   +  E +
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +++        +ARG+ YL  +SR R IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 18/151 (11%)

Query: 251 KLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQG----EIEFKNEVLLLARLQHRNLVRL 305
           KLG+G +  VYKG     G+ +A+K +    ++G     I    E  LL  L+H N+V L
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVTL 68

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK--RYKIIEGIARGLLYLHEDS 363
                 +K   LV+E++ +  L  ++ D      M   +   ++++    RGL Y H   
Sbjct: 69  HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCH--- 120

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           + R++HRDLK  N+L+      K++DFG+AR
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 25/182 (13%)

Query: 236 FETIRVATDNFSDANKLGQGGFG-AVYKGMLSNGETIAVKR--LSKNSKQGEIEFKNEVL 292
           +  IRV          LG+G FG A       +   +  K   L++ S++   +  NE++
Sbjct: 2   YIPIRV----------LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIV 51

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMT-WEKRYKI--I 349
           +L+ LQH N++      ++    ++  E+    +L    +D I R+    +E+   +  +
Sbjct: 52  ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL----YDKIVRQKGQLFEEEMVLWYL 107

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             I   + Y+H+     I+HRD+K  NI L      K+ DFG++++   + + ++T  VV
Sbjct: 108 FQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VV 162

Query: 410 GT 411
           GT
Sbjct: 163 GT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 9/162 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVRLLG 307
            KLG+G +  V+KG     E  +A+K +    ++G       EV LL  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                K   LV+E++ +  L  ++ D  N   M   K +  +  I RGL Y H   R ++
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           +HRDLK  N+L++     K++DFG+AR   +  T + +N VV
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV 166

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 10/147 (6%)

Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    + + G+  A K+L K     ++GE    NE  +L ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           +  E K+ + LV   +    L + I++            +   + I  GL +LH   + R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRR 115

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMA 393
           I++RDLK  N+LLD   N +ISD G+A
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 54/161 (33%), Positives = 83/161 (51%), Gaps = 20/161 (12%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRL-----SKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG VY       G  +AVK++     S+ + +     + E+ LL  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 299 HRNLVRLLGFCL----ERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
           H  +V+  G CL    E+K  I V E++P  S+ D         E++T  +RY     I 
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVT--RRYT--RQIL 116

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +G+ YLH +    I+HRD+K +NIL DS  N K+ DFG ++
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 10/167 (5%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G V+  + ++ G+ +A+K+++   +  +    NE+L++  L++ N+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++IHRD+K+ N+LL  + + K++DFG       +Q+   T  +VGT
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 19/170 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFC 309
           +G G +G VYKG  +  G+  A+K +     + E E K E+ +L +   HRN+    G  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIATYYGAF 72

Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRY--KIIEGIARGLLYLHE 361
           +++       +  LV EF    S+   I    N +  T ++ +   I   I RGL +LH+
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
               ++IHRD+K  N+LL      K+ DFG++   ++D+T    N  +GT
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGT 174

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 32/159 (20%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLLG 307
           +G G +G+V   +    GE +A+K+LS+   Q EI  K    E+ LL  +QH N++ LL 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 308 FCLERKERILVYEFVPNASLDHFI------------FDPINREHMTWEKRYKIIEGIARG 355
                        F    S D F                I    ++ +K   ++  +  G
Sbjct: 82  V------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           L Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 17/173 (9%)

Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHR 300
           +F     +G+G FG V         +  A+K ++K    ++G +    NE  +L  L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 301 NLVRL-LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK-RYKIIEGIARGLLY 358
            LV L   F  + +   LV + +    L + +     +   + E+ ++ I E I   L Y
Sbjct: 61  FLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICE-IVLALEY 115

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           LH      IIHRD+K  NILLD + +  I+DF +A     D     T    GT
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGT 162

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 32/157 (20%)

Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKNSKQGEIEFKNEV----------LLLARL 297
           LG+G FG V   +L+     GE  A+K L    K+G+I  ++EV                
Sbjct: 7   LGRGHFGKV---LLAEYKKTGELYAIKAL----KKGDIIARDEVESLMCEKRIFETANSE 59

Query: 298 QHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARG 355
           +H  LV L   C + ++ +  V E+     L   I        +  E R       +  G
Sbjct: 60  RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLG 113

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM 392
           L YLHE+   +I++RDLK  N+LLD+E   KI+DFG+
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 8/144 (5%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G  +AVK + KN    +  F  E  ++ +L+H NLV+LLG  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 312 RKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
            K  + +V E++   SL  ++     R  +  +   K    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 371 DLKASNILLDSEMNPKISDFGMAR 394
           DL A N+L+  +   K+SDFG+ +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 43/181 (23%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRN 301
             + + + +G+G +G V        G  +A+K++S    Q        E+ +L R +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 302 LVRLL------GFCLERKERILVYEFVP----------NASLDH---FIFDPINREHMTW 342
           ++ +L       F     +  +V E +           + S DH   F+           
Sbjct: 65  IIGILDIIRPPSFE-SFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL----------- 112

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              Y+I+    RGL Y+H  +   ++HRDLK SN+LL++  + KI DFG+AR+ + +  H
Sbjct: 113 ---YQIL----RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162

Query: 403 S 403
           +
Sbjct: 163 T 163

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 16/159 (10%)

Query: 254 QGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           +G FG ++ G+L        E + VK +  ++ + ++     E  LL  L H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 308 FCLERKERILV-YEFVPNASLDHFIFD----PINREH-MTWEKRYKIIEGIARGLLYLHE 361
            C+E  E   V Y ++   +L  F+        N    ++ ++   +   IA G+ YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             +  +IH+D+ A N ++D E+  KI+D  ++R LF MD
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 11/153 (7%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   D+F    K+G+G  G V      + G+ +AVK++    +Q      NEV+++    
Sbjct: 21  REYLDSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V +    L   E  +V EF+   +L     D +    M  E+   +   + R L Y
Sbjct: 78  HENVVDMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSY 133

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           LH      +IHRD+K+ +ILL S+   K+SDFG
Sbjct: 134 LHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 28/171 (16%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHR 300
           D +    K+G+G +G VYK    + G+ +A+K  RL  + +        E+ LL  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 301 N-LVRLLGFCLERKER-------ILVYEFVPNASLDHFIFDPINREHMTWEKR------Y 346
             +VRLL   +E  E         LV+E++ ++ L  F+             +      Y
Sbjct: 61  IYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLF 396
           ++++G+A    + H   +  ++HRDLK  N+L+D +    KI+D G+ R F
Sbjct: 118 QLLKGVA----HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)

Query: 246 FSDANKLGQGGFGAVYKGML----SNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQH 299
           F+    LG+G FG+V +  L     + + +AVK L     S     EF  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 300 RNLVRLLGFCLERKER------ILVYEFVPNASLDHFIF------DPINREHMTWEKRYK 347
            N+++L+G  L  + +      +++  F+ +  L  F+       +P     +  +   +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVR 117

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  IA G+ YL   S    IHRDL A N +L+  M   ++DFG+++
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 11/153 (7%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q      NEV+++   Q
Sbjct: 19  RTYLDNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V +    L   E  +V EF+   +L     D +    M  E+   +   + + L  
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSV 131

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           LH      +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 132 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 40/191 (20%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIE-FKNE 290
           DFE I+V          +G+G FG V+       G+  A+K L K+   K+ +I   + E
Sbjct: 2   DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE 51

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVP-----NASLDHFIFDPINREHMTWEK 344
             +LA      +V+L  +  + +E + LV E++P     N  +   +F           +
Sbjct: 52  RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETAR 104

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA--------RLF 396
            Y     IA  +L L    +L  IHRD+K  NIL+D++ + K++DFG+         R +
Sbjct: 105 FY-----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159

Query: 397 EMDQTHSDTNR 407
            ++ +H+   R
Sbjct: 160 YLNDSHNLLFR 170

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 28/175 (16%)

Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D I R   E 
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-IARVPDEQ 133

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 61.3 bits (148), Expect = 2e-10
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 10/167 (5%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  + ++ G+ +A+K+++   +  +    NE+L++   ++ N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++IHRD+K+ NILL  + + K++DFG       +Q+   T  +VGT
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 9/162 (5%)

Query: 250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVRLLG 307
           +KLG+G +  V+KG        +A+K +    ++G       EV LL  L+H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                +   LV+E++ ++ L  ++ +  N   M   K +     + RGL Y H   + +I
Sbjct: 71  IIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCH---KRKI 124

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           +HRDLK  N+L++ +   K++DFG+AR   +  T + +N VV
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV 165

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 16/148 (10%)

Query: 252 LGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           LG G FG + +G L   S  E  +A+  L    S +    F  E L L +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGLLYLHEDS 363
           G        ++V E++ N +LD F+     R+H   +   +   ++ G+A G+ YL E  
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL-----RKHEGQLVAGQLMGMLPGLASGMKYLSE-- 125

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFG 391
            +  +H+ L A  +L++S++  KIS F 
Sbjct: 126 -MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 10/167 (5%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++IHRD+K+ NILL  + + K++DFG       +Q  S  + +VGT
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 40/182 (21%)

Query: 246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           + D   LG G  G V+  + S+  + +AVK++     Q       E+ ++ RL H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 305 LLGFCLERKERILVYEFVPNA---------SLDHFIFDPINREHMTWEKRYKIIEG---- 351
                        VYE +  +         SL       I +E+M  +    + +G    
Sbjct: 67  -------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113

Query: 352 ---------IARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQT 401
                    + RGL Y+H  +   ++HRDLK +N+ +++E +  KI DFG+AR+ +   +
Sbjct: 114 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170

Query: 402 HS 403
           H 
Sbjct: 171 HK 172

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 26/164 (15%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGEIEFKNEVLLLAR 296
             +     +G G +G V   +   +G+ +A+K++         +K+   E K    +L  
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRH 60

Query: 297 LQHRNLVRLLGFCL----ERKERILVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIE 350
            +H N++ +         + K+  +V + + +  L H I    P+  EH+    RY + +
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHI----RYFLYQ 115

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            + RGL Y+H  +   +IHRDLK SN+L++ +   +I DFGMAR
Sbjct: 116 -LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 56/175 (32%), Positives = 82/175 (46%), Gaps = 19/175 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGM---LSNGE---TIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N S    LG G FG V +     LS  +    +AVK L   +   E E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM-TWEKRYKIIEGIAR 354
           L  H N+V LLG C      +++ E+     L +F+     RE   T E        +A+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAK 152

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           G+ +L   +    IHRDL A N+LL      KI DFG+AR    D  + D+N VV
Sbjct: 153 GMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR----DIMN-DSNYVV 199

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 12/166 (7%)

Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    M + G+  A K+L+K     ++G      E  +LA++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII--EGIARGLLYLHEDSRL 365
               + +  LV   +    L + I++ ++ E+  + +         I  GL +LH+    
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           RII+RDLK  N+LLD++ N +ISD G+A   E+    S T    GT
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGT 160

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 45/175 (25%), Positives = 86/175 (49%), Gaps = 16/175 (9%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKR------LSKNSKQGEIEFKNEVLLLARL 297
           NF    K+G+G F  VY+   L + + +A+K+      +   ++Q  ++   E+ LL +L
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGL 356
            H N+++ L   +E  E  +V E      L   I     ++ +  E+  +K    +   +
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++H  SR R++HRD+K +N+ + +    K+ D G+ R F    T + +  +VGT
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 11/153 (7%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   +N+    K+G+G  G V       +G  +AVK +    +Q      NEV+++   Q
Sbjct: 20  RSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 76

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H+N+V +    L  +E  ++ EF+   +L     D +++  +  E+   + E + + L Y
Sbjct: 77  HQNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCY 132

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           LH      +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFG 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 19/157 (12%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLS--KNSKQGE------IEFKNEVLLLARLQHRNL 302
           +LG+G FG VY  ++ + + +A +RL   K    GE      ++   E  LL++L H  +
Sbjct: 7   RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY---KIIEGIARGLLYL 359
           V+     LER    ++ E+     LD  +      E     K     ++ E   + LL +
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKL-----EELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H   + RI+HRDLKA NI L + +  KI DFG++RL 
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 28/165 (16%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSN--GETIAVKRLSKNSKQGE-IEFKNEVLLLARLQH- 299
           ++  D  ++G+G FG V K ML    G  +AVKR+     + E      ++ ++ R    
Sbjct: 4   EDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62

Query: 300 RNLVRLLG---------FCLERKERILVYEFVPNASLDHF--IFDPINREHMTWEKRYKI 348
             +V+  G          C+E          + + SLD F      + +  +  E   KI
Sbjct: 63  PYIVKFYGALFREGDCWICME----------LMDISLDKFYKYVYEVLKSVIPEEILGKI 112

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
                + L YL E+  L+IIHRD+K SNILLD   N K+ DFG++
Sbjct: 113 AVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 58/154 (37%), Positives = 78/154 (50%), Gaps = 23/154 (14%)

Query: 252 LGQGGFGAV----YKGMLSNGETIAVKRLSKNS--KQGEIEF---KNEVLLLARLQHRNL 302
           LG+G FG V     KG     E  AVK L K+   +  ++E    +  VL LA  +H  L
Sbjct: 3   LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 303 VRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLH 360
            +L   C + K+R+  V E+V    L   +F  I R     E R +     I  GL +LH
Sbjct: 59  TQLHS-CFQTKDRLFFVMEYVNGGDL---MFH-IQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           E     II+RDLK  N+LLDSE + KI+DFGM +
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 57/190 (30%), Positives = 85/190 (44%), Gaps = 14/190 (7%)

Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFK 288
            S     E++   TD +     +G+G +G VYK     +G   AVK L   S   E E +
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIE 66

Query: 289 NEVLLLARL-QHRNLVRLLGFCLERKERI-----LVYEFVPNASLDHFIFDPINREHMTW 342
            E  +L  L  H N+V+  G   +  + +     LV E     S+   +   +       
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 343 EKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           E     I+ G   GL +LH +   RIIHRD+K +NILL +E   K+ DFG++   ++  T
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTST 181

Query: 402 HSDTNRVVGT 411
               N  VGT
Sbjct: 182 RLRRNTSVGT 191

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 23/160 (14%)

Query: 252 LGQGGFGAVYKGMLSNG----------ETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
           LGQG F  +YKG+L             E   V ++  +  +  + F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           LV+L G C+ R E I+V E+V    LD F+    N   + W  +  + + +A  L YL +
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 362 DSRLRIIHRDLKASNILL----DSEMNP---KISDFGMAR 394
               +++H ++   NIL+     +E      K+SD G+  
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 33/175 (18%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    D + D  ++G G +G V   +    G  +A+K+L +   Q E+  K    E+ 
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELR 66

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHF----IFDP---------INREH 339
           LL  ++H N++ LL              F P+ SLD F    +  P         +  E 
Sbjct: 67  LLKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK 114

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           ++ ++   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 27/58 (46%), Positives = 36/58 (62%), Gaps = 3/58 (5%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           I RGL YLH      I+HRD+K  N+L++S    KI DFG+AR+ E D++   T  VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 52/187 (27%), Positives = 86/187 (45%), Gaps = 19/187 (10%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           D   +R     F     +G G +G VYKG  +  G+  A+K +     + E E K E+ +
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINM 65

Query: 294 LARL-QHRNLVRLLGFCLERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           L +   HRN+    G  +++       +  LV EF    S+   +    N +    ++ +
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV---KNTKGNALKEDW 122

Query: 347 --KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
              I   I RGL +LH     ++IHRD+K  N+LL      K+ DFG++   ++D+T   
Sbjct: 123 IAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGR 177

Query: 405 TNRVVGT 411
            N  +GT
Sbjct: 178 RNTFIGT 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 16/152 (10%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQ-HRNLVRLL 306
            K+G+G F  V K      G+  A+K + K+ K  E +    E+  L RL  H N++RL+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 307 GFCLERKER--ILVYEFVPNASLDHFIFDPI-NREHMTWEKRYK-IIEGIARGLLYLHED 362
               +RK     LV+E      +D  +++ I  R+    EKR K  +  + + L ++H  
Sbjct: 65  EVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH-- 117

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            R  I HRD+K  NIL+  +   K++DFG  R
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRL--SKNSKQGEIEFKNEVLLLARLQH- 299
           D+     +LG+G +G V K       TI AVKR+  + NS Q +     ++ +  R    
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDC 59

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHF---IFDPINREHMTWEKRYKIIEGIARGL 356
              V   G  L R+  + +   V + SLD F   ++D      +  +   KI   I + L
Sbjct: 60  PYTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKAL 116

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            YLH   +L +IHRD+K SN+L++     K+ DFG++
Sbjct: 117 EYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 23/154 (14%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEV--------LLLARLQHRNL 302
           +G+G FG V      ++G+  AVK L K +    I  K E         +LL  ++H  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA----ILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 303 VRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLH 360
           V L  +  +  +++  V ++V    L    F  + RE    E R +     IA  L YLH
Sbjct: 59  VGL-HYSFQTADKLYFVLDYVNGGEL----FFHLQRERSFPEPRARFYAAEIASALGYLH 113

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               L II+RDLK  NILLDS+ +  ++DFG+ +
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 54/175 (30%), Positives = 90/175 (51%), Gaps = 26/175 (14%)

Query: 236 FETIRVATDNFSDANK------LGQGGFGAVYKGMLSN-GETIAVKRLSK---NSKQGEI 285
           F +++VA   F+   +      +G G  G V     +  G  +AVK+LS+   N    + 
Sbjct: 7   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 66

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERK------ERILVYEFVPNASLDHFIFDPINREH 339
            ++ E++LL  + H+N++ LL     +K      +  LV E + +A+L   I   ++ E 
Sbjct: 67  AYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHER 124

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           M++   Y+++ GI     +LH      IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 125 MSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 6/105 (5%)

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           E +LL  + H +++R+    +      +V   +P+ S D + +       +  ++   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           + I  GL YLH     RIIHRD+K  NI ++      I D G A+
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 33/175 (18%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 68

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREH 339
           LL  ++H N++ LL              F P  SL+ F             + + +  + 
Sbjct: 69  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 116

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +T +    +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 27/179 (15%)

Query: 252 LGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL-QHRN 301
           LG+G FG V         K   +   T+AVK L  ++   ++ +  +E+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDP--INREHMTWEKRYKI 348
           ++ LLG C +     ++ E+    +L  ++           FD   +  E +T++     
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTN 406
              +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D     TN
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 21/158 (13%)

Query: 252 LGQGGFGAVYKG----MLSNGET----IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           LGQG F  ++KG    +   GE     + +K L K+ +     F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
              G C+   E I+V E+V   SLD ++    N  +++W  + ++ + +A  L +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 364 RLRIIHRDLKASNILLDSEM-----NP---KISDFGMA 393
              + H ++ A N+LL  E      NP   K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 51/151 (33%), Positives = 76/151 (50%), Gaps = 17/151 (11%)

Query: 252 LGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIE---FKNEVLLLARLQHRNLVRL 305
           LG+G FG V    +  +G   AVK L K+   +  ++E    +  +L LAR  H  L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 306 LGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDS 363
              C +  +R+  V EFV    L   +F  I +     E R +     I   L++LH+  
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDL---MFH-IQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              II+RDLK  N+LLD E + K++DFGM +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 52/151 (34%), Positives = 80/151 (52%), Gaps = 16/151 (10%)

Query: 252 LGQGGFGAVY---KGMLSN-GETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG V+   K    + G+  A+K L K + +    +  K E  +LA + H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 306 -LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDS 363
              F  E K   L+ +F+    L    F  +++E M  E+  K  +  +A  L +LH   
Sbjct: 64  HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH--- 115

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L II+RDLK  NILLD E + K++DFG+++
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 16/158 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNS----KQGEIEFKNEVLLLARLQ 298
           D+      +G G FG V+       E   A+K ++       KQ +    NE  +L  + 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ-HVHNEKRVLKEVS 59

Query: 299 HRNLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           H  ++RL  F  E  +R L  + E+VP   L  F +   +         +   E I   L
Sbjct: 60  HPFIIRL--FWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCAL 114

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            YLH      I++RDLK  NILLD E + K++DFG A+
Sbjct: 115 EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 43/148 (29%), Positives = 64/148 (43%), Gaps = 12/148 (8%)

Query: 252 LGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG GGFG V    + S   T A+K + K        +    +E  +L    H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHM-TWEKRYKIIEGIARGLLYLHEDSRLR 366
              ++K   ++ E+     L   + D   R     +  R+  I  +     YLH      
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARF-YIACVVLAFEYLH---NRG 113

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMAR 394
           II+RDLK  N+LLDS    K+ DFG A+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAK 141

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 54/166 (32%), Positives = 77/166 (46%), Gaps = 20/166 (12%)

Query: 246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRN 301
           F     LG+GGFG V    + + G+  A K+L K     ++GE    NE  +L ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 302 LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTW----EKRYKIIEG-IARG 355
           +V L  +  E K+ + LV   +    L   I+      HM      E R       I  G
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIY------HMGEAGFEEGRAVFYAAEICCG 114

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           L  LH++   RI++RDLK  NILLD   + +ISD G+A      QT
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 16/175 (9%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKR------LSKNSKQGEIEFKNEVLLLARL 297
           NF    K+G+G F  VY+   L +G  +A+K+      +   ++   I+   E+ LL +L
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQL 59

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGL 356
            H N+++     +E  E  +V E      L   I     ++ +  EK  +K    +   L
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++H  SR R++HRD+K +N+ + +    K+ D G+ R F    T + +  +VGT
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 47/190 (24%), Positives = 90/190 (47%), Gaps = 27/190 (14%)

Query: 241 VATDNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEV 291
           V  D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+
Sbjct: 15  VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74

Query: 292 LLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDP--INR 337
            ++  + +H+N++ LLG C +     ++ E+    +L  ++           ++P  +  
Sbjct: 75  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LF 396
           E ++++        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR + 
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 397 EMDQTHSDTN 406
            +D     TN
Sbjct: 192 HIDYYKKTTN 201

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 57/191 (29%), Positives = 82/191 (42%), Gaps = 48/191 (25%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSK-----NSKQGEI 285
           +FE +RV          LG G +G V+     G    G+  A+K L K      +K  E 
Sbjct: 1   NFELLRV----------LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH 50

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPIN--------- 336
                 +L A  +   LV L             Y F  +  L H I D +N         
Sbjct: 51  TRTERQVLEAVRRCPFLVTLH------------YAFQTDTKL-HLILDYVNGGELFTHLY 97

Query: 337 -REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
            REH T  +    I  I   L +LH+   L II+RD+K  NILLDSE +  ++DFG+++ 
Sbjct: 98  QREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154

Query: 396 F---EMDQTHS 403
           F   E ++ +S
Sbjct: 155 FLAEEEERAYS 165

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 16/192 (8%)

Query: 228 IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK-NSKQGEI 285
             K++ FD  +    +D +     +G+G +G V+K +   NG   AVK L   +    EI
Sbjct: 4   SGKTIIFD--SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERI-----LVYEFVPNASLDHFIFDPINR-EH 339
           E +  +L  A   H N+V+  G   ++  +      LV E     S+   +   + R E 
Sbjct: 62  EAEYNILK-ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           M       I+     GL +LH +   + IHRD+K +NILL +E   K+ DFG++   ++ 
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QLT 175

Query: 400 QTHSDTNRVVGT 411
            T    N  VGT
Sbjct: 176 STRLRRNTSVGT 187

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 29/188 (15%)

Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK 278
           EDE+ E+ I      D +  R    ++   N +G G FG VY+ + +   E +A+K++ +
Sbjct: 48  EDEDEEKMI------DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101

Query: 279 NSKQGEIEFKN-EVLLLARLQHRNLVRLLGF----CLERKERIL----VYEFVPNASLDH 329
           +      ++KN E+L++  L H N++ L  +    C ++ E+ +    V EF+P     +
Sbjct: 102 DP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKY 156

Query: 330 FIFDPINREH--MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-K 386
                 N     +   K Y     + R L Y+H      I HRDLK  N+L+D   +  K
Sbjct: 157 MKHYARNNHALPLFLVKLYSY--QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLK 211

Query: 387 ISDFGMAR 394
           + DFG A+
Sbjct: 212 LCDFGSAK 219

Length = 440

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 15/148 (10%)

Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRL---SKNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG G  G+V K   +  G  +A K +   +K+S + +I    E+ ++   +   +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70

Query: 308 FCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
             L      +  EF+   SLD       PI  E +      KI   +  GL YL+     
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VH 123

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMA 393
           RI+HRD+K SNIL++S    K+ DFG++
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 51/148 (34%), Positives = 74/148 (50%), Gaps = 12/148 (8%)

Query: 252 LGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    + + G+  A K+L K     ++GE    NE  +L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRL 365
           +  E K+ + LV   +    L   I++  N      E+R       I  GL  LH   R 
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD--EERAVFYAAEITCGLEDLH---RE 121

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMA 393
           RI++RDLK  NILLD   + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)

Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    + N G+  A K+L K     K GE     E  +L ++    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           +  E K  + LV   +    L + I++ +    +  E+       I  G+L+LH    + 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I++RD+K  N+LLD + N ++SD G+A   E+    + T R
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR 154

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 25/139 (17%)

Query: 268 GETIAVKRLSK------NSKQGEIEFKNEVLLLARLQHRNLVRLLG-FCLERK-----ER 315
           G+ +A+K+LS+      ++K+   E      L+  + H+N++ LL  F  ++      + 
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96

Query: 316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS 375
            LV E + +A+L   I   ++ E M++   Y+++ GI     +LH      IIHRDLK S
Sbjct: 97  YLVMELM-DANLCQVIQMDLDHERMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPS 147

Query: 376 NILLDSEMNPKISDFGMAR 394
           NI++ S+   KI DFG+AR
Sbjct: 148 NIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 49/184 (26%), Positives = 72/184 (39%), Gaps = 38/184 (20%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQGEIE-FKNEVLL 293
               D+F    KLG+G FG VYK  L N          +K   K ++ G +E + NE + 
Sbjct: 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK---KATEYGAVEIWMNERVR 184

Query: 294 ------LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD---PINREHMTW-- 342
                  A   +  L  +     +  E  LV+ +   ++L   +     P N E      
Sbjct: 185 RACPNSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK 242

Query: 343 --------EKRYKIIEGIARGLLY----LHEDSRLRIIHRDLKASNILLDSEMNP-KISD 389
                   E+  KII+ I R +L+    LH      I+HRD+K  NI+        KI D
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIID 299

Query: 390 FGMA 393
            G A
Sbjct: 300 LGAA 303

Length = 566

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 23/155 (14%)

Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLLG 307
           +G+G +G V     S   E +A+K+++ N+    I+ K    E+ LL  L H N++ +  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71

Query: 308 FCLERKER------ILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYL 359
             +    R       +VYE + +  L   I     ++ +H     +Y + + + RGL Y+
Sbjct: 72  -IMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHC----QYFLYQ-LLRGLKYI 124

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           H  +   ++HRDLK SN+LL++  + KI DFG+AR
Sbjct: 125 HSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 17/151 (11%)

Query: 252 LGQGGFGAVYKGML-SNGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRL 305
           +G+G FG V      S+G   AVK L K +     +Q  I  +  VLL   L+H  LV L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-KNLKHPFLVGL 61

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDS 363
             +  +  E++  V ++V    L    F  + RE    E R +     +A  + YLH   
Sbjct: 62  -HYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLHS-- 114

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L II+RDLK  NILLDS+ +  ++DFG+ +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 19/150 (12%)

Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 85

Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++   Y+++ GI     +LH    
Sbjct: 86  TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSAG- 139

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 140 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 19/150 (12%)

Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92

Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++   Y+++ GI     +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSAG- 146

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 19/153 (12%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLL- 306
           +G G +G+V         + +AVK+LS+   Q  I  +    E+ LL  ++H N++ LL 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 307 ----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
                  +E    + +   +  A L++ +    ++ EH+ +     +I  + RGL Y+H 
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKYIHS 136

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                IIHRDLK SN+ ++ +   +I DFG+AR
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 15/150 (10%)

Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V       +G+  AVK L K    N K+ +       +LL  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDSR 364
            +  +  E++  V +FV    L    F  + RE    E R +     IA  L YLH    
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           + I++RDLK  NILLDS+ +  ++DFG+ +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 7/154 (4%)

Query: 246 FSDANKLGQGGFG-AVYKGMLSNGETIAVKRL--SKNSKQGEIEFKNEVLLLARLQHRNL 302
           +    K+G+G FG A+      +G+   +K +  SK S +   E + EV +L+ ++H N+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           V+      E     +V ++     L    +  IN +        +I++   +  L L   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQICLALKHV 117

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
              +I+HRD+K+ NI L  +   K+ DFG+AR+ 
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 23/154 (14%)

Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIE---FKNEVLLLARLQHRNL 302
           LG+G FG V   ML+      E  A+K L K+   +  +++    +  +L LA  +H  L
Sbjct: 3   LGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFL 58

Query: 303 VRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLH 360
             L   C + K+R+  V E+V    L   +F  I R     E R +     +   L++LH
Sbjct: 59  TALHC-CFQTKDRLFFVMEYVNGGDL---MFQ-IQRSRKFDEPRSRFYAAEVTLALMFLH 113

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                 +I+RDLK  NILLD+E + K++DFGM +
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 10/147 (6%)

Query: 252 LGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    + + G+  A K+L K     ++GE    NE  +L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           +  E K+ + LV   +    L   I++  N         +   E +  GL  L    R R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RER 122

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMA 393
           I++RDLK  NILLD   + +ISD G+A
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 10/153 (6%)

Query: 246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRN 301
           F     LG+GGFG V    + + G+  A KRL K     ++GE    NE  +L ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 302 LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           +V L  +  E K+ + LV   +    L   I++ +       E+       I  GL  LH
Sbjct: 62  VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLH 119

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            ++    ++RDLK  NILLD   + +ISD G+A
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 24/52 (46%), Positives = 33/52 (63%), Gaps = 5/52 (9%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQT 401
           IA GL +LH      II+RDLK  N++LD+E + KI+DFGM +  +F    T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 16/151 (10%)

Query: 251 KLGQGGFGAVYKGMLSNGETIA---VKRLSKNSKQGEIEFKNEVLLLAR----LQHRNLV 303
           ++G G FG V    +     +A   VK L  N+   E   +NE L        LQH N++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNIL 58

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLLYLHE 361
           + LG C+E    +LV+E+     L  ++       R       +    E IA G+ ++H 
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE-IAAGVTHMH- 116

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGM 392
             +   +H DL   N  L S++  K+ D+G+
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 21/165 (12%)

Query: 254 QGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           +G FG+VY     S G+  A+K L K+   +K      K E  ++        V  L + 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 310 LERKERI-LVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            + K+ + LV E++        I     +  +   W K+Y  I  +  G+  LH+     
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLPED---WAKQY--IAEVVLGVEDLHQRG--- 117

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           IIHRD+K  N+L+D   + K++DFG++R    ++      + VGT
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGT 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 46/190 (24%), Positives = 78/190 (41%), Gaps = 36/190 (18%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNS---KQGEIEFKNE 290
           DFE+I+V          +G+G FG V        G   A+K+L K+    K+     + E
Sbjct: 2   DFESIKV----------IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAE 51

Query: 291 VLLLARLQHRNLVRLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
             +LA   +  +V+L  +   + E    L+ E++P   +            MT   +   
Sbjct: 52  RDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDM------------MTLLMKKDT 97

Query: 349 IEG------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
                    IA  +L +    +L  IHRD+K  N+LLD++ + K+SDFG+    +     
Sbjct: 98  FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Query: 403 SDTNRVVGTL 412
                +   L
Sbjct: 158 EFYRILSHAL 167

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 25/168 (14%)

Query: 243 TDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIEFKN-EVLLLARLQ 298
             NF     LG+G FG V         E  A+K L K+   +  ++E    E  +LA   
Sbjct: 1   DFNFLMV--LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 299 HRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG------ 351
               +  L  C +  +R+  V E+V    L +         H+    ++K  +       
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMY---------HIQQVGKFKEPQAVFYAAE 109

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           I+ GL +LH      II+RDLK  N++LDSE + KI+DFGM +   +D
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G +G VYK    +G+      L +    G  +    E+ LL  L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 310 LERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY-----LHED 362
           L   +R   L++++  +  L H I    +R     +K  ++  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEH-DLWHII--KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 363 SRLRIIHRDLKASNILLDSEMNP-----KISDFGMARLF 396
               ++HRDLK +NIL+  E  P     KI+D G ARLF
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 23/163 (14%)

Query: 251 KLGQGGFGAV----YKGMLSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQ-HRNL 302
           +LGQG +G V         S  ET+A+K+++ N    +I  K    E+ LL   + H+N+
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 303 VRLLGFCLERKER---ILVYEFVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLL 357
             L    +        + +YE +  A L   I    P+   H         I  I  GL 
Sbjct: 65  TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQS-----FIYQILCGLK 119

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           Y+H  +   ++HRDLK  N+L++++   KI DFG+AR F  + 
Sbjct: 120 YIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 17/167 (10%)

Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNS---KQGEIEFKNEV-LLLARLQHRNLVRLL 306
           +G+G FG V        E   AVK L K +   K+ E    +E  +LL  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSR 364
            F  +  +++  V +++    L    F  + RE    E R +     IA  L YLH    
Sbjct: 62  HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS--- 114

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           L I++RDLK  NILLDS+ +  ++DFG+ +  E  + +  T+   GT
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 47/170 (27%), Positives = 72/170 (42%), Gaps = 49/170 (28%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQHR--NLVR- 304
           +G G  G VYK      G  +AVK++ +   + E   I    +V+L +   H    +V+ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVKC 79

Query: 305 ---------------LLGFCLER-KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
                          L+  CL++  +RI     +P   L                   K+
Sbjct: 80  YGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILG------------------KM 119

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFE 397
              I + L YL E     +IHRD+K SNILLD+  N K+ DFG++ RL +
Sbjct: 120 TVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.1 bits (119), Expect = 8e-07
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 27/164 (16%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G +G VYK    +G+      L +    G  +    E+ LL  L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 310 LERKER--ILVYEFVPNASLDHFI----FDPINREHMTWEKR------YKIIEGIARGLL 357
           L   +R   L++++  +  L H I        N++ M   +       Y+I++GI     
Sbjct: 68  LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH---- 122

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP-----KISDFGMARLF 396
           YLH +    ++HRDLK +NIL+  E  P     KI+D G ARLF
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 51/153 (33%), Positives = 73/153 (47%), Gaps = 19/153 (12%)

Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNS--KQGEIE---FKNEVLLLARLQHRNLVRL 305
           LG+G FG V    L    E  A+K L K+   +  ++E    +  VL LA  +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61

Query: 306 LGFC-LERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHED 362
             FC  + KE +  V E++    L   I      +    E R +     I  GL +LH+ 
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD----EARARFYAAEIICGLQFLHKK 115

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
               II+RDLK  N+LLD + + KI+DFGM + 
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 22/162 (13%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE------------IEFK--NEVLLL 294
             LG+G +G V K      G+ +A+K++       +            I F    E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             ++H N++ L+   +E     LV + +  AS    + D   +  +T  +   I+  I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVD--RKIRLTESQVKCILLQILN 130

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           GL  LH+      +HRDL  +NI ++S+   KI+DFG+AR +
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY 169

Length = 335

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 23/169 (13%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGE--TIAVKRLSKNS--KQGEIEFK-NEVLLL 294
           ++  ++F+    LG G FG V      N +   +A+KR  K+   KQ +++   +E  +L
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG--- 351
             + H   V L G   +     LV EFV            I  E  T+ +R K       
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFV------------IGGEFFTFLRRNKRFPNDVG 133

Query: 352 ---IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
               A+ +L       L I++RDLK  N+LLD +   K++DFG A++ +
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182

Length = 340

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 18/163 (11%)

Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSK----NSKQGEIEFKNEVLLLARLQHRNLV 303
           LG+GG+G V++         G+  A+K L K     +++     K E  +L  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHED 362
            L+       +  L+ E++    L    F  + RE +  E      +  I+  L +LH  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLH-- 117

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHS 403
            +  II+RDLK  NILLD++ + K++DFG+ +  + E   TH+
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 14/146 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLG-F 308
           LG G  G VYK   L     +AVK +  + + + + +  +E+ +L +     ++   G F
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            +E +  I   EF+   SLD +   P   EH+      +I   + +GL YL     L+I+
Sbjct: 69  FVENRISICT-EFMDGGSLDVYRKIP---EHVLG----RIAVAVVKGLTYLWS---LKIL 117

Query: 369 HRDLKASNILLDSEMNPKISDFGMAR 394
           HRD+K SN+L+++    K+ DFG++ 
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 19/153 (12%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V   +    GE +A+K+++              E+ LL  L+H ++V +   
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 309 CL-----ERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            L     E K+  +V+E +  + L   I   D +  EH  +      +  + R L Y+H 
Sbjct: 68  MLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQF-----FLYQLLRALKYIHT 121

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +   + HRDLK  NIL +++   KI DFG+AR
Sbjct: 122 AN---VFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 32/133 (24%), Positives = 63/133 (47%), Gaps = 18/133 (13%)

Query: 273 VKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL--------LGFCLERKERILVYEFVPN 324
           + +  K   +  I+ +NE+L L RL H N++++          + + +K    +Y F+ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            + D           +  + R  I++ +   + Y+H+    ++IHRD+K  NI L+ +  
Sbjct: 256 EAFDW------KDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGK 305

Query: 385 PKISDFGMARLFE 397
             + DFG A  FE
Sbjct: 306 IVLGDFGTAMPFE 318

Length = 501

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 25/161 (15%)

Query: 252 LGQGGFGAVYKGML-----------SNGETIAV--KRLSKNSKQGEIEFKNEVLLLARLQ 298
           LG+G    +Y G+L           S  + I V  K L  + +   + F     ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H+++V L G C+   E I+V EFV    LD F+    +     W  ++K+ + +A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 359 LHEDSRLRIIHRDLKASNILL-----DSEMNP--KISDFGM 392
           L ED  L  +H ++   NILL     D E  P  K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 23/170 (13%)

Query: 245 NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           NF     LG G +G V+     +G         K  K+  I  K +     R + + L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 305 LLGFCLERKERILV---YEFVPNASLDHFIFDPINR----EHMTWEKRYK------IIEG 351
           +      R+   LV   Y F  +  L H I D IN      H++  +R+K          
Sbjct: 61  I------RQSPFLVTLHYAFQTDTKL-HLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           I   L +LH   +L II+RD+K  NILLDS  +  ++DFG+++ F  D+ 
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 45.1 bits (107), Expect = 4e-06
 Identities = 17/46 (36%), Positives = 20/46 (43%), Gaps = 5/46 (10%)

Query: 3   PSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDI 48
            S CR C+  A   L   CPNK      YD     +C LRY +Y  
Sbjct: 66  ASDCRSCLATAVSELRRCCPNKKGGRIWYD-----SCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 33/175 (18%)

Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLG 307
           +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L+ +   +   ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV- 60

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-----------EKRYKIIEGIARGL 356
                    + Y F     L  FI D +N   + +           E R+   E I  GL
Sbjct: 61  --------CMTYAFHTPDKL-CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE-IILGL 110

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+     VGT
Sbjct: 111 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 49/157 (31%), Positives = 72/157 (45%), Gaps = 29/157 (18%)

Query: 252 LGQGGFGAVYKGMLSN----GETIAVKRLSKNS--KQGEIEFKN-EVLLLARLQHRNLVR 304
           LG+G FG V   ML+      E  A+K L K+   +  ++E    E  +LA       + 
Sbjct: 8   LGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 305 LLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK------IIEGIARGLL 357
            L  C +  +R+  V E+V    L +          +    R+K          IA GL 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMY---------QIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +LH      II+RDLK  N++LDSE + KI+DFGM +
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 28/66 (42%), Positives = 38/66 (57%), Gaps = 8/66 (12%)

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH-SDT 405
           KI   + RGL YL E  + +I+HRD+K SNIL++S    K+ DFG++      Q   S  
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155

Query: 406 NRVVGT 411
           N  VGT
Sbjct: 156 NSFVGT 161

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 45.5 bits (108), Expect = 6e-06
 Identities = 37/158 (23%), Positives = 60/158 (37%), Gaps = 19/158 (12%)

Query: 247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV--R 304
           S    L  G    VY  + +  E   +K      K    + + EV +L  L  + L   +
Sbjct: 1   SSIKLLKGGLTNRVYL-LGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPK 57

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +L          L+ E++   +LD            + E++  I E +A  L  LH+   
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPL 107

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMA----RLFEM 398
           L + H DL   NIL+D      I D+  A      F++
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDL 145

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 8/148 (5%)

Query: 250 NKLGQGGFGAVYKGMLS-NGETIAVK--RLS-KNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           ++LG+G +G+VYK +    G T+A+K  RL    SK  +I    E+ +L +     +V  
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM--ELDILHKAVSPYIVDF 64

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            G         +  E++   SLD      +  E +  +   +I   + +GL +L E+   
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMA 393
            IIHRD+K +N+L++     K+ DFG++
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 55/175 (31%), Positives = 85/175 (48%), Gaps = 33/175 (18%)

Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLG 307
           +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L+ +   +   ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV- 60

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPIN--------REHMTW---EKRYKIIEGIARGL 356
            C+        Y F     L  FI D +N         +H  +   E R+   E I  GL
Sbjct: 61  -CMS-------YAFHTPDKLS-FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE-IILGL 110

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+     VGT
Sbjct: 111 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 9/146 (6%)

Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARLQHRNLVRLLGF 308
           +G+G +G V K       E +A+K+   + +  E++     E+ +L  L+  N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              R +  LV+E+V    L+      +  E        K+   I + +  +H   +  I+
Sbjct: 69  FRRRGKLYLVFEYVEKNMLE------LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122

Query: 369 HRDLKASNILLDSEMNPKISDFGMAR 394
           HRD+K  N+L+      K+ DFG AR
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.1 bits (112), Expect = 9e-06
 Identities = 49/164 (29%), Positives = 70/164 (42%), Gaps = 30/164 (18%)

Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQH 299
           +F     LG G FG V        GE  A+K L K      KQ +     E  +L  L H
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ-HVAQEKSILMELSH 77

Query: 300 RNLVRLL-GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR---- 354
             +V ++  F  E +   L+ EFV    L    F      H+   K  +    +A+    
Sbjct: 78  PFIVNMMCSFQDENRVYFLL-EFVVGGEL----F-----THL--RKAGRFPNDVAKFYHA 125

Query: 355 ----GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                  YLH      II+RDLK  N+LLD++ + K++DFG A+
Sbjct: 126 ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 14/149 (9%)

Query: 252 LGQGGFGAV-YKGMLSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+G FG V      ++G+  A+K L K    +K        E  +L   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRL 365
           +  + K+R+  V E+V    L    F  ++RE +  E R +     I   L YLH     
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I++RDLK  N++LD + + KI+DFG+ +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 14/151 (9%)

Query: 252 LGQGGFG-AVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G FG A+    +++ +  A+K  RL K+S   E   K E +LLA+++H N+V     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-EAVLLAKMKHPNIVAFKES 66

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINR---EHMTWEKRYKIIEGIARGLLYLHEDSRL 365
                   +V E+     L   I     +   E    +   ++  G+     ++HE    
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ----HIHEK--- 119

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           R++HRD+K+ NI L      K+ DFG ARL 
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 20/157 (12%)

Query: 268 GETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLL--GFCLERKERILVYEFV 322
           G  +A+K L  ++ + E +   F+ E  L ARL H N+V LL  G          V+E+V
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL--- 379
           P  +L   +        +   +  +++  +   L   H      I+HRDLK  NI++   
Sbjct: 62  PGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115

Query: 380 DSEMNPKISDFGMARLF----EMD-QTHSDTNRVVGT 411
               + K+ DFG+  L     + D  T + T  V+GT
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 24/187 (12%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAV----YKGMLSNGETIAVKRLSKNS--KQGEIEFK 288
               +R+  ++F     +G+G FG V    +K   S+ +  A+K LSK    K+ +  F 
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFF 90

Query: 289 -NEVLLLARLQHRNLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKR 345
             E  ++A      +V+L      + ++ L  V E++P   L + + +    E   W + 
Sbjct: 91  WEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARF 146

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSD 404
           Y      A  +L L     +  IHRD+K  N+LLD   + K++DFG   ++        D
Sbjct: 147 Y-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201

Query: 405 TNRVVGT 411
           T   VGT
Sbjct: 202 T--AVGT 206

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 23/95 (24%)

Query: 309 CLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR--------GLLYL 359
           C + + R+  V EFV    L   +F      HM  +++ K+ E  AR         L +L
Sbjct: 64  CFQTESRLFFVIEFVSGGDL---MF------HM--QRQRKLPEEHARFYSAEISLALNFL 112

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           HE     II+RDLK  N+LLD+E + K++D+GM +
Sbjct: 113 HERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 27/156 (17%)

Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIE---FKNEVLLLARLQHRNLVRL 305
           LG+G FG V+   L    +  A+K L K+      ++E    +  VL LA  +H  L  L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61

Query: 306 LGFC-LERKERIL-VYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIARGLLY 358
             +C  + KE +  V E++    L   I     FD         E        I  GL +
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGLQF 111

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           LH      I++RDLK  NILLD++ + KI+DFGM +
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 44/168 (26%)

Query: 252 LGQGGFGAV-YKGMLSNGETIAVKRLS-KNSKQGEIEF-KNEVLLLARLQHRNLVR---- 304
           +G+G +G V      ++G+   +K+L+ +N+ + E +  + E  LL++L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 305 ----------LLGFC----LERKERILVYEFVP-NASLDHFIFDPINREHMTWEKRYKII 349
                     ++GFC    L  K +    + +P N  ++ F+                  
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV------------------ 109

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
             IA  L YLHE     I+HRDLK  N+ L      K+ D G+AR+ E
Sbjct: 110 -QIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 28/156 (17%)

Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVL-------LLARLQHR 300
           LG+G FG V   +L    + G+  A+K L K      I  K+EV        +L   +H 
Sbjct: 3   LGKGTFGKV---ILVREKATGKYYAMKILKKEV----IIAKDEVAHTLTESRVLQNTRHP 55

Query: 301 NLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLY 358
            L  L  +  +  +R+  V E+     L    F  ++RE +  E R +     I   L Y
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALGY 110

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           LH      +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 111 LHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 24/165 (14%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEV-------LLLARLQHRNLVR 304
           +G+G FG V +  +   +T  +  L K  ++  I  ++EV        +LA++    +V 
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRIYAL-KTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57

Query: 305 LLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG---IARGLLYLH 360
           L  F  +  E++ LV  F+    L H         H+  E R+ +       A  L  L 
Sbjct: 58  L-KFSFQSPEKLYLVLAFINGGELFH---------HLQREGRFDLSRARFYTAELLCALE 107

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
              +  +I+RDLK  NILLD + +  + DFG+ +L   D   ++T
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 30/146 (20%), Positives = 58/146 (39%), Gaps = 17/146 (11%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRNLVRLLGFC 309
                   + K        +AVK+++ +S   E     + E++   +LQH N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTW---EK--RYKIIEGIARGLLYLHEDSR 364
           +   E  +V   +   S +  +     + H      E    + I++ +   L Y+H    
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLL-----KTHFPEGLPELAIAF-ILKDVLNALDYIH---S 119

Query: 365 LRIIHRDLKASNILLDSEMNPKISDF 390
              IHR +KAS+ILL  +    +S  
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 14/155 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKN---SKQGEIEFKNEVLLLARLQH 299
           D+F     +G+G FG V      + G   A+K L K     K+     + E  +L     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLL 357
             +V++     +++   L+ EF+P   +   +   D ++ E      ++ I E +    L
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIAETV----L 112

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM 392
            +    +L  IHRD+K  N+LLD++ + K+SDFG+
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 48/155 (30%), Positives = 69/155 (44%), Gaps = 25/155 (16%)

Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIE---FKNEVLLLARLQHRNLVRL 305
           LG+G FG V    L   GE  AVK L K+      ++E    +  VL LA  ++  L  L
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTHL 61

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG------IARGLLYL 359
                 ++    V EF+    L   I D         + R+ +         I  GL +L
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQD---------KGRFDLYRATFYAAEIVCGLQFL 112

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           H      II+RDLK  N++LD + + KI+DFGM +
Sbjct: 113 HSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 47/172 (27%), Positives = 71/172 (41%), Gaps = 32/172 (18%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNS---KQGEIEFKNE 290
           DF T++V          +G+G FG V        G+  A+K L K+    K      K E
Sbjct: 2   DFHTVKV----------IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAE 51

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
             +LA      +V L     + +   L+ EF+P   L            MT   +Y    
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL------------MTMLIKYDTFS 99

Query: 351 G------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
                  +A  +L +    +L  IHRD+K  NIL+D   + K+SDFG++  F
Sbjct: 100 EDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 24/164 (14%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSK-----NSKQGEIEFK 288
           DFE+++V          +G+G FG V      + G   A+K L K       + G I  +
Sbjct: 2   DFESLKV----------IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAE 51

Query: 289 NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
            ++L+ A      +V++     ++    L+ EF+P   +   +   + ++ +T E+    
Sbjct: 52  RDILVEA--DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFY 106

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM 392
           I   A  +L +    +L  IHRD+K  N+LLDS+ + K+SDFG+
Sbjct: 107 I---AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 21/49 (42%), Positives = 32/49 (65%), Gaps = 3/49 (6%)

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
           K I  +A  L YLH      IIHRDLK  N+L+ +E + K++DFG++++
Sbjct: 108 KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 19/101 (18%)

Query: 317 LVYEFVPNASLDHFIFDPIN----------REHMTWEKRYKIIEG-IARGLLYLHEDSRL 365
           L Y F   A L H I D ++          R++ + E   +   G I   L +LH   +L
Sbjct: 70  LHYAFQTEAKL-HLILDYVSGGEMFTHLYQRDNFS-EDEVRFYSGEIILALEHLH---KL 124

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHS 403
            I++RD+K  NILLDSE +  ++DFG+++ F   E ++T+S
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 28/185 (15%)

Query: 239 IRVATDNFSDANKLGQGGFGAV----YKGMLSNGETIAVKRLSKNS---KQGEIEFKNEV 291
           +++  +++     +G+G FG V    +K   S+ +  A+K LSK     +     F  E 
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 292 LLLARLQHRNLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
            ++A      +V+L  FC  + ++ L  V E++P   L + + +    E   W K Y   
Sbjct: 95  DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFYT-- 148

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT---HSDTN 406
              A  +L L     + +IHRD+K  N+LLD   + K++DFG     +MD+T     DT 
Sbjct: 149 ---AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDT- 202

Query: 407 RVVGT 411
             VGT
Sbjct: 203 -AVGT 206

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 15/178 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V K        I  ++L     +  I  +   E+ +L       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V   G      E  +  E +   SLD  + +    + +  E   K+   + RGL YL E
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLRE 121

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRVVGT 411
             + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+ GT
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR-EHMTWEKRYKI 348
           E+ +L  + HR ++ L+      + +  V   +P    D F +  ++R   +  E+   I
Sbjct: 136 EIDILKTISHRAIINLIH---AYRWKSTVCMVMPKYKCDLFTY--VDRSGPLPLEQAITI 190

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
              +   L YLH      IIHRD+K  NI LD   N  + DFG A
Sbjct: 191 QRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +ARG+ +L   SR + IHRDL A NILL      KI DFG+AR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 31/186 (16%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V+K        I  ++L     +  I  +   E+ +L       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE--------GIA 353
           +V   G      E  +  E +   SLD  +           +K  +I E         + 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL-----------KKAGRIPEQILGKVSIAVI 113

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDT 405
           +GL YL E  + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++   
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 171

Query: 406 NRVVGT 411
            R+ GT
Sbjct: 172 ERLQGT 177

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 30/153 (19%)

Query: 252 LGQGGFGAVYKGML-----------------------SNGETIAV--KRLSKNSKQGEIE 286
           LGQG    +Y G L                       +NG  + V  K L  + +   + 
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           F     L++++ H +L  + G C+   E I+V EFV +  LD  +     R  + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILL 379
            + + +A  L YL ED  L  +H ++ A NILL
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +ARG+ +L   SR + IHRDL A NILL      KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 29/174 (16%)

Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFC 309
           +G+G FG VY+    +   I A+K LSK     EI  K EV     +  RN LVR L   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKK----EIVAKKEVA--HTIGERNILVRTL--- 51

Query: 310 LERKERILVYEFVPNASLD-HFIFDPINREHMTW---------EKRYKI-IEGIARGLLY 358
           L+    I+  +F      D + + D ++   + W         E R K  I  +   L +
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGT 411
           LH+     I++RDLK  NILLD+  +  + DFG+++    + T +  TN   GT
Sbjct: 112 LHKYD---IVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGT 159

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 18/151 (11%)

Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRL 305
           LG+G FG V   +L    + G   A+K L K     + E  + V     LQ+     +  
Sbjct: 3   LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDS 363
           L +  +  +R+  V E+     L    F  ++RE +  E+R +     I   L YLH   
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 11/148 (7%)

Query: 252 LGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGF 308
           LG+G FG V      + G   A+K L K     + E  + +     LQ+     +  L +
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 309 CLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLR 366
             +  +R+  V E+     L    F  ++RE +  E R +     I   L YLH  S   
Sbjct: 63  SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKN 116

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMAR 394
           +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 24/106 (22%), Positives = 40/106 (37%), Gaps = 13/106 (12%)

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           LLARL H      L      + R+ +   +  A                 ++  ++ E +
Sbjct: 101 LLARL-HSVPPEALPLARRLRRRLKLLRQLAAALRRL-------VAAELLDRLAELWERL 152

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS---DFGMARL 395
              LL L     L ++H DL   N+L+D     +++   DF  A L
Sbjct: 153 LAALLALLPALPLVLVHGDLHPGNLLVDP--GGRVTGVIDFEDAGL 196

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 7/104 (6%)

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           E  +L  + H ++++L G     K   L+   +P    D + +    + ++       I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLA-AKRNIAICDILAIE 188

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
             + R + YLHE+   RIIHRD+KA NI ++   +  + DFG A
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 24/58 (41%), Positives = 32/58 (55%), Gaps = 8/58 (13%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR        +D+N VV
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVV 272

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +A+G+ +L   SR + IHRDL A NILL      KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 26/184 (14%)

Query: 235 DFETIRVATDNFSDANKLGQGGFG--AVYKGMLSNGETIAVKRLSKNS--KQGEIE-FKN 289
           DFE ++V          +G+G FG  AV K M + G+  A+K L+K    K+ E   F+ 
Sbjct: 2   DFEILKV----------IGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFRE 50

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYK 347
           E  +L     R +  L     +     LV ++     L   +  F+    E M    R+ 
Sbjct: 51  ERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFY 107

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           + E +    L +    +L  +HRD+K  N+LLD   + +++DFG       D T   +N 
Sbjct: 108 LAEMV----LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNV 162

Query: 408 VVGT 411
            VGT
Sbjct: 163 AVGT 166

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 8/58 (13%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           +A+G+ +L   +    IHRD+ A N+LL      KI DFG+AR        +D+N VV
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM-----NDSNYVV 270

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|201633 pfam01163, RIO1, RIO1 family

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 41/161 (25%), Positives = 60/161 (37%), Gaps = 39/161 (24%)

Query: 260 VYKGMLSNGETIAVK--RLSKNS-------KQGEIEFKNE-------VLLLARLQHRNLV 303
           VY     +G+ +AVK  R    S       + G+  F++        V L A  + RNL 
Sbjct: 2   VYHAYSEDGKKVAVKIYRTGTTSFKKRKRYRDGDFRFRDSKTSWRYLVRLWAEKEFRNLK 61

Query: 304 RLLGFCL------ERKERILVYEFV-----PNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           RL    +           +LV EF+     P   L       +  E    E   +II  +
Sbjct: 62  RLYEAGVPVPKPIAVNRHVLVMEFIGDDGVPAPRLKD-----VELEEEAEEIYDEIIREM 116

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            R  LY        ++H DL   N+L+D +  P I D   A
Sbjct: 117 RR--LYQEA----GLVHGDLSEYNVLVDDD-KPVIIDVPQA 150

This is a family of atypical serine kinases which are found in archaea, bacteria and eukaryotes. Activity of Rio1 is vital in Saccharomyces cerevisiae for the processing of ribosomal RNA, as well as for proper cell cycle progression and chromosome maintenance. The structure of RIO1 has been determined. Length = 186

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 46/170 (27%), Positives = 65/170 (38%), Gaps = 38/170 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN-----SKQGEIEFK 288
            F+ I++          LG+G  G V+   L   G+  A+K L K      +K   +  +
Sbjct: 2   HFKKIKL----------LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTE 51

Query: 289 NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
            E+L  A L H  L  L           LV ++ P   L   +            K    
Sbjct: 52  QEIL--ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-------QRQPGKCLS- 101

Query: 349 IEGIAR--------GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF 390
            E +AR         L YLH    L I++RDLK  NILL    +  +SDF
Sbjct: 102 -EEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDF 147

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 17/41 (41%), Positives = 27/41 (65%)

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           LL +H      +IHRD+K++NILL S    K+ DFG ++++
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193

Length = 496

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 28/87 (32%), Positives = 44/87 (50%), Gaps = 7/87 (8%)

Query: 309 CLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
           C +   R+ LV E+V    L   +F    +  +  E        I   L +LHE     I
Sbjct: 64  CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---I 117

Query: 368 IHRDLKASNILLDSEMNPKISDFGMAR 394
           I+RDLK  N+LLD++ + K++D+GM +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 45/180 (25%), Positives = 86/180 (47%), Gaps = 36/180 (20%)

Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET---IAVKRLSKNS----KQGEIE 286
            DFETI++ ++          G +GAVY  ++ + ET    A+K+++K +     Q +  
Sbjct: 1   EDFETIKLISN----------GAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQV 48

Query: 287 F-KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS----LDHFIFDPINREHMT 341
           F + ++L  A  ++  +V +      ++   +V E+V        L +    P++   M 
Sbjct: 49  FVERDILTFA--ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY 106

Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           + +    +E       YLH      I+HRDLK  N+L+ S  + K++DFG++++  M  T
Sbjct: 107 FAETVLALE-------YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 47/219 (21%), Positives = 85/219 (38%), Gaps = 68/219 (31%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAV---KRLSKNSKQGEIEFKN------- 289
           R ++D+F   +KLG G FG  ++G+    +   V    +L+   K+  +  K        
Sbjct: 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG 200

Query: 290 ---------------------EVLLLARLQHRNLV-----RLLGF--------CLERKER 315
                                E  + A+++   +        LG+           +  +
Sbjct: 201 VRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQ 260

Query: 316 ILVYEFVPNASLDHFIFDPIN----------------REHMTWEKR-YKIIEGIAR---- 354
            LV++F  +A+L   +   +                  ++M  +KR   +I+G+ R    
Sbjct: 261 WLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLT 320

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           GL  LH   R+ I+HRD+K  N+L+  +   KI DFG A
Sbjct: 321 GLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	412
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.98
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.97
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG0198	313	consensus MEKK and related serine/threonine protei	99.96
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.95
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.95
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.95
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.95
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.95
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.94
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.94
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.94
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.94
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.94
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.94
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.94
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.94
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.94
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.93
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.93
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.93
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.93
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.93
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
KOG0589	426	consensus Serine/threonine protein kinase [General	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.93
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.93
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.93
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.93
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.93
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.93
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.93
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.93
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.93
PTZ00283	496	serine/threonine protein kinase; Provisional	99.93
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.93
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.93
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.93
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.93
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.93
PHA03212	391	serine/threonine kinase US3; Provisional	99.93
KOG0610	459	consensus Putative serine/threonine protein kinase	99.93
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.93
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.93
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.93
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.93
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.93
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.93
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.93
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.93
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.93
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.93
PHA03211	461	serine/threonine kinase US3; Provisional	99.93
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.93
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.92
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.92
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.92
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.92
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.92
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.92
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.92
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.92
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.92
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.92
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.92
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.92
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.92
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.92
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.92
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.92
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.92
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.92
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.92
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.92
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.92
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.92
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.92
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.92
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.92
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.92
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.92
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.92
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.92
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.92
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.92
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.92
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.92
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.92
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.92
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.92
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.92
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.92
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.92
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.91
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.91
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.91
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.91
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.91
PHA03207	392	serine/threonine kinase US3; Provisional	99.91
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.91
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.91
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.91
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.91
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.91
KOG0584	632	consensus Serine/threonine protein kinase [General	99.91
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.91
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.91
PTZ00036	440	glycogen synthase kinase; Provisional	99.91
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.91
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.91
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.91
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.91
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.91
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.91
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.91
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.91
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.91
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.91
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.91
PHA03209	357	serine/threonine kinase US3; Provisional	99.91
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.91
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.91
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.91
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.91
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.91
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.91
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.91
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.91
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.91
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.91
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.91
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.91
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.91
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.91
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.91
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.91
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.91
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.91
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.9
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.9
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.9
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.9
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.9
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.9
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.9
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.9
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.9
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.9
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.9
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.9
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.9
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.9
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.9
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.9
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.9
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.9
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.9
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.9
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.9
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.9
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.9
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.9
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.9
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.9
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.9
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.9
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.9
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.9
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.9
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.9
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.9
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.89
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.89
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.89
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.89
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.89
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.89
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.89
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.89
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.89
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.89
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.89
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.89
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.89
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.89
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.89
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.89
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.89
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.89
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.89
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.89
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.89
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.89
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.89
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.89
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.89
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.89
PHA03210	501	serine/threonine kinase US3; Provisional	99.89
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.89
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.89
PLN00009	294	cyclin-dependent kinase A; Provisional	99.89
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.89
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.88
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.88
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.88
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.88
PTZ00284	467	protein kinase; Provisional	99.88
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.88
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.88
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.88
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.88
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.88
KOG1152	772	consensus Signal transduction serine/threonine kin	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.88
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.88
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.88
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.88
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.87
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.87
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.87
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.87
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.87
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.87
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.87
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.87
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.87
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.87
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.87
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.87
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.87
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.87
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.87
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.87
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.87
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.87
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.87
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.86
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.86
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.86
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.86
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.86
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.86
PHA02882	294	putative serine/threonine kinase; Provisional	99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.86
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.86
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.85
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.84
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.84
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.84
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.84
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.84
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.83
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.83
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.82
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.81
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
smart00090	237	RIO RIO-like kinase.	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.8
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.78
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.76
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.75
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.71
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.71
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.65
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.65
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.44
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.38
PLN00181	793	protein SPA1-RELATED; Provisional	99.38
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.3
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.3
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.19
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.16
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.09
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.07
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.05
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.92
PF01657	106	Stress-antifung: Salt stress response/antifungal;	98.9
KOG1243	690	consensus Protein kinase [General function predict	98.84
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.79
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.76
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.73
PRK09902	216	hypothetical protein; Provisional	98.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.63
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.59
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.57
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.54
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.48
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.48
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.47
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.42
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.39
PF01636	239	APH: Phosphotransferase enzyme family This family	98.34
PLN02876	822	acyl-CoA dehydrogenase	98.29
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.29
PRK10593	297	hypothetical protein; Provisional	98.09
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.02
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.92
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.88
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.88
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.85
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.72
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.71
PRK05231	319	homoserine kinase; Provisional	97.53
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.36
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.26
PLN02236	344	choline kinase	97.2
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.18
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.12
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.02
KOG0606	1205	consensus Microtubule-associated serine/threonine	96.9
PLN02756	418	S-methyl-5-thioribose kinase	96.84
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.78
KOG2270	520	consensus Serine/threonine protein kinase involved	96.67
COG2334	331	Putative homoserine kinase type II (protein kinase	96.6
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.57
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.44
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.41
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.39
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.24
PRK12396	409	5-methylribose kinase; Reviewed	96.15
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.13
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.06
PRK06148	1013	hypothetical protein; Provisional	95.97
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.74
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.44
PRK11768	325	serine/threonine protein kinase; Provisional	95.42
COG4248	637	Uncharacterized protein with protein kinase and he	95.28
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.87
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.8
PTZ00384	383	choline kinase; Provisional	94.38
PRK10271	188	thiK thiamine kinase; Provisional	93.03

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=315.51  Aligned_cols=168  Identities=55%  Similarity=0.917  Sum_probs=154.1

Q ss_pred             cccccchHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEE
Q 015138          230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC  309 (412)
Q Consensus       230 ~~~~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~  309 (412)
                      ....|++.+++.+|++|+..+.||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568999999999999999999999999999999999999999988776554245699999999999999999999999


Q ss_pred             ecCC-eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEe
Q 015138          310 LERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       310 ~~~~-~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                      .+.+ +.+||||||++|+|+++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875443 89999999999999999999999988899999999999999999999999


Q ss_pred             ccCCcccccC
Q 015138          389 DFGMARLFEM  398 (412)
Q Consensus       389 DfGla~~~~~  398 (412)
                      |||||+....
T Consensus       220 DFGLa~~~~~  229 (361)
T KOG1187|consen  220 DFGLAKLGPE  229 (361)
T ss_pred             CccCcccCCc
Confidence            9999976654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=271.51  Aligned_cols=161  Identities=35%  Similarity=0.592  Sum_probs=141.3

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHc--cCCCCccceeeEEEecCC----eee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLA--RLQHRNLVRLLGFCLERK----ERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~g~~~~~~----~~~  316 (412)
                      ....+..++||+|+||.||||.+. ++.||||++.....+   .|.+|-.+..  .++|+||++|++.-....    +.+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kq---s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQ---SFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHH---HHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            456667889999999999999995 599999999765443   5666666554  568999999999987666    889


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC------CCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED------SRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      ||+||.++|+|.+||    ....++|....+|+..+++||+|||++      .+++|+|||||++||||.+|+++.|+||
T Consensus       285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            999999999999999    457899999999999999999999975      4678999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccc
Q 015138          391 GMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~Gt  411 (412)
                      |||.++.+++...++..-+||
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhh
Confidence            999999999888888788898

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=264.42  Aligned_cols=161  Identities=32%  Similarity=0.525  Sum_probs=141.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ..+|...++||.|+|+.||+|++ .++..||||.+.+.  ..+..+.+..|+.+|+.++|||||+|++++..++.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            36788889999999999999995 56899999999776  4455566899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC------CCeEEeccCCc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE------MNPKISDFGMA  393 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~------~~~ki~DfGla  393 (412)
                      |||.+|+|.+||+.   .+.+++.....++.|+|.||++||+++   ||||||||.||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999954   457999999999999999999999998   9999999999999875      35899999999


Q ss_pred             ccccCCCcccccccccccC
Q 015138          394 RLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       394 ~~~~~~~~~~~~~~~~Gt~  412 (412)
                      |.+.+....   ..++||+
T Consensus       163 R~L~~~~~a---~tlcGSp  178 (429)
T KOG0595|consen  163 RFLQPGSMA---ETLCGSP  178 (429)
T ss_pred             hhCCchhHH---HHhhCCc
Confidence            998755432   1266663

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=262.99  Aligned_cols=163  Identities=36%  Similarity=0.606  Sum_probs=138.7

Q ss_pred             CCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCccc--HHHHHHHHHHHccCCCCccceeeEEEecCC-eeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHRNLVRLLGFCLERK-ERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-~~~lv~Ey  321 (412)
                      .+...+.||+|+||+||+|.+.....||||++.......  ..+|.+|+.+|.+++|||||+|+|.|.+.. ...|||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            334456699999999999999754459999998754333  458999999999999999999999999988 79999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCcccccCCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQ  400 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~~~  400 (412)
                      |++|+|.++++.. ....+++..++.|+.|||+||.|||++++  ||||||||+||||+.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999764 46789999999999999999999999863  99999999999999997 99999999999765432


Q ss_pred             cccccccccccC
Q 015138          401 THSDTNRVVGTL  412 (412)
Q Consensus       401 ~~~~~~~~~Gt~  412 (412)
                        ...+...||+
T Consensus       199 --~~~~~~~GT~  208 (362)
T KOG0192|consen  199 --TSMTSVAGTY  208 (362)
T ss_pred             --ccccCCCCCc
Confidence              1222366774

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-33  Score=263.28  Aligned_cols=161  Identities=33%  Similarity=0.516  Sum_probs=145.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ..|...+.||+|+|.++|+++. .+|+.||+|++.+..   ......+.+||++.+.|+|||||+|+++|++.+.+|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999995 889999999998742   334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+|++++|.+++.   .+..+++.++..++.||+.||.|||+.+   |+|||||..|++|++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999985   4678999999999999999999999988   999999999999999999999999999999876


Q ss_pred             CcccccccccccC
Q 015138          400 QTHSDTNRVVGTL  412 (412)
Q Consensus       400 ~~~~~~~~~~Gt~  412 (412)
                      +....|  ++||+
T Consensus       172 ~Erk~T--lCGTP  182 (592)
T KOG0575|consen  172 GERKKT--LCGTP  182 (592)
T ss_pred             ccccce--ecCCC
Confidence            544433  88985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=263.35  Aligned_cols=159  Identities=31%  Similarity=0.552  Sum_probs=140.1

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +.+..+.+...++||+|.||.||.|.++....||||.++... .....|.+|+.+|++|+|+|||+|+|+|..++.++||
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            333444455678999999999999999877799999998763 3445788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||||+.|+|.+||.. .....+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+||||||...+
T Consensus       280 tE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC
Confidence            999999999999976 34567888999999999999999999987   99999999999999999999999999997666


Q ss_pred             CCcc
Q 015138          399 DQTH  402 (412)
Q Consensus       399 ~~~~  402 (412)
                      ++..
T Consensus       356 ~~Y~  359 (468)
T KOG0197|consen  356 DEYT  359 (468)
T ss_pred             Ccee
Confidence            6543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-33  Score=252.27  Aligned_cols=162  Identities=28%  Similarity=0.446  Sum_probs=138.3

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc-------cHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ-------GEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      ..+.|...+.||+|+||.|-+|. ..+|+.||||++++....       ......+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34567788999999999999999 678999999999875322       1233579999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC---CCeEEecc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDF  390 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~Df  390 (412)
                      ..||||||++||+|.+++..   .+.+.+..-..++.|++.|+.|||+++   |+||||||+|||+..+   -.+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999854   456777777889999999999999998   9999999999999776   67999999


Q ss_pred             CCcccccCCCcccccccccccC
Q 015138          391 GMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      ||||.......   +...+||+
T Consensus       324 GlAK~~g~~sf---m~TlCGTp  342 (475)
T KOG0615|consen  324 GLAKVSGEGSF---MKTLCGTP  342 (475)
T ss_pred             chhhcccccee---hhhhcCCc
Confidence            99998764332   33478885

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=3e-32  Score=253.67  Aligned_cols=161  Identities=31%  Similarity=0.533  Sum_probs=139.6

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  317 (412)
                      .+.|+.+++||+|.||.||+++ ..+|+.||+|++....  .....-..+||.+|++|+||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3567778999999999999999 6889999999997654  22344568999999999999999999998876  68999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |+|||++ +|.-++..  ..-.++..++..++.|++.||+|||..+   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999975 77777643  3457999999999999999999999998   9999999999999999999999999999998


Q ss_pred             CCCccccccccc
Q 015138          398 MDQTHSDTNRVV  409 (412)
Q Consensus       398 ~~~~~~~~~~~~  409 (412)
                      .......|++|+
T Consensus       270 ~~~~~~~T~rVv  281 (560)
T KOG0600|consen  270 PSGSAPYTSRVV  281 (560)
T ss_pred             CCCCcccccceE
Confidence            877666666654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=241.73  Aligned_cols=164  Identities=28%  Similarity=0.394  Sum_probs=143.6

Q ss_pred             hhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ...++|+..++||+|+||+||+++ .++++.+|+|.+++...   ........|..+|.+++||.||+|+..+++.+.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            345789999999999999999999 46688999999987642   23456889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||+||+.||.|..+|.   +++.+++..+.-++.+|+.||.|||+.+   ||||||||+|||||++|+++|+||||++..
T Consensus       102 lVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999984   4677999988889999999999999998   999999999999999999999999999976


Q ss_pred             cCCCcccccccccccC
Q 015138          397 EMDQTHSDTNRVVGTL  412 (412)
Q Consensus       397 ~~~~~~~~~~~~~Gt~  412 (412)
                      ..+...  |+.++||.
T Consensus       176 ~~~~~~--t~tfcGT~  189 (357)
T KOG0598|consen  176 LKDGDA--TRTFCGTP  189 (357)
T ss_pred             ccCCCc--cccccCCc
Confidence            544432  33488984

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=239.01  Aligned_cols=159  Identities=31%  Similarity=0.429  Sum_probs=136.7

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCC-eeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERK-ERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-~~~lv~E  320 (412)
                      ++++..+.||+|..|+||++.+ .+++.+|+|.+...... ..+++.+|++++.+.+||+||+++|.|.... ++.|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            3555688999999999999995 56888999999655433 3567899999999999999999999999988 5999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ||.+|||+.++..   .+.+++...-+|+.+|++||.|||+..  +||||||||+|||+++.+++||+|||.++.+... 
T Consensus       159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999854   366999999999999999999999732  4999999999999999999999999999988644 


Q ss_pred             ccccccccccc
Q 015138          401 THSDTNRVVGT  411 (412)
Q Consensus       401 ~~~~~~~~~Gt  411 (412)
                         ..+..+||
T Consensus       233 ---~a~tfvGT  240 (364)
T KOG0581|consen  233 ---IANTFVGT  240 (364)
T ss_pred             ---hccccccc
Confidence               22336666

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=1.7e-31  Score=263.56  Aligned_cols=160  Identities=31%  Similarity=0.531  Sum_probs=140.0

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEe
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCL  310 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~  310 (412)
                      .....+.+.+..++||+|+||+||+|...      +...||||.++..... ...+|++|+++++.++|||||+|+|+|.
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            34455677788899999999999999953      3457999999887655 6789999999999999999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCC-------C----CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPI-------N----REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill  379 (412)
                      +++..+||+|||..|||.+||....       .    ..+|+..+.+.|+.|||.||.||-+++   +|||||..+|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence            9999999999999999999995311       1    344899999999999999999999987   9999999999999


Q ss_pred             CCCCCeEEeccCCcccccCCC
Q 015138          380 DSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       380 ~~~~~~ki~DfGla~~~~~~~  400 (412)
                      .+++.|||+||||+|.+-..+
T Consensus       637 ge~l~VKIsDfGLsRdiYssD  657 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSD  657 (774)
T ss_pred             ccceEEEecccccchhhhhhh
Confidence            999999999999999764433

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-31  Score=247.31  Aligned_cols=158  Identities=30%  Similarity=0.478  Sum_probs=138.3

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCccc-HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ...+...+.++||+|.||+|.++....+.+||||+++...... +.+|..|+++|.+++||||++|+|+|..++.+++|+
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            3445566789999999999999999888999999998876554 478999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |||++|+|..|+....... +.-...++|+.||+.||+||.+..   +|||||.++|+|+|.++++||+|||++|-+-..
T Consensus       615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999996533222 455667789999999999999876   999999999999999999999999999977655


Q ss_pred             Ccc
Q 015138          400 QTH  402 (412)
Q Consensus       400 ~~~  402 (412)
                      +.+
T Consensus       691 ~yy  693 (807)
T KOG1094|consen  691 DYY  693 (807)
T ss_pred             Cce
Confidence            544

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=1.9e-30  Score=223.67  Aligned_cols=151  Identities=32%  Similarity=0.556  Sum_probs=135.3

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCccc--HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|...++||+|.||.||+|+ ..+|+.||||+++.....+  .....+|++.|+.++|+||+.|++++...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            457778999999999999999 6789999999998664332  3457899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ||+ .+|+..+++  +...++......++.++++||+|||++.   |+||||||.|+|+++++.+||+|||||+.+.+..
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 589999876  4667999999999999999999999998   9999999999999999999999999999986543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-30  Score=234.58  Aligned_cols=169  Identities=30%  Similarity=0.428  Sum_probs=140.4

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHH--ccCCCCccceeeEEEecC
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLL--ARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~g~~~~~  312 (412)
                      ++-..+....+....+.||+|.||.||+|.|+ |+.||||++...++.   .+.+|.++.  ..|+|+||+.|++.-..+
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            34445566678888999999999999999996 899999999765544   455566555  456999999999876544


Q ss_pred             C----eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-----CCCCCceecCCCCCCEEECCCC
Q 015138          313 K----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-----DSRLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       313 ~----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~ivHrdlk~~Nill~~~~  383 (412)
                      .    ++|||++|.++|||.+||    .+..++....++++..+|.||+|||.     +++|.|.|||||+.|||+.+++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            3    689999999999999999    45789999999999999999999995     5789999999999999999999


Q ss_pred             CeEEeccCCcccccCCCc--cccccccccc
Q 015138          384 NPKISDFGMARLFEMDQT--HSDTNRVVGT  411 (412)
Q Consensus       384 ~~ki~DfGla~~~~~~~~--~~~~~~~~Gt  411 (412)
                      .+-|+|+|||.....+..  ....+..+||
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGT  383 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGT  383 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccce
Confidence            999999999998866532  2335556777

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.9e-32  Score=233.23  Aligned_cols=167  Identities=28%  Similarity=0.471  Sum_probs=140.8

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEE-ecCCe-eeEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFC-LERKE-RILV  318 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~-~~~~~-~~lv  318 (412)
                      .+|++.++||.|+||+||++. +.+|..||.|.+.-.  +.+..+.+..|+.+|+.|+|||||+++++. .++.+ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457788999999999999999 788999999988643  344566789999999999999999999954 44444 7899


Q ss_pred             EecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCC-CCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          319 YEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDS-RLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||+..|+|..++... ...+.+++...+++..|++.||.++|..- +..|+||||||.||+|+.+|.+||+||||+|.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998543 23456899999999999999999999842 123999999999999999999999999999999


Q ss_pred             cCCCcccccccccccC
Q 015138          397 EMDQTHSDTNRVVGTL  412 (412)
Q Consensus       397 ~~~~~~~~~~~~~Gt~  412 (412)
                      +...+..  +..+||+
T Consensus       179 ~s~~tfA--~S~VGTP  192 (375)
T KOG0591|consen  179 SSKTTFA--HSLVGTP  192 (375)
T ss_pred             cchhHHH--HhhcCCC
Confidence            8776653  3588885

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=253.43  Aligned_cols=152  Identities=33%  Similarity=0.557  Sum_probs=137.6

Q ss_pred             cCCCccccccccCCeeEEEEEeCC----CCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +...+.++||.|.||.|++|.++.    ...||||.|+... .+.+.+|..|..+|.+++||||++|.|+.......+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            445678899999999999999742    3469999998775 44567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      .|||+||+|+.||+.  +.+.+++.++..+..+||.||.||.+.+   .|||||.++||||+.+..+||+||||+|.+++
T Consensus       709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999976  4567999999999999999999999887   99999999999999999999999999998877


Q ss_pred             CC
Q 015138          399 DQ  400 (412)
Q Consensus       399 ~~  400 (412)
                      +.
T Consensus       784 d~  785 (996)
T KOG0196|consen  784 DP  785 (996)
T ss_pred             CC
Confidence            66

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=1.7e-30  Score=227.79  Aligned_cols=151  Identities=25%  Similarity=0.448  Sum_probs=133.0

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc--HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      +.|+...++|+|+||.||+++. ++|+.||||++.+.....  .+-.++|+++|+.++|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4577788999999999999994 669999999997765432  2336899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc-CC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE-MD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~-~~  399 (412)
                      |++..-|+++-.   ....++.....+++.|++.|+.|+|+++   +|||||||+||||..++.+||+|||+||.+. ++
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            999877776642   3566889999999999999999999998   9999999999999999999999999999987 44


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      +
T Consensus       156 d  156 (396)
T KOG0593|consen  156 D  156 (396)
T ss_pred             c
Confidence            3

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=241.83  Aligned_cols=154  Identities=30%  Similarity=0.397  Sum_probs=137.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc---ccHHHHHHHHHHHccC-CCCccceeeEEEecCCee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  315 (412)
                      ...++|..++.||+|+|++|++++ ..+++.+|||++.+...   ........|-..|.+| .||.|++|+-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            345789999999999999999999 56789999999977532   2233467788888888 899999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      |+|+||.++|+|.++|..   -+.+++.....++.+|+.||+|||+.+   ||||||||+|||||.||++||+|||-|+.
T Consensus       150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999954   577999999999999999999999998   99999999999999999999999999999


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +.+.+
T Consensus       224 l~~~~  228 (604)
T KOG0592|consen  224 LSPSQ  228 (604)
T ss_pred             CChhh
Confidence            87654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-30  Score=244.81  Aligned_cols=156  Identities=33%  Similarity=0.515  Sum_probs=136.6

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEEeCC--C---CEEEEEEecc---CCcccHHHHHHHHHHHccCCCCccceeeEE
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSN--G---ETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF  308 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~--~---~~vavK~l~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~g~  308 (412)
                      ..++...++....++||+|+||.||+|.+..  +   ..||||....   .......+|+.|.++|.+++|||||+|+|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3455666777778999999999999999643  2   2389998875   234556789999999999999999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEe
Q 015138          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       309 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                      +....+++||||++.||+|+++|...  ...++..+++.++.+.|.||+|||+++   +|||||.++|+|++.+..+||+
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence            99999999999999999999999652  336999999999999999999999988   9999999999999999999999


Q ss_pred             ccCCccccc
Q 015138          389 DFGMARLFE  397 (412)
Q Consensus       389 DfGla~~~~  397 (412)
                      ||||++.-.
T Consensus       305 DFGLs~~~~  313 (474)
T KOG0194|consen  305 DFGLSRAGS  313 (474)
T ss_pred             ccccccCCc
Confidence            999988643

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-30  Score=222.66  Aligned_cols=160  Identities=31%  Similarity=0.383  Sum_probs=141.4

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..++|+..+.||.|+||+|.+.+. .+|..+|+|.+.+...-   ..+...+|..+|+.+.||++++|++.+.+.+.++|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            346788999999999999999994 56888999999876432   23457899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||++||.|..+|+.   .+.+++..+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+...
T Consensus       122 vmeyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            9999999999999954   567999999999999999999999988   9999999999999999999999999999876


Q ss_pred             CCCcccccccccccC
Q 015138          398 MDQTHSDTNRVVGTL  412 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt~  412 (412)
                      ..     |..++||+
T Consensus       196 ~r-----T~TlCGTP  205 (355)
T KOG0616|consen  196 GR-----TWTLCGTP  205 (355)
T ss_pred             Cc-----EEEecCCc
Confidence            43     33477874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=5.9e-30  Score=232.19  Aligned_cols=152  Identities=24%  Similarity=0.510  Sum_probs=137.9

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .+|++.+.||+|.||+|-++. ...|+.||||.+.+....   +...+.+||++|..|+||||+.++.+|++.+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            356778899999999999998 578999999999876544   4455789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||..+|.|.+|+.+   ++.|++.+..+++.||..|+.|+|.+.   ++|||||.+|||||.++++||+||||+..+..+
T Consensus       133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999944   677999999999999999999999987   999999999999999999999999999988765


Q ss_pred             Cc
Q 015138          400 QT  401 (412)
Q Consensus       400 ~~  401 (412)
                      ..
T Consensus       207 kf  208 (668)
T KOG0611|consen  207 KF  208 (668)
T ss_pred             cH
Confidence            43

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-30  Score=237.99  Aligned_cols=153  Identities=31%  Similarity=0.456  Sum_probs=135.4

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCccc-HHHHHHHHHHHccCC-CCccceeeEEEecCC-eeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQ-HRNLVRLLGFCLERK-ERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~-~~~l  317 (412)
                      ..++|...++||.|.||.||+|+ ..+++.||||++++.-..- +..=.+|+..|++|. ||||++|..++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            45678889999999999999999 6789999999998764332 222368999999998 999999999999988 9999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |||||+ .+|.+++.++  +..+++..+..|+.||++||+|+|.+|   +.|||+||+|||+.....+||+||||||.+.
T Consensus        88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999995 5899998774  778999999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCC
Q 015138          398 MDQ  400 (412)
Q Consensus       398 ~~~  400 (412)
                      ...
T Consensus       162 Skp  164 (538)
T KOG0661|consen  162 SKP  164 (538)
T ss_pred             cCC
Confidence            544

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-29  Score=228.58  Aligned_cols=166  Identities=28%  Similarity=0.461  Sum_probs=136.4

Q ss_pred             hhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc--------------cHHHHHHHHHHHccCCCCcccee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ--------------GEIEFKNEVLLLARLQHRNLVRL  305 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~l  305 (412)
                      ...++|++.+.||+|.||.|-++. ..+++.||||++.+....              ..+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345789999999999999999999 567899999999764211              13467899999999999999999


Q ss_pred             eEEEecC--CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC
Q 015138          306 LGFCLER--KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       306 ~g~~~~~--~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~  383 (412)
                      +.+..+.  +.+|||+||+..|.+...=   .....++..++.+++.++..||+|||.++   ||||||||+|+||++++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            9998654  5799999999999885442   22233999999999999999999999998   99999999999999999


Q ss_pred             CeEEeccCCcccccCCC---cccccccccccC
Q 015138          384 NPKISDFGMARLFEMDQ---THSDTNRVVGTL  412 (412)
Q Consensus       384 ~~ki~DfGla~~~~~~~---~~~~~~~~~Gt~  412 (412)
                      ++||+|||.+-.+....   .+....+.+||+
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTP  279 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTP  279 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCc
Confidence            99999999998773321   111233577874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=239.22  Aligned_cols=153  Identities=31%  Similarity=0.575  Sum_probs=136.8

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecC
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  312 (412)
                      +.+++.+..+.+.....||+|+||+||+|.|.  ..||||.+......  ..+.|.+|+..+++-+|.||+-|+|+|...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            34566677777888999999999999999985  47999999876443  456799999999999999999999999988


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      .. .||+.+++|-+|..+|+.  .+..++..+.+.|+.||++||.|||.++   |||||||+.||+|.++++|||+||||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            77 999999999999999976  3467899999999999999999999998   99999999999999999999999999


Q ss_pred             ccc
Q 015138          393 ARL  395 (412)
Q Consensus       393 a~~  395 (412)
                      +..
T Consensus       535 atv  537 (678)
T KOG0193|consen  535 ATV  537 (678)
T ss_pred             eee
Confidence            864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-28  Score=224.57  Aligned_cols=165  Identities=33%  Similarity=0.506  Sum_probs=137.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC--eeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--ERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~~lv~  319 (412)
                      ..++...+.||+|+||.||++.. ++|+..|||.+..........+.+|+.+|.+++|||||+.+|......  .+.+.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            35577789999999999999995 458999999987664333566899999999999999999999855444  689999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~  398 (412)
                      ||+++|+|.+++.....  .+++..+..+..||++||.|||+++   |||+||||+||||+. ++.+||+|||+++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999965322  6999999999999999999999988   999999999999999 79999999999998874


Q ss_pred             CCcc-cccccccccC
Q 015138          399 DQTH-SDTNRVVGTL  412 (412)
Q Consensus       399 ~~~~-~~~~~~~Gt~  412 (412)
                      .... .....+.||+
T Consensus       171 ~~~~~~~~~~~~Gtp  185 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTP  185 (313)
T ss_pred             ccccccccccccCCc
Confidence            2211 1222366663

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=1.4e-28  Score=231.06  Aligned_cols=152  Identities=25%  Similarity=0.390  Sum_probs=137.2

Q ss_pred             HhhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      +...++|+.+.+||+|+||.||+++ ..+|+.+|+|+|++..-.   ....+..|-.+|...++|.||+|+..|.+.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            4566899999999999999999999 567999999999886432   334578899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ||||||++||++..+|.   ....|++.....++.+++.|+.-||+.+   +|||||||+|+|||..|++||+||||+.-
T Consensus       217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            99999999999999994   4678999999999999999999999998   99999999999999999999999999975


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      +.
T Consensus       291 l~  292 (550)
T KOG0605|consen  291 LD  292 (550)
T ss_pred             hh
Confidence            53

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=233.35  Aligned_cols=160  Identities=33%  Similarity=0.533  Sum_probs=145.7

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      ..|....+||+|+-|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||+++.-+...+++|.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457777899999999999999 6778999999998877777777899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCcc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~  402 (412)
                      ++|+|.+.+.    ...+++.++..|+.++++||+|||.++   |+|||||..|||++.++.+||+|||++..+.+.+..
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            9999999883    455999999999999999999999998   999999999999999999999999999999888765


Q ss_pred             cccccccccC
Q 015138          403 SDTNRVVGTL  412 (412)
Q Consensus       403 ~~~~~~~Gt~  412 (412)
                      ..+  ++||+
T Consensus       426 R~T--mVGTP  433 (550)
T KOG0578|consen  426 RST--MVGTP  433 (550)
T ss_pred             ccc--ccCCC
Confidence            544  88985

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.95  E-value=6.4e-29  Score=233.92  Aligned_cols=160  Identities=28%  Similarity=0.452  Sum_probs=141.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|...+.||+|+||.||||+. .+.+.||+|.+.+..+  +....+.+|++++++++||||+.++.+|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5677889999999999999994 5678999999976543  345668999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+.+ +|..+|.+   ...++++....|+.++..||.|||+++   |+|||+||+||||+.++++|++|||+||....+.
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9977 99999944   677999999999999999999999987   9999999999999999999999999999876543


Q ss_pred             cccccccccccC
Q 015138          401 THSDTNRVVGTL  412 (412)
Q Consensus       401 ~~~~~~~~~Gt~  412 (412)
                      .  ..+++.||+
T Consensus       155 ~--vltsikGtP  164 (808)
T KOG0597|consen  155 S--VLTSIKGTP  164 (808)
T ss_pred             e--eeeeccCcc
Confidence            2  344678884

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.8e-29  Score=211.99  Aligned_cols=163  Identities=31%  Similarity=0.480  Sum_probs=139.3

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..++|+.++.||+|.||.||.|+. .++-.||+|.+.+..   .+...++.+|+++-..|+||||++++|++.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            447899999999999999999995 556789999997753   2334578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++||..+|+|...|.+. ....+++.....++.|+|.||.|+|..+   ++||||||+|+|++..+..||+|||.+..-+
T Consensus       100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            99999999999998642 3456888888899999999999999887   9999999999999999999999999997654


Q ss_pred             CCCcccccccccccC
Q 015138          398 MDQTHSDTNRVVGTL  412 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt~  412 (412)
                      .+.  ..  ...||+
T Consensus       176 ~~k--R~--tlcgt~  186 (281)
T KOG0580|consen  176 SNK--RK--TLCGTL  186 (281)
T ss_pred             CCC--ce--eeeccc
Confidence            222  11  266774

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.95  E-value=1.2e-28  Score=218.75  Aligned_cols=151  Identities=28%  Similarity=0.478  Sum_probs=129.9

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCccc--HHHHHHHHHHHccCCCCccceeeEEEecC--CeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  317 (412)
                      .++|+.++.|++|.||.||+|+ -++++.||+|+++......  -..-.+||.+|.+++|||||.+-.+....  +.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            3568889999999999999999 5678999999997554221  22357899999999999999998887654  57999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||++. +|..++..  ...++...+...++.|+++|++|||.+.   |+|||||++|+|+...|.+||+||||||.+.
T Consensus       155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999965 78887754  3467888999999999999999999998   9999999999999999999999999999997


Q ss_pred             CC
Q 015138          398 MD  399 (412)
Q Consensus       398 ~~  399 (412)
                      ..
T Consensus       229 sp  230 (419)
T KOG0663|consen  229 SP  230 (419)
T ss_pred             CC
Confidence            65

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-28  Score=229.88  Aligned_cols=150  Identities=29%  Similarity=0.502  Sum_probs=133.9

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccC----Cc-ccHHHHHHHHHHHccCC-CCccceeeEEEecCCe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN----SK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKE  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~  314 (412)
                      ....|...+.||+|+||+|+.|. ..+++.||||.+.+.    .. .....+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            45678899999999999999998 567899999977654    11 22345678999999998 9999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccCCc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMA  393 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla  393 (412)
                      .++||||+.+|+|.+++.+   ...+.+.....++.|++.|++|||+.+   |+||||||+|||+|.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   567888999999999999999999998   9999999999999999 99999999999


Q ss_pred             cccc
Q 015138          394 RLFE  397 (412)
Q Consensus       394 ~~~~  397 (412)
                      ....
T Consensus       169 ~~~~  172 (370)
T KOG0583|consen  169 AISP  172 (370)
T ss_pred             cccC
Confidence            9884

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=250.05  Aligned_cols=157  Identities=33%  Similarity=0.583  Sum_probs=137.5

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCC--CC----EEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSN--GE----TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~--~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      ...++.+..+.||+|.||.||+|...+  +.    .||||.+.+.. .+...+|.+|..+|++++|||||+++|+|.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            335667778899999999999999643  33    48999998874 445668999999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEec
Q 015138          314 ERILVYEFVPNASLDHFIFDPI----NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D  389 (412)
                      ..+|++|||++|+|..||++..    ....|+..+++.++.|||+||.||++++   +|||||.++|+||++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence            9999999999999999997632    2456999999999999999999999987   99999999999999999999999


Q ss_pred             cCCcccccCCC
Q 015138          390 FGMARLFEMDQ  400 (412)
Q Consensus       390 fGla~~~~~~~  400 (412)
                      |||||.+...+
T Consensus       846 FGlArDiy~~~  856 (1025)
T KOG1095|consen  846 FGLARDIYDKD  856 (1025)
T ss_pred             cchhHhhhhch
Confidence            99999554443

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.95  E-value=5e-28  Score=218.29  Aligned_cols=152  Identities=32%  Similarity=0.551  Sum_probs=129.7

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc-c-HHHHHHHHHHHccCCCCc-cceeeEEEecCC------
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ-G-EIEFKNEVLLLARLQHRN-LVRLLGFCLERK------  313 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~------  313 (412)
                      ..|...++||+|.||+||+|+ ..+|+.||+|++...... + -....+|+.++++++|+| |++|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            456667889999999999999 567899999998765432 2 234588999999999999 999999998877      


Q ss_pred             eeeEEEecCCCCChhhhccCCCCC-CCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          314 ERILVYEFVPNASLDHFIFDPINR-EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      .++||+||+ .-+|..++...... ..++...+..++.|++.||+|||+++   |+||||||.||||++++.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            788999999 45899998553221 45777889999999999999999998   99999999999999999999999999


Q ss_pred             cccccCC
Q 015138          393 ARLFEMD  399 (412)
Q Consensus       393 a~~~~~~  399 (412)
                      |+.+.-+
T Consensus       167 Ara~~ip  173 (323)
T KOG0594|consen  167 ARAFSIP  173 (323)
T ss_pred             HHHhcCC
Confidence            9987633

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.95  E-value=9.6e-28  Score=228.81  Aligned_cols=157  Identities=32%  Similarity=0.472  Sum_probs=131.6

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEEec
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  311 (412)
                      +...++|+..++||+|+||.||+|..      .+++.||||++..... .....+.+|+.++.++ +||||+++++.+..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            34567899999999999999999974      2356799999875433 2345689999999999 89999999998876


Q ss_pred             CC-eeeEEEecCCCCChhhhccCCCC------------------------------------------------------
Q 015138          312 RK-ERILVYEFVPNASLDHFIFDPIN------------------------------------------------------  336 (412)
Q Consensus       312 ~~-~~~lv~Ey~~~gsL~~~l~~~~~------------------------------------------------------  336 (412)
                      .+ ..++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            44 57899999999999998854210                                                      


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          337 -----REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       337 -----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                           ...+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~  227 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD  227 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccC
Confidence                 235888899999999999999999987   999999999999999999999999999876433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=3e-27  Score=221.98  Aligned_cols=154  Identities=31%  Similarity=0.511  Sum_probs=131.7

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC-----------------CCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccce
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN-----------------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVR  304 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~  304 (412)
                      .++|...++||+|+||.||++...+                 +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3568888999999999999998532                 3369999987653 334557899999999999999999


Q ss_pred             eeEEEecCCeeeEEEecCCCCChhhhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCce
Q 015138          305 LLGFCLERKERILVYEFVPNASLDHFIFDPI----------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRII  368 (412)
Q Consensus       305 l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv  368 (412)
                      +++++.+.+..++||||+++|+|.+++....                ....++|...+.++.|++.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999884321                1134788999999999999999999987   99


Q ss_pred             ecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          369 HRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       369 Hrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||||||+|||++.++.+||+|||+++.+...
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~  191 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAG  191 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccC
Confidence            9999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=3.8e-27  Score=227.04  Aligned_cols=155  Identities=23%  Similarity=0.317  Sum_probs=135.6

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecC
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  312 (412)
                      ..+....++|+..+.||+|+||.||++.. .+++.+|+|.+.+..   ......+.+|+.++..++||||+++++.+.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            34455668899999999999999999995 467899999986532   22334578999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...++||||+++|+|.+++..    ..+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999843    35788899999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      |+.+..
T Consensus       189 a~~~~~  194 (370)
T cd05621         189 CMKMDE  194 (370)
T ss_pred             ceeccc
Confidence            987653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-27  Score=216.24  Aligned_cols=168  Identities=25%  Similarity=0.350  Sum_probs=144.0

Q ss_pred             hhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCccc-HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ...++|+...+||.|.-+.||+|. .+.++.||||++....... ...+..|+..|+.++||||++.+..|..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            345789999999999999999999 6778999999998654443 47799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |.||.+||+.++++.... ..+.+..+..|..++++||.|||+++   .||||||+.||||+.+|.+||+|||.+..+-.
T Consensus       103 mpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999999976443 44899999999999999999999998   99999999999999999999999998776644


Q ss_pred             CCcccc--cccccccC
Q 015138          399 DQTHSD--TNRVVGTL  412 (412)
Q Consensus       399 ~~~~~~--~~~~~Gt~  412 (412)
                      ......  .+..+||+
T Consensus       179 ~G~R~~~rf~tfvgtp  194 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTP  194 (516)
T ss_pred             cCceeeEeeccccCcc
Confidence            332221  13456664

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.94  E-value=5.4e-27  Score=225.76  Aligned_cols=148  Identities=26%  Similarity=0.402  Sum_probs=132.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||+||++.. .+++.||||.+.+..   ......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4788899999999999999984 568899999997542   222346788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++++||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999854   457899999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-27  Score=227.07  Aligned_cols=164  Identities=30%  Similarity=0.403  Sum_probs=139.6

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccC-CCCccceeeEEEecCCe
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKE  314 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~  314 (412)
                      ....++|...++||+|+||+|+++.. .+++.+|||.+++...   ...+..+.|-.++... +||.|+.|+.++...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            44568899999999999999999995 5678999999998743   3344577788777666 59999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ++.||||+.||++..+.    ....+++..+.-++.+|+.||.|||+++   ||+||||.+|||||.+|++||+||||+|
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999965555    4467999999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCcccccccccccC
Q 015138          395 LFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       395 ~~~~~~~~~~~~~~~Gt~  412 (412)
                      .--....  .|+.+.||+
T Consensus       517 e~m~~g~--~TsTfCGTp  532 (694)
T KOG0694|consen  517 EGMGQGD--RTSTFCGTP  532 (694)
T ss_pred             ccCCCCC--ccccccCCh
Confidence            7432222  344589985

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-28  Score=236.45  Aligned_cols=152  Identities=37%  Similarity=0.643  Sum_probs=134.2

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCC----EEEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .....++||+|+||+||+|.| +.|+    +||||.+... ..+..+++.+|+.+|.+++||||+||+|+|..+. +.||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            345678999999999999995 4454    6889987655 4445678999999999999999999999998877 8899


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++||+.|+|.+|++.  .+..+..+..+.|..|||+||.|||++.   +|||||.++||||.+-..+||.|||+|+.+.+
T Consensus       776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999965  5667888999999999999999999886   99999999999999999999999999999987


Q ss_pred             CCcc
Q 015138          399 DQTH  402 (412)
Q Consensus       399 ~~~~  402 (412)
                      ++..
T Consensus       851 d~~e  854 (1177)
T KOG1025|consen  851 DEKE  854 (1177)
T ss_pred             cccc
Confidence            7653

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.9e-27  Score=225.82  Aligned_cols=147  Identities=27%  Similarity=0.369  Sum_probs=131.0

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..++||+|+||.||++.. .+++.||||.+.+..   ......+.+|+.++.+++||||+++++++.+....+|||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999984 578999999986542   223456888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999853   456888999999999999999999988   999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.94  E-value=9.7e-28  Score=216.26  Aligned_cols=150  Identities=31%  Similarity=0.514  Sum_probs=122.3

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC-----eeeEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ERILV  318 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~lv  318 (412)
                      .|...+++|.|+||.||+|.+ .+++.||||++-....-.    .+|+++|.+++|||||+|+-++....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            356678999999999999995 557999999986654422    46889999999999999998886432     23589


Q ss_pred             EecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccCCcccc
Q 015138          319 YEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLF  396 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~~~  396 (412)
                      ||||+. +|.+.++.. ..+..++.-.+.-+..||.+||.|||+.+   |+||||||.|+|+|.+ +.+||+|||-|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 787777531 12345666677788999999999999977   9999999999999977 89999999999999


Q ss_pred             cCCCcc
Q 015138          397 EMDQTH  402 (412)
Q Consensus       397 ~~~~~~  402 (412)
                      .+++..
T Consensus       177 ~~~epn  182 (364)
T KOG0658|consen  177 VKGEPN  182 (364)
T ss_pred             ccCCCc
Confidence            776643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.7e-27  Score=218.75  Aligned_cols=149  Identities=27%  Similarity=0.373  Sum_probs=132.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            4688899999999999999995 468899999986532   223446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999854   456899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=8.3e-27  Score=221.44  Aligned_cols=150  Identities=27%  Similarity=0.366  Sum_probs=133.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+.+..   ......+.+|+.++.+++||||+++++.+.+.+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            36788899999999999999996 468899999987542   22345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999999854   456888899999999999999999987   99999999999999999999999999987654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1e-26  Score=221.20  Aligned_cols=149  Identities=26%  Similarity=0.390  Sum_probs=132.6

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++... +++.||||.+.+..   ......+.+|+.++..++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999964 58899999987542   223446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999843   456889999999999999999999987   99999999999999999999999999986543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.94  E-value=1.4e-26  Score=219.43  Aligned_cols=141  Identities=26%  Similarity=0.298  Sum_probs=125.8

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      +.||+|+||.||++.. .+|+.||||.+.+..   ......+.+|+.++.+++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999984 578999999987542   223345788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +|.+++..   ...+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            99988843   457899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-27  Score=229.36  Aligned_cols=161  Identities=30%  Similarity=0.490  Sum_probs=139.0

Q ss_pred             CCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCC------eeeE
Q 015138          246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------ERIL  317 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~l  317 (412)
                      |...+.||+|+||.||+|+ -.+|+.||||.+.+.. ....+....|+++|++++|+|||++++.-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4556789999999999999 6789999999987654 334556789999999999999999999865543      5689


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC--CC--CeEEeccCCc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--EM--NPKISDFGMA  393 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~--~~ki~DfGla  393 (412)
                      ||||+.+|||...|.++.+...|++...+.+..++..||.|||+++   |+||||||.||++-.  ++  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999999888889999999999999999999999988   999999999999843  33  3799999999


Q ss_pred             ccccCCCcccccccccccC
Q 015138          394 RLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       394 ~~~~~~~~~~~~~~~~Gt~  412 (412)
                      |.++++..   ...++||.
T Consensus       172 rel~d~s~---~~S~vGT~  187 (732)
T KOG4250|consen  172 RELDDNSL---FTSLVGTE  187 (732)
T ss_pred             ccCCCCCe---eeeecCch
Confidence            99987763   33588984

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.7e-27  Score=224.88  Aligned_cols=148  Identities=26%  Similarity=0.410  Sum_probs=132.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||||.+.+..   ......+.+|+.++..++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4788899999999999999995 568999999997542   223345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999999854   456899999999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=9.2e-27  Score=224.55  Aligned_cols=154  Identities=25%  Similarity=0.334  Sum_probs=134.2

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      +....++|+..+.||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            344567899999999999999999995 568899999986532   2233457889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||+++|+|.+++..    ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999999843    35788888899999999999999987   9999999999999999999999999998


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+...
T Consensus       191 ~~~~~  195 (370)
T cd05596         191 KMDAN  195 (370)
T ss_pred             eccCC
Confidence            76543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=1.2e-26  Score=221.17  Aligned_cols=151  Identities=27%  Similarity=0.358  Sum_probs=132.7

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCC--CCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSN--GETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..++|+..+.||+|+||.||+|....  +..||+|.+.+..   ......+.+|+.++..++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            44678889999999999999998533  3689999986542   223456889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++++||+|||+++.+
T Consensus       108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999999854   456899999999999999999999987   999999999999999999999999999876


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      ..
T Consensus       182 ~~  183 (340)
T PTZ00426        182 DT  183 (340)
T ss_pred             CC
Confidence            43

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.94  E-value=1.1e-26  Score=225.13  Aligned_cols=146  Identities=25%  Similarity=0.366  Sum_probs=130.5

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      +|+..++||+|+||+||++.. .+++.||||++.+..   ......+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999984 568899999997643   2234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++++||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            9999999999854   356888889999999999999999987   999999999999999999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=2e-26  Score=214.44  Aligned_cols=150  Identities=29%  Similarity=0.397  Sum_probs=131.2

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .|+..+.||+|+||.||++.. .+++.||+|.+.+...   .....+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            366788999999999999994 6789999999875432   233457899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++|+|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999998887542 2346899999999999999999999987   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=2.2e-26  Score=218.44  Aligned_cols=141  Identities=28%  Similarity=0.323  Sum_probs=126.0

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      +.||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999994 568999999997642   223456788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            99988843   456899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.94  E-value=2.1e-26  Score=222.09  Aligned_cols=157  Identities=23%  Similarity=0.314  Sum_probs=136.6

Q ss_pred             hHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEec
Q 015138          236 FETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (412)
Q Consensus       236 ~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~  311 (412)
                      ...+....++|+..+.||+|+||.||++.. .+++.+|+|.+.+..   ......+.+|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            344566678999999999999999999995 467899999986532   2233457889999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      +...++||||+++|+|.+++..    ..++...+..++.|++.||.|||+.+   |+||||||+|||++.++++||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999843    35788888899999999999999987   9999999999999999999999999


Q ss_pred             CcccccCC
Q 015138          392 MARLFEMD  399 (412)
Q Consensus       392 la~~~~~~  399 (412)
                      +++.+...
T Consensus       188 ~a~~~~~~  195 (371)
T cd05622         188 TCMKMNKE  195 (371)
T ss_pred             ceeEcCcC
Confidence            99877543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=2e-26  Score=218.19  Aligned_cols=141  Identities=27%  Similarity=0.310  Sum_probs=125.5

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      +.||+|+||.||++.. .+|+.||+|.+.+..   ......+.+|+.++..++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999994 578999999987542   223445778999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            99888843   456899999999999999999999987   999999999999999999999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.7e-26  Score=218.16  Aligned_cols=151  Identities=22%  Similarity=0.318  Sum_probs=132.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688899999999999999995 568899999987532   223345888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999843  2346889999999999999999999987   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=1.6e-26  Score=224.16  Aligned_cols=146  Identities=25%  Similarity=0.372  Sum_probs=130.0

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      +|+..++||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.++++++|+||+++++.+.+.+..+||||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578899999999999999994 568899999987543   2234468899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+++|+|.+++.+   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            9999999999854   356888889999999999999999987   999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.7e-26  Score=216.31  Aligned_cols=140  Identities=25%  Similarity=0.306  Sum_probs=124.9

Q ss_pred             ccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          252 LGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       252 lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999995 468899999987532   23345678899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      .+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            999854   456899999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.94  E-value=1.8e-26  Score=222.85  Aligned_cols=156  Identities=29%  Similarity=0.422  Sum_probs=133.1

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEec
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  311 (412)
                      ....++|+..+.||+|+||.||++..      .++..||||+++... ......+.+|+.++..+ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            34456789999999999999999973      245689999987543 23345688999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCC--------------------------------------------------------
Q 015138          312 RKERILVYEFVPNASLDHFIFDPI--------------------------------------------------------  335 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~--------------------------------------------------------  335 (412)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999998885321                                                        


Q ss_pred             ----------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          336 ----------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       336 ----------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                                      ....++|..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                            0125789999999999999999999987   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=2.2e-26  Score=222.61  Aligned_cols=147  Identities=23%  Similarity=0.360  Sum_probs=130.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||||.+.+..   ......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688899999999999999994 568899999986542   223446789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|..+
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            99999999999854   456888888999999999999999987   999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=2.5e-26  Score=218.32  Aligned_cols=152  Identities=21%  Similarity=0.303  Sum_probs=134.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+.+...   .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688899999999999999994 5788999999976432   23446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998542  356899999999999999999999987   999999999999999999999999999877544


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       156 ~  156 (330)
T cd05601         156 K  156 (330)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=5.9e-27  Score=224.72  Aligned_cols=151  Identities=29%  Similarity=0.463  Sum_probs=135.6

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .-|+.++.||.|+-|.|..|+ ..+|+.+|||.+.+...   .....+.+|+.+|+-+.|||+++|++++.+..++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            347778999999999999999 57899999999987632   22345789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|.|.++|..   .+.+++.+..+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||||.+-.++
T Consensus        92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999954   678999999999999999999999887   999999999999999999999999999875554


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       166 k  166 (786)
T KOG0588|consen  166 K  166 (786)
T ss_pred             c
Confidence            3

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.94  E-value=3.1e-26  Score=217.71  Aligned_cols=151  Identities=21%  Similarity=0.289  Sum_probs=132.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4788899999999999999995 467889999986532   222345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999854  2346889999999999999999999987   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=2.7e-26  Score=228.31  Aligned_cols=151  Identities=20%  Similarity=0.240  Sum_probs=132.2

Q ss_pred             CCccccccccCCeeEEEEEe-CC-CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          246 FSDANKLGQGGFGAVYKGML-SN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      |...+.||+|+||.||++.. .+ ++.|++|.+..........+.+|+.+++.++||||+++++++...+..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            77788999999999999984 34 67888888766555555568889999999999999999999999999999999999


Q ss_pred             CCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          324 NASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       324 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +|+|.+++... .....+++.....++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999887542 23456889999999999999999999987   999999999999999999999999999987543

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=6.2e-26  Score=215.15  Aligned_cols=142  Identities=26%  Similarity=0.294  Sum_probs=125.0

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      +.||+|+||.||++.. .+++.||+|.+.+..   ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999984 578999999987542   223446788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +|..++..   ...+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            99988843   4568999999999999999999997 55   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=3.5e-26  Score=221.91  Aligned_cols=158  Identities=28%  Similarity=0.412  Sum_probs=133.8

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCC-CCccceeeEEE
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFC  309 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~  309 (412)
                      .+....+.|.+.+.||+|+||.||+|...      .+..||||++..... .....+.+|+.++.++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            34455678889999999999999999842      134699999975433 23456899999999996 99999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCC------------------------------------------------------
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPI------------------------------------------------------  335 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~------------------------------------------------------  335 (412)
                      .+....+|||||+++|+|.++|....                                                      
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            99999999999999999998875321                                                      


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          336 ---------------------------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       336 ---------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                                                             ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence                                                   0134788899999999999999999987   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccccC
Q 015138          377 ILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||++.++.+||+|||+++.+..
T Consensus       268 ill~~~~~~kL~DfGla~~~~~  289 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMH  289 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccc
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.94  E-value=7.2e-26  Score=210.99  Aligned_cols=148  Identities=28%  Similarity=0.488  Sum_probs=129.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..++||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            5688899999999999999995 4688999999865432 2344678999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            974 89888743  2345788999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.93  E-value=6.1e-26  Score=217.66  Aligned_cols=145  Identities=29%  Similarity=0.452  Sum_probs=126.7

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..++||+|+||.||++.. .+++.||||.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            4566778999999999999995 5689999999865433 2345689999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++|+|....       .+.+..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999986532       3456778899999999999999987   99999999999999999999999999987643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.93  E-value=3.4e-26  Score=220.80  Aligned_cols=158  Identities=28%  Similarity=0.445  Sum_probs=133.8

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCcc-cHHHHHHHHHHHccC-CCCccceeeEEE
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARL-QHRNLVRLLGFC  309 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~g~~  309 (412)
                      .+....++|+..+.||+|+||.||++..      .+++.||||++...... ....+.+|+.+++.+ +|+||+++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            3445567899999999999999999873      23457999999764332 344688999999999 899999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCC------------------------------------------------------
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPI------------------------------------------------------  335 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~------------------------------------------------------  335 (412)
                      ......++||||+++|+|.+++....                                                      
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999999874311                                                      


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          336 -------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       336 -------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                                   ....+++...+.|+.||+.||.|||+.+   |+||||||+|||+++++++||+|||+++.+..
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence                         1134788999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.93  E-value=7.9e-26  Score=213.59  Aligned_cols=152  Identities=32%  Similarity=0.621  Sum_probs=130.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCC----EEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..+|+..+.||+|+||.||+|.+ .+++    .||+|.+.... .....++.+|+.+++.++||||++++|++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            35789999999999999999985 3344    38999987543 33456789999999999999999999999865 567


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +|+||+++|+|.+++..  ....+++...+.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999999854  2345889999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ..+.
T Consensus       160 ~~~~  163 (316)
T cd05108         160 GADE  163 (316)
T ss_pred             cCCC
Confidence            5443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.93  E-value=9.4e-26  Score=214.55  Aligned_cols=149  Identities=27%  Similarity=0.357  Sum_probs=129.9

Q ss_pred             CCCccccccccCCeeEEEEEe----CCCCEEEEEEeccCC----cccHHHHHHHHHHHccC-CCCccceeeEEEecCCee
Q 015138          245 NFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  315 (412)
                      +|+..+.||+|+||.||++..    .+++.||+|.+.+..    ......+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999874    357899999986532    12234578899999999 599999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999854   456899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      +...
T Consensus       155 ~~~~  158 (332)
T cd05614         155 FLSE  158 (332)
T ss_pred             cccc
Confidence            6433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.93  E-value=8.2e-26  Score=214.95  Aligned_cols=150  Identities=20%  Similarity=0.279  Sum_probs=131.1

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..++||+|+||.||++... +++.+|+|.+.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999964 57789999986532   222335788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999854  2346899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=9.5e-26  Score=213.67  Aligned_cols=142  Identities=27%  Similarity=0.390  Sum_probs=124.8

Q ss_pred             ccccccCCeeEEEEEe----CCCCEEEEEEeccCC----cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          250 NKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +.||+|+||.||++..    .+++.||||.+.+..    ......+.+|+.++..++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357889999987532    22334578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++..   ...+.+.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            999999998843   456788888899999999999999987   9999999999999999999999999998543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.93  E-value=8.1e-26  Score=208.12  Aligned_cols=150  Identities=27%  Similarity=0.449  Sum_probs=131.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC----CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..++|+..+.||+|+||.||+|.+.    .+..||+|.+..... .....|.+|+..+.+++||||++++|++..++..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3467888999999999999999853    356899999876533 23456899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||++...
T Consensus        83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            999999999999998542  346899999999999999999999987   999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=9.2e-26  Score=213.87  Aligned_cols=144  Identities=30%  Similarity=0.404  Sum_probs=124.4

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHH---ccCCCCccceeeEEEecCCeeeEE
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLL---ARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      |++.+.||+|+||.||++.. .+++.||||.+.+..   ......+.+|+.++   ..++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            55678999999999999995 568999999997542   22234466666554   567899999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||+++++|..++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            99999999988873    356999999999999999999999987   999999999999999999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=5.1e-26  Score=217.93  Aligned_cols=151  Identities=26%  Similarity=0.411  Sum_probs=134.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||||.+.+..   ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            4688899999999999999995 478999999987542   233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999854   357899999999999999999999987   999999999999999999999999999876544


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       155 ~  155 (350)
T cd05573         155 K  155 (350)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1.4e-26  Score=217.63  Aligned_cols=164  Identities=27%  Similarity=0.430  Sum_probs=141.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecCCe-eeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-RILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-~~lv  318 (412)
                      .++|...+++|+|+||.++..+. .++..+++|++...  +.........|+.++++++|||||.+.+.+.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            36788899999999999988874 45678999987644  34444567899999999999999999999999888 9999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||++||+|.+.+.+. +...++++.+..++.|++.|+.|||++.   |+|||||+.||++..+..+||.|||+||.+.+
T Consensus        83 m~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998653 2467899999999999999999999876   99999999999999999999999999999987


Q ss_pred             CCcccccccccccC
Q 015138          399 DQTHSDTNRVVGTL  412 (412)
Q Consensus       399 ~~~~~~~~~~~Gt~  412 (412)
                      +.....  .++||+
T Consensus       159 ~~~~a~--tvvGTp  170 (426)
T KOG0589|consen  159 EDSLAS--TVVGTP  170 (426)
T ss_pred             chhhhh--eecCCC
Confidence            764333  388884

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=1.4e-25  Score=213.15  Aligned_cols=151  Identities=28%  Similarity=0.374  Sum_probs=133.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|+..+.||+|+||.||++.. .++..+|+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            57899999999999999999995 4688899998875432 334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            9999999999854   346889999999999999999999853  399999999999999999999999999987643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.93  E-value=8.6e-26  Score=217.20  Aligned_cols=148  Identities=25%  Similarity=0.416  Sum_probs=131.8

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.++..++|+||+++++.+.+.+..+|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688899999999999999995 568899999987532   223446788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            99999999999843   456899999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.93  E-value=1.6e-25  Score=210.19  Aligned_cols=149  Identities=31%  Similarity=0.509  Sum_probs=129.8

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            46789999999999999999995 46889999998754332 23457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |++ ++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            995 677777643  2356888999999999999999999988   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=1.4e-25  Score=213.46  Aligned_cols=151  Identities=27%  Similarity=0.381  Sum_probs=132.7

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ..++|+..++||+|+||.||++... ++..+|+|.+..... .....+.+|++++++++|+||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4578999999999999999999954 678899998875432 23456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++|+|.+++..   ...+++.....++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999843   346888999999999999999999742  39999999999999999999999999998664

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.93  E-value=8.6e-26  Score=214.93  Aligned_cols=160  Identities=31%  Similarity=0.485  Sum_probs=139.8

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc---HHHHHHHHHHHccCC-CCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~l  317 (412)
                      .+.|+..+.||+|.||.||+++. .+|+.+|+|.+.+.....   ...+.+|+.+|.++. |||||.+.+.+.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            45678889999999999999995 459999999998765443   357899999999998 9999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC----CCeEEeccCCc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE----MNPKISDFGMA  393 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGla  393 (412)
                      |||++.+|.|.+.+...    .+++.....++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||+|
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999998653    3999999999999999999999987   9999999999999654    36999999999


Q ss_pred             ccccCCCcccccccccccC
Q 015138          394 RLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       394 ~~~~~~~~~~~~~~~~Gt~  412 (412)
                      +...++..   .+.++||+
T Consensus       187 ~~~~~~~~---~~~~~Gtp  202 (382)
T KOG0032|consen  187 KFIKPGER---LHTIVGTP  202 (382)
T ss_pred             eEccCCce---EeeecCCc
Confidence            99877322   34578874

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=1.5e-25  Score=211.93  Aligned_cols=144  Identities=31%  Similarity=0.344  Sum_probs=126.7

Q ss_pred             ccccccCCeeEEEEEe----CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          250 NKLGQGGFGAVYKGML----SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      +.||+|+||.||++..    .+|+.+|+|.+.+...  .....+..|++++.+++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    4578999999875432  233457789999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            9999998843   456899999999999999999999987   999999999999999999999999999876443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=1.6e-25  Score=212.53  Aligned_cols=141  Identities=28%  Similarity=0.335  Sum_probs=123.7

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+++.+|+|.+.+..   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 567899999997642   22334577888888776 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            999888743   456899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.7e-25  Score=208.18  Aligned_cols=151  Identities=30%  Similarity=0.406  Sum_probs=131.8

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      +|+..+.||+|+||.||++.. .+++.||+|.+.....   .....+.+|+.++++++|+||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477789999999999999995 5688999999875432   223457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++.+...
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999887542 2356899999999999999999999987   999999999999999999999999999876433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.93  E-value=1.9e-25  Score=207.56  Aligned_cols=152  Identities=30%  Similarity=0.502  Sum_probs=131.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-----CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ++|+..++||+|+||.||+|..     .++..|++|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5677889999999999999984     345789999987543 3334578899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC
Q 015138          318 VYEFVPNASLDHFIFDPI--------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~  383 (412)
                      ||||+++++|.+++....              ....+++...+.++.|++.||.|||+++   |+||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999984321              1235889999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccC
Q 015138          384 NPKISDFGMARLFEM  398 (412)
Q Consensus       384 ~~ki~DfGla~~~~~  398 (412)
                      .+||+|||+++.+..
T Consensus       162 ~~kl~dfg~~~~~~~  176 (283)
T cd05090         162 HVKISDLGLSREIYS  176 (283)
T ss_pred             cEEeccccccccccC
Confidence            999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.93  E-value=1.8e-25  Score=204.49  Aligned_cols=148  Identities=30%  Similarity=0.520  Sum_probs=132.4

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      ++|+..+.||+|+||.||++.+.++..+|+|.+.... ....++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            5677889999999999999998888899999886443 334578899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            99999998542  246899999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=228.87  Aligned_cols=153  Identities=29%  Similarity=0.435  Sum_probs=133.9

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCC-CEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeE-EEec------
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNG-ETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLG-FCLE------  311 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g-~~~~------  311 (412)
                      +...++++.+.|.+|||+.||.+....+ ..+|+|++...+......+.+||++|++|. |+|||.+++ ....      
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3445567789999999999999997665 999999998888888889999999999997 999999999 3221      


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      .-+.+|+||||++|+|-++|..+... .|++.++++|+.++++|+.+||... +||||||||-+||||..+++.||||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence            24678999999999999999654443 3999999999999999999999985 789999999999999999999999999


Q ss_pred             Cccc
Q 015138          392 MARL  395 (412)
Q Consensus       392 la~~  395 (412)
                      -|.-
T Consensus       192 Satt  195 (738)
T KOG1989|consen  192 SATT  195 (738)
T ss_pred             cccc
Confidence            8864

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=1.6e-25  Score=212.28  Aligned_cols=146  Identities=30%  Similarity=0.329  Sum_probs=126.9

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCC-ccceeeEEEecCCeeeEEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHR-NLVRLLGFCLERKERILVY  319 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~g~~~~~~~~~lv~  319 (412)
                      +|+..+.||+|+||.||+|.. .+++.||||.+.+..   ......+..|..++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            477889999999999999995 457889999987542   23345678899999999765 6888999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            99999999998843   456889999999999999999999987   999999999999999999999999998753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=1.7e-25  Score=212.46  Aligned_cols=140  Identities=27%  Similarity=0.346  Sum_probs=124.3

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+++.||+|.+++..   ......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999995 568899999997642   22334578899999888 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      |+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence            999888743   457999999999999999999999987   99999999999999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.93  E-value=2.3e-26  Score=199.17  Aligned_cols=163  Identities=27%  Similarity=0.433  Sum_probs=139.0

Q ss_pred             hhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC----ccc----HHHHHHHHHHHccC-CCCccceeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS----KQG----EIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~----~~~----~~~~~~e~~~l~~l-~h~niv~l~g~~~  310 (412)
                      ..-+.|...+.||.|..+.|-++. -.+|+.+|+|++....    ...    .+.-..|+.+|+++ .||+|++|.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            344667888999999999998888 4678899999885421    111    22346789999998 6999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      .+...++|+|.|+.|.|.++|.+   .-.++++...+|+.|+..|++|||..+   ||||||||+|||+|+++++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            99999999999999999999944   567999999999999999999999988   999999999999999999999999


Q ss_pred             CCcccccCCCcccccccccccC
Q 015138          391 GMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      |+|..+++++.-.   .++||+
T Consensus       168 GFa~~l~~GekLr---elCGTP  186 (411)
T KOG0599|consen  168 GFACQLEPGEKLR---ELCGTP  186 (411)
T ss_pred             ceeeccCCchhHH---HhcCCC
Confidence            9999998887643   367774

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.93  E-value=1.9e-25  Score=211.62  Aligned_cols=147  Identities=31%  Similarity=0.316  Sum_probs=126.8

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      +|+..+.||+|+||.||++.. .+++.||||.+.+...   .....+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            477889999999999999995 4578999999876432   2233466777777776 5899999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            99999999988843   356899999999999999999999987   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.93  E-value=1.9e-25  Score=211.49  Aligned_cols=141  Identities=30%  Similarity=0.370  Sum_probs=123.4

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ++||+|+||.||+|.. .+++.||||.+.+..   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999995 457899999987642   22334567888888766 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence            999988843   456899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=218.38  Aligned_cols=148  Identities=34%  Similarity=0.509  Sum_probs=130.6

Q ss_pred             CccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCC
Q 015138          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      ..++=||.|+-|.||+|++. ++.||||++....       ..+|+-|++|+|+||+.|.|+|....-.+|||||++.|-
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34677999999999999996 5899999886543       246788999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCcccccc
Q 015138          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN  406 (412)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~  406 (412)
                      |...|+.   ...++......+..+||.||.|||.+.   |||||||+-||||..+..+||+|||-++...+-.+   ..
T Consensus       199 L~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kM  269 (904)
T KOG4721|consen  199 LYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KM  269 (904)
T ss_pred             HHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh---hh
Confidence            9999954   567888999999999999999999987   99999999999999999999999999998765433   34


Q ss_pred             ccccc
Q 015138          407 RVVGT  411 (412)
Q Consensus       407 ~~~Gt  411 (412)
                      .++||
T Consensus       270 SFaGT  274 (904)
T KOG4721|consen  270 SFAGT  274 (904)
T ss_pred             hhhhh
Confidence            57887

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.93  E-value=2.2e-25  Score=211.34  Aligned_cols=141  Identities=30%  Similarity=0.366  Sum_probs=121.7

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHH-HHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVL-LLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+|+.+|+|.+.+..   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999994 578999999987542   222334555554 56779999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            999888743   456899999999999999999999987   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.93  E-value=2.6e-25  Score=206.34  Aligned_cols=145  Identities=30%  Similarity=0.402  Sum_probs=126.2

Q ss_pred             ccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          252 LGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       252 lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ||+|+||+||++.. .+++.+|+|.+.+....   ....+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999984 57889999998754322   234578899999999999999999999999999999999999999


Q ss_pred             hhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          328 DHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       328 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ..++... .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            8887542 23456899999999999999999999987   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=2.7e-25  Score=206.52  Aligned_cols=152  Identities=34%  Similarity=0.599  Sum_probs=133.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-----CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEec--CCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~  315 (412)
                      ..+|+..+.||+|+||.||++..     .+++.|++|.+..........+.+|++++.+++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35688889999999999999974     3578899999987766666789999999999999999999998754  3468


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            899999999999999854  2346899999999999999999999987   99999999999999999999999999997


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      +..+
T Consensus       158 ~~~~  161 (284)
T cd05081         158 LPQD  161 (284)
T ss_pred             ccCC
Confidence            6543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=9.1e-26  Score=215.59  Aligned_cols=152  Identities=28%  Similarity=0.467  Sum_probs=135.5

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ...|.+.+.||+|.|++|.++. ..++..||||.+.+...  .....+.+|+++|+.++|||||+++.+......+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            4678889999999999999999 45689999999987543  33456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||..+|.+.+|+..   ...+.......+..|+..+++|||++.   |+|||||++||||+.++++||+|||++-.+...
T Consensus       135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999954   444555788889999999999999998   999999999999999999999999999998755


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       209 ~  209 (596)
T KOG0586|consen  209 L  209 (596)
T ss_pred             c
Confidence            4

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=1.9e-25  Score=211.56  Aligned_cols=147  Identities=30%  Similarity=0.331  Sum_probs=127.3

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~  319 (412)
                      +|+..+.||+|+||.||++.. .+++.||+|.+.+..   ......+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467789999999999999995 568899999987542   223345778888888885 577888999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999998843   356999999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.93  E-value=2.1e-25  Score=206.62  Aligned_cols=155  Identities=28%  Similarity=0.525  Sum_probs=132.8

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      +..++|+..+.||+|+||.||+|...      .+..||||++.... .....++.+|+.+++.++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999998752      24679999886543 234456899999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeE
Q 015138          314 ERILVYEFVPNASLDHFIFDPIN-------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k  386 (412)
                      ..++||||+++++|.+++.+...       ...+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999999854211       234688899999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccC
Q 015138          387 ISDFGMARLFEM  398 (412)
Q Consensus       387 i~DfGla~~~~~  398 (412)
                      |+|||+++.+..
T Consensus       160 l~dfg~~~~~~~  171 (277)
T cd05062         160 IGDFGMTRDIYE  171 (277)
T ss_pred             ECCCCCccccCC
Confidence            999999986543

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.93  E-value=1.5e-25  Score=205.62  Aligned_cols=154  Identities=32%  Similarity=0.556  Sum_probs=139.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ....+|+..++||+|+||.||+|...+++.+++|.+..........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567888999999999999999987789999999987766566678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|.+++.+. ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+..
T Consensus        83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999999653 2456899999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.5e-25  Score=223.45  Aligned_cols=162  Identities=22%  Similarity=0.293  Sum_probs=136.1

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~  311 (412)
                      +..+.....++|.+.+.||+|+||.||++. ..+++.||||.+....  ......+.+|+..+..++|+||+++...+..
T Consensus        23 d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         23 DEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             CcccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            344455566899999999999999999998 5678999999986543  3344568899999999999999999887654


Q ss_pred             CC--------eeeEEEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC
Q 015138          312 RK--------ERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE  382 (412)
Q Consensus       312 ~~--------~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~  382 (412)
                      .+        ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSN  179 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCC
Confidence            32        3679999999999999985422 2356899999999999999999999987   9999999999999999


Q ss_pred             CCeEEeccCCcccccCC
Q 015138          383 MNPKISDFGMARLFEMD  399 (412)
Q Consensus       383 ~~~ki~DfGla~~~~~~  399 (412)
                      +.+||+|||+++.+...
T Consensus       180 ~~vkL~DFGls~~~~~~  196 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAAT  196 (496)
T ss_pred             CCEEEEecccCeecccc
Confidence            99999999999877543

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.93  E-value=1.9e-25  Score=207.86  Aligned_cols=149  Identities=26%  Similarity=0.401  Sum_probs=130.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..+.||+|+||.||++.. .+++.||+|++.....  .....+.+|+.++..++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4688899999999999999996 4678899999875432  234567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|..+..   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            999988876542   2356899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-26  Score=187.10  Aligned_cols=149  Identities=30%  Similarity=0.515  Sum_probs=129.5

Q ss_pred             CCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|...++||+|.||+||+++ +.+++.||+|++......  .-....+|+-+++.++|+|||+++++...+..+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45567899999999999999 667899999988754322  233568899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +. .+|..|..+  -.+.++.+....++.|+++||.|+|+++   ++||||||.|.||+.+++.|++|||+||.+.-.
T Consensus        83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            94 578888643  3567899999999999999999999988   999999999999999999999999999987643

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=2.2e-25  Score=216.28  Aligned_cols=156  Identities=26%  Similarity=0.424  Sum_probs=132.9

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCccc-HHHHHHHHHHHccCC-CCccceeeEEEe
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQ-HRNLVRLLGFCL  310 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~-h~niv~l~g~~~  310 (412)
                      +....++|...++||+|+||.||+|.+.      .++.||+|++....... ...+.+|+.++.++. ||||++++|.+.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4555667888999999999999999853      34679999997653332 346889999999997 999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCC-------------------------------------------------------
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPI-------------------------------------------------------  335 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~-------------------------------------------------------  335 (412)
                      .....++||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999985421                                                       


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCC
Q 015138          336 ----------------------------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS  375 (412)
Q Consensus       336 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~  375 (412)
                                                              ....+++...+.++.|++.||.|||+.+   |+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                    1124788888999999999999999887   999999999


Q ss_pred             CEEECCCCCeEEeccCCccccc
Q 015138          376 NILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       376 Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |||++.++.+||+|||+++.+.
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~  290 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIM  290 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecc
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.7e-25  Score=203.95  Aligned_cols=153  Identities=27%  Similarity=0.493  Sum_probs=136.4

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ...++|+..+.||+|+||.||+|...+++.||+|.+.... ....++.+|+.++++++|+||+++++++...+..++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            3456788899999999999999998778889999987543 345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            999999999985532 346899999999999999999999987   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.93  E-value=2.7e-25  Score=209.93  Aligned_cols=142  Identities=30%  Similarity=0.381  Sum_probs=121.4

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHcc-CCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLAR-LQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ++||+|+||.||++.. .+++.||||.+....   ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999995 457889999987542   2223345566666654 4899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            999988843   346889999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.93  E-value=3.1e-25  Score=210.18  Aligned_cols=141  Identities=30%  Similarity=0.360  Sum_probs=121.4

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHH-HHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVL-LLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+|+.||||.+.+...   ....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999995 5789999999875422   22234455544 56789999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            999998843   456889999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=210.14  Aligned_cols=156  Identities=31%  Similarity=0.470  Sum_probs=132.3

Q ss_pred             cccccccCCeeEEEEE-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          249 ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      .++||.|.||+||-|+ ..+|+.||||.+.+..  .+.+..+.+|+.+|.+++||.||.|.-.|+..+..+.|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            4789999999999999 5689999999997753  34456799999999999999999999999999999999999955 


Q ss_pred             ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEEeccCCcccccCCCcc
Q 015138          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARLFEMDQTH  402 (412)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~~~~~~~~  402 (412)
                      +..+++... ..+.|++..-..++.||+.||.|||.++   |+|.||||+||||.+..   .+||+|||+||++.+....
T Consensus       648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            555555442 3456888888889999999999999988   99999999999997653   6999999999999866554


Q ss_pred             cccccccccC
Q 015138          403 SDTNRVVGTL  412 (412)
Q Consensus       403 ~~~~~~~Gt~  412 (412)
                      .   .++||+
T Consensus       724 r---sVVGTP  730 (888)
T KOG4236|consen  724 R---SVVGTP  730 (888)
T ss_pred             h---hhcCCc
Confidence            3   388885

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.93  E-value=2.7e-25  Score=210.24  Aligned_cols=141  Identities=31%  Similarity=0.396  Sum_probs=123.5

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+++.||||.+.+..   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999995 468899999987542   22344567888888776 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            999988843   456899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=2.7e-25  Score=215.47  Aligned_cols=141  Identities=23%  Similarity=0.338  Sum_probs=125.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..+|+..+.||+|+||.||++.. .+++.||+|....      ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            46799999999999999999994 6788999996532      2467899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +. ++|..++..   ...+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            95 788888743   356899999999999999999999987   999999999999999999999999999764

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1.4e-25  Score=204.75  Aligned_cols=151  Identities=26%  Similarity=0.279  Sum_probs=133.8

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC-CCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|.-|+||++.+.+ +..+|+|.+.+..-.   ...+...|-+||..++||.++.|++.+..+...+|+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3556678999999999999999754 588999999876433   344567889999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+||+|..++.. ...+.+++..+.-++.+|+.||+|||..|   ||.|||||+||||.++|++.|+||.|+....
T Consensus       156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999988754 46677999999999999999999999988   9999999999999999999999999998764

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.93  E-value=3.6e-25  Score=209.57  Aligned_cols=141  Identities=30%  Similarity=0.355  Sum_probs=120.8

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHH-HHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVL-LLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ++||+|+||.||++.. .+++.||+|.+.+...   .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999995 5688999999875422   22334555554 67889999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            999888743   456888888999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.93  E-value=3e-25  Score=203.55  Aligned_cols=152  Identities=32%  Similarity=0.517  Sum_probs=135.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..++|+..++||+|+||.||+|...++..|++|.+..... ....+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            3467888999999999999999988888999998865433 345789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence            9999999998542 2456889999999999999999999987   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=4.3e-25  Score=205.20  Aligned_cols=143  Identities=17%  Similarity=0.337  Sum_probs=125.5

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCccc---HHHHHHHHHHHccCCCCccceeeEEEec----CCeeeEEEec
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERILVYEF  321 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~lv~Ey  321 (412)
                      ...|++|++|.||+|.+ +|+.||||++.......   ...|.+|+.++.+++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36899999999999998 68899999997654333   3567899999999999999999999877    3467899999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++|+|.+++..   ...++|...+.++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.+..
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            999999999854   45689999999999999999999974 5   78999999999999999999999999987543

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=1.9e-25  Score=204.86  Aligned_cols=145  Identities=41%  Similarity=0.711  Sum_probs=125.9

Q ss_pred             ccccccccCCeeEEEEEeC-----CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          248 DANKLGQGGFGAVYKGMLS-----NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..+.||.|.||.||+|.+.     .+..|+||.+.... .....+|.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999976     25679999996543 33467899999999999999999999999988889999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +++|+|.++|... ....+++..+..|+.|++.||.|||+.+   ++|+||+++|||+++++.+||+|||+++..
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999999653 2467999999999999999999999987   999999999999999999999999999887

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.93  E-value=6.3e-25  Score=202.07  Aligned_cols=150  Identities=33%  Similarity=0.581  Sum_probs=132.8

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC----CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..+.||+|+||.||+|.+..    ...||||.+..... ....+|.+|+.++.+++|+||+++++.+...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4678889999999999999999642    35799998875433 334578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+|||+++++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999854  2347899999999999999999999987   9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=4.9e-25  Score=201.75  Aligned_cols=149  Identities=29%  Similarity=0.507  Sum_probs=132.5

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      ++|...+.||+|+||.||++...++..+|+|.+.... ....++.+|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577788999999999999998777789999887543 334578999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +|+|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            99999998542  236899999999999999999999987   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=3.9e-25  Score=206.00  Aligned_cols=156  Identities=29%  Similarity=0.512  Sum_probs=132.5

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecC
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  312 (412)
                      ++..++|++.++||+|+||.||+|...      .+..||+|.+..... .....+.+|+.+++.++|+||+++++.+...
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            345678999999999999999999743      245799998865432 2344688999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCe
Q 015138          313 KERILVYEFVPNASLDHFIFDPI-------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~  385 (412)
                      ...++||||+++|+|.+++....       ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence            99999999999999999985421       1234677888999999999999999987   9999999999999999999


Q ss_pred             EEeccCCcccccC
Q 015138          386 KISDFGMARLFEM  398 (412)
Q Consensus       386 ki~DfGla~~~~~  398 (412)
                      ||+|||+++.+..
T Consensus       159 ~L~Dfg~~~~~~~  171 (288)
T cd05061         159 KIGDFGMTRDIYE  171 (288)
T ss_pred             EECcCCccccccc
Confidence            9999999986543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.93  E-value=6.5e-25  Score=202.07  Aligned_cols=149  Identities=26%  Similarity=0.433  Sum_probs=134.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++||||+++++.+...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35788999999999999999995 67889999998765545555688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||+++.+.
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            999999998843   356899999999999999999999987   9999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.93  E-value=6.7e-25  Score=203.50  Aligned_cols=150  Identities=34%  Similarity=0.550  Sum_probs=126.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCC----EEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ++|+..+.||+|+||.||+|.+ .+++    .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            5678889999999999999995 3444    477787754432 234567888889999999999999998754 55789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++||+++|+|.+++..  ....++|..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999854  2356899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CC
Q 015138          398 MD  399 (412)
Q Consensus       398 ~~  399 (412)
                      ++
T Consensus       161 ~~  162 (279)
T cd05111         161 PD  162 (279)
T ss_pred             CC
Confidence            44

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.93  E-value=5.1e-25  Score=205.21  Aligned_cols=153  Identities=31%  Similarity=0.542  Sum_probs=134.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+..........+.+|++++.+++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46788899999999999999984      234568999887766555667999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeE
Q 015138          317 LVYEFVPNASLDHFIFDPI----------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k  386 (412)
                      +||||+++++|.+++....          ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999985321          2235899999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccC
Q 015138          387 ISDFGMARLFEM  398 (412)
Q Consensus       387 i~DfGla~~~~~  398 (412)
                      |+|||+++....
T Consensus       161 l~dfg~~~~~~~  172 (288)
T cd05093         161 IGDFGMSRDVYS  172 (288)
T ss_pred             eccCCccccccC
Confidence            999999986643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.93  E-value=5.3e-25  Score=202.92  Aligned_cols=144  Identities=29%  Similarity=0.489  Sum_probs=122.6

Q ss_pred             ccccccCCeeEEEEEeCC---CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          250 NKLGQGGFGAVYKGMLSN---GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      ++||+|+||.||+|...+   ...+++|.+..... .....+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999998533   34688887765432 23456889999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCC--CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          326 SLDHFIFDPIN--REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       326 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +|.+++.....  ....++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence            99999865322  234567888899999999999999987   999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=3.5e-25  Score=211.02  Aligned_cols=146  Identities=27%  Similarity=0.484  Sum_probs=125.7

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC-----eee
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ERI  316 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~  316 (412)
                      +|+..++||+|+||.||+|.. .+++.||||++....  ......+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            467789999999999999994 578999999987532  233456889999999999999999999886432     479


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||++ ++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 689888743   456899999999999999999999987   999999999999999999999999999865


Q ss_pred             c
Q 015138          397 E  397 (412)
Q Consensus       397 ~  397 (412)
                      .
T Consensus       154 ~  154 (338)
T cd07859         154 F  154 (338)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1e-25  Score=202.90  Aligned_cols=150  Identities=30%  Similarity=0.518  Sum_probs=130.5

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEec--cCCcccHHHHHHHHHHHccCCCCccceeeEEEec-----CCe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-----RKE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-----~~~  314 (412)
                      ...|...+.||+|+||.|..+. ..+|+.||||++.  -......++-.+|+.+|+.++|+||+.++..+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            3455667899999999999999 5678999999997  3444556678899999999999999999998865     357


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .|+|+|+| ..+|...+..   +..|+......++.|+++||.|+|+-+   |+||||||+|+|++.+...||+||||||
T Consensus       101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            89999999 6789888843   445999999999999999999999988   9999999999999999999999999999


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      ...+.
T Consensus       174 ~~~~~  178 (359)
T KOG0660|consen  174 YLDKF  178 (359)
T ss_pred             ecccc
Confidence            98654

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.93  E-value=6.1e-27  Score=205.21  Aligned_cols=159  Identities=26%  Similarity=0.490  Sum_probs=141.6

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      -|.++.+||+|+||.||++.. ..|+.+|||++...+  +.+++..|+.+|...+.|.+|+.+|-+.....+|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            356688999999999999994 679999999987553  46688999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCccc
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~  403 (412)
                      .|++.+.++.  ++.+|++.++..|+...++||+|||...   -+|||||+.||||+-++.+||+|||.|..+.+.....
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            9999999865  5678999999999999999999999875   8999999999999999999999999999887665544


Q ss_pred             ccccccccC
Q 015138          404 DTNRVVGTL  412 (412)
Q Consensus       404 ~~~~~~Gt~  412 (412)
                      .  .+.||+
T Consensus       187 N--TVIGTP  193 (502)
T KOG0574|consen  187 N--TVIGTP  193 (502)
T ss_pred             C--ccccCc
Confidence            3  388885

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=218.15  Aligned_cols=161  Identities=29%  Similarity=0.487  Sum_probs=143.1

Q ss_pred             hHHHHhhhcCCCccccccccCCeeEEEEEeCC-CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       236 ~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      .++|+....++....+||-|.||.||.|.|+. .-.||||.|++.. ....+|..|..+|+.++|||+|+|+|+|.....
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            45677777788889999999999999999854 4579999997654 456689999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .|||+|||.+|+|.+||++- .+..++.-.++.++.||+.||+||..++   +|||||.++|+|+.++..+||+||||+|
T Consensus       338 FYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             eEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999999763 4556777788999999999999999887   9999999999999999999999999999


Q ss_pred             cccCCCc
Q 015138          395 LFEMDQT  401 (412)
Q Consensus       395 ~~~~~~~  401 (412)
                      ++..+..
T Consensus       414 lMtgDTY  420 (1157)
T KOG4278|consen  414 LMTGDTY  420 (1157)
T ss_pred             hhcCCce
Confidence            9876653

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.93  E-value=4.7e-25  Score=226.94  Aligned_cols=150  Identities=23%  Similarity=0.351  Sum_probs=131.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..++||+|+||.||+|.. .+++.||||++.....   ....++.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4688899999999999999995 4689999999975432   22456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          320 EFVPNASLDHFIFDPI--------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      ||+++|+|.+++....        ....+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885311        1234677888999999999999999987   9999999999999999999999999


Q ss_pred             Ccccc
Q 015138          392 MARLF  396 (412)
Q Consensus       392 la~~~  396 (412)
                      +++..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99976

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=218.20  Aligned_cols=156  Identities=34%  Similarity=0.508  Sum_probs=134.1

Q ss_pred             CCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      -|+.++.||.|+||.||.+. ..+.+.||||+++-...   ....++..|+..|.+++|||++.+-||+......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            36678899999999999999 56788999999975433   346679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ||- ||-.+++.-  ...++.+-.+..|..+.+.||.|||+.+   .||||||+.||||.+.+.|||+|||-|.+..+..
T Consensus       107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn  180 (948)
T KOG0577|consen  107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN  180 (948)
T ss_pred             HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence            994 566666522  3567888899999999999999999988   9999999999999999999999999998876654


Q ss_pred             cccccccccccC
Q 015138          401 THSDTNRVVGTL  412 (412)
Q Consensus       401 ~~~~~~~~~Gt~  412 (412)
                      +      ++||+
T Consensus       181 s------FvGTP  186 (948)
T KOG0577|consen  181 S------FVGTP  186 (948)
T ss_pred             c------ccCCc
Confidence            3      66664

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.93  E-value=5.5e-25  Score=207.74  Aligned_cols=141  Identities=29%  Similarity=0.398  Sum_probs=122.2

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHcc-CCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLAR-LQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||+|.. .+++.||||.+....   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 457899999987642   2233445667777765 4899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            999999843   356889999999999999999999987   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=4e-25  Score=217.28  Aligned_cols=157  Identities=22%  Similarity=0.264  Sum_probs=130.8

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ...|.+.+.||+|+||.||++.. ..++.||||....      ..+.+|++++++++|+||+++++++...+..+||||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            34688899999999999999995 4578899995422      2357899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~  401 (412)
                      +. ++|..++..  ....++|..++.|+.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 788888743  2346999999999999999999999987   99999999999999999999999999987654332


Q ss_pred             cccccccccc
Q 015138          402 HSDTNRVVGT  411 (412)
Q Consensus       402 ~~~~~~~~Gt  411 (412)
                      ......+.||
T Consensus       316 ~~~~~~~~GT  325 (461)
T PHA03211        316 TPFHYGIAGT  325 (461)
T ss_pred             cccccccCCC
Confidence            2222234565

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.93  E-value=5.9e-25  Score=208.43  Aligned_cols=141  Identities=29%  Similarity=0.357  Sum_probs=120.0

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHH-HHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEV-LLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+++.||+|.+.+..   ......+..|. .+++.++|+||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999995 467889999987542   12223444444 456788999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|.+++..   ...+.+.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            999998854   355778888899999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.92  E-value=5.2e-25  Score=208.94  Aligned_cols=141  Identities=26%  Similarity=0.323  Sum_probs=124.3

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+++.+|+|.+.+...   .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 5678999999976432   2334578899998888 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            999988743   456999999999999999999999987   999999999999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.92  E-value=3.2e-25  Score=211.14  Aligned_cols=157  Identities=31%  Similarity=0.467  Sum_probs=130.7

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEEec
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  311 (412)
                      ....++|++.+.||+|+||.||+|..      .+++.||+|++..... .....+..|+.++.++ +|+||+++++++..
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            34456789999999999999999973      2347899999875432 2344678899999999 89999999998875


Q ss_pred             C-CeeeEEEecCCCCChhhhccCCCC------------------------------------------------------
Q 015138          312 R-KERILVYEFVPNASLDHFIFDPIN------------------------------------------------------  336 (412)
Q Consensus       312 ~-~~~~lv~Ey~~~gsL~~~l~~~~~------------------------------------------------------  336 (412)
                      . ...+++|||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            4 568899999999999998843211                                                      


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          337 ----REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       337 ----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                          ...++|..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~  226 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD  226 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence                136899999999999999999999987   999999999999999999999999999976443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.92  E-value=5.2e-25  Score=207.91  Aligned_cols=141  Identities=32%  Similarity=0.410  Sum_probs=122.2

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHcc-CCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLAR-LQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ++||+|+||.||++.. .+++.||+|.+.+..   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999995 468899999987642   2233456677777765 4899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            999988843   356889999999999999999999987   999999999999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=6.1e-25  Score=205.40  Aligned_cols=153  Identities=29%  Similarity=0.483  Sum_probs=130.5

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC---------------CCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN---------------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLL  306 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  306 (412)
                      .++|+..++||+|+||.||++....               ...||+|.+.... ......|.+|++++++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4578889999999999999987532               2358999987643 33345689999999999999999999


Q ss_pred             EEEecCCeeeEEEecCCCCChhhhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCE
Q 015138          307 GFCLERKERILVYEFVPNASLDHFIFDPI---------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (412)
Q Consensus       307 g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni  377 (412)
                      +++...+..++||||+++++|.+++....         ....+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999884321         1124788999999999999999999987   99999999999


Q ss_pred             EECCCCCeEEeccCCcccccC
Q 015138          378 LLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       378 ll~~~~~~ki~DfGla~~~~~  398 (412)
                      +++.++.+||+|||+++.+..
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~  181 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYS  181 (295)
T ss_pred             EEcCCCcEEeccccccccccc
Confidence            999999999999999987543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.92  E-value=4.8e-25  Score=210.57  Aligned_cols=153  Identities=30%  Similarity=0.458  Sum_probs=128.9

Q ss_pred             hhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEEecC-
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER-  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~-  312 (412)
                      ..++|+..+.||+|+||.||+|..      .+++.||||.+..... .....+.+|+.++.++ +|+||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            456789999999999999999973      3567899999975432 2345688999999999 689999999988654 


Q ss_pred             CeeeEEEecCCCCChhhhccCCCC--------------------------------------------------------
Q 015138          313 KERILVYEFVPNASLDHFIFDPIN--------------------------------------------------------  336 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~--------------------------------------------------------  336 (412)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            467899999999999998853210                                                        


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          337 --------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       337 --------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                              ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++++||+|||+++.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                    124788889999999999999999987   9999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.92  E-value=7.1e-25  Score=211.82  Aligned_cols=148  Identities=28%  Similarity=0.452  Sum_probs=128.5

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC-----eee
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ERI  316 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~  316 (412)
                      +|+..+.||+|+||.||++.. .+++.||||++....  ......+.+|++++..++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999994 578999999986542  223456889999999999999999999998776     789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +|+||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 578777743   456899999999999999999999987   999999999999999999999999999876


Q ss_pred             cCC
Q 015138          397 EMD  399 (412)
Q Consensus       397 ~~~  399 (412)
                      ...
T Consensus       154 ~~~  156 (372)
T cd07853         154 EPD  156 (372)
T ss_pred             ccC
Confidence            443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.92  E-value=1.1e-24  Score=200.87  Aligned_cols=145  Identities=31%  Similarity=0.461  Sum_probs=124.3

Q ss_pred             ccccccCCeeEEEEEeCC---CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          250 NKLGQGGFGAVYKGMLSN---GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      +.||+|+||.||+|...+   +..+++|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998643   45789998876543 33457889999999999999999999999999999999999999


Q ss_pred             ChhhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          326 SLDHFIFDPI--NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       326 sL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +|.+++....  .....++..+..++.|++.||.|||+.+   ++||||||+||+++.++++||+|||+++...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999985422  2235677888899999999999999987   9999999999999999999999999997543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=8.1e-25  Score=206.00  Aligned_cols=148  Identities=30%  Similarity=0.504  Sum_probs=128.8

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|...++||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            5688899999999999999995 46788999998754332 334578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence            975 78877744  2345888999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.92  E-value=1e-24  Score=199.52  Aligned_cols=148  Identities=28%  Similarity=0.500  Sum_probs=131.8

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      .+|+..+.||+|+||.||++...++..+|+|.+.+... ...++.+|+.++++++|+||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            45778899999999999999987777899998865432 34468899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++|.+++...  ...+++...+.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence            99999998542  336899999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.92  E-value=8.5e-25  Score=202.76  Aligned_cols=157  Identities=25%  Similarity=0.434  Sum_probs=134.4

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCC-----CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEec-CC
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RK  313 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~  313 (412)
                      +..++|+..+.||+|+||.||+|...+     +..|++|++..... .....+.+|+.++++++|+||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            345788889999999999999999755     67899998875432 334568899999999999999999998876 46


Q ss_pred             eeeEEEecCCCCChhhhccCCCCC-----CCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEe
Q 015138          314 ERILVYEFVPNASLDHFIFDPINR-----EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                      ..++++||+++++|.+++......     ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998543222     56899999999999999999999887   9999999999999999999999


Q ss_pred             ccCCcccccCCC
Q 015138          389 DFGMARLFEMDQ  400 (412)
Q Consensus       389 DfGla~~~~~~~  400 (412)
                      |||+++.+.+++
T Consensus       160 d~g~~~~~~~~~  171 (280)
T cd05043         160 DNALSRDLFPMD  171 (280)
T ss_pred             CCCCcccccCCc
Confidence            999999765443

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.92  E-value=8.2e-25  Score=202.78  Aligned_cols=152  Identities=32%  Similarity=0.565  Sum_probs=133.1

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC------CCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      .++|...+.||+|+||.||+|...+      ++.||||.+...... ....+.+|++++.+++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3567888999999999999998633      478999998765444 456799999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          316 ILVYEFVPNASLDHFIFDPI-----------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      ++||||+++++|.+++....           ....+++.....++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999985421           2345889999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCccccc
Q 015138          385 PKISDFGMARLFE  397 (412)
Q Consensus       385 ~ki~DfGla~~~~  397 (412)
                      +||+|||+++.+.
T Consensus       161 ~kl~d~g~~~~~~  173 (280)
T cd05049         161 VKIGDFGMSRDVY  173 (280)
T ss_pred             EEECCcccceecc
Confidence            9999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=1.2e-24  Score=203.67  Aligned_cols=150  Identities=26%  Similarity=0.449  Sum_probs=135.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..+|+..+.||+|+||.||++.. .+++.||+|.+..........+.+|+.++..++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788899999999999999994 67899999999776555566788999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....+
T Consensus        98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999983    345889999999999999999999987   999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=8.4e-25  Score=202.38  Aligned_cols=155  Identities=29%  Similarity=0.513  Sum_probs=133.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCC------CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      ..++|+..+.||+|+||.||+|....      +..||+|.+..... .....+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            45678889999999999999998632      36799999875532 334578899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          315 RILVYEFVPNASLDHFIFDPI-------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                      .++||||+++|+|.+++....       ....++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            999999999999999985422       1234789999999999999999999887   999999999999999999999


Q ss_pred             eccCCcccccCC
Q 015138          388 SDFGMARLFEMD  399 (412)
Q Consensus       388 ~DfGla~~~~~~  399 (412)
                      +|||+++.+...
T Consensus       161 ~dfg~~~~~~~~  172 (277)
T cd05032         161 GDFGMTRDIYET  172 (277)
T ss_pred             CCcccchhhccC
Confidence            999999876443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.92  E-value=1.5e-24  Score=200.06  Aligned_cols=149  Identities=29%  Similarity=0.545  Sum_probs=124.7

Q ss_pred             CccccccccCCeeEEEEEeCCC-C--EEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecC------Cee
Q 015138          247 SDANKLGQGGFGAVYKGMLSNG-E--TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------KER  315 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~~-~--~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~  315 (412)
                      .+.++||+|+||.||+|...+. .  .+|+|.++..  .......+.+|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4578999999999999996543 3  5899988654  233455788999999999999999999987542      246


Q ss_pred             eEEEecCCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          316 ILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      +++|||+++|+|.+++...   .....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887421   12345899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++.+..
T Consensus       159 ~~~~~~  164 (272)
T cd05075         159 SKKIYN  164 (272)
T ss_pred             ccccCc
Confidence            997654

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.92  E-value=1.3e-24  Score=202.84  Aligned_cols=152  Identities=29%  Similarity=0.514  Sum_probs=132.8

Q ss_pred             cCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      .+|...+.||+|+||.||++...      ++..+++|.+..........+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777899999999999999842      345689998876666556679999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          318 VYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      ||||+++++|.+++....             ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985421             1245899999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCcccccC
Q 015138          385 PKISDFGMARLFEM  398 (412)
Q Consensus       385 ~ki~DfGla~~~~~  398 (412)
                      +||+|||+++....
T Consensus       162 ~~l~dfg~a~~~~~  175 (291)
T cd05094         162 VKIGDFGMSRDVYS  175 (291)
T ss_pred             EEECCCCcccccCC
Confidence            99999999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.92  E-value=1e-24  Score=206.08  Aligned_cols=141  Identities=34%  Similarity=0.398  Sum_probs=123.8

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+++.||||.+.+..   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999995 457899999997642   22344567888888877 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            999988843   346999999999999999999999987   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=1.2e-24  Score=200.39  Aligned_cols=152  Identities=32%  Similarity=0.538  Sum_probs=132.1

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-C---CCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-N---GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..+|+..+.||+|+||.||+|... +   +..+|+|.+.... ......+.+|+.++.+++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            356788899999999999999852 2   2369999887543 2334578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++++|.+++...  ...+++.+.+.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999998542  346899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CC
Q 015138          398 MD  399 (412)
Q Consensus       398 ~~  399 (412)
                      ..
T Consensus       158 ~~  159 (267)
T cd05066         158 DD  159 (267)
T ss_pred             cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.92  E-value=1.2e-24  Score=201.77  Aligned_cols=153  Identities=31%  Similarity=0.515  Sum_probs=133.9

Q ss_pred             hcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .+++...++||+|+||.||++...      ++..+++|.+..........+.+|++++..++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            457788899999999999999732      35678999988776666678999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          317 LVYEFVPNASLDHFIFDPIN------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      ++|||+++++|.+++.....            ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999999854221            135899999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCcccccC
Q 015138          385 PKISDFGMARLFEM  398 (412)
Q Consensus       385 ~ki~DfGla~~~~~  398 (412)
                      +||+|||+++....
T Consensus       161 ~kL~dfg~~~~~~~  174 (280)
T cd05092         161 VKIGDFGMSRDIYS  174 (280)
T ss_pred             EEECCCCceeEcCC
Confidence            99999999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.92  E-value=1.6e-24  Score=201.23  Aligned_cols=152  Identities=33%  Similarity=0.591  Sum_probs=131.1

Q ss_pred             cCCCccccccccCCeeEEEEEeCC------CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ++|+..+.||+|+||.||+|....      ...|++|.+..... .....|.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            568889999999999999998532      25799998875433 23456899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC
Q 015138          317 LVYEFVPNASLDHFIFDPIN-------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~  383 (412)
                      ++|||+++++|.+++.....             ...+++...+.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999854211             145889999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccC
Q 015138          384 NPKISDFGMARLFEM  398 (412)
Q Consensus       384 ~~ki~DfGla~~~~~  398 (412)
                      .+||+|||+++....
T Consensus       162 ~~~L~dfg~~~~~~~  176 (283)
T cd05048         162 TVKISDFGLSRDIYS  176 (283)
T ss_pred             cEEECCCcceeeccc
Confidence            999999999986543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=9.9e-25  Score=224.75  Aligned_cols=149  Identities=28%  Similarity=0.363  Sum_probs=132.5

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|.+.++||+|+||.||+|... +++.||||++.....   .....+..|+.++..++|+||+++++.+......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999964 688999999875432   22356889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++|.+++..   ...+++...+.|+.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++....
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            99999999999843   346888999999999999999999987   99999999999999999999999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.92  E-value=1.1e-24  Score=203.49  Aligned_cols=157  Identities=29%  Similarity=0.489  Sum_probs=134.8

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEe
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~  310 (412)
                      +....++|+..+.||+|+||.||++...      ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3455677888999999999999999853      23578999887543 23345688999999999 7999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCE
Q 015138          311 ERKERILVYEFVPNASLDHFIFDP-------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni  377 (412)
                      ..+..+++|||+++|+|.+++...             .....+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            999999999999999999998532             22456899999999999999999999887   99999999999


Q ss_pred             EECCCCCeEEeccCCcccccC
Q 015138          378 LLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       378 ll~~~~~~ki~DfGla~~~~~  398 (412)
                      |++.++.+||+|||+++.+..
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHH  184 (293)
T ss_pred             EEcCCCeEEeCcccccccccc
Confidence            999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.92  E-value=1.5e-24  Score=201.30  Aligned_cols=147  Identities=30%  Similarity=0.458  Sum_probs=131.5

Q ss_pred             CCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      |+..+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++.+...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999964 5778899998776666666789999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++|..++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            999988754  2356899999999999999999999987   9999999999999999999999999997653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.92  E-value=1.7e-24  Score=201.41  Aligned_cols=148  Identities=30%  Similarity=0.404  Sum_probs=129.6

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      |+..+.||+|+||+||++.. .+++.+|+|.+.....   .....+.+|+.++.+++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56678899999999999995 5688999999865432   2234578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            9999999887542 2346999999999999999999999987   9999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.1e-24  Score=202.06  Aligned_cols=150  Identities=29%  Similarity=0.437  Sum_probs=135.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|++.+.||+|+||.||++.. .+++.+++|.+..........+..|++++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            46788899999999999999996 46889999998776666666789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            999999999854  2346899999999999999999999987   9999999999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.92  E-value=1.9e-24  Score=197.27  Aligned_cols=143  Identities=32%  Similarity=0.556  Sum_probs=126.7

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ++||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999995 578899999876543 33345689999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      .+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence            999853  2346899999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.92  E-value=2.1e-24  Score=201.23  Aligned_cols=151  Identities=31%  Similarity=0.472  Sum_probs=129.2

Q ss_pred             CCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      +|+..+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999852      235688888875543 334568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          318 VYEFVPNASLDHFIFDPI---------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                      ++||+++++|.+++....                     ....+++...+.++.|++.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999874321                     1235889999999999999999999887   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccccC
Q 015138          377 ILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++.+||+|||+++.+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~  179 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYE  179 (290)
T ss_pred             EEEcCCCcEEeccccccccccC
Confidence            9999999999999999986543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=1.2e-24  Score=201.25  Aligned_cols=141  Identities=26%  Similarity=0.405  Sum_probs=120.9

Q ss_pred             cccccCCeeEEEEEeCC-------------------------CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcccee
Q 015138          251 KLGQGGFGAVYKGMLSN-------------------------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL  305 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l  305 (412)
                      .||+|+||.||+|.+..                         ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999998521                         13588898876554445678899999999999999999


Q ss_pred             eEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC--
Q 015138          306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM--  383 (412)
Q Consensus       306 ~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~--  383 (412)
                      ++++......++||||+++|+|+.++..  ....+++..++.++.|+++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999999854  2456889999999999999999999887   99999999999997654  


Q ss_pred             -----CeEEeccCCcccc
Q 015138          384 -----NPKISDFGMARLF  396 (412)
Q Consensus       384 -----~~ki~DfGla~~~  396 (412)
                           .+|++|||++...
T Consensus       157 ~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             cCccceeeecCCcccccc
Confidence                 3799999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.3e-24  Score=206.46  Aligned_cols=139  Identities=26%  Similarity=0.312  Sum_probs=119.2

Q ss_pred             ccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccC---CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          252 LGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARL---QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       252 lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ||+|+||.||++.. .+++.||||.+.+....   ....+..|..++...   +||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999995 56899999998653221   222345566666554   699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            999988843   456899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.92  E-value=1.8e-24  Score=202.41  Aligned_cols=149  Identities=26%  Similarity=0.452  Sum_probs=134.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..+|+..+.||+|+||.||+|.. .+++.|++|.+..........+.+|+.++..++|+||+++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            35788889999999999999984 57889999999876655566789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++.    ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            99999999983    345889999999999999999999987   99999999999999999999999999886543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.92  E-value=1.4e-24  Score=199.38  Aligned_cols=151  Identities=30%  Similarity=0.514  Sum_probs=133.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..+|+..++||+|+||.||+|.. ..++.|++|.+... .....++.+|+.++.+++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            35577789999999999999995 45788999988754 33455789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++....
T Consensus        84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999999998542 2356899999999999999999999987   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.92  E-value=2.1e-24  Score=198.86  Aligned_cols=156  Identities=29%  Similarity=0.401  Sum_probs=134.7

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ++.+++++.....||+|+||.||+|.. .++..|++|.+..........+.+|+.++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345667777788999999999999994 5678899999887766666789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEEeccCCcccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLF  396 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~  396 (412)
                      |+||+++++|.+++.........++..+..++.|++.||.|||+.+   |+||||||+||+++. ++.+||+|||++..+
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999999864222212278888899999999999999987   999999999999986 679999999999765


Q ss_pred             c
Q 015138          397 E  397 (412)
Q Consensus       397 ~  397 (412)
                      .
T Consensus       160 ~  160 (268)
T cd06624         160 A  160 (268)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.92  E-value=1.3e-24  Score=203.99  Aligned_cols=155  Identities=28%  Similarity=0.485  Sum_probs=133.0

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe--------CCCCEEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML--------SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~--------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~  310 (412)
                      ...++|.+.+.||+|+||.||++..        .++..||+|.+.... .....++.+|+.++..+ +||||+++++.+.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4567788899999999999999973        124479999886543 33456789999999999 8999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCE
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni  377 (412)
                      .....++||||+++|+|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            9999999999999999999986421             1245889999999999999999999987   99999999999


Q ss_pred             EECCCCCeEEeccCCcccccC
Q 015138          378 LLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       378 ll~~~~~~ki~DfGla~~~~~  398 (412)
                      |++.++.+||+|||+++.+..
T Consensus       169 li~~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNN  189 (304)
T ss_pred             EEcCCCcEEECCCccceeccc
Confidence            999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.5e-24  Score=198.61  Aligned_cols=151  Identities=28%  Similarity=0.508  Sum_probs=128.1

Q ss_pred             CCccccccccCCeeEEEEEeCC----CCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCe-----
Q 015138          246 FSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-----  314 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-----  314 (412)
                      |.+.+.||+|+||.||+|....    +..||+|++....  ......+.+|+..++.++|+||+++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998632    3679999987543  2334578999999999999999999999876554     


Q ss_pred             -eeEEEecCCCCChhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          315 -RILVYEFVPNASLDHFIFDPI---NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       315 -~~lv~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                       .++++||+++|+|..++....   ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999885421   2346899999999999999999999987   999999999999999999999999


Q ss_pred             CCcccccCC
Q 015138          391 GMARLFEMD  399 (412)
Q Consensus       391 Gla~~~~~~  399 (412)
                      |+++.+...
T Consensus       158 g~~~~~~~~  166 (273)
T cd05035         158 GLSKKIYSG  166 (273)
T ss_pred             cceeecccc
Confidence            999876543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.92  E-value=2.5e-24  Score=200.64  Aligned_cols=151  Identities=30%  Similarity=0.533  Sum_probs=123.1

Q ss_pred             cCCCccccccccCCeeEEEEEe--CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccC---CCCccceeeEEEec-----
Q 015138          244 DNFSDANKLGQGGFGAVYKGML--SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARL---QHRNLVRLLGFCLE-----  311 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~-----  311 (412)
                      ++|+..+.||+|+||.||++..  .+++.||+|.+.....  .....+.+|+.++..+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688889999999999999985  3467899998865432  2233456677666655   69999999999853     


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      ....++||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 6898888542 2345899999999999999999999987   9999999999999999999999999


Q ss_pred             CcccccCC
Q 015138          392 MARLFEMD  399 (412)
Q Consensus       392 la~~~~~~  399 (412)
                      +++.....
T Consensus       156 ~~~~~~~~  163 (290)
T cd07862         156 LARIYSFQ  163 (290)
T ss_pred             ceEeccCC
Confidence            99876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.92  E-value=1.2e-24  Score=200.27  Aligned_cols=149  Identities=26%  Similarity=0.465  Sum_probs=133.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|+..++||+|+||.||++.. .+++.||+|.++.........+.+|+.++..++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35677889999999999999985 56889999998766555555688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++..   ...+++.+...++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..+.
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            999999998843   456899999999999999999999987   9999999999999999999999999987654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.92  E-value=1.8e-24  Score=198.75  Aligned_cols=152  Identities=29%  Similarity=0.489  Sum_probs=131.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..++|+..++||+|+||.||+|...+...||+|++..... ....+.+|+.++.+++|+||+++++.+. ....++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            3467888999999999999999987777899999875433 3457899999999999999999999874 4567999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++|+|.+++... ....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999998542 2346899999999999999999999987   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=2.2e-24  Score=202.95  Aligned_cols=149  Identities=29%  Similarity=0.382  Sum_probs=130.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||+|+||.||++.. .++..+++|.+..... ....++.+|++++.+++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4688899999999999999995 4678899998865432 2344688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++..   ...+++.....++.|+++||.|||+..  +++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            999999999854   356889999999999999999999742  39999999999999999999999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.92  E-value=1.2e-24  Score=202.05  Aligned_cols=152  Identities=29%  Similarity=0.508  Sum_probs=130.0

Q ss_pred             cCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCccc-HHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .+|+..++||+|+||.||+|...      +++.||+|++....... ...+.+|+.++.+++||||+++++.+......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            44667889999999999999853      24689999987554332 356889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC
Q 015138          317 LVYEFVPNASLDHFIFDP-------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~  383 (412)
                      +++||+++++|.+++...             .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999997421             11245888999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccC
Q 015138          384 NPKISDFGMARLFEM  398 (412)
Q Consensus       384 ~~ki~DfGla~~~~~  398 (412)
                      .+||+|||+++....
T Consensus       162 ~~kl~Dfg~~~~~~~  176 (283)
T cd05091         162 NVKISDLGLFREVYA  176 (283)
T ss_pred             ceEeccccccccccc
Confidence            999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=2.1e-24  Score=198.95  Aligned_cols=150  Identities=31%  Similarity=0.562  Sum_probs=131.2

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CC---CEEEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NG---ETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~---~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .+|+..+.||+|+||.||+|... ++   ..|+||.+... ......+|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35677899999999999999964 33   35999998764 333456799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999998542  356899999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.92  E-value=2.9e-24  Score=200.80  Aligned_cols=153  Identities=30%  Similarity=0.503  Sum_probs=132.5

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC-----------------CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccce
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN-----------------GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVR  304 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~  304 (412)
                      ..+|+..++||+|+||.||++...+                 +..||+|.+..... .....+.+|+.++.+++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678889999999999999988532                 24589999876543 34557899999999999999999


Q ss_pred             eeEEEecCCeeeEEEecCCCCChhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          305 LLGFCLERKERILVYEFVPNASLDHFIFDPI--------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       305 l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                      +++++...+..+++|||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999985422        1236899999999999999999999987   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccccC
Q 015138          377 ILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++.++.+||+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             eeecCCCceEEccccceeeccc
Confidence            9999999999999999987543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.92  E-value=2.6e-24  Score=200.81  Aligned_cols=149  Identities=30%  Similarity=0.463  Sum_probs=134.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|++.++||+|+||.||+|.. .+++.+++|.+..........+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            46788899999999999999995 45889999999877666667789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +++++|..++.+  ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            999999888744  2346899999999999999999999987   999999999999999999999999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.92  E-value=2.4e-24  Score=201.53  Aligned_cols=153  Identities=28%  Similarity=0.486  Sum_probs=131.2

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-----------------CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccce
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-----------------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVR  304 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~  304 (412)
                      .++|+..++||+|+||.||++...                 ++..+|+|.+.... ......+.+|+.++.+++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            457889999999999999998532                 23468999987543 334567899999999999999999


Q ss_pred             eeEEEecCCeeeEEEecCCCCChhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          305 LLGFCLERKERILVYEFVPNASLDHFIFDPI--------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       305 l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                      +++++...+..++||||+++++|.+++....        ....+++.....++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999999985421        1234788899999999999999999987   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccccC
Q 015138          377 ILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||++.++.+||+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             EEEcCCCCEEeccCcccccccC
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.92  E-value=2.2e-24  Score=199.06  Aligned_cols=153  Identities=30%  Similarity=0.487  Sum_probs=131.6

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecC------
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER------  312 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~------  312 (412)
                      .+++.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4567788899999999999999995 567889999886543 3445788999999998 799999999998753      


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998542 2356899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++....
T Consensus       158 ~~~~~~  163 (272)
T cd06637         158 SAQLDR  163 (272)
T ss_pred             ceeccc
Confidence            987643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.9e-24  Score=196.95  Aligned_cols=153  Identities=32%  Similarity=0.542  Sum_probs=136.5

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ...++|.+.++||+|+||.||++...+++.++||.+..... ...++.+|+.++++++|+||+++++++......++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            44578899999999999999999987788899999875433 34578999999999999999999999999899999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999998552 2346899999999999999999999987   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.92  E-value=3.3e-24  Score=198.77  Aligned_cols=150  Identities=34%  Similarity=0.629  Sum_probs=129.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCC----EEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|+..+.||+|+||.||+|.+ .+++    .||+|.+..... ....++.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            46788899999999999999984 4454    489998875433 335578899999999999999999999875 4578


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +++||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999999854  2346899999999999999999999987   999999999999999999999999999977


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      ..
T Consensus       160 ~~  161 (279)
T cd05109         160 DI  161 (279)
T ss_pred             cc
Confidence            53

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.5e-24  Score=196.89  Aligned_cols=149  Identities=31%  Similarity=0.547  Sum_probs=134.1

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .++|+..+.||+|+||.||++... ++.|++|.+..... ....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            467888999999999999999875 78999999976654 4567899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            999999998542 2236899999999999999999999987   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.92  E-value=2.5e-24  Score=197.39  Aligned_cols=151  Identities=30%  Similarity=0.510  Sum_probs=132.4

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..++|+..++||+|+||.||++...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            3467888999999999999999988888999999876443 3457899999999999999999999875 4568999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++..+..
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            9999999998542 2345899999999999999999999987   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.92  E-value=2.9e-24  Score=199.86  Aligned_cols=150  Identities=30%  Similarity=0.403  Sum_probs=130.2

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      |+..+.||+|+||.||++.. .+++.+|||.+.+....   ....+..|+.++.+++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778999999999999995 56889999998754322   233577899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.....+
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999988542 2345899999999999999999999887   999999999999999999999999999865433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.92  E-value=1.9e-24  Score=203.33  Aligned_cols=155  Identities=27%  Similarity=0.472  Sum_probs=132.6

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEeC--------CCCEEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEE
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFC  309 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~  309 (412)
                      ....++|.+.+.||+|+||.||++...        +...+|+|.+.... .....++.+|+.++.++ +|+||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            334567889999999999999999742        23469999987543 33445688899999999 799999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                      ...+..++||||+++|+|.+++....             ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence            99999999999999999999986422             1235899999999999999999999987   9999999999


Q ss_pred             EEECCCCCeEEeccCCccccc
Q 015138          377 ILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~  397 (412)
                      ||++.++.+||+|||+++.+.
T Consensus       171 ill~~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIH  191 (307)
T ss_pred             eEEcCCCcEEECCCccccccc
Confidence            999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.92  E-value=2.7e-24  Score=197.24  Aligned_cols=151  Identities=34%  Similarity=0.571  Sum_probs=133.3

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      +..++|+..++||+|+||.||++...+++.||+|.+..... ....+.+|+.++++++|+||+++++++ ..+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence            34577889999999999999999988899999999875543 345789999999999999999999986 4557899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.+.
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            99999999988542 3456899999999999999999999887   9999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=3.2e-24  Score=199.40  Aligned_cols=150  Identities=33%  Similarity=0.560  Sum_probs=130.2

Q ss_pred             cCCCccccccccCCeeEEEEEe-----CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecC--Cee
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~  315 (412)
                      ..|+..++||+|+||.||++..     .++..||+|.+.... ......+.+|+.++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4567889999999999999974     357889999987553 33345789999999999999999999998875  568


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998442  345899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      +..
T Consensus       159 ~~~  161 (284)
T cd05079         159 IET  161 (284)
T ss_pred             ccc
Confidence            654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.92  E-value=2.8e-24  Score=197.74  Aligned_cols=152  Identities=23%  Similarity=0.419  Sum_probs=132.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..++||+|+||.||+|.. .+++.||||.+....   ......+.+|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5788899999999999999995 578999999876432   233446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++|.+++.... ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998874322 2345888999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=4.4e-24  Score=197.81  Aligned_cols=143  Identities=29%  Similarity=0.408  Sum_probs=124.3

Q ss_pred             ccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          252 LGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       252 lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ||+|+||.||++.. .+|+.+|+|.+.....   .....+..|++++.+++||||+++++.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999985 5689999999865322   1233456799999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      .+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            9887542 2345899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.92  E-value=4.4e-24  Score=195.58  Aligned_cols=143  Identities=29%  Similarity=0.566  Sum_probs=123.4

Q ss_pred             cccccCCeeEEEEEeC---CCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCC
Q 015138          251 KLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      .||+|+||.||+|.+.   .+..||+|.+...... ....+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999853   3456999988765432 3456899999999999999999999875 457899999999999


Q ss_pred             hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |.+++..  ....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            9999854  2456899999999999999999999987   999999999999999999999999999866443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=3.1e-24  Score=200.10  Aligned_cols=150  Identities=32%  Similarity=0.392  Sum_probs=133.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.+|+|.+....   ......+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4678889999999999999995 468999999986542   223456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999854   356899999999999999999999987   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.92  E-value=3.1e-24  Score=197.77  Aligned_cols=143  Identities=26%  Similarity=0.441  Sum_probs=120.8

Q ss_pred             ccccccCCeeEEEEEeCCCC---EEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          250 NKLGQGGFGAVYKGMLSNGE---TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~---~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      ++||+|+||.||++...++.   .+++|.+.... ......+.+|+.++..++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999854333   45677666543 234557899999999999999999999999999999999999999


Q ss_pred             ChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          326 SLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       326 sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +|.+++.... ....+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence            9999986432 2234677778899999999999999987   99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.92  E-value=4.8e-24  Score=194.25  Aligned_cols=143  Identities=35%  Similarity=0.589  Sum_probs=127.6

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCChh
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD  328 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~  328 (412)
                      ++||+|+||.||+|...++..+|+|.+...... ....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999999888899999998765432 3446889999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       329 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++..  ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence            99854  2345899999999999999999999987   9999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-25  Score=206.55  Aligned_cols=161  Identities=25%  Similarity=0.412  Sum_probs=140.6

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..|...+.||+|.||.||+|. ..+++.||+|.+...... ...++..|+.++..++++||.+.+|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            456777899999999999999 567889999999765443 455789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~  401 (412)
                      +.+|++.+.|..   ...+.+....-|+.+++.||.|||.++   .+|||||+.|||+.+++.+|++|||.+..+..+..
T Consensus        93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999843   444577777788999999999999998   99999999999999999999999999999877665


Q ss_pred             ccccccccccC
Q 015138          402 HSDTNRVVGTL  412 (412)
Q Consensus       402 ~~~~~~~~Gt~  412 (412)
                      ..  ..++||+
T Consensus       167 rr--~tfvGTP  175 (467)
T KOG0201|consen  167 RR--KTFVGTP  175 (467)
T ss_pred             cc--ccccccc
Confidence            54  3488985

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.91  E-value=3.3e-24  Score=199.73  Aligned_cols=153  Identities=31%  Similarity=0.547  Sum_probs=132.9

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      ..++|+..+.||+|+||.||++...      ++..||+|.+..... ....++.+|+.++++++||||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4578999999999999999999853      467899999875432 334568899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCC
Q 015138          315 RILVYEFVPNASLDHFIFDPI-------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS  375 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~  375 (412)
                      .++||||+++|+|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            999999999999999985321                   1235788999999999999999999987   999999999


Q ss_pred             CEEECCCCCeEEeccCCccccc
Q 015138          376 NILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       376 Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++.++.+||+|||+++.+.
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             heEecCCCceEECccccceecc
Confidence            9999999999999999998654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.91  E-value=2.8e-24  Score=201.65  Aligned_cols=155  Identities=29%  Similarity=0.441  Sum_probs=133.4

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEEec
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  311 (412)
                      ....++|...+.||+|+||.||++..      .++..||||.+..... .....+.+|+.+++++ +|+||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            34556789999999999999999974      2345799998876533 3345689999999999 79999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      .+..++||||+++|+|.+++... ....+++.++..++.|++.||.|||+++   |+|+||||+|||++.++.+||+|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            99999999999999999998542 2234899999999999999999999987   9999999999999999999999999


Q ss_pred             CcccccC
Q 015138          392 MARLFEM  398 (412)
Q Consensus       392 la~~~~~  398 (412)
                      +++.+..
T Consensus       187 ~~~~~~~  193 (302)
T cd05055         187 LARDIMN  193 (302)
T ss_pred             ccccccC
Confidence            9987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.91  E-value=5.8e-24  Score=197.18  Aligned_cols=145  Identities=24%  Similarity=0.374  Sum_probs=128.0

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+.... .....++.+|+.++.+++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577789999999999999984 678899999987653 33345689999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|..+.       .+++.....++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++..+..
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            9999996552       4678888899999999999999987   99999999999999999999999999986643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.91  E-value=4.4e-24  Score=196.15  Aligned_cols=143  Identities=27%  Similarity=0.474  Sum_probs=122.8

Q ss_pred             ccccccCCeeEEEEEeCC-------------CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          250 NKLGQGGFGAVYKGMLSN-------------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      +.||+|+||.||+|.+.+             ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2258888876655445557889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC-------eEEec
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-------PKISD  389 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-------~ki~D  389 (412)
                      +||||+++|+|+.++..  ....+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988753  2356899999999999999999999987   999999999999987664       89999


Q ss_pred             cCCccccc
Q 015138          390 FGMARLFE  397 (412)
Q Consensus       390 fGla~~~~  397 (412)
                      ||++..+.
T Consensus       156 ~g~~~~~~  163 (262)
T cd05077         156 PGIPITVL  163 (262)
T ss_pred             CCCCcccc
Confidence            99987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=4.9e-24  Score=194.78  Aligned_cols=151  Identities=28%  Similarity=0.472  Sum_probs=133.4

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.||++.. .+++.|++|.+...  ......++.+|++++++++||||+++++.+.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            467788999999999999995 56889999988643  233456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999998652 2456899999999999999999999987   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=2.6e-24  Score=200.13  Aligned_cols=152  Identities=25%  Similarity=0.428  Sum_probs=132.3

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||+|+||.||++... +++.||+|.+... .......+.+|+.++.+++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999964 7899999988654 223345788999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|..++........+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||++..+.
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999999998855333447899999999999999999999742  39999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=2.4e-24  Score=209.46  Aligned_cols=146  Identities=23%  Similarity=0.341  Sum_probs=127.3

Q ss_pred             hcCCCccccccccCCeeEEEEEeC---CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ..+|...+.||+|+||.||++...   .+..|++|.+....     .+.+|+.++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357889999999999999999753   35789999886532     3468999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |++. ++|.+++.   ....+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9985 68888872   3467999999999999999999999987   999999999999999999999999999876544


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       239 ~  239 (392)
T PHA03207        239 P  239 (392)
T ss_pred             c
Confidence            3

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.91  E-value=4e-24  Score=200.00  Aligned_cols=149  Identities=26%  Similarity=0.487  Sum_probs=134.7

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .+|+..+.||.|+||.||++. ..+++.|++|.+..........+.+|+.+++.++|+||+++++.+...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            468889999999999999998 4678999999997665555667899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ++++|..++.    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+...
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            9999999883    345899999999999999999999987   999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.91  E-value=5e-24  Score=198.03  Aligned_cols=149  Identities=31%  Similarity=0.541  Sum_probs=130.3

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.||+|.. .+++.||+|++.....  .....+.+|+.++..++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            467788999999999999995 4689999999865422  2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++ ++|.+++........+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            97 688888755434467999999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.91  E-value=3.3e-24  Score=201.25  Aligned_cols=150  Identities=31%  Similarity=0.563  Sum_probs=129.0

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCC--EEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGE--TIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..+.||+|+||.||+|... ++.  .+++|.+.... ......+.+|++++.++ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            467888999999999999999963 444  46788776533 33445788999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          318 VYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      ||||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999985421             1235889999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCccc
Q 015138          385 PKISDFGMARL  395 (412)
Q Consensus       385 ~ki~DfGla~~  395 (412)
                      +||+|||+++.
T Consensus       163 ~kl~dfg~~~~  173 (303)
T cd05088         163 AKIADFGLSRG  173 (303)
T ss_pred             EEeCccccCcc
Confidence            99999999974

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.91  E-value=4.5e-24  Score=196.59  Aligned_cols=151  Identities=30%  Similarity=0.619  Sum_probs=132.6

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCC---EEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGE---TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~---~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..+.||+|+||.||+|... +++   .+++|.+.... .....++..|++++.+++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            467888899999999999999964 333   68999887553 3335578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999854  2356899999999999999999999987   9999999999999999999999999998764


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       159 ~  159 (268)
T cd05063         159 D  159 (268)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=6.8e-24  Score=196.67  Aligned_cols=150  Identities=32%  Similarity=0.635  Sum_probs=130.4

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCC----EEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGE----TIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..+|+..+.||+|+||.||+|... +|+    .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            456788899999999999999953 333    589998876543 334578899999999999999999999987 7889


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++..  ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999999854  2345899999999999999999999987   999999999999999999999999999876


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      ..
T Consensus       160 ~~  161 (279)
T cd05057         160 DV  161 (279)
T ss_pred             cC
Confidence            54

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=4.1e-25  Score=211.41  Aligned_cols=158  Identities=28%  Similarity=0.458  Sum_probs=129.5

Q ss_pred             CccccccccCCeeEEEEEe-CCCCEEEEE--Eecc--CCcccHHHHHHHHHHHccCCCCccceeeEEEecCCe--eeEEE
Q 015138          247 SDANKLGQGGFGAVYKGML-SNGETIAVK--RLSK--NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE--RILVY  319 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~-~~~~~vavK--~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~--~~lv~  319 (412)
                      ....+||+|+|-+||+|.. .+|..||=-  ++.+  .+....+.|.+|+.+|+.|+|+||++++..+.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3457899999999999995 456666522  1222  123344689999999999999999999999987765  77999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~~~~~  398 (412)
                      |.+..|+|..|+.+   .+.+..+....|+.||++||.|||++. |||||||||..||+|+.+ |.|||+|+|||.+...
T Consensus       123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999854   556888899999999999999999986 789999999999999865 7999999999998753


Q ss_pred             CCcccccccccccC
Q 015138          399 DQTHSDTNRVVGTL  412 (412)
Q Consensus       399 ~~~~~~~~~~~Gt~  412 (412)
                      ..    ..+++||+
T Consensus       199 s~----aksvIGTP  208 (632)
T KOG0584|consen  199 SH----AKSVIGTP  208 (632)
T ss_pred             cc----cceeccCc
Confidence            32    22488985

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=3.8e-24  Score=195.84  Aligned_cols=141  Identities=28%  Similarity=0.535  Sum_probs=122.1

Q ss_pred             ccccccCCeeEEEEEeCCCC-----------EEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          250 NKLGQGGFGAVYKGMLSNGE-----------TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999975433           4777876654433 5678999999999999999999999988 778999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-------CeEEeccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-------NPKISDFG  391 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-------~~ki~DfG  391 (412)
                      |||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999998542  226899999999999999999999887   99999999999999888       79999999


Q ss_pred             Cccccc
Q 015138          392 MARLFE  397 (412)
Q Consensus       392 la~~~~  397 (412)
                      +++...
T Consensus       154 ~a~~~~  159 (259)
T cd05037         154 IPITVL  159 (259)
T ss_pred             cccccc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.8e-24  Score=195.16  Aligned_cols=148  Identities=31%  Similarity=0.494  Sum_probs=131.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-----ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-----QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ++|...+.||+|++|.||++.. .+++.+++|.+.....     .....+.+|+.++.+++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999984 5689999998865421     123468899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |+||+++++|.+++..   ...+++.....++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998843   346888999999999999999999987   9999999999999999999999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.91  E-value=3.2e-24  Score=211.20  Aligned_cols=150  Identities=26%  Similarity=0.467  Sum_probs=123.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecC--------
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--------  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--------  312 (412)
                      ...+|+..+.||+|+||.||+|.. .+++.||||++.....    ...+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            346799999999999999999995 5688999998865432    245799999999999999999876432        


Q ss_pred             CeeeEEEecCCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEecc
Q 015138          313 KERILVYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDF  390 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~Df  390 (412)
                      ..+++||||+++ +|.+++.. ......+++.....++.||+.||.|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999985 66666532 123456899999999999999999999987   99999999999999665 7999999


Q ss_pred             CCcccccCC
Q 015138          391 GMARLFEMD  399 (412)
Q Consensus       391 Gla~~~~~~  399 (412)
                      |+|+.+...
T Consensus       216 Gla~~~~~~  224 (440)
T PTZ00036        216 GSAKNLLAG  224 (440)
T ss_pred             ccchhccCC
Confidence            999977543

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.91  E-value=3.4e-24  Score=197.18  Aligned_cols=152  Identities=24%  Similarity=0.434  Sum_probs=133.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.++||.+....   .....++.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999994 678999999886532   223457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++|.+++... .....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 22456899999999999999999999987   99999999999999999999999999887643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=8.1e-24  Score=193.44  Aligned_cols=151  Identities=22%  Similarity=0.368  Sum_probs=133.0

Q ss_pred             CCCccccccccCCeeEEEEE-eCCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.||.+. ..+++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47788999999999999888 456889999988654  234455788999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999985422 356899999999999999999999987   999999999999999999999999999876443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=7.6e-24  Score=194.16  Aligned_cols=151  Identities=28%  Similarity=0.468  Sum_probs=135.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|+..+.||+|+||.||++.. .+++.+++|.+..........+.+|+.++++++||||+++++.+......+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            36788899999999999999995 45788999999876655667899999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++..+..
T Consensus        82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999998854  2256899999999999999999999987   99999999999999999999999999987643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.91  E-value=9.8e-25  Score=207.78  Aligned_cols=156  Identities=28%  Similarity=0.543  Sum_probs=134.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCC---CC--EEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSN---GE--TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~---~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      ...+.....+.||+|.||.||+|.+.+   |+  .||||..+.+. ....+.|..|..+|++++||||++|+|.|.+. .
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            334455567899999999999999643   33  48899988753 44466799999999999999999999999865 6


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .|||||..+-|.|.+||..  +...|+......++.||..+|.|||+..   +|||||..+|||+.+..-+|++||||+|
T Consensus       465 ~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence            8999999999999999965  4556888899999999999999999987   9999999999999999999999999999


Q ss_pred             cccCCCcc
Q 015138          395 LFEMDQTH  402 (412)
Q Consensus       395 ~~~~~~~~  402 (412)
                      -++++...
T Consensus       540 ~~ed~~yY  547 (974)
T KOG4257|consen  540 YLEDDAYY  547 (974)
T ss_pred             hccccchh
Confidence            88776644

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.91  E-value=5.2e-24  Score=199.37  Aligned_cols=150  Identities=31%  Similarity=0.560  Sum_probs=128.4

Q ss_pred             cCCCccccccccCCeeEEEEEeCC-CC--EEEEEEeccC-CcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSN-GE--TIAVKRLSKN-SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ++|+..+.||+|+||.||+|...+ +.  .+++|.++.. .......+.+|+.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999998643 33  4788887743 333455789999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCe
Q 015138          319 YEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~  385 (412)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985421             1235889999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCcccc
Q 015138          386 KISDFGMARLF  396 (412)
Q Consensus       386 ki~DfGla~~~  396 (412)
                      ||+|||++...
T Consensus       159 kl~dfg~~~~~  169 (297)
T cd05089         159 KIADFGLSRGE  169 (297)
T ss_pred             EECCcCCCccc
Confidence            99999998743

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=6.1e-24  Score=197.38  Aligned_cols=146  Identities=35%  Similarity=0.572  Sum_probs=126.8

Q ss_pred             CCccccccccCCeeEEEEEe-----CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeE
Q 015138          246 FSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  317 (412)
                      |+..+.||+|+||.||++..     .+++.||+|.+..... .....+.+|++++.+++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988653     4577899999876432 3456788999999999999999999988754  35789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    45999999999999999999999987   9999999999999999999999999998765


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       159 ~  159 (283)
T cd05080         159 E  159 (283)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=9.2e-24  Score=194.17  Aligned_cols=152  Identities=26%  Similarity=0.457  Sum_probs=133.8

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||+|... +++.|++|.+....   ......+.+|++++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999965 78999999886432   223457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++|..++... .....+++..++.++.+++.||.|||+.+   |+||||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988542 23455899999999999999999999987   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.91  E-value=1.9e-24  Score=197.80  Aligned_cols=145  Identities=37%  Similarity=0.588  Sum_probs=129.1

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHH--HHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      |+..+.||+|+||+||++.. .+++.+|+|.+.........  ...+|+.++.+++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            45678999999999999995 45678999999877544332  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ++++|.+++.   ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.++|+|||++..+
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999995   3567899999999999999999999987   999999999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=6.8e-24  Score=197.14  Aligned_cols=150  Identities=26%  Similarity=0.447  Sum_probs=131.7

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..+.||+|+||.||++... +++.||+|++.....  .....+.+|+.++++++|+||+++++.+......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788899999999999999964 689999998865432  223457899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+++++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+...
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999999887633   346899999999999999999999987   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.91  E-value=5e-24  Score=202.85  Aligned_cols=156  Identities=27%  Similarity=0.463  Sum_probs=132.1

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEeC--------CCCEEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEE
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFC  309 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~  309 (412)
                      +....+|++.+.||+|+||.||++...        .+..||+|.+.... .....++.+|+.++.++ +|+||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            334456888999999999999999741        12368999887543 33456789999999999 899999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                      ...+..++++||+++|+|.+++....             ....++|..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence            99999999999999999999985421             2345899999999999999999999987   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccccC
Q 015138          377 ILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||++.++.+||+|||+++.+..
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~  186 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHN  186 (334)
T ss_pred             EEEcCCCcEEECCcccceeccc
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.91  E-value=5.9e-24  Score=196.55  Aligned_cols=150  Identities=27%  Similarity=0.483  Sum_probs=131.3

Q ss_pred             cCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ++|+....||+|+||.||++...      +.+.|++|.+...... ...++.+|+.++.+++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            67888999999999999999953      2457899988655443 3457899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          317 LVYEFVPNASLDHFIFDPIN------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      +||||+++|+|.+++.....      ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999864321      126899999999999999999999987   999999999999999999999999


Q ss_pred             CCcccc
Q 015138          391 GMARLF  396 (412)
Q Consensus       391 Gla~~~  396 (412)
                      |+++..
T Consensus       162 ~~~~~~  167 (275)
T cd05046         162 SLSKDV  167 (275)
T ss_pred             cccccc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.91  E-value=5.9e-24  Score=200.60  Aligned_cols=153  Identities=29%  Similarity=0.500  Sum_probs=131.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC--------CCCEEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEec
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  311 (412)
                      ..++|.+.++||+|+||.||++...        ....+|+|.+.... .....++.+|+.++.++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467888999999999999999741        24568999887543 23345688999999999 69999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEE
Q 015138          312 RKERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNIL  378 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nil  378 (412)
                      ....++||||+++|+|.+++....             ....+++...+.++.|++.||.|||+.+   |+||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence            999999999999999999985421             1245899999999999999999999987   999999999999


Q ss_pred             ECCCCCeEEeccCCccccc
Q 015138          379 LDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       379 l~~~~~~ki~DfGla~~~~  397 (412)
                      ++.++.+||+|||+++...
T Consensus       167 l~~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         167 VTEDNVMKIADFGLARGVH  185 (314)
T ss_pred             EcCCCcEEEcccccccccc
Confidence            9999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=8.3e-24  Score=193.39  Aligned_cols=148  Identities=33%  Similarity=0.534  Sum_probs=131.2

Q ss_pred             CCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC-----cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     ......+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999965 78999999886543     22345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   345889999999999999999999987   99999999999999999999999999987643

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=4.2e-24  Score=204.14  Aligned_cols=149  Identities=29%  Similarity=0.467  Sum_probs=127.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecC------
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------  312 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||++.....  .....+.+|+.++++++|+||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            457899999999999999999984 5788999999875422  2344578899999999999999999987543      


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...++++|++ +++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3568999987 789988873    356999999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++....
T Consensus       165 ~~~~~~  170 (343)
T cd07878         165 ARQADD  170 (343)
T ss_pred             ceecCC
Confidence            987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.91  E-value=1.1e-23  Score=192.64  Aligned_cols=147  Identities=35%  Similarity=0.597  Sum_probs=130.7

Q ss_pred             ccccccCCeeEEEEEeCC----CCEEEEEEeccCCccc-HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++....    +..+++|.+....... ...+.+|+..+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999643    7889999987654433 56789999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          325 ASLDHFIFDPIN------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       325 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++|.+++.....      ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865321      367999999999999999999999987   99999999999999999999999999998765


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       158 ~  158 (262)
T cd00192         158 D  158 (262)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=7.7e-24  Score=194.21  Aligned_cols=150  Identities=31%  Similarity=0.498  Sum_probs=130.1

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .++|...++||+|+||.||++....+..+++|.+.... .....+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            35678889999999999999998777789999886543 23456889999999999999999999875 45688999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+..
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            999999998542 2345899999999999999999999887   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.91  E-value=5.5e-24  Score=204.59  Aligned_cols=147  Identities=31%  Similarity=0.444  Sum_probs=124.9

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC-----
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----  313 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----  313 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+....  ......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            347899999999999999999985 568999999986542  233456889999999999999999999986543     


Q ss_pred             -eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          314 -ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       314 -~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                       ..++||||+++ +|...+.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999975 5555552     34788889999999999999999987   99999999999999999999999999


Q ss_pred             ccccc
Q 015138          393 ARLFE  397 (412)
Q Consensus       393 a~~~~  397 (412)
                      ++...
T Consensus       170 a~~~~  174 (359)
T cd07876         170 ARTAC  174 (359)
T ss_pred             ccccc
Confidence            98654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.91  E-value=4.2e-25  Score=188.94  Aligned_cols=158  Identities=28%  Similarity=0.337  Sum_probs=140.7

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC---
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK---  313 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~---  313 (412)
                      ++.+..++|.+.+.||+|||+.||.++ +.+++.+|+|++.-.+.++....++|++..++++||||++++.+...+.   
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            445667889999999999999999999 7889999999998888777888999999999999999999999876543   


Q ss_pred             --eeeEEEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          314 --ERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       314 --~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                        ..||++.|...|+|.+.+.... +...+++.+.+.|+.++.+||++||+.. ++..||||||.|||+.+.+.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence              4899999999999999886533 4457999999999999999999999986 57999999999999999999999999


Q ss_pred             CCcccc
Q 015138          391 GMARLF  396 (412)
Q Consensus       391 Gla~~~  396 (412)
                      |-+...
T Consensus       174 GS~~~a  179 (302)
T KOG2345|consen  174 GSATQA  179 (302)
T ss_pred             cCcccc
Confidence            988754

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-26  Score=196.07  Aligned_cols=162  Identities=30%  Similarity=0.426  Sum_probs=135.7

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEecc--CCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .+++|+..++||+|.|+.|+++. .++|+.+|+|.+..  -+..+.+++.+|+.+-..|+||||++|.....+....+||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            35678888999999999999988 57789999887743  2444677899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEEeccCCccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARL  395 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~  395 (412)
                      +|+|.|++|..-+..   +..+++...-..+.||+++|.|+|.++   |||||+||+|+||.+..   -+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999999665532   345777888899999999999999998   99999999999997654   489999999999


Q ss_pred             ccCCCcccccccccccC
Q 015138          396 FEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       396 ~~~~~~~~~~~~~~Gt~  412 (412)
                      +..++.   -...+||+
T Consensus       163 l~~g~~---~~G~~GtP  176 (355)
T KOG0033|consen  163 VNDGEA---WHGFAGTP  176 (355)
T ss_pred             eCCccc---cccccCCC
Confidence            883332   22466764

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.91  E-value=5.1e-24  Score=198.11  Aligned_cols=160  Identities=29%  Similarity=0.407  Sum_probs=134.6

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEe--
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCL--  310 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~--  310 (412)
                      .++.+....++|+..+.||+|+||.||++.. .+++.+++|.+.... .....+.+|+.++.++ +|+||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3455666789999999999999999999985 567899999876432 2234678899999999 6999999999884  


Q ss_pred             ---cCCeeeEEEecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeE
Q 015138          311 ---ERKERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (412)
Q Consensus       311 ---~~~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k  386 (412)
                         .++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence               345689999999999999887532 23456889999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccC
Q 015138          387 ISDFGMARLFEM  398 (412)
Q Consensus       387 i~DfGla~~~~~  398 (412)
                      |+|||+++.+..
T Consensus       165 l~dfg~~~~~~~  176 (286)
T cd06638         165 LVDFGVSAQLTS  176 (286)
T ss_pred             EccCCceeeccc
Confidence            999999987643

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=7.4e-24  Score=198.26  Aligned_cols=148  Identities=32%  Similarity=0.518  Sum_probs=130.5

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc-----cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ-----GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +|+..+.||+|+||.||+|.. .+++.|+||.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            367788999999999999995 46899999999765432     234577899999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+ +++|.+++...  ...+++..+..++.||++||.|||+.+   |+|+||+|+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 99999998542  136999999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.91  E-value=7.8e-24  Score=194.17  Aligned_cols=152  Identities=30%  Similarity=0.485  Sum_probs=133.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ...++|+..++||+|+||.||++...++..+++|.+.... .....+.+|+.++++++|+||+++++.+.. ...+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            3457788899999999999999998777889999887543 234578899999999999999999999887 77899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            99999999998542 2456889999999999999999999987   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=5.4e-24  Score=204.41  Aligned_cols=144  Identities=24%  Similarity=0.355  Sum_probs=125.4

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ....+|+..+.||+|+||.||+|... +++.||+|.....      ....|+.++.+++|+||+++++++......++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34567999999999999999999964 5678999975432      2356899999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||+. ++|.+++..  ....+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            9995 688888744  3456899999999999999999999987   999999999999999999999999999854

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.91  E-value=7.3e-24  Score=196.28  Aligned_cols=153  Identities=34%  Similarity=0.578  Sum_probs=131.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      ..++|...+.||+|+||.||+|...      .+..|++|.+.... ......|..|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4577888999999999999999964      35678999886543 3334568999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEE
Q 015138          315 RILVYEFVPNASLDHFIFDPI----NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKI  387 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki  387 (412)
                      .++||||+++++|.+++....    ....++|..++.++.||+.||.|||+.+   ++||||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            999999999999999985422    1235899999999999999999999987   99999999999998754   5999


Q ss_pred             eccCCccccc
Q 015138          388 SDFGMARLFE  397 (412)
Q Consensus       388 ~DfGla~~~~  397 (412)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (277)
T cd05036         161 ADFGMARDIY  170 (277)
T ss_pred             ccCccccccC
Confidence            9999998763

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=5.9e-25  Score=211.71  Aligned_cols=151  Identities=31%  Similarity=0.499  Sum_probs=133.8

Q ss_pred             CCccccccccCCeeEEEEEeCC--CC--EEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          246 FSDANKLGQGGFGAVYKGMLSN--GE--TIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~~--~~--~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ....++||+|.||.|++|.|..  |+  .||||.+...... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3446899999999999999843  43  5899999876554 55689999999999999999999999988 67889999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ..+.|||.+.|++ .....|-...+..++.|||.||.||..++   +|||||..+|+||.....+||+||||.|.+..++
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999977 55677888888999999999999999987   9999999999999999999999999999987665


Q ss_pred             c
Q 015138          401 T  401 (412)
Q Consensus       401 ~  401 (412)
                      .
T Consensus       267 d  267 (1039)
T KOG0199|consen  267 D  267 (1039)
T ss_pred             c
Confidence            4

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.91  E-value=8.3e-24  Score=198.36  Aligned_cols=148  Identities=29%  Similarity=0.495  Sum_probs=129.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..++||+|+||.||++.. .+++.||+|.+..... .....+.+|+.++++++|+||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            5688899999999999999985 4678999999875432 2344678899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++ ++|..++..  ....+++.....++.|+++||.|||+.+   |+|+||||+|||+++++.+||+|||+++...
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            97 589888754  2346889999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.91  E-value=3.5e-25  Score=195.08  Aligned_cols=152  Identities=30%  Similarity=0.506  Sum_probs=126.3

Q ss_pred             cCCCccccccccCCeeEEEEEeCC-----CCEEEEEEeccCCccc--HHHHHHHHHHHccCCCCccceeeEEEec-CCee
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHRNLVRLLGFCLE-RKER  315 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~  315 (412)
                      ..|+....||+|.||.||++.-.+     .+.+|||+++......  .....+|+.+++.++||||+.|..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            457888999999999999997422     2368999987653321  2346789999999999999999999887 7789


Q ss_pred             eEEEecCCCCChhhhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC----CCeEEec
Q 015138          316 ILVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE----MNPKISD  389 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~D  389 (412)
                      +|++||.+. +|.+.++  +......++.....+|+.||+.|+.|||++-   |+||||||.||||..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999976 6766663  2223457888999999999999999999998   9999999999999887    8999999


Q ss_pred             cCCcccccCC
Q 015138          390 FGMARLFEMD  399 (412)
Q Consensus       390 fGla~~~~~~  399 (412)
                      ||+||++...
T Consensus       180 lGlaR~~~~p  189 (438)
T KOG0666|consen  180 LGLARLFNNP  189 (438)
T ss_pred             ccHHHHhhcc
Confidence            9999998644

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.91  E-value=8.6e-24  Score=198.45  Aligned_cols=150  Identities=37%  Similarity=0.696  Sum_probs=127.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCC----EEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|+..+.||+|+||.||+|.. .+++    .||+|.+..... ....++.+|+.++++++||||++++|++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            46678889999999999999985 3444    478888865433 2234688999999999999999999998754 467


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +++||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            99999999999999854  2346889999999999999999999987   999999999999999999999999999876


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      ..
T Consensus       160 ~~  161 (303)
T cd05110         160 EG  161 (303)
T ss_pred             cC
Confidence            54

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.91  E-value=3.8e-24  Score=199.81  Aligned_cols=145  Identities=30%  Similarity=0.464  Sum_probs=129.4

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      |.....||+|+||.||++.. .+++.||||.+..........+.+|+.++.+++|+||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            34456799999999999985 56889999998766555566789999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++|.+++.    ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++..+.
T Consensus       104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658         104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            99999873    345889999999999999999999987   9999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=9.6e-24  Score=194.82  Aligned_cols=147  Identities=31%  Similarity=0.506  Sum_probs=128.4

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---c-------cHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---Q-------GEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~-------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      +|...+.||+|+||.||+|.. .+++.+|+|.+.....   .       ....+.+|+.++..++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            356778999999999999984 5689999998754211   1       1235788999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999999854   356899999999999999999999987   999999999999999999999999999


Q ss_pred             cccc
Q 015138          394 RLFE  397 (412)
Q Consensus       394 ~~~~  397 (412)
                      +...
T Consensus       156 ~~~~  159 (272)
T cd06629         156 KKSD  159 (272)
T ss_pred             cccc
Confidence            8654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.91  E-value=1.7e-23  Score=191.26  Aligned_cols=150  Identities=23%  Similarity=0.348  Sum_probs=131.5

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      +|+..++||+|+||.||++.. .+++.+++|.+.... ......+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            467789999999999999994 568899999886432 334456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++++|.+++... ....+++...+.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999999887532 3345889999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=8.3e-24  Score=198.75  Aligned_cols=146  Identities=22%  Similarity=0.353  Sum_probs=130.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.|++|.+.+...   .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4688899999999999999995 4578999999876532   23456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            99999999999844   356899999999999999999999987   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.91  E-value=8.8e-24  Score=194.28  Aligned_cols=146  Identities=32%  Similarity=0.567  Sum_probs=130.1

Q ss_pred             CCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCc------ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          245 NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4677889999999999999988899999998865421      1224588999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||+++++|.+++.+   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||+++..
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            999999999999843   346889999999999999999999987   999999999999999999999999999865

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=1.2e-23  Score=195.33  Aligned_cols=149  Identities=33%  Similarity=0.581  Sum_probs=131.3

Q ss_pred             cCCCccccccccCCeeEEEEEeC-----CCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEec--CCee
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-----NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKER  315 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~  315 (412)
                      ++|+..+.||+|+||.||++.+.     +++.+|||.+...... ....|.+|+.+++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677889999999999999853     3678999998765543 45679999999999999999999999887  5578


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999998542  335999999999999999999999987   99999999999999999999999999998


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      +.
T Consensus       159 ~~  160 (284)
T cd05038         159 LP  160 (284)
T ss_pred             cc
Confidence            75

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=1.4e-23  Score=193.12  Aligned_cols=148  Identities=36%  Similarity=0.574  Sum_probs=129.9

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc---------HHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG---------EIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      +|.....||+|+||.||+|.. .+++.+|+|.+.......         ...+.+|+.++.+++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366778999999999999985 567899999886543221         2457889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999843   356889999999999999999999987   9999999999999999999999999998


Q ss_pred             cccC
Q 015138          395 LFEM  398 (412)
Q Consensus       395 ~~~~  398 (412)
                      .+..
T Consensus       155 ~~~~  158 (267)
T cd06628         155 KLEA  158 (267)
T ss_pred             cccc
Confidence            7753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.91  E-value=1.2e-23  Score=192.62  Aligned_cols=142  Identities=33%  Similarity=0.591  Sum_probs=123.3

Q ss_pred             cccccCCeeEEEEEe---CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCC
Q 015138          251 KLGQGGFGAVYKGML---SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~---~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      +||+|+||.||+|.+   .++..+|+|++.....  ....++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999975   3578899998865432  23457899999999999999999999875 45678999999999


Q ss_pred             ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            99999843   346899999999999999999999987   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.91  E-value=5.4e-24  Score=199.22  Aligned_cols=145  Identities=29%  Similarity=0.458  Sum_probs=129.5

Q ss_pred             ccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCC
Q 015138          248 DANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      ....||+|+||.||++.. .+++.|++|.+..........+.+|+.++..++||||+++++.+..++..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            355799999999999985 5689999999876555556678899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |..++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..+
T Consensus       105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659         105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            998873    356899999999999999999999987   999999999999999999999999999866443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.91  E-value=1.1e-23  Score=193.67  Aligned_cols=148  Identities=30%  Similarity=0.468  Sum_probs=127.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-----cccHHHHHHHHHHHccCCCCccceeeEEEecC--Cee
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~  315 (412)
                      ++|+..+.||+|+||.||++.. .+++.|+||.+....     ......+.+|+.++.+++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5788899999999999999995 568899999875322     12234688899999999999999999988764  457


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +++|||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999999843   345788889999999999999999987   99999999999999999999999999986


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      +.
T Consensus       156 ~~  157 (265)
T cd06652         156 LQ  157 (265)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=9.8e-24  Score=199.17  Aligned_cols=145  Identities=23%  Similarity=0.280  Sum_probs=116.8

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEeC--CCCEEEEEEeccCC-----cccHHHHHHHHHHHccCCCCccce-eeEEE
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGMLS--NGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVR-LLGFC  309 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~-l~g~~  309 (412)
                      ..+...++|...+.||+|+||+||+|...  +++.||||++....     ......|.+|+++|.+++|+|++. ++.+ 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            44556688999999999999999999853  57778999875431     122456899999999999999985 4432 


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCC-CCCCEEECCCCCeEEe
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDL-KASNILLDSEMNPKIS  388 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdl-k~~Nill~~~~~~ki~  388 (412)
                         +..+|||||+++++|....    ...      ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+
T Consensus        91 ---~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             ---CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence               4579999999999996321    111      1467889999999999987   999999 9999999999999999


Q ss_pred             ccCCcccccCC
Q 015138          389 DFGMARLFEMD  399 (412)
Q Consensus       389 DfGla~~~~~~  399 (412)
                      |||+|+.+...
T Consensus       155 DFGlA~~~~~~  165 (365)
T PRK09188        155 DFQLASVFRRR  165 (365)
T ss_pred             ECccceecccC
Confidence            99999987544

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.91  E-value=1.1e-23  Score=192.67  Aligned_cols=144  Identities=36%  Similarity=0.515  Sum_probs=127.4

Q ss_pred             ccccccCCeeEEEEEeCC--C--CEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGMLSN--G--ETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... .....+.+|+.++++++|+||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  3  2689999987665 455678999999999999999999999988 889999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++|.+++.+... ..++|.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999865322 56899999999999999999999987   99999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=2e-23  Score=225.53  Aligned_cols=143  Identities=28%  Similarity=0.557  Sum_probs=123.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ...+...+.||+|+||.||+|.. .++..||||++.......    ..|++.+++++||||++++|+|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35677888999999999999995 678999999986543322    3468889999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +++|+|.+++.      .++|..+..|+.|+++||+|||+...++|+||||||+||+++.++.+++. ||++...
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999983      38999999999999999999997655679999999999999999988876 6666543

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.91  E-value=1.3e-23  Score=195.87  Aligned_cols=149  Identities=30%  Similarity=0.526  Sum_probs=128.7

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc-HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++++|...+.||+|+||.||+|.. .+++.|++|.+....... ...+.+|+.++..++|+||+++++++...+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357888999999999999999984 568899999987554332 345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||+. ++|.+++..  ....+.+..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            9996 677666643  2345788888999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.91  E-value=1.1e-23  Score=196.88  Aligned_cols=149  Identities=27%  Similarity=0.465  Sum_probs=133.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      ++|...+.||+|+||.||++.. .+++.|++|.+..........+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            6788899999999999999984 567899999987655555567899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ++++|.+++.    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+...
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             CCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            9999999984    345889999999999999999999987   999999999999999999999999998766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.91  E-value=2e-23  Score=190.67  Aligned_cols=150  Identities=29%  Similarity=0.484  Sum_probs=134.8

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC-CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|+..+.||+|+||.||++...+ ++.+++|.+.....  ..++.+|++++++++|+||+++++.+......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            4678899999999999999999654 78999999865533  56799999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++..  ....+++.....++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++..+...
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            999999999843  2456899999999999999999999987   999999999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.91  E-value=8.5e-24  Score=203.01  Aligned_cols=148  Identities=28%  Similarity=0.433  Sum_probs=125.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC------
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------  312 (412)
                      ..++|+..+.||+|+||.||++.. ..++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999984 568899999987543  22345678899999999999999999988643      


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...++||||+++ +|.+++     ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHH-----hhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346899999975 566665     235888999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++....
T Consensus       166 ~~~~~~  171 (355)
T cd07874         166 ARTAGT  171 (355)
T ss_pred             cccCCC
Confidence            987543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.91  E-value=1e-23  Score=194.39  Aligned_cols=151  Identities=25%  Similarity=0.450  Sum_probs=129.6

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC----CCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|...++||+|+||.||+|...+    ...|+||...... ......+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4567888999999999999998533    2468999887654 3445578999999999999999999998875 45789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999999999998542  345899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CC
Q 015138          398 MD  399 (412)
Q Consensus       398 ~~  399 (412)
                      ..
T Consensus       159 ~~  160 (270)
T cd05056         159 DE  160 (270)
T ss_pred             cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-24  Score=199.07  Aligned_cols=165  Identities=29%  Similarity=0.383  Sum_probs=143.8

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC---CcccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      ....+.|+.-++||+|+||.|+-+.. .+|+-+|.|++.+.   ..+++....+|-.+|.+++.+.||.|-..+...+.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            34456788899999999999999984 56888999988654   234555678999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +||+..|.||+|.-+|.... ...+++...+-++.+|+.||++||...   ||.|||||+|||||+.|+++|+|+|||..
T Consensus       261 ClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             EEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence            99999999999999997643 357999999999999999999999987   99999999999999999999999999999


Q ss_pred             ccCCCccccccccccc
Q 015138          396 FEMDQTHSDTNRVVGT  411 (412)
Q Consensus       396 ~~~~~~~~~~~~~~Gt  411 (412)
                      +.+.+....   .+||
T Consensus       337 i~~g~~~~~---rvGT  349 (591)
T KOG0986|consen  337 IPEGKPIRG---RVGT  349 (591)
T ss_pred             cCCCCcccc---ccCc
Confidence            988776543   3666

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.91  E-value=2.3e-23  Score=189.86  Aligned_cols=143  Identities=36%  Similarity=0.588  Sum_probs=128.2

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCChh
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD  328 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~  328 (412)
                      ++||+|+||.||++...+++.|++|.+...... ....+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999766999999988765443 4567899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       329 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++...  ...+++...+.++.+++.+|.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            998542  346889999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.91  E-value=1.9e-23  Score=191.09  Aligned_cols=148  Identities=28%  Similarity=0.487  Sum_probs=128.6

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEe-cCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL-ERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~-~~~~~~lv~Ey  321 (412)
                      .++|+..+.||+|+||.||++... +..+++|.+....  ....+.+|+.++++++|+|++++++++. ..+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            357888899999999999999874 7889999886433  3456899999999999999999999765 45678999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++... ....+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence            9999999998542 2345889999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.90  E-value=2.6e-23  Score=191.11  Aligned_cols=153  Identities=27%  Similarity=0.440  Sum_probs=135.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||.|+||.||++.. .++..+++|.+.... ......+.+|++.++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4788899999999999999995 567899999987543 23456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++........+++.....++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999865333456899999999999999999999987   999999999999999999999999999877544

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.90  E-value=2e-23  Score=197.12  Aligned_cols=145  Identities=29%  Similarity=0.470  Sum_probs=119.1

Q ss_pred             cccccccCCeeEEEEEeC---CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEec--CCeeeEEEecCC
Q 015138          249 ANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILVYEFVP  323 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv~Ey~~  323 (412)
                      .++||+|+||.||+|...   +++.+|+|.+.....  ...+.+|+.++.+++||||+++++.+..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            568999999999999854   467899999865432  2357889999999999999999998864  456789999986


Q ss_pred             CCChhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE----CCCCCeEEeccCCc
Q 015138          324 NASLDHFIFDP------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMA  393 (412)
Q Consensus       324 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DfGla  393 (412)
                       ++|.+++...      .....+++..+..++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4777776321      12235889999999999999999999987   9999999999999    45678999999999


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      +.+...
T Consensus       160 ~~~~~~  165 (317)
T cd07868         160 RLFNSP  165 (317)
T ss_pred             eccCCC
Confidence            877543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.90  E-value=8.1e-24  Score=195.92  Aligned_cols=147  Identities=27%  Similarity=0.472  Sum_probs=129.9

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++.+......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            355678899999999999985 457889999887543 333456899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++++|.+++.    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            9999999883    356899999999999999999999987   99999999999999999999999999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.90  E-value=2.1e-23  Score=193.70  Aligned_cols=149  Identities=30%  Similarity=0.545  Sum_probs=131.1

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      +|+..++||+|++|.||+|.. .+|+.||||.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            577889999999999999996 46889999998765433 3446778999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            85 88888755444456999999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.90  E-value=1.5e-23  Score=201.95  Aligned_cols=148  Identities=27%  Similarity=0.415  Sum_probs=125.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC------
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------  312 (412)
                      ..++|+..+.||+|+||.||++.. ..++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            347899999999999999999994 568899999987542  23345688999999999999999999987643      


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...++||||+++ +|..++.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 6766662     34888999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++....
T Consensus       173 a~~~~~  178 (364)
T cd07875         173 ARTAGT  178 (364)
T ss_pred             ccccCC
Confidence            987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=1.2e-23  Score=195.53  Aligned_cols=149  Identities=27%  Similarity=0.381  Sum_probs=131.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++..++||||+++++.+......+||||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            35678889999999999999995 568899999886543 3335678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+++++|.+++..   ...+++.....++.+++.+|.|||+..  +++||||+|+||+++.++.++|+|||++...
T Consensus        84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            9999999998743   356899999999999999999999742  3999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.90  E-value=1.5e-23  Score=194.66  Aligned_cols=150  Identities=27%  Similarity=0.405  Sum_probs=126.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHH-HccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLL-LARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..+.||+|+||.||++.. .+|+.||+|++..... ....++..|+.. ++.++||||+++++++......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4688899999999999999995 4689999999876432 233455556664 566789999999999999999999999


Q ss_pred             cCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |++ |+|.+++... .....+++..+..++.|++.||.|||++ +   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            996 6887776432 2345689999999999999999999986 5   9999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.90  E-value=1.7e-23  Score=195.17  Aligned_cols=147  Identities=29%  Similarity=0.532  Sum_probs=128.9

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||+|+||.||+|... +++.||||.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67888999999999999999954 6889999998754322 223567899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +++ +|.+++...  ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            985 898887542  346889999999999999999999987   999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=2.5e-23  Score=190.99  Aligned_cols=149  Identities=30%  Similarity=0.489  Sum_probs=133.1

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.||++.. .+++.|++|.+......  ....+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            467789999999999999995 46889999998765443  556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++..   ...+++..+..++.+++.||.|||+.+   |+|+||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            999999999854   345888999999999999999999987   999999999999999999999999999876543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.90  E-value=2.4e-23  Score=190.35  Aligned_cols=148  Identities=30%  Similarity=0.570  Sum_probs=131.7

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      .+|+..+.||+|+||.||++...++..+++|.+..... ...++.+|++++.+++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46777899999999999999987788999998865433 34578999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++|.+++..  ....+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            9999999854  2345889999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=8.5e-24  Score=196.58  Aligned_cols=149  Identities=30%  Similarity=0.486  Sum_probs=131.3

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..++||+|+||.||++... +++.||+|.+.+....  ....+.+|++++..++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46788899999999999999964 5889999988654332  24568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|..+...   ...+++..++.++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++..+..
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999887643   345899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.90  E-value=2.8e-23  Score=192.35  Aligned_cols=148  Identities=24%  Similarity=0.455  Sum_probs=131.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            3567788999999999999995 458899999887543 33455789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++.    ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            99999999884    346889999999999999999999987   99999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.7e-23  Score=192.28  Aligned_cols=148  Identities=28%  Similarity=0.499  Sum_probs=131.2

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCC---CCccceeeEEEecCCeeeEEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .|+..+.||+|+||.||+|.. .+++.+++|.+.... .....++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999995 678999999987543 334456889999999986   999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++++|.+++..    ..+++...+.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    37899999999999999999999987   999999999999999999999999999877544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.90  E-value=3.5e-23  Score=190.49  Aligned_cols=148  Identities=32%  Similarity=0.504  Sum_probs=128.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-----ccHHHHHHHHHHHccCCCCccceeeEEEecC--Cee
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-----QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~  315 (412)
                      .+|+..+.||+|+||.||++.. .++..|++|++.....     .....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788899999999999999985 5688999998864321     2234588999999999999999999988753  567


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++++||+++++|.+++..   ...+++.....++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999843   345889999999999999999999887   99999999999999999999999999986


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      +.
T Consensus       156 ~~  157 (266)
T cd06651         156 LQ  157 (266)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-24  Score=219.79  Aligned_cols=172  Identities=24%  Similarity=0.305  Sum_probs=147.1

Q ss_pred             cchHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC---CcccHHHHHHHHHHHccCCCCccceeeEEE
Q 015138          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFC  309 (412)
Q Consensus       234 ~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~  309 (412)
                      ....+++...++|.+.++||+|+||.|...+. .+++.+|+|++++.   ......-|.+|-.+|..-+.+-|+.|+..|
T Consensus        65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF  144 (1317)
T KOG0612|consen   65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF  144 (1317)
T ss_pred             HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence            34556788889999999999999999999995 56788999999873   233444689999999999999999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEec
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D  389 (412)
                      .+...+|||||||+||+|-.+|..   ...+++.-+..++.+|..||.-||+.|   +|||||||.|||||..|++||+|
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence            999999999999999999999844   236888888888999999999999887   99999999999999999999999


Q ss_pred             cCCcccccCCCcccccccccccC
Q 015138          390 FGMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      ||-+-.+..+.+-. ....+||+
T Consensus       219 FGsClkm~~dG~V~-s~~aVGTP  240 (1317)
T KOG0612|consen  219 FGSCLKMDADGTVR-SSVAVGTP  240 (1317)
T ss_pred             chhHHhcCCCCcEE-eccccCCC
Confidence            99988887555422 23478886

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=3e-23  Score=192.13  Aligned_cols=147  Identities=26%  Similarity=0.458  Sum_probs=130.3

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      -|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++.+++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            366788999999999999985 568899999886543 233456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++++|.+++.    ...+++.....++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            9999999883    346899999999999999999999987   99999999999999999999999999986643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3e-23  Score=195.86  Aligned_cols=151  Identities=26%  Similarity=0.322  Sum_probs=133.2

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++... +++.+|+|.+......   ....+.+|++++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999964 5899999999765432   3456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++|.+++.. .....+++.....++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999853 23456899999999999999999999987   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.90  E-value=3.1e-23  Score=191.30  Aligned_cols=143  Identities=33%  Similarity=0.593  Sum_probs=122.8

Q ss_pred             ccccccCCeeEEEEEeCC-CC--EEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGMLSN-GE--TIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||+|...+ +.  .+++|.+.... ......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999643 43  46888887543 33455788999999999 799999999999999999999999999


Q ss_pred             CChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          325 ASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       325 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      |+|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985421             1235889999999999999999999987   9999999999999999999999999


Q ss_pred             Cccc
Q 015138          392 MARL  395 (412)
Q Consensus       392 la~~  395 (412)
                      +++.
T Consensus       158 l~~~  161 (270)
T cd05047         158 LSRG  161 (270)
T ss_pred             Cccc
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.90  E-value=2.1e-23  Score=194.55  Aligned_cols=161  Identities=30%  Similarity=0.441  Sum_probs=135.9

Q ss_pred             cchHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEec
Q 015138          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (412)
Q Consensus       234 ~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  311 (412)
                      +.+..+..++++|+..+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34455666788999999999999999999995 5688999998865432 234677899999998 89999999999875


Q ss_pred             C-----CeeeEEEecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCe
Q 015138          312 R-----KERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (412)
Q Consensus       312 ~-----~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~  385 (412)
                      .     ...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            4     3579999999999999987532 23456899999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCcccccC
Q 015138          386 KISDFGMARLFEM  398 (412)
Q Consensus       386 ki~DfGla~~~~~  398 (412)
                      ||+|||+++.+..
T Consensus       168 kl~dfg~~~~~~~  180 (291)
T cd06639         168 KLVDFGVSAQLTS  180 (291)
T ss_pred             EEeecccchhccc
Confidence            9999999987543

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3e-23  Score=191.78  Aligned_cols=149  Identities=26%  Similarity=0.430  Sum_probs=133.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||.|+||.||+|.. .+++.|++|.+.... ......+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            3677889999999999999995 468899999987553 33445688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++..    ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999843    37899999999999999999999987   999999999999999999999999999887543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.8e-24  Score=198.66  Aligned_cols=167  Identities=31%  Similarity=0.434  Sum_probs=136.4

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc--cc-----HHHHHHHHHHHccCCCCccceeeEEEe-cC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK--QG-----EIEFKNEVLLLARLQHRNLVRLLGFCL-ER  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~--~~-----~~~~~~e~~~l~~l~h~niv~l~g~~~-~~  312 (412)
                      ..++|-.+..||+|+|+.||++. +...+.||||+-..+..  ..     .....+|-.+.+.|+||-||++++++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            34556678899999999999999 66678899997543321  11     123577889999999999999999986 45


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC---CCeEEec
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISD  389 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~D  389 (412)
                      +..+-|+||++|.+|+-||..   ...+++.++..|++||..||.||.+.. +||||-||||.||||.++   |.+||+|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence            667899999999999999954   567899999999999999999999874 789999999999999655   5799999


Q ss_pred             cCCcccccCCCcccc-----cccccccC
Q 015138          390 FGMARLFEMDQTHSD-----TNRVVGTL  412 (412)
Q Consensus       390 fGla~~~~~~~~~~~-----~~~~~Gt~  412 (412)
                      |||+++++++....+     |...+|||
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTY  644 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTY  644 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCcee
Confidence            999999987765432     45577775

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=1.3e-23  Score=217.21  Aligned_cols=158  Identities=25%  Similarity=0.381  Sum_probs=130.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC--Cee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~  315 (412)
                      ...++|.+.++||+|+||.||++.. .+++.+|+|.+....  ......|..|+.++..|+||||+++++++...  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3457899999999999999999995 557789999886542  23345689999999999999999999988653  568


Q ss_pred             eEEEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCC----CCceecCCCCCCEEECCC--------
Q 015138          316 ILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSR----LRIIHRDLKASNILLDSE--------  382 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~ivHrdlk~~Nill~~~--------  382 (412)
                      +|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999999985421 23569999999999999999999998532    349999999999999643        


Q ss_pred             ---------CCeEEeccCCcccccC
Q 015138          383 ---------MNPKISDFGMARLFEM  398 (412)
Q Consensus       383 ---------~~~ki~DfGla~~~~~  398 (412)
                               ..+||+|||+++.+..
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~  194 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGI  194 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccc
Confidence                     3489999999987643

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.1e-25  Score=210.62  Aligned_cols=162  Identities=27%  Similarity=0.424  Sum_probs=139.3

Q ss_pred             cCCCccccccccCCeeEEEEEeCC-CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      +-|.++..||.|+||+||++...+ +..-|.|.+...+.....+++-||++|+..+||+||+|++.|...+.++|+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            446667899999999999999654 3445678887777777888999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCcc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~  402 (412)
                      +||-.+..+..  -...|++.++..++.|++.||.|||++.   |||||||+.|||+.-+|.++|+|||.+.........
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            99999998865  3567999999999999999999999997   999999999999999999999999998765433333


Q ss_pred             cccccccccC
Q 015138          403 SDTNRVVGTL  412 (412)
Q Consensus       403 ~~~~~~~Gt~  412 (412)
                      .+  .+.||+
T Consensus       187 RD--sFIGTP  194 (1187)
T KOG0579|consen  187 RD--SFIGTP  194 (1187)
T ss_pred             hc--cccCCc
Confidence            33  377774

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.90  E-value=2e-23  Score=192.13  Aligned_cols=149  Identities=31%  Similarity=0.524  Sum_probs=130.7

Q ss_pred             CCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc------ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      +|+..+.||+|+||.||++. ..+++.||+|.+.....      .....+..|+.++++++|+||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47778999999999999998 46789999998865331      123568999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCcccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLF  396 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~  396 (412)
                      |+||+++++|.+++.+   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999854   356889999999999999999999987   99999999999998776 5999999999877


Q ss_pred             cCC
Q 015138          397 EMD  399 (412)
Q Consensus       397 ~~~  399 (412)
                      ...
T Consensus       155 ~~~  157 (268)
T cd06630         155 AAK  157 (268)
T ss_pred             ccc
Confidence            543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.90  E-value=3e-23  Score=193.14  Aligned_cols=149  Identities=32%  Similarity=0.565  Sum_probs=122.5

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccC---CCCccceeeEEEecC-----C
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARL---QHRNLVRLLGFCLER-----K  313 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~-----~  313 (412)
                      +|+..+.||+|+||.||++.. .+++.||+|.+......  ....+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            477789999999999999995 56889999988754222  223456677766655   799999999988642     4


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            5789999997 4888887542 2345899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +.+..
T Consensus       156 ~~~~~  160 (288)
T cd07863         156 RIYSC  160 (288)
T ss_pred             ccccC
Confidence            87653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=3e-23  Score=193.45  Aligned_cols=148  Identities=28%  Similarity=0.344  Sum_probs=129.6

Q ss_pred             CCCccccccccCCeeEEEEEe----CCCCEEEEEEeccCCc----ccHHHHHHHHHHHccC-CCCccceeeEEEecCCee
Q 015138          245 NFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSK----QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  315 (412)
                      +|+..+.||+|+||.||++..    .+|+.||+|.+.....    .....+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467789999999999999985    4688999999875422    2235678899999999 599999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999854   356888999999999999999999987   99999999999999999999999999987


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      +..
T Consensus       155 ~~~  157 (290)
T cd05613         155 FHE  157 (290)
T ss_pred             ccc
Confidence            654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.90  E-value=3.3e-23  Score=192.51  Aligned_cols=149  Identities=28%  Similarity=0.478  Sum_probs=132.4

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.||+|.. .+++.|++|++....  ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            467789999999999999995 568999999987654  22345789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      + +++|.+++...  ...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+...
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 99999988542  356999999999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.90  E-value=4e-23  Score=189.52  Aligned_cols=143  Identities=31%  Similarity=0.530  Sum_probs=121.2

Q ss_pred             ccccccCCeeEEEEEeC----CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEec-CCeeeEEEecCC
Q 015138          250 NKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKERILVYEFVP  323 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv~Ey~~  323 (412)
                      +.||+|+||.||+|...    +...+|+|++.... ......+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    23579999886533 3345578899999999999999999998764 456789999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +|+|.+++...  ...+++...+.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999998542  344678888999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.90  E-value=3.2e-23  Score=196.70  Aligned_cols=144  Identities=21%  Similarity=0.270  Sum_probs=124.8

Q ss_pred             cccccccc--CCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          248 DANKLGQG--GFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       248 ~~~~lg~G--~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      ..++||+|  +|++||++.. .+|+.||+|++.....  .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  7889999984 6789999999875432  22345788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.+..
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~  150 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  150 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhc
Confidence            999999998542 2345899999999999999999999987   99999999999999999999999986544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.90  E-value=1.1e-23  Score=193.11  Aligned_cols=144  Identities=26%  Similarity=0.444  Sum_probs=123.6

Q ss_pred             ccccccCCeeEEEEEeCC--------CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          250 NKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +.||+|+||.||+|....        ..++++|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888887665555556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC--------eEEeccCCc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--------PKISDFGMA  393 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--------~ki~DfGla  393 (412)
                      +++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        +|++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998542  336899999999999999999999987   999999999999988765        699999998


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      .....
T Consensus       156 ~~~~~  160 (258)
T cd05078         156 ITVLP  160 (258)
T ss_pred             cccCC
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.90  E-value=4e-23  Score=194.87  Aligned_cols=149  Identities=30%  Similarity=0.470  Sum_probs=126.2

Q ss_pred             CCccccccccCCeeEEEEEeC---CCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeE
Q 015138          246 FSDANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  317 (412)
                      |+..++||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++.+++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            677889999999999999963   57899999987643   33345678899999999999999999999988  78999


Q ss_pred             EEecCCCCChhhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC----CCCeEEeccC
Q 015138          318 VYEFVPNASLDHFIFDPI--NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS----EMNPKISDFG  391 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~----~~~~ki~DfG  391 (412)
                      ||||+++ +|.+++....  ....+++.....++.|++.||.|||+.+   |+||||||+|||++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 5666553211  2236889999999999999999999987   999999999999999    8999999999


Q ss_pred             CcccccC
Q 015138          392 MARLFEM  398 (412)
Q Consensus       392 la~~~~~  398 (412)
                      +++.+..
T Consensus       158 ~~~~~~~  164 (316)
T cd07842         158 LARLFNA  164 (316)
T ss_pred             cccccCC
Confidence            9997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.90  E-value=6.7e-23  Score=189.21  Aligned_cols=150  Identities=27%  Similarity=0.480  Sum_probs=125.5

Q ss_pred             CCccccccccCCeeEEEEEeC----CCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC------
Q 015138          246 FSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  313 (412)
                      |...+.||+|+||.||+|.+.    +++.||||.+....  .....++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456789999999999999853    36789999987543  334556889999999999999999999886542      


Q ss_pred             eeeEEEecCCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          314 ERILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      ..++++||+++|+|..++...   .....+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            247899999999998887432   12235889999999999999999999987   999999999999999999999999


Q ss_pred             CCcccccC
Q 015138          391 GMARLFEM  398 (412)
Q Consensus       391 Gla~~~~~  398 (412)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99997643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.90  E-value=5.2e-23  Score=188.00  Aligned_cols=150  Identities=35%  Similarity=0.588  Sum_probs=131.1

Q ss_pred             CCccccccccCCeeEEEEEeCC-----CCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          246 FSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      |+..+.||.|+||.||++...+     +..||+|.+...... ....+..|+..+..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3557899999999999999643     378999999765543 4567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999985421 122899999999999999999999987   999999999999999999999999999876544

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.90  E-value=1.6e-23  Score=191.73  Aligned_cols=149  Identities=29%  Similarity=0.356  Sum_probs=132.9

Q ss_pred             CCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      +|+..+.||+|+||.||++... +++.+++|.+.+...   .....+.+|++++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999964 689999999875432   345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+++++|.+++..   ...+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999999844   257899999999999999999999987   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.90  E-value=4.6e-23  Score=188.48  Aligned_cols=150  Identities=24%  Similarity=0.393  Sum_probs=131.5

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.+|++.. .+++.|++|.+...  ......++.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999984 56889999998653  223345789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++... ....+++...+.++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            9999999988542 2345789999999999999999999987   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=8.6e-24  Score=197.45  Aligned_cols=152  Identities=26%  Similarity=0.372  Sum_probs=133.8

Q ss_pred             CCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      -|...+.||+|.|..|-+++ .-+|+.||||.+.+..-.  ....++.|++.|+.++|||||+|+.+...+..+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            35667899999999999988 457999999999775433  344689999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEEeccCCcccccCCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~~~  400 (412)
                      =.+|+|.+|+..  ....+.+....+++.||+.|+.|+|+.+   +|||||||+||.+-+ -|-+||.|||++..|.+++
T Consensus        99 GD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             cCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999954  4556889999999999999999999877   999999999988765 4789999999999998877


Q ss_pred             c
Q 015138          401 T  401 (412)
Q Consensus       401 ~  401 (412)
                      .
T Consensus       174 k  174 (864)
T KOG4717|consen  174 K  174 (864)
T ss_pred             h
Confidence            5

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.90  E-value=4.1e-23  Score=188.70  Aligned_cols=146  Identities=32%  Similarity=0.555  Sum_probs=127.3

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      ++|+..+.||+|+||.||++.. +++.||+|.+....  ....+.+|+.++.+++||||+++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5678889999999999999985 57889999886542  235688999999999999999999998654 4799999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            99999998542 2345889999999999999999999987   9999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.90  E-value=6.6e-23  Score=193.58  Aligned_cols=145  Identities=29%  Similarity=0.476  Sum_probs=118.7

Q ss_pred             cccccccCCeeEEEEEeC---CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEec--CCeeeEEEecCC
Q 015138          249 ANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILVYEFVP  323 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv~Ey~~  323 (412)
                      ..+||+|+||.||+|...   ++..||+|.+.....  ...+.+|+.++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999964   356899998865432  2357889999999999999999998854  457789999987


Q ss_pred             CCChhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE----CCCCCeEEeccCCc
Q 015138          324 NASLDHFIFD------PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMA  393 (412)
Q Consensus       324 ~gsL~~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DfGla  393 (412)
                      + +|.+++..      ......+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 67666531      112335889999999999999999999987   9999999999999    56678999999999


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      +.+...
T Consensus       160 ~~~~~~  165 (317)
T cd07867         160 RLFNSP  165 (317)
T ss_pred             eccCCC
Confidence            977543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=6.7e-23  Score=187.61  Aligned_cols=143  Identities=35%  Similarity=0.598  Sum_probs=124.0

Q ss_pred             ccccccCCeeEEEEEeC--C--CCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGMLS--N--GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~--~--~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ++||+|+||.||+|...  +  +..+|+|.+...... ...++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999842  2  268999998765543 4557899999999999999999999876 4568999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+|.+++..   ...+++..+..++.|++.||.|||..+   ++||||||+|||++.++.+||+|||+++.+...
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            999999954   336899999999999999999999987   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.90  E-value=2.4e-23  Score=193.43  Aligned_cols=148  Identities=28%  Similarity=0.515  Sum_probs=128.1

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.||++.. .+|+.+++|.+.....  .....+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            467788999999999999995 5689999999865422  2234578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++ ++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            97 578777643  2356899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=8.2e-23  Score=186.85  Aligned_cols=150  Identities=26%  Similarity=0.387  Sum_probs=129.2

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec-CCeeeEEEe
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKERILVYE  320 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv~E  320 (412)
                      +|+..+.||+|++|.||++.. .+++.+++|++....  ......+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            477889999999999999994 457889999986543  2334568899999999999999999998764 446789999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|.+++... ....+++.++..++.+++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999998542 2346899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.90  E-value=7.9e-23  Score=187.57  Aligned_cols=150  Identities=29%  Similarity=0.434  Sum_probs=135.0

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||+|++|.||++... +++.|+||++..... .....+.+|+..+.+++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888899999999999999964 589999999876644 3456799999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++..   ...+++...+.++.|+++||.|||+ .+   ++||||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            999999999854   3678999999999999999999999 77   999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.90  E-value=9e-23  Score=189.81  Aligned_cols=147  Identities=29%  Similarity=0.451  Sum_probs=131.0

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      .|...+.||+|++|.||++.. .+++.+++|++..........+.+|+.++..++|+||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            355567999999999999994 5788999999876555555678999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++.....
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            9999999843    46899999999999999999999987   99999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3e-23  Score=204.11  Aligned_cols=154  Identities=25%  Similarity=0.448  Sum_probs=121.8

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-----------------CCCCEEEEEEeccCCcccHHHH--------------HH
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-----------------SNGETIAVKRLSKNSKQGEIEF--------------KN  289 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-----------------~~~~~vavK~l~~~~~~~~~~~--------------~~  289 (412)
                      ...++|++.++||+|+||.||+|..                 .+++.||||++.........+|              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            4578999999999999999999964                 2356799999865433222233              34


Q ss_pred             HHHHHccCCCCcc-----ceeeEEEec--------CCeeeEEEecCCCCChhhhccCCC---------------------
Q 015138          290 EVLLLARLQHRNL-----VRLLGFCLE--------RKERILVYEFVPNASLDHFIFDPI---------------------  335 (412)
Q Consensus       290 e~~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lv~Ey~~~gsL~~~l~~~~---------------------  335 (412)
                      |+..+.+++|.++     ++++++|..        ....+|||||+++++|.++|+...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6667777776654     678888753        356899999999999999885321                     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          336 NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       336 ~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ....++|..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  360 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC  360 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence            1123577888999999999999999987   9999999999999999999999999997654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.90  E-value=8.4e-23  Score=192.10  Aligned_cols=150  Identities=33%  Similarity=0.483  Sum_probs=129.3

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .+.|+..++||+|+||.||+|.. .+++.|++|.+.....   ....++.+|++++..++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            35688889999999999999995 4689999998864432   2334688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +||++ |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||+++...+
T Consensus        94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 567666532  2346899999999999999999999987   99999999999999999999999999986643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=202.16  Aligned_cols=158  Identities=30%  Similarity=0.433  Sum_probs=132.8

Q ss_pred             ccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCChh
Q 015138          250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD  328 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~  328 (412)
                      -+||+|.||+||-|+ ..+...+|||.+.....+..+-+.+||.+.+.|+|.|||+.+|.+.+++..-+.||-++||||.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            379999999999999 5556789999999888777778999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC-CCCCeEEeccCCcccccCCCccccccc
Q 015138          329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNR  407 (412)
Q Consensus       329 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~~~~~~~~~~~~  407 (412)
                      ++|...-..-.=.+.+.-.+..||++||.|||++.   |||||||-.|||++ -.|.+||+|||-+|.+..=.  ..|..
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence            99966432222266777788999999999999998   99999999999997 46899999999999874221  12333


Q ss_pred             ccccC
Q 015138          408 VVGTL  412 (412)
Q Consensus       408 ~~Gt~  412 (412)
                      ..||+
T Consensus       736 FTGTL  740 (1226)
T KOG4279|consen  736 FTGTL  740 (1226)
T ss_pred             cccch
Confidence            55664

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=6.7e-23  Score=188.41  Aligned_cols=148  Identities=30%  Similarity=0.482  Sum_probs=128.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-----cccHHHHHHHHHHHccCCCCccceeeEEEecC--Cee
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~  315 (412)
                      .+|+..+.||+|+||.||++.. .+++.|++|.+....     ......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5788899999999999999995 568999999875321     22334688999999999999999999998764  457


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++++||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998843   345888999999999999999999987   99999999999999999999999999987


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      +.
T Consensus       156 ~~  157 (264)
T cd06653         156 IQ  157 (264)
T ss_pred             cc
Confidence            53

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.89  E-value=6.2e-23  Score=191.57  Aligned_cols=143  Identities=29%  Similarity=0.448  Sum_probs=128.4

Q ss_pred             cccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          249 ANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ..+||+|+||.||++.. .+++.||||++..........+.+|+.++..++|+||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46799999999999985 57899999998665555566789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      .+++.    ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            99873    345899999999999999999999987   99999999999999999999999999876643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.89  E-value=6.3e-23  Score=191.63  Aligned_cols=150  Identities=27%  Similarity=0.432  Sum_probs=127.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCC-CCccceeeEEEecCCe-----
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKE-----  314 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~-----  314 (412)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+......  ....+.+|+.+++++. |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688899999999999999995 56899999987654322  2346788999999995 6999999999887665     


Q ss_pred             eeEEEecCCCCChhhhccCCCC--CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEEeccC
Q 015138          315 RILVYEFVPNASLDHFIFDPIN--REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFG  391 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfG  391 (412)
                      .++||||+++ +|.+++.....  ...+++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 78888754221  346899999999999999999999987   999999999999998 8899999999


Q ss_pred             Cccccc
Q 015138          392 MARLFE  397 (412)
Q Consensus       392 la~~~~  397 (412)
                      +++.+.
T Consensus       157 ~~~~~~  162 (295)
T cd07837         157 LGRAFS  162 (295)
T ss_pred             cceecC
Confidence            998654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.89  E-value=5.9e-23  Score=191.76  Aligned_cols=150  Identities=29%  Similarity=0.474  Sum_probs=129.5

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILV  318 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv  318 (412)
                      ++|+..+.||+|+||.||+|... +++.+++|.+......  ....+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888899999999999999964 6889999998754322  233567899999999999999999998877  889999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||++ ++|.+++...  ...+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 4898887542  236899999999999999999999987   99999999999999999999999999987654


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       159 ~  159 (293)
T cd07843         159 P  159 (293)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.89  E-value=6.7e-23  Score=190.23  Aligned_cols=158  Identities=29%  Similarity=0.487  Sum_probs=133.9

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEec-
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE-  311 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~-  311 (412)
                      ++..+....+.|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4455566778899999999999999999995 568899999886543 2334678899999988 79999999999853 


Q ss_pred             -----CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeE
Q 015138          312 -----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (412)
Q Consensus       312 -----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k  386 (412)
                           .+..+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45789999999999999988542 2345888888999999999999999987   99999999999999999999


Q ss_pred             EeccCCccccc
Q 015138          387 ISDFGMARLFE  397 (412)
Q Consensus       387 i~DfGla~~~~  397 (412)
                      |+|||+++...
T Consensus       162 l~dfg~~~~~~  172 (282)
T cd06636         162 LVDFGVSAQLD  172 (282)
T ss_pred             EeeCcchhhhh
Confidence            99999988653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.89  E-value=5.1e-23  Score=191.17  Aligned_cols=148  Identities=31%  Similarity=0.538  Sum_probs=129.5

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||.|+||.||++.. .+++.|+||++.....  .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            477889999999999999985 5688999998865432  2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +. ++|..++... ....+++.....++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            96 6888887542 3456899999999999999999999987   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=4e-23  Score=179.47  Aligned_cols=141  Identities=20%  Similarity=0.222  Sum_probs=109.5

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcc--c-------HHH-----------------HHHHHHHHccCCCCcc
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--G-------EIE-----------------FKNEVLLLARLQHRNL  302 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~ni  302 (412)
                      ...||+|+||.||+|...+|+.||||.+......  .       ...                 ...|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999998754211  1       011                 2348999999988776


Q ss_pred             ceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHh-HhCCCCCceecCCCCCCEEECC
Q 015138          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL-HEDSRLRIIHRDLKASNILLDS  381 (412)
Q Consensus       303 v~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrdlk~~Nill~~  381 (412)
                      .....+..  ...+|||||+++++|...+.   ....+++.....++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333322  23489999999987765432   235688999999999999999999 6776   99999999999998 


Q ss_pred             CCCeEEeccCCcccccC
Q 015138          382 EMNPKISDFGMARLFEM  398 (412)
Q Consensus       382 ~~~~ki~DfGla~~~~~  398 (412)
                      ++.++|+|||+|.....
T Consensus       153 ~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         153 DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CCcEEEEEccccccCCC
Confidence            57899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=186.24  Aligned_cols=143  Identities=29%  Similarity=0.460  Sum_probs=129.8

Q ss_pred             cccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEecCCCCC
Q 015138          249 ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      .+.||+|+|+.|.-++ +.+|.++|||++.+.....+....+|++++...+ |+||++|+.+++++...|||||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            4689999999999988 7889999999999987777888999999999885 9999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC---eEEeccCCccccc
Q 015138          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFE  397 (412)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfGla~~~~  397 (412)
                      |...+..   +..+++.++.+++.+|+.||.|||.++   |.||||||+|||-....+   +||+||.|..-+.
T Consensus       163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence            9988844   677999999999999999999999998   999999999999976654   8999999987543

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.89  E-value=9.5e-23  Score=188.81  Aligned_cols=142  Identities=31%  Similarity=0.432  Sum_probs=124.7

Q ss_pred             ccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          252 LGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       252 lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ||+|+||+||++.. .+|+.+++|.+....   ......+.+|++++..++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999984 568899999986543   22344567899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      .+++.... ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++..+.
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            99985432 246899999999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.89  E-value=5.2e-23  Score=189.50  Aligned_cols=145  Identities=35%  Similarity=0.569  Sum_probs=124.6

Q ss_pred             ccccccCCeeEEEEEeCC-------CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          250 NKLGQGGFGAVYKGMLSN-------GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~-------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +.||+|+||.||+|...+       ++.++||.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998632       25789998865432 3455789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-----CeEEeccCC
Q 015138          322 VPNASLDHFIFDPI----NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-----NPKISDFGM  392 (412)
Q Consensus       322 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-----~~ki~DfGl  392 (412)
                      +++++|.+++.+..    ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999985421    2345889999999999999999999887   99999999999999887     899999999


Q ss_pred             ccccc
Q 015138          393 ARLFE  397 (412)
Q Consensus       393 a~~~~  397 (412)
                      ++.+.
T Consensus       158 ~~~~~  162 (269)
T cd05044         158 ARDIY  162 (269)
T ss_pred             ccccc
Confidence            98654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=9.7e-23  Score=188.04  Aligned_cols=153  Identities=29%  Similarity=0.475  Sum_probs=132.4

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCC-----
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK-----  313 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~-----  313 (412)
                      ..+++|+..+.||+|+||.||++.. .+++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            3568899999999999999999996 4678899998876543 345789999999999 7999999999997644     


Q ss_pred             -eeeEEEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          314 -ERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       314 -~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999885422 2457899999999999999999999987   9999999999999999999999999


Q ss_pred             Cccccc
Q 015138          392 MARLFE  397 (412)
Q Consensus       392 la~~~~  397 (412)
                      ++....
T Consensus       159 ~~~~~~  164 (275)
T cd06608         159 VSAQLD  164 (275)
T ss_pred             cceecc
Confidence            987654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.89  E-value=6.2e-23  Score=190.88  Aligned_cols=150  Identities=27%  Similarity=0.421  Sum_probs=131.2

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..+.||+|+||.||++... +++.|++|.+....  ......+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36788899999999999999964 58899999886542  2234578999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |++++.|..++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+...
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998888766532   355899999999999999999999987   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.89  E-value=1.3e-22  Score=186.86  Aligned_cols=153  Identities=29%  Similarity=0.497  Sum_probs=127.8

Q ss_pred             CCCccccccccCCeeEEEEEeCC--CCEEEEEEeccCC----------cccHHHHHHHHHHHcc-CCCCccceeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGMLSN--GETIAVKRLSKNS----------KQGEIEFKNEVLLLAR-LQHRNLVRLLGFCLE  311 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~  311 (412)
                      +|+..+.||+|+||.||++....  ++.+|+|.+....          .....++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778999999999999999654  6789999875321          1223457788887765 799999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          312 RKERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      .+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887431 23456899999999999999999999632  3999999999999999999999999


Q ss_pred             CCcccccCC
Q 015138          391 GMARLFEMD  399 (412)
Q Consensus       391 Gla~~~~~~  399 (412)
                      |++......
T Consensus       159 g~~~~~~~~  167 (269)
T cd08528         159 GLAKQKQPE  167 (269)
T ss_pred             cceeecccc
Confidence            999876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.89  E-value=1.6e-22  Score=188.09  Aligned_cols=150  Identities=29%  Similarity=0.481  Sum_probs=134.7

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .+++|+..+.||+|+||.||++... +++.+++|.+..... ....+.+|++++..++|+||+++++.+......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4577888899999999999999965 688999999876554 45678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++....
T Consensus        96 ~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          96 YMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999998542  137999999999999999999999987   9999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2e-22  Score=183.65  Aligned_cols=149  Identities=31%  Similarity=0.496  Sum_probs=133.2

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|++|.||++.. .+++.+++|.+.....  .....+.+|++++.+++|+|++++++++.++...+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            467789999999999999985 4678999999876654  3455789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            999999999844   357899999999999999999999987   999999999999999999999999999977543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.89  E-value=1.1e-22  Score=190.72  Aligned_cols=152  Identities=30%  Similarity=0.543  Sum_probs=129.8

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCC----
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----  313 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----  313 (412)
                      ...++|+..+.||+|+||.||+|.. .+++.|++|.+.....  .....+.+|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            4567899999999999999999996 4688999999865432  23346788999999999999999999987655    


Q ss_pred             ------eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          314 ------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       314 ------~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                            ..++|+||+++ +|..++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 66666643  2346899999999999999999999987   999999999999999999999


Q ss_pred             eccCCcccccC
Q 015138          388 SDFGMARLFEM  398 (412)
Q Consensus       388 ~DfGla~~~~~  398 (412)
                      +|||++..+..
T Consensus       158 ~dfg~~~~~~~  168 (302)
T cd07864         158 ADFGLARLYNS  168 (302)
T ss_pred             CcccccccccC
Confidence            99999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.89  E-value=7.9e-23  Score=194.87  Aligned_cols=149  Identities=31%  Similarity=0.517  Sum_probs=127.7

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccC--CcccHHHHHHHHHHHccC-CCCccceeeEEEecC--Ceee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER--KERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~--~~~~  316 (412)
                      .++|+..+.||+|+||.||+|... +++.+++|++...  .......+..|+.++.++ +|+||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888999999999999999954 6789999988653  223344677899999999 999999999998654  3689


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||++ ++|..++..    ..++|..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 599888743    37889999999999999999999987   999999999999999999999999999876


Q ss_pred             cCC
Q 015138          397 EMD  399 (412)
Q Consensus       397 ~~~  399 (412)
                      ...
T Consensus       158 ~~~  160 (337)
T cd07852         158 SEL  160 (337)
T ss_pred             ccc
Confidence            443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.89  E-value=3.2e-22  Score=181.79  Aligned_cols=150  Identities=34%  Similarity=0.570  Sum_probs=135.0

Q ss_pred             CCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      +|+..+.||+|++|.||++... +++.+++|++..........+.+|+..+++++|+||+++++.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999964 688999999987665556689999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++|.+++...  ...+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999998542  257899999999999999999999977   999999999999999999999999999887654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=1.7e-22  Score=184.61  Aligned_cols=150  Identities=27%  Similarity=0.449  Sum_probs=130.2

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.||++.. .+++.+++|.+....  ......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477789999999999999985 568899999986542  23345789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++... ....+++..+..++.+++.+|.|||+++   ++|+||+|+||+++.+. .+||+|||+++....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999998542 2345899999999999999999999987   99999999999998654 689999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.89  E-value=1.2e-22  Score=185.68  Aligned_cols=151  Identities=27%  Similarity=0.443  Sum_probs=130.6

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||+|+||.||++.. .+|..+|+|.+....  ......+.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            477789999999999999995 458899999986542  23345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++ .+||+|||++..+...
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998542 2345899999999999999999999987   99999999999999886 4699999999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.89  E-value=1.6e-22  Score=185.45  Aligned_cols=156  Identities=28%  Similarity=0.469  Sum_probs=130.1

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec--CCeeeEEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILVY  319 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv~  319 (412)
                      +|+..+.||.|+||.||++.. .+++.+++|.+....  ......+.+|+.++++++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            467789999999999999984 568899999886542  3334568899999999999999999998764  45678999


Q ss_pred             ecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCC--CCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDS--RLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||+++++|.+++... .....+++...+.++.|++.||.|||..+  ..+++|+||+|+||+++.++.+||+|||++..+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998542 22457899999999999999999999332  234999999999999999999999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ....
T Consensus       161 ~~~~  164 (265)
T cd08217         161 GHDS  164 (265)
T ss_pred             cCCc
Confidence            5443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=186.22  Aligned_cols=162  Identities=27%  Similarity=0.294  Sum_probs=136.8

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHH---HHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~---~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|..+++||+|.||+|-+++ ..+++.+|+|++++...-...+   -..|-++|...+||.+..|-..+...+.++.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            4678889999999999999998 5678999999998865443333   45688899999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||..||.|.-+|.   +.+.+++.....+-.+|..||.|||+++   ||.||||.+|.|||.+|++||+||||.+.-..
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999988873   3567888888888999999999999987   99999999999999999999999999986433


Q ss_pred             CCcccccccccccC
Q 015138          399 DQTHSDTNRVVGTL  412 (412)
Q Consensus       399 ~~~~~~~~~~~Gt~  412 (412)
                      ...  .+...+||+
T Consensus       321 ~g~--t~kTFCGTP  332 (516)
T KOG0690|consen  321 YGD--TTKTFCGTP  332 (516)
T ss_pred             ccc--eeccccCCh
Confidence            222  234478874

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=1.3e-22  Score=189.01  Aligned_cols=151  Identities=27%  Similarity=0.400  Sum_probs=129.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv~  319 (412)
                      ++|+..+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4677889999999999999996 4678899998875433 3455689999999999999999999998654  3689999


Q ss_pred             ecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++++|.+++... .....+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999886431 13456889999999999999999999987   9999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.89  E-value=2.2e-22  Score=184.69  Aligned_cols=142  Identities=29%  Similarity=0.362  Sum_probs=126.2

Q ss_pred             ccccCCeeEEEEEeC-CCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       252 lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ||.|+||.||++... +++.+++|.+.+...   .....+.+|+.++..++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999964 588999999876432   2345689999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      .+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            999854   345899999999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.89  E-value=1.5e-22  Score=193.31  Aligned_cols=149  Identities=28%  Similarity=0.493  Sum_probs=128.4

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC-----
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----  313 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----  313 (412)
                      ..++|+..+.||+|+||.||++. ..+++.||||++....  ......+.+|+.++++++|+||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            45789999999999999999998 4578999999986532  223446889999999999999999999987653     


Q ss_pred             -eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          314 -ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       314 -~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                       ..++||||+ +++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             358999998 779988873    356899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++....
T Consensus       165 ~~~~~~  170 (343)
T cd07880         165 ARQTDS  170 (343)
T ss_pred             cccccc
Confidence            987643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-22  Score=200.50  Aligned_cols=171  Identities=27%  Similarity=0.463  Sum_probs=145.1

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEe--
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCL--  310 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~--  310 (412)
                      +++.+...++-|++.++||+|.+|.||+++ ..+++..|||++......+ .++..|..+++.. +|||++.++|++.  
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            445556677889999999999999999999 6788999999887665443 3567788888877 6999999999986  


Q ss_pred             ---cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          311 ---ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       311 ---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                         .++++|||||||.+||..+++.... ...+.|..+..|+.+++.||.|||.+.   ++|||+|=.||||+.++.+|+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence               3578999999999999999987654 677999999999999999999999987   999999999999999999999


Q ss_pred             eccCCcccccCCCcccccccccccC
Q 015138          388 SDFGMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      .|||++..+.......  +..+||+
T Consensus       165 vDFGvSaQldsT~grR--nT~iGtP  187 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVGRR--NTFIGTP  187 (953)
T ss_pred             eeeeeeeeeecccccc--cCcCCCc
Confidence            9999999886554433  3367774

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.89  E-value=2.1e-22  Score=186.78  Aligned_cols=141  Identities=27%  Similarity=0.351  Sum_probs=118.2

Q ss_pred             cccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHH---HccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          251 KLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLL---LARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~---l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      .||+|+||.||++.. .+++.+|+|.+.+...   .....+.+|..+   +...+|+||+++++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999995 5688999998865432   112233444433   334479999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++..+.
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            9999998853   456999999999999999999999987   9999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.89  E-value=9.1e-23  Score=187.07  Aligned_cols=141  Identities=28%  Similarity=0.430  Sum_probs=126.0

Q ss_pred             ccccCCeeEEEEEeC-CCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       252 lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ||+|+||.||++... +++.+++|.+.....   .....+.+|++++.+++|+||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999965 589999999876543   3455688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      .+++.+   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            999854   236899999999999999999999987   99999999999999999999999999886543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.89  E-value=1.2e-22  Score=186.68  Aligned_cols=149  Identities=28%  Similarity=0.423  Sum_probs=132.1

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||+|+||.||++... +++.+++|.+..... ....++.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999964 688999999876543 3455789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++...  ...+++.....++.|++.||.|||+ .+   ++|+||||+||+++.++.+||+|||++..+.
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999998542  2678899999999999999999998 66   9999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=5e-23  Score=205.77  Aligned_cols=153  Identities=25%  Similarity=0.457  Sum_probs=118.7

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC--CCEEEEEE--------------ecc---CCcccHHHHHHHHHHHccCCCCccc
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN--GETIAVKR--------------LSK---NSKQGEIEFKNEVLLLARLQHRNLV  303 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~--------------l~~---~~~~~~~~~~~e~~~l~~l~h~niv  303 (412)
                      .++|++.++||+|+||+||++....  ++..++|.              +.+   ........+.+|+.++.+++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999987532  22222221              111   1112234588999999999999999


Q ss_pred             eeeEEEecCCeeeEEEecCCCCChhhhccCCCC--CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC
Q 015138          304 RLLGFCLERKERILVYEFVPNASLDHFIFDPIN--REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS  381 (412)
Q Consensus       304 ~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~  381 (412)
                      ++++++...+..++|+|++. ++|.+++.....  ...........|+.|++.||.|||+.+   |+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence            99999999999999999985 567676643211  122345567789999999999999987   999999999999999


Q ss_pred             CCCeEEeccCCcccccCC
Q 015138          382 EMNPKISDFGMARLFEMD  399 (412)
Q Consensus       382 ~~~~ki~DfGla~~~~~~  399 (412)
                      ++.+||+|||+++.+...
T Consensus       303 ~~~vkL~DFGla~~~~~~  320 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKE  320 (501)
T ss_pred             CCCEEEEeCCCceecCcc
Confidence            999999999999987544

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.89  E-value=3.4e-22  Score=188.84  Aligned_cols=148  Identities=32%  Similarity=0.500  Sum_probs=127.6

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .|+..+.||+|+||.||++.. .+++.+|+|.+.....   .....+.+|+.++++++|+|++++++++.+....++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            366788999999999999995 5688999999875432   223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |++ |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++.....
T Consensus       106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            997 577776643  2456899999999999999999999987   99999999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.89  E-value=1.9e-22  Score=189.87  Aligned_cols=150  Identities=33%  Similarity=0.547  Sum_probs=128.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  317 (412)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|.+......  ....+.+|+.++.+++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46788999999999999999995 56899999998654322  123467899999999999999999998765  46899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||++ ++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            999996 4788887442  356899999999999999999999988   9999999999999999999999999998765


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       160 ~  160 (309)
T cd07845         160 L  160 (309)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.89  E-value=3.2e-22  Score=186.83  Aligned_cols=149  Identities=32%  Similarity=0.497  Sum_probs=126.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..+.||+|++|.||+|.. .+++.|++|.+.....  .....+.+|+.++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            4688899999999999999995 4688999998865432  223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~  397 (412)
                      |++ ++|.+++... ....+++.....++.||+.||.|||+.+   ++||||+|+||+++. ++.+||+|||+++...
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            996 5777776432 2334678888899999999999999987   999999999999985 5679999999998654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.89  E-value=1.3e-22  Score=193.25  Aligned_cols=148  Identities=28%  Similarity=0.499  Sum_probs=127.1

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecC-----Cee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~  315 (412)
                      .++|+..+.||+|+||.||+|. ..+++.||||.+..... .....+.+|+.++.+++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4689999999999999999998 45789999999865332 2345678899999999999999999987654     357


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++|+||+++ +|..++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999974 7877762    356999999999999999999999987   99999999999999999999999999987


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      ...
T Consensus       156 ~~~  158 (336)
T cd07849         156 ADP  158 (336)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.88  E-value=2.5e-22  Score=186.58  Aligned_cols=148  Identities=30%  Similarity=0.552  Sum_probs=129.2

Q ss_pred             CCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeEEEe
Q 015138          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILVYE  320 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv~E  320 (412)
                      |+..++||+|+||.||+|... +++.+++|.+....  ......+.+|+.++++++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556789999999999999964 58899999998763  23345688999999999999999999999988  88999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+++ +|.+++...  ...+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 888887542  247899999999999999999999987   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.88  E-value=4.1e-22  Score=181.89  Aligned_cols=150  Identities=31%  Similarity=0.494  Sum_probs=133.6

Q ss_pred             CCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeEEE
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILVY  319 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv~  319 (412)
                      +|...+.||+|++|.||+|... +++.|++|.+.....  .....+.+|+.++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999965 688999999876543  3456789999999999999999999999988  8899999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++++|.+++..   ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999854   237999999999999999999999987   999999999999999999999999999987654


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       155 ~  155 (260)
T cd06606         155 E  155 (260)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.88  E-value=7.9e-23  Score=197.36  Aligned_cols=148  Identities=30%  Similarity=0.453  Sum_probs=127.6

Q ss_pred             CCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-C-----CccceeeEEEecCCeeeE
Q 015138          245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-H-----RNLVRLLGFCLERKERIL  317 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~g~~~~~~~~~l  317 (412)
                      +|++.+.||+|.||.|.++. ..+++.||||+++....- ..+-..|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            67889999999999999999 577999999999765433 334577999999986 4     489999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC--CeEEeccCCccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM--NPKISDFGMARL  395 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~--~~ki~DfGla~~  395 (412)
                      |+|.+ ..+|.++|... +...++...+..|+.||+.||.+||+.+   |||.||||+||||..-.  .+||+|||.|..
T Consensus       266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99977 66999999764 3455999999999999999999999887   99999999999997654  699999999987


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      ...
T Consensus       341 ~~q  343 (586)
T KOG0667|consen  341 ESQ  343 (586)
T ss_pred             cCC
Confidence            554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3.5e-22  Score=174.18  Aligned_cols=142  Identities=21%  Similarity=0.236  Sum_probs=112.7

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcc---------------------c-----HHHHHHHHHHHccCCCCcc
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ---------------------G-----EIEFKNEVLLLARLQHRNL  302 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni  302 (412)
                      ...||+|+||.||+|...+|+.||||.+......                     .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999778999999998765211                     0     1123578899999999987


Q ss_pred             ceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCceecCCCCCCEEECC
Q 015138          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDS  381 (412)
Q Consensus       303 v~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~  381 (412)
                      .....+...  ..+|||||++++++.....   ....++......++.|++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544444332  3489999999886544321   23457788889999999999999999 77   99999999999998 


Q ss_pred             CCCeEEeccCCcccccCC
Q 015138          382 EMNPKISDFGMARLFEMD  399 (412)
Q Consensus       382 ~~~~ki~DfGla~~~~~~  399 (412)
                      ++.++|+|||+|+.++.+
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            889999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.88  E-value=2.7e-22  Score=188.57  Aligned_cols=150  Identities=31%  Similarity=0.569  Sum_probs=126.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCC------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  313 (412)
                      .++|+..++||+|+||.||++.. .+++.||||.+.....  .....+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            35788899999999999999995 5689999998865432  22335678999999999999999999987654      


Q ss_pred             --eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          314 --ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       314 --~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                        ..++||||+++ +|.+++..  ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              34999999964 78777643  2346899999999999999999999987   9999999999999999999999999


Q ss_pred             CcccccC
Q 015138          392 MARLFEM  398 (412)
Q Consensus       392 la~~~~~  398 (412)
                      ++..+..
T Consensus       165 ~~~~~~~  171 (310)
T cd07865         165 LARAFSL  171 (310)
T ss_pred             CcccccC
Confidence            9987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.88  E-value=1.1e-22  Score=188.32  Aligned_cols=150  Identities=31%  Similarity=0.459  Sum_probs=133.0

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv  318 (412)
                      ++|...+.||+|+||.||++.. .+++.|++|.+.+..   ......+.+|..++.+++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688889999999999999995 478999999886532   223456888999999998 99999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++..   ...+++..+..|+.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999854   347999999999999999999999987   99999999999999999999999999987654


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       155 ~  155 (280)
T cd05581         155 N  155 (280)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00284 protein kinase; Provisional

Probab=99.88  E-value=1.5e-22  Score=201.34  Aligned_cols=148  Identities=24%  Similarity=0.327  Sum_probs=118.3

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC------CCccceeeEEEecC
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ------HRNLVRLLGFCLER  312 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~g~~~~~  312 (412)
                      ...+++|++.++||+|+||+||++.. .+++.||||++..... ...++..|+.++.+++      |.+++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            34568899999999999999999995 5678899999864322 2233455666666554      45688999988764


Q ss_pred             -CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCC-------
Q 015138          313 -KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEM-------  383 (412)
Q Consensus       313 -~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~-------  383 (412)
                       ...++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||++ +   ||||||||+|||++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence             4688999988 6788887743   35699999999999999999999974 6   99999999999998765       


Q ss_pred             ---------CeEEeccCCccc
Q 015138          384 ---------NPKISDFGMARL  395 (412)
Q Consensus       384 ---------~~ki~DfGla~~  395 (412)
                               .+||+|||++..
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~  297 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCD  297 (467)
T ss_pred             ccccCCCCceEEECCCCcccc
Confidence                     499999998864

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.88  E-value=4e-22  Score=184.81  Aligned_cols=141  Identities=27%  Similarity=0.345  Sum_probs=118.6

Q ss_pred             cccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHH---HHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          251 KLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVL---LLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~---~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      .||+|+||.||++.. .+++.||+|.+.+....   ....+.+|..   .+....||||+++++.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 56889999998764321   1222344433   3444679999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +|+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            9999988843   456999999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.88  E-value=2.6e-22  Score=186.87  Aligned_cols=149  Identities=30%  Similarity=0.386  Sum_probs=128.9

Q ss_pred             CCCccccccccCCeeEEEEEe----CCCCEEEEEEeccCC----cccHHHHHHHHHHHccC-CCCccceeeEEEecCCee
Q 015138          245 NFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  315 (412)
                      +|+..+.||+|+||.||++..    .+++.||||.+.+..    ......+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999884    356889999987532    12334678999999999 599999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++|+|.+++..   ...+++.....++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999999843   356889999999999999999999887   99999999999999999999999999987


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      +...
T Consensus       155 ~~~~  158 (288)
T cd05583         155 FLAE  158 (288)
T ss_pred             cccc
Confidence            6543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.88  E-value=3.1e-22  Score=185.78  Aligned_cols=147  Identities=31%  Similarity=0.525  Sum_probs=128.2

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      |+..++||.|++|.||+|.. .+|+.|++|++.....  .....+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56678999999999999995 5789999999875432  22346889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      + ++|.+++... ....+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++.+||+|||+++.+.
T Consensus        81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            5 6899888442 2246899999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.88  E-value=4.2e-22  Score=184.69  Aligned_cols=146  Identities=27%  Similarity=0.430  Sum_probs=123.8

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCC-CCccceeeEEEecC--CeeeEEEe
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLER--KERILVYE  320 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~E  320 (412)
                      |+..++||+|+||.||++.. .+++.+|+|++..... .......+|+..+.++. |+||+++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45678999999999999994 5688999999876432 22334567888888885 99999999999987  88999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |++ ++|.+++..  ....++|..+..++.|++.||.|||+.+   |+||||+|+||+++. +.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            997 578777743  2356899999999999999999999987   999999999999999 9999999999987643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.88  E-value=3.7e-22  Score=190.82  Aligned_cols=153  Identities=31%  Similarity=0.487  Sum_probs=129.7

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC-
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-  312 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-  312 (412)
                      ..+-..+++|+..+.||+|+||.||++. ..+++.||+|++....  ......+.+|+.++.+++|+||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            3455677899999999999999999998 4678999999987542  22345678899999999999999999988643 


Q ss_pred             -----CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          313 -----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       313 -----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                           ...++++|++ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467888876 789988873    346899999999999999999999987   999999999999999999999


Q ss_pred             eccCCccccc
Q 015138          388 SDFGMARLFE  397 (412)
Q Consensus       388 ~DfGla~~~~  397 (412)
                      +|||+++...
T Consensus       162 ~dfg~~~~~~  171 (345)
T cd07877         162 LDFGLARHTD  171 (345)
T ss_pred             eccccccccc
Confidence            9999998654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.88  E-value=1.9e-22  Score=192.00  Aligned_cols=149  Identities=26%  Similarity=0.484  Sum_probs=128.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEec----CCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~  315 (412)
                      .++|+..+.||+|+||.||++.. .+++.|++|++.....  .....+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36788899999999999999994 5689999999876432  234567889999999999999999998753    3468


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+. ++|.+++..   ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 689888743   345899999999999999999999987   99999999999999999999999999987


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      ...
T Consensus       157 ~~~  159 (334)
T cd07855         157 LSS  159 (334)
T ss_pred             ecc
Confidence            643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.88  E-value=7.2e-23  Score=193.73  Aligned_cols=158  Identities=27%  Similarity=0.397  Sum_probs=132.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--------cHHHHHHHHHHHccCC---CCccceeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQ---HRNLVRLLGFCLE  311 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~---h~niv~l~g~~~~  311 (412)
                      .+|...+.+|+|+||.|+.+.. ++...|+||.+.+...-        ..-..-.||.+|+.++   |+||++++.+|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            4578889999999999999996 44667999988775321        1113567999999997   9999999999999


Q ss_pred             CCeeeEEEecC-CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          312 RKERILVYEFV-PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       312 ~~~~~lv~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      ++..+|+||-. ++.+|.+++   .....+++.....|..||+.|+++||+++   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999977 456888887   34567999999999999999999999998   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccc
Q 015138          391 GMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~Gt  411 (412)
                      |-|.....+...    ..+||
T Consensus       715 gsaa~~ksgpfd----~f~gt  731 (772)
T KOG1152|consen  715 GSAAYTKSGPFD----VFVGT  731 (772)
T ss_pred             cchhhhcCCCcc----eeeee
Confidence            999876655443    25565

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=3.5e-22  Score=191.64  Aligned_cols=148  Identities=29%  Similarity=0.452  Sum_probs=126.1

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecC------
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------  312 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+.+.  .......+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            347789999999999999999994 57899999998653  223345678899999999999999999988643      


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...++||||+. ++|.+.+..     .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            34699999996 578777632     2888899999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++....
T Consensus       165 ~~~~~~  170 (353)
T cd07850         165 ARTAGT  170 (353)
T ss_pred             ceeCCC
Confidence            987644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.88  E-value=7e-22  Score=180.33  Aligned_cols=152  Identities=26%  Similarity=0.423  Sum_probs=134.1

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..+.||.|+||.||++.. .+++.+++|++.....  .....+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            467788999999999999996 4688999999876533  4456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999985421 2367999999999999999999999987   999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.88  E-value=5.2e-22  Score=188.43  Aligned_cols=150  Identities=29%  Similarity=0.468  Sum_probs=128.9

Q ss_pred             HhhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec-CCee
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKER  315 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~  315 (412)
                      ...+++|+..+.||+|+||.||++. ..+++.||||++.+..  ......+..|+.++.+++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            3467889999999999999999998 4578999999886532  2234567899999999999999999999876 5578


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++|+||+ +++|.+++.    ...+++.....++.|+++||.|||+.+   |+||||+|+|||++.++.+||+|||+++.
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 568988873    346788888899999999999999987   99999999999999999999999999986


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      ..
T Consensus       158 ~~  159 (328)
T cd07856         158 QD  159 (328)
T ss_pred             cC
Confidence            54

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=2.5e-22  Score=204.11  Aligned_cols=162  Identities=30%  Similarity=0.437  Sum_probs=138.4

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEeC--------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeE
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLG  307 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g  307 (412)
                      .++...++..+.+.||+|.||.|++|...        ....||||.++.... .....+..|+++|..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            56667777777889999999999999842        134699999986544 3456799999999999 6999999999


Q ss_pred             EEecCCeeeEEEecCCCCChhhhccCCC------C-----C--CCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCC
Q 015138          308 FCLERKERILVYEFVPNASLDHFIFDPI------N-----R--EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKA  374 (412)
Q Consensus       308 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~  374 (412)
                      +|......++|+||++.|+|.+||+...      .     .  ..++..+.+.++.|||.||+||++..   +|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999996533      0     0  24899999999999999999999886   99999999


Q ss_pred             CCEEECCCCCeEEeccCCcccccCCCcc
Q 015138          375 SNILLDSEMNPKISDFGMARLFEMDQTH  402 (412)
Q Consensus       375 ~Nill~~~~~~ki~DfGla~~~~~~~~~  402 (412)
                      +|||+.++..+||+||||||.....+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y  474 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYY  474 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCce
Confidence            9999999999999999999976555443

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.88  E-value=4.5e-22  Score=189.65  Aligned_cols=150  Identities=26%  Similarity=0.490  Sum_probs=128.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecC-----Ce
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~  314 (412)
                      .+.|...+.||+|+||.||++.. .+++.||||.+...  .......+.+|+.++..++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35688899999999999999994 56899999998754  222344678899999999999999999987654     34


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++|+||+. ++|.+++..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 688888743   456999999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .....
T Consensus       157 ~~~~~  161 (337)
T cd07858         157 TTSEK  161 (337)
T ss_pred             ccCCC
Confidence            76443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=9.7e-22  Score=180.16  Aligned_cols=142  Identities=25%  Similarity=0.356  Sum_probs=120.0

Q ss_pred             ccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHH-HccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLL-LARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~-l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      +.||+|+||.||++.. .+++.||+|.+.+....   ....+..|..+ ....+|+|++++++.+...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999995 56889999998754321   22234445444 4456899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++...
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            999999843   346889999999999999999999987   9999999999999999999999999988653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.87  E-value=9.3e-22  Score=187.10  Aligned_cols=147  Identities=30%  Similarity=0.437  Sum_probs=123.1

Q ss_pred             CCCccccccccCCeeEEEEEeC-C--CCEEEEEEeccCCc--ccHHHHHHHHHHHccC-CCCccceeeEEEecC----Ce
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS-N--GETIAVKRLSKNSK--QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER----KE  314 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~-~--~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~----~~  314 (412)
                      +|+..+.||+|+||.||++... .  +..||+|++.....  .....+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999953 3  77899999875322  2245678899999999 599999999976433    35


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++++||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688889886 689888743   456899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccC
Q 015138          395 LFEM  398 (412)
Q Consensus       395 ~~~~  398 (412)
                      .+..
T Consensus       154 ~~~~  157 (332)
T cd07857         154 GFSE  157 (332)
T ss_pred             eccc
Confidence            7653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.87  E-value=9.7e-23  Score=207.47  Aligned_cols=150  Identities=33%  Similarity=0.502  Sum_probs=120.8

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecC------
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------  312 (412)
                      ...++|++.+.||+||||.||+++. -||..+|||++.... .+....+.+|+.++++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4567899999999999999999993 489999999997653 33345688999999999999999988632200      


Q ss_pred             --------------------------------------------------------------------------------
Q 015138          313 --------------------------------------------------------------------------------  312 (412)
Q Consensus       313 --------------------------------------------------------------------------------  312 (412)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 015138          313 ---------------------------------KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL  359 (412)
Q Consensus       313 ---------------------------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL  359 (412)
                                                       .-+||=||||+...|.+++.+.....  .....++++.+|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             01256677887777777764321110  3566788999999999999


Q ss_pred             HhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       360 H~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      |+++   ||||||||.||+||++..|||+|||+|..
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            9998   99999999999999999999999999997

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=9.9e-23  Score=194.50  Aligned_cols=147  Identities=24%  Similarity=0.354  Sum_probs=128.9

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .-|..++.||-|+||+|.++. .++...+|.|.|.+.+.-   .......|-.||+..+.+-||+|+.-|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            346778899999999999998 556678999999876533   2334678999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||++||++-.+|-   +.+.+.+..+..++.++..|+++.|..+   +|||||||.|||||.+|++||+||||..-|
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence            9999999999983   4567888888888999999999999887   999999999999999999999999998644

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.87  E-value=4.7e-22  Score=181.56  Aligned_cols=152  Identities=31%  Similarity=0.499  Sum_probs=132.3

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +|+..++||+|+||.||++.. .+++.+++|.+....  .....++.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            467789999999999999984 578899999987543  23345678999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++++|.+++.+.. ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999885421 2356899999999999999999999987   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.87  E-value=7.7e-22  Score=187.87  Aligned_cols=147  Identities=26%  Similarity=0.412  Sum_probs=126.4

Q ss_pred             cCCC-ccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc--------------HHHHHHHHHHHccCCCCccceeeE
Q 015138          244 DNFS-DANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG--------------EIEFKNEVLLLARLQHRNLVRLLG  307 (412)
Q Consensus       244 ~~~~-~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~g  307 (412)
                      ++|. ..+.||+|+||.||++.. .+++.||||.+.......              ...+.+|++++..++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 356799999999999994 568999999886543221              124678999999999999999999


Q ss_pred             EEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       308 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                      ++...+..++||||+. |+|.+++..   ...+++.....++.|++.||.|||+.+   |+|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 689888843   456899999999999999999999987   999999999999999999999


Q ss_pred             eccCCccccc
Q 015138          388 SDFGMARLFE  397 (412)
Q Consensus       388 ~DfGla~~~~  397 (412)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (335)
T PTZ00024        161 ADFGLARRYG  170 (335)
T ss_pred             CCccceeecc
Confidence            9999998765

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.87  E-value=2e-21  Score=178.97  Aligned_cols=147  Identities=20%  Similarity=0.292  Sum_probs=120.9

Q ss_pred             hhhcCCCccccc--cccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHcc-CCCCccceeeEEEecCCeee
Q 015138          241 VATDNFSDANKL--GQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLAR-LQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       241 ~~~~~~~~~~~l--g~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~~  316 (412)
                      ...++|+..+.+  |+|+||.||++.. .+++.+++|.+........     |+..... .+|+||+++++.+...+..+
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            334566666666  9999999999994 5678899998865432211     2222221 27999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARL  395 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~  395 (412)
                      +||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||+++.
T Consensus        86 iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~  159 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI  159 (267)
T ss_pred             EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence            99999999999999854   337999999999999999999999987   99999999999999998 999999999987


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      ...
T Consensus       160 ~~~  162 (267)
T PHA03390        160 IGT  162 (267)
T ss_pred             cCC
Confidence            653

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.87  E-value=4.2e-23  Score=211.09  Aligned_cols=166  Identities=30%  Similarity=0.428  Sum_probs=138.1

Q ss_pred             hhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..+-+|.....||.|.||.||-+. .++|+..|+|-+.....  .......+|+.++..|+|||+|+.+|+-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            334467778899999999999999 77899999997765432  334467899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      .||||++|+|.+.+..   .+..++....-+..|++.|+.|||+++   ||||||||.||+|+.++.+|++|||-|+.+.
T Consensus      1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999843   344666666677889999999999998   9999999999999999999999999999886


Q ss_pred             CCCcc--cccccccccC
Q 015138          398 MDQTH--SDTNRVVGTL  412 (412)
Q Consensus       398 ~~~~~--~~~~~~~Gt~  412 (412)
                      .+-..  ...+..+||+
T Consensus      1386 ~~~~~~~~el~~~~GT~ 1402 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTP 1402 (1509)
T ss_pred             CchhcCCHHHHhhcCCc
Confidence            65311  1233466663

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.87  E-value=1.2e-21  Score=184.46  Aligned_cols=149  Identities=33%  Similarity=0.502  Sum_probs=127.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC---CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      +.|+..+.||+|+||.||+|.. .+++.+++|.+...   ......++.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3466678999999999999995 46788999988643   2223446788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+. |+|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||++.....
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 677776643  2345889999999999999999999987   99999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.87  E-value=6.9e-22  Score=183.41  Aligned_cols=148  Identities=32%  Similarity=0.472  Sum_probs=127.8

Q ss_pred             CCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcc-cHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEecC
Q 015138          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      |+..+.||+|+||.||+|... +++.|+||++...... ......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            556789999999999999964 5788999998765332 2334567899999999 999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||+++....
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence             889988875422 346899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.87  E-value=4.1e-23  Score=174.77  Aligned_cols=148  Identities=26%  Similarity=0.498  Sum_probs=129.3

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecCC--eeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERK--ERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~--~~~lv  318 (412)
                      .++|++.+++|+|.++.||.|. ..+.++++||.+++...   ..+.+|+.+|..|. ||||++|++...+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4788999999999999999999 67789999999976543   36789999999997 999999999988754  46799


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~~~~  397 (412)
                      +||+.+.+...+-      ..|+...+...+.++++||.|+|+.|   |+|||+||.|+++|.. ...+|+|+|||.++.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998887664      45777788899999999999999998   9999999999999965 579999999999998


Q ss_pred             CCCcc
Q 015138          398 MDQTH  402 (412)
Q Consensus       398 ~~~~~  402 (412)
                      +.+..
T Consensus       185 p~~eY  189 (338)
T KOG0668|consen  185 PGKEY  189 (338)
T ss_pred             CCcee
Confidence            87654

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.87  E-value=2.6e-21  Score=182.46  Aligned_cols=145  Identities=33%  Similarity=0.500  Sum_probs=125.2

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      |...++||+|+||.||+|.. .+++.|++|.+.....   .....+.+|++++..++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999995 5688999999875432   2234688899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +. |+|.+++..  ....+++..+..++.|++.+|.|||+.+   |+|+||+|+||+++.++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            96 577776643  2356899999999999999999999987   999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.87  E-value=6.7e-22  Score=184.10  Aligned_cols=152  Identities=29%  Similarity=0.441  Sum_probs=125.2

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|...++||+|+||.||++.. .+++.+|+|.+..... .....+.+|+.++.++. |+||+++++++......+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            4566678999999999999995 5689999999875432 33456889999999996 9999999999999999999999


Q ss_pred             cCCCCChhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+.. +|.++...  ......+++.....++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 55443211  112356899999999999999999999752  399999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.87  E-value=1.2e-21  Score=183.28  Aligned_cols=150  Identities=25%  Similarity=0.454  Sum_probs=126.2

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCC-CCEEEEEEeccCCc-ccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv  318 (412)
                      ..++|+..+.||+|+||.||++...+ ++.||||.+.+... ....++..|+.++.+.. |+||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            44678889999999999999999754 88999999876432 23445667777676664 99999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |||++ ++|.+++..  ....+++..+..++.|++.||.|||+. +   |+||||+|+||++++++.+||+|||+++.+.
T Consensus        93 ~e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99985 467766643  234789999999999999999999974 5   9999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.87  E-value=1.1e-21  Score=184.90  Aligned_cols=144  Identities=20%  Similarity=0.225  Sum_probs=121.9

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCC
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      .+.+|.|+++.|+++.. +++.||||++...  .......+.+|+++++.++|+||+++++++.+.+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555555666555 6899999998764  33345678999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |.+++... ....+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+..+.
T Consensus        86 l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          86 CEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence            99998543 2345888999999999999999999987   9999999999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.87  E-value=1.4e-21  Score=186.55  Aligned_cols=146  Identities=28%  Similarity=0.495  Sum_probs=124.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  313 (412)
                      .++|...+.||+|+||.||+|.. .+++.||||++.+..  ......+.+|+.++.+++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            36788899999999999999994 578999999987542  222346789999999999999999999987543      


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 776665     245889999999999999999999987   999999999999999999999999999


Q ss_pred             cccc
Q 015138          394 RLFE  397 (412)
Q Consensus       394 ~~~~  397 (412)
                      +...
T Consensus       165 ~~~~  168 (342)
T cd07879         165 RHAD  168 (342)
T ss_pred             cCCC
Confidence            8653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.87  E-value=6.6e-22  Score=187.92  Aligned_cols=148  Identities=32%  Similarity=0.497  Sum_probs=129.7

Q ss_pred             CCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC-----eee
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ERI  316 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~  316 (412)
                      +|+..+.||+|+||.||++... +++.++||++....  ......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4777899999999999999964 58999999987654  334457899999999999999999999988775     789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||++ ++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 588888744   347999999999999999999999987   999999999999999999999999999987


Q ss_pred             cCC
Q 015138          397 EMD  399 (412)
Q Consensus       397 ~~~  399 (412)
                      ...
T Consensus       154 ~~~  156 (330)
T cd07834         154 DPD  156 (330)
T ss_pred             ccc
Confidence            554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=2.9e-22  Score=188.94  Aligned_cols=167  Identities=25%  Similarity=0.385  Sum_probs=141.7

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEecc--CCcccHHHHHHHHHHHccCC-CCccceeeEEEecCCee
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKER  315 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~  315 (412)
                      +.+....|++.++||.||.+.||++...+.+.+|+|++..  .+.+....|.+|+.+|.+|+ |.+||+|++|-..++.+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            4455567899999999999999999988888899988754  35556677999999999995 99999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      |||||| ...+|.++|.... .....| .+..+..|++.++.+.|+++   |||-||||.|+|+ -.|.+||+|||+|..
T Consensus       436 YmvmE~-Gd~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  436 YMVMEC-GDIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             EEEeec-ccccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            999995 4789999996532 223344 66789999999999999998   9999999999999 567899999999999


Q ss_pred             ccCCCcccccccccccC
Q 015138          396 FEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       396 ~~~~~~~~~~~~~~Gt~  412 (412)
                      +.++.+.......+||+
T Consensus       509 I~~DTTsI~kdsQvGT~  525 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTV  525 (677)
T ss_pred             cCccccceeeccccCcc
Confidence            99888876655678884

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.87  E-value=1.5e-21  Score=185.34  Aligned_cols=142  Identities=23%  Similarity=0.308  Sum_probs=122.5

Q ss_pred             cccccc--CCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQG--GFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G--~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ..||+|  +||+||++.. .+|+.||+|.+....  ......+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456776  8999999995 578999999987543  22345688999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++|.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++||+.+..
T Consensus        84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            9999988553 2345889999999999999999999887   99999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.86  E-value=1.1e-21  Score=187.47  Aligned_cols=146  Identities=26%  Similarity=0.482  Sum_probs=126.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecC----------
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER----------  312 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~----------  312 (412)
                      .+|...+.||+|+||.||+|.. .+++.|++|.+..........+.+|++++++++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6788899999999999999995 56889999998776655666788999999999999999999776543          


Q ss_pred             ----CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEE
Q 015138          313 ----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKI  387 (412)
Q Consensus       313 ----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki  387 (412)
                          ...++||||++ ++|.+++.    ...+++.....++.|++.||.|||+.+   |+||||||+||+++. +..+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 58888873    346889999999999999999999987   999999999999984 567899


Q ss_pred             eccCCccccc
Q 015138          388 SDFGMARLFE  397 (412)
Q Consensus       388 ~DfGla~~~~  397 (412)
                      +|||+++.+.
T Consensus       157 ~dfg~~~~~~  166 (342)
T cd07854         157 GDFGLARIVD  166 (342)
T ss_pred             CCcccceecC
Confidence            9999998654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.86  E-value=2.6e-22  Score=167.49  Aligned_cols=155  Identities=27%  Similarity=0.431  Sum_probs=126.7

Q ss_pred             hhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC-cccHHHHHHHHHHHcc-CCCCccceeeEEEecCCeeeE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIEFKNEVLLLAR-LQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~~l  317 (412)
                      +..++......||+|++|.|-+-+ ..+|..+|+|++...- .+...++.+|+.+..+ ...|.+|.|+|........++
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            444555667899999999987777 4679999999997653 3344567778876655 479999999999999999999


Q ss_pred             EEecCCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          318 VYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      .||.| ..||+.|-.+ ......+++..+-+|+..+.+||.|||++  +.++|||+||+|||++.+|++||+|||++..+
T Consensus       123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            99998 4588777432 12456688888889999999999999985  56999999999999999999999999999876


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      .+
T Consensus       200 ~d  201 (282)
T KOG0984|consen  200 VD  201 (282)
T ss_pred             hh
Confidence            53

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.86  E-value=1.4e-21  Score=181.18  Aligned_cols=149  Identities=30%  Similarity=0.506  Sum_probs=129.6

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      |+..+.||+|++|.||++.. .+++.+++|.+......  ....+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            45678899999999999995 46889999998765433  3456888999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||.+..+....
T Consensus        81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            75 88887744  2357899999999999999999999987   9999999999999999999999999998775543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=1.7e-21  Score=180.63  Aligned_cols=147  Identities=32%  Similarity=0.546  Sum_probs=128.9

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      |+..+.||+|+||.||+|.. .+++.+++|.+....  ......+..|+.++.+++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            45678899999999999995 458999999987653  223456788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      + ++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++....
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            8 5899998542  146999999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.86  E-value=1.4e-21  Score=183.82  Aligned_cols=150  Identities=31%  Similarity=0.532  Sum_probs=126.3

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCC------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  313 (412)
                      .++|+..++||+|+||.||++.. .+++.++||++......  ....+.+|++++++++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            47899999999999999999995 46889999988654322  2335678999999999999999999875443      


Q ss_pred             --eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          314 --ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       314 --~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                        ..++|+||+.+ +|...+..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999975 66666543  2346999999999999999999999987   9999999999999999999999999


Q ss_pred             CcccccC
Q 015138          392 MARLFEM  398 (412)
Q Consensus       392 la~~~~~  398 (412)
                      +++....
T Consensus       161 ~~~~~~~  167 (311)
T cd07866         161 LARPYDG  167 (311)
T ss_pred             cchhccC
Confidence            9987643

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.86  E-value=1.4e-21  Score=179.04  Aligned_cols=150  Identities=27%  Similarity=0.412  Sum_probs=123.7

Q ss_pred             CCCccccccccCCeeEEEEEeC-CCCEEEEEEeccC-----CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN-----SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +|.+.++||+|+||.||++... .+..+++|.++..     .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            3677899999999999999853 3444555554432     122334577899999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.+||+|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887532 23457999999999999999999999987   999999999999975 569999999998764


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       157 ~  157 (260)
T cd08222         157 G  157 (260)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.86  E-value=3.6e-21  Score=179.89  Aligned_cols=150  Identities=20%  Similarity=0.291  Sum_probs=111.2

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCC----CEEEEEEeccCCcccH-----------HHHHHHHHHHccCCCCccceee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNG----ETIAVKRLSKNSKQGE-----------IEFKNEVLLLARLQHRNLVRLL  306 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~  306 (412)
                      ..+.|++.++||+|+||.||+|...++    ..+++|..........           .....+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346788999999999999999996443    4556664332221111           1122334456678999999999


Q ss_pred             EEEecCC----eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC
Q 015138          307 GFCLERK----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE  382 (412)
Q Consensus       307 g~~~~~~----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~  382 (412)
                      +++....    ..++++|++. .++.+.+..   ....++..+..|+.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~  162 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN  162 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence            9776543    3467888764 356555522   223577888999999999999999987   9999999999999999


Q ss_pred             CCeEEeccCCcccccC
Q 015138          383 MNPKISDFGMARLFEM  398 (412)
Q Consensus       383 ~~~ki~DfGla~~~~~  398 (412)
                      +.+||+|||+|+.+..
T Consensus       163 ~~~~l~DFGla~~~~~  178 (294)
T PHA02882        163 NRGYIIDYGIASHFII  178 (294)
T ss_pred             CcEEEEEcCCceeecc
Confidence            9999999999998753

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=4.5e-21  Score=178.21  Aligned_cols=149  Identities=32%  Similarity=0.580  Sum_probs=123.8

Q ss_pred             CCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcc--cHHHHHHHHHHHccC---CCCccceeeEEEecCCe-----
Q 015138          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARL---QHRNLVRLLGFCLERKE-----  314 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~~~-----  314 (412)
                      |++.+.||+|+||.||++... +++.+|+|++......  ....+.+|+.++.++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999975 4899999998743222  233466777766555   69999999999988776     


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .+++|||+. ++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            899999997 4888887442 2235899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+...
T Consensus       156 ~~~~~  160 (287)
T cd07838         156 IYSFE  160 (287)
T ss_pred             eccCC
Confidence            76443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.3e-23  Score=180.24  Aligned_cols=151  Identities=32%  Similarity=0.642  Sum_probs=122.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEecc-CCccc-HHHHHHHHHHHccCCCCccceeeEEEecC--------
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSK-NSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLER--------  312 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~-~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~--------  312 (412)
                      +.|+...+||+|.||.||+++. ++|+.||+|++.- +...+ -..-.+|+.+|..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            3456678999999999999995 5577889886543 22222 23457899999999999999999887532        


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...+||+.+++. +|.-+|.+  ....++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347899999965 67777643  2356888999999999999999999887   99999999999999999999999999


Q ss_pred             cccccCCC
Q 015138          393 ARLFEMDQ  400 (412)
Q Consensus       393 a~~~~~~~  400 (412)
                      ||.+...+
T Consensus       171 ar~fs~~~  178 (376)
T KOG0669|consen  171 ARAFSTSK  178 (376)
T ss_pred             ccceeccc
Confidence            99886443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.86  E-value=3.1e-21  Score=175.51  Aligned_cols=141  Identities=31%  Similarity=0.394  Sum_probs=125.8

Q ss_pred             ccccCCeeEEEEEeC-CCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       252 lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      ||+|+||.||++... +++.+++|.+.+....   ....+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999964 5889999998765432   344688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      .+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            999854   346899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.85  E-value=2e-21  Score=185.65  Aligned_cols=149  Identities=30%  Similarity=0.480  Sum_probs=128.2

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCe----
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE----  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~----  314 (412)
                      ..++|+..+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.++++++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457889999999999999999996 467899999886532  2233457789999999999999999998766554    


Q ss_pred             --eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          315 --RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       315 --~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                        .++|+||+ +++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 679988874    356999999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      +.....
T Consensus       165 ~~~~~~  170 (343)
T cd07851         165 ARHTDD  170 (343)
T ss_pred             cccccc
Confidence            987643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-22  Score=175.87  Aligned_cols=154  Identities=27%  Similarity=0.460  Sum_probs=126.9

Q ss_pred             CCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC-----Ceee
Q 015138          245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KERI  316 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~~  316 (412)
                      +.+..+.||-|+||.||..+ -++|+.||.|++..--  -..-..+.+|+.+|.-++|.|++..++...-.     .++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            34556889999999999998 5789999999885432  22345688999999999999999988876533     3567


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      .++|.| ..+|.+++.+   ...++.....-+..||++||.|||+.+   |+||||||.|.|++++-..||+||||||.-
T Consensus       134 V~TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            889988 4588888844   667888888889999999999999987   999999999999999999999999999987


Q ss_pred             cCCCccccc
Q 015138          397 EMDQTHSDT  405 (412)
Q Consensus       397 ~~~~~~~~~  405 (412)
                      +.++....|
T Consensus       207 e~d~~~hMT  215 (449)
T KOG0664|consen  207 DQRDRLNMT  215 (449)
T ss_pred             chhhhhhhH
Confidence            766654333

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.3e-20  Score=165.24  Aligned_cols=139  Identities=21%  Similarity=0.312  Sum_probs=108.0

Q ss_pred             CccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-----CCCccceeeEEEecCC---eee-E
Q 015138          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLLGFCLERK---ERI-L  317 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~g~~~~~~---~~~-l  317 (412)
                      .....||+|+||.||. ...++.. +||++..........+.+|+.+++.+     +||||++++|++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4467899999999996 3334444 69988765555566799999999999     5799999999998874   333 7


Q ss_pred             EEec--CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHhHhCCCCCceecCCCCCCEEECCC----CCeEEecc
Q 015138          318 VYEF--VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL-LYLHEDSRLRIIHRDLKASNILLDSE----MNPKISDF  390 (412)
Q Consensus       318 v~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~Df  390 (412)
                      |+||  ..+|+|.+++.+    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++..    ..++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  558999999943    235554  35677888787 8999998   9999999999999743    37999995


Q ss_pred             CCcccc
Q 015138          391 GMARLF  396 (412)
Q Consensus       391 Gla~~~  396 (412)
                      +-++.+
T Consensus       154 ~G~~~~  159 (210)
T PRK10345        154 IGESTF  159 (210)
T ss_pred             CCCcce
Confidence            545444

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=5.3e-22  Score=181.11  Aligned_cols=165  Identities=31%  Similarity=0.325  Sum_probs=133.2

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCccc---HHHHHHHHHHHccC-CCCccceeeEEEecCCe
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQG---EIEFKNEVLLLARL-QHRNLVRLLGFCLERKE  314 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~  314 (412)
                      ++...+|..+.+||+|+||+|.++..+ +.+.+|||++++...-.   .+--+.|-++|+.. +-|.+++|..++..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            344567888999999999999999854 46789999998763222   11235677777766 46789999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      +|.||||+.+|+|-..+..   -+.+.+..+.-++.+||-||-|||+++   ||.||||..|||||.++++||+||||.+
T Consensus       425 LyFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999999877743   455777788899999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcccccccccccC
Q 015138          395 LFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       395 ~~~~~~~~~~~~~~~Gt~  412 (412)
                      .---+..  .|....||+
T Consensus       499 Eni~~~~--TTkTFCGTP  514 (683)
T KOG0696|consen  499 ENIFDGV--TTKTFCGTP  514 (683)
T ss_pred             ccccCCc--ceeeecCCC
Confidence            6433322  233478874

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.84  E-value=8.3e-21  Score=171.70  Aligned_cols=132  Identities=25%  Similarity=0.255  Sum_probs=114.8

Q ss_pred             cCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCChhhhccC
Q 015138          255 GGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD  333 (412)
Q Consensus       255 G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~  333 (412)
                      |.||.||++. ..+++.+|+|++.+..     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            7899999999 4678999999987653     233455555566799999999999999999999999999999998854


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       334 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                         ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.++++|||++..+.
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~  136 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE  136 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence               345899999999999999999999987   9999999999999999999999999887654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.84  E-value=1.2e-21  Score=172.01  Aligned_cols=147  Identities=28%  Similarity=0.359  Sum_probs=121.0

Q ss_pred             hhcCCCcc-ccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecC----Ce
Q 015138          242 ATDNFSDA-NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER----KE  314 (412)
Q Consensus       242 ~~~~~~~~-~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~----~~  314 (412)
                      .+++|++. ++||-|-.|+|-.+. ..+++++|+|.|....     ...+|+++.-.. .|||||++++++.+.    .-
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556543 579999999999988 4678999999885432     346778765555 699999999998753    45


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC---CCeEEeccC
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFG  391 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DfG  391 (412)
                      +++|||.|+||.|.+.+.+ .....+++.++-.|+.||..|+.|||+.+   |.||||||+|+|....   -.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            7899999999999998855 34556999999999999999999999987   9999999999999654   468999999


Q ss_pred             Cccccc
Q 015138          392 MARLFE  397 (412)
Q Consensus       392 la~~~~  397 (412)
                      +||.-.
T Consensus       210 FAK~t~  215 (400)
T KOG0604|consen  210 FAKETQ  215 (400)
T ss_pred             cccccC
Confidence            999755

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.84  E-value=8.4e-21  Score=191.19  Aligned_cols=150  Identities=25%  Similarity=0.308  Sum_probs=106.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC-C----CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEE------Ee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS-N----GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF------CL  310 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~-~----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~------~~  310 (412)
                      ..++|+..++||+|+||.||+|... +    +..||||++.......  ...+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999964 4    6899999886433211  11111  1122222233222211      24


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCC
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPINR-----------------EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK  373 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk  373 (412)
                      .....+|||||+++++|.+++......                 .......+..|+.|++.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566889999999999999988542110                 01122345578999999999999987   9999999


Q ss_pred             CCCEEECC-CCCeEEeccCCcccccC
Q 015138          374 ASNILLDS-EMNPKISDFGMARLFEM  398 (412)
Q Consensus       374 ~~Nill~~-~~~~ki~DfGla~~~~~  398 (412)
                      |+|||++. ++.+||+|||+|+.+..
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~  308 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRV  308 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccc
Confidence            99999986 57999999999986643

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.84  E-value=2.5e-22  Score=173.57  Aligned_cols=152  Identities=29%  Similarity=0.455  Sum_probs=124.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .++.+.+..||.|.||+|+|-.. +.|+.+|||++..... ...++|..|.+...+- +.||||+++|.+...+..|+.|
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            35566678999999999999884 6799999999986644 4556788888766555 6899999999999999999999


Q ss_pred             ecCCCCChhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |.| ..||+.+-..  ......+++..+-+|..-+..||.||-++-  .|||||+||+|||||..|.+||+|||++..+.
T Consensus       143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            998 4577665321  123456777777788888999999999764  69999999999999999999999999987664

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.83  E-value=5.5e-21  Score=149.48  Aligned_cols=103  Identities=39%  Similarity=0.666  Sum_probs=76.2

Q ss_pred             eEeec---cCCcccchHHHHHHHHHHHHHHHHHhhCCCCCCcceeceeeccCcceEEEEecCCCCCChhhHHHHHHHHHH
Q 015138           58 FFVYA---ESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTK  134 (412)
Q Consensus        58 ~~~~~---~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~~a~~~~~~~~~~~vy~l~qC~~dls~~~C~~Cl~~~~~  134 (412)
                      |..|+   .++.+.+...|..++.+||..|++.|+.. .+.+|+++.. ..+..+||||+||++|+++.+|..||.++..
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~-~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~   78 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASS-SSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVA   78 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGT-T-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhc-cccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence            34555   33332245559999999999999998764 2578999986 4466799999999999999999999999999


Q ss_pred             hhhhhccCCCCcEEECCcccccccCCcc
Q 015138          135 LMSKCCDRRQGGRVINPSCSFRYETNKF  162 (412)
Q Consensus       135 ~~~~~c~~~~gg~v~~~~C~~ry~~~~~  162 (412)
                      .++.+|+++.||++++++|++||+.++|
T Consensus        79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   79 NISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence            9999999999999999999999999876

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.83  E-value=4.5e-21  Score=166.48  Aligned_cols=155  Identities=25%  Similarity=0.434  Sum_probs=125.3

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc-HHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG-EIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .++.+.+..||.|..|.|++.+. .+|..+|||.+.+..... ...+...+.++.+- +.|.||+.+|+|..+...++.|
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            34455678899999999999995 568899999998765443 34566666665554 4899999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |.|. .-++.+|.+  ...++++..+-++...+.+||.||.+++  .|+|||+||+|||+|+.|++|++|||++..+-+.
T Consensus       171 elMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  171 ELMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            9884 345555543  2456888888889999999999999876  5999999999999999999999999999988665


Q ss_pred             Ccc
Q 015138          400 QTH  402 (412)
Q Consensus       400 ~~~  402 (412)
                      ..+
T Consensus       246 kAh  248 (391)
T KOG0983|consen  246 KAH  248 (391)
T ss_pred             ccc
Confidence            544

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.83  E-value=7.6e-20  Score=163.30  Aligned_cols=148  Identities=35%  Similarity=0.543  Sum_probs=131.8

Q ss_pred             CCccccccccCCeeEEEEEeCC-CCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCC
Q 015138          246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ....+.+|++.+.+++|+|++++++.+......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999754 889999999876544 56678999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCC-CCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          324 NASLDHFIFDPINREH-MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +++|.+++...   .. +++.....++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            99999998542   23 889999999999999999999987   999999999999999999999999999987554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=3e-20  Score=158.72  Aligned_cols=151  Identities=24%  Similarity=0.420  Sum_probs=127.0

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC-CccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ...|...++||.|+||.+|.|. +.+|+.||||.-+......  .+.-|..+...|+| ..|..+..+..+.....|||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--chhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4678889999999999999999 7889999999765544332  46678888888876 678888888888899999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~~~  397 (412)
                      .+ +.||++++.-  -.+.++..+.+.++-|++.-++|+|..+   +|||||||+|+|+.-+.   .+.++|||||+.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            77 8899888632  3456889999999999999999999998   99999999999997664   58899999999986


Q ss_pred             CCCc
Q 015138          398 MDQT  401 (412)
Q Consensus       398 ~~~~  401 (412)
                      +..+
T Consensus       166 d~~t  169 (341)
T KOG1163|consen  166 DIRT  169 (341)
T ss_pred             cccc
Confidence            5543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.82  E-value=1.8e-20  Score=184.56  Aligned_cols=158  Identities=31%  Similarity=0.431  Sum_probs=122.8

Q ss_pred             CCccccccccCCee-EEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCC
Q 015138          246 FSDANKLGQGGFGA-VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       246 ~~~~~~lg~G~fg~-V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      |...+.+|.|+-|+ ||+|.. +|+.||||++-.....   -..+|+..|..- +|||||++++.-.++...||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~---~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFD---FAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHH---HHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            45567899999875 799998 4789999998654332   347899988777 6999999999999999999999998 


Q ss_pred             CCChhhhccCCCCC-CCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC---C--CCeEEeccCCccccc
Q 015138          324 NASLDHFIFDPINR-EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---E--MNPKISDFGMARLFE  397 (412)
Q Consensus       324 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~--~~~ki~DfGla~~~~  397 (412)
                      ..+|++++...... ....-...+.+..|++.||+|||+.+   ||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            57999998552111 11111334678899999999999977   999999999999976   3  469999999999998


Q ss_pred             CCCccc-cccccccc
Q 015138          398 MDQTHS-DTNRVVGT  411 (412)
Q Consensus       398 ~~~~~~-~~~~~~Gt  411 (412)
                      .+++.- ......||
T Consensus       663 ~~~sS~~r~s~~sGt  677 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGT  677 (903)
T ss_pred             CCcchhhcccCCCCc
Confidence            777532 23345665

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=2.5e-21  Score=180.80  Aligned_cols=162  Identities=26%  Similarity=0.310  Sum_probs=138.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCC-EEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~-~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ...+++....||-|+||.|=+....... .+|+|.+++..   ......+..|-.+|...+.|.||+|+-.+.++...|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            3456666788999999999988865433 37888887653   3334457889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +||-|-||.|...|++   ++.++..+...++..+++|++|||.++   ||.|||||+|.|||.+|-+||.|||+|+.+.
T Consensus       498 LmEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  498 LMEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hHHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999999965   567888888899999999999999998   9999999999999999999999999999987


Q ss_pred             CCCcccccccccccC
Q 015138          398 MDQTHSDTNRVVGTL  412 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt~  412 (412)
                      .++.   |...+||+
T Consensus       572 ~g~K---TwTFcGTp  583 (732)
T KOG0614|consen  572 SGRK---TWTFCGTP  583 (732)
T ss_pred             cCCc---eeeecCCc
Confidence            6553   44578884

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.81  E-value=6.1e-19  Score=155.14  Aligned_cols=143  Identities=36%  Similarity=0.617  Sum_probs=126.6

Q ss_pred             ccccCCeeEEEEEeCC-CCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCChhh
Q 015138          252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH  329 (412)
Q Consensus       252 lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~  329 (412)
                      ||+|.+|.||++...+ ++.+++|.+...... ....+.+|+..+..++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999998766443 34578999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEEeccCCcccccCC
Q 015138          330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEMD  399 (412)
Q Consensus       330 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~~  399 (412)
                      ++...  ...+++..+..++.+++++|.|||+.+   ++|+||+|.||+++. ++.++|+|||.+......
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            98432  146899999999999999999999987   999999999999999 899999999999876543

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.5e-19  Score=159.04  Aligned_cols=136  Identities=21%  Similarity=0.307  Sum_probs=114.3

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEEEeccCCcc--------cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      +.||+|++|.||+|.. +|..+++|........        ....+.+|+.++..++|++|.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6778999976543221        123578899999999999998888887777888999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++..      ..+ .+..++.+++.+|.+||+.+   ++|+|++|+|||++ ++.++|+|||+++...
T Consensus        81 ~~G~~L~~~~~~------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINS------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHh------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            999999998843      122 77899999999999999987   99999999999999 7899999999998643

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=4.6e-20  Score=164.42  Aligned_cols=164  Identities=25%  Similarity=0.309  Sum_probs=134.4

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCe
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKE  314 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~  314 (412)
                      ....++|..+++||+|+|.+|.++++ ++.+.+|+|.+++.-   .....-.+.|-.++... +||.+|-|..++...+.
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            34457899999999999999999995 567889999887642   22233345565555554 79999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ++.|.||+++|+|--++   ..++.|+++.+..+..+|..||.|||+.+   ||.||||..|||||..+++|++|+|+.+
T Consensus       326 lffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             EEEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence            99999999999996655   45677999999999999999999999998   9999999999999999999999999998


Q ss_pred             cc-cCCCcccccccccccC
Q 015138          395 LF-EMDQTHSDTNRVVGTL  412 (412)
Q Consensus       395 ~~-~~~~~~~~~~~~~Gt~  412 (412)
                      .- .+..+   |....||+
T Consensus       400 e~l~~gd~---tstfcgtp  415 (593)
T KOG0695|consen  400 EGLGPGDT---TSTFCGTP  415 (593)
T ss_pred             cCCCCCcc---cccccCCC
Confidence            64 33332   33477874

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=3.5e-19  Score=179.44  Aligned_cols=141  Identities=17%  Similarity=0.313  Sum_probs=114.3

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEE-eccCCc-------ccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR-LSKNSK-------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~-l~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      ....|...++||+|+||.||+|.+.... +++|+ +.+...       .....+.+|++++..++|++++....++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3445566889999999999999975544 34443 322111       11245889999999999999998888888877


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++||||+++++|.+++.           ....++.+++++|.|||+.+   |+||||||+|||+ .++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999998873           35678999999999999987   9999999999999 6789999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       475 ~~~~~  479 (535)
T PRK09605        475 KYSDL  479 (535)
T ss_pred             ccCCc
Confidence            87543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=1.6e-19  Score=158.83  Aligned_cols=141  Identities=16%  Similarity=0.166  Sum_probs=115.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHH---------HHHHHHHHccCCCCccceeeEEEecC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE---------FKNEVLLLARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~g~~~~~  312 (412)
                      ..++|...+.+|.|+||.||+... ++..+|||.+.+........         +.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999655 57789999997654333222         57899999999999999998886533


Q ss_pred             --------CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          313 --------KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       313 --------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                              ...+|||||++|.+|.++..       ++.    ....+++.+|..||+.+   ++|||+||+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999988741       222    34568999999999998   99999999999999988 


Q ss_pred             eEEeccCCcccccC
Q 015138          385 PKISDFGMARLFEM  398 (412)
Q Consensus       385 ~ki~DfGla~~~~~  398 (412)
                      ++|+|||..+....
T Consensus       173 i~liDfg~~~~~~e  186 (232)
T PRK10359        173 LRIIDLSGKRCTAQ  186 (232)
T ss_pred             EEEEECCCcccccc
Confidence            99999999987643

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.7e-19  Score=160.72  Aligned_cols=147  Identities=18%  Similarity=0.232  Sum_probs=113.7

Q ss_pred             cCCCccccccccCCeeEEEEE--eCCCCEEEEEEeccCCcc------------------------cHHHHHHHHHHHccC
Q 015138          244 DNFSDANKLGQGGFGAVYKGM--LSNGETIAVKRLSKNSKQ------------------------GEIEFKNEVLLLARL  297 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~e~~~l~~l  297 (412)
                      ..|.+.+.||+|+||.||+|.  ..+|+.||||.+......                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347778999999999999998  578999999988653210                        012356899999999


Q ss_pred             CCCc--cceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCC
Q 015138          298 QHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS  375 (412)
Q Consensus       298 ~h~n--iv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~  375 (412)
                      .+.+  +.+++++    ...+|||||+++++|..++..   ...+.......++.|++.+|.+||+.+  +|+||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            7633  4445543    235899999999988766422   234556667889999999999999875  4999999999


Q ss_pred             CEEECCCCCeEEeccCCcccccCCC
Q 015138          376 NILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       376 Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ||+++ +++++|+|||+|.......
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccCCcc
Confidence            99999 8899999999998765443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=3.9e-19  Score=156.16  Aligned_cols=142  Identities=20%  Similarity=0.251  Sum_probs=111.2

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcc----------------------cHHHHHHHHHHHccCCC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ----------------------GEIEFKNEVLLLARLQH  299 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~e~~~l~~l~h  299 (412)
                      ....|...+.||+|+||.||++...+|+.||||++......                      ....+..|..++.++.|
T Consensus        13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   92 (198)
T cd05144          13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE   92 (198)
T ss_pred             cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence            33347778999999999999999888999999987543210                      01125678888888888


Q ss_pred             Cc--cceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCE
Q 015138          300 RN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (412)
Q Consensus       300 ~n--iv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni  377 (412)
                      ++  +++.++.    ...++||||+++++|..+...         .....++.+++.++.++|+.+   |+||||||+||
T Consensus        93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Ni  156 (198)
T cd05144          93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNI  156 (198)
T ss_pred             cCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccE
Confidence            74  4444442    455899999999999765420         234578899999999999987   99999999999


Q ss_pred             EECCCCCeEEeccCCcccccCC
Q 015138          378 LLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       378 ll~~~~~~ki~DfGla~~~~~~  399 (412)
                      ++++++.++|+|||++..+..+
T Consensus       157 ll~~~~~~~liDfg~~~~~~~~  178 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTDHP  178 (198)
T ss_pred             EEcCCCcEEEEECCccccCCCc
Confidence            9999999999999999876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-20  Score=181.71  Aligned_cols=151  Identities=28%  Similarity=0.438  Sum_probs=136.6

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ..++|+....+|.|.||.|||++ ...++..|||.++........-++.|+-+++..+|+||+.++|-+...+..++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            34778889999999999999999 57789999999988777666677889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+.+|+|++.-+-   ..++++.++..+..+.++||+|||+.+   -+|||||=.|||+.+.+.+|++|||.+..+..
T Consensus        93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence            9999999887643   567888899999999999999999988   89999999999999999999999999987653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=2.6e-19  Score=159.65  Aligned_cols=151  Identities=26%  Similarity=0.439  Sum_probs=126.3

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      -+|.++++||+|+||.++.|+ +-+++.||||.-...++.  -++..|-...+.|. -++|...+.+-.++-...||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            368889999999999999999 778999999976544432  35677877777774 68999999888888888999997


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-----CeEEeccCCcccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-----NPKISDFGMARLF  396 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-----~~ki~DfGla~~~  396 (412)
                      + |.||+++. + .-.+.++.++...|+.|++.-++|+|+++   +|.|||||+|+||...+     .+.|+|||||+.+
T Consensus       106 L-GPSLEDLF-D-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLF-D-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHH-H-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            7 78998875 2 23567999999999999999999999998   99999999999997544     4899999999999


Q ss_pred             cCCCcc
Q 015138          397 EMDQTH  402 (412)
Q Consensus       397 ~~~~~~  402 (412)
                      .+.++.
T Consensus       180 rDp~Tk  185 (449)
T KOG1165|consen  180 RDPKTK  185 (449)
T ss_pred             cCcccc
Confidence            766653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.80  E-value=4.9e-19  Score=159.62  Aligned_cols=138  Identities=31%  Similarity=0.492  Sum_probs=123.7

Q ss_pred             CCeeEEEEEeC-CCCEEEEEEeccCCccc-HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCChhhhccC
Q 015138          256 GFGAVYKGMLS-NGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD  333 (412)
Q Consensus       256 ~fg~V~~~~~~-~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~  333 (412)
                      +||.||++... +++.+++|.+....... ...+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999975 58999999997765544 67899999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       334 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      .   ..+++..+..++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            2   23899999999999999999999987   999999999999999999999999999987553

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.1e-18  Score=150.51  Aligned_cols=133  Identities=23%  Similarity=0.197  Sum_probs=107.0

Q ss_pred             ccccccccCCeeEEEEEeCCCCEEEEEEeccCCccc----HHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEecC
Q 015138          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG----EIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      ....|+.|+||+|+.+.- .+.+++.+.+.......    ...+.+|+++|.+|+ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999997665 67888888776654421    124789999999995 5889999886    4569999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCC-CCCCEEECCCCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDL-KASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdl-k~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      .+.+|...+.    .      ....++.|++.+|.++|+.+   |+|||| ||.|||++.++.++|+|||+|.....
T Consensus        81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            9999865431    1      11357789999999999998   999999 79999999999999999999986554

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=6.2e-19  Score=155.04  Aligned_cols=132  Identities=22%  Similarity=0.367  Sum_probs=107.9

Q ss_pred             cccccCCeeEEEEEeCCCCEEEEEEeccCCcc--------cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .||+|+||.||+|.+ ++..+++|........        ....+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 5788999986543211        1245778999999999887766666666677789999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++++|.+++...    .      ..++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||+++...
T Consensus        80 ~g~~l~~~~~~~----~------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEG----N------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhc----H------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            999999887331    0      078999999999999987   99999999999999 8899999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.78  E-value=2.5e-19  Score=162.83  Aligned_cols=162  Identities=23%  Similarity=0.374  Sum_probs=136.0

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEeCC------CCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEe
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCL  310 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~  310 (412)
                      ++.....+++....+.+|.||.||+|.|.+      .+.|-+|.++... ......+..|..++..+.|||+..+.|++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            445556678888899999999999997643      4457788776553 334456888999999999999999999987


Q ss_pred             cC-CeeeEEEecCCCCChhhhcc-----CCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          311 ER-KERILVYEFVPNASLDHFIF-----DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       311 ~~-~~~~lv~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      +. +..+.+|.++.-|+|+.||.     +....+.++..+...++.|++.||+|||..+   +||.||.++|++||+...
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence            64 56789999999999999997     5556667888999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccccCCCcc
Q 015138          385 PKISDFGMARLFEMDQTH  402 (412)
Q Consensus       385 ~ki~DfGla~~~~~~~~~  402 (412)
                      +||+|=.|+|-+-+.+.+
T Consensus       435 VkltDsaLSRDLFP~DYh  452 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYH  452 (563)
T ss_pred             EEeccchhccccCccccc
Confidence            999999999977555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.3e-19  Score=171.80  Aligned_cols=147  Identities=27%  Similarity=0.376  Sum_probs=122.9

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .++.|.....+|.|+|+.|-++. ..+++..+||++.+....    -.+|+.++... +||||+++.+.+.++.+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            35677778889999999999988 567888999999876332    24566555554 7999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE-CCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL-DSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill-~~~~~~ki~DfGla~~~~~  398 (412)
                      |.+.++-|.+.++.   ..... ..+..|+.+|+.++.|||+++   +|||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            99999988777643   22233 677789999999999999988   9999999999999 5889999999999998866


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      +
T Consensus       469 ~  469 (612)
T KOG0603|consen  469 S  469 (612)
T ss_pred             h
Confidence            5

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.3e-18  Score=151.15  Aligned_cols=147  Identities=22%  Similarity=0.420  Sum_probs=119.1

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEE-EecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGF-CLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~-~~~~~~~~lv~  319 (412)
                      .+.|.+.+.||+|.||.+.++..+ ....+++|.+.+. .....+|.+|...--.| .|.||+.-+.. +...+....++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            466888899999999999999964 4667888877543 33456788888765555 58999977765 45566778999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC-CC-CCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SE-MNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~-~~~ki~DfGla~~~~  397 (412)
                      ||++.|+|.+-+    ....+.+.-...++.|++.|+.|+|+++   +||||||.+||||- .| ..+|++|||+.+...
T Consensus       102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999997766    3456777888899999999999999998   99999999999993 33 479999999998654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.75  E-value=2.3e-18  Score=158.24  Aligned_cols=148  Identities=24%  Similarity=0.452  Sum_probs=127.9

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeC----CCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCC
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~  313 (412)
                      +....+.|...++||+|.|+.||+++..    ..+.||+|.+...+...  .+.+|++.|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~--ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS--RILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch--HHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445577888999999999999999943    46789999987665443  478999999998 5999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccCC
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGM  392 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGl  392 (412)
                      ...+|+||++.-...++..      .++...+..++..++.||.|+|.++   ||||||||+|+|.+.. +.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            9999999999999988873      3667888899999999999999998   9999999999999865 5788999999


Q ss_pred             ccccc
Q 015138          393 ARLFE  397 (412)
Q Consensus       393 a~~~~  397 (412)
                      |-..+
T Consensus       180 A~~~d  184 (418)
T KOG1167|consen  180 AQRYD  184 (418)
T ss_pred             HHHHH
Confidence            98543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=1e-17  Score=158.24  Aligned_cols=145  Identities=25%  Similarity=0.346  Sum_probs=120.2

Q ss_pred             CCCccccccccCCeeEEEEEeCCC--CEEEEEEeccCCcccHHHHHHHHHHHccCCC----CccceeeEEE-ecCCeeeE
Q 015138          245 NFSDANKLGQGGFGAVYKGMLSNG--ETIAVKRLSKNSKQGEIEFKNEVLLLARLQH----RNLVRLLGFC-LERKERIL  317 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~~~--~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~g~~-~~~~~~~l  317 (412)
                      +|.+.++||+|+||.||.+.....  +.+|+|............+..|..++..+.+    +++.+++... ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788999999999999999995443  4788887765433332267788888888873    5888898888 47778899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-----CCeEEeccCC
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-----MNPKISDFGM  392 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-----~~~ki~DfGl  392 (412)
                      ||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|.+||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99966 889999764433 577999999999999999999999998   9999999999999865     4699999999


Q ss_pred             cc
Q 015138          393 AR  394 (412)
Q Consensus       393 a~  394 (412)
                      |+
T Consensus       174 ar  175 (322)
T KOG1164|consen  174 AR  175 (322)
T ss_pred             Cc
Confidence            99

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=4e-17  Score=136.34  Aligned_cols=137  Identities=25%  Similarity=0.225  Sum_probs=116.1

Q ss_pred             ccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC--CccceeeEEEecCCeeeEEEecCCCC
Q 015138          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+..+..++|  .++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35789999999999999854 7899998865543  4578899999999976  58999999888888899999999988


Q ss_pred             ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      .+..+          +......++.+++++|.+||.....+++|+|++|+|||+++++.+++.|||+++...
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            77543          556677889999999999998654569999999999999998999999999998644

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=2.3e-17  Score=143.49  Aligned_cols=139  Identities=22%  Similarity=0.274  Sum_probs=99.3

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCccc--HHH----------------------HHHHHHHHccCCCCc--c
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG--EIE----------------------FKNEVLLLARLQHRN--L  302 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i  302 (412)
                      .+.||+|+||.||++...+++.||||.+.......  ...                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998789999999886542211  111                      134555555554432  4


Q ss_pred             ceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCceecCCCCCCEEECC
Q 015138          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDS  381 (412)
Q Consensus       303 v~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~  381 (412)
                      .+.+++    ...++||||++++.+.......   .... .....++.+++.++.++|. .+   |+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    2458999999996543221110   0011 5567899999999999998 66   99999999999999 


Q ss_pred             CCCeEEeccCCcccccCC
Q 015138          382 EMNPKISDFGMARLFEMD  399 (412)
Q Consensus       382 ~~~~ki~DfGla~~~~~~  399 (412)
                      ++.++|+|||.+.....+
T Consensus       150 ~~~~~liDfg~a~~~~~~  167 (187)
T cd05119         150 DGKVYIIDVPQAVEIDHP  167 (187)
T ss_pred             CCcEEEEECcccccccCc
Confidence            999999999999876553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.71  E-value=5.8e-18  Score=150.41  Aligned_cols=146  Identities=31%  Similarity=0.475  Sum_probs=117.6

Q ss_pred             cCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecC------Ce
Q 015138          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------KE  314 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~  314 (412)
                      .+|..++.+|.|.- .|-.+. .-.+++||+|++...  .........+|..++..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666677887776 444444 234789999987543  233455678999999999999999999998644      35


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||| ..+|...+.     ..++-.+...|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            68999999 567877763     45777888899999999999999988   9999999999999999999999999999


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .-..+
T Consensus       167 ~e~~~  171 (369)
T KOG0665|consen  167 TEDTD  171 (369)
T ss_pred             ccCcc
Confidence            76554

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.71  E-value=2.8e-17  Score=149.37  Aligned_cols=152  Identities=23%  Similarity=0.302  Sum_probs=123.3

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC--C----ccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--R----NLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~g~~~~~~~~  315 (412)
                      +++|.+...+|+|.||.|-++.. ..+..||||+++.-..- .+.-+-|+++|.++.+  |    -+|.+.+|+...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            67899999999999999999983 44788999988644332 2234678899998842  2    267888999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC--------------
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--------------  381 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--------------  381 (412)
                      +||+|.+ |-|+.++|.. .+..+++...+..|+.|++++++|||+..   ++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999977 6699999965 34567888999999999999999999987   999999999999832              


Q ss_pred             ------CCCeEEeccCCcccccCCC
Q 015138          382 ------EMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       382 ------~~~~ki~DfGla~~~~~~~  400 (412)
                            +..+||+|||-|.......
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h  266 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH  266 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc
Confidence                  2348999999998765444

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=5.8e-17  Score=151.32  Aligned_cols=135  Identities=27%  Similarity=0.373  Sum_probs=109.3

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-----C---CccceeeEEEec--
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-----H---RNLVRLLGFCLE--  311 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~g~~~~--  311 (412)
                      ..+|...++||-|.|++||++. ..+.+.||+|+.+....- .+..+.||++|..++     |   ..||+|++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            3678889999999999999999 456678999988654322 234578999999884     3   369999999974  


Q ss_pred             --CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC
Q 015138          312 --RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE  382 (412)
Q Consensus       312 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~  382 (412)
                        +.+++||+|++ |-+|..++... .-+.++.....+|+.||+.||.|||.+.  +|||-||||+||||..+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence              45889999999 55676766442 3456888999999999999999999976  69999999999999665

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=3.1e-16  Score=141.21  Aligned_cols=137  Identities=22%  Similarity=0.267  Sum_probs=106.4

Q ss_pred             ccccc-ccCCeeEEEEEeCCCCEEEEEEeccCC-------------cccHHHHHHHHHHHccCCCCcc--ceeeEEEecC
Q 015138          249 ANKLG-QGGFGAVYKGMLSNGETIAVKRLSKNS-------------KQGEIEFKNEVLLLARLQHRNL--VRLLGFCLER  312 (412)
Q Consensus       249 ~~~lg-~G~fg~V~~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~g~~~~~  312 (412)
                      ...|| .|+.|+||+.... +..++||++....             ......+.+|+.++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 7899999998875 6788998775321             1123457889999999998875  6777765433


Q ss_pred             C----eeeEEEecCCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          313 K----ERILVYEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       313 ~----~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                      .    ..++|+||+++ .+|.+++..    ..++..    .+.+++.+|.+||+.+   |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 699888733    334443    3568999999999998   999999999999999999999


Q ss_pred             eccCCccccc
Q 015138          388 SDFGMARLFE  397 (412)
Q Consensus       388 ~DfGla~~~~  397 (412)
                      +|||.++...
T Consensus       184 IDfg~~~~~~  193 (239)
T PRK01723        184 IDFDRGELRT  193 (239)
T ss_pred             EECCCcccCC
Confidence            9999998765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.65  E-value=2.3e-15  Score=141.47  Aligned_cols=150  Identities=34%  Similarity=0.511  Sum_probs=127.6

Q ss_pred             CCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCC-ccceeeEEEecCCeeeEEEec
Q 015138          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHR-NLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++...+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556788999999999999976  78899998766443   356789999999999988 799999999777778999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCcccccCCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQ  400 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~~~  400 (412)
                      +.+++|.+++........+.......++.|++.++.|+|+.+   ++|||+||+||+++... .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977643211136888899999999999999999988   99999999999999998 79999999998665443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.65  E-value=2.3e-16  Score=148.26  Aligned_cols=156  Identities=19%  Similarity=0.274  Sum_probs=131.7

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC------CCccceeeEEEecCC
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ------HRNLVRLLGFCLERK  313 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~g~~~~~~  313 (412)
                      ...+.|.+....|+|-|++|.+|.. .-|+.||||++..+...... =..|+++|++|+      ..|.++|+-.|...+
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt-Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT-GLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh-hhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            3456788888899999999999994 45789999999776543322 257899999995      358999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCC
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGM  392 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGl  392 (412)
                      +++||+|-+ .-+|.+.|........|.......++.|+..||..|-..+   |+|.||||.|||+++.. .+||||||-
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence            999999976 5689999877667777888899999999999999999887   99999999999999865 689999999


Q ss_pred             cccccCCCc
Q 015138          393 ARLFEMDQT  401 (412)
Q Consensus       393 a~~~~~~~~  401 (412)
                      |-...+++.
T Consensus       584 A~~~~enei  592 (752)
T KOG0670|consen  584 ASFASENEI  592 (752)
T ss_pred             ccccccccc
Confidence            988776654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=6.3e-16  Score=159.14  Aligned_cols=147  Identities=25%  Similarity=0.336  Sum_probs=116.9

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC---CCccceeeEEEecCCeeeE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~l  317 (412)
                      ...+.|.+.+.||+|+||.||+|...+|+.||+|.-+.....   +|.--.+++.+|+   -+.|+.+.......+.-+|
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            444567888999999999999999888999999987655433   2222223334443   3456666666777788899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-------CCCeEEecc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-------EMNPKISDF  390 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-------~~~~ki~Df  390 (412)
                      |+||.+.|+|.+++.   ..+.++|.....++.|++.-+++||..+   |||+||||+|+||..       ...++|+||
T Consensus       772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999995   5677999999999999999999999988   999999999999943       235899999


Q ss_pred             CCcccc
Q 015138          391 GMARLF  396 (412)
Q Consensus       391 Gla~~~  396 (412)
                      |-+.-+
T Consensus       846 G~siDm  851 (974)
T KOG1166|consen  846 GRSIDM  851 (974)
T ss_pred             ccceee
Confidence            988643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=4.6e-15  Score=144.95  Aligned_cols=143  Identities=22%  Similarity=0.298  Sum_probs=100.5

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCccc----------------------------------------HHHHH
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG----------------------------------------EIEFK  288 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~  288 (412)
                      .+.||.|++|.||+|++.+|+.||||...+.....                                        +.+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986542111                                        01244


Q ss_pred             HHHHHHccC----CCCccceeeEEE-ecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHhHhC
Q 015138          289 NEVLLLARL----QHRNLVRLLGFC-LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR-GLLYLHED  362 (412)
Q Consensus       289 ~e~~~l~~l----~h~niv~l~g~~-~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~  362 (412)
                      +|...+.++    +|.+-+.+-..+ ......+|||||++|++|.++....  ....+   +..++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCCC---HHHHHHHHHHHHHHHHHhC
Confidence            455544444    232222222222 2345679999999999998876321  11122   3456666665 46788887


Q ss_pred             CCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       363 ~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +   ++|+|+||.||+++.++.+++.|||+++.+++.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            7   999999999999999999999999999988643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=2.9e-13  Score=115.64  Aligned_cols=132  Identities=22%  Similarity=0.199  Sum_probs=98.1

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEecCCCCCh
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      .+.|+.|.++.||+.... ++.+++|....... ....+..|...+..+.+.++ .+++++.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            457889999999999875 77899998765432 22346788888888866554 4555543  2345899999999887


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCC--CCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS--RLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ....        .   ....++.+++++|..||..+  +..++|+|++|.||+++ ++.++++|||.+..-
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            5431        0   11245678999999999876  23469999999999998 678999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.44  E-value=1.1e-13  Score=137.01  Aligned_cols=143  Identities=16%  Similarity=0.224  Sum_probs=92.9

Q ss_pred             cCCCccccccccCCeeEEEEEeCC-CCEEEEEEeccCCccc----------------------------------H----
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQG----------------------------------E----  284 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~----------------------------------~----  284 (412)
                      .+|+. +.||.|++|.||+|++.+ |+.||||.+.+.....                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999877 9999999987542110                                  0    


Q ss_pred             --HHHHHHHHHHccCC----CCccceeeEEEe-cCCeeeEEEecCCCCChhhhccCCCCCCC-----CCHHHHHHHHHHH
Q 015138          285 --IEFKNEVLLLARLQ----HRNLVRLLGFCL-ERKERILVYEFVPNASLDHFIFDPINREH-----MTWEKRYKIIEGI  352 (412)
Q Consensus       285 --~~~~~e~~~l~~l~----h~niv~l~g~~~-~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~-----l~~~~~~~i~~~i  352 (412)
                        .+|.+|...+.+++    +.+.+.+-.++. .....+|||||++|+.|.++..-  ....     +.......++.|+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHHHHHHHHHHHHHHHH
Confidence              12334444443332    333333323332 24567899999999999775211  1111     2222222233333


Q ss_pred             HHHHHHhHhCCCCCceecCCCCCCEEECCCC----CeEEeccCCcccccCC
Q 015138          353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFGMARLFEMD  399 (412)
Q Consensus       353 ~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfGla~~~~~~  399 (412)
                             +..+   ++|+|+||.||+++.++    .+++.|||++..+++.
T Consensus       277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   3455   99999999999999988    9999999999988654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3.1e-13  Score=136.33  Aligned_cols=145  Identities=26%  Similarity=0.389  Sum_probs=112.1

Q ss_pred             ccccccccCCeeEEEEEe-CCCCEEEEEEec----c-CCccc-HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          248 DANKLGQGGFGAVYKGML-SNGETIAVKRLS----K-NSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~----~-~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ..+.+|.|.+|.|+.... ...+..+.|...    . ..... ...+..|..+-..+.|+|++..+....+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            467899999997776663 333444444332    1 11111 1125667778888999999888777777766666799


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+++ +|..++.+   ...++..++..++.|+..|+.|||+.+   |.|||+|++|+++..++.+||+|||.+..+.-+
T Consensus       402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9999 99998843   246888888999999999999999998   999999999999999999999999999887543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.38  E-value=3.3e-13  Score=142.71  Aligned_cols=95  Identities=18%  Similarity=0.270  Sum_probs=75.4

Q ss_pred             cCCC-CccceeeEEE-------ecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCc
Q 015138          296 RLQH-RNLVRLLGFC-------LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI  367 (412)
Q Consensus       296 ~l~h-~niv~l~g~~-------~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i  367 (412)
                      .++| +||.++++++       ......++++||+ +++|.++|..  ....+++..++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4556 6888888887       2334567888987 6699999954  2456999999999999999999999988   9


Q ss_pred             eecCCCCCCEEECC-------------------CCCeEEeccCCcccc
Q 015138          368 IHRDLKASNILLDS-------------------EMNPKISDFGMARLF  396 (412)
Q Consensus       368 vHrdlk~~Nill~~-------------------~~~~ki~DfGla~~~  396 (412)
                      +||||||+||||+.                   ++.+||+|||+++..
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~  149 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE  149 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence            99999999999954                   455677777777653

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=1.5e-11  Score=109.76  Aligned_cols=144  Identities=20%  Similarity=0.292  Sum_probs=112.1

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCC--CccceeeEEEecCC---eeeEEEecC
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQH--RNLVRLLGFCLERK---ERILVYEFV  322 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~---~~~lv~Ey~  322 (412)
                      .+.|+.|..+.||+....+|+.+++|....... .....+..|..++..+.+  .++.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            356899999999999987778999998765432 134467899999999876  44677888776543   568999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCC---------------------------------------
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS---------------------------------------  363 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------  363 (412)
                      ++.+|.+.+.    ...++...+..++.++++.|.+||+..                                       
T Consensus        83 ~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9998877652    135777788888899999999998521                                       


Q ss_pred             --------------CCCceecCCCCCCEEECC--CCCeEEeccCCcccc
Q 015138          364 --------------RLRIIHRDLKASNILLDS--EMNPKISDFGMARLF  396 (412)
Q Consensus       364 --------------~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~  396 (412)
                                    +..++|+|+++.|||++.  ++.+.|+||+.+..-
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                          245799999999999998  667899999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.30  E-value=6.1e-13  Score=116.17  Aligned_cols=137  Identities=22%  Similarity=0.411  Sum_probs=113.1

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCC
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      .-+|.+...|..|+|+|. |..+++|++......  -..+|.+|.-.|+-+.||||+.++|.|.....+.++..||+.||
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            447888889999999996 556667777554322  23478999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEe
Q 015138          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                      |...|+.. ..-..+-.+..+++.++++||+|||+..++ |----|.++.+++|++.+++|+
T Consensus       274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee
Confidence            99999763 234467788999999999999999998632 4445689999999999998885

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.30  E-value=4e-13  Score=130.12  Aligned_cols=144  Identities=26%  Similarity=0.269  Sum_probs=117.1

Q ss_pred             cccccCCeeEEEEE----eCCCCEEEEEEeccCCccc--HHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEecCC
Q 015138          251 KLGQGGFGAVYKGM----LSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       251 ~lg~G~fg~V~~~~----~~~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      .+|+|.||.|++..    .+.|..+|.|.+.+.....  ......|..++..++ ||.++++...+......+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998755    2346678888776643221  113456777888887 9999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      +|.|...+.   ....++.........+++.++.++|+.+   |+|||+|++||+++.+|++|+.|||+++.+-+.+
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            999987773   3455666677777889999999999988   9999999999999999999999999999875444

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=3.1e-11  Score=100.70  Aligned_cols=134  Identities=22%  Similarity=0.353  Sum_probs=102.7

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEE-EeccCCccc-------HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVK-RLSKNSKQG-------EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK-~l~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..+.+|+-+.++.+.+. |.++.+| ++++.....       ...-.+|..++.+++--.|....-+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774 3445555 344432221       12357899999998766666666667788888999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++-.|.+++...          ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||++.-..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~  143 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE  143 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccccc
Confidence            9999999888432          2567778888889999998   99999999999997665 99999999986543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.29  E-value=6.6e-11  Score=102.16  Aligned_cols=136  Identities=15%  Similarity=0.136  Sum_probs=98.2

Q ss_pred             ccccccCCeeEEEEEeCC-------CCEEEEEEeccCC------------c---------cc-HHHH----HHHHHHHcc
Q 015138          250 NKLGQGGFGAVYKGMLSN-------GETIAVKRLSKNS------------K---------QG-EIEF----KNEVLLLAR  296 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~-------~~~vavK~l~~~~------------~---------~~-~~~~----~~e~~~l~~  296 (412)
                      ..||.|.-+.||.|.-.+       +..+|||......            .         .. ...+    ..|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998543       4789999754311            0         01 1122    378888888


Q ss_pred             CCC--CccceeeEEEecCCeeeEEEecCCCCChhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHh-HhCCCCCceecCC
Q 015138          297 LQH--RNLVRLLGFCLERKERILVYEFVPNASLDH-FIFDPINREHMTWEKRYKIIEGIARGLLYL-HEDSRLRIIHRDL  372 (412)
Q Consensus       297 l~h--~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrdl  372 (412)
                      +..  -++.+++++    ...+|||||+.+..+.. .+.    ...++......+..+++.+|..| |..+   |+|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            854  466677764    56789999998754422 221    22344556677889999999999 7776   999999


Q ss_pred             CCCCEEECCCCCeEEeccCCccccc
Q 015138          373 KASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       373 k~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++.|||++ ++.+.|+|||-|...+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999996 5689999999987664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.19  E-value=1.8e-10  Score=95.76  Aligned_cols=145  Identities=28%  Similarity=0.385  Sum_probs=106.2

Q ss_pred             ccccccccCCeeEEEEEeCCCCEEEEE-EeccCCcc-------cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          248 DANKLGQGGFGAVYKGMLSNGETIAVK-RLSKNSKQ-------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~~~~~~vavK-~l~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ....|-||+-+.|+++.+. |+...|| +..+....       ......+|++++.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4567889999999999985 6776666 44443222       2335678999999887656655555566666778999


Q ss_pred             ecCCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEEeccCCccc
Q 015138          320 EFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARL  395 (412)
Q Consensus       320 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~  395 (412)
                      ||+++ .++.+++....... ........++.+|-+.+.-||.++   |+|+||..+||+|..++   .+.++||||+-.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 57888875432222 222333678888999999999998   99999999999997765   358999999875


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      -.
T Consensus       166 s~  167 (229)
T KOG3087|consen  166 SR  167 (229)
T ss_pred             cc
Confidence            43

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.16  E-value=4.4e-11  Score=115.79  Aligned_cols=100  Identities=32%  Similarity=0.535  Sum_probs=91.0

Q ss_pred             HccCCCCccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCC
Q 015138          294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK  373 (412)
Q Consensus       294 l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk  373 (412)
                      |+.+.|.|+.+|+|.+.++...+.|++|+..|+|.+.+..  ....++|.....++.++++||.|||...  -..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4568999999999999999999999999999999999965  4567999999999999999999999754  23999999


Q ss_pred             CCCEEECCCCCeEEeccCCccccc
Q 015138          374 ASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       374 ~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++|+++|....+||+|||+..+..
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             cccceeeeeEEEEechhhhccccc
Confidence            999999999999999999998874

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.09  E-value=4.7e-10  Score=102.14  Aligned_cols=148  Identities=20%  Similarity=0.296  Sum_probs=95.3

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCC----------CccceeeEEEe-
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQH----------RNLVRLLGFCL-  310 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~g~~~-  310 (412)
                      +...+.||.|+++.||.++. .+++++|+|......   ....+++.+|......+.+          -.++.-++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            44577899999999999995 568999999764332   2345567777766665443          11111111111 


Q ss_pred             --------cC---C-----eeeEEEecCCCCChhhhcc---CC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceec
Q 015138          311 --------ER---K-----ERILVYEFVPNASLDHFIF---DP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR  370 (412)
Q Consensus       311 --------~~---~-----~~~lv~Ey~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHr  370 (412)
                              ..   .     ..+++|+-+ .++|.+++.   .. .....+....++.+..|+.+.+++||..+   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                    11   1     235677766 678877752   11 11223445566778899999999999998   9999


Q ss_pred             CCCCCCEEECCCCCeEEeccCCccccc
Q 015138          371 DLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       371 dlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+|+|++++.+|.++|+||+-.....
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g  196 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAG  196 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecC
Confidence            999999999999999999998776543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=9.1e-10  Score=94.72  Aligned_cols=126  Identities=25%  Similarity=0.361  Sum_probs=82.8

Q ss_pred             eEEEEEeCCCCEEEEEEeccCC--------------c-------cc-----HHHHHHHHHHHccCCCC--ccceeeEEEe
Q 015138          259 AVYKGMLSNGETIAVKRLSKNS--------------K-------QG-----EIEFKNEVLLLARLQHR--NLVRLLGFCL  310 (412)
Q Consensus       259 ~V~~~~~~~~~~vavK~l~~~~--------------~-------~~-----~~~~~~e~~~l~~l~h~--niv~l~g~~~  310 (412)
                      .||.|.-.+|+.+|||......              .       ..     ......|.+.|.++...  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998889999999765421              0       00     12357799999999766  566776552 


Q ss_pred             cCCeeeEEEecCC--CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHh-HhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          311 ERKERILVYEFVP--NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL-HEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       311 ~~~~~~lv~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                         ...|||||++  +..+..+..     ..++......++.+++..+..+ |..+   |+|+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               4579999998  655554431     1122334456777777766664 6666   9999999999999888 9999


Q ss_pred             eccCCccccc
Q 015138          388 SDFGMARLFE  397 (412)
Q Consensus       388 ~DfGla~~~~  397 (412)
                      +|||.|....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.07  E-value=2.4e-11  Score=124.27  Aligned_cols=143  Identities=21%  Similarity=0.221  Sum_probs=111.8

Q ss_pred             CCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC-cccHHHHHHHHHH--HccCCCCccceeeEEEecCCeeeEEEec
Q 015138          245 NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS-KQGEIEFKNEVLL--LARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++...+.||.+.|=+|.+++.+.|. |+||.+.+.. .-....|.++++-  ...++|||.+.+.-+-..+..-|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4666789999999999999988777 8899886654 3344444443332  4556899998887776666677888888


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ..+ +|.+.|.   -+..+..-+..=|+.|++.||.-+|..+   |.|||||.+||||++-.-+.|+||.--|-
T Consensus       103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence            854 7777662   2445666777779999999999999988   99999999999999999999999986553

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=2.4e-10  Score=105.21  Aligned_cols=89  Identities=27%  Similarity=0.497  Sum_probs=69.7

Q ss_pred             CCCccceeeEEEecC---------------------------CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHH
Q 015138          298 QHRNLVRLLGFCLER---------------------------KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE  350 (412)
Q Consensus       298 ~h~niv~l~g~~~~~---------------------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  350 (412)
                      +|||||++.+.|.+.                           ..+||||.-. ..+|..|+.    ....+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh----cCCCchHHHHHHHH
Confidence            599999998876532                           2357888766 358888884    34566677788899


Q ss_pred             HHHHHHHHhHhCCCCCceecCCCCCCEEEC--CCC--CeEEeccCCcc
Q 015138          351 GIARGLLYLHEDSRLRIIHRDLKASNILLD--SEM--NPKISDFGMAR  394 (412)
Q Consensus       351 ~i~~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~--~~ki~DfGla~  394 (412)
                      |+++|+.|||.++   |.|||+|+.||||.  +|.  ...|+|||.+-
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence            9999999999998   99999999999984  333  46899999764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=3.5e-09  Score=96.57  Aligned_cols=140  Identities=16%  Similarity=0.143  Sum_probs=99.3

Q ss_pred             cccccCCeeEEEEEeCCCCEEEEEEeccCCc-----------ccHHHHHHHHHHHccCCCCcc--ceeeEEEec-----C
Q 015138          251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-----------QGEIEFKNEVLLLARLQHRNL--VRLLGFCLE-----R  312 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~e~~~l~~l~h~ni--v~l~g~~~~-----~  312 (412)
                      .+-+.....|.+..+ +|+.+.||+......           .....+.+|...+.++...+|  +.++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333333344667666 577899997643221           111246788888888854443  455666543     2


Q ss_pred             CeeeEEEecCCCC-ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-------CCC
Q 015138          313 KERILVYEFVPNA-SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-------EMN  384 (412)
Q Consensus       313 ~~~~lv~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-------~~~  384 (412)
                      ..-+||+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..+   |+|+|++++|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3468999999986 8988874211 234556677789999999999999998   999999999999985       467


Q ss_pred             eEEeccCCccc
Q 015138          385 PKISDFGMARL  395 (412)
Q Consensus       385 ~ki~DfGla~~  395 (412)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.95  E-value=4.9e-09  Score=100.02  Aligned_cols=140  Identities=22%  Similarity=0.333  Sum_probs=113.3

Q ss_pred             eeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEe----cCCeeeEEEecCCC-CChhhhc
Q 015138          258 GAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL----ERKERILVYEFVPN-ASLDHFI  331 (412)
Q Consensus       258 g~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~----~~~~~~lv~Ey~~~-gsL~~~l  331 (412)
                      .+.|++. ..||..++.|++.....+.......-++.++++.|+|||+|..++.    .+..+.|||+|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            5789998 5689999999995544333323345577899999999999998876    34578999999986 7787765


Q ss_pred             cCC------------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          332 FDP------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       332 ~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +..            ......++..++.++.|+..||.++|+.|   +..+-|.+++||++.+.+++|+..|+...+.++
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            432            22334778899999999999999999998   888999999999999999999999999988766


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       447 ~  447 (655)
T KOG3741|consen  447 P  447 (655)
T ss_pred             C
Confidence            6

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.92  E-value=2.8e-10  Score=115.07  Aligned_cols=164  Identities=23%  Similarity=0.359  Sum_probs=122.8

Q ss_pred             hcCCCccccccccCCeeEEEEEe--CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML--SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~l  317 (412)
                      ...|...+.||+|+|+.|-....  .....+|+|.+....  .........|..+-..+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            34566778899999999988775  234456777665443  222223445666666776 9999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhH-hCCCCCceecCCCCCCEEECCCC-CeEEeccCCccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-EDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARL  395 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~  395 (412)
                      ++||..++++.+-+... .....+....-.+..|+..++.|+| ..+   +.|||+||+|.+++..+ ..|++|||+|..
T Consensus        99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999997776321 1114555566778999999999999 776   99999999999999999 999999999998


Q ss_pred             ccC-CCcccccccccc
Q 015138          396 FEM-DQTHSDTNRVVG  410 (412)
Q Consensus       396 ~~~-~~~~~~~~~~~G  410 (412)
                      +.. +..........|
T Consensus       175 ~~~~~g~~~~~~~~~g  190 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCG  190 (601)
T ss_pred             ccccCCcceeeecccC
Confidence            866 443333333444

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=98.90  E-value=1e-09  Score=85.68  Aligned_cols=43  Identities=42%  Similarity=0.862  Sum_probs=38.8

Q ss_pred             CChhhhHHHHHHHHHHHhhcCCCCceeEEEecCCCCcceEEEecCCCC
Q 015138            1 MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDI   48 (412)
Q Consensus         1 ~~~~~C~~C~~~a~~~~~~~C~~~~~a~~~~d~~~~~~C~lrys~~~f   48 (412)
                      +++++|..||+.|...+.+.|+..+++++||+     .|+|||++.+|
T Consensus        64 ls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~-----~C~lRY~~~~F  106 (106)
T PF01657_consen   64 LSPSDCRACLADAVANISSCCPGSRGGRVWYD-----SCFLRYENYPF  106 (106)
T ss_dssp             S-HHHHHHHHHHHHCCHHHHTTSBSSEEEEES-----SEEEEEESS--
T ss_pred             CChhhhHHHHHHHHHHHHHhCCCCceEEEECC-----CEEEEEECCCC
Confidence            57899999999999999999999999999999     89999999988

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.84  E-value=1.1e-08  Score=100.57  Aligned_cols=123  Identities=18%  Similarity=0.218  Sum_probs=99.1

Q ss_pred             eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHH
Q 015138          265 LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK  344 (412)
Q Consensus       265 ~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~  344 (412)
                      ..++.+|.|...+...........+.++.|+.++||||++++.........|||+|-+.  -|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            45788899888876665333446778889999999999999999999999999999773  35555522      22344


Q ss_pred             HHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       345 ~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ..-.+.||+.||.|||+.+  .++|++|.-..|++++.|..||++|-++...+
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            4556889999999999776  59999999999999999999999999886543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.79  E-value=2e-08  Score=99.20  Aligned_cols=143  Identities=17%  Similarity=0.267  Sum_probs=93.5

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEEEeccCCcccH----------------------------------------HHHHH
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGE----------------------------------------IEFKN  289 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~  289 (412)
                      +-|+.++-|.||+|++.+|+.||||...++-.+..                                        .++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67899999999999999999999998766422110                                        01233


Q ss_pred             HHHHHccCC-----CCccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCC
Q 015138          290 EVLLLARLQ-----HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR  364 (412)
Q Consensus       290 e~~~l~~l~-----h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~  364 (412)
                      |...+.+++     .+++.----+........|+|||++|..+.+...-  .....+.........++.  +..+-..+ 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q~~~dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQLLRDG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence            444343332     23332222233345677899999999999888422  123344333332222222  12222234 


Q ss_pred             CCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       365 ~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                        ++|.|.+|.||+++.++++-+.|||+...+++.
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              999999999999999999999999999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.76  E-value=7.4e-08  Score=85.54  Aligned_cols=134  Identities=19%  Similarity=0.256  Sum_probs=91.8

Q ss_pred             CccccccccCCeeEEEEEeCCCCEEEEEEeccCCc-----------------c-----cHHHHHHHHHHHccCCCC--cc
Q 015138          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-----------------Q-----GEIEFKNEVLLLARLQHR--NL  302 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~-----------------~-----~~~~~~~e~~~l~~l~h~--ni  302 (412)
                      .++.+||.|.-+.||.|..+.|.++|||.-.....                 .     ......+|.+.|.+|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45689999999999999999999999995322110                 0     112356788889888654  66


Q ss_pred             ceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC
Q 015138          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE  382 (412)
Q Consensus       303 v~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~  382 (412)
                      .+.+++    +...+||||+++-.|...-.     ..-....++   ..|++-+.-+-..|   |||+|+.+-||+++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il---~~il~~~~~~~~~G---iVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEIL---DKILEEVRKAYRRG---IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecccC-----cccCHHHHH---HHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence            666654    45679999999877643320     122223333   33333333333444   9999999999999999


Q ss_pred             CCeEEeccCCccc
Q 015138          383 MNPKISDFGMARL  395 (412)
Q Consensus       383 ~~~ki~DfGla~~  395 (412)
                      +.+.++||==+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            9999999965543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=9e-08  Score=84.34  Aligned_cols=107  Identities=26%  Similarity=0.334  Sum_probs=84.4

Q ss_pred             HHHHHHHHHHccCCCC--ccceeeEEEecCC----eeeEEEecCCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 015138          285 IEFKNEVLLLARLQHR--NLVRLLGFCLERK----ERILVYEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLL  357 (412)
Q Consensus       285 ~~~~~e~~~l~~l~h~--niv~l~g~~~~~~----~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~  357 (412)
                      ....+|...+..+...  ...+.+++.....    ..+||+|++++ -+|.+++...   ..++......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence            3567888887777543  3456677766532    35899999988 4899988431   12556677889999999999


Q ss_pred             HhHhCCCCCceecCCCCCCEEECCCC---CeEEeccCCccccc
Q 015138          358 YLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARLFE  397 (412)
Q Consensus       358 yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~~~  397 (412)
                      -||+.+   |+|+|++++|||++.+.   .+.++||+-++...
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999998   99999999999999887   89999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=5.9e-07  Score=77.94  Aligned_cols=141  Identities=17%  Similarity=0.173  Sum_probs=103.1

Q ss_pred             cccccCCeeEEEEEeCCCCEEEEEEeccC---C---cccHHHHHHHHHHHccCCCCc--cceeeEEEecC----CeeeEE
Q 015138          251 KLGQGGFGAVYKGMLSNGETIAVKRLSKN---S---KQGEIEFKNEVLLLARLQHRN--LVRLLGFCLER----KERILV  318 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~~~~vavK~l~~~---~---~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~~----~~~~lv  318 (412)
                      --|.||-+-|++-.+. |+.+-+|+-...   +   ..+...|.+|+..|.++...+  +.+.+......    -.-+||
T Consensus        25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            3466888889987774 457888876411   1   335678999999999986433  44554222221    235799


Q ss_pred             EecCCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC--eEEeccCCccc
Q 015138          319 YEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--PKISDFGMARL  395 (412)
Q Consensus       319 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DfGla~~  395 (412)
                      +|-+++ -+|.+++.+. ...+.+...+..++.++++.+.-||+.+   +.|+|+.+.|||++.++.  ++++||--++.
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 7888887432 2234577778899999999999999998   999999999999986666  99999987765


Q ss_pred             c
Q 015138          396 F  396 (412)
Q Consensus       396 ~  396 (412)
                      .
T Consensus       180 ~  180 (216)
T PRK09902        180 R  180 (216)
T ss_pred             h
Confidence            3

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.64  E-value=1.7e-08  Score=98.23  Aligned_cols=149  Identities=23%  Similarity=0.273  Sum_probs=117.7

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe--CCCCEEEEEEeccCCcccHHH--HHHHHHHHccC-CCCccceeeEEEecCCee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML--SNGETIAVKRLSKNSKQGEIE--FKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~l~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  315 (412)
                      ....+|..+..||.|.|+.|++...  .++..+++|.+.+.......+  -..|+.+...+ .|.++++....+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788899999999999998774  457788999876654332222  24555555555 588888887777777888


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccCCcc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMAR  394 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~  394 (412)
                      ++-.||++++++...+   .-...++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||.+.
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            8999999999987765   22445777788899999999999999876   9999999999999886 788999999986


Q ss_pred             c
Q 015138          395 L  395 (412)
Q Consensus       395 ~  395 (412)
                      .
T Consensus       416 ~  416 (524)
T KOG0601|consen  416 R  416 (524)
T ss_pred             c
Confidence            3

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.63  E-value=3.1e-08  Score=96.40  Aligned_cols=151  Identities=22%  Similarity=0.280  Sum_probs=116.9

Q ss_pred             cCCCccccccc--cCCeeEEEEEe---CCCCEEEEEEecc--CCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCee
Q 015138          244 DNFSDANKLGQ--GGFGAVYKGML---SNGETIAVKRLSK--NSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       244 ~~~~~~~~lg~--G~fg~V~~~~~---~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  315 (412)
                      ..|.....+|.  |.+|.||.+..   .++..+|+|+-+.  ........=.+|+.-.+++ .|+|.++....+..++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34556778999  99999999886   4678899987332  2222222235667767777 499999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEecc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR----GLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDF  390 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~Df  390 (412)
                      ++-+|++. .+|..+...  ....++......+..+...    ||.++|...   |+|-|+||.||++..+ ...++.||
T Consensus       194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999875 788777644  2333555566666666666    999999987   9999999999999999 89999999


Q ss_pred             CCcccccCCC
Q 015138          391 GMARLFEMDQ  400 (412)
Q Consensus       391 Gla~~~~~~~  400 (412)
                      |+...+.+..
T Consensus       268 ~~v~~i~~~~  277 (524)
T KOG0601|consen  268 GLVSKISDGN  277 (524)
T ss_pred             ceeEEccCCc
Confidence            9999887665

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.59  E-value=9e-07  Score=79.04  Aligned_cols=139  Identities=14%  Similarity=0.204  Sum_probs=85.5

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc--cceeeEEEecCCeeeEEEecCCCCC-
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGFCLERKERILVYEFVPNAS-  326 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~Ey~~~gs-  326 (412)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+++..+..-+  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999983   24567778765533  2335688999998886443  4677888877777889999999863 


Q ss_pred             hhhhc---------------------cCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHhHh-CCCCCceecCC
Q 015138          327 LDHFI---------------------FDPINREHMTWEKRYK-IIE----------GIAR-GLLYLHE-DSRLRIIHRDL  372 (412)
Q Consensus       327 L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~i~~-~l~yLH~-~~~~~ivHrdl  372 (412)
                      +...+                     +.. ............ +-.          .+.. ...+|.. ...+.++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            22111                     110 000111111000 000          0011 1122221 12345789999


Q ss_pred             CCCCEEECCCCCeEEeccCCccc
Q 015138          373 KASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       373 k~~Nill~~~~~~ki~DfGla~~  395 (412)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.57  E-value=1.1e-07  Score=81.37  Aligned_cols=61  Identities=23%  Similarity=0.183  Sum_probs=53.4

Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+|.+++..  ....++|..+..|+.|++.||.|||+++         ||+|||++.++.+|+  ||+++....
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence            688888854  2456999999999999999999999875         999999999999999  999987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.54  E-value=1.4e-06  Score=75.94  Aligned_cols=138  Identities=14%  Similarity=0.192  Sum_probs=90.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHH---------HHHHHHHccCCC---CccceeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEF---------KNEVLLLARLQH---RNLVRLLGFC  309 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~---------~~e~~~l~~l~h---~niv~l~g~~  309 (412)
                      ...+|...+++-......|.+-.. +|+.+.+|.........+..|         .+++..+.+++.   ..++.++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            345677667777666666776666 468888887765443332222         233343444432   2233333322


Q ss_pred             e-----cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          310 L-----ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       310 ~-----~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      .     .....+|+|||++|..|.++.       .++.    .+...+.+.|.-||..|   ++|+|.+|+|++++.+ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence            2     234557999999999886654       1222    34566778899999998   9999999999999855 4


Q ss_pred             eEEeccCCccc
Q 015138          385 PKISDFGMARL  395 (412)
Q Consensus       385 ~ki~DfGla~~  395 (412)
                      +++.||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.51  E-value=2.8e-08  Score=95.11  Aligned_cols=81  Identities=26%  Similarity=0.411  Sum_probs=72.9

Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      .+++.|+++...+|.+||.++......++...+.++.|++.|+.|   ++   .+|||+||.||+...+..+||.||||.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999876667778899999999999999999   55   899999999999999999999999999


Q ss_pred             ccccCCC
Q 015138          394 RLFEMDQ  400 (412)
Q Consensus       394 ~~~~~~~  400 (412)
                      .......
T Consensus       404 ts~~~~~  410 (516)
T KOG1033|consen  404 TSQDKDE  410 (516)
T ss_pred             eecccCC
Confidence            8776655

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=6.8e-08  Score=87.29  Aligned_cols=95  Identities=26%  Similarity=0.375  Sum_probs=78.9

Q ss_pred             HHccCCCCccceeeEEEecC-----CeeeEEEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCC
Q 015138          293 LLARLQHRNLVRLLGFCLER-----KERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR  366 (412)
Q Consensus       293 ~l~~l~h~niv~l~g~~~~~-----~~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~  366 (412)
                      -|-.+.|.|||+++.|+.+.     ....++.|||..|+|..+|++.. ....+......+++-||+.||.|||+.. |+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence            34456799999999988654     35789999999999999996532 2345677777889999999999999976 67


Q ss_pred             ceecCCCCCCEEECCCCCeEEe
Q 015138          367 IIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       367 ivHrdlk~~Nill~~~~~~ki~  388 (412)
                      |+|+++..+-|++..++-+||.
T Consensus       199 iihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cccCCcchhheeecCCceEEec
Confidence            9999999999999999988875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.48  E-value=1.1e-07  Score=97.83  Aligned_cols=112  Identities=25%  Similarity=0.412  Sum_probs=75.5

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|..++.|..|++|.||....+ ..+.+|+| +.++..-    +.+   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence            467888999999999999999854 45677773 3322110    011   22222333333                  


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                         |+=...+..   .+.++-        +++.+++|||+.+   |+|||+||.|.||..-+++|+.||||++...
T Consensus       136 ---gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ---GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ---chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence               333333321   222321        2378899999987   9999999999999999999999999998643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.47  E-value=7.7e-07  Score=76.88  Aligned_cols=106  Identities=26%  Similarity=0.256  Sum_probs=83.8

Q ss_pred             HHHHHHHccCCC-CccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCC
Q 015138          288 KNEVLLLARLQH-RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR  366 (412)
Q Consensus       288 ~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~  366 (412)
                      .+|..++..+++ +++++++|.|    ..++|.||.+.+++...-.....-...+|..+.+|+.++++.+.+|++...-.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457788888876 6999999999    34789999998876432100011234789999999999999999999865445


Q ss_pred             ceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          367 IIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       367 ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +.-.|++++|+-+++++++|+.|...+-..+
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.42  E-value=2.9e-06  Score=76.94  Aligned_cols=142  Identities=15%  Similarity=0.147  Sum_probs=86.6

Q ss_pred             cccccCC-eeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEecCCCCChh
Q 015138          251 KLGQGGF-GAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLD  328 (412)
Q Consensus       251 ~lg~G~f-g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~  328 (412)
                      .|..|.. ..||+.... +..+.||......   ..++..|+.++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 678998764 4678888775443   234677888887774 444668888877766789999999998876


Q ss_pred             hhc-------------------cCCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHhHh----C
Q 015138          329 HFI-------------------FDPIN-REHMT--WEKRYKIIE--------------------GIARGLLYLHE----D  362 (412)
Q Consensus       329 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~i~~~l~yLH~----~  362 (412)
                      ...                   +.... ...+.  ....+....                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   11000 00111  000000000                    01111222211    1


Q ss_pred             CCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       363 ~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ..+.++|+|+.|.|||++++..+.|+||+.|..-
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence            2355999999999999999888899999988743

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.39  E-value=2.1e-06  Score=84.72  Aligned_cols=141  Identities=16%  Similarity=0.250  Sum_probs=92.9

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCccc-------------------------------------HHHHHHHH
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-------------------------------------EIEFKNEV  291 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~e~  291 (412)
                      .+.||.-+.|.||++++.+|+.||||.-++.-...                                     +.+|..|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999866532211                                     01133343


Q ss_pred             HHHc----cCCCCc------cceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh
Q 015138          292 LLLA----RLQHRN------LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE  361 (412)
Q Consensus       292 ~~l~----~l~h~n------iv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~  361 (412)
                      +-..    .+.|-+      |.+++-  .......|+||||+|..+.+...  .....++...+..-+.+...-+-+-| 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~~-  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFKT-  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHhc-
Confidence            3222    233444      222221  22456789999999998877642  13344565555555555443343333 


Q ss_pred             CCCCCceecCCCCCCEEECC----CCCeEEeccCCcccccC
Q 015138          362 DSRLRIIHRDLKASNILLDS----EMNPKISDFGMARLFEM  398 (412)
Q Consensus       362 ~~~~~ivHrdlk~~Nill~~----~~~~ki~DfGla~~~~~  398 (412)
                       |   ++|.|-+|.||++..    +..+.+-|||+.+.+..
T Consensus       321 -G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 -G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             -C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence             3   999999999999984    56899999999987653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.34  E-value=3.3e-06  Score=75.69  Aligned_cols=145  Identities=22%  Similarity=0.216  Sum_probs=85.8

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCC--ccceeeEEEecC---CeeeEEEecCC
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR--NLVRLLGFCLER---KERILVYEFVP  323 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~g~~~~~---~~~~lv~Ey~~  323 (412)
                      .+.|+.|..+.||+....+ ..+++|.....  .....+..|..++..+...  .+.+++......   ...+++||+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578899999999999877 68999987554  3445677888888877533  356777755333   34689999999


Q ss_pred             CCChhh----------------hc---cCC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHhHh
Q 015138          324 NASLDH----------------FI---FDP-INREHMTWEKR---------YKI------------IEGIAR-GLLYLHE  361 (412)
Q Consensus       324 ~gsL~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~i~~-~l~yLH~  361 (412)
                      +..+..                .+   +.. .....+.+...         ...            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111 01111111110         000            111222 2333332


Q ss_pred             ----CCCCCceecCCCCCCEEEC-CCCCeEEeccCCcccc
Q 015138          362 ----DSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLF  396 (412)
Q Consensus       362 ----~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~  396 (412)
                          ..+..++|+|+.|.|||++ +++.+.|.||+.+..-
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence                2345699999999999999 5666689999988653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.29  E-value=1.2e-05  Score=85.57  Aligned_cols=79  Identities=14%  Similarity=0.325  Sum_probs=57.8

Q ss_pred             cccccccCCeeEEEEEeCCC---CEEEEEEeccCCc-ccHHHHHHHHHHHccCC-CCcc--ceeeEEEecC---CeeeEE
Q 015138          249 ANKLGQGGFGAVYKGMLSNG---ETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNL--VRLLGFCLER---KERILV  318 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~---~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv  318 (412)
                      ...++.|.+..+|+....++   ..+++|+...... .....+.+|..++..+. |.++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56788899999999876554   3567776654322 23446889999999995 6665  7888888764   357899


Q ss_pred             EecCCCCCh
Q 015138          319 YEFVPNASL  327 (412)
Q Consensus       319 ~Ey~~~gsL  327 (412)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.29  E-value=3.4e-06  Score=74.39  Aligned_cols=152  Identities=21%  Similarity=0.266  Sum_probs=94.5

Q ss_pred             chHHHHhhhcCCCcccc---ccccCCeeEEEEEeCCCCEEEEEEeccCCcccH---------HH---------------H
Q 015138          235 DFETIRVATDNFSDANK---LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGE---------IE---------------F  287 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~---lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~---------~~---------------~  287 (412)
                      +++.+....+...+...   |..|.-..||+|.-.++..+|||+.........         ..               .
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            34455555555554444   445666789999988899999998765322111         01               1


Q ss_pred             HHHHHHHccCC--CCccceeeEEEecCCeeeEEEecCCCCCh-hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCC
Q 015138          288 KNEVLLLARLQ--HRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR  364 (412)
Q Consensus       288 ~~e~~~l~~l~--h~niv~l~g~~~~~~~~~lv~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~  364 (412)
                      ..|..-|.++.  +-.+.+-+++.    ...|||||+....+ .-.|    +...+.......+..++++.|.-|-... 
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            33444454442  23333444432    34699999965421 1111    1222333355667777777887777632 


Q ss_pred             CCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       365 ~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                       ++||+||..=|||+. ++.+.|+|||=|....
T Consensus       187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence             399999999999999 9999999999887654

>PRK10593 hypothetical protein; Provisional

Probab=98.09  E-value=7e-05  Score=69.85  Aligned_cols=78  Identities=15%  Similarity=0.112  Sum_probs=56.5

Q ss_pred             CccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC---CccceeeEEEecC---CeeeEEEe
Q 015138          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH---RNLVRLLGFCLER---KERILVYE  320 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~g~~~~~---~~~~lv~E  320 (412)
                      ...+.||.|..+.||+-...++ .+.+|..+...  ....+..|.+.|+.|..   -.+.++++++...   +..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456899999999999876555 45566643211  22368889998888853   3678899887643   56899999


Q ss_pred             cCCCCCh
Q 015138          321 FVPNASL  327 (412)
Q Consensus       321 y~~~gsL  327 (412)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=5.5e-05  Score=65.73  Aligned_cols=134  Identities=19%  Similarity=0.338  Sum_probs=88.7

Q ss_pred             ccccccccCCeeEEEEEeCCCCEEEEEEeccCC----------------cccHHHHHHHHHHHccCC------CCcccee
Q 015138          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS----------------KQGEIEFKNEVLLLARLQ------HRNLVRL  305 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l  305 (412)
                      ....||+|+.-.||.-  ++.....||.+....                .....+..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3567999999888864  344556778776554                112344556665544444      7899999


Q ss_pred             eEEEecCCeeeEEEecCCC------CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE
Q 015138          306 LGFCLERKERILVYEFVPN------ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (412)
Q Consensus       306 ~g~~~~~~~~~lv~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill  379 (412)
                      +|+...+...-+|+|.+.+      .+|.+++.    ...++. .....+.+.   ..||-+++   |+.+|++|.||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence            9999999999999998642      35667763    344555 334444444   44555555   9999999999999


Q ss_pred             CCCC----CeEEec-cCCcc
Q 015138          380 DSEM----NPKISD-FGMAR  394 (412)
Q Consensus       380 ~~~~----~~ki~D-fGla~  394 (412)
                      ....    .+.|+| ||-..
T Consensus       152 ~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             EecCCCceEEEEEeCCCCcc
Confidence            6543    466666 44433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.02  E-value=5.5e-05  Score=68.13  Aligned_cols=140  Identities=19%  Similarity=0.171  Sum_probs=76.1

Q ss_pred             ccccccCCe-eEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCC---ccceeeEEEecCC---eeeEEEecC
Q 015138          250 NKLGQGGFG-AVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR---NLVRLLGFCLERK---ERILVYEFV  322 (412)
Q Consensus       250 ~~lg~G~fg-~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~g~~~~~~---~~~lv~Ey~  322 (412)
                      +.|+.|+.. .||+.    +..+++|.....  .....+..|.+++..+...   .+.+.++.....+   ..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            456766665 58874    234666654332  2344688899888877532   3445555443322   347899999


Q ss_pred             CCCChhhhc------------------cCCCCCC-C------------C-CHHHHH--HHH-------HHHHHH-HH-Hh
Q 015138          323 PNASLDHFI------------------FDPINRE-H------------M-TWEKRY--KII-------EGIARG-LL-YL  359 (412)
Q Consensus       323 ~~gsL~~~l------------------~~~~~~~-~------------l-~~~~~~--~i~-------~~i~~~-l~-yL  359 (412)
                      +|.++.+..                  +...... .            + .|....  .+.       .+.+.. ++ ++
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            998774321                  1100000 0            0 111110  000       011111 11 11


Q ss_pred             Hh--CCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          360 HE--DSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       360 H~--~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +.  ..++.++|+|+.+.|||++.+....|+||+.+..
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            11  1234589999999999998776678999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.92  E-value=9.2e-05  Score=66.59  Aligned_cols=141  Identities=18%  Similarity=0.261  Sum_probs=81.4

Q ss_pred             ccccccCCeeEEEEEeCC--CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc-cceeeEEEecCCeeeEEEecCCCCC
Q 015138          250 NKLGQGGFGAVYKGMLSN--GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~--~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      +.|..|-...+|+....+  ++.+++|........ ..+..+|+.++..+...+ .+++++...    ..+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            456677778999988664  678888876543222 123356888888875433 345554432    248999999877


Q ss_pred             hhhh-----------------ccCCCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 015138          327 LDHF-----------------IFDPINR--------EHM-TWEKRYKIIE----------------------GIARGLLY  358 (412)
Q Consensus       327 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~i~~~l~y  358 (412)
                      +...                 ++.....        ... .|.....+..                      .+..-+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6322                 0111111        111 1222111111                      11111111


Q ss_pred             ----hHhC-CCCCceecCCCCCCEEECC-CCCeEEeccCCccc
Q 015138          359 ----LHED-SRLRIIHRDLKASNILLDS-EMNPKISDFGMARL  395 (412)
Q Consensus       359 ----LH~~-~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~  395 (412)
                          +... .+..++|+|+.+.|||++. +..+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence                1111 2345999999999999998 57899999998874

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.88  E-value=9.7e-05  Score=67.43  Aligned_cols=138  Identities=15%  Similarity=0.094  Sum_probs=78.7

Q ss_pred             ccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEecCCCCChhhh
Q 015138          252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVPNASLDHF  330 (412)
Q Consensus       252 lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~Ey~~~gsL~~~  330 (412)
                      +..|-...+|+... +++.+++|........-..+..+|..+++.+....+ .++++...    ..+||||++|..+..-
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            44566778898874 567788887654332211235678888888864433 34554432    3689999998776432


Q ss_pred             -----------------ccCCC-CCCCCCHHHHH-HHHHH---------HHHHHHHhHhC-----CCCCceecCCCCCCE
Q 015138          331 -----------------IFDPI-NREHMTWEKRY-KIIEG---------IARGLLYLHED-----SRLRIIHRDLKASNI  377 (412)
Q Consensus       331 -----------------l~~~~-~~~~l~~~~~~-~i~~~---------i~~~l~yLH~~-----~~~~ivHrdlk~~Ni  377 (412)
                                       |+... ....++....+ ....+         +..-+..+-..     .++.++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111 11122222111 11111         11112222111     123589999999999


Q ss_pred             EECCCCCeEEeccCCccc
Q 015138          378 LLDSEMNPKISDFGMARL  395 (412)
Q Consensus       378 ll~~~~~~ki~DfGla~~  395 (412)
                      ++++++ ++|+||..|..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.88  E-value=0.00014  Score=62.81  Aligned_cols=125  Identities=29%  Similarity=0.418  Sum_probs=87.9

Q ss_pred             cCCCccccccccCC-eeEEEEEeCCCCEEEEEEecc---CC--------c----------ccHHHHHHHHHHHccCC---
Q 015138          244 DNFSDANKLGQGGF-GAVYKGMLSNGETIAVKRLSK---NS--------K----------QGEIEFKNEVLLLARLQ---  298 (412)
Q Consensus       244 ~~~~~~~~lg~G~f-g~V~~~~~~~~~~vavK~l~~---~~--------~----------~~~~~~~~e~~~l~~l~---  298 (412)
                      .+++..+.||.|.. |.||+..+. |+.+|+|....   ..        .          .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            66778899999999 999999994 78999998321   00        0          01124788998877775   


Q ss_pred             CCcc--ceeeEEEecCC------------------eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 015138          299 HRNL--VRLLGFCLERK------------------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY  358 (412)
Q Consensus       299 h~ni--v~l~g~~~~~~------------------~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~y  358 (412)
                      +.++  |+.+||..-..                  ...||.||.+...            .++.    .-+.+|.+-|.-
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            4566  89999974321                  1246777664432            1222    335567777888


Q ss_pred             hHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       359 LH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99887   999999999985     3589999865

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.85  E-value=0.00014  Score=60.93  Aligned_cols=128  Identities=18%  Similarity=0.242  Sum_probs=87.0

Q ss_pred             ccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccc-eeeEEEecCCeeeEEEecCCCCC
Q 015138          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV-RLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      ..+.|++|.+|.||+|.+. |..+|+|.-...+  ....+..|.++|..++-.++. +++.+-.    .++.|||+.|-.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence            3578999999999999996 4578888654433  344688899999988866654 4555433    345599999988


Q ss_pred             hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCC-CCCEEECCCCCeEEeccCCccc
Q 015138          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK-ASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk-~~Nill~~~~~~ki~DfGla~~  395 (412)
                      |.+.-..      .+....+.    +++.---|-..+   |-|+.|. |...+|..+..+.|+||.-|..
T Consensus        99 L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8776411      13333333    344433333334   8888886 6666666777999999999884

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.72  E-value=0.00039  Score=64.87  Aligned_cols=143  Identities=19%  Similarity=0.154  Sum_probs=85.0

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc--cceeeEE------EecCCeeeEEEe
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGF------CLERKERILVYE  320 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~------~~~~~~~~lv~E  320 (412)
                      .+.|..|....+|+....+ ..+++|....   .....+..|+.++..+.+.+  +.+++..      ....+..++|+|
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567777778899887644 4688887754   22345666777777774332  4454432      122345689999


Q ss_pred             cCCCCChhhh----c----------cC---C-C----CCCCCCHHHHHH----------HHHHHHHHHHHhHh----CCC
Q 015138          321 FVPNASLDHF----I----------FD---P-I----NREHMTWEKRYK----------IIEGIARGLLYLHE----DSR  364 (412)
Q Consensus       321 y~~~gsL~~~----l----------~~---~-~----~~~~l~~~~~~~----------i~~~i~~~l~yLH~----~~~  364 (412)
                      |++|..+...    .          +.   . .    ......|.....          ....+...+.++..    .-+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9998876431    0          10   0 0    011123322210          11123344455543    122


Q ss_pred             CCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          365 LRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       365 ~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ..++|+|+.|.|||++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3599999999999999987789999988763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.71  E-value=0.00098  Score=64.28  Aligned_cols=76  Identities=16%  Similarity=0.193  Sum_probs=53.0

Q ss_pred             cccccccCCeeEEEEEeCCC-CEEEEEEeccC------C-cccHHHHHHHHHHHccCC---CCccceeeEEEecCCeeeE
Q 015138          249 ANKLGQGGFGAVYKGMLSNG-ETIAVKRLSKN------S-KQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~-~~vavK~l~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~l  317 (412)
                      .+.||.|.+..||+....+| +.|.||.-...      . ......+..|.+.|..+.   -.++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46789999999999998777 48999974321      1 123345666777777652   2457777777  3355789


Q ss_pred             EEecCCCCC
Q 015138          318 VYEFVPNAS  326 (412)
Q Consensus       318 v~Ey~~~gs  326 (412)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>PRK05231 homoserine kinase; Provisional

Probab=97.53  E-value=0.0036  Score=59.08  Aligned_cols=142  Identities=14%  Similarity=0.156  Sum_probs=75.9

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCC--ccceeeEE------EecCCeeeEEEe
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR--NLVRLLGF------CLERKERILVYE  320 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~g~------~~~~~~~~lv~E  320 (412)
                      .+.|..|....+|+....+| .+++|+.....   ...+..|+.++..|...  .+.+.+..      ....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            34566677778998886555 67888765212   22333455555444322  23333321      122456789999


Q ss_pred             cCCCCChhh-----h------c---cCC------C--CCCCCCH-HHHHH------------HH-HHHHHHHHHhHhC--
Q 015138          321 FVPNASLDH-----F------I---FDP------I--NREHMTW-EKRYK------------II-EGIARGLLYLHED--  362 (412)
Q Consensus       321 y~~~gsL~~-----~------l---~~~------~--~~~~l~~-~~~~~------------i~-~~i~~~l~yLH~~--  362 (412)
                      |++|..+..     .      |   +..      .  ....+.| .....            .+ ..+...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999876521     1      1   100      0  0111222 21111            11 1111122333211  


Q ss_pred             --CCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          363 --SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       363 --~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                        -+..++|+|+++.|||++.+...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23459999999999999876666899999885

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.36  E-value=0.0045  Score=58.11  Aligned_cols=143  Identities=19%  Similarity=0.200  Sum_probs=81.3

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCC--ccceeeEEE------ecCCeeeEEEe
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR--NLVRLLGFC------LERKERILVYE  320 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~g~~------~~~~~~~lv~E  320 (412)
                      .+.++.|.-..+|+....+| .+++|.......  ..++..|+.++..|...  .+.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45566676678998876555 566787654321  23445566666666422  244444421      12356789999


Q ss_pred             cCCCCChhhh--------------ccC---CC-C--C---CCCCHHHHHH------------HHHHHHHHHHHhHh----
Q 015138          321 FVPNASLDHF--------------IFD---PI-N--R---EHMTWEKRYK------------IIEGIARGLLYLHE----  361 (412)
Q Consensus       321 y~~~gsL~~~--------------l~~---~~-~--~---~~l~~~~~~~------------i~~~i~~~l~yLH~----  361 (412)
                      |++|..+...              ++.   .. .  .   ..-.|.....            ....+.+.+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998665311              111   00 0  0   0112221110            11123344555542    


Q ss_pred             CCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       362 ~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .-+..++|+|+++.||+++.++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999988877999999884

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.26  E-value=0.003  Score=59.06  Aligned_cols=141  Identities=27%  Similarity=0.366  Sum_probs=82.7

Q ss_pred             cccccCCeeEEEEEeCC-------CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEecC
Q 015138          251 KLGQGGFGAVYKGMLSN-------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~-------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .+..|--..+|+....+       ++.+++|....... ...+..+|.+++..+...++ .++++.+..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            44445556888887654       47888888655432 22355778888877754333 455665532    3689999


Q ss_pred             CCCChhhh-c----------------cCCCCC--------CCCCHHHHHH--------------------------HHHH
Q 015138          323 PNASLDHF-I----------------FDPINR--------EHMTWEKRYK--------------------------IIEG  351 (412)
Q Consensus       323 ~~gsL~~~-l----------------~~~~~~--------~~l~~~~~~~--------------------------i~~~  351 (412)
                      +|..+... +                ++....        ...-|.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            98877432 1                111111        0111111111                          1112


Q ss_pred             HHHHHHHhHh------CCCCCceecCCCCCCEEECCC----CCeEEeccCCcccc
Q 015138          352 IARGLLYLHE------DSRLRIIHRDLKASNILLDSE----MNPKISDFGMARLF  396 (412)
Q Consensus       352 i~~~l~yLH~------~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGla~~~  396 (412)
                      +..-+.+|..      ..+..++|+|+.+.|||++.+    +.++++||..|..-
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            2223334432      234569999999999999985    88999999998743

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.20  E-value=0.0036  Score=59.72  Aligned_cols=141  Identities=18%  Similarity=0.256  Sum_probs=81.2

Q ss_pred             cccccCCeeEEEEEeCC-----CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccc-eeeEEEecCCeeeEEEecCCC
Q 015138          251 KLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV-RLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      .+-.|-.-.+|+..+.+     ++.+.+|........ ..+-.+|..++..+...++. ++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            44445566788877532     357888877655432 22346788888887654443 566665432    58999988


Q ss_pred             CChhhh-----------------ccCCC---CCCCCCHHHHHHHHHH-----------------HHHHHHHh----Hh-C
Q 015138          325 ASLDHF-----------------IFDPI---NREHMTWEKRYKIIEG-----------------IARGLLYL----HE-D  362 (412)
Q Consensus       325 gsL~~~-----------------l~~~~---~~~~l~~~~~~~i~~~-----------------i~~~l~yL----H~-~  362 (412)
                      .+|..-                 ++...   ......|.....+..+                 +...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            777422                 11111   0111222322222211                 11112222    22 2


Q ss_pred             CCCCceecCCCCCCEEECC-CCCeEEeccCCcccc
Q 015138          363 SRLRIIHRDLKASNILLDS-EMNPKISDFGMARLF  396 (412)
Q Consensus       363 ~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~  396 (412)
                      .+..++|+|+++.|||+++ ++.++|+||..|..-
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            2345899999999999986 468999999988743

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.18  E-value=0.0036  Score=57.72  Aligned_cols=32  Identities=25%  Similarity=0.456  Sum_probs=26.7

Q ss_pred             CCceecCCCCCCEEECCCCC-eEEeccCCcccc
Q 015138          365 LRIIHRDLKASNILLDSEMN-PKISDFGMARLF  396 (412)
Q Consensus       365 ~~ivHrdlk~~Nill~~~~~-~ki~DfGla~~~  396 (412)
                      +.++|+|+++.|||++.++. .-|.||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997554 579999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.12  E-value=0.008  Score=56.08  Aligned_cols=129  Identities=19%  Similarity=0.325  Sum_probs=75.6

Q ss_pred             CCEEEEEEecc--CCcccHHHHHHHHHHHccCCC--CccceeeEEEecCC--eeeEEEecCCCCChhhhccCC-------
Q 015138          268 GETIAVKRLSK--NSKQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERK--ERILVYEFVPNASLDHFIFDP-------  334 (412)
Q Consensus       268 ~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~--~~~lv~Ey~~~gsL~~~l~~~-------  334 (412)
                      ++++++. ...  ..........+|..+|+.+.-  .-+.+.++.|.++.  ..+.||+|+++..+...+...       
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            6677777 331  222333455677777777643  33456677777766  679999999884432222100       


Q ss_pred             ----------------------------CCCCCCCHHHHHHH--------HHHHHHHHHHhHhC-----CCCCceecCCC
Q 015138          335 ----------------------------INREHMTWEKRYKI--------IEGIARGLLYLHED-----SRLRIIHRDLK  373 (412)
Q Consensus       335 ----------------------------~~~~~l~~~~~~~i--------~~~i~~~l~yLH~~-----~~~~ivHrdlk  373 (412)
                                                  ..++.-.|......        +-....-..+|+.+     +++.++|+|++
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                                        00001112211110        00122234455543     34569999999


Q ss_pred             CCCEEECCCCCeEEeccCCccccc
Q 015138          374 ASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       374 ~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      +.|++++.+.-+-|.||+++..=+
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccCC
Confidence            999999999889999999997543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.02  E-value=0.009  Score=55.25  Aligned_cols=75  Identities=19%  Similarity=0.273  Sum_probs=47.1

Q ss_pred             CccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC---CCccceeeEEEecCCeeeEEEecCC
Q 015138          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      +..+.++-|....+|+.. .+++.+.||.-...   ....|..|.+-|+.|.   --.+.+.+++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345678888889999877 56788999977622   2235777887777773   4457789999888778899999998


Q ss_pred             CC
Q 015138          324 NA  325 (412)
Q Consensus       324 ~g  325 (412)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            77

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=96.90  E-value=0.00015  Score=75.39  Aligned_cols=148  Identities=18%  Similarity=0.190  Sum_probs=98.1

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..+.+.+.+-+..|.++.++...- ..|...++|...+..   .........+-.++-..+||-+++...-+.......|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            445667777788888998887663 223333333222211   1111111222222323445666666555666788899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      |++|+.+++|...|+..   ..++..-....+..+.++++|||...   +.|||++|.|.|...+++.+++|||+.+.
T Consensus       882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence            99999999998888542   23444444455667889999999865   89999999999999999999999995554

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.84  E-value=0.035  Score=53.61  Aligned_cols=73  Identities=12%  Similarity=0.138  Sum_probs=47.1

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCc-------ccHHHHHHHHHHHccCC---CCccceeeEEEecCCeeeEE
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-------QGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lv  318 (412)
                      .+.||-|..-.||+.... +..++||.-.....       .....-..|...|..+.   ..++.+++.++.  +.-+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            567899999999997764 55788987542110       11222233455554442   357888888887  445789


Q ss_pred             EecCCC
Q 015138          319 YEFVPN  324 (412)
Q Consensus       319 ~Ey~~~  324 (412)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.78  E-value=0.014  Score=55.25  Aligned_cols=72  Identities=18%  Similarity=0.186  Sum_probs=44.3

Q ss_pred             cccccCCeeEEEEEeCCC-CEEEEEEecc-------CCcccHHHHHHHHHHHccCC--CC-ccceeeEEEecCCeeeEEE
Q 015138          251 KLGQGGFGAVYKGMLSNG-ETIAVKRLSK-------NSKQGEIEFKNEVLLLARLQ--HR-NLVRLLGFCLERKERILVY  319 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~e~~~l~~l~--h~-niv~l~g~~~~~~~~~lv~  319 (412)
                      +||-|....||++..++| +.|+||.-..       .-.....+..-|...|....  -| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            578999999999997654 5899985321       11222333445556554442  23 45555543  445567999


Q ss_pred             ecCCC
Q 015138          320 EFVPN  324 (412)
Q Consensus       320 Ey~~~  324 (412)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99965

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.67  E-value=0.019  Score=53.97  Aligned_cols=140  Identities=21%  Similarity=0.256  Sum_probs=94.0

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCC---------cccH-----------------HHHHHHHHHHccCCCCcc
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS---------KQGE-----------------IEFKNEVLLLARLQHRNL  302 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~---------~~~~-----------------~~~~~e~~~l~~l~h~ni  302 (412)
                      ...|..|.-..||.+.-.+|..+|||+.+-.-         ..++                 .-...|++-|++|+...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34677788889999999999999999764320         0010                 012446666777665444


Q ss_pred             ceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC
Q 015138          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE  382 (412)
Q Consensus       303 v~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~  382 (412)
                      ...--...  ....|||+|+..-.   |-.-..+...++...+..+-.+++.-|.-|-+.+  ++||.||.-=|+|+ .+
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hd  300 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HD  300 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-EC
Confidence            32111111  12368999996321   1111123455777788888889999999888876  59999999999998 67


Q ss_pred             CCeEEeccCCcccc
Q 015138          383 MNPKISDFGMARLF  396 (412)
Q Consensus       383 ~~~ki~DfGla~~~  396 (412)
                      |.+.|+|-+=+...
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            78999999877644

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.60  E-value=0.03  Score=52.81  Aligned_cols=136  Identities=22%  Similarity=0.285  Sum_probs=79.7

Q ss_pred             CCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc------cceeeEEEe--cC--CeeeEEEecCCCC
Q 015138          256 GFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN------LVRLLGFCL--ER--KERILVYEFVPNA  325 (412)
Q Consensus       256 ~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~g~~~--~~--~~~~lv~Ey~~~g  325 (412)
                      .--.+|+....+|+. ++|.....  ....++..|+..+..|.-.+      |..+-|-..  -.  ...+-|.||++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            345688888877776 77766655  34445666777776663222      223323221  12  3678899999998


Q ss_pred             Chhh-hc------------------c-----CCCCCCCCCHHH-------------HHHHHHHHHHHHHHhHhC------
Q 015138          326 SLDH-FI------------------F-----DPINREHMTWEK-------------RYKIIEGIARGLLYLHED------  362 (412)
Q Consensus       326 sL~~-~l------------------~-----~~~~~~~l~~~~-------------~~~i~~~i~~~l~yLH~~------  362 (412)
                      .+.. .-                  .     .+.......|..             ......++...+..+.+.      
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8872 11                  0     111111234431             011233344444444432      


Q ss_pred             -CCCCceecCCCCCCEEECCCCC-eEEeccCCcc
Q 015138          363 -SRLRIIHRDLKASNILLDSEMN-PKISDFGMAR  394 (412)
Q Consensus       363 -~~~~ivHrdlk~~Nill~~~~~-~ki~DfGla~  394 (412)
                       ....+||+|+.|.||+++.+.. +.+.|||-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             1122899999999999999885 9999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.57  E-value=0.00062  Score=67.60  Aligned_cols=149  Identities=17%  Similarity=0.108  Sum_probs=98.5

Q ss_pred             hHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc-cceeeEEEecCCe
Q 015138          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKE  314 (412)
Q Consensus       236 ~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~~  314 (412)
                      .-+++..+.-+.....++++++++++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+...+.
T Consensus       234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~  308 (829)
T KOG0576|consen  234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY  308 (829)
T ss_pred             CCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence            33444444555556678899999999987433333335544332     34566889999999999 6666666666778


Q ss_pred             eeEEEecCCCC-ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          315 RILVYEFVPNA-SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       315 ~~lv~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      .+++++|+..+ +......  .....+...+...+...-.++++|||+..   -+|+|    ||+..+ ...|..||+.+
T Consensus       309 ~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~  378 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVP  378 (829)
T ss_pred             cchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCC
Confidence            88999999877 2211110  01112333334455666788999999864   58998    777655 78899999998


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      ..+...
T Consensus       379 ~~L~~~  384 (829)
T KOG0576|consen  379 PQLTRT  384 (829)
T ss_pred             cccCcc
Confidence            877654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.44  E-value=0.038  Score=51.82  Aligned_cols=29  Identities=28%  Similarity=0.357  Sum_probs=25.3

Q ss_pred             CCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          365 LRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       365 ~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46899999999999987 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.41  E-value=0.032  Score=52.91  Aligned_cols=140  Identities=17%  Similarity=0.303  Sum_probs=78.1

Q ss_pred             cccccCCeeEEEEEeCC----CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEecCCCC
Q 015138          251 KLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVPNA  325 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~Ey~~~g  325 (412)
                      .|..|---.+|+....+    +..+.+|........ ..+-.+|..++..+...++ .++++++..+    +|.||+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            34335455688776543    237888877654432 2334678888888865555 3566665322    589999877


Q ss_pred             Chhhh-----------------ccCCC---CCCCCCHHHHHHHHHH----------------------HHHHHH----Hh
Q 015138          326 SLDHF-----------------IFDPI---NREHMTWEKRYKIIEG----------------------IARGLL----YL  359 (412)
Q Consensus       326 sL~~~-----------------l~~~~---~~~~l~~~~~~~i~~~----------------------i~~~l~----yL  359 (412)
                      .|..-                 +++..   ....--|....++..+                      +.+-+.    ++
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            66321                 11111   0111123322222211                      111111    12


Q ss_pred             Hh-CCCCCceecCCCCCCEEECC-CCCeEEeccCCccc
Q 015138          360 HE-DSRLRIIHRDLKASNILLDS-EMNPKISDFGMARL  395 (412)
Q Consensus       360 H~-~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~  395 (412)
                      .. ..+.-+.|.|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 12234799999999999975 57899999998864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.39  E-value=0.0093  Score=52.62  Aligned_cols=123  Identities=25%  Similarity=0.339  Sum_probs=60.3

Q ss_pred             CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEecCCCCChhhh-c--------------
Q 015138          268 GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVPNASLDHF-I--------------  331 (412)
Q Consensus       268 ~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~Ey~~~gsL~~~-l--------------  331 (412)
                      ++.|.|+..... ......-..|..+++.+...++ .++++.+.++    +|+||+++..|..- +              
T Consensus         2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            456777777655 3344566788888888865444 4566654332    67799977665331 0              


Q ss_pred             --cC----CCCCCCCCHHHHHHH----------------------HHHHHHHHHHhH----h-CCCCCceecCCCCCCEE
Q 015138          332 --FD----PINREHMTWEKRYKI----------------------IEGIARGLLYLH----E-DSRLRIIHRDLKASNIL  378 (412)
Q Consensus       332 --~~----~~~~~~l~~~~~~~i----------------------~~~i~~~l~yLH----~-~~~~~ivHrdlk~~Nil  378 (412)
                        +.    ......--|.....+                      ...+..-+..+.    . ..+.-+.|.|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              00    001111111211111                      111111222221    1 11234899999999999


Q ss_pred             E-CCCCCeEEeccCCccc
Q 015138          379 L-DSEMNPKISDFGMARL  395 (412)
Q Consensus       379 l-~~~~~~ki~DfGla~~  395 (412)
                      + +.++.++++||..|..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.24  E-value=0.0061  Score=56.21  Aligned_cols=143  Identities=17%  Similarity=0.265  Sum_probs=92.7

Q ss_pred             ccchHHHHhhhc---CCCccccccccCCeeEEEEEeCCCCEEEEEEeccC--C---------------cc-----cHHHH
Q 015138          233 QFDFETIRVATD---NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--S---------------KQ-----GEIEF  287 (412)
Q Consensus       233 ~~~~~~l~~~~~---~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~--~---------------~~-----~~~~~  287 (412)
                      .+++-.|....+   -++.+++||-|.-+-||.+...+|.+.++|.-...  +               .-     .+...
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            455555544333   35678999999999999999988999888732111  0               00     01123


Q ss_pred             HHHHHHHccCCCC--ccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCC
Q 015138          288 KNEVLLLARLQHR--NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL  365 (412)
Q Consensus       288 ~~e~~~l~~l~h~--niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~  365 (412)
                      ..|...|+.|.-.  -+.+.+++    +..++|||++.+-.|...-      ...+..++..   .+..-+--|..++  
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~---~lm~~Iv~la~~G--  222 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYD---DLMGLIVRLANHG--  222 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHH---HHHHHHHHHHHcC--
Confidence            5677778777431  23333333    4567899999887774432      1223333333   2333344555666  


Q ss_pred             CceecCCCCCCEEECCCCCeEEeccC
Q 015138          366 RIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       366 ~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                       +||+|..-=||+++++..++++||=
T Consensus       223 -lIHgDFNEFNimv~dd~~i~vIDFP  247 (465)
T KOG2268|consen  223 -LIHGDFNEFNIMVKDDDKIVVIDFP  247 (465)
T ss_pred             -ceecccchheeEEecCCCEEEeech
Confidence             9999999999999999999999995

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.15  E-value=0.024  Score=54.47  Aligned_cols=74  Identities=15%  Similarity=0.174  Sum_probs=46.6

Q ss_pred             cccccccCCeeEEEEEeCC-CCEEEEEEecc------CCcccHHHHHHHHHHHccCC--CC-ccceeeEEEecCCeeeEE
Q 015138          249 ANKLGQGGFGAVYKGMLSN-GETIAVKRLSK------NSKQGEIEFKNEVLLLARLQ--HR-NLVRLLGFCLERKERILV  318 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~------~~~~~~~~~~~e~~~l~~l~--h~-niv~l~g~~~~~~~~~lv  318 (412)
                      .+.||-|.-..||++...+ ++.|+||.-..      .-.-...+..-|.+.|+...  -| .+.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5688999999999999743 56799985321      11223344455666665542  23 45566654  44455788


Q ss_pred             EecCCC
Q 015138          319 YEFVPN  324 (412)
Q Consensus       319 ~Ey~~~  324 (412)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.13  E-value=0.082  Score=49.61  Aligned_cols=32  Identities=25%  Similarity=0.359  Sum_probs=28.5

Q ss_pred             CCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          364 RLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       364 ~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +..++|+|+.+.|||++.++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34599999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.06  E-value=0.027  Score=49.26  Aligned_cols=114  Identities=16%  Similarity=0.141  Sum_probs=71.5

Q ss_pred             CeeEEEEEeCCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCChhhhccCCC
Q 015138          257 FGAVYKGMLSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI  335 (412)
Q Consensus       257 fg~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~  335 (412)
                      -.+.-.+...- .+..+|++....-. ...-|.++-.++++++  .|++|..-  +....-++.|++-...         
T Consensus        75 NsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~---------  140 (308)
T PF07387_consen   75 NSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK---------  140 (308)
T ss_pred             ceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc---------
Confidence            33444444322 23456666555444 4456788888888875  46666622  3334568888873321         


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          336 NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       336 ~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                         .+..    .++.-=++.|.-.|+.+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus       141 ---i~~~----N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  141 ---INFS----NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ---cchh----HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence               1111    12221246677888654 4699999999999999999999999774

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.97  E-value=0.11  Score=56.71  Aligned_cols=140  Identities=19%  Similarity=0.298  Sum_probs=75.6

Q ss_pred             cccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC--CCc--cceeeE--------EEec-CC--ee
Q 015138          251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ--HRN--LVRLLG--------FCLE-RK--ER  315 (412)
Q Consensus       251 ~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--h~n--iv~l~g--------~~~~-~~--~~  315 (412)
                      .|+ |..-..|+....+|..+++|........  ..+..|...|..|.  ++.  +.+++-        .... ..  ..
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            443 3456788888778888999988765322  23344445554442  122  222221        1111 11  45


Q ss_pred             eEEEecCCCCChhhhc-----------------------cC-CCCCCCCCHHH-----------------HHHHHHHHHH
Q 015138          316 ILVYEFVPNASLDHFI-----------------------FD-PINREHMTWEK-----------------RYKIIEGIAR  354 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l-----------------------~~-~~~~~~l~~~~-----------------~~~i~~~i~~  354 (412)
                      +-+++|++|..|.+..                       +. ......+.|..                 ...++.++..
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            6789999998775510                       00 11112233321                 1122223322


Q ss_pred             HHH-----HhHhCCCCCceecCCCCCCEEECCCC--Ce-EEeccCCcc
Q 015138          355 GLL-----YLHEDSRLRIIHRDLKASNILLDSEM--NP-KISDFGMAR  394 (412)
Q Consensus       355 ~l~-----yLH~~~~~~ivHrdlk~~Nill~~~~--~~-ki~DfGla~  394 (412)
                      ...     .|.+ -+..+||+|+.+.|||++.+.  ++ -|+|||-+.
T Consensus       189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            221     1222 133599999999999999875  44 499999875

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.74  E-value=0.051  Score=51.09  Aligned_cols=74  Identities=23%  Similarity=0.210  Sum_probs=55.3

Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...+++|++. +++|..       ...-.|++.+.++.+.+.-+.-|..+  .+.=|||+.-.||||+ +|++-|+||-+
T Consensus       299 ~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             eEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence            3456777765 455522       23456888888888877666665543  5689999999999999 99999999999


Q ss_pred             ccccc
Q 015138          393 ARLFE  397 (412)
Q Consensus       393 a~~~~  397 (412)
                      +|.-.
T Consensus       368 sRl~~  372 (488)
T COG5072         368 SRLSY  372 (488)
T ss_pred             eeccc
Confidence            99543

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.44  E-value=0.09  Score=46.34  Aligned_cols=68  Identities=22%  Similarity=0.312  Sum_probs=46.0

Q ss_pred             eeEEEEE-eC-CCCEEEEEEeccCCcccHHHHHHHHHHHccC---CCCccceeeEEEecCCeeeEEEecCCCCChh
Q 015138          258 GAVYKGM-LS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL---QHRNLVRLLGFCLERKERILVYEFVPNASLD  328 (412)
Q Consensus       258 g~V~~~~-~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~  328 (412)
                      |.|..|. +. ...++-||.-..   .....|..|+.-|..|   +--++.+.+.+-......+||+||++-|.++
T Consensus        27 G~inea~~v~dg~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccccceeEeecCCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            4454444 33 346788885422   2234577777655555   3456778888888899999999999988776

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.42  E-value=0.39  Score=45.42  Aligned_cols=70  Identities=13%  Similarity=0.078  Sum_probs=42.1

Q ss_pred             CeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCC--cccee---eE--EEecCCeeeEEEecCCCCCh
Q 015138          257 FGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR--NLVRL---LG--FCLERKERILVYEFVPNASL  327 (412)
Q Consensus       257 fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l---~g--~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      --.||+....++..+++|...... ....++..|+..+..|...  .++..   -|  ....++..+.|+++++|..+
T Consensus        38 eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         38 ENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            357899887778888888765332 2444566777776665321  12221   12  12224567789999987654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=95.28  E-value=0.12  Score=49.37  Aligned_cols=135  Identities=18%  Similarity=0.225  Sum_probs=82.7

Q ss_pred             CccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEe------cCC-eeeE
Q 015138          247 SDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCL------ERK-ERIL  317 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~------~~~-~~~l  317 (412)
                      ...+.||+|+.+.+|--- ..  .. +.|+...-......+.   +..|.+. .||-+-.=+.|-.      +.. ..-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~--d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVR--DQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchhh--ch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            457889999999998532 22  12 3355544333222222   2223333 5654432122211      111 2446


Q ss_pred             EEecCCCCChhhhcc----CCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          318 VYEFVPNASLDHFIF----DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~----~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      +|..+++..--..++    ++.......|...++++..++.+.+-||+.+   .+-+|+.++|+|+.++..+.+.|=
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence            666665542222222    2233456899999999999999999999998   888999999999998888877663

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.87  E-value=0.23  Score=44.97  Aligned_cols=76  Identities=21%  Similarity=0.218  Sum_probs=53.4

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHH---HHHccCCCCccceeeEEEecCCeeeEEEecC-CC
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEV---LLLARLQHRNLVRLLGFCLERKERILVYEFV-PN  324 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~---~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~-~~  324 (412)
                      ...+..|..+.|+.+...+|.+.++|........     ..|.   ..|...+-...|+++..-  .+...|++|.+ ++
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~-----~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g   79 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEA-----EHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPG   79 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccc-----hhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCC
Confidence            3456678889999999999999999987654332     2232   446666667788988864  33457888998 55


Q ss_pred             CChhhhc
Q 015138          325 ASLDHFI  331 (412)
Q Consensus       325 gsL~~~l  331 (412)
                      .+|.++.
T Consensus        80 ~~L~~~~   86 (253)
T PF04655_consen   80 RSLASLP   86 (253)
T ss_pred             Cchhhcc
Confidence            6776554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.80  E-value=0.086  Score=50.39  Aligned_cols=61  Identities=21%  Similarity=0.215  Sum_probs=38.8

Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhH-hCCCCCceecCCCCCCEEECCC
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-EDSRLRIIHRDLKASNILLDSE  382 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivHrdlk~~Nill~~~  382 (412)
                      ..|+=+|+++-++..++..    ...++....+++.-.+.|+.-+- -++   ++|.|++|.||++.-+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEec
Confidence            3567778889999888843    22333344455544444443222 223   9999999999999543

>PTZ00384 choline kinase; Provisional

Probab=94.38  E-value=0.45  Score=46.00  Aligned_cols=74  Identities=19%  Similarity=0.323  Sum_probs=43.9

Q ss_pred             ccccccCCeeEEEEEeCCC--CE-----EEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEec
Q 015138          250 NKLGQGGFGAVYKGMLSNG--ET-----IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEF  321 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~--~~-----vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~Ey  321 (412)
                      +.|..|--..+|+....++  ..     |.++...... .-..+-..|.++++.+...++ .++++.+..    .+|+||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            3454566678898876433  22     3333322211 111233668888888866555 456666543    599999


Q ss_pred             CCCCChh
Q 015138          322 VPNASLD  328 (412)
Q Consensus       322 ~~~gsL~  328 (412)
                      ++|..|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9988774

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.03  E-value=0.076  Score=45.55  Aligned_cols=29  Identities=21%  Similarity=0.286  Sum_probs=25.8

Q ss_pred             CceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          366 RIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       366 ~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ..+|+|+.|.||++.+++ ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            479999999999998777 99999999864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	412
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-39
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-31
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-30
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-29
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-29
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 81/184 (44%), Positives = 121/184 (65%), Gaps = 2/184 (1%)
Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
           +E+ E  + +  +F    ++VA+DNFS+ N LG+GGFG VYKG L++G  +AVKRL +  
Sbjct: 15  EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 74
Query: 281 KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD-PINRE 338
            QG E++F+ EV +++   HRNL+RL GFC+   ER+LVY ++ N S+   + + P ++ 
Sbjct: 75  XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 134
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            + W KR +I  G ARGL YLH+    +IIHRD+KA+NILLD E    + DFG+A+L + 
Sbjct: 135 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194
Query: 399 DQTH 402
              H
Sbjct: 195 KDXH 198

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/184 (43%), Positives = 120/184 (65%), Gaps = 2/184 (1%)
Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
           +E+ E  + +  +F    ++VA+DNF + N LG+GGFG VYKG L++G  +AVKRL +  
Sbjct: 7   EEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEER 66
Query: 281 KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD-PINRE 338
            QG E++F+ EV +++   HRNL+RL GFC+   ER+LVY ++ N S+   + + P ++ 
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            + W KR +I  G ARGL YLH+    +IIHRD+KA+NILLD E    + DFG+A+L + 
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 399 DQTH 402
              H
Sbjct: 187 KDXH 190

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/189 (42%), Positives = 116/189 (61%), Gaps = 12/189 (6%)
Query: 223 NVEETIAKSLQFDFETIRV-------ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR 275
           ++ + ++ S    FE+ RV       AT+NF     +G G FG VYKG+L +G  +A+KR
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 276 LSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD-HFIFDP 334
            +  S QG  EF+ E+  L+  +H +LV L+GFC ER E IL+Y+++ N +L  H     
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 335 INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +    M+WE+R +I  G ARGL YLH  +   IIHRD+K+ NILLD    PKI+DFG+++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 395 L-FEMDQTH 402
              E+DQTH
Sbjct: 188 KGTELDQTH 196

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/189 (41%), Positives = 115/189 (60%), Gaps = 12/189 (6%)
Query: 223 NVEETIAKSLQFDFETIRV-------ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR 275
           ++ + ++ S    FE+ RV       AT+NF     +G G FG VYKG+L +G  +A+KR
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 276 LSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD-HFIFDP 334
            +  S QG  EF+ E+  L+  +H +LV L+GFC ER E IL+Y+++ N +L  H     
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 335 INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +    M+WE+R +I  G ARGL YLH  +   IIHRD+K+ NILLD    PKI+DFG+++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 395 L-FEMDQTH 402
              E+ QTH
Sbjct: 188 KGTELGQTH 196

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 119/202 (58%), Gaps = 14/202 (6%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAV 273
           E++++E +  +   F F  ++  T+NF +       NK+G+GGFG VYKG ++N  T+AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 274 KRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
           K+L+      +++ + +F  E+ ++A+ QH NLV LLGF  +  +  LVY ++PN SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
            +        ++W  R KI +G A G+ +LHE+     IHRD+K++NILLD     KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 390 FGMARLFEMDQTHSDTNRVVGT 411
           FG+AR  E        +R+VGT
Sbjct: 177 FGLARASEKFAQTVMXSRIVGT 198

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 118/202 (58%), Gaps = 14/202 (6%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAV 273
           E++++E +  +   F F  ++  T+NF +       NK+G+GGFG VYKG ++N  T+AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 274 KRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
           K+L+      +++ + +F  E+ ++A+ QH NLV LLGF  +  +  LVY ++PN SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
            +        ++W  R KI +G A G+ +LHE+     IHRD+K++NILLD     KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 390 FGMARLFEMDQTHSDTNRVVGT 411
           FG+AR  E         R+VGT
Sbjct: 177 FGLARASEKFAQTVMXXRIVGT 198

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 74/188 (39%), Positives = 110/188 (58%), Gaps = 14/188 (7%)
Query: 234 FDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAVKRLSK----NSKQG 283
           F F  ++  T+NF +       NK+G+GGFG VYKG ++N  T+AVK+L+      +++ 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
           + +F  E+ ++A+ QH NLV LLGF  +  +  LVY ++PN SL   +        ++W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R KI +G A G+ +LHE+     IHRD+K++NILLD     KISDFG+AR  E      
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 404 DTNRVVGT 411
              R+VGT
Sbjct: 185 MXXRIVGT 192

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 74/188 (39%), Positives = 108/188 (57%), Gaps = 14/188 (7%)
Query: 234 FDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAVKRLSK----NSKQG 283
           F F  ++  T+NF +       NK G+GGFG VYKG ++N  T+AVK+L+      +++ 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
           + +F  E+ + A+ QH NLV LLGF  +  +  LVY + PN SL   +        ++W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R KI +G A G+ +LHE+     IHRD+K++NILLD     KISDFG+AR  E      
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 404 DTNRVVGT 411
             +R+VGT
Sbjct: 182 XXSRIVGT 189

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 106/189 (56%), Gaps = 13/189 (6%)
Query: 219 LEDENVEETIAKSLQFDFETIRVATDN-FSDANKLGQGGFGAVYKGM-LSNGETI----A 272
           LE E VE         +   +R+  +        LG G FG VYKG+ +  GET+    A
Sbjct: 12  LETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVA 71
Query: 273 VKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
           +K L++ +  +  +EF +E L++A + H +LVRLLG CL    + LV + +P+  L  ++
Sbjct: 72  IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYV 130
Query: 332 FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
            +  +++++  +        IA+G++YL E    R++HRDL A N+L+ S  + KI+DFG
Sbjct: 131 HE--HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFG 185
Query: 392 MARLFEMDQ 400
           +ARL E D+
Sbjct: 186 LARLLEGDE 194

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 96/155 (61%), Gaps = 12/155 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ +  GET+    A+K L++ +  +  +EF +E L++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG CL    + LV + +P+  L  ++ +  +++++  +        IA+G++YL E    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           R++HRDL A N+L+ S  + KI+DFG+ARL E D+
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 171

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 90/154 (58%), Gaps = 11/154 (7%)
Query: 252 LGQGGFGAVYKGML--SNGET---IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           +G G FG VYKGML  S+G+    +A+K L    +++  ++F  E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            G   + K  +++ E++ N +LD F+ +       +  +   ++ GIA G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             +HRDL A NIL++S +  K+SDFG++R+ E D
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/165 (35%), Positives = 93/165 (56%), Gaps = 14/165 (8%)
Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ + +GE +    A+K L +N S +   E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG CL    + LV + +P   L   + +  NR  +  +        IA+G+ YL +   +
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRE--NRGRLGSQDLLNWCMQIAKGMSYLED---V 138
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRV 408
           R++HRDL A N+L+ S  + KI+DFG+ARL ++D+T  H+D  +V
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 183

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 92/171 (53%), Gaps = 16/171 (9%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGL 356
            N++RL G   + K  ++V E++ N SLD F+     R+H    T  +   ++ GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            YL   S +  +HRDL A NIL++S +  K+SDFG+AR+ E D   + T R
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 80/147 (54%), Gaps = 4/147 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLGF 308
           K+G G FG V++    +G  +AVK L +     E   EF  EV ++ RL+H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
             +     +V E++   SL   +     RE +   +R  +   +A+G+ YLH +    I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 369 HRDLKASNILLDSEMNPKISDFGMARL 395
           HRDLK+ N+L+D +   K+ DFG++RL
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E S   +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           HRDL A N L+      K+SDFGM R    DQ  S T 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 163

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 145
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 146 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 155
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 20  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 78
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 79  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 136
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 137 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 170

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 251 KLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 306 LGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C    R+   L+ EF+P  SL  ++    ++E +   K  +    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
             R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 91/171 (53%), Gaps = 16/171 (9%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGL 356
            N++RL G   + K  ++V E++ N SLD F+     R+H    T  +   ++ GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            YL   S +  +HRDL A NIL++S +  K+SDFG+ R+ E D   + T R
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 6/158 (3%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + S   E +F  E  ++ +L H  LV+L G 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           HRDL A N L+      K+SDFGM R    DQ  S T 
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 183

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 75  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 132
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 133 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 166

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 75  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 132
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 133 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 166

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 18  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 76
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 77  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 134
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 135 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 168

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 15  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 74  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 131
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 132 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 165

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 19  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 77
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 78  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 135
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 136 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 169

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 4/147 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLGF 308
           K+G G FG V++    +G  +AVK L +     E   EF  EV ++ RL+H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
             +     +V E++   SL   +     RE +   +R  +   +A+G+ YLH +    I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 369 HRDLKASNILLDSEMNPKISDFGMARL 395
           HR+LK+ N+L+D +   K+ DFG++RL
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 12  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 70
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 71  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 128
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 129 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 162

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 11  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 69
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 70  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 127
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 128 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 161

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 5   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 63
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 64  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 121
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 122 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 155

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 6/158 (3%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           HRDL A N L+      K+SDFGM R    DQ  S T 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 163

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 6/158 (3%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 68
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           HRDL A N L+      K+SDFGM R    DQ  S T 
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 6/158 (3%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 73
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           HRDL A N L+      K+SDFGM R    DQ  S T 
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/157 (36%), Positives = 84/157 (53%), Gaps = 13/157 (8%)
Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           LG+G FG V    Y     N GE +AVK L   S    I + K E+ +L  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 306 LGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C E       L+ EF+P+ SL  ++  P N+  +  +++ K    I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           R + +HRDL A N+L++SE   KI DFG+ +  E D+
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 93/174 (53%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E + N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 135
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 173

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 137
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 175

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 136
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 174

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/157 (36%), Positives = 84/157 (53%), Gaps = 13/157 (8%)
Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           LG+G FG V    Y     N GE +AVK L   S    I + K E+ +L  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 306 LGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C E       L+ EF+P+ SL  ++  P N+  +  +++ K    I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           R + +HRDL A N+L++SE   KI DFG+ +  E D+
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 168

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 166

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 18/167 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
           +A +      ++G+GGFG V+KG ++ +   +A+K L     +GE E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           +++ L H N+V+L G  L      +V EFVP   L H + D      + W  + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNP---KISDFGMAR 394
           A G+ Y+ ++    I+HRDL++ NI L S  E  P   K++DFG+++
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 129
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 167

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 172

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 93/174 (53%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E + N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 93/174 (53%), Gaps = 22/174 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E + N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 86/158 (54%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    + E +   K  +    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 6   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 65  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 122
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHR+L+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 123 ERN---YIHRNLRAANILVSDTLSCKIADFGLARLIE 156

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 10/164 (6%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V +G L         +A+K L    +++   EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G        +++ EF+ N +LD F+   +N    T  +   ++ GIA G+ YL E   + 
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAE---MS 138
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            +HRDL A NIL++S +  K+SDFG++R  E + +       +G
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 89/167 (53%), Gaps = 18/167 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
           +A +      ++G+GGFG V+KG ++ +   +A+K L     +GE E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           +++ L H N+V+L G  L      +V EFVP   L H + D      + W  + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNP---KISDFGMAR 394
           A G+ Y+ ++    I+HRDL++ NI L S  E  P   K++DFG ++
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 10/164 (6%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V +G L         +A+K L    +++   EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G        +++ EF+ N +LD F+   +N    T  +   ++ GIA G+ YL E   + 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAE---MS 136
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            +HRDL A NIL++S +  K+SDFG++R  E + +       +G
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 131
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              R IHR+L   NIL+++E   KI DFG+ ++   D+ +
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEY 171

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 6/158 (3%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           HRDL A N L+      K+SDFGM R    DQ  S T 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G  G V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 10  VPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M  +K   I    ARG+ YLH  S   II
Sbjct: 77  S-TKPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---II 130
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  +   KI DFG+A
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLA 155

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 89/172 (51%), Gaps = 21/172 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER 312
            +G FG V+K  L N E +AVK      KQ   + + EV  L  ++H N+++ +G   E+
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIG--AEK 88
Query: 313 K------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED---- 362
           +      +  L+  F    SL  F+   +    ++W +   I E +ARGL YLHED    
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
               +  I HRD+K+ N+LL + +   I+DFG+A  FE  ++  DT+  VGT
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M  +K   I    ARG+ YLH  S   II
Sbjct: 89  S-TKPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---II 142
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  +   KI DFG+A
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 18/167 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
           +A +      ++G+GGFG V+KG ++ +   +A+K L     +GE E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           +++ L H N+V+L G  L      +V EFVP   L H + D      + W  + +++  I
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNP---KISDFGMAR 394
           A G+ Y+ ++    I+HRDL++ NI L S  E  P   K++DF +++
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           FSD  ++G G FGAVY    + N E +A+K++S + KQ   ++++   EV  L +L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            ++  G  L      LV E+   ++ D      ++++ +   +   +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   +IHRD+KA NILL      K+ DFG A +       +  N  VGT
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGT 213

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           FSD  ++G G FGAVY    + N E +A+K++S + KQ   ++++   EV  L +L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            ++  G  L      LV E+   ++ D      ++++ +   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   +IHRD+KA NILL      K+ DFG A +       +  N  VGT
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGT 174

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++L H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 88  ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++L H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
                +  +V ++   +SL H +     +  M  +K   I    ARG+ YLH  S   II
Sbjct: 89  STA-PQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---II 142
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  +   KI DFG+A
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
           ED N  +T+ +    D     +     +   ++G G FG VYKG       + +  ++  
Sbjct: 13  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 70
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
           + Q    FKNEV +L + +H N++  +G+   + +  +V ++   +SL H +     +  
Sbjct: 71  TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFE 129
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           M   K   I    A+G+ YLH  S   IIHRDLK++NI L  ++  KI DFG+A
Sbjct: 130 MI--KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 178

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
           ED N  +T+ +    D     +     +   ++G G FG VYKG       + +  ++  
Sbjct: 14  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 71
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
           + Q    FKNEV +L + +H N++  +G+   + +  +V ++   +SL H +     +  
Sbjct: 72  TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFE 130
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           M   K   I    A+G+ YLH  S   IIHRDLK++NI L  ++  KI DFG+A
Sbjct: 131 MI--KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
           ED N  +T+ +    D     +     +   ++G G FG VYKG       + +  ++  
Sbjct: 14  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 71
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
           + Q    FKNEV +L + +H N++  +G+   + +  +V ++   +SL H +     +  
Sbjct: 72  TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFE 130
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           M   K   I    A+G+ YLH  S   IIHRDLK++NI L  ++  KI DFG+A
Sbjct: 131 MI--KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG V      + G+ +A+K      L+K+  QG IE   E+  L  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H ++++L      + E I+V E+  N   D+ +     R+ M+ ++  +  + I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 118
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            H   R +I+HRDLK  N+LLD  +N KI+DFG++ + 
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 153

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 96
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       +V E++P  +L  ++ +  NRE +T      +   I+  + YL + +    I
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYLEKKN---FI 152
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGD 183

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  ++  KI DFG+A
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG V      + G+ +A+K      L+K+  QG IE   E+  L  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H ++++L      + E I+V E+  N   D+ +     R+ M+ ++  +  + I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 122
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            H   R +I+HRDLK  N+LLD  +N KI+DFG++ + 
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 157

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG V      + G+ +A+K      L+K+  QG IE   E+  L  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H ++++L      + E I+V E+  N   D+ +     R+ M+ ++  +  + I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            H   R +I+HRDLK  N+LLD  +N KI+DFG++ + 
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG V      + G+ +A+K      L+K+  QG IE   E+  L  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H ++++L      + E I+V E+  N   D+ +     R+ M+ ++  +  + I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 128
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            H   R +I+HRDLK  N+LLD  +N KI+DFG++ + 
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 163

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 74/147 (50%), Gaps = 5/147 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLG G FG V+ G  +N   +AVK L   +   +  F  E  L+  LQH  LVRL     
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           + +   ++ EF+   SL  F+      + +   K       IA G+ Y+    R   IHR
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+N+L+   +  KI+DFG+AR+ E
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIE 160

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I++ E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I++ E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 75  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 128
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  ++  KI DFG+A
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLA 153

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  ++  KI DFG+A
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 126
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  ++  KI DFG+A
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 126
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  ++  KI DFG+A
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 93  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 146
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  ++  KI DFG+A
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 75  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIE 156

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 73  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIE 154

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 191

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIE 414

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 45  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 104
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 164
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR
Sbjct: 165 RDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 209

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 19  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 78
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 79  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 138
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR
Sbjct: 139 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR
Sbjct: 188 RDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 232

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 44  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 103
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 163
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR
Sbjct: 164 RDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 208

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 138 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 74  EEPIXI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIE 155

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 10/164 (6%)
Query: 252 LGQGGFGAVYKGMLS-NGET---IAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L   G+    +A+K L S  +++   +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   +    +++ EF+ N SLD F+    N    T  +   ++ GIA G+ YL +   + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MN 155
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            +HRDL A NIL++S +  K+SDFG++R  E D +       +G
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VCEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE 165

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 34  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 93
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 94  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 153
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR
Sbjct: 154 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE 331

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE 331

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L         +A+K L    +++   +F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  ++V E++ N SLD F+    N    T  +   ++ GI+ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKK--NDGQFTVIQLVGMLRGISAGMKYL---SDMG 144
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRDL A NIL++S +  K+SDFG++R+ E D   + T R
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 136 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 134 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 135 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 85/161 (52%), Gaps = 10/161 (6%)
Query: 252 LGQGGFGAVYKGMLS-NGE---TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L   G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  +++ E++ N SLD F+    N    T  +   ++ GI  G+ YL   S + 
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL---SDMS 151
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRDL A NIL++S +  K+SDFGM+R+ E D   + T R
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 135 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 80  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 137 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 77  EEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIE 158

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           +D +   +  ++     +LG G FG V+ G  +N   +AVK L   +   +  F  E  L
Sbjct: 3   WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANL 61
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  LQH  LVRL       +   ++ E++   SL  F+      + +   K       IA
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIA 120
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            G+ Y+    R   IHRDL+A+N+L+   +  KI+DFG+AR+ E
Sbjct: 121 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 161

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 134 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 159 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 206

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 54  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 113
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 173
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL     P    KI DFGMAR
Sbjct: 174 RDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR 218

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 137 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 134 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 137 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
               +  I V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 73  STAPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 126
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRDLK++NI L  ++  KI DFG+A
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 137 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 136 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 141 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 87  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 144 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 191

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 EEPIYI-VGEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE 331

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 134 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 83  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 140 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L         +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  +++ E++ N SLD F+    N    T  +   ++ GI  G+ YL   S + 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL---SDMS 136
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRDL A NIL++S +  K+SDFGM+R+ E D   + T R
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL A+NIL+   +  K++DFG+ARL E
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIE 165

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 85/161 (52%), Gaps = 10/161 (6%)
Query: 252 LGQGGFGAVYKGMLS-NGE---TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L   G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  +++ E++ N SLD F+    N    T  +   ++ GI  G+ YL   S + 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL---SDMS 130
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRDL A NIL++S +  K+SDFGM+R+ E D   + T R
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +++H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 91/167 (54%), Gaps = 10/167 (5%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           F    KLG+G +G+VYK +    G+ +A+K++   S   EI    E+ ++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI--IKEISIMQQCDSPHVVK 88
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             G   +  +  +V E+    S+   I   +  + +T ++   I++   +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +R IHRD+KA NILL++E + K++DFG+A   ++    +  N V+GT
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDXMAKRNXVIGT 188

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 94/172 (54%), Gaps = 14/172 (8%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 127 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLL 293
            +   N     +LG+G FG V+     N         +AVK L   S     +F  E  L
Sbjct: 9   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH-------------- 339
           L  LQH ++V+  G C+E    I+V+E++ +  L+ F+     R H              
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL-----RAHGPDAVLMAEGNPPT 123
Query: 340 -MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            +T  +   I + IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---- 176
Query: 399 DQTHSDTNRVVG 410
           D   +D  RV G
Sbjct: 177 DVYSTDYYRVGG 188

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++    L  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VMEYMSKGCLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 251 EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ RL E
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIE 332

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 25/178 (14%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI------------FDPINREHMTWEKRYKIIEGI 352
             G C E +  ++V+E++ +  L+ F+             + +    +   +   +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D   +D  RV G
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 218

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 93/172 (54%), Gaps = 14/172 (8%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA G+ Y
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAEGMNY 129
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 130 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 81  EEPIYI-VTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIE 162

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 81  EEPIYI-VTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIE 162

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 25/178 (14%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI------------FDPINREHMTWEKRYKIIEGI 352
             G C E +  ++V+E++ +  L+ F+             + +    +   +   +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D   +D  RV G
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 189

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 35/183 (19%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREH-----------------MTWEKRYK 347
             G C E +  ++V+E++ +  L+ F+     R H                 +   +   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFL-----RSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D   +D  R
Sbjct: 140 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR 192
Query: 408 VVG 410
           V G
Sbjct: 193 VGG 195

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 20/172 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL-----G 307
            +G FG V+K  L N + +AVK      KQ   + + E+     ++H NL++ +     G
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS-WQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED----- 362
             LE  E  L+  F    SL  ++   I    +TW +   + E ++RGL YLHED     
Sbjct: 82  SNLE-VELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
               +  I HRD K+ N+LL S++   ++DFG+A  FE  +   DT+  VGT
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGT 188

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++    L  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VTEYMSKGCLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+A+NIL+   +  K++DFG+ARL E
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 92/156 (58%), Gaps = 22/156 (14%)
Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLS---KNSKQGEIEFKNEVLLLARLQ-HRNLVRL 305
           KLG+G +G V+K +    GE +AVK++    +NS   +  F+ E+++L  L  H N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 306 LGFCLERKER--ILVYEFVP---NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           L       +R   LV++++    +A +   I +P++++++     Y++I+ I     YLH
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV----YQLIKVIK----YLH 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
                 ++HRD+K SNILL++E + K++DFG++R F
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMAR 394
             IA G  YL E+     IHRD+ A N LL         KI DFGMA+
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRL----SKNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           +G GGFG VY+     G+ +AVK       ++  Q     + E  L A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
            CL+     LV EF     L+  +    + + +  +        IARG+ YLH+++ + I
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 368 IHRDLKASNILLDSEMNP--------KISDFGMAR 394
           IHRDLK+SNIL+  ++          KI+DFG+AR
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V
Sbjct: 136 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V
Sbjct: 136 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 9/159 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQH 299
           ++F   N LG+G F  VY+   +  G  +A+K + K +  K G ++  +NEV +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            +++ L  +  +     LV E   N  ++ ++ + + +     E R+  +  I  G+LYL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARH-FMHQIITGMLYL 128
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
           H      I+HRDL  SN+LL   MN KI+DFG+A   +M
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V
Sbjct: 138 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 185

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V
Sbjct: 134 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G FG VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V
Sbjct: 136 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V
Sbjct: 141 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 188

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V    Y  +  N G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 305 LLG--FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G  +   R E  LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYL--G 128
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           SR R +HRDL A NIL++SE + KI+DFG+A+L  +D+
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 165

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V+LL       +  LV+EF+     D      +    +   K Y  +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 153

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V+LL       +  LV+EF+     D      +    +   K Y  +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V+LL       +  LV+EF+     D      +    +   K Y  +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 120
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 155

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 88/166 (53%), Gaps = 6/166 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             + YL + +    IHRDL A N L+      K++DFG++RL   D
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 82
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     L  G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 84  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 141 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     L  G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 134 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 89/166 (53%), Gaps = 22/166 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARL 297
           V  +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 298 QHRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIE 350
            H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQ 118
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           G+A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 119 GLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 157

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V    Y  +  N G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 305 LLG--FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G  +   R+   LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYL--G 132
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           SR R +HRDL A NIL++SE + KI+DFG+A+L  +D+ +
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 171

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 119 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 156

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V    Y  +  N G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 305 LLG--FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G  +   R+   LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           SR R +HRDL A NIL++SE + KI+DFG+A+L  +D+ +
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 170

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V    Y  +  N G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 305 LLG--FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G  +   R+   LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           SR R +HRDL A NIL++SE + KI+DFG+A+L  +D+ +
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 93/172 (54%), Gaps = 14/172 (8%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+  L +  S +   E  +E  ++A + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 166
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 167 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 88/166 (53%), Gaps = 6/166 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             + YL + +    IHRDL A N L+      K++DFG++RL   D
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 154

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 85/164 (51%), Gaps = 10/164 (6%)
Query: 252 LGQGGFGAVYKGMLS-NGET---IAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L   G+    +A+K L S  +++   +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   +    +++ EF+ N SLD F+    N    T  +   ++ GIA G+ YL +   + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MN 129
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            +HR L A NIL++S +  K+SDFG++R  E D +       +G
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 93/171 (54%), Gaps = 14/171 (8%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     L  G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRV 408
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V
Sbjct: 141 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 252 LGQGGFG-AVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           LG+G FG A+       GE + +K L +  ++ +  F  EV ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           + K    + E++   +L   I   ++ ++  W +R    + IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTL-RGIIKSMDSQY-PWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           DL + N L+    N  ++DFG+ARL   ++T  +  R
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L         +A+K L    +++   +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGLLYLHEDS 363
           G     K  ++V EF+ N +LD F+     R+H    T  +   ++ GIA G+ YL +  
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL-----RKHDGQFTVIQLVGMLRGIAAGMRYLAD-- 163
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            +  +HRDL A NIL++S +  K+SDFG++R+ E D
Sbjct: 164 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 118 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 155

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 82
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 119
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 120 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 157

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 118 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 155

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 154

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 154

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 118 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 155

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 82
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 81
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 137
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 168

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 124
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 125 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 160

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             + YL + +    IHRDL A N L+      K++DFG++RL   D
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 154

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 124
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 125 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 160

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 82
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 122
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             + YL + +    IHRDL A N L+      K++DFG++RL   D
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 78
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 82
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 95/173 (54%), Gaps = 20/173 (11%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
           K+GQG FG V+K      G+ +A+K+ L +N K+G  I    E+ +L  L+H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 308 FCLERKERI--------LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            C  +            LV++F  +  L   + + + +  ++  KR  +++ +  GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVV 409
           H   R +I+HRD+KA+N+L+  +   K++DFG+AR F +    Q +   NRVV
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 11/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRL--SKNSKQGEIEFKNEVLLLARLQ 298
           + + + +   +G+G +G V K    + G  +A+K+   S + K  +     E+ LL +L+
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGLL 357
           H NLV LL  C ++K   LV+EFV +  LD     P   ++   +K  ++II GI  G  
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GFC 140
Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           + H      IIHRD+K  NIL+      K+ DFG AR
Sbjct: 141 HSH-----NIIHRDIKPENILVSQSGVVKLCDFGFAR 172

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/173 (32%), Positives = 97/173 (56%), Gaps = 20/173 (11%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
           K+GQG FG V+K      G+ +A+K+ L +N K+G  I    E+ +L  L+H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 308 FCLER-------KERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            C  +       K  I LV++F  +  L   + + + +  ++  KR  +++ +  GL Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVV 409
           H   R +I+HRD+KA+N+L+  +   K++DFG+AR F +    Q +   NRVV
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G  G V  G L         +A+K L    +++   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGLLYLHEDS 363
           G     +  ++V E++ N SLD F+     R H    T  +   ++ G+  G+ YL   S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            L  +HRDL A N+L+DS +  K+SDFG++R+ E D   + T 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT 211

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 118
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 119 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 154

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 79
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 25/173 (14%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           ++R A+D F +   LGQG FG V K   + +    A+K++ +++++      +EV+LLA 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 297 LQHRNLVRLLGFCLERKERI-------------LVYEFVPNASLDHFIFDPINREHMTWE 343
           L H+ +VR     LER+  +             +  E+  N +L    +D I+ E++  +
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQ 114
Query: 344 K--RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +   +++   I   L Y+H      IIHRDLK  NI +D   N KI DFG+A+
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 134
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             + YL + +    IHRDL A N L+      K++DFG++RL   D
Sbjct: 135 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 123
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             + YL + +    IHRDL A N L+      K++DFG++RL   D
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 79
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HRDL A N L+      K++DFG++RL   D
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 92/168 (54%), Gaps = 22/168 (13%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 208
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTN 406
            +  + +HRDL A N +LD +   K++DFG+AR     E D  H+ T 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G  G V  G L         +A+K L    +++   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGLLYLHEDS 363
           G     +  ++V E++ N SLD F+     R H    T  +   ++ G+  G+ YL   S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            L  +HRDL A N+L+DS +  K+SDFG++R+ E D
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 95/173 (54%), Gaps = 20/173 (11%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
           K+GQG FG V+K      G+ +A+K+ L +N K+G  I    E+ +L  L+H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 308 FCLERKERI--------LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            C  +            LV++F  +  L   + + + +  ++  KR  +++ +  GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVV 409
           H   R +I+HRD+KA+N+L+  +   K++DFG+AR F +    Q +   NRVV
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 95/173 (54%), Gaps = 20/173 (11%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
           K+GQG FG V+K      G+ +A+K+ L +N K+G  I    E+ +L  L+H N+V L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 308 FCLERKERI--------LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            C  +            LV++F  +  L   + + + +  ++  KR  +++ +  GL Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 140
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVV 409
           H   R +I+HRD+KA+N+L+  +   K++DFG+AR F +    Q +   NRVV
Sbjct: 141 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 92/168 (54%), Gaps = 22/168 (13%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTN 406
            +  + +HRDL A N +LD +   K++DFG+AR     E D  H+ T 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 196

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 22/167 (13%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDT 405
            +  + +HRDL A N +LD +   K++DFG+AR     E D  H+ T
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 22/167 (13%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 147
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDT 405
            +  + +HRDL A N +LD +   K++DFG+AR     E D  H+ T
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 193

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 22/167 (13%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 154
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDT 405
            +  + +HRDL A N +LD +   K++DFG+AR     E D  H+ T
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 200

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 22/167 (13%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDT 405
            +  + +HRDL A N +LD +   K++DFG+AR     E D  H+ T
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT 196

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 22/167 (13%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDT 405
            +  + +HRDL A N +LD +   K++DFG+AR     E D  H+ T
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 196

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 25/173 (14%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           ++R A+D F +   LGQG FG V K   + +    A+K++ +++++      +EV+LLA 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 297 LQHRNLVRLLGFCLERKERI-------------LVYEFVPNASLDHFIFDPINREHMTWE 343
           L H+ +VR     LER+  +             +  E+  N +L    +D I+ E++  +
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL----YDLIHSENLNQQ 114
Query: 344 K--RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +   +++   I   L Y+H      IIHRDLK  NI +D   N KI DFG+A+
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 87/171 (50%), Gaps = 15/171 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRN 301
           + +    K+G+G +G VYK   S G  +A+KR+  +++   I      E+ LL  L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 302 LVRLLGFCLERKERILVYEFVPN---ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +V L+      +   LV+EF+       LD       N+  +   +    +  + RG+ +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDE------NKTGLQDSQIKIYLYQLLRGVAH 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
            H+    RI+HRDLK  N+L++S+   K++DFG+AR F +    S T+ VV
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV 181

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 87/171 (50%), Gaps = 15/171 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRN 301
           + +    K+G+G +G VYK   S G  +A+KR+  +++   I      E+ LL  L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 302 LVRLLGFCLERKERILVYEFVPN---ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +V L+      +   LV+EF+       LD       N+  +   +    +  + RG+ +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDE------NKTGLQDSQIKIYLYQLLRGVAH 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
            H+    RI+HRDLK  N+L++S+   K++DFG+AR F +    S T+ VV
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV 181

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 6/147 (4%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +LG G FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+ D   R  +       +   +A G+ Y+    R+  IHR
Sbjct: 75  EEPIYI-VTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 371 DLKASNILLDSEMNPKISDFGMARLFE 397
           DL+++NIL+ + +  KI+DFG+ARL E
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIE 156

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 88/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G++
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLS 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 6/151 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           HR+L A N L+      K++DFG++RL   D
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 88/165 (53%), Gaps = 22/165 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+E V        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 148
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 149
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 87/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+E V        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 168
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 167
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 147
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 149
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 148
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 144
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 19/153 (12%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 141
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +  + +HRDL A N +LD +   K++DFG+AR
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQH 299
           ++  F    KLG G +  VYKG+  + G  +A+K +  +S++G       E+ L+  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPN---ASLDHFIFDPINR-------EHMTWEKRYKII 349
            N+VRL        +  LV+EF+ N     +D        R       ++  W+      
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ------ 116
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
             + +GL + HE+   +I+HRDLK  N+L++     K+ DFG+AR F
Sbjct: 117 --LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 308
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 367
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             + YL + +    IHR+L A N L+      K++DFG++RL   D
Sbjct: 368 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 410

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 87/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+ ++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 87/163 (53%), Gaps = 22/163 (13%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+ ++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               + H     R++HRDLK  N+L+++E   K++DFG+AR F
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 16/168 (9%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNE 290
           L++D+E      D   D   LG+G +G VY G  LSN   IA+K + +   +       E
Sbjct: 15  LEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 69
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---FDPINREHMTWEKRYK 347
           + L   L+H+N+V+ LG   E     +  E VP  SL   +   + P+     T     K
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
               I  GL YLH++   +I+HRD+K  N+L+++     KISDFG ++
Sbjct: 130 ---QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 92/169 (54%), Gaps = 13/169 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNG-ETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+  +++G+G FG VYKG+ ++  E +A+K +  + ++    + + E+ +L++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           R  G  L+  +  ++ E++   S LD     P+   ++       I+  I +GL YLH +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 135
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
              R IHRD+KA+N+LL  + + K++DFG+A   ++  T    N  VGT
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNXFVGT 179

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 25/165 (15%)
Query: 251 KLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNL 302
           +LG+  FG VYKG L         + +A+K L K+  +G +  EF++E +L ARLQH N+
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIF-------------DPINREHMTWEKRYKII 349
           V LLG   + +   +++ +  +  L  F+              D   +  +       ++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 25/165 (15%)
Query: 251 KLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNL 302
           +LG+  FG VYKG L         + +A+K L K+  +G +  EF++E +L ARLQH N+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIF-------------DPINREHMTWEKRYKII 349
           V LLG   + +   +++ +  +  L  F+              D   +  +       ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 16/168 (9%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNE 290
           L++D+E      D   D   LG+G +G VY G  LSN   IA+K + +   +       E
Sbjct: 1   LEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 55
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---FDPINREHMTWEKRYK 347
           + L   L+H+N+V+ LG   E     +  E VP  SL   +   + P+     T     K
Sbjct: 56  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 115
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
               I  GL YLH++   +I+HRD+K  N+L+++     KISDFG ++
Sbjct: 116 ---QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 157

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           + +    K+G+G +G VYK   + GET A+K  RL K  +        E+ +L  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L      +K  +LV+E +               E +T +     +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS---FLLQLLNGIAYCHD 118
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               R++HRDLK  N+L++ E   KI+DFG+AR F
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF 150

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           + +    K+G+G +G VYK   + GET A+K  RL K  +        E+ +L  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L      +K  +LV+E +               E +T +     +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS---FLLQLLNGIAYCHD 118
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               R++HRDLK  N+L++ E   KI+DFG+AR F
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF 150

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           + +    K+G+G +G VYK   + GET A+K  RL K  +        E+ +L  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L      +K  +LV+E +               E +T +     +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS---FLLQLLNGIAYCHD 118
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               R++HRDLK  N+L++ E   KI+DFG+AR F
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF 150

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +AVK + + S   E EF  E   + +L H  LV+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 310 LERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +     +V E++ N  L +++       +P     M     Y + EG+A   L  H+  
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC----YDVCEGMA--FLESHQ-- 124
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
               IHRDL A N L+D ++  K+SDFGM R    DQ  S   
Sbjct: 125 ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARL 297
           +AT  +    ++G G +G VYK     +G  +A+K +   N ++G  I    EV LL RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL+  C   R +R     LV+E V +  L  ++ D      +  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARL 297
           +AT  +    ++G G +G VYK     +G  +A+K +   N ++G  I    EV LL RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL+  C   R +R     LV+E V +  L  ++ D      +  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARL 297
           +AT  +    ++G G +G VYK     +G  +A+K +   N ++G  I    EV LL RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL+  C   R +R     LV+E V +  L  ++ D      +  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 25/173 (14%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           ++R A+D F +   LGQG FG V K   + +    A+K++ +++++      +EV LLA 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLAS 58
Query: 297 LQHRNLVRLLGFCLERKERI-------------LVYEFVPNASLDHFIFDPINREHMTWE 343
           L H+ +VR     LER+  +             +  E+  N +L    +D I+ E++  +
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL----YDLIHSENLNQQ 114
Query: 344 K--RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +   +++   I   L Y+H      IIHR+LK  NI +D   N KI DFG+A+
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           DN      +G+G +GAVYKG L +   +AVK  S  ++Q  I  KN +  +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 304 RLLG-----FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           R +          R E +LV E+ PN SL  ++    +     W    ++   + RGL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 359 LHED------SRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           LH +       +  I HRDL + N+L+ ++    ISDFG++
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 82/164 (50%), Gaps = 32/164 (19%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFK---NEVLLLARLQHRNLVRL 305
           LG G FG V+KG+ +  GE+I +    K    K G   F+   + +L +  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 306 LGFCLERKERILVYEFVPNASL-DHFIFDPINREH---------MTWEKRYKIIEGIARG 355
           LG C     + LV +++P  SL DH       R+H         + W  +      IA+G
Sbjct: 99  LGLCPGSSLQ-LVTQYLPLGSLLDHV------RQHRGALGPQLLLNWGVQ------IAKG 145
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           + YL E     ++HR+L A N+LL S    +++DFG+A L   D
Sbjct: 146 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 186

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 82/164 (50%), Gaps = 32/164 (19%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFK---NEVLLLARLQHRNLVRL 305
           LG G FG V+KG+ +  GE+I +    K    K G   F+   + +L +  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 306 LGFCLERKERILVYEFVPNASL-DHFIFDPINREH---------MTWEKRYKIIEGIARG 355
           LG C     + LV +++P  SL DH       R+H         + W  +      IA+G
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHV------RQHRGALGPQLLLNWGVQ------IAKG 127
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           + YL E     ++HR+L A N+LL S    +++DFG+A L   D
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 6/145 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           + ++G G FG VYKG       + + ++   + +    F+NEV +L + +H N++  +G+
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            + +    +V ++   +SL   +     +  M   +   I    A+G+ YLH  +   II
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---II 154
Query: 369 HRDLKASNILLDSEMNPKISDFGMA 393
           HRD+K++NI L   +  KI DFG+A
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLA 179

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 26/179 (14%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L   +     +F+ E  LL  LQH ++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHF----------IFDPINRE---HMTWEKRYKIIEG 351
             G C +    I+V+E++ +  L+ F          + D   R+    +   +   I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           IA G++YL   +    +HRDL   N L+ + +  KI DFGM+R    D   +D  RV G
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGG 193

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 252 LGQGGFGAVYKGML-----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V            GE +AVK L  +   Q    +K E+ +L  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 306 LGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C ++ E+ L  V E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               IHR+L A N+LLD++   KI DFG+A+
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 252 LGQGGFGAVYKGML-----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V            GE +AVK L  +   Q    +K E+ +L  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 306 LGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C ++ E+ L  V E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               IHR+L A N+LLD++   KI DFG+A+
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 143
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSD 404
           G+ Y+H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D
Sbjct: 144 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 193

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSNG--ETIAVKRLSKN-SKQGEIEFKNEVLLLAR 296
           +N      +G+G FG V++    G+L       +AVK L +  S   + +F+ E  L+A 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP---INREHMTWEKRYK---- 347
             + N+V+LLG C   K   L++E++    L+ F+    P    +  H     R +    
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 348 ------------IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR- 394
                       I   +A G+ YL E    + +HRDL   N L+   M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 395 LFEMDQTHSDTNRVV 409
           ++  D   +D N  +
Sbjct: 224 IYSADYYKADGNDAI 238

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + D +    KLG+G +G VYK + +   ET+A+KR+    ++  +      EV LL  LQ
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           HRN++ L           L++E+  N    +   +P     +     Y++I G+     +
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN----F 147
Query: 359 LHEDSRLRIIHRDLKASNILL---DSEMNP--KISDFGMARLF 396
            H  SR R +HRDLK  N+LL   D+   P  KI DFG+AR F
Sbjct: 148 CH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLA 295
           +   D+F     LG+G FG VY       + I A+K L K+   K+G E + + E+ + +
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASL-----DHFIFDPINREHMTWEKRYKIIE 350
            L+H N++R+  +  +RK   L+ EF P   L      H  FD         ++    +E
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE--------QRSATFME 121
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            +A  L Y HE    ++IHRD+K  N+L+  +   KI+DFG +
Sbjct: 122 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS 161

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLA 295
           +   D+F     LG+G FG VY       + I A+K L K+   K+G E + + E+ + +
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASL-----DHFIFDPINREHMTWEKRYKIIE 350
            L+H N++R+  +  +RK   L+ EF P   L      H  FD         ++    +E
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE--------QRSATFME 122
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            +A  L Y HE    ++IHRD+K  N+L+  +   KI+DFG +
Sbjct: 123 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS 162

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 137
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSD 404
           G+ Y+H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 20/194 (10%)
Query: 229 AKSL-QFDFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE 286
           A+SL + D   +R     F     +G G +G VYKG  +  G+  A+K +     + E E
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-E 66
Query: 287 FKNEVLLLARL-QHRNLVRLLGFCLERK------ERILVYEFVPNASLDHFIFDPINREH 339
            K E+ +L +   HRN+    G  +++       +  LV EF    S+   I    N + 
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKG 123
Query: 340 MTWEKRY--KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            T ++ +   I   I RGL +LH+    ++IHRD+K  N+LL      K+ DFG++   +
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--Q 178
Query: 398 MDQTHSDTNRVVGT 411
           +D+T    N  +GT
Sbjct: 179 LDRTVGRRNTFIGT 192

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 160
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSD 404
           G+ Y+H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D
Sbjct: 161 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 210

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 161
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSD 404
           G+ Y+H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D
Sbjct: 162 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 211

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP-----INREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++    P       R   T ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 184

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP-----INREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++    P       R   T ++  
Sbjct: 73  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 132
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 133 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 183

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 77/146 (52%), Gaps = 6/146 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
             +LG G FG VYK        +A  ++ +   + E+E +  E+ +LA   H  +V+LLG
Sbjct: 24  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                 +  ++ EF P  ++D  + + ++R  +T  +   +   +   L +LH     RI
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLE-LDR-GLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 368 IHRDLKASNILLDSEMNPKISDFGMA 393
           IHRDLKA N+L+  E + +++DFG++
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 77/146 (52%), Gaps = 6/146 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
             +LG G FG VYK        +A  ++ +   + E+E +  E+ +LA   H  +V+LLG
Sbjct: 16  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 75
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                 +  ++ EF P  ++D  + + ++R  +T  +   +   +   L +LH     RI
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLE-LDR-GLTEPQIQVVCRQMLEALNFLHSK---RI 130
Query: 368 IHRDLKASNILLDSEMNPKISDFGMA 393
           IHRDLKA N+L+  E + +++DFG++
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 132
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 185

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS--LRPEMENNPVLAPPSLSK 139
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDPI--NREHMTWEKRYKII 349
           +      ++VRLLG   + +  +++ E +    L  ++    P   N   +      K+I
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 350 E---GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           +    IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNL 302
           D +    +LG G FG VYK        +A  ++     + E+E +  E+ +LA   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 303 VRLL-GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLH 360
           V+LL  F  E    IL+ EF    ++D  + +    E    E + +++ +     L YLH
Sbjct: 97  VKLLDAFYYENNLWILI-EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH 152
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           ++   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 132
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 185

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 133
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 186

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 126
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 179

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNL 302
           D +    +LG G FG VYK        +A  ++     + E+E +  E+ +LA   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 303 VRLL-GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLH 360
           V+LL  F  E    IL+ EF    ++D  + +    E    E + +++ +     L YLH
Sbjct: 97  VKLLDAFYYENNLWILI-EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH 152
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           ++   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 87/167 (52%), Gaps = 17/167 (10%)
Query: 242 ATDNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARL 297
           A   +    ++G+G +G V+K   + + G  +A+KR+   + +  +      EV +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL   C + R +R     LV+E V +  L  ++ D +    +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
             + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 130
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 131 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 183

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNL 302
           D +    +LG G FG VYK        +A  ++     + E+E +  E+ +LA   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 303 VRLL-GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLH 360
           V+LL  F  E    IL+ EF    ++D  + +    E    E + +++ +     L YLH
Sbjct: 97  VKLLDAFYYENNLWILI-EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH 152
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           ++   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF--------DPINREHMTWEKR 345
           +      ++VRLLG   + +  +++ E +    L  ++         +P+     +  K 
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP-SLSKM 130
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
            ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 182

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 10/150 (6%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+    +    +AVK +   S   E  F  E  ++  LQH  LV+L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL--HA 77
Query: 310 LERKERI-LVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
           +  KE I ++ EF+   SL  F+  D  +++ +   K       IA G+ ++ + +    
Sbjct: 78  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---Y 132
Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFE 397
           IHRDL+A+NIL+ + +  KI+DFG+AR+ E
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIE 162

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 161
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D
Sbjct: 162 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 214

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 88/172 (51%), Gaps = 12/172 (6%)
Query: 244 DNFSDAN-KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
           DN   A+ +LG G FG+V +G   M      +A+K L + +++ + E    E  ++ +L 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +  +VRL+G C + +  +LV E      L  F+     RE +      +++  ++ G+ Y
Sbjct: 69  NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKY 125
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           L E +    +HRDL A N+LL +    KISDFG+++    D ++  T R  G
Sbjct: 126 LEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAG 173

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 87/167 (52%), Gaps = 17/167 (10%)
Query: 242 ATDNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARL 297
           A   +    ++G+G +G V+K   + + G  +A+KR+   + +  +      EV +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL   C + R +R     LV+E V +  L  ++ D +    +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
             + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 252 LGQGGFGAVYKGMLSNGET---IAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
           +G+G FG V K  +         A+KR+ +  SK    +F  E+ +L +L H  N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDPI------NREHMTWEKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+        DP           ++ ++       +A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           RG+ YL   S+ + IHRDL A NIL+      KI+DFG++R
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE----TIAVKRLS-KNSKQG 283
           ++ LQ   E + +  +       LG+G FG+V +G L   +     +AVK +   NS Q 
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 284 EIE-FKNEVLLLARLQHRNLVRLLGFCLERKER-----ILVYEFVPNASLDHFIFDP--- 334
           EIE F +E   +    H N++RLLG C+E   +     +++  F+    L  ++      
Sbjct: 79  EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 335 INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +H+  +   K +  IA G+ YL   S    +HRDL A N +L  +M   ++DFG+++
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP-----INREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++    P       R   T ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 87/167 (52%), Gaps = 17/167 (10%)
Query: 242 ATDNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARL 297
           A   +    ++G+G +G V+K   + + G  +A+KR+   + +  +      EV +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL   C + R +R     LV+E V +  L  ++ D +    +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
             + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 252 LGQGGFGAVYKGMLSNGET---IAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
           +G+G FG V K  +         A+KR+ +  SK    +F  E+ +L +L H  N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDPI------NREHMTWEKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+        DP           ++ ++       +A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           RG+ YL   S+ + IHRDL A NIL+      KI+DFG++R
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP-----INREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++    P       R   T ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 10/150 (6%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+    +    +AVK +   S   E  F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL--HA 250
Query: 310 LERKERI-LVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
           +  KE I ++ EF+   SL  F+  D  +++ +   K       IA G+ ++ + +    
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---Y 305
Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFE 397
           IHRDL+A+NIL+ + +  KI+DFG+AR+ E
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE 335

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP-----INREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++    P       R   T ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ + A L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           RDL A N L++ +   K+SDFG++R    D+  S   
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVG 180

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           RDL A N L++ +   K+SDFG++R    D+  S   
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 370 RDLKASNILLDSEMNPKISDFGMAR 394
           RDL A N L++ +   K+SDFG++R
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSR 148

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 133
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D   +D
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETD 186
Query: 405 TNRVVG 410
             R  G
Sbjct: 187 XXRKGG 192

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 124
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D   +D
Sbjct: 125 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETD 177
Query: 405 TNRVVG 410
             R  G
Sbjct: 178 XXRKGG 183

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 11  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 70
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP-----INREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++    P       R   T ++  
Sbjct: 71  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 130
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R
Sbjct: 131 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 12/172 (6%)
Query: 244 DNFSDAN-KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
           DN   A+ +LG G FG+V +G   M      +A+K L + +++ + E    E  ++ +L 
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 394
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +  +VRL+G C + +  +LV E      L  F+     RE +      +++  ++ G+ Y
Sbjct: 395 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKY 451
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           L E +    +HR+L A N+LL +    KISDFG+++    D ++  T R  G
Sbjct: 452 LEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAG 499

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 17/173 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+ +L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 137
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSD 404
           G+ Y H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D
Sbjct: 138 GITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKD 187

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           RDL A N L++ +   K+SDFG++R    D+  S   
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 171

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 370 RDLKASNILLDSEMNPKISDFGMAR 394
           RDL A N L++ +   K+SDFG++R
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSR 152

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 370 RDLKASNILLDSEMNPKISDFGMAR 394
           RDL A N L++ +   K+SDFG++R
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 80/171 (46%), Gaps = 23/171 (13%)
Query: 251 KLGQGGFGAVYKGMLSNGET---IAVKRLS-----------KNSKQGEIEFKNEVLLLAR 296
           KLG G +G V      NG +   I V + S           KN ++   E  NE+ LL  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           L H N+++L     ++K   LV EF     L   I   INR          I++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGI 159
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSD 404
            YLH+ +   I+HRD+K  NILL+++   +N KI DFG++  F  D    D
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 127
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 370 RDLKASNILLDSEMNPKISDFGMAR 394
           RDL A N L++ +   K+SDFG++R
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 252 LGQGGFGAVYKG----MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G       N    A+K LS+ ++  ++E F  E LL+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 307 GFCL--ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           G  L  E    +L+  ++ +  L  FI  P  + + T +        +ARG+ YL E   
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            + +HRDL A N +LD     K++DFG+AR
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 252 LGQGGFGAVYKGML-----SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V            GE +AVK L  ++  Q    +K E+ +L  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 306 LGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C +     L  V E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               IHRDL A N+LLD++   KI DFG+A+
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 241 VATDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLL 294
           +AT  +    ++G G +G VYK      G     +++ V           I    EV LL
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 295 ARLQ---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
            RL+   H N+VRL+  C   R +R     LV+E V +  L  ++ D      +  E   
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIK 123
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            ++    RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 126
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
             ++   IA G+ YL+ +   + +HRDL A N  +  +   KI DFGM R ++E D
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD 179

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           LG+G FG VY+G+ +N  GE I  AVK   K+      E F +E +++  L H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G  +E +   ++ E  P   L H++    N   +     Y +   I + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 145
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            +HRD+   NIL+ S    K+ DFG++R  E
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIE 176

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           LG+G FG VY+G+ +N  GE I  AVK   K+      E F +E +++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G  +E +   ++ E  P   L H++    N   +     Y +   I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            +HRD+   NIL+ S    K+ DFG++R  E
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIE 160

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           LG+G FG VY+G+ +N  GE I  AVK   K+      E F +E +++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G  +E +   ++ E  P   L H++    N   +     Y +   I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            +HRD+   NIL+ S    K+ DFG++R  E
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP-----INREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++    P       R   T ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           ++   IA G+ YL+     + +HR+L A N ++  +   KI DFGM R ++E D
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 184

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 15  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP-----INREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++    P       R   T ++  
Sbjct: 75  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           ++   IA G+ YL+     + +HR+L A N ++  +   KI DFGM R ++E D
Sbjct: 135 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 185

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 123
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 123
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 133
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 133
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 252 LGQGGFGAVYKGML-----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V            GE +AVK L +    Q    ++ E+ +L  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 306 LGFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C ++ E+   LV E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               IHR L A N+LLD++   KI DFG+A+
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 127
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 252 LGQGGFGAVYKGML-----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V            GE +AVK L +    Q    ++ E+ +L  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 306 LGFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C ++ E+   LV E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               IHR L A N+LLD++   KI DFG+A+
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNS--KQG-EIEFKNE 290
           D  T     D+F     LG+G FG VY          +A+K L K+   K+G E + + E
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-II 349
           + + A L H N++RL  +  +R+   L+ E+ P   L    +  + +     E+R   I+
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQRTATIM 129
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           E +A  L+Y H     ++IHRD+K  N+LL  +   KI+DFG +
Sbjct: 130 EELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS 170

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 123
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 240 RVATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSKNSKQGE---IEFKNEVLLL 294
           ++  + +   +KLG GG   VY  +  + N + +A+K +    ++ E     F+ EV   
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIEGI 352
           ++L H+N+V ++    E     LV E++   +L  +I       H  ++ +        I
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQI 120
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
             G+ + H+   +RI+HRD+K  NIL+DS    KI DFG+A+    + + + TN V+GT+
Sbjct: 121 LDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTV 176

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 7/148 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHRNLVRLL 306
             ++G+G FG V+ G L    T+   +  + +   +++  F  E  +L +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C +++   +V E V     D   F       +  +   +++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMAR 394
            IHRDL A N L+  +   KISDFGM+R
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 7/148 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHRNLVRLL 306
             ++G+G FG V+ G L    T+   +  + +   +++  F  E  +L +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C +++   +V E V     D   F       +  +   +++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMAR 394
            IHRDL A N L+  +   KISDFGM+R
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-----GEIEFKNEVLL 293
           RV   ++   + LG G FG V  G     G  +AVK L++   +     G+I  + E+  
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI--RREIQN 69
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIEGI 352
           L   +H ++++L        +  +V E+V    L    FD I +     EK  + + + I
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQI 125
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
             G+ Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ + 
Sbjct: 126 LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+    +    +AVK +   S   E  F  E  ++  LQH  LV+L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL--HA 244
Query: 310 LERKERI-LVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
           +  KE I ++ EF+   SL  F+  D  +++ +   K       IA G+ ++ + +    
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---Y 299
Query: 368 IHRDLKASNILLDSEMNPKISDFGMARL 395
           IHRDL+A+NIL+ + +  KI+DFG+AR+
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRN 301
           + +   +KLG+G +  VYKG        +A+K +    ++G       EV LL  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V L       K   LV+E++ +  L  ++ D  N  +M   K +  +  + RGL Y H 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCH- 117
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             R +++HRDLK  N+L++     K++DFG+AR
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           L   E  +V E++   SL     D +    M   +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           RD+K+ NILL  + + K++DFG       +Q+   T  +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSK 278
           E+   EE  +K    + +  + A ++F     LG+G FG VY       + I A+K L K
Sbjct: 10  ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 69
Query: 279 NS--KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI 335
               K G E + + EV + + L+H N++RL G+  +     L+ E+ P  +    ++  +
Sbjct: 70  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYREL 125
Query: 336 NREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            +     E+R    I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 126 QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 19  ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 75
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 76  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 131
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 132 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 172

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 8   ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 64
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 65  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 120
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 121 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 161

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 252 LGQGGFGAVYKGMLSNGET---IAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
           +G+G FG V K  +         A+KR+ +  SK    +F  E+ +L +L H  N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDPI------NREHMTWEKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+        DP           ++ ++       +A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           RG+ YL   S+ + IHR+L A NIL+      KI+DFG++R
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 17  ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 73
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 74  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 130 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 170

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 139 ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 195
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 196 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 251
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 252 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 292

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSK 278
           E+   EE  +K    + +  + A ++F     LG+G FG VY       + I A+K L K
Sbjct: 10  ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 69
Query: 279 NS--KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI 335
               K G E + + EV + + L+H N++RL G+  +     L+ E+ P  +    ++  +
Sbjct: 70  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYREL 125
Query: 336 NREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            +     E+R    I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 126 QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 12  ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 68
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 69  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 124
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 125 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 165

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 171

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 103
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 162 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 199

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 62  ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 118
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 119 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 174
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 175 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 215

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 109
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 168 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P       ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 113
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 172 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 111
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 170 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 207

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSK 278
           E+   EE  +K    + +  + A ++F     LG+G FG VY       + I A+K L K
Sbjct: 1   ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 60
Query: 279 NS--KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI 335
               K G E + + EV + + L+H N++RL G+  +     L+ E+ P  +    ++  +
Sbjct: 61  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYREL 116
Query: 336 NREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            +     E+R    I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 117 QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 172

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 109
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 168 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY     N + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     ++IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +  + ++    + + E+ +L++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 143
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGT 187

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +  + ++    + + E+ +L++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 138
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGT 182

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 80
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 139 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 176

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P       ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 9/154 (5%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRNL 302
           +    K+G+G +G V+K       E +A+KR+  +     +      E+ LL  L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           VRL       K+  LV+EF  +  L  + FD  N + +  E     +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR 120
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +   ++HRDLK  N+L++     K++DFG+AR F
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLADFGLARAF 151

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 154
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 213 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 250

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           L   E  +V E++   SL     D +    M   +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           RD+K+ NILL  + + K++DFG       +Q  S  + +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSEMVGT 179

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 94
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 153 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 190

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +  + ++    + + E+ +L++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 123
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGT 167

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 88
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 147 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 184

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 83
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 142 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 179

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +  + ++    + + E+ +L++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 123
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGT 167

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 87
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 146 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 199
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 200 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 87
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 146 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 76
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 135 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 172

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++IHRD+K+ NILL  + + K++DFG       +Q  S  + +VGT
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGT 179

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 136
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++IHRD+K+ NILL  + + K++DFG       +Q  S  + +VGT
Sbjct: 137 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGT 180

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  FC +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 147
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 148 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 140
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 141 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 123
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 145
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 146 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   ++G+G FG V+KG+ +   + +A+K +  + ++    + + E+ +L++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P +   +       +++ I +GL YLH +
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHSE 139
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   IHRD+KA+N+LL  + + K++DFG+A   ++  T    N  VGT
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGT 183

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G  G V      + G+ +AVK++    +Q      NEV+++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           L   E  +V EF+   +L     D +    M  E+   +   + R L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 370 RDLKASNILLDSEMNPKISDFG 391
           RD+K+ +ILL S+   K+SDFG
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG 186

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 79
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 138 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 175

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-----GEIEFKNEVLL 293
           RV   ++   + LG G FG V  G     G  +AVK L++   +     G+I  K E+  
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKI--KREIQN 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           L   +H ++++L        +  +V E+V    L  +I      E M  E R ++ + I 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EAR-RLFQQIL 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
             + Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ + 
Sbjct: 122 SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      +I+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 142
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 143 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 120
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 121 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 154

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-----GEIEFKNEVLL 293
           RV   ++   + LG G FG V  G     G  +AVK L++   +     G+I  K E+  
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKI--KREIQN 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           L   +H ++++L        +  +V E+V    L  +I      E M  E R ++ + I 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EAR-RLFQQIL 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
             + Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ + 
Sbjct: 122 SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 125
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 159

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ----YC 122
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F
Sbjct: 123 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 156

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 32/184 (17%)
Query: 245 NFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL 297
           N      LG+G FG V K         +   T+AVK L +N+   E+ +  +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---------------------FDPIN 336
            H ++++L G C +    +L+ E+    SL  F+                      D  +
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-L 395
              +T          I++G+ YL E   ++++HRDL A NIL+      KISDFG++R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 396 FEMD 399
           +E D
Sbjct: 201 YEED 204

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 136
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ++IHR++K+ NILL  + + K++DFG       +Q+   T  +VGT
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 180

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 32/184 (17%)
Query: 245 NFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL 297
           N      LG+G FG V K         +   T+AVK L +N+   E+ +  +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---------------------FDPIN 336
            H ++++L G C +    +L+ E+    SL  F+                      D  +
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-L 395
              +T          I++G+ YL E   ++++HRDL A NIL+      KISDFG++R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 396 FEMD 399
           +E D
Sbjct: 201 YEED 204

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G  G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 86/164 (52%), Gaps = 13/164 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 304 RLLGF----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            +        +E+ + + +   +  A L    +  +  +H++ +     +  I RGL Y+
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADL----YKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 201

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++     QG+  FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 63/222 (28%)
Query: 227 TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI 285
           T+ K    DF+ I +          +G GGFG V+K     +G+T  ++R+  N+++ E 
Sbjct: 5   TVDKRFGMDFKEIEL----------IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE- 53
Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP---NASLDHFIFDPINREHMT- 341
               EV  LA+L H N+V   G C +       +++ P   + SL+   +DP N ++ + 
Sbjct: 54  ---REVKALAKLDHVNIVHYNG-CWDG------FDYDPETSDDSLESSDYDPENSKNSSR 103
Query: 342 --------------------W-EKR----------YKIIEGIARGLLYLHEDSRLRIIHR 370
                               W EKR           ++ E I +G+ Y+H     ++IHR
Sbjct: 104 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHR 160
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           DLK SNI L      KI DFG+    + D   +   R  GTL
Sbjct: 161 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT---RSKGTL 199

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++     QG+  FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 118
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 119 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 152

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 243 TDNFSDANKLGQGGFGAVY--KGMLSNGETIA--VKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +D +    KLG G +G V   K  L+  E     +K+ S  +        +EV +L +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLL 357
           H N+++L  F  +++   LV E      L    FD I  R+  +      I++ +  G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEM 398
           YLH+ +   I+HRDLK  N+LL+S+      KI DFG++  FE+
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV 176

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++  +    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR +K+S++G    + + EV +L  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 127
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
            YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
           + YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 21/161 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L  +GE +A+K++     QG+  FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR +K+S++G    + + EV +L  
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 127
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
            YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR +K+S++G    + + EV +L  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 127
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
            YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARLQH 299
           ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLY 358
            N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L Y
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSY 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 149 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 187

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 140 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 178

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 79/154 (51%), Gaps = 9/154 (5%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRNL 302
           +    K+G+G +G V+K       E +A+KR+  +     +      E+ LL  L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           VRL       K+  LV+EF  +  L  + FD  N + +  E     +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR 120
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +   ++HRDLK  N+L++     K+++FG+AR F
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAF 151

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR +K+S++G    + + EV +L  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
            YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 68
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 125
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
           + YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 126 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
           + YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
           + YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 32/184 (17%)
Query: 245 NFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL 297
           N      LG+G FG V K         +   T+AVK L +N+   E+ +  +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---------------------FDPIN 336
            H ++++L G C +    +L+ E+    SL  F+                      D  +
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-L 395
              +T          I++G+ YL E S   ++HRDL A NIL+      KISDFG++R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 396 FEMD 399
           +E D
Sbjct: 201 YEED 204

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
           + YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARLQH 299
           ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLY 358
            N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L Y
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSY 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            H     R+IHRD+K  N+LL S    KI+DFG +
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
           + YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
           + YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 243 TDNFSDANKLGQGGFGAVY--KGMLSNGETIA--VKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +D +    KLG G +G V   K  L+  E     +K+ S  +        +EV +L +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLL 357
           H N+++L  F  +++   LV E      L    FD I  R+  +      I++ +  G  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEM 398
           YLH+ +   I+HRDLK  N+LL+S+      KI DFG++  FE+
Sbjct: 119 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV 159

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 252 LGQGGFGAV-----YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           LG+G FG V     YK           ++L K S    +  + E+  L  L+H ++++L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM-HMRVEREISYLKLLRHPHIIKLY 75
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
                  + ++V E+      D+ +     ++ MT ++  +  + I   + Y H   R +
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCH---RHK 128
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLF 396
           I+HRDLK  N+LLD  +N KI+DFG++ + 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 189

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAV--YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           ++L F    + +   ++    KLG+GGF  V   +G L +G   A+KR+  + +Q   E 
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA 73
Query: 288 KNEVLLLARLQHRNLVRLLGFCLE----RKERILVYEFVPNASLDHFIFDPINR-----E 338
           + E  +     H N++RL+ +CL     + E  L+  F    +L    ++ I R      
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGN 129
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
            +T ++   ++ GI RGL  +H        HRDLK +NILL  E  P + D G
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 32/173 (18%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHR 300
            +     +G G +G+V   +   +GE +A+K+LS+   Q EI  K    E+LLL  +QH 
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHE 83
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL----DHFIFDPINREHM--------TWEKRYKI 348
           N++ LL              F P +SL    D ++  P  +  +        + EK   +
Sbjct: 84  NVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           +  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR  + + T
Sbjct: 132 VYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 201

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G  +A+K + K   N    +  F+ EV ++  L H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   L+ E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+    RI+HRDLKA N+LLD++MN KI+DFG +  F
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V K      + +A+K++   S++    F  E+  L+R+ H N+V+L G CL 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL- 72
Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
                LV E+    SL + +       + T           ++G+ YLH      +IHRD
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 372 LKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNR 407
           LK  N+LL +     KI DFG A      QTH   N+
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK 165

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 28/175 (16%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++  +    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 123
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI++FG +
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS 157

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 251 KLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G  G V       +G  +AVK +    +Q      NEV+++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           L  +E  ++ EF+   +L     D +++  +  E+   + E + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 370 RDLKASNILLDSEMNPKISDFG 391
           RD+K+ +ILL  +   K+SDFG
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFG 186

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHT 181

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR +K+S++G    + + EV +L  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 127
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
            YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR +K+S++G    + + EV +L  
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 127
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
            YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 32/173 (18%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHR 300
            +     +G G +G+V   +   +GE +A+K+LS+   Q EI  K    E+LLL  +QH 
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHE 101
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL----DHFIFDPINREHM--------TWEKRYKI 348
           N++ LL              F P +SL    D ++  P  +  +        + EK   +
Sbjct: 102 NVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYL 149
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           +  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR  + + T
Sbjct: 150 VYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 199

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AV+ + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AV+ + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G  +A+K + K   N    +  F+ EV ++  L H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 71
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   L+ E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 127
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+    RI+HRDLKA N+LLD++MN KI+DFG +  F
Sbjct: 128 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 161

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            Y H     R+IHRD+K  N+LL S    KI++FG +
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS 158

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V K      + +A+K++   S++    F  E+  L+R+ H N+V+L G CL 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL- 71
Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
                LV E+    SL + +       + T           ++G+ YLH      +IHRD
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 372 LKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNR 407
           LK  N+LL +     KI DFG A      QTH   N+
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK 164

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR +K+S++G    + + EV +L  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 127
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMA 393
            YLH    L+I H DLK  NI+L     P    KI DFG+A
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + +   + +G G +G+V     + +G  IAVK+LS+   Q  I  K    E+ 
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR-PFQSIIHAKRTYRELR 102
Query: 293 LLARLQHRNLVRLL-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 103 LLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 158
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 159 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A++++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHVQF 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 37/178 (20%)
Query: 245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           +F +   +G GGFG V+K     +G+T  +KR+  N+++ E     EV  LA+L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67
Query: 304 RLLGFCLE-----------------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
              G C +                  K   +  EF    +L+ +I      E    EK  
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI------EKRRGEKLD 120
Query: 347 KII-----EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           K++     E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+    + D
Sbjct: 121 KVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 16/161 (9%)
Query: 252 LGQGGFGAVYK--GMLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRNLVRLLG 307
           LG+G FG V K    ++  E  AVK ++K S + +       EV LL +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
              +     +V E      L    FD I  R+  +     +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 367 IIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSD 404
           I+HRDLK  NILL+S   + + KI DFG++  F+ +    D
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 125
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 126 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 16/161 (9%)
Query: 252 LGQGGFGAVYK--GMLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRNLVRLLG 307
           LG+G FG V K    ++  E  AVK ++K S + +       EV LL +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
              +     +V E      L    FD I  R+  +     +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 367 IIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSD 404
           I+HRDLK  NILL+S   + + KI DFG++  F+ +    D
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF 125
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHVQF 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 16/161 (9%)
Query: 252 LGQGGFGAVYK--GMLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRNLVRLLG 307
           LG+G FG V K    ++  E  AVK ++K S + +       EV LL +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
              +     +V E      L    FD I  R+  +     +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 367 IIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSD 404
           I+HRDLK  NILL+S   + + KI DFG++  F+ +    D
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 93
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 149
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 150 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LSK   Q  I  K    E+ 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELR 85
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 141
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 142 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 92
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 93  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 148
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 149 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 79
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 135
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 136 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHR 300
           + +    K+G+G +G V+K      G+ +A+K+  ++     I+     E+ +L +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR------EHMTWEKRYKIIEGIAR 354
           NLV LL     ++   LV+E+      DH +   ++R      EH+     ++ ++ +  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVN- 116
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
              + H+ +    IHRD+K  NIL+      K+ DFG ARL 
Sbjct: 117 ---FCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL 152

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 93
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 149
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 150 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIE---FKNEVLL 293
           R+  DNF     LG+G FG V    +   G+  AVK L K+   +  ++E    +  +L 
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 294 LARLQHRNLVRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           LAR  H  L +L   C +  +R+  V EFV    L   I    +R       R+   E I
Sbjct: 79  LAR-NHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAE-I 133
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              L++LH+     II+RDLK  N+LLD E + K++DFGM +
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 436 MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 490
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 491 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 526

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 120
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           +DN+    +LG+G F  V +      G+    + I  K+LS    Q   + + E  +  +
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQH N+VRL     E     LV++ V    L     D + RE  +       I+ I   +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMA 393
            Y H +    I+HR+LK  N+LL S+      K++DFG+A
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 154

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 238 TIRVATD------NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEF 287
           +I  ATD      N+     +G+G F  V     +  G  +AVK + K   N    +  F
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRY 346
           + EV ++  L H N+V+L       K   LV E+     + D+ +     +E     K  
Sbjct: 63  R-EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 121
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           +I+  +     Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 122 QIVSAVQ----YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF 164

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 435 MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 489
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 490 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 78
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 135 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 119
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           +DN+    +LG+G F  V +      G+    + I  K+LS    Q   + + E  +  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQH N+VRL     E     LV++ V    L     D + RE  +       I+ I   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 118
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMA 393
            Y H +    I+HR+LK  N+LL S+      K++DFG+A
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 147
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 148 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 147
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 148 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF---- 125
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 126 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 118
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 78
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 135 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 91  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 145
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 146 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           +DN+    +LG+G F  V +      G+    + I  K+LS    Q   + + E  +  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQH N+VRL     E     LV++ V    L     D + RE  +       I+ I   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 118
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMA 393
            Y H +    I+HR+LK  N+LL S+      K++DFG+A
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 252 LGQGGFG-AVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           LG G F   V     + G+  AVK + K + +G E   +NE+ +L +++H N+V L    
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRII 368
                  LV + V    L    FD I  +    EK    +I  +   + YLH   R+ I+
Sbjct: 90  ESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLH---RMGIV 142
Query: 369 HRDLKASNILL---DSEMNPKISDFGMARL 395
           HRDLK  N+L    D E    ISDFG++++
Sbjct: 143 HRDLKPENLLYYSQDEESKIMISDFGLSKM 172

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           +DN+    +LG+G F  V +      G+    + I  K+LS    Q   + + E  +  +
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 84
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQH N+VRL     E     LV++ V    L     D + RE  +       I+ I   +
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 141
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMA 393
            Y H +    I+HR+LK  N+LL S+      K++DFG+A
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 143
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 84
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 85  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 140
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 141 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVF 92
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHSAG 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 143
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + +   +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 83
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 84  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 139
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 140 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 140
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 140
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 80
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 136
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 145
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 80
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 136
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 140
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 131
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 132 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 80
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 136
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 83  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 137
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 124
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 70
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 71  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF 126
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 75
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 131
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 78
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 135 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 71
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 72  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF 127
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 75
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 131
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 72
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 73  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 128
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 129 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 139
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF 125
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 70
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 71  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF 126
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 80
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 136
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 75
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 131
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 92
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 93  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 148
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 149 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 78
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 135 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 139
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 85
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 141
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 142 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 127
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 85
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 141
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 142 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 18/154 (11%)
Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-----EVLLLARLQHRNLVRL 305
           LG+G F  VYK    N  + +A+K++    +    +  N     E+ LL  L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 306 LGFCLERKERILVYEFVPNASLDHFIFD---PINREHMTWEKRYKIIEGIARGLLYLHED 362
           L     +    LV++F+    L+  I D    +   H+   K Y ++    +GL YLH+ 
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHI---KAYMLMT--LQGLEYLHQH 131
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
               I+HRDLK +N+LLD     K++DFG+A+ F
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 76/150 (50%), Gaps = 14/150 (9%)
Query: 252 LGQGGFGAVY--KGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           LG G F  V+  K  L+ G+  A+K + K+    +   +NE+ +L +++H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRII 368
                  LV + V    L    FD I    +  EK    +I+ +   + YLHE+    I+
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 369 HRDLKASNIL-LDSEMNPK--ISDFGMARL 395
           HRDLK  N+L L  E N K  I+DFG++++
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM 158

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 71  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 125
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 126 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 84
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 85  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 140
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 141 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 96
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 97  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 152
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 153 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 79
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 135
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 136 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 75
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 131
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 96
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 97  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 152
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 153 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 79
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 135
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 136 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 82/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS---KNSKQGEIEFKNEVLLLARLQHR 300
           NF    K+G+G F  VY+   L +G  +A+K++        +   +   E+ LL +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-------YKIIEGIA 353
           N+++     +E  E  +V E      L   I      +H   +KR       +K    + 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMI------KHFKKQKRLIPERTVWKYFVQLC 146
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L ++H  SR R++HRD+K +N+ + +    K+ D G+ R F    T + +  +VGT
Sbjct: 147 SALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 14/152 (9%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           LG G FG V+K    + G  +A K +     + + E KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 311 ERKERILVYEFVPNASLDHFIFDPINRE--HMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            + + +LV E+V    L    FD I  E  ++T       ++ I  G+ ++H+   + I+
Sbjct: 157 SKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYIL 209
Query: 369 HRDLKASNILL---DSEMNPKISDFGMARLFE 397
           H DLK  NIL    D++   KI DFG+AR ++
Sbjct: 210 HLDLKPENILCVNRDAK-QIKIIDFGLARRYK 240

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 93
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 149
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 150 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 79
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 135
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 136 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 20/165 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 131
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD------QTHS 403
              +HRDL A N+LL ++   KISDFG+++    D      QTH 
Sbjct: 132 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV +   L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           H+     I+HRDLKA N+LLD++ N KI+DFG +  F
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF 163

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 244 DNFSDANKLGQGGFGA-VYKGMLSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F   V    L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 140
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 243 TDNFSDANKLGQGGFGAVY--KGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQH 299
           ++ +    KLG G +G V   +  +++ E  I + R +  S     +   EV +L  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLY 358
            N+++L  F  +++   LV E      L    FD I +R          II+ +  G+ Y
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFE 397
           LH+ +   I+HRDLK  N+LL+S+      KI DFG++ +FE
Sbjct: 152 LHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 82/160 (51%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHT 183

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 15/159 (9%)
Query: 252 LGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLVRLLGFC 309
           LGQG    V++G     G+  A+K  +  S    ++ +  E  +L +L H+N+V+L  F 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FA 74
Query: 310 LER----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           +E     + ++L+ EF P  SL   + +P N   +   +   ++  +  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 366 RIIHRDLKASNILL----DSEMNPKISDFGMARLFEMDQ 400
            I+HR++K  NI+     D +   K++DFG AR  E D+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQH 299
           TD +     +G+G F  V + + L  G   A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            N+VRL     E     LV++ V    L     D + RE+ +       I+ I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQ 400
           H+   + ++HRDLK  N+LL S+      K++DFG+A   + DQ
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ 160

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 22/160 (13%)
Query: 246 FSDANKLGQGGFG---AVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQH 299
           + +   +G G  G   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 300 RNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           +N++ LL        LE  + + +   + +A+L   I   ++ E M++   Y+++ GI  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK- 140
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +LH      IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++   Y+++ GI     +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 22/160 (13%)
Query: 246 FSDANKLGQGGFG---AVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQH 299
           + +   +G G  G   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 300 RNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           +N++ LL        LE  + + +   + +A+L   I   ++ E M++   Y+++ GI  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK- 140
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +LH      IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KSQKLTDDHVQF 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+ R
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 91/176 (51%), Gaps = 28/176 (15%)
Query: 236 FETIRVATDNFSDANK------LGQGGFG---AVYKGMLSNGETIAVKRLSK---NSKQG 283
           F +++VA   F+   +      +G G  G   A +  +L  G  +AVK+LS+   N    
Sbjct: 8   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 65
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINRE 338
           +  ++ E++LL  + H+N++ LL        LE  + + +   + +A+L   I   ++ E
Sbjct: 66  KRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE 124
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            M++   Y+++ GI     +LH      IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 125 RMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 92
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHSAG 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D++    +LG G FG V++    + G   A K +    +  +   + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIEGIARGLLYLH 360
           V L     +  E +++YEF+    L    F+ +  EH  M+ ++  + +  + +GL ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 361 EDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQT 401
           E++    +H DLK  NI+  ++ +   K+ DFG+    +  Q+
Sbjct: 273 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 236 FETIRVATDNFSDANK------LGQGGFGAVYKGMLSN-GETIAVKRLSK---NSKQGEI 285
           F ++ VA   F+   +      +G G  G V     +  G  +AVK+LS+   N    + 
Sbjct: 10  FYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 69
Query: 286 EFKNEVLLLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHM 340
            ++ E++LL  + H+N++ LL        LE  + + +   + +A+L   I   ++ E M
Sbjct: 70  AYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERM 128
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           ++     ++  +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 85
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++   Y+++ GI     +LH   
Sbjct: 86  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-LLYQMLXGIK----HLHSAG 139
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 140 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR 167

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D+G+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLARLQHRNLVRLLGF 308
           +G G +G   K    S+G+ +  K L   S  + E +   +EV LL  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 309 CLERKERIL--VYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLH--EDS 363
            ++R    L  V E+     L   I      R+++  E   +++  +   L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
              ++HRDLK +N+ LD + N K+ DFG+AR+   D + + T   VGT
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 15/159 (9%)
Query: 252 LGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLVRLLGFC 309
           LGQG    V++G     G+  A+K  +  S    ++ +  E  +L +L H+N+V+L  F 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FA 74
Query: 310 LER----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           +E     + ++L+ EF P  SL   + +P N   +   +   ++  +  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 366 RIIHRDLKASNILL----DSEMNPKISDFGMARLFEMDQ 400
            I+HR++K  NI+     D +   K++DFG AR  E D+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D++    +LG G FG V++    + G   A K +    +  +   + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIEGIARGLLYLH 360
           V L     +  E +++YEF+    L    F+ +  EH  M+ ++  + +  + +GL ++H
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 361 EDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQT 401
           E++    +H DLK  NI+  ++ +   K+ DFG+    +  Q+
Sbjct: 167 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 206

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 82/160 (51%), Gaps = 22/160 (13%)
Query: 246 FSDANKLGQGGFG---AVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQH 299
           + +   +G G  G   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 300 RNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           +N++ LL        LE  + + +   + +A+L   I   ++ E M++     ++  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLC 137
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           F+P +   E +
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 400 QTHSDTN 406
                TN
Sbjct: 205 XXKKTTN 211

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 97/188 (51%), Gaps = 15/188 (7%)
Query: 232 LQFDF-ETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKN 289
           LQ+ + E   +  D F D   LG+GGFG V+   M + G+  A K+L+K   +    ++ 
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 290 EVL---LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
            ++   +LA++  R +V L  +  E K  + LV   +    + + I++ ++ ++  +++ 
Sbjct: 232 AMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEP 289
Query: 346 YKII--EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
             I     I  GL +LH+ +   II+RDLK  N+LLD + N +ISD G+A   E+    +
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQT 344
Query: 404 DTNRVVGT 411
            T    GT
Sbjct: 345 KTKGYAGT 352

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 97/188 (51%), Gaps = 15/188 (7%)
Query: 232 LQFDF-ETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKN 289
           LQ+ + E   +  D F D   LG+GGFG V+   M + G+  A K+L+K   +    ++ 
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 290 EVL---LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
            ++   +LA++  R +V L  +  E K  + LV   +    + + I++ ++ ++  +++ 
Sbjct: 232 AMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEP 289
Query: 346 YKII--EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
             I     I  GL +LH+ +   II+RDLK  N+LLD + N +ISD G+A   E+    +
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQT 344
Query: 404 DTNRVVGT 411
            T    GT
Sbjct: 345 KTKGYAGT 352

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 91/183 (49%), Gaps = 16/183 (8%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKR 275
           +DE V + I+ +      + +    +F     LGQG FG V+         +G   A+K 
Sbjct: 4   KDEGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKV 63
Query: 276 LSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL-LGFCLERKERILVYEFVPNASLDHFIF 332
           L K + +    +  K E  +LA + H  +V+L   F  E K   L+ +F+    L    F
Sbjct: 64  LKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGK-LYLILDFLRGGDL----F 118
Query: 333 DPINREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
             +++E M  E+  K  +  +A GL +LH    L II+RDLK  NILLD E + K++DFG
Sbjct: 119 TRLSKEVMFTEEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 175
Query: 392 MAR 394
           +++
Sbjct: 176 LSK 178

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 97/188 (51%), Gaps = 15/188 (7%)
Query: 232 LQFDF-ETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKN 289
           LQ+ + E   +  D F D   LG+GGFG V+   M + G+  A K+L+K   +    ++ 
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 290 EVL---LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
            ++   +LA++  R +V L  +  E K  + LV   +    + + I++ ++ ++  +++ 
Sbjct: 232 AMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEP 289
Query: 346 YKII--EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
             I     I  GL +LH+ +   II+RDLK  N+LLD + N +ISD G+A   E+    +
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQT 344
Query: 404 DTNRVVGT 411
            T    GT
Sbjct: 345 KTKGYAGT 352

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKN---EVLLLARLQH 299
           DN+   + +G+G +G VY     N E  +A+K++++   +  I+ K    E+ +L RL+ 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRLKS 84
Query: 300 RNLVRLLGFC-----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             ++RL         L+  E  +V E + ++ L      PI    +T E    I+  +  
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPI---FLTEEHIKTILYNLLL 140
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
           G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR      +  DTN V
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI---NSEKDTNIV 188

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 21/181 (11%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D  +    LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI---------FD 333
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++         + 
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+A
Sbjct: 135 DLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLA 191
Query: 394 R 394
           R
Sbjct: 192 R 192

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 97/188 (51%), Gaps = 15/188 (7%)
Query: 232 LQFDF-ETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKN 289
           LQ+ + E   +  D F D   LG+GGFG V+   M + G+  A K+L+K   +    ++ 
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 290 EVL---LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
            ++   +LA++  R +V L  +  E K  + LV   +    + + I++ ++ ++  +++ 
Sbjct: 232 AMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEP 289
Query: 346 YKII--EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
             I     I  GL +LH+ +   II+RDLK  N+LLD + N +ISD G+A   E+    +
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQT 344
Query: 404 DTNRVVGT 411
            T    GT
Sbjct: 345 KTKGYAGT 352

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 80/160 (50%), Gaps = 5/160 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           ++    +G+G +G V        +T +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  + ++ +     +  I RGL Y+H  +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
              ++HRDLK SN+L+++  + KI DFG+AR+ + +  H+
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHT 201

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 21/154 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 104
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
               +  I HRDLK+ NIL+       I+D G+A
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 74  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 130
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 131 TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 184
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 21/154 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 66
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 122
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
               +  I HRDLK+ NIL+       I+D G+A
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 21/181 (11%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D  +    LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI---------FD 333
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++         + 
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+A
Sbjct: 135 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLA 191
Query: 394 R 394
           R
Sbjct: 192 R 192

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 8/172 (4%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
           +E T+A   +F      +          +G+G FG V  G    G  +AVK + KN    
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATA 230
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTW 342
           +  F  E  ++ +L+H NLV+LLG  +E K  + +V E++   SL  ++     R  +  
Sbjct: 231 Q-AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGG 288
Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +   K    +   + YL  ++    +HRDL A N+L+  +   K+SDFG+ +
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 21/154 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 91
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 147
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
               +  I HRDLK+ NIL+       I+D G+A
Sbjct: 148 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 24/185 (12%)
Query: 228 IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI-- 285
           I+  L+   E + +    F+    LG+G FG+V +  L   +   VK   K  K   I  
Sbjct: 7   ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66
Query: 286 ----EFKNEVLLLARLQHRNLVRLLGFCLERKER------ILVYEFVPNASLDHFIF--- 332
               EF  E   +    H ++ +L+G  L  + +      +++  F+ +  L  F+    
Sbjct: 67  SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 333 ---DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
              +P N   +  +   + +  IA G+ YL   S    IHRDL A N +L  +M   ++D
Sbjct: 127 IGENPFN---LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 390 FGMAR 394
           FG++R
Sbjct: 181 FGLSR 185

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 34/189 (17%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D  +    LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 16  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 75
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILVY------------------EFVPNA 325
               +E+ +L  +  H N+V LLG C +    ++V                   EFVP  
Sbjct: 76  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 135
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP 385
           + +    D +  EH+     Y     +A+G+ +L   +  + IHRDL A NILL  +   
Sbjct: 136 TPEDLYKDFLTLEHLIC---YSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 187
Query: 386 KISDFGMAR 394
           KI DFG+AR
Sbjct: 188 KICDFGLAR 196

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 251 KLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G F  V +      G     + I  K+LS    Q   + + E  +   L+H N+VR
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIVR 85
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L     E     L+++ V    L     D + RE+ +       I+ I   +L+ H+   
Sbjct: 86  LHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ--- 139
Query: 365 LRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQ 400
           + ++HRDLK  N+LL S++     K++DFG+A   E +Q
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 178

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 25/175 (14%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGM---------LSNGETIAVKRLSKNSKQGEIE 286
           F  IR     F+++  LGQG F  ++KG+         L   E + +K L K  +     
Sbjct: 2   FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVL-LKVLDKAHRNYSES 58
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           F     ++++L H++LV   G C+   E ILV EFV   SLD ++    N  ++ W  + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-----NP---KISDFGMA 393
           ++ + +A  + +L E++   +IH ++ A NILL  E      NP   K+SD G++
Sbjct: 117 EVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           ++ V  D+     +LG+G +G V K   + +G+ +AVKR+       E   +  +L+   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLD 57
Query: 297 LQHRNL-----VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIE 350
           +  R +     V   G      +  +  E + + SLD F    I++     E    KI  
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 21/154 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 68
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 124
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
               +  I HRDLK+ NIL+       I+D G+A
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 21/154 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 65
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
               +  I HRDLK+ NIL+       I+D G+A
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 15/170 (8%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V++G L +GE++AVK  S   +Q    E E  N VLL    +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-----S 363
            +  +        + +      ++D + R+ +      ++    A GL +LH +      
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGT 411
           +  I HRD K+ N+L+ S +   I+D G+A +      + D   N  VGT
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 21/154 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 71
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 127
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
               +  I HRDLK+ NIL+       I+D G+A
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 36/191 (18%)
Query: 215 GKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAV 273
           GKLK+  E           +DF       ++  D  ++G+G +G+V K +   +G+ +AV
Sbjct: 7   GKLKISPEQ---------HWDF-----TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAV 52
Query: 274 KRLSKNSKQGEIEFKNEVLLLARLQHRN-----LVRLLGFCLERKERILVYEFVPNASLD 328
           KR+     + E   + ++L+   +  R+     +V+  G      +  +  E + + S D
Sbjct: 53  KRIRSTVDEKE---QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFD 108
Query: 329 HF------IFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE 382
            F      + D +  E +      KI     + L +L E+  L+IIHRD+K SNILLD  
Sbjct: 109 KFYKYVYSVLDDVIPEEILG----KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRS 162
Query: 383 MNPKISDFGMA 393
            N K+ DFG++
Sbjct: 163 GNIKLCDFGIS 173

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D +    +LG G FG V++ +  + G     K ++      +   KNE+ ++ +L H  L
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE--HMTWEKRYKIIEGIARGLLYLH 360
           + L     ++ E +L+ EF+    L    FD I  E   M+  +    +     GL ++H
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 361 EDSRLRIIHRDLKASNILLDSEM--NPKISDFGMARLFEMDQ 400
           E S   I+H D+K  NI+ +++   + KI DFG+A     D+
Sbjct: 167 EHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 23/183 (12%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 17  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 76
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 335 ---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
              + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI DFG
Sbjct: 137 PEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFG 193
Query: 392 MAR 394
           +AR
Sbjct: 194 LAR 196

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 7/158 (4%)
Query: 242 ATDNFSDANKLGQGGFG-AVYKGMLSNGETIAVKRL--SKNSKQGEIEFKNEVLLLARLQ 298
           + + +    K+G+G FG A+      +G    +K +  S+ S +   E + EV +LA ++
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V+      E     +V ++     L    F  IN +     +  +I++   +  L 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDL----FKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
           L      +I+HRD+K+ NI L  +   ++ DFG+AR+ 
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           +   V  D+     +LG+G +G V K   + +G+ +AVKR+       E   +  +L+  
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDL 100
Query: 296 RLQHRNL-----VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KII 349
            +  R +     V   G      +  +  E + + SLD F    I++     E    KI 
Sbjct: 101 DISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIA 159
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
             I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++
Sbjct: 160 VSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 25/175 (14%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGM---------LSNGETIAVKRLSKNSKQGEIE 286
           F  IR     F+++  LGQG F  ++KG+         L   E + +K L K  +     
Sbjct: 2   FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVL-LKVLDKAHRNYSES 58
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           F     ++++L H++LV   G C    E ILV EFV   SLD ++    N  ++ W  + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-----NP---KISDFGMA 393
           ++ + +A  + +L E++   +IH ++ A NILL  E      NP   K+SD G++
Sbjct: 117 EVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 74  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 130
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 131 TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 184
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLARLQHRNLVRLLGF 308
           +G G +G   K    S+G+ +  K L   S  + E +   +EV LL  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 309 CLERKERIL--VYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLH--EDS 363
            ++R    L  V E+     L   I      R+++  E   +++  +   L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
              ++HRDLK +N+ LD + N K+ DFG+AR+   D + +     VGT
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGT 179

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI  FG+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 25/188 (13%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQ 282
           A+ L +D        D       LG+G FG V +         +   T+AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 283 GEIE-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FD 333
            E     +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F 
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 122
Query: 334 P-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK 386
           P       + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   K
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 179
Query: 387 ISDFGMAR 394
           I DFG+AR
Sbjct: 180 ICDFGLAR 187

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 92
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 25/188 (13%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQ 282
           A+ L +D        D       LG+G FG V +         +   T+AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 283 GEIE-FKNEVLLLARL-QHRNLVRLLGFCLERKERILVY-EFVPNASLDHFI------FD 333
            E     +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F 
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 334 P-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK 386
           P       + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   K
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 179
Query: 387 ISDFGMAR 394
           I DFG+AR
Sbjct: 180 ICDFGLAR 187

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 400 QTHSDTN 406
                TN
Sbjct: 190 YYKKTTN 196

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 400 QTHSDTN 406
                TN
Sbjct: 205 YYKKTTN 211

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLARLQHRNLVRLLGF 308
           +G G +G   K    S+G+ +  K L   S  + E +   +EV LL  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 309 CLERKERIL--VYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLH--EDS 363
            ++R    L  V E+     L   I      R+++  E   +++  +   L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
              ++HRDLK +N+ LD + N K+ DFG+AR+   D+  +     VGT
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGT 179

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 35  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 91
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 92  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 145
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 146 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 173

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNG-ETIAVKRLSKNSKQGEIEFKN---EVLLLARLQH 299
           DN+   + +G+G +G VY     N  + +A+K++++   +  I+ K    E+ +L RL+ 
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMF-EDLIDCKRILREITILNRLKS 86
Query: 300 RNLVRLLGFC-----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             ++RL         L+  E  +V E + ++ L      PI    +T +    I+  +  
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPI---FLTEQHVKTILYNLLL 142
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           G  ++HE     IIHRDLK +N LL+ + + KI DFG+AR    D+
Sbjct: 143 GEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 25/188 (13%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQ 282
           A+ L +D        D       LG+G FG V +         +   T+AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 283 GEIE-FKNEVLLLARL-QHRNLVRLLGFCLERKERILVY-EFVPNASLDHFI------FD 333
            E     +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F 
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 334 P-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK 386
           P       + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   K
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 179
Query: 387 ISDFGMAR 394
           I DFG+AR
Sbjct: 180 ICDFGLAR 187

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQH 299
           TD +    +LG+G F  V + M +  G+  A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            N+VRL     E     LV++ V    L     D + RE+ +       I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQ 400
           H +    I+HRDLK  N+LL S+      K++DFG+A   + DQ
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 86
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 87  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 140
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 141 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 84/194 (43%), Gaps = 36/194 (18%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSNGETI--AVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V      G+   G +I  AVK L + +   E E   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREH-------- 339
           L  H N+V LLG C       L++E+     L        + F  D I  E+        
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 340 ----MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
               +T+E        +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR- 220
Query: 396 FEMDQTHSDTNRVV 409
                  SD+N VV
Sbjct: 221 ----DIMSDSNYVV 230

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 86
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 87  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 140
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 141 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 93
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 94  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 147
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 148 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 41  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 97
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 98  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 151
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 152 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 179

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 93
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 94  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 147
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 148 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 92
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 137 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 400 QTHSDTN 406
                TN
Sbjct: 194 YYKKTTN 200

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 141 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 400 QTHSDTN 406
                TN
Sbjct: 198 YYKKTTN 204

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 86
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 87  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 140
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 141 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 400 QTHSDTN 406
                TN
Sbjct: 205 YYKKTTN 211

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 140 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 400 QTHSDTN 406
                TN
Sbjct: 197 YYKKTTN 203

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQH 299
           TD +    +LG+G F  V + M +  G+  A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            N+VRL     E     LV++ V    L     D + RE+ +       I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQ 400
           H +    I+HRDLK  N+LL S+      K++DFG+A   + DQ
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 21/151 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 85
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 86  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 139
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 18/167 (10%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           T+ +    +LG+G F  V +      G       I  K+LS    Q   + + E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRL 66
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           L+H N+VRL     E     L+++ V    L     D + RE+ +       I+ I   +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQ 400
           L+ H+   + ++HR+LK  N+LL S++     K++DFG+A   E +Q
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 400 QTHSDTN 406
                TN
Sbjct: 205 YYKKTTN 211

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           E   V  D+     +LG+G +G V K   + +G+  AVKR+       E   +  +L   
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQE---QKRLLXDL 83
Query: 296 RLQHRNL-----VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KII 349
            +  R +     V   G  L R+  + +   + + SLD F    I++     E    KI 
Sbjct: 84  DISXRTVDCPFTVTFYG-ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIA 142
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
             I + L +LH  S+L +IHRD+K SN+L+++    K  DFG++
Sbjct: 143 VSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS 184

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 68/141 (48%), Gaps = 6/141 (4%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG VY G       I +  + ++++     FK EV+   + +H N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
                ++       +L   + D   +  +   K  +I + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 372 LKASNILLDSEMNPKISDFGM 392
           LK+ N+  D+     I+DFG+
Sbjct: 156 LKSKNVFYDNG-KVVITDFGL 175

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 19/169 (11%)
Query: 241 VATDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVL 292
           +  D++    +LG G F  V K      G     + I  +RLS +S++G    E + EV 
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVN 60
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           +L  ++H N++ L      + + +L+ E V    L  F+ +   +E +T ++  + ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQI 117
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNI-LLDSEM-NPKIS--DFGMARLFE 397
             G+ YLH     RI H DLK  NI LLD  + NP+I   DFG+A   E
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 27/187 (14%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 400 QTHSDTN 406
                TN
Sbjct: 246 YYKKTTN 252

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 93
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 94  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 147
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 148 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D++    +LG G F  V K      G     + I  +RLS +S++G    E + EV +L 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 70
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            ++H N++ L      + + +L+ E V    L  F+ +   +E +T ++  + ++ I  G
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDG 127
Query: 356 LLYLHEDSRLRIIHRDLKASNI-LLDSEM-NPKIS--DFGMARLFE 397
           + YLH     RI H DLK  NI LLD  + NP+I   DFG+A   E
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 170

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 38  AQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 94
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 95  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 148
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 149 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 176

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G  +AVK + KN    +  F  E  ++ +L+H NLV+LLG  +E
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 312 RKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
            K  + +V E++   SL  ++     R  +  +   K    +   + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 371 DLKASNILLDSEMNPKISDFGMAR 394
           DL A N+L+  +   K+SDFG+ +
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G  +AVK + KN    +  F  E  ++ +L+H NLV+LLG  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 312 RKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
            K  + +V E++   SL  ++     R  +  +   K    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 371 DLKASNILLDSEMNPKISDFGMAR 394
           DL A N+L+  +   K+SDFG+ +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 29/194 (14%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKN 289
           E      +N      LG G FG V +      G       +AVK L   +   E E   +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 290 EVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN- 336
           E+ +++ L QH N+V LLG C      +++ E+     L +F+           ++P + 
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 337 -REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
             E ++          +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR 
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR- 214
Query: 396 FEMDQTHSDTNRVV 409
                  +D+N +V
Sbjct: 215 ----DIMNDSNYIV 224

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IIHRDLK SNI++ S+   KI DFG+AR
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G  +AVK + KN    +  F  E  ++ +L+H NLV+LLG  +E
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 312 RKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
            K  + +V E++   SL  ++     R  +  +   K    +   + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 371 DLKASNILLDSEMNPKISDFGMAR 394
           DL A N+L+  +   K+SDFG+ +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 390 FGMAR 394
           FG+AR
Sbjct: 192 FGLAR 196

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 219 LEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSK 278
           L+D N    + K L  D +T       +++   +G G FG V++  L   + +A+K++ +
Sbjct: 18  LDDPN---KVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ 74
Query: 279 NSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCL---ERKERI---LVYEFVPNASLDHFI 331
           + +     FKN  L + R+ +H N+V L  F     ++K+ +   LV E+VP        
Sbjct: 75  DKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASR 129
Query: 332 FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDF 390
                ++ M        +  + R L Y+H    + I HRD+K  N+LLD      K+ DF
Sbjct: 130 HYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDF 186
Query: 391 GMARLF 396
           G A++ 
Sbjct: 187 GSAKIL 192

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 390 FGMAR 394
           FG+AR
Sbjct: 192 FGLAR 196

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 390 FGMAR 394
           FG+AR
Sbjct: 192 FGLAR 196

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 42/182 (23%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAV-------KRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           ++G+G F  VYKG L    T+ V       ++L+K+ +Q    FK E   L  LQH N+V
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 304 RLL----GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE--------- 350
           R           +K  +LV E   + +L  ++            KR+K+ +         
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYL------------KRFKVXKIKVLRSWCR 136
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVV 409
            I +GL +LH  +   IIHRDLK  NI +       KI D G+A L    +  S    V+
Sbjct: 137 QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVI 191
Query: 410 GT 411
           GT
Sbjct: 192 GT 193

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 6   LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILVY-EFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 390 FGMAR 394
           FG+AR
Sbjct: 183 FGLAR 187

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 27/185 (14%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--------FDP---INREHMTWEK 344
           L QH N+V LLG C      +++ E+     L +F+         DP   I    ++   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
                  +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR        +D
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMND 217
Query: 405 TNRVV 409
           +N +V
Sbjct: 218 SNYIV 222

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 17  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 76
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 137 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 193
Query: 390 FGMAR 394
           FG+AR
Sbjct: 194 FGLAR 198

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           +D F   ++LG+G    VY+      +     ++ K +   +I  + E+ +L RL H N+
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLSHPNI 110
Query: 303 VRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++L        E  LV E V    L D  +      E    +   +I+E +A    YLHE
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA----YLHE 166
Query: 362 DSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFE 397
           +    I+HRDLK  N+L  +   +   KI+DFG++++ E
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 33/200 (16%)
Query: 215 GKLKLEDENVEETIA-KSLQF----DFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NG 268
           G +K E  +   ++A K+L       F+      D +     +G G +G V        G
Sbjct: 21  GPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTG 80
Query: 269 ETIAVKRLS------KNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL------ERKERI 316
           + +A+K++        N+K+   E K    +L   +H N++ +           E K   
Sbjct: 81  QQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIAIKDILRPTVPYGEFKSVY 136
Query: 317 LVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKA 374
           +V + +  + L   I    P+  EH+    RY + + + RGL Y+H     ++IHRDLK 
Sbjct: 137 VVLDLM-ESDLHQIIHSSQPLTLEHV----RYFLYQ-LLRGLKYMHS---AQVIHRDLKP 187
Query: 375 SNILLDSEMNPKISDFGMAR 394
           SN+L++     KI DFGMAR
Sbjct: 188 SNLLVNENCELKIGDFGMAR 207

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 52  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 111
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 112 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 171
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 228
Query: 390 FGMAR 394
           FG+AR
Sbjct: 229 FGLAR 233

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 29/174 (16%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS--KQGEIEFKN-EVL 292
           RV   +F+    LG+G FG V   ML++     E  A+K L K+   +  ++E    E  
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKR 71
Query: 293 LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           +LA L     +  L  C +  +R+  V E+V    L +         H+    ++K  + 
Sbjct: 72  VLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMY---------HIQQVGKFKEPQA 122
Query: 352 ------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
                 I+ GL +LH+     II+RDLK  N++LDSE + KI+DFGM +   MD
Sbjct: 123 VFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD 173

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-------FDPINREHMTWEKRYKI 348
           L QH N+V LLG C      +++ E+     L +F+        D  +   +        
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR        +D+N +
Sbjct: 158 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYI 209
Query: 409 V 409
           V
Sbjct: 210 V 210

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 17/168 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSK----NSKQG--EIEFKNEVLL 293
           +  D++    +LG G F  V K      G+  A K + K    +S++G    E + EV +
Sbjct: 23  MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           L  ++H N++ L      + + +L+ E V    L  F+ +   +E +T ++  + ++ I 
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQIL 139
Query: 354 RGLLYLHEDSRLRIIHRDLKASNI-LLDSEM-NPKIS--DFGMARLFE 397
            G+ YLH     RI H DLK  NI LLD  + NP+I   DFG+A   E
Sbjct: 140 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 184

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-------FDPINREHMTWEKRYKI 348
           L QH N+V LLG C      +++ E+     L +F+        D  +   +        
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR        +D+N +
Sbjct: 166 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYI 217
Query: 409 V 409
           V
Sbjct: 218 V 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 33/166 (19%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           + D   +G G +GAV   +    G  +A+K+L +   Q E+  K    E+ LL  ++H N
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHEN 85
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRYKI 348
           ++ LL              F P+ +LD F             +   +  E +  ++   +
Sbjct: 86  VIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 133
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 134 VYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHR 300
           + +F   + LG+G +G V        GE +A+K++    K    +    E+ +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 301 NLVRLLGFCLERKERILVYE--FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           N++ +  F ++R +    +   ++    +   +   I+ + ++ +     I    R +  
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           LH  +   +IHRDLK SN+L++S  + K+ DFG+AR+  +D++ +D +   G
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTG 174

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHR 300
           + +F   + LG+G +G V        GE +A+K++    K    +    E+ +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 301 NLVRLLGFCLERKERILVYE--FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           N++ +  F ++R +    +   ++    +   +   I+ + ++ +     I    R +  
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           LH  +   +IHRDLK SN+L++S  + K+ DFG+AR+  +D++ +D +   G
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTG 174

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHR 300
           + +F   + LG+G +G V        GE +A+K++    K    +    E+ +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 301 NLVRLLGFCLERKERILVYE--FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           N++ +  F ++R +    +   ++    +   +   I+ + ++ +     I    R +  
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           LH  +   +IHRDLK SN+L++S  + K+ DFG+AR+  +D++ +D +   G
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTG 174

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 24/173 (13%)
Query: 246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           + D   LG GG G V+  + ++  + +A+K++     Q       E+ ++ RL H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 305 L--------------LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
           +              +G   E     +V E++     +     P+  EH         + 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-----FMY 127
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTH 402
            + RGL Y+H  +   ++HRDLK +N+ +++E +  KI DFG+AR+ +   +H
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 29  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 85
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 139
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D     T
Sbjct: 140 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT 180

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 27/185 (14%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--------FDP---INREHMTWEK 344
           L QH N+V LLG C      +++ E+     L +F+         DP   I     +   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
                  +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR        +D
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMND 217
Query: 405 TNRVV 409
           +N +V
Sbjct: 218 SNYIV 222

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 33/200 (16%)
Query: 215 GKLKLEDENVEETIA-KSLQF----DFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NG 268
           G +K E  +   ++A K+L       F+      D +     +G G +G V        G
Sbjct: 20  GPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTG 79
Query: 269 ETIAVKRLS------KNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL------ERKERI 316
           + +A+K++        N+K+   E K    +L   +H N++ +           E K   
Sbjct: 80  QQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135
Query: 317 LVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKA 374
           +V + +  + L   I    P+  EH+    RY + + + RGL Y+H     ++IHRDLK 
Sbjct: 136 VVLDLM-ESDLHQIIHSSQPLTLEHV----RYFLYQ-LLRGLKYMHS---AQVIHRDLKP 186
Query: 375 SNILLDSEMNPKISDFGMAR 394
           SN+L++     KI DFGMAR
Sbjct: 187 SNLLVNENCELKIGDFGMAR 206

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 25  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 135
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D     T
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT 176

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 25  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 135
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D     T
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT 176

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 18/160 (11%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           TD++    +LG+G F  V + +          + I  K+LS    Q   + + E  +   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRL 86
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           L+H N+VRL     E     LV++ V    L     D + RE+ +       I  I   +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIHQILESV 143
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMA 393
            ++H+     I+HRDLK  N+LL S+      K++DFG+A
Sbjct: 144 NHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA 180

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 16/155 (10%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 49  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 105
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 159
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 16/155 (10%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 47  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 103
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 157
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D
Sbjct: 158 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 192

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 12/172 (6%)
Query: 233 QFDF--ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN 289
           Q DF  +T+ +          L +GGF  VY+   + +G   A+KRL  N ++       
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ 74
Query: 290 EVLLLARLQ-HRNLVRLLGFCLERKER-------ILVYEFVPNASLDHFIFDPINREHMT 341
           EV  + +L  H N+V+        KE         L+   +    L  F+    +R  ++
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS 134
Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            +   KI     R + ++H   +  IIHRDLK  N+LL ++   K+ DFG A
Sbjct: 135 CDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 17/174 (9%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   +N E +AVK + +  K  E   K E++    L+H 
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQAN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGT 411
           H    +++ HRDLK  N LLD    P  KI+DFG ++   +   HS     VGT
Sbjct: 132 HA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVL---HSQPKSAVGT 179

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 23/155 (14%)
Query: 252 LGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRL 305
           +G G +G+V   Y   L   + +AVK+LS+   Q  I  +    E+ LL  L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 306 L-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYL 359
           L        +E    + +   +  A L++ +    ++ EH+ +     ++  + RGL Y+
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-----LVYQLLRGLKYI 147
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           H      IIHRDLK SN+ ++ +   +I DFG+AR
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 23/162 (14%)
Query: 252 LGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRL 305
           +G G +G+V   Y   L   + +AVK+LS+   Q  I  +    E+ LL  L+H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 306 L-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYL 359
           L        +E    + +   +  A L++ +    ++ EH+ +     ++  + RGL Y+
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYI 139
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           H      IIHRDLK SN+ ++ +   +I DFG+AR  + + T
Sbjct: 140 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT 178

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 23/162 (14%)
Query: 252 LGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRL 305
           +G G +G+V   Y   L   + +AVK+LS+   Q  I  +    E+ LL  L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 306 L-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYL 359
           L        +E    + +   +  A L++ +    ++ EH+ +     ++  + RGL Y+
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYI 147
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           H      IIHRDLK SN+ ++ +   +I DFG+AR  + + T
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT 186

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRN 301
           D++     +G G    V     +   E +A+KR++    Q  + E   E+  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR-EHMTWEKRYKIIEGIAR----GL 356
           +V      + + E  LV + +   S+   I   + + EH +       I  I R    GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            YLH++ +   IHRD+KA NILL  + + +I+DFG++   
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 166

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 16/155 (10%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 23  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 79
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 133
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQGEIEFKNEV----LLLARLQHRNLVRLL 306
           +G+G FG V        E   AVK L K +   + E K+ +    +LL  ++H  LV L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 104
Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSR 364
            F  +  +++  V +++    L    F  + RE    E R +     IA  L YLH    
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS--- 157
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           L I++RDLK  NILLDS+ +  ++DFG+ +  E  + +S T+   GT
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGT 202

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           LG G F  V        +  +A+K ++K + +G E   +NE+ +L +++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEK-RYKIIEGIARGLLYLHEDSRLRII 368
                  L+ + V    L    FD I  +    E+   ++I  +   + YLH+   L I+
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 369 HRDLKASNIL---LDSEMNPKISDFGMARL 395
           HRDLK  N+L   LD +    ISDFG++++
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   Y+   +   E  A K + K+       + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKIIEGIARGLLYLHEDSRLR 366
           F  +     +V E     SL         R+ +T  E RY + + I +G+ YLH +   R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           +IHRDLK  N+ L+ +M+ KI DFG+A   E D     T
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT 201

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           LG G F  V        +  +A+K ++K + +G E   +NE+ +L +++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEK-RYKIIEGIARGLLYLHEDSRLRII 368
                  L+ + V    L    FD I  +    E+   ++I  +   + YLH+   L I+
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 369 HRDLKASNIL---LDSEMNPKISDFGMARL 395
           HRDLK  N+L   LD +    ISDFG++++
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   SN E +AVK + +  K  E   K E++    L+H 
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGT 411
           H    +++ HRDLK  N LLD    P  KI DFG ++       HS     VGT
Sbjct: 131 HA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 178

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRN 301
           D++     +G G    V     +   E +A+KR++    Q  + E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR-EHMTWEKRYKIIEGIAR----GL 356
           +V      + + E  LV + +   S+   I   + + EH +       I  I R    GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            YLH++ +   IHRD+KA NILL  + + +I+DFG++   
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 171

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           LG G F  V        +  +A+K ++K + +G E   +NE+ +L +++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEK-RYKIIEGIARGLLYLHEDSRLRII 368
                  L+ + V    L    FD I  +    E+   ++I  +   + YLH+   L I+
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 369 HRDLKASNIL---LDSEMNPKISDFGMARL 395
           HRDLK  N+L   LD +    ISDFG++++
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 106 GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 199

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           LG G F  V        +  +A+K ++K + +G E   +NE+ +L +++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEK-RYKIIEGIARGLLYLHEDSRLRII 368
                  L+ + V    L    FD I  +    E+   ++I  +   + YLH+   L I+
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 369 HRDLKASNIL---LDSEMNPKISDFGMARL 395
           HRDLK  N+L   LD +    ISDFG++++
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   Y+   +   E  A K + K+       + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKIIEGIARGLLYLHEDSRLR 366
           F  +     +V E     SL         R+ +T  E RY + + I +G+ YLH +   R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           +IHRDLK  N+ L+ +M+ KI DFG+A   E D
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD 195

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   Y+   +   E  A K + K+       + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKIIEGIARGLLYLHEDSRLR 366
           F  +     +V E     SL         R+ +T  E RY + + I +G+ YLH +   R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           +IHRDLK  N+ L+ +M+ KI DFG+A   E D
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD 195

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 171

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 171

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 80  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 173

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 41/176 (23%)
Query: 238 TIRVATDNFSDANKLGQGGFGA-VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
            + V   +F   + LG G  G  VY+GM  N + +AVKR+          F +  + L R
Sbjct: 18  VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPEC----FSFADREVQLLR 72
Query: 297 L--QHRNLVRLLGFCLERKERILVY-----------EFVPNASLDHFIFDPINREHMTWE 343
              +H N++R   FC E K+R   Y           E+V      H   +PI        
Sbjct: 73  ESDEHPNVIRY--FCTE-KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT------- 122
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-----SEMNPKISDFGMAR 394
               +++    GL +LH    L I+HRDLK  NIL+       ++   ISDFG+ +
Sbjct: 123 ----LLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 83  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 176

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 81  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 174

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   Y+   +   E  A K + K+       + +   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKIIEGIARGLLYLHEDSRLR 366
           F  +     +V E     SL         R+ +T  E RY + + I +G+ YLH +   R
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 146
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           +IHRDLK  N+ L+ +M+ KI DFG+A   E D
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD 179

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 75  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 168

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 240 RVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKN--SKQGEIEFKN-EVLLLA 295
           + +  +F     LG G FG V+      NG   A+K L K    +  ++E  N E L+L+
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
            + H  ++R+ G   + ++  ++ +++    L    F  + +         K     +  
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH      II+RDLK  NILLD   + KI+DFG A+
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V++G    GE +AVK  S   ++    E E  N V+L    +H N++  +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-----EDS 363
            +  +        + +      ++D +    +      +I+  IA GL +LH        
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGT 411
           +  I HRDLK+ NIL+       I+D G+A +        D   N  VGT
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 252 LGQGGFGAVYKGMLSNG----ETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG V+     +G    +  A+K L K + +    +  K E  +L  + H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 306 -LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDS 363
              F  E K   L+ +F+    L    F  +++E M  E+  K  +  +A  L +LH   
Sbjct: 92  HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L II+RDLK  NILLD E + K++DFG+++
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYK 347
           L  H N+V LLG C      +++ E+     L        D FI    +   M  ++   
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 348 IIEG-------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----H 217
Query: 401 THSDTNRVV 409
             +D+N VV
Sbjct: 218 IKNDSNYVV 226

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V++G    GE +AVK  S   ++    E E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-----EDS 363
            +  +        + +      ++D +    +      +I+  IA GL +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGT 411
           +  I HRDLK+ NIL+       I+D G+A +        D   N  VGT
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGETI--AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           ++  N +G+G +G V K  +  G  I  A K++ K   +    FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 304 RLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           RL     +  +  LV E      L +  +   + RE        +I++ +   + Y H  
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE----SDAARIMKDVLSAVAYCH-- 123
Query: 363 SRLRIIHRDLKASNILL--DSEMNP-KISDFGMARLFE 397
            +L + HRDLK  N L   DS  +P K+ DFG+A  F+
Sbjct: 124 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 244 DNFSDANKLGQGGFGAVY-KGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRN 301
           D F    KLG G FG V+     S+G    +K ++K+  Q  +E  + E+ +L  L H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIARGLLYLH 360
           ++++     +     +V E      L   I     R     E    ++++ +   L Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 361 EDSRLRIIHRDLKASNILLD--SEMNP-KISDFGMARLFEMDQ 400
                 ++H+DLK  NIL    S  +P KI DFG+A LF+ D+
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V++G    GE +AVK  S   ++    E E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-----EDS 363
            +  +        + +      ++D +    +      +I+  IA GL +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGT 411
           +  I HRDLK+ NIL+       I+D G+A +        D   N  VGT
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   SN E +AVK + +  K      K E++    L+H 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIAA-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGT 411
           H    +++ HRDLK  N LLD    P  KI DFG ++   +   HS     VGT
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGT 179

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYK 347
           L  H N+V LLG C      +++ E+     L        D FI    +   M  ++   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 348 IIEG-------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----D 194
Query: 401 THSDTNRVV 409
             +D+N VV
Sbjct: 195 IKNDSNYVV 203

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 75/175 (42%), Gaps = 23/175 (13%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH 299
           +V  +NF     LG G +G V+     +G         K  K+  I  K +     R + 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 300 RNLVRLLGFCLERKERILV---YEFVPNASLDHFIFDPIN----------REHMTWEKRY 346
           + L  +      R+   LV   Y F     L H I D IN          RE  T  +  
Sbjct: 110 QVLEHI------RQSPFLVTLHYAFQTETKL-HLILDYINGGELFTHLSQRERFTEHEVQ 162
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
             +  I   L +LH   +L II+RD+K  NILLDS  +  ++DFG+++ F  D+T
Sbjct: 163 IYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 252 LGQGGFGAVYKGMLSNG----ETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG V+     +G    +  A+K L K + +    +  K E  +L  + H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 306 -LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDS 363
              F  E K   L+ +F+    L    F  +++E M  E+  K  +  +A  L +LH   
Sbjct: 93  HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 145
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L II+RDLK  NILLD E + K++DFG+++
Sbjct: 146 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK 175

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYK 347
           L  H N+V LLG C      +++ E+     L        D FI    +   M  ++   
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 348 IIEG-------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----D 217
Query: 401 THSDTNRVV 409
             +D+N VV
Sbjct: 218 IKNDSNYVV 226

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYK 347
           L  H N+V LLG C      +++ E+     L        D FI    +   M  ++   
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 348 IIEG-------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----D 210
Query: 401 THSDTNRVV 409
             +D+N VV
Sbjct: 211 IKNDSNYVV 219

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGETI--AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           ++  N +G+G +G V K  +  G  I  A K++ K   +    FK E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 304 RLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           RL     +  +  LV E      L +  +   + RE        +I++ +   + Y H  
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE----SDAARIMKDVLSAVAYCH-- 140
Query: 363 SRLRIIHRDLKASNILL--DSEMNP-KISDFGMARLFE 397
            +L + HRDLK  N L   DS  +P K+ DFG+A  F+
Sbjct: 141 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 177

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 11/151 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            +HRD+ A N+L+ S    K+ DFG++R  E
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYK 347
           L  H N+V LLG C      +++ E+     L        D FI    +   M  ++   
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 348 IIEG-------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----D 212
Query: 401 THSDTNRVV 409
             +D+N VV
Sbjct: 213 IKNDSNYVV 221

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ +    K+ DFG++R  E D T+   ++
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASK 171

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 551

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 11/155 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFC 309
           LG+G +  V   + L NG+  AVK + K +         EV  L + Q ++N++ L+ F 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +     LV+E +   S+   I     ++H    +  +++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 370 RDLKASNILLDS--EMNP-KISDFGMARLFEMDQT 401
           RDLK  NIL +S  +++P KI DF +    +++ +
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNS 169

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 252 LGQGGFGAVYKGMLSNG----ETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG V+     +G    +  A+K L K + +    +  K E  +L  + H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 306 -LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDS 363
              F  E K   L+ +F+    L    F  +++E M  E+  K  +  +A  L +LH   
Sbjct: 92  HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L II+RDLK  NILLD E + K++DFG+++
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLV--RLL 306
           +LG GGFG V + +  + GE +A+K+  +  S +    +  E+ ++ +L H N+V  R +
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 307 GFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
              L++       +L  E+     L  ++    N   +       ++  I+  L YLHE+
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 363 SRLRIIHRDLKASNILLD---SEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              RIIHRDLK  NI+L      +  KI D G A+  E+DQ    T   VGTL
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTL 187

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLV--RLL 306
           +LG GGFG V + +  + GE +A+K+  +  S +    +  E+ ++ +L H N+V  R +
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 307 GFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
              L++       +L  E+     L  ++    N   +       ++  I+  L YLHE+
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 363 SRLRIIHRDLKASNILLD---SEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              RIIHRDLK  NI+L      +  KI D G A+  E+DQ    T   VGTL
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTL 188

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 15/173 (8%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +  L+  E +AVK + + +   E   + E++    L+H 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIERGAAIDE-NVQREIINHRSLRHP 76
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N+VR     L      ++ E+     L   I    N    + ++     + +  G+ Y H
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 361 EDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGT 411
               ++I HRDLK  N LLD    P  KI DFG ++   +   HS     VGT
Sbjct: 134 S---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGT 180

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           + +  A  LG+G FG V++ + ++ +   + +  K     ++  K E+ +L   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI--IEGIARGLLYLHE 361
            L       +E ++++EF+  + LD  IF+ IN       +R  +  +  +   L +LH 
Sbjct: 65  HLHESFESMEELVMIFEFI--SGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 362 DSRLRIIHRDLKASNILLDSEMNP--KISDFGMAR 394
            +   I H D++  NI+  +  +   KI +FG AR
Sbjct: 121 HN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   SN E +AVK + +  K  E   K E++    L+H 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGT 411
           H    +++ HRDLK  N LLD    P  KI  FG ++   +   HS     VGT
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVL---HSQPKSTVGT 179

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 28/157 (17%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSK-------QGEIEFKNEVLLLARLQHRNLVR 304
           LG+G +G V + +  + ET+  + +    K        GE   K E+ LL RL+H+N+++
Sbjct: 13  LGEGSYGKVKEVL--DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 305 LLGFCL--ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG------IARGL 356
           L+      E+++  +V E+      +     P        EKR+ + +       +  GL
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP--------EKRFPVCQAHGYFCQLIDGL 122
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            YLH      I+H+D+K  N+LL +    KIS  G+A
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 27/185 (14%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
           I +  ++FS    +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 295 ARLQHRN--LVRLLGFCLERKERI-LVYEFVPNASL-----DHFIFDPINREHMTWEKRY 346
           + +   +   +  + +     +++  + + +    L      H +F   +      E   
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--- 299
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
                I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+   
Sbjct: 300 -----IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 349
Query: 407 RVVGT 411
             VGT
Sbjct: 350 --VGT 352

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 27/185 (14%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
           I +  ++FS    +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 ARLQHRN--LVRLLGFCLERKERI-LVYEFVPNASL-----DHFIFDPINREHMTWEKRY 346
           + +   +   +  + +     +++  + + +    L      H +F   +      E   
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--- 300
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
                I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+   
Sbjct: 301 -----IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 350
Query: 407 RVVGT 411
             VGT
Sbjct: 351 --VGT 353

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +HRD+ A N+L+ +    K+ DFG++R  E D T+   ++
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASK 551

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 33/188 (17%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
           I +  ++FS    +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW-----------E 343
           + +   +   ++  C+        Y F     L  FI D +N   + +           +
Sbjct: 244 SLVSTGDCPFIV--CMS-------YAFHTPDKLS-FILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R+   E I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+
Sbjct: 294 MRFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 404 DTNRVVGT 411
                VGT
Sbjct: 350 S----VGT 353

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 33/188 (17%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
           I +  ++FS    +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW-----------E 343
           + +   +   ++  C+        Y F     L  FI D +N   + +           +
Sbjct: 244 SLVSTGDCPFIV--CMS-------YAFHTPDKLS-FILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R+   E I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+
Sbjct: 294 MRFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 404 DTNRVVGT 411
                VGT
Sbjct: 350 S----VGT 353

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 31/199 (15%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
           V+ TIAK +Q                 ++G+G +G V+ G    GE +AVK     +++ 
Sbjct: 31  VQRTIAKQIQM--------------VKQIGKGRYGEVWMGKW-RGEKVAVKVFF-TTEEA 74
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERILVYEFVPNASLDHFIFDPINREH 339
               + E+     ++H N++  +   ++      +  L+ ++  N SL    +D +    
Sbjct: 75  SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTT 130
Query: 340 MTWEKRYKIIEGIARGLLYLHED-----SRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +  +   K+      GL +LH +      +  I HRDLK+ NIL+       I+D G+A 
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 395 LFEMDQTHSDT--NRVVGT 411
            F  D    D   N  VGT
Sbjct: 191 KFISDTNEVDIPPNTRVGT 209

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 36/194 (18%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--------------------FDPI 335
           L QH N+V LLG C      +++ E+     L +F+                     D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 336 NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
           +   +           +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR- 206
Query: 396 FEMDQTHSDTNRVV 409
                  +D+N +V
Sbjct: 207 ----DIMNDSNYIV 216

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 77/176 (43%), Gaps = 20/176 (11%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARL 297
           R  TD F     LG+GGFG V++      +   A+KR+   N +    +   EV  LA+L
Sbjct: 2   RYLTD-FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM--------TWEKRYK-- 347
           +H  +VR     LE+     +    P   L +       +E++        T E+R +  
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYL-YIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 348 ---IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+    + D+
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   SN E +AVK + +  K  E   K E++    L+H 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGT 411
           H    +++ HRDLK  N LLD    P  KI  FG ++   +   HS     VGT
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVL---HSQPKDTVGT 179

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 13/157 (8%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G +G VYK    +G+      L +    G  +    E+ LL  L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY-----LHEDSR 364
           L   +R  V+     A  D +     +R     +K  ++  G+ + LLY     +H    
Sbjct: 88  LSHADR-KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 365 LRIIHRDLKASNILLDSEMNP-----KISDFGMARLF 396
             ++HRDLK +NIL+  E  P     KI+D G ARLF
Sbjct: 147 NWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 182

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 13/154 (8%)
Query: 249 ANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHRNLV 303
           + +LG+G F  V + +  S G+  A K L K  +    + EI  +  VL LA+   R ++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VI 92
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            L        E IL+ E+     +      P   E ++     ++I+ I  G+ YLH+++
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 364 RLRIIHRDLKASNILLDSEM---NPKISDFGMAR 394
              I+H DLK  NILL S     + KI DFGM+R
Sbjct: 152 ---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 38/187 (20%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKN-------------------- 279
           V  + ++  +++G+G +G V      N  T  A+K LSK                     
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 280 -----SKQGEIE-FKNEVLLLARLQHRNLVRLLGFCLERKERIL--VYEFVPNASLDHF- 330
                  +G IE    E+ +L +L H N+V+L+    +  E  L  V+E V    +    
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 331 IFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF 390
              P++ +   +       + + +G+ YLH     +IIHRD+K SN+L+  + + KI+DF
Sbjct: 130 TLKPLSEDQARF-----YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 391 GMARLFE 397
           G++  F+
Sbjct: 182 GVSNEFK 188

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 84/187 (44%), Gaps = 11/187 (5%)
Query: 232 LQFDF-ETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIE 286
           LQ+ + E   V  + F     LG+GGFG V    + + G+  A K+L K   +   GE  
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
             NE  +L ++  R +V L  +  E K+ + LV   +    L   I+  + +      + 
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARA 288
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 I  GL  LH   R RI++RDLK  NILLD   + +ISD G+A      QT    
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345
Query: 406 NRVVGTL 412
              VG +
Sbjct: 346 VGTVGYM 352

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 14/145 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARL- 297
           T  F +  K+G G FG+V+K +   +G   A+KR SK    G ++ +N   EV   A L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK---IIEGIAR 354
           QH ++VR      E    ++  E+    SL   I +  N   M++ K  +   ++  + R
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE--NYRIMSYFKEAELKDLLLQVGR 124
Query: 355 GLLYLHEDSRLRIIHRDLKASNILL 379
           GL Y+H    + ++H D+K SNI +
Sbjct: 125 GLRYIHS---MSLVHMDIKPSNIFI 146

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARL- 297
           T  F +  K+G G FG+V+K +   +G   A+KR SK    G ++ +N   EV   A L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK---IIEGIAR 354
           QH ++VR      E    ++  E+    SL   I +  N   M++ K  +   ++  + R
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE--NYRIMSYFKEAELKDLLLQVGR 124
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP 385
           GL Y+H    + ++H D+K SNI +     P
Sbjct: 125 GLRYIHS---MSLVHMDIKPSNIFISRTSIP 152

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIEFKN-EVL 292
           R+   +F+    LG+G FG V   MLS      E  AVK L K+   +  ++E    E  
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 293 LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK---- 347
           +LA       +  L  C +  +R+  V E+V    L +         H+    R+K    
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY---------HIQQVGRFKEPHA 123
Query: 348 --IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                 IA GL +L       II+RDLK  N++LDSE + KI+DFGM +
Sbjct: 124 VFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARL- 297
           T  F +  K+G G FG+V+K +   +G   A+KR SK    G ++ +N   EV   A L 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK---IIEGIAR 354
           QH ++VR      E    ++  E+    SL   I +  N   M++ K  +   ++  + R
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE--NYRIMSYFKEAELKDLLLQVGR 126
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP 385
           GL Y+H    + ++H D+K SNI +     P
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRTSIP 154

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 84/187 (44%), Gaps = 11/187 (5%)
Query: 232 LQFDF-ETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIE 286
           LQ+ + E   V  + F     LG+GGFG V    + + G+  A K+L K   +   GE  
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
             NE  +L ++  R +V L  +  E K+ + LV   +    L   I+  + +      + 
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARA 288
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 I  GL  LH   R RI++RDLK  NILLD   + +ISD G+A      QT    
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345
Query: 406 NRVVGTL 412
              VG +
Sbjct: 346 VGTVGYM 352

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIEFKN-EVL 292
           R+   +F+    LG+G FG V   MLS      E  AVK L K+   +  ++E    E  
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 293 LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK---- 347
           +LA       +  L  C +  +R+  V E+V    L +         H+    R+K    
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY---------HIQQVGRFKEPHA 444
Query: 348 --IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                 IA GL +L       II+RDLK  N++LDSE + KI+DFGM +
Sbjct: 445 VFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 24/136 (17%)
Query: 266 SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
           SN + I++K     SK  +  FKNE+ ++  +++   +   G      E  ++YE++ N 
Sbjct: 76  SNNDKISIK-----SKYDD--FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEND 128
Query: 326 SLDHFIFDPINREHMTWEKRYK----------IIEGIARGLLYLHEDSRLRIIHRDLKAS 375
           S+  F     +      +K Y           II+ +     Y+H +    I HRD+K S
Sbjct: 129 SILKF-----DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPS 181
Query: 376 NILLDSEMNPKISDFG 391
           NIL+D     K+SDFG
Sbjct: 182 NILMDKNGRVKLSDFG 197

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 14/145 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARL- 297
           T  F +  K+G G FG+V+K +   +G   A+KR SK    G ++ +N   EV   A L 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 64
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK---IIEGIAR 354
           QH ++VR      E    ++  E+    SL   I +  N   M++ K  +   ++  + R
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE--NYRIMSYFKEAELKDLLLQVGR 122
Query: 355 GLLYLHEDSRLRIIHRDLKASNILL 379
           GL Y+H    + ++H D+K SNI +
Sbjct: 123 GLRYIHS---MSLVHMDIKPSNIFI 144

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 84/187 (44%), Gaps = 24/187 (12%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLL 293
           F+++ V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 294 LARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           L +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+ 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDP 126
Query: 352 IARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK 185
Query: 406 NRVVGTL 412
           +  VGT+
Sbjct: 186 DSQVGTV 192

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 35/178 (19%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLL 306
           LG G  G V       G  +AVKR+        I+F +  L+  +L      H N++R  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRY- 74
Query: 307 GFCLERKERILVYEF-VPNASLDHFIFDP-INREHMTWEKRY---KIIEGIARGLLYLHE 361
            +C E  +R L     + N +L   +    ++ E++  +K Y    ++  IA G+ +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 362 DSRLRIIHRDLKASNILLDSE-------------MNPKISDFGMARLFEMDQTHSDTN 406
              L+IIHRDLK  NIL+ +              +   ISDFG+ +  +  Q+   TN
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 140
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 187

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 140
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 187

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 141
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 188

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 141
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 188

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 153
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 200

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 141
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 188

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 160
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 207

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 153
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 200

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 154
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 201

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 154
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 201

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 154
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 201

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 153
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 200

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 154
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 201

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 153
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 200

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIE---FKNEVL 292
           I++  ++F     LG+G FG V+        +  A+K L K+      ++E    +  VL
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            LA  +H  L  +      ++    V E++    L + I    ++  ++    Y     I
Sbjct: 73  SLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAA--EI 128
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             GL +LH      I++RDLK  NILLD + + KI+DFGM +  E     + TN   GT
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGT 182

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR-N 301
           D++    KLG+G +  V++ + ++N E + VK L K  K+ +I  K E+ +L  L+   N
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKNKI--KREIKILENLRGGPN 93
Query: 302 LVRLLGFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           ++ L     +   R   LV+E V N       F  + +    ++ R+ + E I + L Y 
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTD-----FKQLYQTLTDYDIRFYMYE-ILKALDYC 147
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHS 403
           H    + I+HRD+K  N+++D E    ++ D+G+A  +   Q ++
Sbjct: 148 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 189

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 126
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 173

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 168
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 215

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 290 EVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
           EV +L ++  H N+++L           LV++ +    L  ++ + +    ++ ++  KI
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKI 116
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           +  +   +  LH   +L I+HRDLK  NILLD +MN K++DFG +
Sbjct: 117 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 76  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 125
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 172

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 168
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 215

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 126
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 173

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 126
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 173

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 290 EVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
           EV +L ++  H N+++L           LV++ +    L  ++ + +    ++ ++  KI
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKI 129
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           +  +   +  LH   +L I+HRDLK  NILLD +MN K++DFG +
Sbjct: 130 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 290 EVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
           EV +L ++  H N+++L           LV++ +    L  ++ + +    ++ ++  KI
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKI 129
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           +  +   +  LH   +L I+HRDLK  NILLD +MN K++DFG +
Sbjct: 130 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 124 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 173
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 220

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 121
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTN 406
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD 170

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 121
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTN 406
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD 170

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 75  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 124
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTN 406
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD 173

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 121
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTN 406
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD 170

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 5   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 64
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL             Y++       + + +  N +  +W K+ K I+  
Sbjct: 65  NKLQQHSDKIIRL-------------YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW 111
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 112 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 170
Query: 407 RVVGTL 412
             VGT+
Sbjct: 171 SQVGTV 176

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 99  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 148
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTN 406
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD 197

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 10/160 (6%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQGEIEFKN---EVLLLAR 296
           V  D+F     +G+G FG V     ++ + + A+K ++K       E +N   E+ ++  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           L+H  LV L     + ++  +V + +    L + +   +   H   E     I  +   L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMAL 128
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            YL      RIIHRD+K  NILLD   +  I+DF +A + 
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 121
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 119
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 24/186 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+  
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDPW 155
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 407 RVVGTL 412
             VGT+
Sbjct: 215 SQVGTV 220

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL             Y++       + + +  N +  +W K+ K I+  
Sbjct: 61  NKLQQHSDKIIRL-------------YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW 107
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 108 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 166
Query: 407 RVVGTL 412
             VGT+
Sbjct: 167 SQVGTV 172

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK----------NSKQGEIEFKNEV 291
           +  +S  + LG G FG V+  +     + + VK + K          + K G++    E+
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL--EI 80
Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIE 350
            +L+R++H N++++L     +    LV E    + LD F F  I+R     E     I  
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVME-KHGSGLDLFAF--IDRHPRLDEPLASYIFR 137
Query: 351 GIARGLLYLHEDSRLR-IIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            +   + YL    RL+ IIHRD+K  NI++  +   K+ DFG A   E
Sbjct: 138 QLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 120
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 121 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIE---FKNEVL 292
           I++  ++F     LG+G FG V+        +  A+K L K+      ++E    +  VL
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            LA  +H  L  +      ++    V E++    L + I    ++  ++    Y     I
Sbjct: 72  SLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYA--AEI 127
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             GL +LH      I++RDLK  NILLD + + KI+DFGM +  E     + TN   GT
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGT 181

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 15/178 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V K        I  ++L     +  I  +   E+ +L       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V   G      E  +  E +   SLD  + +    + +  E   K+   + RGL YL E
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE 132
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRVVGT 411
             + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+ GT
Sbjct: 133 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGT 188

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 15/128 (11%)
Query: 272 AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
           AVK + K+ +    E +   +LL   QH N++ L     + K   LV E +    L    
Sbjct: 56  AVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---- 108
Query: 332 FDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNIL-LDSEMNP---K 386
            D I R+    E+    ++  I + + YLH      ++HRDLK SNIL +D   NP   +
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 387 ISDFGMAR 394
           I DFG A+
Sbjct: 166 ICDFGFAK 173

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------EVLLLARLQ----HR 300
           LG+GGFG V+ G  L++   +A+K + +N   G     +      EV LL ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYL 359
            ++RLL +  E +E  ++    P  + D  +FD I  +    E   +   G +   + + 
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 360 HEDSRLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMDQTHSD 404
           H      ++HRD+K  NIL+D      K+ DFG   L   D+ ++D
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD 197

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 24/186 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+  
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDPW 108
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 167
Query: 407 RVVGTL 412
             VGT+
Sbjct: 168 SQVGTV 173

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYK----GMLSNGETIAVKRLSK----NSKQGEIEF 287
           FE +RV          LG+GG+G V++       + G+  A+K L K     + +     
Sbjct: 19  FELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT 68
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-- 345
           K E  +L  ++H  +V L+       +  L+ E++    L    F  + RE +  E    
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTAC 124
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           + + E I+  L +LH+     II+RDLK  NI+L+ + + K++DFG+ +    D T + T
Sbjct: 125 FYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 24/186 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+  
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDPW 155
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 407 RVVGTL 412
             VGT+
Sbjct: 215 SQVGTV 220

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 15/178 (8%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L +   +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
            L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 15/178 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V   G      E  +  E +   SLD  +        +  +   K+   + +GL YL E
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRVVGT 411
             + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+ GT
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 240

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 15/178 (8%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L +   +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
            L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 15/128 (11%)
Query: 272 AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
           AVK + K+ +    E +   +LL   QH N++ L     + K   LV E +    L    
Sbjct: 56  AVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---- 108
Query: 332 FDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNIL-LDSEMNP---K 386
            D I R+    E+    ++  I + + YLH      ++HRDLK SNIL +D   NP   +
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 387 ISDFGMAR 394
           I DFG A+
Sbjct: 166 ICDFGFAK 173

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L +   +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
            L + H++    IIHRD+K +NIL+ +    K+ DFG+AR + +   +   T  V+GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 259
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 28/169 (16%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 303 VRLLGFCLERKERILVYEFV-PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY--- 358
           +RLL +       +L+ E + P   L  FI            +R  + E +AR   +   
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFI-----------TERGALQEELARSFFWQVL 124
Query: 359 --LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSD 404
             +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 172

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 262
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 263 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRV 408
            YL E  + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 409 VGT 411
            GT
Sbjct: 176 QGT 178

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 15/178 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V   G      E  +  E +   SLD  +        +  +   K+   + +GL YL E
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRVVGT 411
             + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 218 KLEDENVEETIAKSLQ-FDFETIRVAT---DNFSDANKLGQGGFGAVYK-GMLSNGETIA 272
           KLE+  ++E   K L+ F  +  +V     D+F   ++LG G  G V+K     +G  +A
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 273 VKRLSKNSKQGEIEFKNEVLLLARLQHR----NLVRLLGFCLERKERILVYEFVPNASLD 328
            K +    K      +N+++   ++ H      +V   G      E  +  E +   SLD
Sbjct: 63  RKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS 388
             +     R  +  +   K+   + +GL YL E  + +I+HRD+K SNIL++S    K+ 
Sbjct: 120 Q-VLKKAGR--IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLC 174
Query: 389 DFG--------MARLFEMDQTHSDTNRVVGT 411
           DFG        MA  F   +++    R+ GT
Sbjct: 175 DFGVSGQLIDSMANSFVGTRSYMSPERLQGT 205

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 28/169 (16%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYK----GMLSNGETIAVKRLSK----NSKQGEIEF 287
           FE +RV          LG+GG+G V++       + G+  A+K L K     + +     
Sbjct: 19  FELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT 68
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-- 345
           K E  +L  ++H  +V L+       +  L+ E++    L    F  + RE +  E    
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTAC 124
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           + + E I+  L +LH+     II+RDLK  NI+L+ + + K++DFG+ +
Sbjct: 125 FYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRV 408
            YL E  + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 409 VGT 411
            GT
Sbjct: 176 QGT 178

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLL 293
           F+++ V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 294 LARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           L +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+ 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDP 126
Query: 352 IARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D      
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVK 185
Query: 406 NRVVGTL 412
           +  VGT+
Sbjct: 186 DSQVGTV 192

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  EIE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 388 SDFGMAR 394
           +DFG+A+
Sbjct: 183 TDFGLAK 189

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 30/177 (16%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI-----------EFKNEVLLLARLQHR 300
           +  G +GAV  G+ S G  +A+KR+      G                 E+ LL    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 301 NLVRLLGFCLERKE-----RILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGI 352
           N++ L    +  +E       LV E +    L   I D    I+ +H+ +      +  I
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-----FMYHI 143
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHSDTNR 407
             GL  LHE     ++HRDL   NILL    +  I DF +AR    + ++TH  T+R
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 30/177 (16%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI-----------EFKNEVLLLARLQHR 300
           +  G +GAV  G+ S G  +A+KR+      G                 E+ LL    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 301 NLVRLLGFCLERKE-----RILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGI 352
           N++ L    +  +E       LV E +    L   I D    I+ +H+ +      +  I
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-----FMYHI 143
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHSDTNR 407
             GL  LHE     ++HRDL   NILL    +  I DF +AR    + ++TH  T+R
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 119
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH      +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 120 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 18/163 (11%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           +V  ++F     LG+G FG V   +L    + G   A+K L K     + E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 296 RLQHRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG- 351
            LQ+     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAE 113
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I   L YLH      +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRV 408
            YL E  + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 409 VGT 411
            GT
Sbjct: 176 QGT 178

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRV 408
            YL E  + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 409 VGT 411
            GT
Sbjct: 176 QGT 178

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 130 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 184 TDFGFAK 190

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 35/172 (20%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLL 306
           LG G  G V       G  +AVKR+        I+F +  L+  +L      H N++R  
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRY- 92
Query: 307 GFCLERKERILVYEF-VPNASLDHFIFDP-INREHMTWEKRY---KIIEGIARGLLYLHE 361
            +C E  +R L     + N +L   +    ++ E++  +K Y    ++  IA G+ +LH 
Sbjct: 93  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 362 DSRLRIIHRDLKASNILLDSE-------------MNPKISDFGMARLFEMDQ 400
              L+IIHRDLK  NIL+ +              +   ISDFG+ +  +  Q
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 116
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH      +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 TDFGFAK 189

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 18/163 (11%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           +V  ++F     LG+G FG V   +L    + G   A+K L K     + E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 296 RLQHRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG- 351
            LQ+     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAE 113
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I   L YLH      +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 18/163 (11%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           +V  ++F     LG+G FG V   +L    + G   A+K L K     + E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 296 RLQHRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG- 351
            LQ+     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAE 113
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I   L YLH      +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 TDFGFAK 189

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 35/172 (20%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLL 306
           LG G  G V       G  +AVKR+        I+F +  L+  +L      H N++R  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRY- 74
Query: 307 GFCLERKERILVYEF-VPNASLDHFIFDP-INREHMTWEKRY---KIIEGIARGLLYLHE 361
            +C E  +R L     + N +L   +    ++ E++  +K Y    ++  IA G+ +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 362 DSRLRIIHRDLKASNILLDSE-------------MNPKISDFGMARLFEMDQ 400
              L+IIHRDLK  NIL+ +              +   ISDFG+ +  +  Q
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 35/172 (20%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLL 306
           LG G  G V       G  +AVKR+        I+F +  L+  +L      H N++R  
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRY- 92
Query: 307 GFCLERKERILVYEF-VPNASLDHFIFDP-INREHMTWEKRY---KIIEGIARGLLYLHE 361
            +C E  +R L     + N +L   +    ++ E++  +K Y    ++  IA G+ +LH 
Sbjct: 93  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 362 DSRLRIIHRDLKASNILLDSE-------------MNPKISDFGMARLFEMDQ 400
              L+IIHRDLK  NIL+ +              +   ISDFG+ +  +  Q
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     +G G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 ADFGFAK 189

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 130 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 184 TDFGFAK 190

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 18/163 (11%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           +V  ++F     LG+G FG V   +L    + G   A+K L K     + E  + V    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 296 RLQHRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG- 351
            LQ+     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAE 113
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I   L YLH      +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 223 NVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS- 280
           N  E I K ++     +++  +++     +G+G FG V        + + A+K LSK   
Sbjct: 58  NRYEKIVKKIR----GLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEM 113
Query: 281 --KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE 338
             +     F  E  ++A      +V+L     + K   +V E++P   L + + +    E
Sbjct: 114 IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE 173
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
              W K Y      A  +L L     + +IHRD+K  N+LLD   + K++DFG     +M
Sbjct: 174 --KWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKM 224
Query: 399 DQT---HSDTNRVVGT 411
           D+T   H DT   VGT
Sbjct: 225 DETGMVHCDT--AVGT 238

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L     +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER------ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           H  +V +  +     E        +V E+V   +L   +        MT ++  ++I   
Sbjct: 71  HPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADA 125
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
            + L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 130 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 184 TDFGFAK 190

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 121
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            L YLH      +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 122 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 TDFGFAK 189

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 TDFGFAK 189

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 TDFGFAK 189

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF              D F     LG G FG V   ML      G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 67  NHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF              D F     LG G FG V   ML      G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 67  NHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 15/178 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL YL E
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGLTYLRE 125
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRVVGT 411
             + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+ GT
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGT 181

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF              D F     LG G FG V   ML      G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 67  NHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           +G+G F  V + +    G+  AVK     + + +      + K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL----YLHE 361
           L          +V+EF+  A L    F+ + R    +     +     R +L    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 362 DSRLRIIHRDLKASNILLDSEMNP---KISDFGMA 393
           ++   IIHRD+K  N+LL S+ N    K+ DFG+A
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVA 180

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRL--SKNSKQGEIEFKNEVLLLARLQHR 300
           ++  +  ++G G  G V+K      G  IAVK++  S N ++ +    +  ++L      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 301 NLVRLLGFCLERKERILVYEFVPNAS--LDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
            +V+  G  +   +  +  E +   +  L   +  PI    +      K+   I + L Y
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYY 139
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
           L E  +  +IHRD+K SNILLD     K+ DFG++
Sbjct: 140 LKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 181 IQVTDFGFAK 190

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 181 IQVTDFGFAK 190

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 181 IQVTDFGFAK 190

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 32  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 87
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 88  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 147
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 148 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 200
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 201 IQVTDFGFAK 210

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 244 DNFSDANKLGQGGFGAVY-KGMLSNGETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQH 299
           D F     LG G FG V     +  G   A+K L K    K  +IE   NE  +L  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLY 358
             LV+L     +     +V E+VP   +    F  + R     E   +     I     Y
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           LH    L +I+RDLK  N+L+D +   +++DFG A+
Sbjct: 143 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 175

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE----FKNE 290
           DF+ +RV          +G+G +  V    L   + I   R+ K     + E     + E
Sbjct: 53  DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE 102
Query: 291 VLLLARLQHRNLVRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +  +  +   +  L  C + + R+  V E+V    L   +F    +  +  E      
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 159
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +
Sbjct: 160 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+  
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDPW 155
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 407 RVVGTL 412
             VG +
Sbjct: 215 SQVGAV 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  EIE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 388 SDFGMAR 394
           +DFG+A+
Sbjct: 183 TDFGLAK 189

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 45/184 (24%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLL-- 293
           E  R   D F      GQG FG V  G   S G ++A+K++ ++ +     F+N  L   
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIM 70
Query: 294 --LARLQHRNLVRLLGFCLERKERI-------LVYEFVPNASLDHFIFDPINREHMTWEK 344
             LA L H N+V+L  +     ER        +V E+VP         D ++R    + +
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---------DTLHRCCRNYYR 121
Query: 345 R-------------YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL-DSEMNPKISDF 390
           R             +++I  I  G L+L     + + HRD+K  N+L+ +++   K+ DF
Sbjct: 122 RQVAPPPILIKVFLFQLIRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 391 GMAR 394
           G A+
Sbjct: 177 GSAK 180

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/159 (23%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQH 299
           D +   + +G G +G V +         +A+K++ +   +  I+ K    E+ +L RL H
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-VFEDLIDCKRILREIAILNRLNH 111
Query: 300 RNLVRLLGFCL----ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            ++V++L   +    E+ + + V   + ++        P+   ++T      ++  +  G
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV---YLTELHIKTLLYNLLVG 168
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           + Y+H      I+HRDLK +N L++ + + K+ DFG+AR
Sbjct: 169 VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L     +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
            L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFC 309
           LG+G F    K +   + +  AVK +SK   + E   + E+  L   + H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 310 LERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            ++    LV E +    L    F+ I ++ H +  +   I+  +   + ++H+   + ++
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 369 HRDLKASNILLDSE---MNPKISDFGMARL 395
           HRDLK  N+L   E   +  KI DFG ARL
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL 158

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 79/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 129 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 TDFGFAK 189

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 68/159 (42%), Gaps = 18/159 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEFK-NEVLLLAR 296
           D F     LG G FG V   ML      G   A+K L K    K  +IE   NE  +L  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARG 355
           +    LV+L     +     +V E+VP   +    F  + R     E   +     I   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLT 146
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             YLH    L +I+RDLK  N+L+D +   +++DFG A+
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 182

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     +G G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E++P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 ADFGFAK 189

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     +G G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E++P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 ADFGFAK 189

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 79/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 TDFGFAK 189

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR-- 300
           D+F   ++LG G  G V+K     +G  +A K +    K      +N+++   ++ H   
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECN 81
Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
              +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL Y
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGLTY 138
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFG--------MARLFEMDQTHSDTNRVVG 410
           L E  + +I+HRD+K SNIL++S    K+ DFG        MA  F   +++    R+ G
Sbjct: 139 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 196
Query: 411 T 411
           T
Sbjct: 197 T 197

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L     +AVK L  +  +     + F+ E    A L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 144
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
            L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 199

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 68/159 (42%), Gaps = 18/159 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEFK-NEVLLLAR 296
           D F     LG G FG V   ML      G   A+K L K    K  +IE   NE  +L  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARG 355
           +    LV+L     +     +V E+VP   +    F  + R     E   +     I   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 146
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             YLH    L +I+RDLK  N+L+D +   +++DFG A+
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 182

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 30/180 (16%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGA----VYKGMLSNGETIAVKRLSKN 279
           V++    S+QF        TD +     +G G +      ++K   +N E  AVK + K+
Sbjct: 10  VQQLHRNSIQF--------TDGYEVKEDIGVGSYSVCKRCIHKA--TNME-FAVKIIDKS 58
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
            +    E +   +LL   QH N++ L     + K   +V E +    L     D I R+ 
Sbjct: 59  KRDPTEEIE---ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQK 111
Query: 340 MTWEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNIL-LDSEMNP---KISDFGMAR 394
              E+    ++  I + + YLH      ++HRDLK SNIL +D   NP   +I DFG A+
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+ P  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+++D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGY 180
Query: 385 PKISDFGMAR 394
            K++DFG A+
Sbjct: 181 IKVTDFGFAK 190

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 32  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 87
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 88  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 147
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 148 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 200
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 201 IQVTDFGFAK 210

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 26/178 (14%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM--LSNGETIAVKRLSKNSK 281
           V++    S+QF        TD +     +G G +    + +   +N E  AVK + K+ +
Sbjct: 10  VQQLHRNSIQF--------TDGYEVKEDIGVGSYSVCKRCIHKATNXE-FAVKIIDKSKR 60
Query: 282 QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMT 341
               E +   +LL   QH N++ L     + K   +V E      L     D I R+   
Sbjct: 61  DPTEEIE---ILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGEL----LDKILRQKFF 113
Query: 342 WEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNIL-LDSEMNP---KISDFGMAR 394
            E+    ++  I + + YLH      ++HRDLK SNIL +D   NP   +I DFG A+
Sbjct: 114 SEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLF 396
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++ 
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLF 396
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++ 
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLF 396
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++ 
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 6   EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 61
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 62  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 121
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 122 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 174
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 175 IQVTDFGFAK 184

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLF 396
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++ 
Sbjct: 135 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 173

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 154

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 32  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 87
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 88  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 147
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 148 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 200
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 201 IQVTDFGFAK 210

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 181 IQVTDFGFAK 190

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 11/178 (6%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFG--AVYKGMLSNGETIAVKRLSKNS--KQGE 284
           A+ +    + +R+  D+F     +G+G F   AV K M   G+  A+K ++K    K+GE
Sbjct: 46  AEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVK-MKQTGQVYAMKIMNKWDMLKRGE 104
Query: 285 IE-FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
           +  F+ E  +L     R + +L     +     LV E+     L   +     R      
Sbjct: 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           + Y     +A  ++ +    RL  +HRD+K  NILLD   + +++DFG       D T
Sbjct: 165 RFY-----LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLF 396
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++ 
Sbjct: 128 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 166

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 20/174 (11%)
Query: 230 KSLQFDF-ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF 287
           K + +++ E +  AT       +LG+G FG V++      G   AVK++       E+  
Sbjct: 82  KPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVRL-----EVFR 132
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
             E++  A L    +V L G   E     +  E +   SL   +      +    E R  
Sbjct: 133 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRAL 188
Query: 348 IIEGIA-RGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMD 399
              G A  GL YLH  SR RI+H D+KA N+LL S+  +  + DFG A   + D
Sbjct: 189 YYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPD 239

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 78/190 (41%), Gaps = 48/190 (25%)
Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQ----GEIE-FKNEVLLLARLQHRNLVRL 305
           +GQG +G V   + +    I A+K ++KN  +     ++E  K EV L+ +L H N+ RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 306 LGFCLERKERILVYEFVPNA----SLDHFIFD-----------------------PIN-- 336
                + +   LV E          L+ FI D                        IN  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 337 ----REHMTWEKRYKIIEGIAR----GLLYLHEDSRLRIIHRDLKASNILLDS--EMNPK 386
               RE + + +R K+I  I R     L YLH      I HRD+K  N L  +      K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 387 ISDFGMARLF 396
           + DFG+++ F
Sbjct: 211 LVDFGLSKEF 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 230 KSLQFDF-ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF 287
           K + +++ E +  AT       +LG+G FG V++      G   AVK++       E+  
Sbjct: 63  KPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVRL-----EVFR 113
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
             E++  A L    +V L G   E     +  E +   SL   +      +    E R  
Sbjct: 114 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRAL 169
Query: 348 IIEGIA-RGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSD 404
              G A  GL YLH  SR RI+H D+KA N+LL S+  +  + DFG A   + D    D
Sbjct: 170 YYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKD 225

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 183 TDFGFAK 189

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    L +L     +     +V E+ P   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 130 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 184 TDFGFAK 190

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 15/172 (8%)
Query: 228 IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVY--KGMLSNG--ETIAVKRLSKNSKQG 283
           + K ++  +E +   ++ F   +K+G+G F +VY     L  G  E IA+K L   S   
Sbjct: 5   VKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPI 64
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
            I  + + L +A  Q    V  + +C  + + +++   +P    + F+ D +N   ++++
Sbjct: 65  RIAAELQCLTVAGGQDN--VMGVKYCFRKNDHVVIA--MPYLEHESFL-DILNS--LSFQ 117
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMAR 394
           +  + +  + + L  +H+     I+HRD+K SN L +  +    + DFG+A+
Sbjct: 118 EVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 242 ATDNFS---------DANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEV 291
           +TD+FS           + LG+G    V   + L   +  AVK + K           EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 292 LLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
            +L + Q HRN++ L+ F  E     LV+E +   S+   I     R H    +   +++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQ 118
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLD--SEMNP-KISDFGMA 393
            +A  L +LH      I HRDLK  NIL +  ++++P KI DFG+ 
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLG 161

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    L +L     +     +V E+ P   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 130 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 184 TDFGFAK 190

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+++D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGY 179
Query: 385 PKISDFGMAR 394
            +++DFG A+
Sbjct: 180 IQVTDFGFAK 189

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 20/187 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVY-KGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    L +L     +     +V E+ P   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 130 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 388 SDFGMAR 394
           +DFG A+
Sbjct: 184 TDFGFAK 190

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	412
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-103
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-100
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-92
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-68
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-56
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-45
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-35
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-25
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-24
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-24
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	8e-24
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	9e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-22
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  306 bits (787), Expect = e-103
 Identities = 78/203 (38%), Positives = 121/203 (59%), Gaps = 16/203 (7%)

Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAV 273
           E++++E +  +   F F  ++  T+NF +       NK+G+GGFG VYKG + N  T+AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59

Query: 274 KRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
           K+L+      +++ + +F  E+ ++A+ QH NLV LLGF  +  +  LVY ++PN SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
            +        ++W  R KI +G A G+ +LHE+     IHRD+K++NILLD     KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176

Query: 390 FGMARLF-EMDQTHSDTNRVVGT 411
           FG+AR   +  QT   T+R+VGT
Sbjct: 177 FGLARASEKFAQTV-MTSRIVGT 198

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  299 bits (767), Expect = e-100
 Identities = 83/181 (45%), Positives = 119/181 (65%), Gaps = 3/181 (1%)

Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVL 292
           F    ++VA+DNFS+ N LG+GGFG VYKG L++G  +AVKRL +   QG E++F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEG 351
           +++   HRNL+RL GFC+   ER+LVY ++ N S+   + +   ++  + W KR +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ARGL YLH+    +IIHRD+KA+NILLD E    + DFG+A+L +   TH  T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 412 L 412
           +
Sbjct: 199 I 199

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  279 bits (717), Expect = 3e-92
 Identities = 79/184 (42%), Positives = 114/184 (61%), Gaps = 6/184 (3%)

Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKN 289
           +S +     +  AT+NF     +G G FG VYKG+L +G  +A+KR +  S QG  EF+ 
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKI 348
           E+  L+  +H +LV L+GFC ER E IL+Y+++ N +L   ++   +    M+WE+R +I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-EMDQTHSDTNR 407
             G ARGL YLH  +   IIHRD+K+ NILLD    PKI+DFG+++   E+DQTH  T  
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-V 200

Query: 408 VVGT 411
           V GT
Sbjct: 201 VKGT 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  218 bits (556), Expect = 3e-68
 Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 17/192 (8%)

Query: 231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNE 290
            +    E +   +          +G FG V+K  L   E +AVK      KQ   + + E
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYE 68

Query: 291 VLLLARLQHRNLVRLLGFCLE----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           V  L  ++H N+++ +G          +  L+  F    SL  F+        ++W +  
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELC 124

Query: 347 KIIEGIARGLLYLHED-------SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            I E +ARGL YLHED        +  I HRD+K+ N+LL + +   I+DFG+A  FE  
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 400 QTHSDTNRVVGT 411
           ++  DT+  VGT
Sbjct: 185 KSAGDTHGQVGT 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  187 bits (476), Expect = 3e-56
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 27/199 (13%)

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNE- 290
           ++       +  DN      +G+G +GAVYKG L +   +AVK  S  ++Q    F NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEK 56

Query: 291 -VLLLARLQHRNLVRLLGFCLE-----RKERILVYEFVPNASLDHFIFDPINREHMTWEK 344
            +  +  ++H N+ R +          R E +LV E+ PN SL  ++    +     W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVS 112

Query: 345 RYKIIEGIARGLLYLHED------SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-- 396
             ++   + RGL YLH +       +  I HRDL + N+L+ ++    ISDFG++     
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 397 ----EMDQTHSDTNRVVGT 411
                  +  +     VGT
Sbjct: 173 NRLVRPGEEDNAAISEVGT 191

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  167 bits (424), Expect = 7e-49
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 6/165 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLG 307
            K+G G FG V++    +G  +AVK L +     E   EF  EV ++ RL+H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
              +     +V E++   SL   +     RE +   +R  +   +A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           +HR+LK+ N+L+D +   K+ DFG++R      T   +    GT 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTP 203

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  157 bits (398), Expect = 5e-45
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)

Query: 250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             LG+G FG   K      GE + +K L +  ++ +  F  EV ++  L+H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
             + K    + E++   +L   I          W +R    + IA G+ YLH    + II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           HRDL + N L+    N  ++DFG+ARL   ++T  +  R
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  156 bits (397), Expect = 8e-45
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 11/170 (6%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
                   +G+G FG V K      + +A+K++   S+     F  E+  L+R+ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           +L G CL      LV E+    SL + +       + T           ++G+ YLH   
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 364 RLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMDQTHSDTNRVVGTL 412
              +IHRDLK  N+LL +     KI DFG A   +   T++      G+ 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSA 167

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  152 bits (387), Expect = 1e-43
 Identities = 55/175 (31%), Positives = 85/175 (48%), Gaps = 21/175 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRL----SKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
             +G GGFG VY+     G+ +AVK       ++  Q     + E  L A L+H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            G CL+     LV EF     L+  +    + + +  +        IARG+ YLH+++ +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 366 RIIHRDLKASNILLDSEMNP--------KISDFGMARLFEMDQTHSDTNRVVGTL 412
            IIHRDLK+SNIL+  ++          KI+DFG+AR  E  +T   +    G  
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA--AGAY 178

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  151 bits (384), Expect = 3e-43
 Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 23/176 (13%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI-------EFKNEVLLLARLQHRN 301
            ++G+GGFG V+KG  + +   +A+K L     +GE        EF+ EV +++ L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L G         +V EFVP   L H + D      + W  + +++  IA G+ Y+  
Sbjct: 85  IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQ- 139

Query: 362 DSRLRIIHRDLKASNILLDS-----EMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           +    I+HRDL++ NI L S      +  K++DFG+++      +      ++G  
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG-----LLGNF 190

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  148 bits (375), Expect = 4e-42
 Identities = 36/153 (23%), Positives = 63/153 (41%), Gaps = 7/153 (4%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLG 307
            KL +   G ++KG    G  I VK L           +F  E   L    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 308 FCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            C          +  ++P  SL + + +  N   +   +  K    +ARG+ +LH    L
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            I    L + ++++D +M  +IS   +   F+ 
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQS 165

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  148 bits (376), Expect = 2e-41
 Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 35/205 (17%)

Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
              V+ TIAK +Q                 ++G+G +G V+ G    GE +AVK      
Sbjct: 28  PLLVQRTIAKQIQMV--------------KQIGKGRYGEVWMGKW-RGEKVAVKVFFT-- 70

Query: 281 KQGEIEFKNE--VLLLARLQHRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDP 334
              E  +  E  +     ++H N++  +   ++         L+ ++  N SL  ++   
Sbjct: 71  -TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--- 126

Query: 335 INREHMTWEKRYKIIEGIARGLLYLHEDSRLR-----IIHRDLKASNILLDSEMNPKISD 389
                +  +   K+      GL +LH +         I HRDLK+ NIL+       I+D
Sbjct: 127 -KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185

Query: 390 FGMARLFEMDQTHSD--TNRVVGTL 412
            G+A  F  D    D   N  VGT 
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGTK 210

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  146 bits (371), Expect = 4e-41
 Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 35/201 (17%)

Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
           ++ T+A+ +                   +G+G +G V++G    GE +AVK  S    + 
Sbjct: 2   MQRTVARDITLL--------------ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RD 43

Query: 284 EIEFKNE--VLLLARLQHRNLVRLLGFCL----ERKERILVYEFVPNASLDHFIFDPINR 337
           E  +  E  +     L+H N++  +   +       +  L+  +    SL    +D +  
Sbjct: 44  EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQL 99

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLR-----IIHRDLKASNILLDSEMNPKISDFGM 392
             +      +I+  IA GL +LH +         I HRDLK+ NIL+       I+D G+
Sbjct: 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159

Query: 393 ARLFEMDQTHSDT--NRVVGT 411
           A +        D   N  VGT
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGT 180

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  146 bits (370), Expect = 5e-41
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 12/166 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLG 307
            ++G G FG VYKG   +G+ +AVK L+  +   +    FKNEV +L + +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           +      ++ +V ++   +SL H +           +K   I    ARG+ YLH      
Sbjct: 88  YS--TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH---AKS 140

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           IIHRDLK++NI L  +   KI DFG+A             ++ G++
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  143 bits (363), Expect = 1e-39
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 35/202 (17%)

Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
           V+ TIA+++                   +G+G FG V++G    GE +AVK  S    + 
Sbjct: 36  VQRTIARTIVLQ--------------ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---RE 77

Query: 284 EIEFKNE--VLLLARLQHRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDPINR 337
           E  +  E  +     L+H N++  +    +         LV ++  + SL    FD +NR
Sbjct: 78  ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR 133

Query: 338 EHMTWEKRYKIIEGIARGLLYLHED-----SRLRIIHRDLKASNILLDSEMNPKISDFGM 392
             +T E   K+    A GL +LH +      +  I HRDLK+ NIL+       I+D G+
Sbjct: 134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193

Query: 393 ARLFEMDQTHSDT--NRVVGTL 412
           A   +      D   N  VGT 
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTK 215

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  142 bits (359), Expect = 3e-39
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 13/168 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLG 307
             +G+G FG VY G   +GE +A++ +       +    FK EV+   + +H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
            C+      ++       +L   + D   +  +   K  +I + I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTL 412
           +H+DLK+ N+  D      I+DFG+  +  + Q     ++     G L
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  134 bits (339), Expect = 7e-36
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 7/152 (4%)

Query: 251 KLGQGGFGAVYKGMLSNGET-IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           ++G+G FG V+ G L    T +AVK   +      + +F  E  +L +  H N+VRL+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C +++   +V E V       F+        +  +   +++   A G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           HRDL A N L+  +   KISDFGM+R      
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV 267

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  132 bits (334), Expect = 2e-35
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 12/158 (7%)

Query: 250 NKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V          + G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 305 LLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G       +   LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R +HRDL A NIL++SE + KI+DFG+A+L  +D+
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  130 bits (330), Expect = 3e-35
 Identities = 50/158 (31%), Positives = 84/158 (53%), Gaps = 12/158 (7%)

Query: 250 NKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V          + GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 305 LLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C     R   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  130 bits (330), Expect = 5e-35
 Identities = 50/158 (31%), Positives = 84/158 (53%), Gaps = 12/158 (7%)

Query: 250 NKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V          + GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 305 LLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C     R   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL   NIL+++E   KI DFG+ ++   D+
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  129 bits (326), Expect = 1e-34
 Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 13/159 (8%)

Query: 250 NKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLV 303
             LG+G FG V          + GE +AVK L   S    I + K E+ +L  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 304 RLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +  G C E       L+ EF+P+ SL  ++  P N+  +  +++ K    I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
               + +HRDL A N+L++SE   KI DFG+ +  E D+
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  128 bits (325), Expect = 3e-34
 Identities = 44/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGE-----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLV 303
             LG G FG VYKG+           +A+K L + +      E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           RLLG CL      L+ + +P   L  ++ +  +++++  +        IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
             R++HRDL A N+L+ +  + KI+DFG+A+L   ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  126 bits (319), Expect = 5e-34
 Identities = 48/151 (31%), Positives = 72/151 (47%), Gaps = 6/151 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            ++G G FG V+ G   N + +A+K + +     E +F  E  ++ +L H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           LE+    LV EF+ +  L  ++     R     E    +   +  G+ YL       +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           RDL A N L+      K+SDFGM R    DQ
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (318), Expect = 1e-33
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 10/154 (6%)

Query: 251 KLGQGGFGAVYKGML-SNGETI--AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +LG G FG+V +G+     + I  A+K L +   K    E   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C      + V E      L  F+     RE +      +++  ++ G+ YL       
Sbjct: 77  GVCQAEALML-VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            +HRDL A N+LL +    KISDFG+++    D 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  126 bits (319), Expect = 1e-33
 Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 15/159 (9%)

Query: 250 NKLGQGGFGAVYKGMLSN-----GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLV 303
             LG+G FG V            GE +AVK L  +   Q    +K E+ +L  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 304 RLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +  G C +       LV E+VP  SL  ++     R  +   +     + I  G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
                 IHRDL A N+LLD++   KI DFG+A+      
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  126 bits (318), Expect = 2e-33
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 15/166 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           LG+G +G VY G  LSN   IA+K + +   +       E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR----GLLYLHEDSRLR 366
           E     +  E VP  SL       +  +    +   + I    +    GL YLH++   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSAL----LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142

Query: 367 IIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQTHSDTNRVVGT 411
           I+HRD+K  N+L+++     KISDFG ++   +   +  T    GT
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGT 186

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  125 bits (317), Expect = 2e-33
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 14/158 (8%)

Query: 251 KLGQGGFGAVYKGMLSNGE---TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRL 305
           +LG G FG V KG     +   T+AVK L         + E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +G C    E   LV E      L+ ++       H+  +   +++  ++ G+ YL     
Sbjct: 84  IGICE--AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              +HRDL A N+LL ++   KISDFG+++    D+ +
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  125 bits (317), Expect = 2e-33
 Identities = 40/151 (26%), Positives = 76/151 (50%), Gaps = 6/151 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   + EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           RDL A N L++ +   K+SDFG++R    D+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  124 bits (315), Expect = 2e-33
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 6/150 (4%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +LG G FG V  G       +AVK + + S   + EF  E   + +L H  LV+  G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           +     +V E++ N  L +++    + + +   +  ++   +  G+ +L      + IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           DL A N L+D ++  K+SDFGM R    DQ
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  126 bits (319), Expect = 2e-33
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 10/156 (6%)

Query: 250 NKLGQGGFGAVYKGML---SNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVR 304
             +G G  G V  G L      +  +A+K L     + +  +F +E  ++ +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L G     +  ++V E++ N SLD F+    +    T  +   ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL---SD 169

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           L  +HRDL A N+L+DS +  K+SDFG++R+ E D 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  125 bits (315), Expect = 3e-33
 Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 21/166 (12%)

Query: 251 KLGQGGFGAVYKGMLSNGE--------TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
            LGQG F  ++KG+              + +K L K  +     F     ++++L H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           V   G C+   E ILV EFV   SLD ++    N+  +    + ++ + +A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 363 SRLRIIHRDLKASNILLDSEMNP--------KISDFGMARLFEMDQ 400
               +IH ++ A NILL  E +         K+SD G++       
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  124 bits (313), Expect = 6e-33
 Identities = 47/152 (30%), Positives = 80/152 (52%), Gaps = 6/152 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+       +AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           HRDL A N L+      K++DFG++RL   D 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  124 bits (314), Expect = 7e-33
 Identities = 39/184 (21%), Positives = 84/184 (45%), Gaps = 12/184 (6%)

Query: 233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNE 290
              F+++ V    +S   ++G GG   V++ +    +  A+K ++      +    ++NE
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76

Query: 291 VLLLARLQHRNL--VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
           +  L +LQ  +   +RL  + +  +   +V E   N  L+ ++     ++ +   +R   
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSY 132

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
            + +   +  +H+     I+H DLK +N L+  +   K+ DFG+A   + D T    +  
Sbjct: 133 WKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 188

Query: 409 VGTL 412
           VGT+
Sbjct: 189 VGTV 192

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  124 bits (314), Expect = 1e-32
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 21/163 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
            +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 304 RLLGFCLERKERILVYEFVPNASLDHF------------IFDPINREHMTWEKRYKIIEG 351
           R  G C E +  ++V+E++ +  L+ F              + +    +   +   +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  123 bits (311), Expect = 2e-32
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 22/164 (13%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
            +LG+G FG V+     N         +AVK L   +     +F+ E  LL  LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 304 RLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRYKIIE 350
           +  G C +    I+V+E++ +  L+ F                   +  +   +   I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            IA G++YL   +    +HRDL   N L+ + +  KI DFGM+R
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  126 bits (318), Expect = 2e-32
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 8/146 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
             +G+G FG V  G    G  +AVK +  ++      F  E  ++ +L+H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 310 LERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           +E K  + +V E++   SL  ++     R  +  +   K    +   + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 369 HRDLKASNILLDSEMNPKISDFGMAR 394
           HRDL A N+L+  +   K+SDFG+ +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK 337

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  123 bits (310), Expect = 2e-32
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 11/151 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
             +G+G FG VY G L + +      AVK L++ +  GE+ +F  E +++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 305 LLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           LLG CL  +   L V  ++ +  L +FI +     + T +        +A+G+ YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS-- 146

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             + +HRDL A N +LD +   K++DFG+AR
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  122 bits (309), Expect = 2e-32
 Identities = 52/158 (32%), Positives = 73/158 (46%), Gaps = 15/158 (9%)

Query: 251 KLGQGGFGAVYKGML--SNGETI--AVKRL---SKNSKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L     +  +   +F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 304 RLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           RL G  L     + +V E  P  SL   +    ++ H       +    +A G+ YL   
Sbjct: 85  RLYGVVLT--PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYL--- 137

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              R IHRDL A N+LL +    KI DFG+ R    + 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  122 bits (309), Expect = 2e-32
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 8/146 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
             +G+G FG V  G    G  +AVK +  ++      F  E  ++ +L+H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 310 LERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           +E K  + +V E++   SL  ++     R  +  +   K    +   + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 369 HRDLKASNILLDSEMNPKISDFGMAR 394
           HRDL A N+L+  +   K+SDFG+ +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  123 bits (311), Expect = 2e-32
 Identities = 44/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGE-----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLV 303
             LG G FG VYKG+           +A+K L + +      E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           RLLG CL      L+ + +P   L  ++ +  +++++  +        IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
             R++HRDL A N+L+ +  + KI+DFG+A+L   ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  122 bits (308), Expect = 2e-32
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 13/153 (8%)

Query: 251 KLGQGGFGAVYKGML--SNGETI--AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
            LG+G FG VY+G+     GE I  AVK   K+ +   + +F +E +++  L H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +G     +E   ++ E  P   L H++    N+  +           I + + YL     
Sbjct: 79  IGIIE--EEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYL---ES 131

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           +  +HRD+   NIL+ S    K+ DFG++R  E
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (311), Expect = 3e-32
 Identities = 49/156 (31%), Positives = 86/156 (55%), Gaps = 11/156 (7%)

Query: 251 KLGQGGFGAVYKGMLSNGE-----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
            +G G FG VYKGML          +A+K L    +++  ++F  E  ++ +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L G   + K  +++ E++ N +LD F+ +       +  +   ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---AN 165

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           +  +HRDL A NIL++S +  K+SDFG++R+ E D 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  123 bits (310), Expect = 3e-32
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 12/157 (7%)

Query: 250 NKLGQGGFGAVYKGML----SNGET-IAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLV 303
             LG G FG V+KG+      + +  + +K +   S +Q      + +L +  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           RLLG C     ++ V +++P  SL   +    +R  +  +        IA+G+ YL    
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
              ++HR+L A N+LL S    +++DFG+A L   D 
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  123 bits (310), Expect = 5e-32
 Identities = 40/180 (22%), Positives = 82/180 (45%), Gaps = 12/180 (6%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K ++      +    ++NE+  L
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 295 ARLQHRNL--VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +   +RL  + +  +   +V E   N  L+ ++     ++ +   +R    + +
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNM 117

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              +  +H+     I+H DLK +N L+  +   K+ DFG+A   + D T    +  VGT+
Sbjct: 118 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (319), Expect = 5e-32
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 10/154 (6%)

Query: 251 KLGQGGFGAVYKGML--SNGET-IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +LG G FG+V +G+      +  +A+K L +   K    E   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C   +  +LV E      L  F+     RE +      +++  ++ G+ YL       
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            +HR+L A N+LL +    KISDFG+++    D 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  123 bits (311), Expect = 6e-32
 Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 10/156 (6%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
             +G G FG V  G L        ++A+K L    +++   +F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L G   + K  ++V E++ N SLD F+    +    T  +   ++ GIA G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           +  +HRDL A NIL++S +  K+SDFG+ R+ E D 
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  121 bits (307), Expect = 6e-32
 Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 11/154 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
             +G+G FG VY G   +        A+K LS+ ++  ++  F  E LL+  L H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 305 LLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           L+G  L  +     +  ++ +  L  FI     + + T +        +ARG+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYL---A 141

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
             + +HRDL A N +LD     K++DFG+AR   
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (306), Expect = 6e-32
 Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 13/153 (8%)

Query: 251 KLGQGGFGAVYKGML---SNGET-IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
            +G+G FG V++G+     N    +A+K      S     +F  E L + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +G     +  + ++ E      L  F+     +  +           ++  L YL     
Sbjct: 82  IGVIT--ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYL---ES 134

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            R +HRD+ A N+L+ S    K+ DFG++R  E
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  120 bits (304), Expect = 1e-31
 Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 6/151 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +    I + E++ N SL  F+  P +   +T  K   +   IA G+ ++        IH
Sbjct: 78  TQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           RDL+A+NIL+   ++ KI+DFG+ARL E ++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  124 bits (312), Expect = 1e-31
 Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 6/151 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+    +    +AVK + K        F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +    I + EF+   SL  F+            K       IA G+ ++    +   IH
Sbjct: 253 TKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           RDL+A+NIL+ + +  KI+DFG+AR+ E ++
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE 338

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  120 bits (304), Expect = 1e-31
 Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 20/171 (11%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           ++G+G F  VYKG+       +A    +  K +K     FK E  +L  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 308 FCLERKER----ILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIEGIARGLLYLHE 361
                 +     +LV E + + +L  ++     +    M  +        I +GL +LH 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 362 DSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   IIHRDLK  NI +     + KI D G+A L       +    V+GT
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGT 193

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  120 bits (303), Expect = 2e-31
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 23/165 (13%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNL 302
            +LG+  FG VYKG L           +A+K L          EF++E +L ARLQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRYKII 349
           V LLG   + +   +++ +  +  L  F               D   +  +       ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  124 bits (312), Expect = 2e-31
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 6/152 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+       +AVK L K       EF  E  ++  ++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           HR+L A N L+      K++DFG++RL   D 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  121 bits (306), Expect = 3e-31
 Identities = 46/151 (30%), Positives = 80/151 (52%), Gaps = 11/151 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
             +G+G FG VY G L + +      AVK L++ +  GE+ +F  E +++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 305 LLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           LLG CL  +   L V  ++ +  L +FI +     + T +        +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             + +HRDL A N +LD +   K++DFG+AR
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  120 bits (302), Expect = 5e-31
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNL 302
            +LGQG FG VY+G+            +A+K +++ +   E IEF NE  ++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHF-------IFDPINREHMTWEKRYKIIEGIARG 355
           VRLLG   + +  +++ E +    L  +       + +       +  K  ++   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           + YL+     + +HRDL A N ++  +   KI DFGM R
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  120 bits (302), Expect = 6e-31
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 21/163 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGE---TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRNLVR 304
           + +G+G FG V K  +         A+KR+ + + + +  +F  E+ +L +L  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 305 LLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRYKIIEG 351
           LLG C  R    L  E+ P+ +L  F                      ++ ++       
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +ARG+ YL   S+ + IHRDL A NIL+      KI+DFG++R
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (301), Expect = 6e-31
 Identities = 42/170 (24%), Positives = 68/170 (40%), Gaps = 22/170 (12%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
            ++G+G FG V++      G   AVK++  +  +  E+         A L    +V L G
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV------ACAGLSSPRIVPLYG 117

Query: 308 FCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
              E     +  E +   SL   I     +  +          +     GL YLH     
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-----YYLGQALEGLEYLHTR--- 169

Query: 366 RIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQ---THSDTNRVVGT 411
           RI+H D+KA N+LL S+ +   + DFG A   + D    +    + + GT
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  118 bits (299), Expect = 9e-31
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 36/197 (18%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
             +F +   LGQG FG V K     +    A+K++    ++      +EV+LLA L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQY 63

Query: 302 LVRLLGFCLERKERI-------------LVYEFVPNASLDHFIFDPINREHMTWEKRY-- 346
           +VR     LER+  +             +  E+  N +L    +D I+ E++  ++    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--------- 397
           ++   I   L Y+H      IIHRDLK  NI +D   N KI DFG+A+            
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 398 ---MDQTHSDTNRVVGT 411
              +  +  +    +GT
Sbjct: 177 SQNLPGSSDNLTSAIGT 193

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (302), Expect = 1e-30
 Identities = 40/180 (22%), Positives = 81/180 (45%), Gaps = 12/180 (6%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--SKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K ++      Q    ++NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 295 ARLQHRNL--VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +   +RL  + +  +   +V E   N  L+ ++     ++ +   +R    + +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNM 164

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              +  +H+     I+H DLK +N L+  +   K+ DFG+A   + D T    +  VG +
Sbjct: 165 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  118 bits (297), Expect = 2e-30
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 9/163 (5%)

Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
            + +   ++    KLG+GGF  V     L +G   A+KR+  + +Q   E + E  +   
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82

Query: 297 LQHRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEG 351
             H N++RL+ +CL  +       L+  F    +L + I         +T ++   ++ G
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           I RGL  +H        HRDLK +NILL  E  P + D G   
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  117 bits (295), Expect = 3e-30
 Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 14/154 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   ++       E  A K + K+   K  + E    E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMT-WEKRYKIIEGIARGLLYLHEDSRL 365
              E  + + +V E     SL         R+ +T  E RY + + I  G  YLH   R 
Sbjct: 83  -FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQ-IVLGCQYLH---RN 134

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           R+IHRDLK  N+ L+ ++  KI DFG+A   E D
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (295), Expect = 3e-30
 Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 10/173 (5%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEF-KNEVLLLARLQH 299
            NF    K+G+G F  VY+   L +G  +A+K  ++              E+ LL +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGLLY 358
            N+++     +E  E  +V E      L   I     ++ +  E+  +K    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +H     R++HRD+K +N+ + +    K+ D G+ R F    T + +  +VGT
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  117 bits (295), Expect = 4e-30
 Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLV 303
             LG+G FG+V +G L   +     +AVK +  +  S++   EF +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 304 RLLGFCLERKERI-----LVYEFVPNASLDHFI---FDPINREHMTWEKRYKIIEGIARG 355
           RLLG C+E   +      ++  F+    L  ++         +H+  +   K +  IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           + YL   S    +HRDL A N +L  +M   ++DFG+++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  117 bits (296), Expect = 4e-30
 Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 14/154 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   ++       E  A K + K+   K  + E    E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMT-WEKRYKIIEGIARGLLYLHEDSRL 365
              E  + + +V E     SL         R+ +T  E RY + + I  G  YLH   R 
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQ-IVLGCQYLH---RN 160

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           R+IHRDLK  N+ L+ ++  KI DFG+A   E D
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  119 bits (301), Expect = 4e-30
 Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 6/151 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            E    I V E++   SL  F+      +++   +   +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           RDL+A+NIL+   +  K++DFG+ARL E ++
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNE 334

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  120 bits (303), Expect = 5e-30
 Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 6/151 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            E    I V E++   SL  F+      +++   +   +   IA G+ Y+    R+  +H
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           RDL+A+NIL+   +  K++DFG+ARL E ++
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNE 417

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (292), Expect = 5e-30
 Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 38/204 (18%)

Query: 225 EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG 283
             T+ K    DF+ I            +G GGFG V+K     +G+T  +KR+  N++  
Sbjct: 2   AHTVDKRFGMDFKEIE----------LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-- 49

Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERI----------------LVYEFVPNASL 327
             + + EV  LA+L H N+V   G                         +  EF    +L
Sbjct: 50  --KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL 107

Query: 328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
           + +I +    E +      ++ E I +G+ Y+H     ++I+RDLK SNI L      KI
Sbjct: 108 EQWI-EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKI 163

Query: 388 SDFGMARLFEMDQTHSDTNRVVGT 411
            DFG+    + D       R  GT
Sbjct: 164 GDFGLVTSLKNDGKR---TRSKGT 184

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  117 bits (294), Expect = 6e-30
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 17/159 (10%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNL 302
             LG G FG VY+G +S          +AVK L +   + + ++F  E L++++  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLY 358
           VR +G  L+   R ++ E +    L  F+      P     +       +   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 359 LHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMAR 394
           L        IHRD+ A N LL         KI DFGMAR
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  120 bits (302), Expect = 9e-30
 Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 14/220 (6%)

Query: 183 PRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVA 242
           P+K+    L ++          +    + +       E  + E+T       D+E  R  
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR-- 389

Query: 243 TDNFSDANKLGQGGFGAVYKGMLSNGE----TIAVKRLSKN-SKQGEIEFKNEVLLLARL 297
            +       +G+G FG V++G+  + E     +A+K      S     +F  E L + + 
Sbjct: 390 -ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL 357
            H ++V+L+G   E     ++ E      L  F+     +  +           ++  L 
Sbjct: 449 DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALA 505

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           YL      R +HRD+ A N+L+ S    K+ DFG++R  E
Sbjct: 506 YL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  117 bits (295), Expect = 9e-30
 Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 17/159 (10%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNL 302
             LG G FG VY+G +S          +AVK L +  S+Q E++F  E L++++  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLY 358
           VR +G  L+   R ++ E +    L  F+      P     +       +   IA G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 359 LHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMAR 394
           L        IHRD+ A N LL         KI DFGMAR
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  116 bits (292), Expect = 1e-29
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 18/160 (11%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLV 303
             LG+G FG+V +  L   +     +AVK L  +  +     EF  E   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 304 RLLGFCLERKERI------LVYEFVPNASLDHFIFD---PINREHMTWEKRYKIIEGIAR 354
           +L+G  L  + +       ++  F+ +  L  F+       N  ++  +   + +  IA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           G+ YL   S    IHRDL A N +L  +M   ++DFG++R
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  115 bits (290), Expect = 2e-29
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 31/173 (17%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNL 302
             LG+G FG V K    + +      T+AVK L +N+   E  +  +E  +L ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHF---------------------IFDPINREHMT 341
           ++L G C +    +L+ E+    SL  F                       D  +   +T
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                     I++G+ YL   + ++++HRDL A NIL+      KISDFG++R
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  115 bits (291), Expect = 2e-29
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 31/173 (17%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNL 302
             +G+G FG V++              +AVK L +  S   + +F+ E  L+A   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHF---------------------IFDPINREHMT 341
           V+LLG C   K   L++E++    L+ F                              ++
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             ++  I   +A G+ YL   S  + +HRDL   N L+   M  KI+DFG++R
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  115 bits (290), Expect = 4e-29
 Identities = 44/199 (22%), Positives = 82/199 (41%), Gaps = 28/199 (14%)

Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RL 276
            D   E    +S++  +  ++          K+G+G FG         +G    +K   +
Sbjct: 11  VDLGTENLYFQSME-KYVRLQ----------KIGEGSFGKAILVKSTEDGRQYVIKEINI 59

Query: 277 SKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI----F 332
           S+ S +   E + EV +LA ++H N+V+      E     +V ++     L   I     
Sbjct: 60  SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119

Query: 333 DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM 392
               +E             I   L ++H+    +I+HRD+K+ NI L  +   ++ DFG+
Sbjct: 120 VLF-QEDQIL----DWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171

Query: 393 ARLFEMDQTHSDTNRVVGT 411
           AR+  ++ T       +GT
Sbjct: 172 ARV--LNSTVELARACIGT 188

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  113 bits (286), Expect = 9e-29
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 26/168 (15%)

Query: 250 NKLGQGGFGAVYKGMLSNGE--------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QH 299
             LG+G FG V        +        T+AVK L  ++ + +  +  +E+ ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRY 346
           +N++ LLG C +     ++ E+    +L  +               + +  E MT++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  113 bits (285), Expect = 9e-29
 Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 11/168 (6%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
            +   +  ++ LGQG    V++G     G+  A+K  +  S    ++    E  +L +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 299 HRNLVRLLGF--CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           H+N+V+L         + ++L+ EF P  SL   + +P N   +   +   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 357 LYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMARLFEMDQ 400
            +L E     I+HR++K  NI+     D +   K++DFG AR  E D+
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  113 bits (286), Expect = 2e-28
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 26/168 (15%)

Query: 250 NKLGQGGFGAVYKGMLSNGE--------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QH 299
             LG+G FG V        +        T+AVK L  ++ + +  +  +E+ ++  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRY 346
           +N++ LLG C +     ++ E+    +L  +               + +  E MT++   
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (280), Expect = 2e-28
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 17/156 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG+G F  VY+   +  G  +A+K + K +  K G ++  +NEV +  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMT---WEKRYKIIEGIARGLLYLHEDS 363
              E    + LV E   N  +       +          E R+ + + I  G+LYLH   
Sbjct: 79  -YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQ-IITGMLYLH--- 129

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
              I+HRDL  SN+LL   MN KI+DFG+A   +M 
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  112 bits (282), Expect = 3e-28
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 25/167 (14%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRN 301
             LG+G FG V +      +      T+AVK L + +   E     +E+ +L  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 302 LVRLLGFCLERKERILV-YEFVPNASLDHF-------------IFDPINREHMTWEKRYK 347
           +V LLG C +    ++V  EF    +L  +               + + ++ +T E    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
               +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  111 bits (280), Expect = 3e-28
 Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 17/176 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRN 301
            +F     LG+GGFG V++     +    A+KR+   +++   E    EV  LA+L+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 302 LVRLLGFCLE---------RKERILVY---EFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +VR     LE            ++ +Y   +     +L  ++      E         I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             IA  + +LH      ++HRDLK SNI    +   K+ DFG+    + D+     
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (285), Expect = 3e-28
 Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 11/168 (6%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
            +   +  ++ LGQG    V++G     G+  A+K  +  S    ++    E  +L +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 299 HRNLVRLLGF--CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           H+N+V+L         + ++L+ EF P  SL   + +P N   +   +   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 357 LYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMARLFEMDQ 400
            +L E     I+HR++K  NI+     D +   K++DFG AR  E D+
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  111 bits (281), Expect = 3e-28
 Identities = 46/168 (27%), Positives = 68/168 (40%), Gaps = 26/168 (15%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRN 301
             LG G FG V +             T+AVK L  ++   E     +E+ +L+ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHF---------------IFDPINREHMTWEKRY 346
           +V LLG C      +++ E+     L +F                    +   +  E   
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                +A+G+ +L   +    IHRDL A NILL      KI DFG+AR
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (282), Expect = 7e-28
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 26/168 (15%)

Query: 250 NKLGQGGFGAVYKGML--------SNGETIAVKRLSKNSKQGE-IEFKNEVLLLARL-QH 299
             LG+G FG V             +    +AVK L  ++ + +  +  +E+ ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRY 346
           +N++ LLG C +     ++ E+    +L  +                    E ++ +   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (276), Expect = 1e-27
 Identities = 42/171 (24%), Positives = 85/171 (49%), Gaps = 12/171 (7%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
              ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLH 360
           +V  L   L   E  +V E++   SL   +    ++   +       +     + L +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH 133

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            +   ++IHRD+K+ NILL  + + K++DFG     ++    S  + +VGT
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGT 179

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (277), Expect = 2e-27
 Identities = 43/164 (26%), Positives = 68/164 (41%), Gaps = 22/164 (13%)

Query: 250 NKLGQGGFGAVYKGML-----SNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRN 301
             LG G FG V +         +    +AVK L   +   E     +E+ +++ L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHF-----------IFDPINREHMTWEKRYKIIE 350
           +V LLG C      +++ E+     L +F               I     +         
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  109 bits (275), Expect = 3e-27
 Identities = 45/185 (24%), Positives = 78/185 (42%), Gaps = 10/185 (5%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           +T+ +          L +GGF  VY+   + +G   A+KRL  N ++       EV  + 
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80

Query: 296 RLQ-HRNLVRLLGFCLERKER-------ILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           +L  H N+V+        KE         L+   +    L  F+    +R  ++ +   K
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I     R + ++H   +  IIHRDLK  N+LL ++   K+ DFG A        +S + +
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 408 VVGTL 412
               +
Sbjct: 200 RRALV 204

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (274), Expect = 3e-27
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 10/170 (5%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
                   K+G+G  G V       +G  +AVK +    +Q      NEV+++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V +    L  +E  ++ EF+   +L     D +++  +  E+   + E + + L YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
                +IHRD+K+ +ILL  +   K+SDFG     ++ +       +VGT
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGT 204

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  109 bits (275), Expect = 4e-27
 Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 31/173 (17%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRN 301
             LG G FG V                +AVK L + +   E     +E+ ++ +L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHF------IFDPINREHMTWEKRYKIIEG---- 351
           +V LLG C       L++E+     L ++       F     E+   ++  +  +     
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 352 ----------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                     +A+G+ +L        +HRDL A N+L+      KI DFG+AR
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (272), Expect = 4e-27
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 14/173 (8%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            + +    +LG G FG VYK      G   A K +   S++   ++  E+ +LA   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 302 LVRLLGFCLERKERILVYEFVPNASLD---HFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +V+LLG      +  ++ EF P  ++D     +   +    +       +   +   L +
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEALNF 132

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           LH     RIIHRDLKA N+L+  E + +++DFG++   +  +T    +  +GT
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGT 180

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  107 bits (269), Expect = 9e-27
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 10/176 (5%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHR 300
           +++     +G G +G   K    S+G+ +  K       ++  +    +EV LL  L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 301 NLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGLL 357
           N+VR     ++R    L  V E+     L   I           E+   +++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 358 YLHE--DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             H   D    ++HRDLK +N+ LD + N K+ DFG+AR+   D + + T   VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  109 bits (275), Expect = 1e-26
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 18/183 (9%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
             + V   +F   + LG G  G +    + +   +AVKR+             EV LL  
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRE 73

Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIAR 354
             +H N++R      +R+ + +  E    A+L  ++     ++          +++    
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTS 129

Query: 355 GLLYLHEDSRLRIIHRDLKASNILL-----DSEMNPKISDFGMARLFEMDQ-THSDTNRV 408
           GL +LH    L I+HRDLK  NIL+       ++   ISDFG+ +   + + + S  + V
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 409 VGT 411
            GT
Sbjct: 187 PGT 189

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (268), Expect = 2e-26
 Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 13/172 (7%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHR 300
            + F+   K+G+G FG V+KG+     + +A+K +     + EIE  + E+ +L++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYL 359
            + +  G  L+  +  ++ E++   S    +   P++   +       I+  I +GL YL
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGLDYL 135

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           H +   + IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGT 182

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  107 bits (269), Expect = 2e-26
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 21/181 (11%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-------EIEFKNEVLL 293
           ++  F    KLG G +  VYKG+  + G  +A+K +  +S++G       EI       L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS------L 56

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPN--ASLDHFIFDPINREHMTWEKRYKIIEG 351
           +  L+H N+VRL        +  LV+EF+ N                 +           
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           + +GL + HE+   +I+HRDLK  N+L++     K+ DFG+AR F     ++ ++ VV T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-T 171

Query: 412 L 412
           L
Sbjct: 172 L 172

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  106 bits (266), Expect = 2e-26
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 21/174 (12%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIE-FKNEVLLLA 295
           + A ++F     LG+G FG VY      +   +A+K L K    K G     + EV + +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 296 RLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIA 353
            L+H N++RL G+      R+ L+ E+ P  ++    +  + +     E+R    I  +A
Sbjct: 65  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELA 119

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
             L Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSR 163

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  110 bits (276), Expect = 2e-26
 Identities = 42/188 (22%), Positives = 84/188 (44%), Gaps = 19/188 (10%)

Query: 233 QFDFETIRVATDNFSD----ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF 287
           Q+  + + +  D+  D      +LG G FG V++    + G   A K +    +  +   
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV 201

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI--NREHMTWEKR 345
           + E+  ++ L+H  LV L     +  E +++YEF+    L    F+ +      M+ ++ 
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEA 257

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHS 403
            + +  + +GL ++HE      +H DLK  NI+  ++ +   K+ DFG+    +  Q+  
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314

Query: 404 DTNRVVGT 411
                 GT
Sbjct: 315 V---TTGT 319

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  105 bits (265), Expect = 5e-26
 Identities = 57/188 (30%), Positives = 86/188 (45%), Gaps = 28/188 (14%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKN----EVLLLA 295
           AT  +    ++G G +G VYK     +G  +A+K +   N   G          EV LL 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 296 RLQ---HRNLVRLL----GFCLERKERI-LVYEFVPNASLDH---FIFDPINREHMTWEK 344
           RL+   H N+VRL+        +R+ ++ LV+E      +D       D      +  E 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAET 121

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
              ++    RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++        
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-- 176

Query: 405 TNRVVGTL 412
           T  VV TL
Sbjct: 177 TPVVV-TL 183

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (268), Expect = 6e-26
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 22/205 (10%)

Query: 216 KLKLEDENVEETIAKSLQFDFETIRVATDNFSD----ANKLGQGGFGAVYKGM-LSNGET 270
           K+   D+  E+   K   +  + + V   +  D      +LG G FG V++ +  + G  
Sbjct: 22  KINDYDKFYEDIWKK---YVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRV 78

Query: 271 IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHF 330
              K ++      +   KNE+ ++ +L H  L+ L     ++ E +L+ EF+    L   
Sbjct: 79  FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL--- 135

Query: 331 IFDPI-NREHMTWEKR-YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP--K 386
            FD I   ++   E      +     GL ++HE     I+H D+K  NI+ +++     K
Sbjct: 136 -FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVK 191

Query: 387 ISDFGMARLFEMDQTHSDTNRVVGT 411
           I DFG+A     D+          T
Sbjct: 192 IIDFGLATKLNPDEIVKV---TTAT 213

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  105 bits (264), Expect = 7e-26
 Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 22/178 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLL 294
           +NF    K+G+G +G VYK      GE +A+K++      +G       EI       LL
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS------LL 56

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             L H N+V+LL       +  LV+EF+    L  F+ D      +        +  + +
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQ 114

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           GL + H     R++HRDLK  N+L+++E   K++DFG+AR F      + T+ VV TL
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TL 167

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  105 bits (265), Expect = 7e-26
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 22/177 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-------EIEFKNEVLLLA 295
           + +   +KLG+G +  VYKG        +A+K +    ++G       E+       LL 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS------LLK 55

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            L+H N+V L       K   LV+E++    L  ++ D  N  +M   K +  +  + RG
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLLRG 112

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           L Y H     +++HRDLK  N+L++     K++DFG+AR      T +  N VV TL
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TL 164

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (263), Expect = 1e-25
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 22/177 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLLA 295
           + +    K+G+G +G VYK   S G  +A+KR+      +G       EI       LL 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS------LLK 74

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            L H N+V L+      +   LV+EF+    L   + +  N+  +   +    +  + RG
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRG 131

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           + + H+    RI+HRDLK  N+L++S+   K++DFG+AR F      S T+ VV TL
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TL 183

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (265), Expect = 1e-25
 Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 21/189 (11%)

Query: 234 FDFETIRVATDNFSD------ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE 286
           FD   +       +          LG G FG V+K    + G  +A K +     + + E
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132

Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE--HMTWEK 344
            KNE+ ++ +L H NL++L      + + +LV E+V    L    FD I  E  ++T   
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELD 188

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTH 402
               ++ I  G+ ++H+   + I+H DLK  NIL  +      KI DFG+AR ++  +  
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245

Query: 403 SDTNRVVGT 411
                  GT
Sbjct: 246 KV---NFGT 251

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  105 bits (264), Expect = 1e-25
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 20/178 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN--------EVLLL 294
             +   + LG+G F  VYK    +  + +A+K++         E K+        E+ LL
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             L H N++ LL     +    LV++F+    L+  I D      +T       +    +
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQ 123

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           GL YLH+     I+HRDLK +N+LLD     K++DFG+A+ F      + T++VV T 
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TR 176

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  104 bits (261), Expect = 1e-25
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 22/180 (12%)

Query: 243 TDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHR 300
            D F    KLG G FG V+     S+G    +K ++K+  Q  +E  + E+ +L  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY------KIIEGIAR 354
           N++++     +     +V E      L     + I        K        ++++ +  
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGEL----LERI-VSAQARGKALSEGYVAELMKQMMN 135

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            L Y H      ++H+DLK  NIL          KI DFG+A LF+ D+  ++     GT
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGT 189

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  105 bits (264), Expect = 1e-25
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 35/190 (18%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKN----EVLLLARL 297
             +    K+GQG FG V+K      G+ +A+K++  +N K+G   F      E+ +L  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73

Query: 298 QHRNLVRLLGFCLERKERI--------LVYEFVPNASLDH----FIFDPINREHMTWEKR 345
           +H N+V L+  C  +            LV++F      +H     + +       T  + 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNV--LVKFTLSEI 126

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD- 404
            ++++ +  GL Y+H +   +I+HRD+KA+N+L+  +   K++DFG+AR F + +     
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 405 --TNRVVGTL 412
             TNRVV TL
Sbjct: 184 RYTNRVV-TL 192

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (262), Expect = 1e-25
 Identities = 49/173 (28%), Positives = 88/173 (50%), Gaps = 16/173 (9%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            + F    KLG+G +G+VYK +    G+ +A+K++   S   EI    E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII--KEISIMQQCDSPH 85

Query: 302 LVRLLGFCLERKERILVYEFVPNASLD---HFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +V+  G   +  +  +V E+    S+          +  + +       I++   +GL Y
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-----ILQSTLKGLEY 140

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           LH     R IHRD+KA NILL++E + K++DFG+A   ++  T +  N V+GT
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGT 188

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (260), Expect = 2e-25
 Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 22/181 (12%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEVLLLA 295
            D++    +LG G F  V K      G+  A K + K             E + EV +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
            ++H N++ L      + + +L+ E V    L    FD +  +E +T ++  + ++ I  
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILD 119

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVG 410
           G+ YLH     RI H DLK  NI+L  +  P    K+ DFG+A   E      +   + G
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173

Query: 411 T 411
           T
Sbjct: 174 T 174

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  103 bits (260), Expect = 2e-25
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 24/174 (13%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKN--SKQGEIE-FKNE 290
           DF+  R           LG+G FG VY      N   +A+K L K+   K+G     + E
Sbjct: 15  DFDIGRP----------LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR-YKI 348
           + + + L+H N++R+  +    ++RI L+ EF P   L    +  + +     E+R    
Sbjct: 65  IEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATF 119

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           +E +A  L Y H     ++IHRD+K  N+L+  +   KI+DFG +      +  
Sbjct: 120 MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  106 bits (267), Expect = 2e-25
 Identities = 59/185 (31%), Positives = 90/185 (48%), Gaps = 22/185 (11%)

Query: 239 IRVATDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKN---SKQGEIEFKNE 290
           ++ +T  FSD       LG+G FG V        G+  AVK +SK     K  +     E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKII 349
           V LL +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARII 132

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTN 406
             +  G+ Y+H+    +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D  
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-- 187

Query: 407 RVVGT 411
             +GT
Sbjct: 188 -KIGT 191

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  103 bits (259), Expect = 2e-25
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 22/177 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLLA 295
           + +    K+G+G +G VYK   + GET A+K++  +   +G       EI       +L 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS------ILK 55

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            L+H N+V+L      +K  +LV+E +    L   +            K +  +  +  G
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNG 112

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           + Y H+    R++HRDLK  N+L++ E   KI+DFG+AR F        T+ +V TL
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TL 164

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  106 bits (267), Expect = 2e-25
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 21/184 (11%)

Query: 239 IRVATDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKN--SKQGEIEFKNEV 291
           I     + S+      KLG G +G V            A+K + K   S     +   EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIE 350
            +L  L H N+++L  F  +++   LV E      L    FD I +R          II+
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIK 143

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNR 407
            +  G+ YLH+     I+HRDLK  N+LL+S   +   KI DFG++ +FE  +   +   
Sbjct: 144 QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--- 197

Query: 408 VVGT 411
            +GT
Sbjct: 198 RLGT 201

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  103 bits (260), Expect = 3e-25
 Identities = 41/174 (23%), Positives = 58/174 (33%), Gaps = 17/174 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARL-QH 299
            +F   ++LG G +G V+K     +G   AVKR        +       EV    ++ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR--EHMTWEKRYKIIEGIARGLL 357
              VRL     E     L  E     SL            E   W      +      L 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW----GYLRDTLLALA 171

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +LH      ++H D+K +NI L      K+ DFG+        T        G 
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGD 219

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  102 bits (258), Expect = 4e-25
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 23/178 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLL 294
             +    K+G+G +G V+K       E +A+KR+   +  +G       EI       LL
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC------LL 55

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             L+H+N+VRL       K+  LV+EF     L  +             K +  +  + +
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLK 112

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           GL + H      ++HRDLK  N+L++     K+++FG+AR F        +  VV TL
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TL 165

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (259), Expect = 4e-25
 Identities = 51/185 (27%), Positives = 77/185 (41%), Gaps = 26/185 (14%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEV 291
                D      +LG G F  V K    S G   A K + K   +         E + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIE 350
            +L ++ H N++ L      R + +L+ E V    L    FD +  +E ++ E+    I+
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIK 122

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTN 406
            I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177

Query: 407 RVVGT 411
            + GT
Sbjct: 178 -IFGT 181

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  106 bits (266), Expect = 5e-25
 Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 14/161 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-- 306
           +LG GGFG V + +    GE +A+K+  +       E +  E+ ++ +L H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 307 ----GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
                        +L  E+     L  ++    N   +       ++  I+  L YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 363 SRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQ 400
              RIIHRDLK  NI+L         KI D G A+  +  +
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  103 bits (259), Expect = 5e-25
 Identities = 37/170 (21%), Positives = 72/170 (42%), Gaps = 27/170 (15%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEF-----------------KNEVLL 293
            L QG F  +      + +  A+K+  K+  + + +F                 KNE+ +
Sbjct: 38  TLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 294 LARLQHRNLVRLLGFCLERKERI-LVYEFVPNASL-----DHFIFDPINREHMTWEKRYK 347
           +  +++   +   G  +   + + ++YE++ N S+       F+ D      +  +    
Sbjct: 97  ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           II+ +     Y+H  +   I HRD+K SNIL+D     K+SDFG +    
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 6e-25
 Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 26/185 (14%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEV 291
            +N  D      +LG G F  V K    S G   A K + K   +         + + EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIE 350
            +L  +QH N++ L      + + IL+ E V    L    FD +  +E +T E+  + ++
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLK 121

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTN 406
            I  G+ YLH    L+I H DLK  NI+L     P    KI DFG+A   +      +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176

Query: 407 RVVGT 411
            + GT
Sbjct: 177 -IFGT 180

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (258), Expect = 6e-25
 Identities = 37/174 (21%), Positives = 74/174 (42%), Gaps = 16/174 (9%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            + +  A  LG+G FG V++ +  S+ +T   K +       ++  K E+ +L   +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE--HMTWEKRYKIIEGIARGLLYL 359
           ++ L       +E ++++EF+    +    F+ IN     +   +    +  +   L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGT 411
           H      I H D++  NI+  +  +   KI +FG AR  +          +   
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTA 166

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (256), Expect = 6e-25
 Identities = 46/193 (23%), Positives = 67/193 (34%), Gaps = 33/193 (17%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKR--LSKNSKQGEIEFKNEVLLLARL-Q 298
           T  F +  K+G G FG+V+K +   +G   A+KR          E     EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGLL 357
           H ++VR      E    ++  E+    SL   I +         E     ++  + RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP-------------------KISDFGMARLFEM 398
           Y+H      ++H D+K SNI +     P                   KI D G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 399 DQTHSDTNRVVGT 411
            Q         G 
Sbjct: 187 PQV------EEGD 193

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  102 bits (256), Expect = 6e-25
 Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 19/178 (10%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
             + +      N +G+G +G V            A K++ K   +    FK E+ ++  L
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGL 356
            H N++RL     +  +  LV E      L    F+ + ++         +I++ +   +
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAV 119

Query: 357 LYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            Y H+   L + HRDLK  N L  +   +   K+ DFG+A  F+  +        VGT
Sbjct: 120 AYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGT 171

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  103 bits (259), Expect = 7e-25
 Identities = 51/185 (27%), Positives = 77/185 (41%), Gaps = 26/185 (14%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEV 291
                D      +LG G F  V K    S G   A K + K   +         E + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIE 350
            +L ++ H N++ L      R + +L+ E V    L    FD +  +E ++ E+    I+
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIK 122

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTN 406
            I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177

Query: 407 RVVGT 411
            + GT
Sbjct: 178 -IFGT 181

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  103 bits (258), Expect = 8e-25
 Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 20/175 (11%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK---NEVLLLARLQ 298
              FSD  ++G G FGAVY    + N E +A+K++S + KQ   +++    EV  L +L+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLD--HFIFDPINREHMTWEKRYKIIEGIARGL 356
           H N ++  G  L      LV E+   ++ D       P+    +       +  G  +GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-----VTHGALQGL 167

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            YLH      +IHRD+KA NILL      K+ DFG A         +  N  VGT
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGT 213

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (255), Expect = 8e-25
 Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 17/168 (10%)

Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
            LG+G FG V K       +  AVK ++K S K  +      EV LL +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
              +     +V E      L    FD I  R+  +     +II+ +  G+ Y+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141

Query: 367 IIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           I+HRDLK  NILL+S   + + KI DFG++  F+ +    D    +GT
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGT 186

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  101 bits (254), Expect = 1e-24
 Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLA 295
           +  FSD      +LG+G F  V + +  + G   A K ++       + +  + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +LQH N+VRL     E     LV++ V    L    F+ I  RE  +       I+ I  
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGT 411
            + Y H      I+HR+LK  N+LL S+      K++DFG+A      +         GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGT 170

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (255), Expect = 1e-24
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 13/178 (7%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRN 301
           D++     +G G    V         E +A+KR++    Q  ++    E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIAR----GL 356
           +V      + + E  LV + +   S+   I       EH +       I  I R    GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM-ARLFEMDQTHSDTNR--VVGT 411
            YLH++     IHRD+KA NILL  + + +I+DFG+ A L        +  R   VGT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (254), Expect = 2e-24
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           LG+G +G V + +        AVK L K        GE   K E+ LL RL+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 307 G-FCLERKERI-LVYEFVPNASLDHFIFDPINREHMT-WEKRYK---IIEGIARGLLYLH 360
                E K+++ +V E+      +  + D +  +     +       +I+G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
                 I+H+D+K  N+LL +    KIS  G+A     
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  103 bits (260), Expect = 2e-24
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 17/189 (8%)

Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGE--IE 286
            S + +        + ++    LG+G FG V K       +  AVK ++K S + +    
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67

Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKR 345
              EV LL +L H N+++L     +     +V E      L    FD I  R+  +    
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDA 123

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTH 402
            +II+ +  G+ Y+H+     I+HRDLK  NILL+S   + + KI DFG++  F+ +   
Sbjct: 124 ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180

Query: 403 SDTNRVVGT 411
            D    +GT
Sbjct: 181 KD---RIGT 186

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  101 bits (254), Expect = 2e-24
 Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 13/173 (7%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQH 299
           + +    K+G+G +G V+K      G+ +A+K+    S+   +  K    E+ +L +L+H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            NLV LL     ++   LV+E+  + ++ H +     +  +       I     + + + 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H   +   IHRD+K  NIL+      K+ DFG ARL     +    + V  T 
Sbjct: 119 H---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TR 166

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  101 bits (254), Expect = 2e-24
 Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 15/174 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN----EVLLLARLQ 298
           + + +   +G+G +G V K      G  +A+K+    S   ++  K     E+ LL +L+
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKM-VKKIAMREIKLLKQLR 82

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H NLV LL  C ++K   LV+EFV + ++   +        + ++   K +  I  G+ +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLEL--FPNGLDYQVVQKYLFQIINGIGF 139

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
            H      IIHRD+K  NIL+      K+ DFG AR           + V  T 
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TR 188

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (257), Expect = 3e-24
 Identities = 45/188 (23%), Positives = 70/188 (37%), Gaps = 27/188 (14%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNL 302
           +       LG G  G V       G  +AVKR+  +          E+ LL     H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNV 71

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLY 358
           +R        +   +  E   N +L   +        N +         ++  IA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNP-------------KISDFGMARLFEMDQT--HS 403
           LH    L+IIHRDLK  NIL+ +                  ISDFG+ +  +  Q+   +
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 404 DTNRVVGT 411
           + N   GT
Sbjct: 188 NLNNPSGT 195

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  101 bits (253), Expect = 3e-24
 Identities = 52/186 (27%), Positives = 92/186 (49%), Gaps = 30/186 (16%)

Query: 244 DNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLS-KNSKQG-------EIEFKNEVLL 293
             +    ++G+G +G V+K   + + G  +A+KR+  +  ++G       E+      +L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-----VL 65

Query: 294 --LARLQHRNLVRLL----GFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRY 346
             L   +H N+VRL         +R+ ++ LV+E V    L  ++ D +    +  E   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIK 123

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            ++  + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++        T+
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TS 178

Query: 407 RVVGTL 412
            VV TL
Sbjct: 179 VVV-TL 183

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (252), Expect = 4e-24
 Identities = 45/187 (24%), Positives = 85/187 (45%), Gaps = 12/187 (6%)

Query: 231 SLQFDFE-TIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-F 287
            L+   E       ++  D  ++G+G +G+V K +   +G+ +AVKR+     + E +  
Sbjct: 8   KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL 67

Query: 288 KNEV-LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
             ++ +++       +V+  G      +  +  E + + S D F     +       +  
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEI 126

Query: 347 --KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
             KI     + L +L E+  L+IIHRD+K SNILLD   N K+ DFG++   ++  + + 
Sbjct: 127 LGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAK 182

Query: 405 TNRVVGT 411
           T    G 
Sbjct: 183 TR-DAGC 188

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (251), Expect = 4e-24
 Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 26/186 (13%)

Query: 242 ATDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSK---------NSKQGEIEF 287
           +T  F +       LG+G    V + +     +  AVK +             ++     
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 288 KNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKR 345
             EV +L ++  H N+++L           LV++ +    L    FD +  +  ++ ++ 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKET 126

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            KI+  +   +  LH+   L I+HRDLK  NILLD +MN K++DFG +   +  +   + 
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182

Query: 406 NRVVGT 411
             V GT
Sbjct: 183 --VCGT 186

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 98.8 bits (247), Expect = 9e-24
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 18/167 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLGFC 309
           LG+G +G V   +     E +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 310 LERKERILVYEFVPNASLDHFIFDPI-NREHMT-WEKRYK---IIEGIARGLLYLHEDSR 364
            E   + L  E+     L    FD I     M   + +     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 37/187 (19%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLL 294
           D +    KLG+G +G VYK +     ET+A+KR+  ++ ++G       E+       LL
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS------LL 87

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPN---ASLDHFI-FDPINREHMTWEKRYKIIE 350
             LQHRN++ L           L++E+  N     +D          +   ++       
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ------- 140

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-----KISDFGMARLFEMDQTHSDT 405
            +  G+ + H     R +HRDLK  N+LL           KI DFG+AR F        T
Sbjct: 141 -LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFT 195

Query: 406 NRVVGTL 412
           + ++ TL
Sbjct: 196 HEII-TL 201

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (254), Expect = 1e-23
 Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 32/195 (16%)

Query: 239 IRVATDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKN-------------S 280
           +R       ++     KLG G +G V      +     A+K + K+              
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 281 KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREH 339
           ++   E  NE+ LL  L H N+++L     ++K   LV EF     L    F+ I NR  
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHK 142

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLF 396
                   I++ I  G+ YLH+     I+HRD+K  NILL++    +N KI DFG++  F
Sbjct: 143 FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 397 EMDQTHSDTNRVVGT 411
             D    D    +GT
Sbjct: 200 SKDYKLRD---RLGT 211

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 18/167 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLGFC 309
           LG+G +G V   +     E +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 310 LERKERILVYEFVPNASLDHFIFDPI-NREHMT-WEKRYK---IIEGIARGLLYLHEDSR 364
            E   + L  E+     L    FD I     M   + +     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 16/166 (9%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            LG G F  V+       G+  A+K + K+    +   +NE+ +L +++H N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 310 LERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
                  LV + V    L    FD I  R   T +    +I+ +   + YLHE     I+
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIV 128

Query: 369 HRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           HRDLK  N+L  +        I+DFG++++ +     +      GT
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGT 170

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 15/186 (8%)

Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVL 292
            D   +R     F     +G G +G VYKG  +  G+  A+K +   +   E E K E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72

Query: 293 LLARL-QHRNLVRLLGFCLERKERI------LVYEFVPNASLDHFIFDPINREHMTWEKR 345
           +L +   HRN+    G  +++          LV EF    S+   +        +  E  
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             I   I RGL +LH+    ++IHRD+K  N+LL      K+ DFG++   ++D+T    
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRR 186

Query: 406 NRVVGT 411
           N  +GT
Sbjct: 187 NTFIGT 192

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 45/171 (26%), Positives = 70/171 (40%), Gaps = 18/171 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFC 309
           LG+G    V   + L   +  AVK + K           EV +L + Q HRN++ L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 310 LERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            E     LV+E +   S+       I  R H    +   +++ +A  L +LH      I 
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIA 133

Query: 369 HRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNR-----VVGT 411
           HRDLK  NIL +        KI DF +    +++   S  +        G+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 39/172 (22%), Positives = 76/172 (44%), Gaps = 21/172 (12%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE--------FKNEVLLLARL-QHR 300
            +G+G    V + +  + G   AVK +   +++   E         + E  +L ++  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           +++ L+          LV++ +    L    FD +  +  ++ ++   I+  +   + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFL 216

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           H      I+HRDLK  NILLD  M  ++SDFG +   E  +   +   + GT
Sbjct: 217 HA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGT 262

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 21/186 (11%)

Query: 237 ETIRVATDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIE-FKN 289
           E +  A+  FSD      +LG+G F  V + +  + G   A K ++       + +  + 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKI 348
           E  +  +LQH N+VRL     E     LV++ V    L    F+ I  RE  +       
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHC 133

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDT 405
           I+ I   + Y H      I+HR+LK  N+LL S+      K++DFG+A      +     
Sbjct: 134 IQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG- 189

Query: 406 NRVVGT 411
               GT
Sbjct: 190 --FAGT 193

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.5 bits (248), Expect = 3e-23
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 40/187 (21%)

Query: 251 KLGQGGFGAVYKGM---LSNGETIAVKRLSKN----SKQGEIEFKNEVLLLARLQHRNLV 303
           K+G+G +G VYK       + +  A+K++       S   EI       LL  L+H N++
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA------LLRELKHPNVI 81

Query: 304 RLLGFCLERKERI--LVYEFVPNASLDH---FIFDPINREHMTWEKRYKIIEG------- 351
            L    L   +R   L++++      +H    I    +R     +K  ++  G       
Sbjct: 82  SLQKVFLSHADRKVWLLFDY-----AEHDLWHIIK-FHRASKANKKPVQLPRGMVKSLLY 135

Query: 352 -IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLF-EMDQTHSDT 405
            I  G+ YLH +    ++HRDLK +NIL+  E       KI+D G ARLF    +  +D 
Sbjct: 136 QILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

Query: 406 NRVVGTL 412
           + VV T 
Sbjct: 193 DPVVVTF 199

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.4 bits (245), Expect = 5e-23
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 19/202 (9%)

Query: 218 KLEDENVEETIAKS----LQFDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIA 272
           KLE+  ++E   K     L    +   +  D+F   ++LG G  G V+K     +G  +A
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62

Query: 273 VKRLSKNSKQGEIEF-KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
            K +    K         E+ +L       +V   G      E  +  E +   SLD  +
Sbjct: 63  RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122

Query: 332 --FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                I  + +      K+   + +GL YL E    +I+HRD+K SNIL++S    K+ D
Sbjct: 123 KKAGRIPEQILG-----KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 390 FGMARLFEMDQTHSDTNRVVGT 411
           FG++   ++  + +++   VGT
Sbjct: 176 FGVSG--QLIDSMANSF--VGT 193

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.9 bits (242), Expect = 9e-23
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 25/184 (13%)

Query: 243 TDNFSD-----ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLL 294
            +NF++     + +LG+G F  V + +  S G+  A K L K    +    E  +E+ +L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 295 ARLQHR-NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI---NREHMTWEKRYKIIE 350
              +    ++ L        E IL+ E+     +    F        E ++     ++I+
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIK 138

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTNR 407
            I  G+ YLH+     I+H DLK  NILL S     + KI DFGM+R         +   
Sbjct: 139 QILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--- 192

Query: 408 VVGT 411
           ++GT
Sbjct: 193 IMGT 196

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 10/178 (5%)

Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEV-LLL 294
           ++ V  D+     +LG+G +G V K   + +G+ +AVKR+       E +    ++ + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIA 353
             +     V   G      +  +  E + + SLD F    I++     E    KI   I 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++    +    +  +   G 
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVA-KDIDAGC 172

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 19/171 (11%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN-EVLLLARL 297
           R    +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKL 104

Query: 298 QHRNLVRLLGFCLERKERI------LVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIE 350
            H N+VRL  F     E+       LV ++VP  ++          ++ +        + 
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQ 400
            + R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     +
Sbjct: 164 QLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 35/221 (15%)

Query: 215 GKLKLEDENVEETIAKSLQFDF-------ETIRVATDNFSD----ANKLGQGGFGAVYKG 263
           GK +  + N E  ++ S    F       +   V      D    +  LG G  G V   
Sbjct: 95  GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA 154

Query: 264 M-LSNGETIAVKRLSKN--------SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE 314
                 + +A++ +SK              +  + E+ +L +L H  ++++  F  + ++
Sbjct: 155 FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAED 213

Query: 315 RILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK 373
             +V E +    L    FD +   + +           +   + YLHE     IIHRDLK
Sbjct: 214 YYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 266

Query: 374 ASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGT 411
             N+LL S+      KI+DFG +++            + GT
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGT 304

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 26/180 (14%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKN-EVLL 293
           D +T       +++   +G G FG V++  L   + +A+K++ +     +  FKN E+ +
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQI 85

Query: 294 LARLQHRNLVRLLGFCLERKERI------LVYEFVP---NASLDHFIF--DPINREHMTW 342
           +  ++H N+V L  F     ++       LV E+VP     +  H+      +    +  
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI-- 143

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQT 401
            K Y  +  + R L Y+H    + I HRD+K  N+LLD      K+ DFG A++    + 
Sbjct: 144 -KLY--MYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 24/174 (13%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKN--------SKQGEIEFKNEVLLLARLQHRN 301
            LG G  G V         + +A+K +SK              +  + E+ +L +L H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLH 360
           ++++  F  + ++  +V E +    L    FD +   + +           +   + YLH
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 361 EDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           E     IIHRDLK  N+LL S   +   KI+DFG +++            + GT
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGT 179

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 20/182 (10%)

Query: 241 VATDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIE-FKNEVLL 293
           +    F++      +LG+G F  V + + +  G+  A   ++       + +  + E  +
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGI 352
              L+H N+VRL     E     L+++ V    L    F+ I  RE+ +       I+ I
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQI 119

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVV 409
              +L+ H+   + ++HR+LK  N+LL S++     K++DFG+A   E +Q         
Sbjct: 120 LEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FA 174

Query: 410 GT 411
           GT
Sbjct: 175 GT 176

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 95.1 bits (237), Expect = 6e-22
 Identities = 43/176 (24%), Positives = 68/176 (38%), Gaps = 25/176 (14%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +G+G F  V + +    G+  AVK     + + +      + K E  +   L+H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY------KIIEGIARGLLY 358
           LL          +V+EF+  A L       I  +       Y        +  I   L Y
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL----CFEIV-KRADAGFVYSEAVASHYMRQILEALRY 145

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGT 411
            H+     IIHRD+K   +LL S+ N    K+  FG+A         +     VGT
Sbjct: 146 CHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGT 196

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 96.8 bits (241), Expect = 8e-22
 Identities = 36/169 (21%), Positives = 60/169 (35%), Gaps = 23/169 (13%)

Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
            +  GG G +Y       NG  + +K L  +           E   LA + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 308 FCLERKERI-----LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           F             +V E+V   SL          + +   +    +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
             + +++ DLK  NI+L  E   K+ D G           +    + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGT 240

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 95.1 bits (236), Expect = 9e-22
 Identities = 18/176 (10%), Positives = 37/176 (21%), Gaps = 36/176 (20%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLG 307
           L  G    V+    +   E  A+K  +  ++    E           ARL   +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 308 FC--------------------------LERKERILVYEFVP---NASLDHFIFDPINRE 338
                                             +L+                F  + R 
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
                  + +   + R    L       ++H      N+ +  +    + D     
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 48/184 (26%), Positives = 88/184 (47%), Gaps = 22/184 (11%)

Query: 234 FDFETIRVA---TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN 289
           +D+E+  V     D++    KLG+G +  V++ + ++N E + VK L    K+   + K 
Sbjct: 23  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKR 79

Query: 290 EVLLLARLQ-HRNLVRLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           E+ +L  L+   N++ L     +   R   LV+E V N      ++  +    +    R+
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDI----RF 134

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDT 405
            + E I + L Y H  S   I+HRD+K  N+++D E    ++ D+G+A  +   Q +   
Sbjct: 135 YMYE-ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 188

Query: 406 NRVV 409
            RV 
Sbjct: 189 VRVA 192

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 21/178 (11%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
            D  SD     ++LG+G    VY+       +  A+K L K     +   + E+ +L RL
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRL 105

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGL 356
            H N+++L        E  LV E V    L    FD I  + + +       ++ I   +
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAV 161

Query: 357 LYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            YLHE     I+HRDLK  N+L      +   KI+DFG++++ E          V GT
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGT 213

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 26/184 (14%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIEF-KNE 290
           DF+  ++          LG+G F  V     L+     A+K L K    K+ ++ +   E
Sbjct: 31  DFKFGKI----------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK-- 347
             +++RL H   V+L  F  +  E++     +  N  L       I +     E   +  
Sbjct: 81  RDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFY 135

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
             E I   L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N 
Sbjct: 136 TAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191

Query: 408 VVGT 411
            VGT
Sbjct: 192 FVGT 195

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 34/201 (16%), Positives = 63/201 (31%), Gaps = 36/201 (17%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM------LSNGETIAVKRLSKNSKQGEIEFKNE 290
              ++ +      + LG+G F  VY+          N +   +K     +     EF   
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIG 114

Query: 291 VLLLARLQ---HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY- 346
             L+ RL+       ++     L +   +LV E     +L     + IN    T EK   
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL----LNAINLYKNTPEKVMP 170

Query: 347 -----KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-----------KISDF 390
                     +   +  +H+     IIH D+K  N +L +                + D 
Sbjct: 171 QGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227

Query: 391 GMARLFEMDQTHSDTNRVVGT 411
           G +   ++    +       T
Sbjct: 228 GQSIDMKLFPKGTIFTAKCET 248

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 45/185 (24%), Positives = 78/185 (42%), Gaps = 29/185 (15%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN----E 290
            E  R   D F      GQG FG V  G     G ++A+K++ ++ +     F+N     
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQI 69

Query: 291 VLLLARLQHRNLVRLLGFCLERKER-------ILVYEFVP---NASLDHFIF--DPINRE 338
           +  LA L H N+V+L  +     ER        +V E+VP   +    ++          
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129

Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFE 397
            +   K +  +  + R +  LH  S + + HRD+K  N+L++      K+ DFG A+   
Sbjct: 130 LI---KVF--LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 398 MDQTH 402
             + +
Sbjct: 184 PSEPN 188

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 37/184 (20%), Positives = 65/184 (35%), Gaps = 22/184 (11%)

Query: 243 TDNFSDANKLGQG--GFGAVYKGM-LSNGETIAVKR--LSKNSKQGEIEFKNEVLLLARL 297
              +     +G+G      V        GE + V+R  L   S +     + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIA 353
            H N+V      +   E  +V  F+   S    I     D +N   + +     I++G+ 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-----ILQGVL 138

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG-MARLFEMDQ----THSDTNRV 408
           + L Y+H       +HR +KAS+IL+  +    +S       +    Q     H      
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 409 VGTL 412
           V  L
Sbjct: 196 VKVL 199

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 13/154 (8%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G F  V     +  G  +A+K + K   +     +   EV ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81

Query: 309 CLERKERI-LVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            +E ++ + L+ E+     +    FD +     M  ++       I   + Y H   + R
Sbjct: 82  VIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKR 134

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           I+HRDLKA N+LLD++MN KI+DFG +  F +  
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.5 bits (228), Expect = 5e-21
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 11/165 (6%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQHRNLVRLL 306
           KLG GG   VY          +A+K +    ++ E     F+ EV   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
               E     LV E++   +L  +I        ++ +        I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           I+HRD+K  NIL+DS    KI DFG+A+    + + + TN V+GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGT 175

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 91.2 bits (227), Expect = 8e-21
 Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 35/166 (21%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------EVLLLARLQHR--NL 302
           LG GGFG+VY G+ +S+   +A+K + K+      E  N      EV+LL ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 303 VRLLGFCLERKERI-LVYEFV-PNASLDHFIFDPINREHMTWEKRYKIIEGIAR------ 354
           +RLL +  ER +   L+ E   P   L    FD I        +R  + E +AR      
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDL----FDFI-------TERGALQEELARSFFWQV 158

Query: 355 --GLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFE 397
              + + H      ++HRD+K  NIL+D      K+ DFG   L +
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.3 bits (227), Expect = 9e-21
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 18/160 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKN------EVLLLARLQHRNL 302
           LG G FG V+  +     + + VK + K    +   IE         E+ +L+R++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 303 VRLLGFCLERKERI-LVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLH 360
           +++L    E +    LV E   +  LD  +F  I     +       I   +   + YL 
Sbjct: 92  IKVLDI-FENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
                 IIHRD+K  NI++  +   K+ DFG A   E  +
Sbjct: 148 ---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 22/159 (13%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG G FG V  G     G  +AVK L++        +   K E+  L   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEK---RY--KIIEGIARGLLYLHE 361
             +       +V E+V    L    FD I +     E    R   +I+  +     Y H 
Sbjct: 79  -VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH- 128

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
             R  ++HRDLK  N+LLD+ MN KI+DFG++ +    +
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 42/180 (23%), Positives = 72/180 (40%), Gaps = 24/180 (13%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
           +  F+D       +G G +    + +  +     AVK + K+ +        E+ +L R 
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRY 72

Query: 298 -QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARG 355
            QH N++ L     + K   +V E +    L     D I  ++  +  +   ++  I + 
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKT 128

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH      ++HRDLK SNIL   E       +I DFG A+    +     T     T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 40/186 (21%), Positives = 75/186 (40%), Gaps = 17/186 (9%)

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKN 289
           L    +  +   ++  +  ++G G  G V+K      G  IAVK++ ++  + E +    
Sbjct: 13  LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM 72

Query: 290 EV-LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---FDPINREHMTWEKR 345
           ++ ++L       +V+  G  +   +  +  E +     +        PI    +     
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG---- 127

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            K+   I + L YL E     +IHRD+K SNILLD     K+ DFG++    +    +  
Sbjct: 128 -KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKD 182

Query: 406 NRVVGT 411
               G 
Sbjct: 183 R-SAGC 187

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 37/168 (22%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------EVLLLARL----QHR 300
           LG+GGFG V+ G  L++   +A+K + +N   G     +      EV LL ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 301 NLVRLLGFCLERKERI-LVYEF-VPNASLDHFIFDPINREHMTWEKRYKIIEGIAR---- 354
            ++RLL +  E +E   LV E  +P   L    FD I        ++  + EG +R    
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDL----FDYI-------TEKGPLGEGPSRCFFG 146

Query: 355 ----GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFE 397
                + + H      ++HRD+K  NIL+D      K+ DFG   L  
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 30/194 (15%), Positives = 52/194 (26%), Gaps = 38/194 (19%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQH-------- 299
           LGQ    A  +      GE+  V       +         K EVL L  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 300 --------RNLVRLLGFCL--------ERKERILVYEFVPNASLDHFIF------DPINR 337
                    +LV+                   +  +   P    +   F           
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           + +    R ++   + R L  LH      ++H  L+  +I+LD      ++ F      +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261

Query: 398 MDQTHSDTNRVVGT 411
                S   R    
Sbjct: 262 GASAVSPIGRGFAP 275

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 22/183 (12%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNE 290
            F   RV          LG+GGFG V+   + + G+  A K+L+K     ++G      E
Sbjct: 186 WFLDFRV----------LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKI- 348
             +LA++  R +V L  +  E K  + LV   +    + + I++         E R    
Sbjct: 236 KKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              I  GL +LH+     II+RDLK  N+LLD + N +ISD G+A   +  QT   T   
Sbjct: 295 TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGY 349

Query: 409 VGT 411
            GT
Sbjct: 350 AGT 352

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 18/167 (10%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGF 308
            LG+G F    K +   + +  AVK +SK  +      + E+  L   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVKLHEV 74

Query: 309 CLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
             ++    LV E +    L    F+ I  ++H +  +   I+  +   + ++H+   + +
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGV 127

Query: 368 IHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGT 411
           +HRDLK  N+L   E +    KI DFG ARL   D     T     T
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 22/159 (13%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG G FG V  G     G  +AVK L++        +   + E+  L   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEK---RY--KIIEGIARGLLYLHE 361
             +     I +V E+V    L    FD I +     EK   R   +I+ G+     Y H 
Sbjct: 84  V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH- 133

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
             R  ++HRDLK  N+LLD+ MN KI+DFG++ +    +
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 43/240 (17%), Positives = 74/240 (30%), Gaps = 50/240 (20%)

Query: 219 LEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--- 274
           +   +   +  ++L F   ++      +     +GQG +G V   +        A+K   
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 275 --RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF 332
             ++ + + +     K EV L+ +L H N+ RL     + +   LV E      L   + 
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 333 DPINREHMTWEKRY-------------------------------------KIIEGIARG 355
             I+                                                I+  I   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMDQTHSDT--NRVVGT 411
           L YLH      I HRD+K  N L  +      K+ DFG+++ F               GT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 15/170 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQHRNLVRLL 306
            LG GG   V+    L +   +AVK L  +  +       F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 307 --GFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G        +  +V E+V   +L   +        MT ++  ++I    + L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH-- 133

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
            +  IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.0 bits (218), Expect = 4e-19
 Identities = 37/181 (20%), Positives = 76/181 (41%), Gaps = 33/181 (18%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
            D +   + +G G +G V +         +A+K++ +        F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 293 LLARLQHRNLVRLL-----GFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKR 345
           +L RL H ++V++L         +  E  +V E    +           +   H     +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELH----IK 159

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             ++  +  G+ Y+H  S   I+HRDLK +N L++ + + K+ DFG+AR  +  +  +  
Sbjct: 160 T-LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 406 N 406
            
Sbjct: 216 L 216

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 36/166 (21%), Positives = 63/166 (37%), Gaps = 11/166 (6%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE--IE-FKNEVLLLARLQHRNLVRLL 306
            +G+GG G VY+         +A+K +S+            + E     RLQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            F     +  +    +    L   +     +  +   +   I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAA---G 154

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
             HRD+K  NIL+ ++    + DFG+A     D+  +     VGTL
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTL 199

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.4 bits (219), Expect = 5e-19
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 32/202 (15%)

Query: 219 LEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLS 277
            + +NVE  I  ++  DF   R+          +G+GGFG VY       G+  A+K L 
Sbjct: 175 CQWKNVELNIHLTMN-DFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLD 223

Query: 278 KN---SKQGEIEFKNEVLLLARL---QHRNLVRLLGFCLERKERI-LVYEFVPNASLDHF 330
           K     KQGE    NE ++L+ +       +V +  +     +++  + + +    L   
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--- 279

Query: 331 IFDPINREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
               +++  +  E   +     I  GL ++H      +++RDLK +NILLD   + +ISD
Sbjct: 280 -HYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISD 335

Query: 390 FGMARLFEMDQTHSDTNRVVGT 411
            G+A  F   + H+     VGT
Sbjct: 336 LGLACDFSKKKPHA----SVGT 353

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 27/184 (14%), Positives = 52/184 (28%), Gaps = 37/184 (20%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQ--------- 298
           LGQ    A  +      GE+  V       +         K EVL L  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 299 ----------------HRNLVRLLGFC--LERKERILVYEFVPNASLDHF--IFD-PINR 337
                            + ++R+      +    R  +Y  + +        +       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           + +    R ++   + R L  LH      ++H  L+  +I+LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 398 MDQT 401
               
Sbjct: 258 ARVV 261

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 20/157 (12%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +G G FG           E +AVK + + +   E   + E++    L+H N+VR     L
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFKEVIL 86

Query: 311 ERKERILVYEFVPNASLDHFIFDPI-NREHMT-WEKRYK---IIEGIARGLLYLHEDSRL 365
                 ++ E+     L    ++ I N    +  E R+    ++ G++    Y H    +
Sbjct: 87  TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---SM 135

Query: 366 RIIHRDLKASNILLDS--EMNPKISDFGMARLFEMDQ 400
           +I HRDLK  N LLD       KI DFG ++   +  
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 21/158 (13%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIEFK--NEVLLLARLQHRNLVRLLG 307
           LG+G FG V         + +A+K +S+   K+ ++  +   E+  L  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK---RY--KIIEGIARGLLYLHED 362
                 + ++V E+         +FD I  +    E    R+  +II  I     Y H  
Sbjct: 77  VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            R +I+HRDLK  N+LLD  +N KI+DFG++ +     
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 57/190 (30%), Positives = 79/190 (41%), Gaps = 39/190 (20%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNE 290
            F   RV          LG+GGFG V    + + G+  A K+L K     ++GE    NE
Sbjct: 185 TFRQYRV----------LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +L ++  R +V L  +  E K+ + LV   +    L  F        H+    +    
Sbjct: 235 KQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL-KF--------HIYHMGQAGFP 284

Query: 350 EGIAR--------GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           E  A         GL  LH     RI++RDLK  NILLD   + +ISD G+A      QT
Sbjct: 285 EARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341

Query: 402 HSDTNRVVGT 411
                  VGT
Sbjct: 342 ---IKGRVGT 348

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 38/208 (18%), Positives = 80/208 (38%), Gaps = 52/208 (25%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN-EVLL 293
            ET    +  +S    LG G FG V +     +G+  A+K++ ++ +     +KN E+ +
Sbjct: 2   LETS---SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDI 53

Query: 294 LARLQHRNLVRLLGF---CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR----- 345
           +  L H N+++L+ +     + + +        N           + + +          
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 346 -----------YKIIEG-------------------IARGLLYLHEDSRLRIIHRDLKAS 375
                      +K+++                    + R + ++H    L I HRD+K  
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQ 170

Query: 376 NILLDSEMNP-KISDFGMARLFEMDQTH 402
           N+L++S+ N  K+ DFG A+     +  
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPS 198

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 40/179 (22%), Positives = 76/179 (42%), Gaps = 44/179 (24%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF----------------------- 287
           +G+G +G V      ++    A+K LSK     +  F                       
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 288 ---KNEVLLLARLQHRNLVRLLGFCLE------RKERILVYEFVPNASLDHFIFDPINRE 338
                E+ +L +L H N+V+L+    E           +V+E V    +     +    +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132

Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            ++ ++     + + +G+ YLH     +IIHRD+K SN+L+  + + KI+DFG++  F+
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 32/175 (18%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              +     +G G +G+V   +   +GE +A+K+LS+        F++         E+L
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75

Query: 293 LLARLQHRNLVRLL------GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           LL  +QH N++ LL             +  LV  F+    L   +    + E +    +Y
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKI----QY 130

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
            ++  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR  + + T
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 45/184 (24%), Positives = 70/184 (38%), Gaps = 28/184 (15%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKN---- 289
              +      ++    +  G +GAV  G+ S G  +A+KR+      G       +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 290 -----EVLLLARLQHRNLVRLLGFCL-----ERKERILVYEFVPNASLDHFI---FDPIN 336
                E+ LL    H N++ L    +        +  LV E +    L   I      I+
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVIS 132

Query: 337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            +H+    +Y  +  I  GL  LHE     ++HRDL   NILL    +  I DF +AR  
Sbjct: 133 PQHI----QY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 397 EMDQ 400
             D 
Sbjct: 185 TADA 188

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 46/190 (24%), Positives = 76/190 (40%), Gaps = 40/190 (21%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNS--KQGEIE-FKNE 290
           D+E ++V          +G+G FG V      S  +  A+K LSK    K+ +   F  E
Sbjct: 70  DYEVVKV----------IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             ++A      +V+L  +  +    + +V E++P   L            +     Y + 
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVP 166

Query: 350 EGIAR--------GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           E  AR         L  +H    +  IHRD+K  N+LLD   + K++DFG       +  
Sbjct: 167 EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223

Query: 402 HSDTNRVVGT 411
               +  VGT
Sbjct: 224 -VRCDTAVGT 232

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.2 bits (206), Expect = 7e-18
 Identities = 41/199 (20%), Positives = 70/199 (35%), Gaps = 33/199 (16%)

Query: 230 KSLQFDFETIRVATDNFSD-----ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG 283
             L+  F+         +D        LG G  G V +      G+  A+K L  + K  
Sbjct: 10  SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-- 67

Query: 284 EIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDPI-NR 337
               + EV    +     ++V +L              ++ E +    L    F  I  R
Sbjct: 68  ---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQER 120

Query: 338 EHMTWEKRY--KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGM 392
               + +R   +I+  I   + +LH      I HRD+K  N+L  S+      K++DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 393 ARLFEMDQTHSDTNRVVGT 411
           A+    +   +       T
Sbjct: 178 AKETTQNALQT----PCYT 192

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 18/201 (8%)

Query: 220 EDENVEETI--AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRL 276
           +D+ V + +  A+ +    + +R+  D+F     +G+G F  V    M   G+  A+K +
Sbjct: 35  QDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM 94

Query: 277 SKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFI- 331
           +K    K+GE+  F+ E  +L     R + +L  F  + +  + LV E+     L   + 
Sbjct: 95  NKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS 153

Query: 332 -FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF 390
            F       M    R+ + E I   +  +H    L  +HRD+K  NILLD   + +++DF
Sbjct: 154 KFGERIPAEMA---RFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADF 206

Query: 391 GMARLFEMDQTHSDTNRVVGT 411
           G       D T   +   VGT
Sbjct: 207 GSCLKLRADGT-VRSLVAVGT 226

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 27/173 (15%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGF 308
            LG G  G V +       E  A+K L    K      + EV L  R     ++VR++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123

Query: 309 C----LERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRY--KIIEGIARGLLYLHE 361
                  RK  ++V E +    L    F  I +R    + +R   +I++ I   + YLH 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179

Query: 362 DSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGT 411
              + I HRD+K  N+L  S+      K++DFG A+      + +       T
Sbjct: 180 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYT 226

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 46/208 (22%), Positives = 92/208 (44%), Gaps = 35/208 (16%)

Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK 278
              ++    A   +     +      +++ + +G+G +G V       N   +A+K++S 
Sbjct: 3   HHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP 62

Query: 279 NSKQGEIEFKN---------EVLLLARLQHRNLVRLLGFCL-----ERKERILVYEFVPN 324
                   F++         E+ +L R +H N++ +          + K+  +V + +  
Sbjct: 63  --------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME- 113

Query: 325 ASLDHFIF-DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM 383
             L   +    ++ +H+     Y  +  I RGL Y+H  +   ++HRDLK SN+LL++  
Sbjct: 114 TDLYKLLKTQHLSNDHI----CY-FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 165

Query: 384 NPKISDFGMARLFEMDQTHSD--TNRVV 409
           + KI DFG+AR+ + D  H+   T  V 
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVA 193

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 43/182 (23%), Positives = 83/182 (45%), Gaps = 33/182 (18%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
            DN+   + +G+G +G VY     +  + +A+K++++        F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77

Query: 293 LLARLQHRNLVRLLGFCL-----ERKERILVYEFVPNASLDHFI--FDPINREHMTWEKR 345
           +L RL+   ++RL    +     +  E  +V E    + L         +  EH+    +
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHI----K 132

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             I+  +  G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR    ++  +  
Sbjct: 133 T-ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 406 NR 407
           N 
Sbjct: 189 ND 190

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 32/174 (18%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              + +   +G G  G V           +A+K+LS+        F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113

Query: 293 LLARLQHRNLVRLL------GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           L+  + H+N++ LL          E ++  LV E +  A+L   I   ++ E M     Y
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERM----SY 168

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            + + +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR      
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 28/179 (15%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKNS--KQGEIEFK 288
            FE ++V          LGQG FG V+           +  A+K L K +   +  +  K
Sbjct: 25  QFELLKV----------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK 74

Query: 289 NEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            E  +L  + H  +V+L  +  + + ++ L+ +F+    L    F  +++E M  E+  K
Sbjct: 75  MERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVK 129

Query: 348 I-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHS 403
             +  +A  L +LH    L II+RDLK  NILLD E + K++DFG+++  +    + +S
Sbjct: 130 FYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 46/195 (23%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              + D   LG GG G V+  +     + +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 293 LLARLQHRNLVRLL--------------GFCLERKERILVYEFVPNASLDHFIF-DPINR 337
           ++ RL H N+V++               G   E     +V E++    L + +   P+  
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLE 119

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLF 396
           EH     R   +  + RGL Y+H  +   ++HRDLK +N+ +++E +  KI DFG+AR+ 
Sbjct: 120 EHA----RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 397 EMDQTHSD--TNRVV 409
           +   +H    +  +V
Sbjct: 172 DPHYSHKGHLSEGLV 186

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 32/174 (18%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              + +   +G G  G V           +A+K+LS+        F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76

Query: 293 LLARLQHRNLVRLL------GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           L+  + H+N++ LL          E ++  +V E +  A+L   I   ++ E M     Y
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERM----SY 131

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            ++  +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR      
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 46/204 (22%), Positives = 90/204 (44%), Gaps = 24/204 (11%)

Query: 220 EDENVEETIAKSLQFDFET--IRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAV 273
            ++N+ E +  +  F  +   +R+  ++F     +G+G FG V    +    +  +  A+
Sbjct: 48  REKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEV---AVVKLKNADKVFAM 104

Query: 274 KRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDH 329
           K L+K    K+ E   F+ E  +L     + +  L  +  +    + LV ++     L  
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLT 163

Query: 330 FI--FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
            +  F+    E M    R+ + E +   +  +H+   L  +HRD+K  NIL+D   + ++
Sbjct: 164 LLSKFEDRLPEEMA---RFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRL 216

Query: 388 SDFGMARLFEMDQTHSDTNRVVGT 411
           +DFG       D T   ++  VGT
Sbjct: 217 ADFGSCLKLMEDGT-VQSSVAVGT 239

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 49/243 (20%), Positives = 73/243 (30%), Gaps = 76/243 (31%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVL 292
           DFE I+           +G+GGFG V++     +    A+KR+   +++   E    EV 
Sbjct: 7   DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI---- 348
            LA+L+H  +VR     LE        E       D     P++          KI    
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116

Query: 349 -----------IEGIARGLLYLH-----------------------EDSRLRI------- 367
                           +  LY+                            L I       
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176

Query: 368 ---------IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN----------RV 408
                    +HRDLK SNI    +   K+ DFG+    + D+                  
Sbjct: 177 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236

Query: 409 VGT 411
           VGT
Sbjct: 237 VGT 239

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 35/187 (18%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEF- 287
            FE +R           +G+G FG V    +       +  A+K ++K    ++ E+   
Sbjct: 16  HFEILRA----------IGKGSFGKV---CIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRY 346
             E+ ++  L+H  LV L  +  + +E + +V + +    L       + +     E+  
Sbjct: 63  FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETV 117

Query: 347 K--IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
           K  I E +   L YL      RIIHRD+K  NILLD   +  I+DF +A +   +     
Sbjct: 118 KLFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--- 170

Query: 405 TNRVVGT 411
              + GT
Sbjct: 171 ITTMAGT 177

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 33/179 (18%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIE-F 287
           DF+ +R           LG G FG V    L     NG   A+K L K    +  ++E  
Sbjct: 7   DFQILRT----------LGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT 53

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRY 346
            +E L+L+ + H  ++R+     +  ++I ++ +++    L    F  + +         
Sbjct: 54  NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVA 108

Query: 347 K--IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
           K    E +   L YLH      II+RDLK  NILLD   + KI+DFG A+    D T++
Sbjct: 109 KFYAAE-VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYT 162

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.2 bits (191), Expect = 6e-16
 Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 30/181 (16%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKNS---KQGEIEF 287
            FE +RV          LG+GG+G V+        + G+  A+K L K        +   
Sbjct: 18  CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67

Query: 288 -KNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
            K E  +L  ++H  +V L+ +  +   ++ L+ E++    L    F  + RE +  E  
Sbjct: 68  TKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDT 122

Query: 346 YKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTH 402
               +  I+  L +LH+     II+RDLK  NI+L+ + + K++DFG+ +  + +   TH
Sbjct: 123 ACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179

Query: 403 S 403
           +
Sbjct: 180 T 180

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.9 bits (190), Expect = 6e-16
 Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 24/155 (15%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGF 308
            LG G  G V +       E  A+K L    K      + EV L  R  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 79

Query: 309 C----LERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRY--KIIEGIARGLLYLHE 361
                  RK  ++V E +    L    F  I +R    + +R   +I++ I   + YLH 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135

Query: 362 DSRLRIIHRDLKASNILLDSE---MNPKISDFGMA 393
              + I HRD+K  N+L  S+      K++DFG A
Sbjct: 136 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 42/176 (23%), Positives = 79/176 (44%), Gaps = 33/176 (18%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              + D   +G G +GAV   +    G  +A+K+L +        F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELR 76

Query: 293 LLARLQHRNLVRLL------GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKR 345
           LL  ++H N++ LL          +  +  LV  F+    L   +  + +  + +    +
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRI----Q 131

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           + ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR  + + T
Sbjct: 132 F-LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 39/184 (21%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           +FE +++          LG+G FG V   +L    + G   A+K L K      I  K+E
Sbjct: 149 EFEYLKL----------LGKGTFGKV---ILVKEKATGRYYAMKILKK----EVIVAKDE 191

Query: 291 V-------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTW 342
           V        +L   +H  L  L  +  +  +R+  V E+     L    F  ++RE +  
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL----FFHLSRERVFS 246

Query: 343 EKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMD 399
           E R +     I   L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  + +  
Sbjct: 247 EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304

Query: 400 QTHS 403
              +
Sbjct: 305 TMKT 308

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 18/150 (12%), Positives = 45/150 (30%), Gaps = 16/150 (10%)

Query: 251 KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQHRNLVR 304
             G       ++     L     +A+  +       +    E  +  L L+R+    + R
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +L     R   ++V E++   SL             +     + ++ +A      H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR 394
             +       S + +  + +  ++      
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 41/186 (22%), Positives = 77/186 (41%), Gaps = 33/186 (17%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------ 289
             +   + +F   + LG+G +G V        GE +A+K++          F        
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55

Query: 290 ---EVLLLARLQHRNLVRLL-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHM 340
              E+ +L   +H N++ +             E  ++ E +    L   I    ++ +H+
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHI 114

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
               +Y  I    R +  LH  +   +IHRDLK SN+L++S  + K+ DFG+AR+ +   
Sbjct: 115 ----QY-FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

Query: 401 THSDTN 406
             +   
Sbjct: 167 ADNSEP 172

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 40/184 (21%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF+ +++          LG+G FG V   +L    + G   A+K L K      I  K+E
Sbjct: 6   DFDYLKL----------LGKGTFGKV---ILVREKATGRYYAMKILRK----EVIIAKDE 48

Query: 291 VL-------LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTW 342
           V        +L   +H  L  L  +  +  +R+  V E+     L    F  ++RE +  
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL----FFHLSRERVFT 103

Query: 343 EKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMD 399
           E+R +     I   L YLH      +++RD+K  N++LD + + KI+DFG+ +  + +  
Sbjct: 104 EERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160

Query: 400 QTHS 403
              +
Sbjct: 161 TMKT 164

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 47/185 (25%), Positives = 73/185 (39%), Gaps = 41/185 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF   ++          LG+G FG V    L       +  A+K L K      +   ++
Sbjct: 18  DFILHKM----------LGKGSFGKV---FLAEFKKTNQFFAIKALKK----DVVLMDDD 60

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           V        +L    +H  L  +     + KE +  V E++    L       I   H  
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKF 115

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
              R       I  GL +LH      I++RDLK  NILLD + + KI+DFGM +  +   
Sbjct: 116 DLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

Query: 399 DQTHS 403
            +T++
Sbjct: 173 AKTNT 177

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 29/177 (16%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIE-F 287
            F+ I+           LG G FG V   ML     +G   A+K L K    K  +IE  
Sbjct: 42  QFDRIKT----------LGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NE  +L  +    LV+L     +     +V E+V    +    F  + R     E   +
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHAR 144

Query: 348 IIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
                I     YLH    L +I+RDLK  N+L+D +   +++DFG A+  +  +T +
Sbjct: 145 FYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWT 197

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 41/185 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF  + V          LG+G FG V   ML       E  AVK L K      +   ++
Sbjct: 21  DFNFLMV----------LGKGSFGKV---MLSERKGTDELYAVKILKK----DVVIQDDD 63

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           V        +L    +   L +L   C +  +R+  V E+V    L       I +    
Sbjct: 64  VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRF 118

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E         IA GL +L       II+RDLK  N++LDSE + KI+DFGM +  +++ 
Sbjct: 119 KEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175

Query: 399 DQTHS 403
             T +
Sbjct: 176 VTTKT 180

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 56/185 (30%), Positives = 78/185 (42%), Gaps = 41/185 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           +FE IRV          LG+G FG V   ML      G+  AVK L K      I   ++
Sbjct: 24  NFEFIRV----------LGKGSFGKV---MLARVKETGDLYAVKVLKK----DVILQDDD 66

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           V        +L     H  L +L   C +  +R+  V EFV    L       I +    
Sbjct: 67  VECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRF 121

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA--RLFEM 398
            E R +     I   L++LH+     II+RDLK  N+LLD E + K++DFGM    +   
Sbjct: 122 DEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178

Query: 399 DQTHS 403
             T +
Sbjct: 179 VTTAT 183

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 30/185 (16%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------ 289
              R     +    KLG+G +G V+K +    GE +AVK++          F+N      
Sbjct: 2   RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQR 54

Query: 290 ---EVLLLARLQ-HRNLVRLLGFCL--ERKERILVYEFVPNASLDHFIF-DPINREHMTW 342
              E+++L  L  H N+V LL        ++  LV++++    L   I  + +   H   
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHK-- 111

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
             +Y ++  + + + YLH  S   ++HRD+K SNILL++E + K++DFG++R F   +  
Sbjct: 112 --QY-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165

Query: 403 SDTNR 407
           ++   
Sbjct: 166 TNNIP 170

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 33/176 (18%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
            + + + + +G G +G+V        G  +AVK+LS+        F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 293 LLARLQHRNLVRLL-----GFCLERKERI-LVYEFVPNASLDHFI-FDPINREHMTWEKR 345
           LL  ++H N++ LL        LE    + LV   +  A L++ +    +  +H+    +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHV----Q 135

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           + +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR    + T
Sbjct: 136 F-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 41/185 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF+ +RV          +G+G +  V   +L          A+K + K      +    +
Sbjct: 10  DFDLLRV----------IGRGSYAKV---LLVRLKKTDRIYAMKVVKK----ELVNDDED 52

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           +        +      H  LV L   C + + R+  V E+V    L       + R+   
Sbjct: 53  IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKL 107

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E+  +     I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  L   
Sbjct: 108 PEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164

Query: 399 DQTHS 403
           D T +
Sbjct: 165 DTTST 169

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 41/185 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF  ++V          +G+G FG V   +L    +     AVK L K +    I  K E
Sbjct: 39  DFHFLKV----------IGKGSFGKV---LLARHKAEEVFYAVKVLQKKA----ILKKKE 81

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
                    +LL  ++H  LV L  F  +  +++  V +++    L    F  + RE   
Sbjct: 82  EKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCF 136

Query: 342 WEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E R +     IA  L YLH    L I++RDLK  NILLDS+ +  ++DFG+ +  +   
Sbjct: 137 LEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193

Query: 399 DQTHS 403
             T +
Sbjct: 194 STTST 198

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 41/185 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF  + V          LG+G FG V   ML       E  AVK L K      +   ++
Sbjct: 342 DFNFLMV----------LGKGSFGKV---MLSERKGTDELYAVKILKK----DVVIQDDD 384

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           V        +L    +   L +L   C +  +R+  V E+V    L       I +    
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRF 439

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E         IA GL +L       II+RDLK  N++LDSE + KI+DFGM +  +++ 
Sbjct: 440 KEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496

Query: 399 DQTHS 403
             T +
Sbjct: 497 VTTKT 501

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 41/185 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF+ +RV          +G+G +  V   +L          A++ + K      +    +
Sbjct: 53  DFDLLRV----------IGRGSYAKV---LLVRLKKTDRIYAMRVVKK----ELVNDDED 95

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           +        +      H  LV L   C + + R+  V E+V    L       + R+   
Sbjct: 96  IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKL 150

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E+  +     I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  L   
Sbjct: 151 PEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207

Query: 399 DQTHS 403
           D T +
Sbjct: 208 DTTST 212

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 34/184 (18%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKN---SKQGEIEF 287
           +FE ++V          LG G +G V+          G+  A+K L K     K    E 
Sbjct: 55  NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104

Query: 288 -KNEVLLLARLQHRN-LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEK 344
            + E  +L  ++    LV L  +  + + ++ L+ +++    L    F  +++     E 
Sbjct: 105 TRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEH 159

Query: 345 RYK--IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMD 399
             +  + E I   L +LH+   L II+RD+K  NILLDS  +  ++DFG+++ F   E +
Sbjct: 160 EVQIYVGE-IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215

Query: 400 QTHS 403
           + + 
Sbjct: 216 RAYD 219

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.5 bits (169), Expect = 2e-13
 Identities = 28/199 (14%), Positives = 62/199 (31%), Gaps = 46/199 (23%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRL--------SKNSKQGEIEFKNEVL 292
           + T+      K+G+G FG V++ +  +   +A+K +        + + ++   E   E++
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 293 LLARLQ---------HRNLVRLLGFCLER----KERILVYE----------FVPNASLDH 329
           +   L              + L      +       +  ++            P+   D 
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 330 FIF------------DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI 377
            +F            + +  +  +      I+  +   L        LR  HRDL   N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193

Query: 378 LLDSEMNPKISDFGMARLF 396
           LL      K+      +  
Sbjct: 194 LLKKTSLKKLHYTLNGKSS 212

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 13/157 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGF 308
           K+G G FG +Y G  ++ GE +A+K     +K  ++    E  +   +Q    +  +   
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
             E    ++V E +   SL+  +F+  +R   + +    + + +   + Y+H  +    I
Sbjct: 74  GAEGDYNVMVMELL-GPSLED-LFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---FI 127

Query: 369 HRDLKASNILLDSEMNPK---ISDFGMARLFEMDQTH 402
           HRD+K  N L+          I DFG+A+ +   +TH
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 37/157 (23%), Positives = 73/157 (46%), Gaps = 13/157 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV-RLLGF 308
           K+G G FG +Y G  +   E +A+K  +  +K  ++ +  E  +   LQ    +  +  F
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            +E    +LV + +   SL+  +F+  +R  ++ +    + + +   + ++H  S    +
Sbjct: 72  GVEGDYNVLVMDLL-GPSLED-LFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FL 125

Query: 369 HRDLKASNILLDSEMNPK---ISDFGMARLFEMDQTH 402
           HRD+K  N L+          I DFG+A+ +    TH
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.0 bits (153), Expect = 4e-11
 Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 19/163 (11%)

Query: 250 NKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL-QHRN 301
             LG+G FG V +         +   T+AVK L + +   E     +E+ +L  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 302 LVRLLGFCLERKERILV-YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           +V LLG C +    ++V  EF    +L  ++            KR + +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
               +  I  DLK     + S  +   S F   +     +   
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 67/195 (34%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ----------- 298
           KLG G F  V+    + N   +A+K + +  K      ++E+ LL R+            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH--MTWE----------KRY 346
             ++++LL                     DHF     N  H  M +E          K+Y
Sbjct: 85  ANHILKLL---------------------DHFNHKGPNGVHVVMVFEVLGENLLALIKKY 123

Query: 347 K-------IIEGIAR----GLLYLHEDSRLRIIHRDLKASNILLDSEMNP------KISD 389
           +        ++ I++    GL Y+H   R  IIH D+K  N+L++   +P      KI+D
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181

Query: 390 FGMARLFEMDQTHSD 404
            G A     D+ +++
Sbjct: 182 LGNACW--YDEHYTN 194

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 31/175 (17%), Positives = 64/175 (36%), Gaps = 27/175 (15%)

Query: 250 NKLGQGGFGAVYKGM---------LSNGETIAVKRLSKNSKQ-GEIEF------KNEVLL 293
           +   +   G +Y+               +  ++K  +K+ +   E  F        +V  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 294 LARLQHRNLV---RLLGF-CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +L    L+     +GF   + K R LV   +   SL     D   +  ++     ++ 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVA 165

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI--SDFGMARLFEMDQTH 402
             +   L +LHE+     +H ++ A NI +D E   ++  + +G A  +     H
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 36/163 (22%), Positives = 69/163 (42%), Gaps = 23/163 (14%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGF 308
           ++G+G FG +++G  L N + +A+K   + S   ++    E      L     +  +  F
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYF 74

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL----YLHEDSR 364
             E    +LV + +   SL+  + D   R   +     K +   A+ +L     +HE S 
Sbjct: 75  GQEGLHNVLVIDLLG-PSLED-LLDLCGR-KFS----VKTVAMAAKQMLARVQSIHEKS- 126

Query: 365 LRIIHRDLKASNILLDSEMNPK-----ISDFGMARLFEMDQTH 402
             +++RD+K  N L+    +       + DFGM + +    T 
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 38/162 (23%), Positives = 67/162 (41%), Gaps = 21/162 (12%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G G FG +  G  L   E +A+K     S+  ++  +             + ++  F 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFG 74

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL----YLHEDSRL 365
              K   +V E +   SL+  +FD  +R   +     K +  IA  L+    Y+H  +  
Sbjct: 75  PCGKYNAMVLELL-GPSLED-LFDLCDR-TFS----LKTVLMIAIQLISRMEYVHSKN-- 125

Query: 366 RIIHRDLKASNILLDSEMNPK-----ISDFGMARLFEMDQTH 402
            +I+RD+K  N L+    N       I DF +A+ +   +T 
Sbjct: 126 -LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 34/179 (18%), Positives = 73/179 (40%), Gaps = 37/179 (20%)

Query: 251 KLGQGGFGAVYKGMLSNGETI------AVKRLSKNSKQGEIEFK-----NEVLLLARLQH 299
            +GQGGFG +Y   +++ E++       VK    ++     E K      +   + +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 300 RNLVRLLGFC----------LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
              ++ LG              +  R ++ +    + L   I++   +   +     K +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAK-RFS----RKTV 154

Query: 350 EGIARGLL----YLHEDSRLRIIHRDLKASNILLDSEMNPKI--SDFGMARLFEMDQTH 402
             ++  +L    Y+HE      +H D+KASN+LL+ +   ++   D+G+A  +  +  H
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 29/161 (18%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR---- 300
           + +G+G FG V K       E +A+K + KN K    Q +IE    V LL  +       
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIE----VRLLELMNKHDTEM 114

Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIAR 354
              +V L    + R    LV+E + + +L   +    F  ++          K  + +  
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLT-----RKFAQQMCT 168

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMA 393
            LL+L     L IIH DLK  NILL +      KI DFG +
Sbjct: 169 ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 33/179 (18%), Positives = 66/179 (36%), Gaps = 40/179 (22%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV----- 303
           K+G GGFG +Y     +  E  A   +  +  + G +   +E+    R+  ++ +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF--SELKFYQRVAKKDCIKKWIE 101

Query: 304 ----------RLLGF----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
                        G        R  R +V E +    L   I                 +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKK------STV 153

Query: 350 EGIARGLL----YLHEDSRLRIIHRDLKASNILLDSEMNPKI--SDFGMARLFEMDQTH 402
             +   +L    Y+HE+     +H D+KA+N+LL  +   ++  +D+G++  +  +  H
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 33/169 (19%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR------ 300
           +G+G FG V K       + +A+K + +N K    Q   E +    +L  L+ +      
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIR----ILEHLRKQDKDNTM 159

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGL 356
           N++ +L     R    + +E + + +L   I    F   +   +      K    I + L
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLV-----RKFAHSILQCL 213

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHS 403
             LH   + RIIH DLK  NILL  +     K+ DFG +      Q   
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVY 257

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 2e-07
 Identities = 63/472 (13%), Positives = 130/472 (27%), Gaps = 120/472 (25%)

Query: 6   CR-DCINVARKNLTSLCPNKVTAIGGYDDRGYNNCM------------LRYANYDIFGLM 52
            R       R+ L  L P K   I G         +                +Y +   M
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDG---------VLGSGKTWVALDVCL--SYKVQCKM 180

Query: 53  ENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYAT--GKEAVSDIVTM 110
           +   ++      N  E ++E  Q     ++  ++  +   S  K      +  +  ++  
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 111 YALVQC--------TPDLSEA---DCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRY-- 157
                C              A    CK  L  TT+      D        + S       
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILL--TTRFKQ-VTDFLSAATTTHISLDHHSMT 297

Query: 158 ----ETNKFFKPSIAGPPGSPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLR 213
               E        +   P         P      +   +++I                +R
Sbjct: 298 LTPDEVKSLLLKYLDCRPQD------LPREVLTTNPRRLSIIAE-------------SIR 338

Query: 214 VGK------LKLEDENVEETIAKSL-QFDFETIRVATDNFS----DAN---KLGQGGFGA 259
            G         +  + +   I  SL   +    R   D  S     A+    L       
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL----LSL 394

Query: 260 VYKGMLSNGETIAVKRLSKNS---KQGE----------IEFKNEVLLLARLQHRNLVR-- 304
           ++  ++ +   + V +L K S   KQ +          +E K ++     L HR++V   
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHY 453

Query: 305 --LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
                F  +        + +P   LD + +  I   H+   +  + +       ++L  D
Sbjct: 454 NIPKTFDSD--------DLIPP-YLDQYFYSHIGH-HLKNIEHPERMTLFRM--VFL--D 499

Query: 363 SRLRIIHRDLKASNILLD--SEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              R + + ++  +   +    +   +      + +  D       R+V  +
Sbjct: 500 --FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DPKYERLVNAI 548

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 3e-05
 Identities = 53/451 (11%), Positives = 119/451 (26%), Gaps = 104/451 (23%)

Query: 7   RDCINVARKNLTSLC--PNKVTA--IGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYA 62
           +D ++   +   +L     ++    +       Y   M           M    Y  +  
Sbjct: 58  KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY--IEQ 115

Query: 63  ES---NISENLIEFNQTRQRLLERLFSEAAARPSPNKYAT-------GK-----EAVSDI 107
                N ++   ++N +R +   +L  +A     P K          GK     +     
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKL-RQALLELRPAKNVLIDGVLGSGKTWVALDVCLS- 173

Query: 108 VTMYALVQCTPD----LSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRY-----E 158
              Y +          L+  +C        +++ K   +           S         
Sbjct: 174 ---YKVQCKMDFKIFWLNLKNCNS-PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 159 TNKFFKPSIAGPPGSP-----DPVTPEPPPRKKNH---------TILITVIVSVVASVIL 204
                +  +   P          V      +              +L T    V   +  
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNV------QNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283

Query: 205 ITGICIFLRVGKLKLEDENVEETIAKSLQFDFETI-RVATDNFSDANKLGQGGFGAVYKG 263
            T   I L    + L  + V+  + K L    + + R         N           + 
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT----NPRRLSIIAESIRD 339

Query: 264 MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP 323
            L+            N K    +    ++  +       + +L     RK    +++   
Sbjct: 340 GLA---------TWDNWKHVNCDKLTTIIESS-------LNVLEPAEYRK----MFD--- 376

Query: 324 NASLDHFIFD-----PINREHMTW-EKRYKIIEGIA-----RGLLYLH-EDSRLRI--IH 369
                  +F      P     + W +     +  +        L+    ++S + I  I+
Sbjct: 377 ----RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 370 RDLKASNILLDSEMNPKISD-FGMARLFEMD 399
            +LK   +  +  ++  I D + + + F+ D
Sbjct: 433 LELKV-KLENEYALHRSIVDHYNIPKTFDSD 462

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 40/171 (23%), Positives = 64/171 (37%), Gaps = 28/171 (16%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR----- 300
           K+G G FG V     + N +  AVK + +N K      +IE      +L ++Q+      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEAD----ILKKIQNDDINNN 96

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGL 356
           N+V+  G  +      L++E +   SL   I    ++  + E +           I + L
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI-----KLYCIEILKAL 150

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            YL +   + + H DLK  NILLD     K                  T  
Sbjct: 151 NYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 40/190 (21%), Positives = 64/190 (33%), Gaps = 54/190 (28%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-------RNL 302
           KLG G F  V+    +   + +A+K +       E    +E+ LL  +++       R +
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM------------TWEKRYK--- 347
           V  L                    LD F    +N  H+             W  +     
Sbjct: 103 VVQL--------------------LDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG 142

Query: 348 --------IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
                   II+ + +GL YLH  ++ RIIH D+K  NILL             A  ++  
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 400 QTHSDTNRVV 409
                +   V
Sbjct: 201 GAPPPSGSAV 210

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 34/188 (18%), Positives = 67/188 (35%), Gaps = 51/188 (27%)

Query: 251 KLGQGGFGAVYKGM--LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR---- 300
            LG+G FG V + +        +A+K + +N         +E      +L +++ +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEIN----VLKKIKEKDKEN 80

Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIAR 354
               V +  +        + +E +   +   F+    F P    H+       +   +  
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHV-----RHMAYQLCH 134

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-------------------KISDFGMARL 395
            L +LHE    ++ H DLK  NIL  +                       +++DFG A  
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-T 190

Query: 396 FEMDQTHS 403
           F+  + H+
Sbjct: 191 FD-HEHHT 197

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 37/160 (23%), Positives = 61/160 (38%), Gaps = 30/160 (18%)

Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR---- 300
            LG+G FG V +     + G  +AVK + KN          E +    +L  L       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQ----VLEHLNTTDPNS 75

Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIAR 354
               V++L +        +V+E +   S   FI    F P   +H+      K+   I +
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI-----RKMAYQICK 129

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            + +LH     ++ H DLK  NIL       +  +  + R
Sbjct: 130 SVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	412
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
3niz_A	311	Rhodanese family protein; structural genomics, str	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.95
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.95
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.95
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.94
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.94
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.94
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.94
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.94
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.94
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.94
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.94
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.94
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.94
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.94
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.94
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.94
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.94
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.94
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.94
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.94
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.93
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.93
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.93
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.93
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.93
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.93
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.93
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.93
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.93
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.93
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.93
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.93
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.93
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.93
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.93
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.93
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.93
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.93
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.93
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.93
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.92
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.92
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.92
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.92
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.92
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.92
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.92
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.92
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.91
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.91
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.91
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.91
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.91
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.91
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.9
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.88
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.87
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.14
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.78
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.57
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.51
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.05
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.0
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.82
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.64
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.57
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.54
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.53
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.5
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.42
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.37
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.17
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.63
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.35
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.07
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.37
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.02
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	87.99
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.96
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	86.85

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3e-39  Score=299.64  Aligned_cols=166  Identities=29%  Similarity=0.478  Sum_probs=143.2

Q ss_pred             hcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|...++||+|+||+||+|.+.      ++..||||+++..+.....+|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            467888899999999999999863      46789999998877777778999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeE
Q 015138          317 LVYEFVPNASLDHFIFDP----------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k  386 (412)
                      |||||+++|+|.++|...          .....++|.+++.|+.||+.||.|||+++   ||||||||+||||++++++|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            999999999999999542          23457999999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccc
Q 015138          387 ISDFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       387 i~DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      |+|||+|+..........+....||
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt  193 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLP  193 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEEC
T ss_pred             ECCcccceecCCCCceeecCceecC
Confidence            9999999987655444334445666

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.9e-39  Score=300.42  Aligned_cols=167  Identities=27%  Similarity=0.455  Sum_probs=135.5

Q ss_pred             hcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|...++||+|+||.||+|.+.      +++.||||++...+....++|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            356777889999999999999864      47789999998877777788999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          317 LVYEFVPNASLDHFIFDPI------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      |||||+++|+|.++|....            ....++|.+++.|+.||+.||.|||+.+   ||||||||+||||+++++
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            9999999999999986532            2346999999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCcccccCCCcccccccccccC
Q 015138          385 PKISDFGMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       385 ~ki~DfGla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      +||+|||+|+.+........+....||+
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~  224 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPI  224 (329)
T ss_dssp             EEECCCC----------------CCCCG
T ss_pred             EEEcccccceeccCCCcceecCcccccc
Confidence            9999999999876555443344566763

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.9e-38  Score=294.17  Aligned_cols=166  Identities=27%  Similarity=0.440  Sum_probs=140.2

Q ss_pred             cCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ++++..++||+|+||+||+|.+.      +++.||||++.... .....+|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            44566789999999999999963      46789999997653 334568999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC
Q 015138          317 LVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~  383 (412)
                      |||||+++|+|.++|....             ....++|..++.|+.||+.||.|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999996432             1346999999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccCCCcccccccccccC
Q 015138          384 NPKISDFGMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       384 ~~ki~DfGla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      ++||+|||+|+.+........+....||+
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~  211 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPI  211 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred             CEEECCcccceeccCCCceeEecccccCC
Confidence            99999999999876554433344466763

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=288.33  Aligned_cols=166  Identities=27%  Similarity=0.462  Sum_probs=135.7

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      +++..++++..++||+|+||+||+|++.  ..||||.++...  ......|.+|+.++++++|||||+++|++.+ +..+
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            3455678888999999999999999975  369999987543  3345679999999999999999999998865 5689


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||||+++|+|.++|..  ....++|..++.|+.||+.||.|||+++   ||||||||+||||++++++||+|||+|+..
T Consensus       108 iVmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            99999999999999965  3456999999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCCcccccccccccC
Q 015138          397 EMDQTHSDTNRVVGTL  412 (412)
Q Consensus       397 ~~~~~~~~~~~~~Gt~  412 (412)
                      ........+...+||+
T Consensus       183 ~~~~~~~~~~~~~GT~  198 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSV  198 (307)
T ss_dssp             -----------CCCCT
T ss_pred             ccCCcceeecccccCC
Confidence            6544333344577874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-37  Score=288.05  Aligned_cols=163  Identities=28%  Similarity=0.385  Sum_probs=145.2

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..++||+|+||+||++.. .+++.||||.+.+..   ......+.+|+++|++++|||||++++++.+.+..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5688999999999999999994 678999999997542   234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+..+
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999953   457999999999999999999999998   999999999999999999999999999998766


Q ss_pred             CcccccccccccC
Q 015138          400 QTHSDTNRVVGTL  412 (412)
Q Consensus       400 ~~~~~~~~~~Gt~  412 (412)
                      .....++.++||+
T Consensus       186 ~~~~~~~~~~GTp  198 (311)
T 4aw0_A          186 SKQARANSFVGTA  198 (311)
T ss_dssp             TTCCCBCCCCSCG
T ss_pred             CCcccccCcccCc
Confidence            5544455678884

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-37  Score=291.52  Aligned_cols=160  Identities=28%  Similarity=0.435  Sum_probs=142.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      +.|+..++||+|+||.||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+.+.++|||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            5688889999999999999995 579999999997665555567899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCcc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~  402 (412)
                      ++|+|.+++..    ..+++..+..|+.||+.||.|||+++   ||||||||+||||+.++++||+|||+|+.+..+...
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999843    56999999999999999999999998   999999999999999999999999999988655433


Q ss_pred             cccccccccC
Q 015138          403 SDTNRVVGTL  412 (412)
Q Consensus       403 ~~~~~~~Gt~  412 (412)
                        ....+||+
T Consensus       227 --~~~~~GTp  234 (346)
T 4fih_A          227 --RKSLVGTP  234 (346)
T ss_dssp             --BCCCCSCG
T ss_pred             --ccccccCc
Confidence              23477884

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.1e-37  Score=290.37  Aligned_cols=163  Identities=23%  Similarity=0.366  Sum_probs=135.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..++||+|+||.||++.. .+|+.||||++.+..  ......+.+|+.+|++++|||||++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999994 679999999997653  3345679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+++|+|.++|... ....+++..++.|+.||+.||.|||+++   ||||||||+||||+.++++||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999998542 3456789999999999999999999998   9999999999999999999999999999875432


Q ss_pred             cccccccccccC
Q 015138          401 THSDTNRVVGTL  412 (412)
Q Consensus       401 ~~~~~~~~~Gt~  412 (412)
                      ..  ++..+||+
T Consensus       180 ~~--~~~~~GT~  189 (350)
T 4b9d_A          180 EL--ARACIGTP  189 (350)
T ss_dssp             HH--HHHHHSCC
T ss_pred             cc--ccccCCCc
Confidence            21  23467874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=292.79  Aligned_cols=161  Identities=28%  Similarity=0.432  Sum_probs=143.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .+.|+..++||+|+||.||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            35688999999999999999995 57999999999876665666789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~  401 (412)
                      +++|+|.+++.    ...+++..+..|+.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus       230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            99999999984    346999999999999999999999998   99999999999999999999999999998865543


Q ss_pred             ccccccccccC
Q 015138          402 HSDTNRVVGTL  412 (412)
Q Consensus       402 ~~~~~~~~Gt~  412 (412)
                      .  ....+||+
T Consensus       303 ~--~~~~~GTp  311 (423)
T 4fie_A          303 R--RKSLVGTP  311 (423)
T ss_dssp             C--BCCCEECT
T ss_pred             c--ccccccCc
Confidence            3  23477884

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-36  Score=286.94  Aligned_cols=179  Identities=28%  Similarity=0.398  Sum_probs=150.4

Q ss_pred             ccccchHHHHhhhcCCCccccccccCCeeEEEEEeCC------CCEEEEEEeccCCcc-cHHHHHHHHHHHccCCC-Ccc
Q 015138          231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQH-RNL  302 (412)
Q Consensus       231 ~~~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h-~ni  302 (412)
                      .+.++..++++..++|+..++||+|+||.||+|.+..      ++.||||++...... ....|.+|+.+|.+++| |||
T Consensus        51 ~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI  130 (353)
T 4ase_A           51 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV  130 (353)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence            3456677888889999999999999999999998532      357999999765443 35579999999999965 899


Q ss_pred             ceeeEEEecC-CeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCce
Q 015138          303 VRLLGFCLER-KERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRII  368 (412)
Q Consensus       303 v~l~g~~~~~-~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv  368 (412)
                      |+++|+|.+. +.++|||||+++|+|.++|+...             ....++|..++.|+.|||+||.|||+++   ||
T Consensus       131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---ii  207 (353)
T 4ase_A          131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI  207 (353)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---ee
Confidence            9999999764 56899999999999999995421             2356999999999999999999999987   99


Q ss_pred             ecCCCCCCEEECCCCCeEEeccCCcccccCCCcccccccccccC
Q 015138          369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       369 Hrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      ||||||+||||++++++||+|||+|+.+..+.....+....||+
T Consensus       208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~  251 (353)
T 4ase_A          208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  251 (353)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred             cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence            99999999999999999999999999886665544444566763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.1e-36  Score=276.90  Aligned_cols=154  Identities=27%  Similarity=0.445  Sum_probs=127.8

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCC--------
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--------  313 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--------  313 (412)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4688899999999999999995 5789999999975543 33457899999999999999999999987544        


Q ss_pred             ----eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEec
Q 015138          314 ----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (412)
Q Consensus       314 ----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D  389 (412)
                          .++|||||+++|+|.+++.........++..++.|+.||+.||+|||+++   |+||||||+||||+.++++||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976544455677888999999999999999998   99999999999999999999999


Q ss_pred             cCCcccccCCC
Q 015138          390 FGMARLFEMDQ  400 (412)
Q Consensus       390 fGla~~~~~~~  400 (412)
                      ||+|+.+..+.
T Consensus       162 FGla~~~~~~~  172 (299)
T 4g31_A          162 FGLVTAMDQDE  172 (299)
T ss_dssp             CCCC-------
T ss_pred             CccceecCCCc
Confidence            99999886544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.5e-36  Score=278.64  Aligned_cols=163  Identities=28%  Similarity=0.387  Sum_probs=131.4

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC----eeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----ERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~lv~  319 (412)
                      +++...++||+|+||.||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|++.+.+    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3466788999999999999998 5899999999654322 223445677778899999999999998654    579999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-----CCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-----SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ||+++|+|.++|.    ...++|..+++|+.|++.||.|||++     +.++||||||||+||||+.++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999994    35699999999999999999999986     23469999999999999999999999999999


Q ss_pred             cccCCCccc--ccccccccC
Q 015138          395 LFEMDQTHS--DTNRVVGTL  412 (412)
Q Consensus       395 ~~~~~~~~~--~~~~~~Gt~  412 (412)
                      .........  .+...+||+
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~  176 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTK  176 (303)
T ss_dssp             EEETTTTEESCC-----CCG
T ss_pred             cccCCCCceeeecccccccc
Confidence            876544322  233467774

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-35  Score=273.42  Aligned_cols=158  Identities=31%  Similarity=0.437  Sum_probs=133.5

Q ss_pred             CccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec----CCeeeEEE
Q 015138          247 SDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERILVY  319 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~lv~  319 (412)
                      +..++||+|+||.||+|.. .+++.||||++....  ......|.+|+.++++++|||||++++++.+    ...++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4567899999999999995 568899999997542  3345679999999999999999999999865    34579999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~  398 (412)
                      ||+++|+|.+++..   ...+++..+..|+.||+.||.|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954   457999999999999999999999875 45999999999999984 78999999999986543


Q ss_pred             CCcccccccccccC
Q 015138          399 DQTHSDTNRVVGTL  412 (412)
Q Consensus       399 ~~~~~~~~~~~Gt~  412 (412)
                      ..    +..++||+
T Consensus       185 ~~----~~~~~GTp  194 (290)
T 3fpq_A          185 SF----AKAVIGTP  194 (290)
T ss_dssp             TS----BEESCSSC
T ss_pred             Cc----cCCcccCc
Confidence            32    23467885

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.7e-36  Score=278.92  Aligned_cols=159  Identities=26%  Similarity=0.335  Sum_probs=134.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .+.|+..++||+|+||.||+|.. .+|+.||||++.....     ..+|+.++++++|||||++++++.+.+..+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            35677788999999999999995 5789999999976533     24699999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCcccccCCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQ  400 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~~~~  400 (412)
                      +++|+|.++|..   ...+++..+..|+.||+.||.|||+++   ||||||||+||||+.++ ++||+|||+|+.+..+.
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999954   457999999999999999999999988   99999999999999987 69999999999886554


Q ss_pred             ccc---ccccccccC
Q 015138          401 THS---DTNRVVGTL  412 (412)
Q Consensus       401 ~~~---~~~~~~Gt~  412 (412)
                      ...   ....++||+
T Consensus       206 ~~~~~~~~~~~~GT~  220 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTE  220 (336)
T ss_dssp             --------CCCCCCG
T ss_pred             cccceecCCccccCc
Confidence            221   223467884

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.9e-35  Score=268.78  Aligned_cols=159  Identities=28%  Similarity=0.504  Sum_probs=126.7

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|++.+.||+|+||.||++.. .+|+.||||.+.+..   ......+.+|+.++++++|||||++++++.+.+..+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999994 679999999997643   223457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+ +|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++++||+|||+|+...+.
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6899998854   467999999999999999999999998   999999999999999999999999999977544


Q ss_pred             CcccccccccccC
Q 015138          400 QTHSDTNRVVGTL  412 (412)
Q Consensus       400 ~~~~~~~~~~Gt~  412 (412)
                      ...   ...+||+
T Consensus       166 ~~~---~~~~GT~  175 (275)
T 3hyh_A          166 NFL---KTSCGSP  175 (275)
T ss_dssp             ------------C
T ss_pred             Ccc---CCeeECc
Confidence            322   2366774

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.9e-36  Score=278.21  Aligned_cols=161  Identities=28%  Similarity=0.321  Sum_probs=132.1

Q ss_pred             cCCCccccccccCCeeEEEEEe----CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ++|++.++||+|+||+||+++.    .+++.||||.+.+..  ......+.+|+.+|++++|||||++++++.+.+..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            6799999999999999999984    246789999997643  2233468899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954   457999999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCcccccccccccC
Q 015138          398 MDQTHSDTNRVVGTL  412 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt~  412 (412)
                      .....  ....+||+
T Consensus       178 ~~~~~--~~~~~GT~  190 (304)
T 3ubd_A          178 DHEKK--AYSFCGTV  190 (304)
T ss_dssp             ---CC--CCSCCCCG
T ss_pred             CCCcc--ccccccCc
Confidence            44332  22367874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-32  Score=265.26  Aligned_cols=162  Identities=26%  Similarity=0.433  Sum_probs=135.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEec------CCe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLE------RKE  314 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~------~~~  314 (412)
                      ++|++.++||+|+||.||+|.. .+|+.||||++.+...  .....+.+|+.+|++++|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5789999999999999999994 6799999999976432  334568899999999999999999998764      357


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ++|||||++ |+|.+++..   ...+++..+..|+.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 789999854   567999999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCc--ccccccccccC
Q 015138          395 LFEMDQT--HSDTNRVVGTL  412 (412)
Q Consensus       395 ~~~~~~~--~~~~~~~~Gt~  412 (412)
                      .+.....  .......+||+
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~  226 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATR  226 (398)
T ss_dssp             CC-------CCCCCSSCCCC
T ss_pred             ecccCccccccccccceeCh
Confidence            8754322  12233467874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=4.6e-32  Score=272.76  Aligned_cols=160  Identities=27%  Similarity=0.341  Sum_probs=137.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHH---HHHHHHHccCCCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEF---KNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      .++|++.++||+|+||.||++.. .+|+.||||.+.+..   ......+   ..++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            47899999999999999999995 579999999997532   1222223   3446777888999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +|||||++||+|.++|..   ...+++..+..++.||+.||.|||+++   ||||||||+||||+.++++||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999954   467999999999999999999999988   99999999999999999999999999998


Q ss_pred             ccCCCcccccccccccC
Q 015138          396 FEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       396 ~~~~~~~~~~~~~~Gt~  412 (412)
                      +.....    ...+||+
T Consensus       342 ~~~~~~----~t~~GTp  354 (689)
T 3v5w_A          342 FSKKKP----HASVGTH  354 (689)
T ss_dssp             CSSCCC----CSCCSCG
T ss_pred             cCCCCC----CCccCCc
Confidence            765543    2367884

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=1e-31  Score=255.96  Aligned_cols=150  Identities=21%  Similarity=0.350  Sum_probs=132.5

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEe----CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCC
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~  313 (412)
                      +....+.|++.++||+|+||.||+|+.    .+++.||||++.+..  ....+.+|+++|..+ +||||+++++++.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            334567899999999999999999984    246789999986643  344678999999988 6999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccCC
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGM  392 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGl  392 (412)
                      ..+|||||+++|+|.+++      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+
T Consensus        94 ~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            999999999999999998      24899999999999999999999998   9999999999999877 7999999999


Q ss_pred             cccccCC
Q 015138          393 ARLFEMD  399 (412)
Q Consensus       393 a~~~~~~  399 (412)
                      |+...+.
T Consensus       165 a~~~~~~  171 (361)
T 4f9c_A          165 AQGTHDT  171 (361)
T ss_dssp             CEECTTC
T ss_pred             CcccCCc
Confidence            9976543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=1e-31  Score=270.87  Aligned_cols=162  Identities=25%  Similarity=0.441  Sum_probs=143.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|++.++||+|+||.||++.. .+|+.||||.+..........+.+|+.+|+.++|||||++++++.+...++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36899999999999999999995 67999999999877666667789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC--CCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE--MNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~--~~~ki~DfGla~~~~~~  399 (412)
                      +++|+|.++|..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+|+.+.+.
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999854  3456999999999999999999999998   9999999999999865  79999999999988765


Q ss_pred             CcccccccccccC
Q 015138          400 QTHSDTNRVVGTL  412 (412)
Q Consensus       400 ~~~~~~~~~~Gt~  412 (412)
                      ...   ...+||+
T Consensus       311 ~~~---~~~~GT~  320 (573)
T 3uto_A          311 QSV---KVTTGTA  320 (573)
T ss_dssp             SEE---EEECSSG
T ss_pred             Cce---eeeEECc
Confidence            432   2356763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=2.2e-30  Score=243.77  Aligned_cols=162  Identities=43%  Similarity=0.732  Sum_probs=145.7

Q ss_pred             cchHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       234 ~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      +++.++...+++|+..+.||+|+||.||+|...+++.||||++..........+.+|+.++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44455666789999999999999999999998889999999998776666778999999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          314 ERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ..++||||+++|+|.+++.... ....++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999986532 2346999999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++....
T Consensus       186 ~~~~~~  191 (321)
T 2qkw_B          186 SKKGTE  191 (321)
T ss_dssp             CEECSS
T ss_pred             cccccc
Confidence            987653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=9e-31  Score=255.86  Aligned_cols=173  Identities=21%  Similarity=0.281  Sum_probs=147.0

Q ss_pred             ccchHHHHhhhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEE
Q 015138          233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGF  308 (412)
Q Consensus       233 ~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~  308 (412)
                      ...+.+++...++|+..++||+|+||+||++... +++.||||++.+...   .....+.+|..++..++||||++++++
T Consensus        63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  142 (437)
T 4aw2_A           63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA  142 (437)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3456677788899999999999999999999964 578899999975321   112237899999999999999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEe
Q 015138          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       309 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                      +.+.+..+|||||+++|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+||||+.++++||+
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence            9999999999999999999999964  2456999999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccccCCCccccccccccc
Q 015138          389 DFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      |||+|+.+..+.... ....+||
T Consensus       218 DFGla~~~~~~~~~~-~~~~~GT  239 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQ-SSVAVGT  239 (437)
T ss_dssp             CCTTCEECCTTSCEE-CCSCCSC
T ss_pred             chhhhhhcccCCCcc-cccccCC
Confidence            999998876554332 2235566

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=1.1e-29  Score=239.52  Aligned_cols=171  Identities=45%  Similarity=0.829  Sum_probs=148.8

Q ss_pred             cccccchHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEE
Q 015138          230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGF  308 (412)
Q Consensus       230 ~~~~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~  308 (412)
                      ....+++.++....++|+..+.||+|+||.||+|...+++.||||++...... ....+.+|+.++.+++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            34567889999999999999999999999999999888999999999765322 23368999999999999999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          309 CLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       309 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                      +......++||||+++|+|.+++.... ....++|..+..|+.|++.||.|||+...++|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999996643 3345999999999999999999999983334999999999999999999999


Q ss_pred             eccCCcccccCCC
Q 015138          388 SDFGMARLFEMDQ  400 (412)
Q Consensus       388 ~DfGla~~~~~~~  400 (412)
                      +|||+++.+....
T Consensus       176 ~Dfg~~~~~~~~~  188 (326)
T 3uim_A          176 GDFGLAKLMDYKD  188 (326)
T ss_dssp             CCCSSCEECCSSS
T ss_pred             ccCccccccCccc
Confidence            9999999875443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=1.8e-29  Score=235.05  Aligned_cols=153  Identities=26%  Similarity=0.473  Sum_probs=139.2

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ..++|+..+.||+|+||.||++. ..+++.||||.+..........+.+|+.++++++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            34679999999999999999999 46789999999987666667778999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+++|+|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999843    46899999999999999999999987   9999999999999999999999999999876544


Q ss_pred             c
Q 015138          401 T  401 (412)
Q Consensus       401 ~  401 (412)
                      .
T Consensus       171 ~  171 (297)
T 3fxz_A          171 S  171 (297)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=3.3e-29  Score=235.80  Aligned_cols=161  Identities=27%  Similarity=0.409  Sum_probs=142.0

Q ss_pred             ccchHHHHhhhcC----------CCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc
Q 015138          233 QFDFETIRVATDN----------FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN  301 (412)
Q Consensus       233 ~~~~~~l~~~~~~----------~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n  301 (412)
                      .++.+++..+++.          |...+.||+|+||.||+|... +|+.||||.+..........+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            3555665555543          556678999999999999964 79999999998777667778999999999999999


Q ss_pred             cceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC
Q 015138          302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS  381 (412)
Q Consensus       302 iv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~  381 (412)
                      |+++++++...+..++||||+++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL  176 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence            9999999999999999999999999999984    346999999999999999999999987   999999999999999


Q ss_pred             CCCeEEeccCCcccccCCC
Q 015138          382 EMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       382 ~~~~ki~DfGla~~~~~~~  400 (412)
                      ++.+||+|||+++.+..+.
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             TCCEEECCCTTCEECCSSS
T ss_pred             CCcEEEeeeeeeeecccCc
Confidence            9999999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=235.71  Aligned_cols=153  Identities=29%  Similarity=0.526  Sum_probs=138.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|...++||+|+||.||++.. .+++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46788899999999999999995 56899999999777666777899999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      +++|+|.+++..  ....+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999854  2456999999999999999999999988   9999999999999999999999999999875443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=4.5e-29  Score=233.14  Aligned_cols=167  Identities=42%  Similarity=0.699  Sum_probs=147.8

Q ss_pred             cccccchHHHHhhhcCCCcc------ccccccCCeeEEEEEeCCCCEEEEEEeccCC----cccHHHHHHHHHHHccCCC
Q 015138          230 KSLQFDFETIRVATDNFSDA------NKLGQGGFGAVYKGMLSNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQH  299 (412)
Q Consensus       230 ~~~~~~~~~l~~~~~~~~~~------~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h  299 (412)
                      ....+++.++...+++|...      +.||+|+||.||+|.. +++.||||++....    ......+.+|+.++.+++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34567888999999998877      8999999999999987 57899999987532    2335678999999999999


Q ss_pred             CccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE
Q 015138          300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (412)
Q Consensus       300 ~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill  379 (412)
                      |||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999865444567999999999999999999999987   9999999999999


Q ss_pred             CCCCCeEEeccCCcccccCCC
Q 015138          380 DSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       380 ~~~~~~ki~DfGla~~~~~~~  400 (412)
                      +.++.+||+|||+++......
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCS
T ss_pred             cCCCcEEEeeccccccccccc
Confidence            999999999999998776543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=2.8e-29  Score=236.83  Aligned_cols=153  Identities=27%  Similarity=0.457  Sum_probs=137.3

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ..++|+..+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++......++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            346789999999999999999995 679999999997642  33455688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++++||+|||+++.+..
T Consensus        93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            999999999999854   356999999999999999999999988   99999999999999999999999999987765


Q ss_pred             CC
Q 015138          399 DQ  400 (412)
Q Consensus       399 ~~  400 (412)
                      ..
T Consensus       167 ~~  168 (328)
T 3fe3_A          167 GG  168 (328)
T ss_dssp             SC
T ss_pred             CC
Confidence            43

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=8.4e-30  Score=247.08  Aligned_cols=169  Identities=23%  Similarity=0.313  Sum_probs=143.3

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEe
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCL  310 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~  310 (412)
                      ....++...++|+..++||+|+||.||++.. .+++.||+|++.+..   ......+.+|+.++..++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3455667788999999999999999999996 468899999986532   112234789999999999999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      +....+|||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+||
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999843    45899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccc
Q 015138          391 GMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~Gt  411 (412)
                      |+|+.+....... ....+||
T Consensus       213 G~a~~~~~~~~~~-~~~~~gt  232 (410)
T 3v8s_A          213 GTCMKMNKEGMVR-CDTAVGT  232 (410)
T ss_dssp             TTCEECCTTSEEE-CCSCCSC
T ss_pred             ceeEeeccCCccc-ccCCcCC
Confidence            9999876543221 2235565

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=246.43  Aligned_cols=173  Identities=24%  Similarity=0.281  Sum_probs=146.4

Q ss_pred             ccchHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEE
Q 015138          233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGF  308 (412)
Q Consensus       233 ~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~  308 (412)
                      .+.++++....++|+..+.||+|+||.||++.. .+++.||||++.+...   .....+.+|..++..++||||++++++
T Consensus        50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            345566777789999999999999999999996 5789999999975321   122347889999999999999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEe
Q 015138          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       309 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                      +.+.+..+|||||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence            99999999999999999999998531  246999999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccccCCCccccccccccc
Q 015138          389 DFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      |||+++.+..+.... +...+||
T Consensus       205 DFGla~~~~~~~~~~-~~~~~Gt  226 (412)
T 2vd5_A          205 DFGSCLKLRADGTVR-SLVAVGT  226 (412)
T ss_dssp             CCTTCEECCTTSCEE-CSSCCSC
T ss_pred             echhheeccCCCccc-cceeccc
Confidence            999999876554321 2234566

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=3.8e-29  Score=239.97  Aligned_cols=156  Identities=28%  Similarity=0.474  Sum_probs=136.1

Q ss_pred             hhcCCCccccccccCCeeEEEEEe--------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEEec
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML--------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  311 (412)
                      ..++|+..+.||+|+||.||+|..        .++..||||.+..... .....+.+|+.++.++ +||||+++++++.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            457788899999999999999985        2345799999976533 3345789999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEE
Q 015138          312 RKERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNIL  378 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nil  378 (412)
                      .+..++||||+++|+|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            999999999999999999986432             1245899999999999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccccCCC
Q 015138          379 LDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       379 l~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ++.++.+||+|||+++.+....
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~  257 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNID  257 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCC
T ss_pred             ECCCCCEEEccccCCcccCccc
Confidence            9999999999999999775543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=3.1e-29  Score=237.31  Aligned_cols=149  Identities=26%  Similarity=0.308  Sum_probs=134.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC---CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+.+.   .......+.+|+.++..++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            46788899999999999999995 56899999999764   233455788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999998843   456899999999999999999999988   9999999999999999999999999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=6.6e-29  Score=234.28  Aligned_cols=154  Identities=26%  Similarity=0.429  Sum_probs=134.9

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCC-------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-------  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-------  313 (412)
                      .++|+..+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467888999999999999999964 789999999975443 34567999999999999999999999986543       


Q ss_pred             --------------------------------------------------eeeEEEecCCCCChhhhccCCCCCCCCCHH
Q 015138          314 --------------------------------------------------ERILVYEFVPNASLDHFIFDPINREHMTWE  343 (412)
Q Consensus       314 --------------------------------------------------~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~  343 (412)
                                                                        ..++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999999776555667888


Q ss_pred             HHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       344 ~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      .++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            89999999999999999988   999999999999999999999999999987654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=4.8e-29  Score=234.87  Aligned_cols=163  Identities=29%  Similarity=0.442  Sum_probs=137.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            36788999999999999999995 4789999999865433 223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999999853   456999999999999999999999988   9999999999999999999999999999775443


Q ss_pred             ccccccccccc
Q 015138          401 THSDTNRVVGT  411 (412)
Q Consensus       401 ~~~~~~~~~Gt  411 (412)
                      .........||
T Consensus       160 ~~~~~~~~~gt  170 (323)
T 3tki_A          160 RERLLNKMCGT  170 (323)
T ss_dssp             EECCBCSCCSC
T ss_pred             cccccCCCccC
Confidence            32222234454

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=2.1e-29  Score=237.24  Aligned_cols=167  Identities=32%  Similarity=0.517  Sum_probs=138.1

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC----e
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----E  314 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~  314 (412)
                      +....++|+..++||+|+||.||+|... ++.||||++..... ....+..|+.++.+++||||+++++++....    .
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            3345678899999999999999999975 78999999965433 2335667999999999999999999998754    4


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-------CCCCceecCCCCCCEEECCCCCeEE
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-------SRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-------~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                      .++||||+++|+|.+++..    ..+++..+..|+.|++.||.|||+.       +.++|+||||||+|||++.++.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            6999999999999999943    4599999999999999999999987       0112999999999999999999999


Q ss_pred             eccCCcccccCCCccccccccccc
Q 015138          388 SDFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      +|||+|+.+.............||
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt  196 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGT  196 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCC
T ss_pred             ccCCcccccccccCccccccCccC
Confidence            999999987655543333334555

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=2.9e-29  Score=239.67  Aligned_cols=168  Identities=30%  Similarity=0.455  Sum_probs=143.3

Q ss_pred             ccccchHHHHhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCcc
Q 015138          231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNL  302 (412)
Q Consensus       231 ~~~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~ni  302 (412)
                      ...++...+....++|+..+.||+|+||.||+|.+      .+++.||||++..... .....+.+|+.++.++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            34566777888899999999999999999999973      3457899999976543 3345689999999999 79999


Q ss_pred             ceeeEEEecCC-eeeEEEecCCCCChhhhccCCCC---------------------------------------------
Q 015138          303 VRLLGFCLERK-ERILVYEFVPNASLDHFIFDPIN---------------------------------------------  336 (412)
Q Consensus       303 v~l~g~~~~~~-~~~lv~Ey~~~gsL~~~l~~~~~---------------------------------------------  336 (412)
                      +++++++.+.+ ..++||||+++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99999998765 48999999999999999865322                                             


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          337 ------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       337 ------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                                        ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              122899999999999999999999988   99999999999999999999999999997755


Q ss_pred             CCc
Q 015138          399 DQT  401 (412)
Q Consensus       399 ~~~  401 (412)
                      +..
T Consensus       246 ~~~  248 (359)
T 3vhe_A          246 DPD  248 (359)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=4.5e-29  Score=237.72  Aligned_cols=151  Identities=30%  Similarity=0.385  Sum_probs=133.4

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  316 (412)
                      ..++|+..++||+|+||.||++.. .+++.||||.+.+..   ......+..|..++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            457899999999999999999995 568999999997642   23345678899999988 7999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+|||+|+..
T Consensus       101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999854   456999999999999999999999998   999999999999999999999999999865


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      ..
T Consensus       175 ~~  176 (353)
T 3txo_A          175 IC  176 (353)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=3.1e-29  Score=234.68  Aligned_cols=162  Identities=29%  Similarity=0.498  Sum_probs=133.6

Q ss_pred             hHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       236 ~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      ...+....++|+..+.||+|+||.||++.. +++.||||.+.....  ....++.+|+.++++++||||+++++++.+..
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            344556667899999999999999999987 578999999876543  33457899999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            99999999999999999965333334999999999999999999999875 35999999999999999999999999999


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      +.....
T Consensus       187 ~~~~~~  192 (309)
T 3p86_A          187 RLKAST  192 (309)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            865443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=9.5e-29  Score=237.43  Aligned_cols=154  Identities=33%  Similarity=0.563  Sum_probs=129.1

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC----CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..++|+..+.||+|+||.||+|...    ++..||||.+.... .....+|.+|+.++.+++||||+++++++.+....+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3468899999999999999999864    56789999997653 334567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++..  ....+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999964  3456999999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ..+.
T Consensus       198 ~~~~  201 (373)
T 2qol_A          198 EDDP  201 (373)
T ss_dssp             ----
T ss_pred             ccCC
Confidence            6543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=2.4e-28  Score=233.35  Aligned_cols=151  Identities=31%  Similarity=0.445  Sum_probs=135.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc------cHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      .+.|+..+.||+|+||.||++.. .+|+.||+|.+.+....      ....+.+|+.++.+++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46788899999999999999995 56899999999765322      356789999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC----CeEEeccC
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfG  391 (412)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999943   457999999999999999999999988   99999999999998877    79999999


Q ss_pred             CcccccCC
Q 015138          392 MARLFEMD  399 (412)
Q Consensus       392 la~~~~~~  399 (412)
                      +++.+...
T Consensus       165 ~a~~~~~~  172 (361)
T 2yab_A          165 LAHEIEDG  172 (361)
T ss_dssp             SCEECCTT
T ss_pred             CceEcCCC
Confidence            99987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=1.5e-28  Score=231.64  Aligned_cols=152  Identities=30%  Similarity=0.527  Sum_probs=134.3

Q ss_pred             hcCCCccccccccCCeeEEEEEeC----CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..+.||+|+||.||+|...    .+..||||.+.... ......+.+|+.++.+++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            466888899999999999999963    34469999997653 3345679999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++..  ....+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999854  2456999999999999999999999988   9999999999999999999999999999876


Q ss_pred             CC
Q 015138          398 MD  399 (412)
Q Consensus       398 ~~  399 (412)
                      .+
T Consensus       203 ~~  204 (325)
T 3kul_A          203 DD  204 (325)
T ss_dssp             --
T ss_pred             cC
Confidence            54

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=7.7e-29  Score=235.27  Aligned_cols=153  Identities=26%  Similarity=0.377  Sum_probs=133.8

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCe
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKE  314 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~  314 (412)
                      ....++|+..+.||+|+||.||++.. .+++.||||.+.+..   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            44567899999999999999999996 468899999997642   23445678889888876 99999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            9999999999999999853   356899999999999999999999988   9999999999999999999999999998


Q ss_pred             cccC
Q 015138          395 LFEM  398 (412)
Q Consensus       395 ~~~~  398 (412)
                      ....
T Consensus       167 ~~~~  170 (345)
T 1xjd_A          167 ENML  170 (345)
T ss_dssp             CCCC
T ss_pred             hccc
Confidence            7543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=7.5e-29  Score=239.18  Aligned_cols=149  Identities=26%  Similarity=0.321  Sum_probs=131.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccC-CCCccceeeEEEecCCeee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  316 (412)
                      ..++|+..++||+|+||.||++.. .+++.||||++.+....   ....+..|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            346788999999999999999995 45788999999765322   223478899998877 8999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+|||+|+..
T Consensus       130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            99999999999999853   456999999999999999999999998   999999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=1.3e-28  Score=228.73  Aligned_cols=151  Identities=27%  Similarity=0.430  Sum_probs=133.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+.....   .....+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46788899999999999999994 5689999999865433   2345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999853   356999999999999999999999988   99999999999999999999999999997754


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       164 ~  164 (294)
T 4eqm_A          164 T  164 (294)
T ss_dssp             -
T ss_pred             c
Confidence            4

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=2e-28  Score=227.95  Aligned_cols=150  Identities=25%  Similarity=0.434  Sum_probs=128.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--------------------------cHHHHHHHHHHHc
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--------------------------GEIEFKNEVLLLA  295 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--------------------------~~~~~~~e~~~l~  295 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+......                          ....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46788899999999999999995 56889999998754311                          1245889999999


Q ss_pred             cCCCCccceeeEEEec--CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCC
Q 015138          296 RLQHRNLVRLLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK  373 (412)
Q Consensus       296 ~l~h~niv~l~g~~~~--~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk  373 (412)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++..+..++.|++.||.|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  56789999999999998875    3457999999999999999999999998   9999999


Q ss_pred             CCCEEECCCCCeEEeccCCcccccCC
Q 015138          374 ASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       374 ~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+|||++.++.+||+|||+++.+...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~  190 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGS  190 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccc
Confidence            99999999999999999999987544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=1.4e-28  Score=236.48  Aligned_cols=151  Identities=26%  Similarity=0.377  Sum_probs=135.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46788899999999999999995 568899999986542   23456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999854   456999999999999999999999998   99999999999999999999999999998754


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       168 ~  168 (384)
T 4fr4_A          168 E  168 (384)
T ss_dssp             T
T ss_pred             C
Confidence            4

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.95  E-value=4.5e-29  Score=240.15  Aligned_cols=155  Identities=28%  Similarity=0.480  Sum_probs=136.7

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      +....++|...+.||+|+||.||+|... +++.||||.+..... .....|.+|+.++++++||||+++++++...+..+
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            3445678888999999999999999975 789999999876532 23346889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       189 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            99999999999999854  2345899999999999999999999988   999999999999999999999999999875


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      ..
T Consensus       264 ~~  265 (377)
T 3cbl_A          264 AD  265 (377)
T ss_dssp             TT
T ss_pred             CC
Confidence            43

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=1.5e-28  Score=230.91  Aligned_cols=150  Identities=27%  Similarity=0.388  Sum_probs=134.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+|+.||+|.+.+..   ......+.+|..++..++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            36788899999999999999995 578999999997542   23455688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999854   456899999999999999999999987   99999999999999999999999999987653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=4.8e-29  Score=238.93  Aligned_cols=168  Identities=18%  Similarity=0.204  Sum_probs=137.9

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEE------eCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC---CCccceeeEE
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGM------LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGF  308 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~------~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~  308 (412)
                      ++....++|...++||+|+||.||+|.      ..+++.||||++....   ..++..|+.++..++   |+||++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            344566789999999999999999994      4568899999997653   346677777777776   9999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-----
Q 015138          309 CLERKERILVYEFVPNASLDHFIFDP--INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-----  381 (412)
Q Consensus       309 ~~~~~~~~lv~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-----  381 (412)
                      +...+..+|||||+++|+|.+++...  .....+++..++.|+.||+.||.|||+.+   |+||||||+||||+.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence            99999999999999999999998531  13466999999999999999999999987   999999999999998     


Q ss_pred             ------CCCeEEeccCCcccccCCCccccccccccc
Q 015138          382 ------EMNPKISDFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       382 ------~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                            ++.+||+|||+|+.+.............||
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt  248 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET  248 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence                  899999999999876433222222335566

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=9.3e-29  Score=234.62  Aligned_cols=159  Identities=28%  Similarity=0.509  Sum_probs=138.7

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEe
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCL  310 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~  310 (412)
                      .+....++|+..+.||+|+||.||++...      +++.||||.+..... .....+.+|+.++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34556788999999999999999999963      347899999976543 33557899999999999999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCcee
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPIN---------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH  369 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH  369 (412)
                      +.+..++||||+++|+|.+++.....                     ...+++..++.|+.||+.||.|||+.+   |+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            99999999999999999999854211                     256999999999999999999999988   999


Q ss_pred             cCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          370 RDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       370 rdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |||||+|||++.++.+||+|||+++.+...
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  227 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSA  227 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccC
Confidence            999999999999999999999999876443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=1.6e-28  Score=233.33  Aligned_cols=149  Identities=27%  Similarity=0.317  Sum_probs=132.8

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+.+...   .....+.+|..++.++ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            36788899999999999999996 4688999999976532   2344578899999887 89999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++++||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999999853   356999999999999999999999988   9999999999999999999999999998643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=2.3e-28  Score=223.94  Aligned_cols=152  Identities=31%  Similarity=0.546  Sum_probs=137.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ...++|+..+.||+|+||.||++...+++.||+|++..... ...++.+|+.++.+++||||+++++++.+....++|||
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            34567888999999999999999988889999999976543 34578999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           86 FMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             CCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence            9999999999854  3456899999999999999999999988   99999999999999999999999999987654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=2e-28  Score=231.02  Aligned_cols=151  Identities=25%  Similarity=0.341  Sum_probs=126.3

Q ss_pred             hhcCCCccccccccCCeeEEEEEe----CCCCEEEEEEeccCC----cccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      ..++|+..+.||+|+||.||++..    .+++.||+|.+.+..    ......+.+|+.++.+++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            346788999999999999999996    478999999997653    223445788999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999999853   456899999999999999999999988   999999999999999999999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       169 ~~~~~  173 (327)
T 3a62_A          169 KESIH  173 (327)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            86543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.8e-28  Score=227.80  Aligned_cols=152  Identities=23%  Similarity=0.369  Sum_probs=135.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            46788899999999999999995 468899999987543 3345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC--CCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~~~~  399 (412)
                      +++|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999854  2346999999999999999999999988   999999999999997  789999999999987654


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       158 ~  158 (321)
T 1tki_A          158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.95  E-value=4.7e-28  Score=226.91  Aligned_cols=151  Identities=30%  Similarity=0.516  Sum_probs=132.1

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ..++|+..++||+|+||.||++...+++.||+|++......  ....+.+|+.++.+++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            34778899999999999999999888999999998754322  2456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99985 78777754  3456999999999999999999999987   99999999999999999999999999997753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=6.6e-28  Score=227.43  Aligned_cols=151  Identities=31%  Similarity=0.472  Sum_probs=135.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc------ccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      .++|...+.||+|+||.||++.. .+++.||+|.+.....      .....+.+|+.++.+++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35688899999999999999995 5689999999876432      1356799999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC----CeEEeccC
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfG  391 (412)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999843   457999999999999999999999987   99999999999999887    79999999


Q ss_pred             CcccccCC
Q 015138          392 MARLFEMD  399 (412)
Q Consensus       392 la~~~~~~  399 (412)
                      +++.+...
T Consensus       164 ~a~~~~~~  171 (326)
T 2y0a_A          164 LAHKIDFG  171 (326)
T ss_dssp             TCEECCTT
T ss_pred             CCeECCCC
Confidence            99987544

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.95  E-value=6.7e-28  Score=232.29  Aligned_cols=153  Identities=27%  Similarity=0.425  Sum_probs=137.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.++..++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            36788999999999999999995 56889999999876655666789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC--CCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~~~~  399 (412)
                      +++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+..+
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999854  2346999999999999999999999988   999999999999984  467999999999987654


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       205 ~  205 (387)
T 1kob_A          205 E  205 (387)
T ss_dssp             S
T ss_pred             c
Confidence            4

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=1.4e-28  Score=242.38  Aligned_cols=157  Identities=29%  Similarity=0.470  Sum_probs=138.8

Q ss_pred             hHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       236 ~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      ...++...++|+..+.||+|+||.||+|...++..||||++.... .....|.+|+.++++++||||+++++++. .+..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            344566778899999999999999999999888999999997654 34668999999999999999999999986 5678


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            9999999999999999542 1235889999999999999999999987   99999999999999999999999999997


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      +..
T Consensus       334 ~~~  336 (454)
T 1qcf_A          334 IED  336 (454)
T ss_dssp             BCC
T ss_pred             cCC
Confidence            754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=4.1e-28  Score=228.06  Aligned_cols=155  Identities=28%  Similarity=0.446  Sum_probs=136.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCC--eeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--ERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~~lv  318 (412)
                      .++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            46788899999999999999996 458999999997543 334567889999999999999999999998765  77999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE----CCCCCeEEeccCCcc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMAR  394 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DfGla~  394 (412)
                      |||+++++|.+++........+++..++.|+.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976444455999999999999999999999998   9999999999999    788889999999999


Q ss_pred             cccCCC
Q 015138          395 LFEMDQ  400 (412)
Q Consensus       395 ~~~~~~  400 (412)
                      .+..+.
T Consensus       165 ~~~~~~  170 (319)
T 4euu_A          165 ELEDDE  170 (319)
T ss_dssp             ECCTTC
T ss_pred             ecCCCC
Confidence            876544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.95  E-value=3.2e-28  Score=234.67  Aligned_cols=158  Identities=26%  Similarity=0.445  Sum_probs=136.8

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe--------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEE
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML--------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFC  309 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~  309 (412)
                      ....++|...++||+|+||.||++..        ..+..||||++..... .....+.+|++++.++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            34557888899999999999999985        2235799999976533 3446789999999999 999999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                      ...+..++||||+++|+|.+++....             ....+++..++.|+.|++.||.|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            99999999999999999999986432             1245999999999999999999999987   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccccCCC
Q 015138          377 ILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ||++.++.+||+|||+|+.+....
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~  245 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHID  245 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCC
T ss_pred             EEEcCCCcEEEcccCccccccccc
Confidence            999999999999999999775443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=3.5e-28  Score=231.39  Aligned_cols=150  Identities=25%  Similarity=0.304  Sum_probs=135.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+|+.||||.+.+..   ......+.+|+.++..++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            36788899999999999999995 468999999986542   23455788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999854   356899999999999999999999988   99999999999999999999999999997654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=2.2e-28  Score=232.88  Aligned_cols=151  Identities=30%  Similarity=0.305  Sum_probs=133.3

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  315 (412)
                      ...++|+..+.||+|+||.||++... +++.||||.+.+..   ......+..|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            34578999999999999999999964 57889999997642   23455688999999988 899999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++++||+|||+++.
T Consensus        97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            999999999999999853   356999999999999999999999988   99999999999999999999999999987


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      ..
T Consensus       171 ~~  172 (353)
T 2i0e_A          171 NI  172 (353)
T ss_dssp             CC
T ss_pred             cc
Confidence            54

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.95  E-value=1.4e-28  Score=228.51  Aligned_cols=153  Identities=31%  Similarity=0.577  Sum_probs=132.9

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-----CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecC--Ce
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KE  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~  314 (412)
                      ..++|+..++||+|+||.||++.+     .+++.||||++..........+.+|+.++.+++||||+++++++...  ..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            346788899999999999999984     36789999999877766667899999999999999999999998654  45


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            89999999999999998542  345999999999999999999999987   9999999999999999999999999999


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+..+
T Consensus       163 ~~~~~  167 (295)
T 3ugc_A          163 VLPQD  167 (295)
T ss_dssp             -----
T ss_pred             cccCC
Confidence            87544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=1.6e-28  Score=244.44  Aligned_cols=157  Identities=29%  Similarity=0.509  Sum_probs=139.5

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEeCC-CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++...++|+..++||+|+||.||+|.+.. +..||||.+..... ...+|.+|+.++++++||||+++++++......+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            344556778889999999999999999754 78999999976543 4567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||||+++|+|.+++... ....+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       293 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence            999999999999999642 2456899999999999999999999988   999999999999999999999999999987


Q ss_pred             cCC
Q 015138          397 EMD  399 (412)
Q Consensus       397 ~~~  399 (412)
                      ..+
T Consensus       369 ~~~  371 (495)
T 1opk_A          369 TGD  371 (495)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.95  E-value=2.9e-28  Score=223.13  Aligned_cols=154  Identities=29%  Similarity=0.487  Sum_probs=138.1

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ...++|+..+.||+|+||.||++...++..||||.+..... ...++.+|+.++.+++||||+++++++.+....++|||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            34577888999999999999999988888999999976543 34578999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....+.
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           84 YISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             ccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999854  2345899999999999999999999987   9999999999999999999999999999775543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=3.8e-28  Score=224.20  Aligned_cols=156  Identities=26%  Similarity=0.475  Sum_probs=136.9

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..+....++|+..+.||+|+||.||++...++..||||++..... ...++.+|+.++.+++||||+++++++.+....+
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            344556678899999999999999999998888999999976543 3457899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        96 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           96 IITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEECCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             EEEeccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999999854  2356999999999999999999999988   999999999999999999999999999876


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      ..
T Consensus       171 ~~  172 (283)
T 3gen_A          171 LD  172 (283)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=6.4e-28  Score=223.77  Aligned_cols=150  Identities=28%  Similarity=0.495  Sum_probs=130.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..++||+|+||.||++.. .+++.||||++.....  .....+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4688899999999999999995 5689999999975433  234578899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |++++ |.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99864 4444432  2456999999999999999999999998   999999999999999999999999999877543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.9e-28  Score=231.48  Aligned_cols=160  Identities=28%  Similarity=0.439  Sum_probs=135.9

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEe
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~  310 (412)
                      ++...++|...+.||+|+||.||+|..      .++..||||.+.... ......+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            445668899999999999999999995      245679999997543 23345789999999999 8999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHhHhCCCCCceec
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPINR--------------------EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR  370 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHr  370 (412)
                      ..+..++||||+++|+|.+++......                    ..+++..++.++.|++.||.|||+.+   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            999999999999999999999653221                    34899999999999999999999987   9999


Q ss_pred             CCCCCCEEECCCCCeEEeccCCcccccCCCc
Q 015138          371 DLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (412)
Q Consensus       371 dlk~~Nill~~~~~~ki~DfGla~~~~~~~~  401 (412)
                      ||||+|||++.++.+||+|||+++.+..+..
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  227 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSN  227 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTT
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCcc
Confidence            9999999999999999999999998765443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=3.7e-28  Score=243.36  Aligned_cols=156  Identities=30%  Similarity=0.422  Sum_probs=138.3

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ...++|+..+.||+|+||.||++.. .+|+.||||++.+..   ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            4557799999999999999999996 578999999996542   234556889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||||+++|+|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+.+
T Consensus       261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            999999999999998653 2345999999999999999999999988   999999999999999999999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ..+.
T Consensus       337 ~~~~  340 (576)
T 2acx_A          337 PEGQ  340 (576)
T ss_dssp             CTTC
T ss_pred             ccCc
Confidence            6544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.95  E-value=2.7e-28  Score=228.43  Aligned_cols=159  Identities=29%  Similarity=0.447  Sum_probs=137.5

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEec
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~  311 (412)
                      +....++|...+.||+|+||.||++..      .+++.||||.+.... ......+.+|+.++++++||||+++++++.+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            344567888899999999999999985      345789999997653 3344678999999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceec
Q 015138          312 RKERILVYEFVPNASLDHFIFDPIN---------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR  370 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHr  370 (412)
                      .+..++||||+++++|.+++.....                     ...+++..++.++.|++.||.|||+++   |+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence            9999999999999999999864322                     234899999999999999999999988   9999


Q ss_pred             CCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          371 DLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       371 dlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ||||+|||++.++.+||+|||+++.+....
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~  204 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEED  204 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred             ccchheEEEcCCCCEEEccccccccccccc
Confidence            999999999999999999999999775543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.95  E-value=1.8e-28  Score=230.73  Aligned_cols=162  Identities=26%  Similarity=0.493  Sum_probs=124.1

Q ss_pred             hHHHHhhhcCCCccccccccCCeeEEEEEeCC-CC---EEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEE
Q 015138          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSN-GE---TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFC  309 (412)
Q Consensus       236 ~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~---~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~  309 (412)
                      ++++....++|+..+.||+|+||.||+|.... ++   .||||.+...  .......+.+|+.++++++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34455667889999999999999999999643 32   7999998765  333456799999999999999999999999


Q ss_pred             ecCCee------eEEEecCCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC
Q 015138          310 LERKER------ILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD  380 (412)
Q Consensus       310 ~~~~~~------~lv~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~  380 (412)
                      ......      ++||||+++|+|.+++...   .....+++..++.|+.|++.||.|||+.+   |+||||||+|||++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~  171 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLA  171 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEc
Confidence            887655      9999999999999998532   12236999999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeccCCcccccCCC
Q 015138          381 SEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       381 ~~~~~ki~DfGla~~~~~~~  400 (412)
                      .++.+||+|||+++.+....
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~  191 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGD  191 (323)
T ss_dssp             TTSCEEECCCCC--------
T ss_pred             CCCCEEEeeccccccccccc
Confidence            99999999999998775443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.95  E-value=1.5e-28  Score=235.68  Aligned_cols=154  Identities=34%  Similarity=0.555  Sum_probs=133.1

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      ..++|+..+.||+|+||.||+|.+.      +++.||||++... .......+.+|+.++.+++||||+++++++.+...
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3467888999999999999999953      4668999999754 33445578999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEE
Q 015138          315 RILVYEFVPNASLDHFIFDP----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKI  387 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki  387 (412)
                      .++||||+++|+|.+++...    .....+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            99999999999999998542    12346999999999999999999999998   99999999999999554   5999


Q ss_pred             eccCCcccccC
Q 015138          388 SDFGMARLFEM  398 (412)
Q Consensus       388 ~DfGla~~~~~  398 (412)
                      +|||+|+.+..
T Consensus       226 ~DFG~a~~~~~  236 (367)
T 3l9p_A          226 GDFGMARDIYR  236 (367)
T ss_dssp             CCCHHHHHHHH
T ss_pred             CCCcccccccc
Confidence            99999986643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=9.2e-28  Score=229.61  Aligned_cols=153  Identities=29%  Similarity=0.438  Sum_probs=134.9

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||+|.+....  ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            346788999999999999999995 568999999997653  23345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEEeccCCccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARL  395 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~  395 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++.
T Consensus       107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999998854   456899999999999999999999998   99999999999998654   599999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +....
T Consensus       181 ~~~~~  185 (362)
T 2bdw_A          181 VNDSE  185 (362)
T ss_dssp             CTTCC
T ss_pred             ecCCc
Confidence            76443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=5e-28  Score=232.33  Aligned_cols=147  Identities=31%  Similarity=0.445  Sum_probs=127.4

Q ss_pred             cccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          249 ANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      .+.||+|+||.||+|.. .+|+.||+|.+..........+.+|+.++.+++||||+++++++.+.+..+|||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56899999999999995 57899999999877666667899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE--CCCCCeEEeccCCcccccCCC
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL--DSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill--~~~~~~ki~DfGla~~~~~~~  400 (412)
                      .+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.+....
T Consensus       174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            988854  2346899999999999999999999988   9999999999999  667899999999999876544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=1.7e-28  Score=241.37  Aligned_cols=151  Identities=26%  Similarity=0.301  Sum_probs=125.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC---CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+.+.   .......+.+|+.++..++||||+++++++...+..+||
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46788899999999999999994 57899999999754   223345678899999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||+ .+   |+||||||+||||+.++.+||+|||+|+...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999843   4569999999999999999999998 76   9999999999999999999999999998754


Q ss_pred             CC
Q 015138          398 MD  399 (412)
Q Consensus       398 ~~  399 (412)
                      ..
T Consensus       301 ~~  302 (446)
T 4ejn_A          301 KD  302 (446)
T ss_dssp             C-
T ss_pred             CC
Confidence            33

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=3.6e-28  Score=233.02  Aligned_cols=161  Identities=27%  Similarity=0.310  Sum_probs=129.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHHHH-HccCCCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLL-LARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+.+...   .....+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            36788899999999999999996 4588999999976532   223446667776 577899999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999853   456889999999999999999999988   9999999999999999999999999998754


Q ss_pred             CCCccccccccccc
Q 015138          398 MDQTHSDTNRVVGT  411 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt  411 (412)
                      .....  +....||
T Consensus       191 ~~~~~--~~~~~gt  202 (373)
T 2r5t_A          191 EHNST--TSTFCGT  202 (373)
T ss_dssp             CCCCC--CCSBSCC
T ss_pred             cCCCc--cccccCC
Confidence            33221  2235566

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=3e-28  Score=232.16  Aligned_cols=155  Identities=26%  Similarity=0.340  Sum_probs=133.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-----cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .+.|+..+.||+|+||.||++.. .+++.||||.+....     ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35688899999999999999995 578999999986421     224567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC---eEEeccCC
Q 015138          317 LVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGM  392 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfGl  392 (412)
                      +||||+++++|.+++... .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998877432 12345899999999999999999999988   999999999999987654   99999999


Q ss_pred             cccccCCC
Q 015138          393 ARLFEMDQ  400 (412)
Q Consensus       393 a~~~~~~~  400 (412)
                      ++.+....
T Consensus       180 a~~~~~~~  187 (351)
T 3c0i_A          180 AIQLGESG  187 (351)
T ss_dssp             CEECCTTS
T ss_pred             eeEecCCC
Confidence            99876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=7.3e-28  Score=223.00  Aligned_cols=149  Identities=29%  Similarity=0.521  Sum_probs=132.8

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..+.||+|+||.||++...+++.||||++.....  .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999988899999999865432  2235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            985 89888854  2356899999999999999999999987   99999999999999999999999999987653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=9.7e-28  Score=239.62  Aligned_cols=166  Identities=31%  Similarity=0.422  Sum_probs=142.3

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..++|...+.||+|+||.||++.. .+|+.||||++.+..   ......+.+|+.++.+++||||+++++++.+....++
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            457888999999999999999996 568999999997542   2335578899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          318 VYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      ||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+|||+++.+
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            999999999999986532 2456999999999999999999999988   999999999999999999999999999987


Q ss_pred             cCCCcccccccccccC
Q 015138          397 EMDQTHSDTNRVVGTL  412 (412)
Q Consensus       397 ~~~~~~~~~~~~~Gt~  412 (412)
                      ......  +....||+
T Consensus       340 ~~~~~~--~~~~~GT~  353 (543)
T 3c4z_A          340 KAGQTK--TKGYAGTP  353 (543)
T ss_dssp             CTTCCC--BCCCCSCT
T ss_pred             cCCCcc--cccccCCc
Confidence            654432  22345663

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=1.1e-27  Score=236.31  Aligned_cols=152  Identities=27%  Similarity=0.483  Sum_probs=136.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|...+.||+|+||.||+|.. .+|+.||||.+.+..   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            36788899999999999999995 478999999997542   22345789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999853   456999999999999999999999987   99999999999999999999999999998765


Q ss_pred             CC
Q 015138          399 DQ  400 (412)
Q Consensus       399 ~~  400 (412)
                      ..
T Consensus       169 ~~  170 (476)
T 2y94_A          169 GE  170 (476)
T ss_dssp             TC
T ss_pred             cc
Confidence            43

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=9.6e-28  Score=227.01  Aligned_cols=159  Identities=28%  Similarity=0.467  Sum_probs=136.5

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEe--------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEE
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGML--------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGF  308 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~  308 (412)
                      +....++|+..+.||+|+||.||++..        .++..||||.+..... .....+.+|+.++.++ +||||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            345567899999999999999999985        3467899999976533 3455789999999999 89999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCC
Q 015138          309 CLERKERILVYEFVPNASLDHFIFDPIN-------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS  375 (412)
Q Consensus       309 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~  375 (412)
                      +.+.+..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+.+   |+||||||+
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  186 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR  186 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence            9999999999999999999999965321             234899999999999999999999987   999999999


Q ss_pred             CEEECCCCCeEEeccCCcccccCCC
Q 015138          376 NILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       376 Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |||++.++.+||+|||+++.+....
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~  211 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNID  211 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTS
T ss_pred             eEEEcCCCCEEEccccccccccccc
Confidence            9999999999999999999776543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=1e-27  Score=234.99  Aligned_cols=153  Identities=26%  Similarity=0.382  Sum_probs=133.6

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ..++|+..+.||+|+||.||++.. .+|+.+|+|.+.....  .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            456788999999999999999984 6789999999876542  2345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC---CCCCeEEeccCCccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD---SEMNPKISDFGMARL  395 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DfGla~~  395 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+|+.
T Consensus        89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999998854   456999999999999999999999998   99999999999998   457899999999988


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +....
T Consensus       163 ~~~~~  167 (444)
T 3soa_A          163 VEGEQ  167 (444)
T ss_dssp             CCTTC
T ss_pred             ecCCC
Confidence            76543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.95  E-value=5.7e-28  Score=228.43  Aligned_cols=151  Identities=26%  Similarity=0.487  Sum_probs=133.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|...+.||+|+||.||+|.. .+++.||||.+.+..   ......+.+|+.+++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36788899999999999999995 678999999986532   12234688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+ +|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 7889888744   456999999999999999999999988   99999999999999999999999999997754


Q ss_pred             CC
Q 015138          399 DQ  400 (412)
Q Consensus       399 ~~  400 (412)
                      ..
T Consensus       161 ~~  162 (336)
T 3h4j_B          161 GN  162 (336)
T ss_dssp             SB
T ss_pred             Cc
Confidence            43

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=2.3e-27  Score=222.78  Aligned_cols=152  Identities=30%  Similarity=0.518  Sum_probs=119.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46789999999999999999995 5689999999976543 234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |++ |+|.+++...   .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 6998887431   12345899999999999999999999987   9999999999999999999999999999775


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       160 ~  160 (317)
T 2pmi_A          160 I  160 (317)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.95  E-value=6.9e-29  Score=235.08  Aligned_cols=148  Identities=20%  Similarity=0.282  Sum_probs=124.0

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC--------cccHHHHHHHHHHHccCC---------CCcccee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--------KQGEIEFKNEVLLLARLQ---------HRNLVRL  305 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l  305 (412)
                      .++|+..+.||+|+||.||+|.. +|+.||||++....        ......+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46688899999999999999998 68999999997653        223467888999888885         6676666


Q ss_pred             eEEE-----------------ec-------------CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 015138          306 LGFC-----------------LE-------------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG  355 (412)
Q Consensus       306 ~g~~-----------------~~-------------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~  355 (412)
                      .+.+                 .+             ....+|||||+++|++.+.+.    ...+++..+..|+.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence            6654                 22             678999999999997766662    3568999999999999999


Q ss_pred             HHHhH-hCCCCCceecCCCCCCEEECCCC--------------------CeEEeccCCcccccC
Q 015138          356 LLYLH-EDSRLRIIHRDLKASNILLDSEM--------------------NPKISDFGMARLFEM  398 (412)
Q Consensus       356 l~yLH-~~~~~~ivHrdlk~~Nill~~~~--------------------~~ki~DfGla~~~~~  398 (412)
                      |.||| +.+   |+||||||+||||+.++                    .+||+|||+|+.+..
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            99999 887   99999999999999887                    899999999997754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=2.7e-28  Score=228.50  Aligned_cols=151  Identities=26%  Similarity=0.395  Sum_probs=129.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCe----
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKE----  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~----  314 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+......   ....+.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46788999999999999999994 67899999999765332   24568899999999999999999999876543    


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            3999999999999999853   456999999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+...
T Consensus       165 ~~~~~  169 (311)
T 3ork_A          165 AIADS  169 (311)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            77544

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.95  E-value=5.8e-28  Score=226.08  Aligned_cols=160  Identities=29%  Similarity=0.434  Sum_probs=138.7

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEEe
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~  310 (412)
                      +....++|+..+.||+|+||.||++..      .+++.||||.+..... .....+.+|+.++.++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            345567888999999999999999984      3467899999976543 3346789999999999 9999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCC---------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCC
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPIN---------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS  375 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~  375 (412)
                      ..+..++||||+++|+|.+++.....               ...+++..++.++.|++.||.|||+.+   |+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            99999999999999999999864321               225899999999999999999999987   999999999


Q ss_pred             CEEECCCCCeEEeccCCcccccCCCc
Q 015138          376 NILLDSEMNPKISDFGMARLFEMDQT  401 (412)
Q Consensus       376 Nill~~~~~~ki~DfGla~~~~~~~~  401 (412)
                      |||++.++.+||+|||+++.+.....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~  200 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSN  200 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTT
T ss_pred             eEEEcCCCCEEEcccccccccccccc
Confidence            99999999999999999998765543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=1.4e-27  Score=219.58  Aligned_cols=152  Identities=24%  Similarity=0.396  Sum_probs=137.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|+..+.||+|+||.||++.. .++..||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            46688899999999999999995 45778999999877666677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE---CCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++..   ...+++..+..|+.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999998854   456899999999999999999999988   9999999999999   7889999999999988765


Q ss_pred             CC
Q 015138          399 DQ  400 (412)
Q Consensus       399 ~~  400 (412)
                      ..
T Consensus       162 ~~  163 (277)
T 3f3z_A          162 GK  163 (277)
T ss_dssp             TS
T ss_pred             cc
Confidence            44

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=2.6e-28  Score=229.49  Aligned_cols=164  Identities=27%  Similarity=0.486  Sum_probs=140.9

Q ss_pred             cchHHHHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceee
Q 015138          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLL  306 (412)
Q Consensus       234 ~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~  306 (412)
                      +..++++...++|+..+.||+|+||.||+|...      +++.||||.+..... .....+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344556677788999999999999999999853      367899999976533 3445689999999999999999999


Q ss_pred             EEEecCCeeeEEEecCCCCChhhhccCC-------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE
Q 015138          307 GFCLERKERILVYEFVPNASLDHFIFDP-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (412)
Q Consensus       307 g~~~~~~~~~lv~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill  379 (412)
                      +++.+.+..++||||+++|+|.+++...       .....+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            9999999999999999999999998531       11245799999999999999999999997   9999999999999


Q ss_pred             CCCCCeEEeccCCcccccCCC
Q 015138          380 DSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       380 ~~~~~~ki~DfGla~~~~~~~  400 (412)
                      +.++.+||+|||+++......
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~  192 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETD  192 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGG
T ss_pred             cCCCeEEECcCcccccccccc
Confidence            999999999999998765443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=3.4e-28  Score=239.49  Aligned_cols=157  Identities=29%  Similarity=0.498  Sum_probs=135.1

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..++...++|+..++||+|+||.||+|...++..||||++.... ....+|.+|+.++++++||||+++++++.+ +..+
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            34556667888999999999999999999888889999997654 345679999999999999999999999876 6789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++... ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       255 iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence            999999999999999431 2245899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCC
Q 015138          397 EMD  399 (412)
Q Consensus       397 ~~~  399 (412)
                      ..+
T Consensus       331 ~~~  333 (452)
T 1fmk_A          331 EDN  333 (452)
T ss_dssp             ---
T ss_pred             CCC
Confidence            543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.95  E-value=4.8e-28  Score=228.47  Aligned_cols=153  Identities=30%  Similarity=0.612  Sum_probs=128.3

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCC----EEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|+..+.||+|+||.||+|.. .+++    +||+|.+.... .....++.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            46788899999999999999995 3444    35888876443 345667999999999999999999999998765 78


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +|+||+++|+|.+++..  ....+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++++||+|||+|+.+
T Consensus        93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999865  2456999999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCCc
Q 015138          397 EMDQT  401 (412)
Q Consensus       397 ~~~~~  401 (412)
                      .....
T Consensus       168 ~~~~~  172 (327)
T 3poz_A          168 GAEEK  172 (327)
T ss_dssp             TTTCC
T ss_pred             cCCcc
Confidence            65543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=7.9e-28  Score=236.79  Aligned_cols=152  Identities=28%  Similarity=0.475  Sum_probs=134.3

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC-eeeE
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-ERIL  317 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-~~~l  317 (412)
                      +....++|+..+.||+|+||.||+|... ++.||||.++...  ....|.+|+.++++++||||+++++++.+.. ..++
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            3455678888999999999999999985 7899999997654  3457899999999999999999999987765 7899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++... ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       265 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999999642 2334799999999999999999999988   9999999999999999999999999998654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.95  E-value=1.9e-27  Score=221.38  Aligned_cols=148  Identities=27%  Similarity=0.428  Sum_probs=126.7

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHcc--CCCCccceeeEEEecC----Cee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR--LQHRNLVRLLGFCLER----KER  315 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~g~~~~~----~~~  315 (412)
                      ..++|+..+.||+|+||.||+|.. +++.||||++....   ...+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            457899999999999999999998 68999999986542   3345556666555  8999999999987643    458


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhH--------hCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH--------EDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                      ++||||+++|+|.+++.    ...+++..++.|+.|++.||.|||        +.+   |+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            99999999999999993    457999999999999999999999        665   999999999999999999999


Q ss_pred             eccCCcccccCCC
Q 015138          388 SDFGMARLFEMDQ  400 (412)
Q Consensus       388 ~DfGla~~~~~~~  400 (412)
                      +|||+|+......
T Consensus       155 ~Dfg~a~~~~~~~  167 (301)
T 3q4u_A          155 ADLGLAVMHSQST  167 (301)
T ss_dssp             CCCTTCEEEETTT
T ss_pred             eeCCCeeeccccc
Confidence            9999998776544

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.95  E-value=5.4e-28  Score=227.90  Aligned_cols=153  Identities=31%  Similarity=0.535  Sum_probs=130.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCE----EEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGET----IAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~----vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|+..+.||+|+||.||+|.. .+++.    |++|.+.... ......+.+|+.++.+++||||+++++++. +...+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            36788899999999999999995 44544    7888775443 223345778999999999999999999886 45688


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            99999999999999864  2356899999999999999999999998   999999999999999999999999999988


Q ss_pred             cCCCc
Q 015138          397 EMDQT  401 (412)
Q Consensus       397 ~~~~~  401 (412)
                      ..+..
T Consensus       166 ~~~~~  170 (325)
T 3kex_A          166 PPDDK  170 (325)
T ss_dssp             CCCTT
T ss_pred             Ccccc
Confidence            65544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=1.4e-27  Score=228.23  Aligned_cols=149  Identities=25%  Similarity=0.372  Sum_probs=130.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||++...... ...+.+|+.+++.++||||+++++++.+....++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            346788999999999999999995 47899999999765433 3468899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC--eEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--PKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DfGla~~~~  397 (412)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.  +||+|||+|+...
T Consensus        97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            9999999999843   456999999999999999999999988   999999999999988765  9999999998543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=9.6e-28  Score=224.90  Aligned_cols=168  Identities=30%  Similarity=0.458  Sum_probs=142.9

Q ss_pred             cccccchHHHHhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCc
Q 015138          230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRN  301 (412)
Q Consensus       230 ~~~~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~n  301 (412)
                      +.+.++...+....++|+..+.||+|+||.||++..      .+++.||||.+..... .....+.+|+.++.++ +|||
T Consensus        13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   92 (316)
T 2xir_A           13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN   92 (316)
T ss_dssp             GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence            344566677778889999999999999999999984      3567899999976543 3345689999999999 7999


Q ss_pred             cceeeEEEecCC-eeeEEEecCCCCChhhhccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCc
Q 015138          302 LVRLLGFCLERK-ERILVYEFVPNASLDHFIFDPIN-------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRI  367 (412)
Q Consensus       302 iv~l~g~~~~~~-~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i  367 (412)
                      |+++++++...+ ..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+.+   |
T Consensus        93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i  169 (316)
T 2xir_A           93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C  169 (316)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence            999999988755 58999999999999999965322             223899999999999999999999987   9


Q ss_pred             eecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       368 vHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      +||||||+|||++.++.+||+|||+++.+..+.
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  202 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDP  202 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCc
Confidence            999999999999999999999999999775544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=1.4e-27  Score=235.74  Aligned_cols=150  Identities=23%  Similarity=0.429  Sum_probs=122.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC-----Ce
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~  314 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||++....  ......+.+|+.+|.+++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36788999999999999999984 578999999997542  33445789999999999999999999998543     56


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||+ +++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+|+
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5789988854   456999999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+...
T Consensus       205 ~~~~~  209 (458)
T 3rp9_A          205 TVDYP  209 (458)
T ss_dssp             CTTSC
T ss_pred             hccCc
Confidence            87543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=1.2e-27  Score=224.16  Aligned_cols=151  Identities=25%  Similarity=0.294  Sum_probs=128.0

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc--ccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..++||+|+||+||+|... +++.||||++.....  .....+..|+..+.++ +||||+++++++.+....+||
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367888999999999999999964 789999999865432  2333455666655555 899999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+ +++|.+++..  ....++|..+..|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 7789888754  2356999999999999999999999987   99999999999999999999999999987754


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       210 ~  210 (311)
T 3p1a_A          210 A  210 (311)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=8.5e-28  Score=228.28  Aligned_cols=163  Identities=24%  Similarity=0.383  Sum_probs=133.7

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCC--CccceeeEEEecCCeee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERKERI  316 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~~~~  316 (412)
                      ...++|+..+.||+|+||.||++...+++.||||++....  ......+.+|+.++.+++|  +||+++++++......+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            3456788999999999999999998889999999987543  3334678999999999986  99999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||| +.+++|.+++..   ...+++..+..|+.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+
T Consensus        86 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            9999 568899999854   457999999999999999999999987   99999999999997 678999999999987


Q ss_pred             cCCCccccccccccc
Q 015138          397 EMDQTHSDTNRVVGT  411 (412)
Q Consensus       397 ~~~~~~~~~~~~~Gt  411 (412)
                      ..+..........||
T Consensus       158 ~~~~~~~~~~~~~gt  172 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGT  172 (343)
T ss_dssp             ------------CCC
T ss_pred             CcccccccCCCCcCC
Confidence            655443223334565

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=2.8e-27  Score=217.38  Aligned_cols=151  Identities=29%  Similarity=0.446  Sum_probs=135.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            36788899999999999999996 478999999986543 3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..+
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999843   456899999999999999999999987   999999999999999999999999999876543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.95  E-value=1.7e-27  Score=224.95  Aligned_cols=150  Identities=23%  Similarity=0.302  Sum_probs=132.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+......  ..+.+|+.+++++ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46788999999999999999994 67899999998755332  2578999999999 99999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC-----eEEeccCCccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-----PKISDFGMARL  395 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~ki~DfGla~~  395 (412)
                      |+ +++|.+++...  ...+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998542  457999999999999999999999987   999999999999999887     99999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +....
T Consensus       160 ~~~~~  164 (330)
T 2izr_A          160 YIDPE  164 (330)
T ss_dssp             SBCTT
T ss_pred             eecCC
Confidence            75543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=4.9e-28  Score=243.14  Aligned_cols=156  Identities=29%  Similarity=0.496  Sum_probs=137.7

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..+++..++|+..++||+|+||.||+|.+.++..||||++.... ....+|.+|+.+|++++|+||+++++++.+ +..+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            34556677888899999999999999999888889999997654 345679999999999999999999999876 6789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||||+++|+|.++|... ....+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus       338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            999999999999999431 1245899999999999999999999987   999999999999999999999999999976


Q ss_pred             cC
Q 015138          397 EM  398 (412)
Q Consensus       397 ~~  398 (412)
                      ..
T Consensus       414 ~~  415 (535)
T 2h8h_A          414 ED  415 (535)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=4.5e-27  Score=218.15  Aligned_cols=152  Identities=31%  Similarity=0.439  Sum_probs=133.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      +++.....||+|+||.||+|.. .+++.||||.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            4455667999999999999994 668899999998776666678999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-CCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DfGla~~~~~  398 (412)
                      ++++|.+++........+++..+..++.|++.||.|||+.+   |+||||||+|||++. ++.+||+|||+++.+..
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            99999999966444456789999999999999999999987   999999999999987 89999999999987654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.6e-27  Score=230.84  Aligned_cols=155  Identities=28%  Similarity=0.446  Sum_probs=135.3

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCC--eeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--ERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~~lv  318 (412)
                      .++|...++||+|+||.||+|.. .+++.||||.+.... ......+.+|++++.+++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            46788899999999999999996 458999999997643 334567889999999999999999999998765  67999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE----CCCCCeEEeccCCcc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMAR  394 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DfGla~  394 (412)
                      |||+++|+|.+++........+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999966444445999999999999999999999998   9999999999999    778889999999999


Q ss_pred             cccCCC
Q 015138          395 LFEMDQ  400 (412)
Q Consensus       395 ~~~~~~  400 (412)
                      .+..+.
T Consensus       165 ~~~~~~  170 (396)
T 4eut_A          165 ELEDDE  170 (396)
T ss_dssp             ECCCGG
T ss_pred             EccCCC
Confidence            875543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=2e-27  Score=226.29  Aligned_cols=150  Identities=29%  Similarity=0.453  Sum_probs=122.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ..++|+..+.||+|+||.||++... +++.||||.+....  ....+.+|+.++.+++||||+++++++.+....++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567888999999999999999964 57899999997643  23467889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC---CCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla~~~~  397 (412)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999854   456899999999999999999999987   999999999999976   8899999999999765


Q ss_pred             CC
Q 015138          398 MD  399 (412)
Q Consensus       398 ~~  399 (412)
                      ..
T Consensus       203 ~~  204 (349)
T 2w4o_A          203 HQ  204 (349)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=1.2e-27  Score=221.37  Aligned_cols=150  Identities=29%  Similarity=0.475  Sum_probs=134.3

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CC-------CEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NG-------ETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~-------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      .++|...+.||+|+||.||+|... ++       ..||+|.+..........+.+|+.++.+++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467888999999999999999853 33       4699999987766677789999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC--------eE
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--------PK  386 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--------~k  386 (412)
                      .++||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999954  2334899999999999999999999998   999999999999998887        99


Q ss_pred             EeccCCccccc
Q 015138          387 ISDFGMARLFE  397 (412)
Q Consensus       387 i~DfGla~~~~  397 (412)
                      |+|||+++...
T Consensus       162 l~Dfg~~~~~~  172 (289)
T 4fvq_A          162 LSDPGISITVL  172 (289)
T ss_dssp             ECCCCSCTTTS
T ss_pred             eccCccccccc
Confidence            99999997654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.95  E-value=2e-27  Score=217.81  Aligned_cols=153  Identities=34%  Similarity=0.545  Sum_probs=125.9

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCc----ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..++|+..+.||+|+||.||++... ++.||||.+.....    .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3467888999999999999999975 88999999875432    234578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC--------CCCeEEec
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--------EMNPKISD  389 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--------~~~~ki~D  389 (412)
                      ||||+++++|.+++.    ...+++..+..++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+|
T Consensus        84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999983    457999999999999999999999987556999999999999986        67899999


Q ss_pred             cCCcccccCC
Q 015138          390 FGMARLFEMD  399 (412)
Q Consensus       390 fGla~~~~~~  399 (412)
                      ||+++.+...
T Consensus       160 fg~~~~~~~~  169 (271)
T 3dtc_A          160 FGLAREWHRT  169 (271)
T ss_dssp             CCC-------
T ss_pred             CCcccccccc
Confidence            9999876543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.94  E-value=1.4e-27  Score=223.74  Aligned_cols=166  Identities=27%  Similarity=0.507  Sum_probs=130.6

Q ss_pred             ccccchHHHHhhhcCCCccccccccCCeeEEEEEeC----CCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccce
Q 015138          231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVR  304 (412)
Q Consensus       231 ~~~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~  304 (412)
                      .++..+..+....++|...+.||+|+||.||+|...    +++.||||.+....  ......+.+|+.++++++||||++
T Consensus        21 el~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~  100 (313)
T 3brb_A           21 ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR  100 (313)
T ss_dssp             ---CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeee
Confidence            344455566677788999999999999999999853    34579999987543  333457899999999999999999


Q ss_pred             eeEEEecCCe-----eeEEEecCCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          305 LLGFCLERKE-----RILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       305 l~g~~~~~~~-----~~lv~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                      +++++.+...     .++||||+++|+|.+++...   .....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus       101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N  177 (313)
T 3brb_A          101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN  177 (313)
T ss_dssp             CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred             eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence            9999987653     49999999999999998421   23456999999999999999999999987   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccccCC
Q 015138          377 ILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||++.++.+||+|||+++.+...
T Consensus       178 Ili~~~~~~kl~Dfg~~~~~~~~  200 (313)
T 3brb_A          178 CMLRDDMTVCVADFGLSKKIYSG  200 (313)
T ss_dssp             EEECTTSCEEECSCSCC------
T ss_pred             EEEcCCCcEEEeecCcceecccc
Confidence            99999999999999999877544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.94  E-value=3.6e-27  Score=217.03  Aligned_cols=151  Identities=30%  Similarity=0.542  Sum_probs=134.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+....   ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            36788899999999999999995 678999999986542   22345789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999864  2356899999999999999999999987   99999999999999999999999999987653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=5.5e-27  Score=219.87  Aligned_cols=149  Identities=29%  Similarity=0.411  Sum_probs=130.9

Q ss_pred             cCCCcc-ccccccCCeeEEEEE-eCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDA-NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~-~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      +.|++. +.||+|+||.||++. ..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            556664 789999999999999 457899999999877666677899999999885 79999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC---eEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfGla~~~~  397 (412)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||+++.+.
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999854   356899999999999999999999997   999999999999998776   9999999998764


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       166 ~  166 (316)
T 2ac3_A          166 L  166 (316)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=7.2e-28  Score=229.84  Aligned_cols=152  Identities=28%  Similarity=0.369  Sum_probs=133.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe----CCCCEEEEEEeccCC----cccHHHHHHHHHHHccC-CCCccceeeEEEecCC
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~  313 (412)
                      .++|+..+.||+|+||.||++..    .+++.||||++.+..    ......+.+|+.++.++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46788999999999999999996    478999999987542    12234567899999999 6999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..+|||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999854   356899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCC
Q 015138          394 RLFEMDQ  400 (412)
Q Consensus       394 ~~~~~~~  400 (412)
                      +.+..+.
T Consensus       207 ~~~~~~~  213 (355)
T 1vzo_A          207 KEFVADE  213 (355)
T ss_dssp             EECCGGG
T ss_pred             eecccCC
Confidence            9775443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.94  E-value=2.1e-27  Score=217.07  Aligned_cols=151  Identities=31%  Similarity=0.527  Sum_probs=136.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ..++|+..+.||+|+||.||++...+++.||+|.+..... ....+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4567888999999999999999988888999999976543 345789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           85 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999854  2356899999999999999999999988   99999999999999999999999999987643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.94  E-value=3e-27  Score=220.14  Aligned_cols=152  Identities=34%  Similarity=0.579  Sum_probs=131.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-----CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecC--Cee
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~  315 (412)
                      +.|+..+.||+|+||.||++.+     .+++.||||++.... ......+.+|+.++.+++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4577889999999999999984     468899999997543 33456789999999999999999999999876  568


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            999999999999999844  2356999999999999999999999988   99999999999999999999999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +....
T Consensus       176 ~~~~~  180 (302)
T 4e5w_A          176 IETDK  180 (302)
T ss_dssp             CCTTC
T ss_pred             ccCCC
Confidence            76544

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.94  E-value=2.4e-27  Score=243.92  Aligned_cols=164  Identities=30%  Similarity=0.307  Sum_probs=138.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccC-CCCccceeeEEEecCCee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  315 (412)
                      ...++|+..++||+|+||.||++.. .+++.||||++.+..   ......+..|..++..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            3456788999999999999999995 568899999997542   23345678899999887 799999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +|||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+|||+|+.
T Consensus       418 ~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence            999999999999999854   356999999999999999999999987   99999999999999999999999999997


Q ss_pred             ccCCCcccccccccccC
Q 015138          396 FEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       396 ~~~~~~~~~~~~~~Gt~  412 (412)
                      ...+...  +....||+
T Consensus       492 ~~~~~~~--~~~~~GT~  506 (674)
T 3pfq_A          492 NIWDGVT--TKTFCGTP  506 (674)
T ss_dssp             CCCTTCC--BCCCCSCS
T ss_pred             cccCCcc--cccccCCC
Confidence            5433322  22356663

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.94  E-value=3.8e-27  Score=220.49  Aligned_cols=149  Identities=26%  Similarity=0.426  Sum_probs=133.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..++||+|+||.||++.. .+++.||||++......  ....+.+|+.++.+++||||+++++++......++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            5788899999999999999996 45899999998665432  24568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999998743   456999999999999999999999988   99999999999999999999999999987653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=2.4e-27  Score=218.32  Aligned_cols=156  Identities=34%  Similarity=0.565  Sum_probs=135.9

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +....++|+..+.||+|+||.||+|...+++.||||.+.... .....+.+|+.++.+++||||+++++++. .+..++|
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            344557888899999999999999998888899999997654 34567899999999999999999999986 4568999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            9999999999998431 1226899999999999999999999988   99999999999999999999999999998764


Q ss_pred             CC
Q 015138          399 DQ  400 (412)
Q Consensus       399 ~~  400 (412)
                      ..
T Consensus       162 ~~  163 (279)
T 1qpc_A          162 NE  163 (279)
T ss_dssp             SC
T ss_pred             cc
Confidence            43

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.94  E-value=3.3e-27  Score=230.24  Aligned_cols=151  Identities=25%  Similarity=0.408  Sum_probs=128.3

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--------ccHHHHHHHHHHHccCCCCccceeeEEEecC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--------QGEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  312 (412)
                      ..++|...+.||+|+||.||+|.. .+++.||||.+.+...        .....+.+|+.++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            457899999999999999999995 5689999999875421        11224789999999999999999999975 4


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEEec
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISD  389 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~D  389 (412)
                      +..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++   .+||+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            568999999999999998854   467999999999999999999999987   99999999999997544   599999


Q ss_pred             cCCcccccCC
Q 015138          390 FGMARLFEMD  399 (412)
Q Consensus       390 fGla~~~~~~  399 (412)
                      ||+|+.+...
T Consensus       286 FG~a~~~~~~  295 (419)
T 3i6u_A          286 FGHSKILGET  295 (419)
T ss_dssp             SSTTTSCC--
T ss_pred             cccceecCCC
Confidence            9999987543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.94  E-value=2.7e-27  Score=231.84  Aligned_cols=150  Identities=27%  Similarity=0.458  Sum_probs=131.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC-----Ce
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~  314 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||++....  ......+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            47889999999999999999995 568899999997642  33455789999999999999999999999766     56


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||++ ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 699999854   456999999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+...
T Consensus       178 ~~~~~  182 (432)
T 3n9x_A          178 TINSE  182 (432)
T ss_dssp             EC---
T ss_pred             ccccc
Confidence            87544

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=1.2e-27  Score=221.23  Aligned_cols=159  Identities=30%  Similarity=0.509  Sum_probs=140.3

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      +.+....++|+..+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++.+++||||+++++++.+....
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            344556788999999999999999999964 47889999997543 3456789999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            9999999999999998542 3456999999999999999999999988   99999999999999999999999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      ...+.
T Consensus       161 ~~~~~  165 (288)
T 3kfa_A          161 MTGDT  165 (288)
T ss_dssp             SCSSS
T ss_pred             ccCCc
Confidence            76544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.94  E-value=2.1e-27  Score=229.43  Aligned_cols=153  Identities=20%  Similarity=0.259  Sum_probs=136.0

Q ss_pred             hhhcCCCcccccccc--CCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          241 VATDNFSDANKLGQG--GFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G--~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      ...++|+..++||+|  +||.||++.. .+++.||||++....  ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            445789999999999  9999999996 478999999997653  23345688899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++|+|.+++... ....+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999998542 2356999999999999999999999988   99999999999999999999999999876


Q ss_pred             cc
Q 015138          396 FE  397 (412)
Q Consensus       396 ~~  397 (412)
                      ..
T Consensus       178 ~~  179 (389)
T 3gni_B          178 MI  179 (389)
T ss_dssp             CE
T ss_pred             ec
Confidence            53

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=226.04  Aligned_cols=153  Identities=25%  Similarity=0.378  Sum_probs=134.8

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc--------cHHHHHHHHHHHccCCCCccceeeEEEecC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  312 (412)
                      ..++|+..+.||+|+||.||++. ..+++.||||.+......        ....+.+|+.++.+++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45678999999999999999999 467889999998765321        223467899999999999999999999999


Q ss_pred             CeeeEEEecCCCC-ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          313 KERILVYEFVPNA-SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       313 ~~~~lv~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      +..++||||+.+| +|.+++..   ...+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99999854   456999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccccCCC
Q 015138          392 MARLFEMDQ  400 (412)
Q Consensus       392 la~~~~~~~  400 (412)
                      +++.+..+.
T Consensus       176 ~a~~~~~~~  184 (335)
T 3dls_A          176 SAAYLERGK  184 (335)
T ss_dssp             TCEECCTTC
T ss_pred             cceECCCCC
Confidence            999876544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=1.4e-27  Score=226.69  Aligned_cols=158  Identities=26%  Similarity=0.349  Sum_probs=133.6

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC-----CcccHHHHHHHHHHHccCCCCccceeeEEEec
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN-----SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~  311 (412)
                      .+....++|+..+.||+|+||.||++.. .+++.||+|.+.+.     .......+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3445668899999999999999999995 56889999998654     23445679999999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 015138          312 RKERILVYEFVPNASLDHFIFDPI-------------------------------------NREHMTWEKRYKIIEGIAR  354 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~  354 (412)
                      .+..++||||+++|+|.+++....                                     ....+++..+..|+.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999884100                                     0112456778889999999


Q ss_pred             HHHHhHhCCCCCceecCCCCCCEEECCCC--CeEEeccCCcccccC
Q 015138          355 GLLYLHEDSRLRIIHRDLKASNILLDSEM--NPKISDFGMARLFEM  398 (412)
Q Consensus       355 ~l~yLH~~~~~~ivHrdlk~~Nill~~~~--~~ki~DfGla~~~~~  398 (412)
                      ||.|||+.+   |+||||||+|||++.++  .+||+|||+++.+..
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            999999987   99999999999998776  899999999997643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=5.5e-27  Score=220.59  Aligned_cols=151  Identities=31%  Similarity=0.452  Sum_probs=135.3

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc------cHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+......      ....+.+|+.++.+++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            46688899999999999999995 46899999998764322      356799999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC----CeEEeccC
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfG  391 (412)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999954   456899999999999999999999987   99999999999999888    79999999


Q ss_pred             CcccccCC
Q 015138          392 MARLFEMD  399 (412)
Q Consensus       392 la~~~~~~  399 (412)
                      +++.+...
T Consensus       165 ~~~~~~~~  172 (321)
T 2a2a_A          165 LAHEIEDG  172 (321)
T ss_dssp             TCEECCTT
T ss_pred             cceecCcc
Confidence            99987654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=5.6e-27  Score=217.61  Aligned_cols=151  Identities=28%  Similarity=0.422  Sum_probs=134.4

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|...+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467888999999999999999964 57889999987543   23345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998843   356899999999999999999999987   99999999999999999999999999987654


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       168 ~  168 (294)
T 2rku_A          168 D  168 (294)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=4.7e-27  Score=222.40  Aligned_cols=150  Identities=28%  Similarity=0.424  Sum_probs=133.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|...+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            5677889999999999999995 457899999987542   234556899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       121 e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          121 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999998843   356899999999999999999999987   999999999999999999999999999977543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.94  E-value=6.8e-27  Score=220.36  Aligned_cols=142  Identities=30%  Similarity=0.426  Sum_probs=125.5

Q ss_pred             cccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEecCCCCC
Q 015138          249 ANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      .+.||+|+||.||++.. .+++.||||.+.+.   ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            47899999999999996 56899999999654   3446788999999997 9999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---CeEEeccCCcccccCC
Q 015138          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARLFEMD  399 (412)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DfGla~~~~~~  399 (412)
                      |.+++..   ...+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++   .+||+|||+++....+
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999854   456999999999999999999999988   99999999999997765   8999999999876544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=2.3e-27  Score=225.61  Aligned_cols=149  Identities=34%  Similarity=0.506  Sum_probs=131.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      +.|+..+.||+|+||.||+|.. .+++.||||++......   ....+.+|+.++.+++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4577889999999999999994 67899999999754322   2356889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+. |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 678777643  2456999999999999999999999987   99999999999999999999999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=1.2e-26  Score=216.40  Aligned_cols=151  Identities=26%  Similarity=0.458  Sum_probs=135.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .+.|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++.+++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35688899999999999999985 568999999997654 3345679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999983    356999999999999999999999988   9999999999999999999999999998875543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=3.5e-27  Score=218.12  Aligned_cols=155  Identities=26%  Similarity=0.412  Sum_probs=132.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            36788899999999999999995 568899999987654 3346678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE---CCCCCeEEeccCCcccc
Q 015138          321 FVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLF  396 (412)
Q Consensus       321 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~  396 (412)
                      |+++|+|.+++... .....+++..+..|+.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988432 12356999999999999999999999988   9999999999999   45678999999999877


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ..+.
T Consensus       178 ~~~~  181 (285)
T 3is5_A          178 KSDE  181 (285)
T ss_dssp             ----
T ss_pred             CCcc
Confidence            5443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=9.6e-28  Score=226.79  Aligned_cols=160  Identities=28%  Similarity=0.433  Sum_probs=137.7

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEeC-CC-----CEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEEE
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NG-----ETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFC  309 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~-----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~  309 (412)
                      .++...++|+..+.||+|+||.||+|... ++     ..||+|.+..... .....+.+|+.++.++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            45666788999999999999999999953 22     4799999976543 3455689999999999 899999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEE
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPI-----------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNIL  378 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nil  378 (412)
                      .+.+..++||||+++|+|.+++....           ....+++..++.++.|++.||.|||+.+   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            99999999999999999999985311           1346899999999999999999999987   999999999999


Q ss_pred             ECCCCCeEEeccCCcccccCCC
Q 015138          379 LDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       379 l~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ++.++.+||+|||+++.+..+.
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~  218 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDS  218 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCT
T ss_pred             ECCCCeEEECcccccccccccc
Confidence            9999999999999999775443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.94  E-value=5.8e-27  Score=223.92  Aligned_cols=163  Identities=28%  Similarity=0.335  Sum_probs=139.9

Q ss_pred             cccccchHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-----CCccc
Q 015138          230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-----HRNLV  303 (412)
Q Consensus       230 ~~~~~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----h~niv  303 (412)
                      +...+++.......++|+..++||+|+||.||++.. .+++.||||.+... ......+..|+.++.+++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            344566666667788999999999999999999995 57889999998643 233446778999998886     99999


Q ss_pred             eeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC--
Q 015138          304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--  381 (412)
Q Consensus       304 ~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--  381 (412)
                      ++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence            9999999999999999999 99999998542 2345999999999999999999999988   999999999999986  


Q ss_pred             -----------------------CCCeEEeccCCcccccC
Q 015138          382 -----------------------EMNPKISDFGMARLFEM  398 (412)
Q Consensus       382 -----------------------~~~~ki~DfGla~~~~~  398 (412)
                                             ++.+||+|||+|+....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~  214 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD  214 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence                                   78999999999987543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.94  E-value=3.9e-27  Score=218.18  Aligned_cols=151  Identities=34%  Similarity=0.549  Sum_probs=124.9

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ++..++|+..++||+|+||.||+|...  ..||||.+....  ......+.+|+.++++++||||+++++++ .....++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            445678999999999999999999864  469999987553  33346789999999999999999999965 4566899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence            9999999999999854  3456999999999999999999999988   9999999999999999999999999998765


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       172 ~  172 (289)
T 3og7_A          172 R  172 (289)
T ss_dssp             -
T ss_pred             c
Confidence            3

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.94  E-value=4.3e-27  Score=227.21  Aligned_cols=162  Identities=23%  Similarity=0.372  Sum_probs=133.3

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCC--CCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQ--HRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~l  317 (412)
                      ..++|+..+.||+|+||.||++...+++.||||++....  ......+.+|+.++.+++  ||||+++++++...+..+|
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            345688999999999999999998779999999987543  334567899999999996  5999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||| +.+++|.+++..   ...+++..+..|+.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+.
T Consensus       134 v~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             EEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            999 678999999854   346899999999999999999999987   99999999999995 5889999999999876


Q ss_pred             CCCccccccccccc
Q 015138          398 MDQTHSDTNRVVGT  411 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt  411 (412)
                      .+.........+||
T Consensus       206 ~~~~~~~~~~~~gt  219 (390)
T 2zmd_A          206 PDTTSVVKDSQVGA  219 (390)
T ss_dssp             --------CCSCCC
T ss_pred             CCCccccCCCCCcC
Confidence            55433222334555

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.94  E-value=4.1e-27  Score=232.25  Aligned_cols=148  Identities=28%  Similarity=0.430  Sum_probs=124.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecC------C
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------K  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~  313 (412)
                      .++|+..++||+|+||.||++.. .+++.||||++.+.  .......+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47789999999999999999984 56899999999764  333455788999999999999999999999654      3


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..+|||||++++ |.+.+.     ..+++..+..++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            579999999765 555552     34899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      +.....
T Consensus       212 ~~~~~~  217 (464)
T 3ttj_A          212 RTAGTS  217 (464)
T ss_dssp             -----C
T ss_pred             eecCCC
Confidence            977543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.94  E-value=3.8e-27  Score=222.22  Aligned_cols=153  Identities=31%  Similarity=0.544  Sum_probs=135.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-----CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEe--cCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL--ERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~--~~~~~  315 (412)
                      .++|+..+.||+|+||.||++.+     .+++.||||++..........+.+|+.++.+++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            46788899999999999999984     467899999998776666677999999999999999999999987  45568


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++..  ....+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            999999999999999853  1345899999999999999999999987   99999999999999999999999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +....
T Consensus       177 ~~~~~  181 (327)
T 3lxl_A          177 LPLDK  181 (327)
T ss_dssp             CCTTC
T ss_pred             cccCC
Confidence            75443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=5.3e-27  Score=226.61  Aligned_cols=149  Identities=29%  Similarity=0.532  Sum_probs=123.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCC-CCccceeeEEEecCC--ee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERK--ER  315 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~--~~  315 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||++...  .......+.+|+.++.++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            347889999999999999999994 67899999998654  2334556889999999997 999999999997544  68


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||++ ++|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999997 689888843    56899999999999999999999998   99999999999999999999999999997


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      +..
T Consensus       159 ~~~  161 (388)
T 3oz6_A          159 FVN  161 (388)
T ss_dssp             SSS
T ss_pred             ccc
Confidence            643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.94  E-value=1.4e-26  Score=214.02  Aligned_cols=152  Identities=33%  Similarity=0.619  Sum_probs=130.6

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc-------HHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG-------EIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+.......       ...+.+|+.++.+++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            346788899999999999999995 578999999986543322       157899999999999999999999987655


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC-----eEEe
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-----PKIS  388 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~ki~  388 (412)
                        ++||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.     +||+
T Consensus        97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence              699999999999888865  3457999999999999999999999875 34999999999999988776     9999


Q ss_pred             ccCCcccccC
Q 015138          389 DFGMARLFEM  398 (412)
Q Consensus       389 DfGla~~~~~  398 (412)
                      |||+++....
T Consensus       172 Dfg~~~~~~~  181 (287)
T 4f0f_A          172 DFGLSQQSVH  181 (287)
T ss_dssp             CCTTCBCCSS
T ss_pred             CCCccccccc
Confidence            9999986543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=6.4e-27  Score=238.49  Aligned_cols=150  Identities=31%  Similarity=0.567  Sum_probs=129.6

Q ss_pred             cCCCccc-cccccCCeeEEEEEeC---CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          244 DNFSDAN-KLGQGGFGAVYKGMLS---NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       244 ~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +++...+ +||+|+||.||+|.+.   ++..||||.+..... ....+|.+|+.++++++||||+++++++.. +..+||
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999863   456799999986533 356789999999999999999999999976 568999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..  ....+++..++.|+.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999999854  3456999999999999999999999987   99999999999999999999999999998754


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      +
T Consensus       489 ~  489 (613)
T 2ozo_A          489 D  489 (613)
T ss_dssp             -
T ss_pred             C
Confidence            4

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=6e-27  Score=222.67  Aligned_cols=152  Identities=30%  Similarity=0.470  Sum_probs=126.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc-----HHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG-----EIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      ..++|+..+.||+|+||.||++.. .+|+.||||.+.......     ...+.+|+.++.+++||||+++++++.+....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            457899999999999999999995 568999999987543221     23578999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 88888754  3346888999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      +...
T Consensus       162 ~~~~  165 (346)
T 1ua2_A          162 FGSP  165 (346)
T ss_dssp             TTSC
T ss_pred             ccCC
Confidence            7543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=5.7e-27  Score=216.37  Aligned_cols=156  Identities=29%  Similarity=0.398  Sum_probs=133.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC--cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..++|+..+.||+|+||.||++... +++.||||.+....  .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467888999999999999999964 78999999987643  33455788999999999 99999999999999999999


Q ss_pred             EEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC--------------
Q 015138          318 VYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE--------------  382 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~--------------  382 (412)
                      ||||+++++|.+++.... ....+++..+..|+.|++.||.|||+.+   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999985421 1256899999999999999999999988   9999999999999844              


Q ss_pred             -----CCeEEeccCCcccccCCC
Q 015138          383 -----MNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       383 -----~~~ki~DfGla~~~~~~~  400 (412)
                           ..+||+|||+++......
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~  188 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ  188 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC
T ss_pred             ccCCceEEEEcccccccccCCcc
Confidence                 479999999999876443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.5e-26  Score=218.83  Aligned_cols=158  Identities=25%  Similarity=0.399  Sum_probs=129.7

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHcc--CCCCccceeeEEEecC
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR--LQHRNLVRLLGFCLER  312 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~g~~~~~  312 (412)
                      +........++|+..++||+|+||.||+|... ++.||||++....   ...+..|.+++..  ++||||+++++++...
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            33444455688999999999999999999985 8999999986433   2334445555544  4999999999999887


Q ss_pred             ----CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCC-----CCCceecCCCCCCEEECCCC
Q 015138          313 ----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS-----RLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       313 ----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivHrdlk~~Nill~~~~  383 (412)
                          ...++||||+++|+|.+++.    ...+++..++.++.|++.||.|||+..     +++|+||||||+|||++.++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCCceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence                67899999999999999994    346999999999999999999999871     12399999999999999999


Q ss_pred             CeEEeccCCcccccCCC
Q 015138          384 NPKISDFGMARLFEMDQ  400 (412)
Q Consensus       384 ~~ki~DfGla~~~~~~~  400 (412)
                      .+||+|||+++.+....
T Consensus       180 ~~kl~Dfg~a~~~~~~~  196 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDT  196 (337)
T ss_dssp             CEEECCCTTCEECC---
T ss_pred             CEEEEeCCCceeecccc
Confidence            99999999998775443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.94  E-value=7.9e-27  Score=219.97  Aligned_cols=153  Identities=31%  Similarity=0.577  Sum_probs=135.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-----CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC--ee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--ER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~  315 (412)
                      .++|+..+.||+|+||.||++.+     .+++.||||++..........+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45688899999999999999984     468899999998776666678999999999999999999999987654  68


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            999999999999999854  2346999999999999999999999987   99999999999999999999999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +..+.
T Consensus       195 ~~~~~  199 (326)
T 2w1i_A          195 LPQDK  199 (326)
T ss_dssp             CCSSC
T ss_pred             ccccc
Confidence            76543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=6e-27  Score=215.72  Aligned_cols=151  Identities=29%  Similarity=0.443  Sum_probs=132.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+....   ......+.+|+.++.+++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            457788899999999999999985 557789999986532   2234568999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999999853   356899999999999999999999987   9999999999999999999999999987654


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       161 ~  161 (279)
T 3fdn_A          161 S  161 (279)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=2.2e-26  Score=215.06  Aligned_cols=154  Identities=33%  Similarity=0.556  Sum_probs=127.3

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-----ccHHHHHHHHHHHccC---CCCccceeeEEEecC
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-----QGEIEFKNEVLLLARL---QHRNLVRLLGFCLER  312 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~  312 (412)
                      ..++|+..++||+|+||.||++.. .+++.||||++.....     .....+.+|+.++.++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999994 6789999999864321     1123566777777666   499999999999876


Q ss_pred             C-----eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          313 K-----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       313 ~-----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                      .     ..++||||++ ++|.+++... ....+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 6999998653 2344999999999999999999999998   999999999999999999999


Q ss_pred             eccCCcccccCCC
Q 015138          388 SDFGMARLFEMDQ  400 (412)
Q Consensus       388 ~DfGla~~~~~~~  400 (412)
                      +|||+++.+....
T Consensus       162 ~Dfg~a~~~~~~~  174 (308)
T 3g33_A          162 ADFGLARIYSYQM  174 (308)
T ss_dssp             CSCSCTTTSTTCC
T ss_pred             eeCccccccCCCc
Confidence            9999998775433

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=9.4e-27  Score=222.61  Aligned_cols=159  Identities=27%  Similarity=0.382  Sum_probs=132.6

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcc-----------cHHHHHHHHHHHccCCCCccc
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ-----------GEIEFKNEVLLLARLQHRNLV  303 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~h~niv  303 (412)
                      ...++....++|+..+.||+|+||.||++...+++.||||++......           ....+.+|+.++.+++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            345677888999999999999999999999878999999998653221           135789999999999999999


Q ss_pred             eeeEEEec-----CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEE
Q 015138          304 RLLGFCLE-----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNIL  378 (412)
Q Consensus       304 ~l~g~~~~-----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nil  378 (412)
                      ++++++..     ....++||||++ |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            99999854     336799999998 688887754  3456999999999999999999999998   999999999999


Q ss_pred             ECCCCCeEEeccCCcccccCC
Q 015138          379 LDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       379 l~~~~~~ki~DfGla~~~~~~  399 (412)
                      ++.++.+||+|||+++.....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~  187 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTAD  187 (362)
T ss_dssp             ECTTCCEEECCTTC-------
T ss_pred             EcCCCCEEEEecCcccccccc
Confidence            999999999999999865433

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.94  E-value=3.4e-27  Score=217.69  Aligned_cols=153  Identities=22%  Similarity=0.410  Sum_probs=124.5

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCC----CCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      ...++|+..+.||+|+||.||+|....    +..||+|.+.... ......+.+|+.++++++||||+++++++. .+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            445778889999999999999999632    4569999987643 334557899999999999999999999974 5678


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence            999999999999999854  2346999999999999999999999987   99999999999999999999999999998


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      +...
T Consensus       166 ~~~~  169 (281)
T 1mp8_A          166 MEDS  169 (281)
T ss_dssp             ----
T ss_pred             cCcc
Confidence            7543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=9.5e-27  Score=220.79  Aligned_cols=149  Identities=26%  Similarity=0.418  Sum_probs=129.2

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+.+....    ..+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            346788899999999999999995 46889999999765433    34678888877 7999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-C---CeEEeccCCccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-M---NPKISDFGMARL  395 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~---~~ki~DfGla~~  395 (412)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+..+ +   .+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999854   456999999999999999999999998   9999999999998543 3   499999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +....
T Consensus       170 ~~~~~  174 (342)
T 2qr7_A          170 LRAEN  174 (342)
T ss_dssp             CBCTT
T ss_pred             CcCCC
Confidence            75443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=1.1e-26  Score=219.52  Aligned_cols=150  Identities=31%  Similarity=0.519  Sum_probs=130.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||++......  ....+.+|+.++.+++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            36788899999999999999996 45899999998655433  2445789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999988643   456999999999999999999999998   99999999999999999999999999987654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=1.3e-26  Score=217.83  Aligned_cols=148  Identities=32%  Similarity=0.536  Sum_probs=131.1

Q ss_pred             CCccccccccCCeeEEEEEeC-----CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeE
Q 015138          246 FSDANKLGQGGFGAVYKGMLS-----NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  317 (412)
                      |+..++||+|+||.||++.+.     +++.||||++..... .....+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998752     678899999976543 3455789999999999999999999999874  57899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++..    ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999843    45999999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCC
Q 015138          398 MDQ  400 (412)
Q Consensus       398 ~~~  400 (412)
                      ...
T Consensus       186 ~~~  188 (318)
T 3lxp_A          186 EGH  188 (318)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.94  E-value=1.4e-26  Score=221.76  Aligned_cols=155  Identities=22%  Similarity=0.415  Sum_probs=136.6

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--------cHHHHHHHHHHHccC-CCCccceeeEEE
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARL-QHRNLVRLLGFC  309 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~g~~  309 (412)
                      ....++|+..+.||+|+||.||++.. .+|+.||||.+......        ....+.+|+.++.++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            34457788999999999999999996 47999999998765321        134578899999999 799999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEec
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D  389 (412)
                      ......+|||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999853   356999999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccccCCC
Q 015138          390 FGMARLFEMDQ  400 (412)
Q Consensus       390 fGla~~~~~~~  400 (412)
                      ||+++.+....
T Consensus       244 fG~~~~~~~~~  254 (365)
T 2y7j_A          244 FGFSCHLEPGE  254 (365)
T ss_dssp             CTTCEECCTTC
T ss_pred             cCcccccCCCc
Confidence            99999876543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=1.6e-26  Score=230.81  Aligned_cols=152  Identities=32%  Similarity=0.494  Sum_probs=131.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-------------ccHHHHHHHHHHHccCCCCccceeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-------------QGEIEFKNEVLLLARLQHRNLVRLLGF  308 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~g~  308 (412)
                      .++|...++||+|+||.||++.. .+++.||||.+.+...             .....+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            46788899999999999999995 5678999999876431             234578999999999999999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC---Ce
Q 015138          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NP  385 (412)
Q Consensus       309 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~  385 (412)
                      +.+....++||||+++|+|.+++..   ...+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999998854   456999999999999999999999988   99999999999998876   69


Q ss_pred             EEeccCCcccccCCC
Q 015138          386 KISDFGMARLFEMDQ  400 (412)
Q Consensus       386 ki~DfGla~~~~~~~  400 (412)
                      ||+|||+++.+..+.
T Consensus       189 kl~Dfg~a~~~~~~~  203 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY  203 (504)
T ss_dssp             EECCCTTCEECCTTS
T ss_pred             EEEECCCCEEcCCCC
Confidence            999999999876543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.94  E-value=6.4e-27  Score=224.08  Aligned_cols=153  Identities=22%  Similarity=0.313  Sum_probs=127.7

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCC------CCEEEEEEeccCCcccH-----------HHHHHHHHHHccCCCCccce
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGE-----------IEFKNEVLLLARLQHRNLVR  304 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~  304 (412)
                      ..++|+..+.||+|+||.||+|....      ++.||||.+........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45688999999999999999998754      47899999876543211           12345666788889999999


Q ss_pred             eeEEEecC----CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC
Q 015138          305 LLGFCLER----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD  380 (412)
Q Consensus       305 l~g~~~~~----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~  380 (412)
                      +++++...    ...+|||||+ +++|.+++..  ....+++..++.|+.||+.||.|||+.+   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998765    4589999999 9999999854  2456999999999999999999999987   99999999999999


Q ss_pred             --CCCCeEEeccCCcccccCCC
Q 015138          381 --SEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       381 --~~~~~ki~DfGla~~~~~~~  400 (412)
                        .++.+||+|||+|+.+....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~  208 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEG  208 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGG
T ss_pred             cCCCCeEEEEECCcceecccCC
Confidence              88999999999998875443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=1.5e-26  Score=213.56  Aligned_cols=152  Identities=29%  Similarity=0.449  Sum_probs=134.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+....  ......+.+|+.++.+++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57889999999999999999995 568999999986543  333456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC---eEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfGla~~~  396 (412)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999888743   456899999999999999999999988   999999999999987665   999999999877


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ....
T Consensus       159 ~~~~  162 (284)
T 3kk8_A          159 NDSE  162 (284)
T ss_dssp             CSSC
T ss_pred             ccCc
Confidence            5443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=1.1e-26  Score=231.38  Aligned_cols=152  Identities=31%  Similarity=0.476  Sum_probs=129.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .+.|+..++||+|+||.||++.. .+++.||||.+.+..  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            35688899999999999999995 468899999987653  333557899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC---CCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DfGla~~~  396 (412)
                      ||+++|+|.+++..   ...+++..+..|+.||+.||.|||+.+   |+||||||+|||++..   +.+||+|||+|+.+
T Consensus       116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999888843   456899999999999999999999988   9999999999999764   45999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ....
T Consensus       190 ~~~~  193 (494)
T 3lij_A          190 ENQK  193 (494)
T ss_dssp             BTTB
T ss_pred             CCCc
Confidence            6543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.8e-26  Score=214.36  Aligned_cols=149  Identities=31%  Similarity=0.470  Sum_probs=129.2

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCC---EEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCee-eEE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGE---TIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER-ILV  318 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~---~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~-~lv  318 (412)
                      .|...++||+|+||.||+|.. .+++   .+|+|.+..... .....+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            345568999999999999985 3333   699999876443 3456789999999999999999999999877665 999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+.+|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999965  3466899999999999999999999998   99999999999999999999999999987644

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.94  E-value=7.3e-27  Score=220.34  Aligned_cols=152  Identities=31%  Similarity=0.617  Sum_probs=126.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCE----EEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGET----IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~----vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|+..++||+|+||.||+|.. .+++.    |++|.+... .......+.+|+.++.+++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            46788999999999999999995 44543    577777544 3445678999999999999999999999998765 78


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +|+||+++|+|.+++..  ....+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999854  2456999999999999999999999988   999999999999999999999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ....
T Consensus       168 ~~~~  171 (327)
T 3lzb_A          168 GAEE  171 (327)
T ss_dssp             ----
T ss_pred             cCcc
Confidence            5443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1e-26  Score=219.86  Aligned_cols=152  Identities=32%  Similarity=0.595  Sum_probs=128.6

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC-----CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .++|...+.||+|+||.||+|....     +..||||.+..... .....+.+|+.++.+++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4567778999999999999998532     23599999976533 34457899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999854  2456999999999999999999999988   999999999999999999999999999987


Q ss_pred             cCC
Q 015138          397 EMD  399 (412)
Q Consensus       397 ~~~  399 (412)
                      ...
T Consensus       198 ~~~  200 (333)
T 1mqb_A          198 EDD  200 (333)
T ss_dssp             ---
T ss_pred             ccc
Confidence            544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=1.6e-26  Score=213.25  Aligned_cols=150  Identities=29%  Similarity=0.472  Sum_probs=133.1

Q ss_pred             cCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCc------ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ++|+..+.||+|+||.||++... +++.||+|.+.....      .....+.+|+.++.+++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888999999999999999964 689999999875432      23567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC----CeEEeccCC
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFGM  392 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfGl  392 (412)
                      +||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999843   456899999999999999999999987   99999999999999877    899999999


Q ss_pred             cccccCC
Q 015138          393 ARLFEMD  399 (412)
Q Consensus       393 a~~~~~~  399 (412)
                      ++.+...
T Consensus       159 ~~~~~~~  165 (283)
T 3bhy_A          159 AHKIEAG  165 (283)
T ss_dssp             CEECC--
T ss_pred             ceeccCC
Confidence            9876543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=4.8e-27  Score=221.81  Aligned_cols=153  Identities=29%  Similarity=0.498  Sum_probs=127.6

Q ss_pred             HhhhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ....++|+..++||+|+||.||++. ..+++.||||++......  ....+.+|+.++++++||||+++++++.+....+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            3445789999999999999999999 457889999999755432  2345789999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE-----CCCCCeEEeccC
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL-----DSEMNPKISDFG  391 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill-----~~~~~~ki~DfG  391 (412)
                      +||||++ |+|.+++..   ...+++..+..|+.|++.||.|||+.+   |+||||||+|||+     +.++.+||+|||
T Consensus       110 lv~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            9999998 599998854   346999999999999999999999988   9999999999999     445569999999


Q ss_pred             CcccccCC
Q 015138          392 MARLFEMD  399 (412)
Q Consensus       392 la~~~~~~  399 (412)
                      +++.+...
T Consensus       183 ~a~~~~~~  190 (329)
T 3gbz_A          183 LARAFGIP  190 (329)
T ss_dssp             HHHHHC--
T ss_pred             CccccCCc
Confidence            99877533

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=1.2e-26  Score=220.54  Aligned_cols=152  Identities=24%  Similarity=0.378  Sum_probs=135.0

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCccc-----------------HHHHHHHHHHHccCCCCcccee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-----------------EIEFKNEVLLLARLQHRNLVRL  305 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l  305 (412)
                      .++|+..+.||+|+||.||++.. +++.||||.+.......                 ...+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999999999 89999999986542211                 1679999999999999999999


Q ss_pred             eEEEecCCeeeEEEecCCCCChhhh------ccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCceecCCCCCCEE
Q 015138          306 LGFCLERKERILVYEFVPNASLDHF------IFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNIL  378 (412)
Q Consensus       306 ~g~~~~~~~~~lv~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nil  378 (412)
                      ++++.+.+..++||||+++|+|.++      +.. .....+++..+..++.|++.||.|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 225679999999999999999999998 77   999999999999


Q ss_pred             ECCCCCeEEeccCCcccccCC
Q 015138          379 LDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       379 l~~~~~~ki~DfGla~~~~~~  399 (412)
                      ++.++.+||+|||+++.+...
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~  205 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK  205 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT
T ss_pred             EcCCCcEEEeccccccccccc
Confidence            999999999999999876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=1.2e-26  Score=217.11  Aligned_cols=151  Identities=21%  Similarity=0.284  Sum_probs=130.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+......   ....+.+|+.++.+++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            46788999999999999999995 46889999999765332   245789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999854   356999999999999999999999987   99999999999999999999999999987654


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       187 ~  187 (309)
T 2h34_A          187 E  187 (309)
T ss_dssp             -
T ss_pred             c
Confidence            3

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=1e-26  Score=218.07  Aligned_cols=156  Identities=29%  Similarity=0.405  Sum_probs=135.2

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEe----cCC
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL----ERK  313 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~----~~~  313 (412)
                      +....++|+..+.||+|+||.||++.. .+++.||||++..........+.+|+.++.+++||||+++++++.    ...
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            334567899999999999999999995 678999999997766666778999999999999999999999987    345


Q ss_pred             eeeEEEecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          314 ERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCc
Confidence            789999999999999988531 12456999999999999999999999987   99999999999999999999999999


Q ss_pred             ccccc
Q 015138          393 ARLFE  397 (412)
Q Consensus       393 a~~~~  397 (412)
                      ++...
T Consensus       181 ~~~~~  185 (317)
T 2buj_A          181 MNQAC  185 (317)
T ss_dssp             CEESC
T ss_pred             chhcc
Confidence            87653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=6e-27  Score=218.06  Aligned_cols=156  Identities=24%  Similarity=0.394  Sum_probs=121.2

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ....++|+..+.||+|+||.||++.. .+++.||||.+.... .....++.+|+.++.+++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            45568899999999999999999994 578999999886543 2334568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccC-----CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          318 VYEFVPNASLDHFIFD-----PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ||||+++++|.+++..     ......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999852     113456999999999999999999999987   99999999999999999999999999


Q ss_pred             cccccC
Q 015138          393 ARLFEM  398 (412)
Q Consensus       393 a~~~~~  398 (412)
                      ++.+..
T Consensus       168 ~~~~~~  173 (303)
T 2vwi_A          168 SAFLAT  173 (303)
T ss_dssp             HHHCC-
T ss_pred             hheecc
Confidence            987654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.94  E-value=1.6e-26  Score=214.91  Aligned_cols=152  Identities=29%  Similarity=0.490  Sum_probs=130.4

Q ss_pred             hcCCCccccccccCCeeEEEEEeCC----CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEec-CCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~  316 (412)
                      ..+|+..+.||+|+||.||+|...+    ...+|+|.+..... .....+.+|+.++++++||||+++++++.. ....+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3567788999999999999999532    22589999876443 344678999999999999999999998654 55789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999965  3456899999999999999999999988   999999999999999999999999999876


Q ss_pred             cCC
Q 015138          397 EMD  399 (412)
Q Consensus       397 ~~~  399 (412)
                      ...
T Consensus       179 ~~~  181 (298)
T 3f66_A          179 YDK  181 (298)
T ss_dssp             SCG
T ss_pred             ccc
Confidence            543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.94  E-value=9.2e-27  Score=219.57  Aligned_cols=156  Identities=33%  Similarity=0.552  Sum_probs=131.1

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      ...++|+..+.||+|+||.||+|..      .+++.||||.+... .......+.+|+.++.+++||||+++++++.+..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            3457899999999999999999984      34678999999754 3344557899999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC---CCCeE
Q 015138          314 ERILVYEFVPNASLDHFIFDPI----NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPK  386 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~k  386 (412)
                      ..++||||+++++|.+++....    ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999986432    1245899999999999999999999987   999999999999994   44699


Q ss_pred             EeccCCcccccCC
Q 015138          387 ISDFGMARLFEMD  399 (412)
Q Consensus       387 i~DfGla~~~~~~  399 (412)
                      |+|||+++.+...
T Consensus       184 l~Dfg~~~~~~~~  196 (327)
T 2yfx_A          184 IGDFGMARDIYRA  196 (327)
T ss_dssp             ECCCHHHHHHHC-
T ss_pred             ECccccccccccc
Confidence            9999999866443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=6.7e-27  Score=223.51  Aligned_cols=150  Identities=27%  Similarity=0.372  Sum_probs=134.4

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            356789999999999999999996 468999999997653 333557899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       111 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          111 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             ECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999854   34689999999999999999999985 6   9999999999999999999999999998653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.3e-26  Score=214.33  Aligned_cols=152  Identities=32%  Similarity=0.577  Sum_probs=132.0

Q ss_pred             hcCCCccc-cccccCCeeEEEEEeC---CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDAN-KLGQGGFGAVYKGMLS---NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|...+ .||+|+||.||+|...   ++..||||.+.... ......+.+|+.++.+++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            45565565 8999999999999853   57789999997753 33456789999999999999999999999 5566899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999854  3456999999999999999999999988   9999999999999999999999999999875


Q ss_pred             CCC
Q 015138          398 MDQ  400 (412)
Q Consensus       398 ~~~  400 (412)
                      ...
T Consensus       162 ~~~  164 (287)
T 1u59_A          162 ADD  164 (287)
T ss_dssp             TCS
T ss_pred             cCc
Confidence            443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.94  E-value=1e-26  Score=217.44  Aligned_cols=151  Identities=29%  Similarity=0.425  Sum_probs=125.7

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .++|+..+.||+|+||.||++... ++.||||.+...  .....|.+|+.++.+++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            356788899999999999999985 788999998643  334578999999999999999999998874  479999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC-eEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-~ki~DfGla~~~~~  398 (412)
                      ++|+|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||+++.+..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999976444446889999999999999999999943334999999999999998886 79999999986643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.94  E-value=2.3e-26  Score=214.44  Aligned_cols=151  Identities=27%  Similarity=0.431  Sum_probs=128.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC----cccHHHHHHHHHHHccCCCCccceeeEEEe--cCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQHRNLVRLLGFCL--ERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~--~~~~~  315 (412)
                      .++|...+.||+|+||.||++.. .+++.||+|.+....    ......+.+|+.++.+++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36799999999999999999995 568899999987542    234567899999999999999999999984  45578


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||++++ |.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999887 66665432 3456999999999999999999999988   99999999999999999999999999987


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      +..
T Consensus       159 ~~~  161 (305)
T 2wtk_C          159 LHP  161 (305)
T ss_dssp             CCT
T ss_pred             cCc
Confidence            754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=1.2e-26  Score=230.56  Aligned_cols=152  Identities=33%  Similarity=0.516  Sum_probs=135.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||++.+..   ......+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46788899999999999999995 478999999986543   33466799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE---CCCCCeEEeccCCccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARL  395 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~  395 (412)
                      |||+.+|+|.+++..   ...+++..+..|+.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+|+.
T Consensus       105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999998854   456999999999999999999999998   9999999999999   5678999999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +....
T Consensus       179 ~~~~~  183 (484)
T 3nyv_A          179 FEASK  183 (484)
T ss_dssp             BCCCC
T ss_pred             ccccc
Confidence            76544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.94  E-value=9.1e-27  Score=216.88  Aligned_cols=150  Identities=28%  Similarity=0.467  Sum_probs=132.1

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ..++|+..+.||+|+||.||++... +++.||+|.+..........+.+|+.++.+++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3467888999999999999999964 588999999987766677789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            9999999998853  2356999999999999999999999987   999999999999999999999999998643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.94  E-value=4e-27  Score=221.82  Aligned_cols=149  Identities=30%  Similarity=0.520  Sum_probs=127.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccH-HHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~-~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|...+.||+|+||.||++.. .+++.||||++........ ..+.+|+.++.+++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5688899999999999999996 4789999999865432221 1356799999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++ |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            97 588888754  2456899999999999999999999988   99999999999999999999999999987653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.1e-26  Score=223.02  Aligned_cols=150  Identities=29%  Similarity=0.513  Sum_probs=122.2

Q ss_pred             CCCccccccccCCeeEEEEEeC--CC--CEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEec-CCeeeEE
Q 015138          245 NFSDANKLGQGGFGAVYKGMLS--NG--ETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKERILV  318 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~--~~--~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv  318 (412)
                      .|...+.||+|+||.||+|...  ++  ..||||.+..... .....|.+|+.++++++||||+++++++.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999953  22  3589999875433 345679999999999999999999999765 4578999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999964  3456899999999999999999999988   99999999999999999999999999997654


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       245 ~  245 (373)
T 3c1x_A          245 K  245 (373)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=9.6e-27  Score=223.02  Aligned_cols=148  Identities=28%  Similarity=0.472  Sum_probs=124.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  313 (412)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46788899999999999999995 578999999996542  233456889999999999999999999997653      


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++||||+ +++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899999843    56899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       176 ~~~~~  180 (367)
T 1cm8_A          176 RQADS  180 (367)
T ss_dssp             EECCS
T ss_pred             ccccc
Confidence            97654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=1.8e-26  Score=215.82  Aligned_cols=153  Identities=24%  Similarity=0.430  Sum_probs=126.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||++.. .+++.||||++....   ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5688899999999999999995 678999999997532   333556899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++|.+++... .....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999988431 12456899999999999999999999988   99999999999999999999999999987654


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       189 ~  189 (310)
T 2wqm_A          189 K  189 (310)
T ss_dssp             -
T ss_pred             C
Confidence            3

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=2.5e-26  Score=213.46  Aligned_cols=153  Identities=25%  Similarity=0.382  Sum_probs=135.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---------ccHHHHHHHHHHHccCC-CCccceeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---------QGEIEFKNEVLLLARLQ-HRNLVRLLGFCL  310 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~g~~~  310 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+.....         .....+.+|+.++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            347888999999999999999996 4688999999875431         12345789999999995 999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      .....++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999854   356899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccccCCC
Q 015138          391 GMARLFEMDQ  400 (412)
Q Consensus       391 Gla~~~~~~~  400 (412)
                      |+++.+....
T Consensus       169 g~~~~~~~~~  178 (298)
T 1phk_A          169 GFSCQLDPGE  178 (298)
T ss_dssp             TTCEECCTTC
T ss_pred             cchhhcCCCc
Confidence            9998875443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=1.9e-26  Score=211.94  Aligned_cols=151  Identities=27%  Similarity=0.463  Sum_probs=134.8

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|...+.||+|+||.||++... +++.||||.+....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467888999999999999999964 78999999986542   23355789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999854   346899999999999999999999988   99999999999999999999999999987754


Q ss_pred             C
Q 015138          399 D  399 (412)
Q Consensus       399 ~  399 (412)
                      .
T Consensus       164 ~  164 (276)
T 2h6d_A          164 G  164 (276)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.94  E-value=1.1e-26  Score=219.83  Aligned_cols=150  Identities=32%  Similarity=0.549  Sum_probs=123.2

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHH--HHHHHccCCCCccceeeEEEec-----CCe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARLQHRNLVRLLGFCLE-----RKE  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~g~~~~-----~~~  314 (412)
                      ..++|+..+.||+|+||.||+|.. +++.||||++.....   ..+..  |+..+..++||||+++++.+..     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            457888999999999999999987 589999999865432   23344  4444556899999999986542     235


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCC------CCCceecCCCCCCEEECCCCCeEEe
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS------RLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                      .++||||+++|+|.+++..    ...++..+..|+.|++.||.|||+..      +++|+||||||+|||++.++.+||+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            6899999999999999943    45689999999999999999999881      1139999999999999999999999


Q ss_pred             ccCCcccccCC
Q 015138          389 DFGMARLFEMD  399 (412)
Q Consensus       389 DfGla~~~~~~  399 (412)
                      |||+++.+...
T Consensus       163 DFG~a~~~~~~  173 (336)
T 3g2f_A          163 DFGLSMRLTGN  173 (336)
T ss_dssp             CCTTCEECSSS
T ss_pred             eccceeecccc
Confidence            99999987543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.94  E-value=1.8e-26  Score=223.52  Aligned_cols=146  Identities=29%  Similarity=0.357  Sum_probs=122.9

Q ss_pred             cCCCcc-ccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHc-cCCCCccceeeEEEec----CCeee
Q 015138          244 DNFSDA-NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLA-RLQHRNLVRLLGFCLE----RKERI  316 (412)
Q Consensus       244 ~~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~g~~~~----~~~~~  316 (412)
                      ++|... +.||+|+||.||++.. .+++.||||++...     ..+.+|+.++. ..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            455554 6899999999999995 56899999998632     35677888774 4589999999999875    56789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC---CCCeEEeccCCc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMA  393 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla  393 (412)
                      |||||+++|+|.+++... ....+++..+..|+.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999652 2346999999999999999999999987   999999999999998   789999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       212 ~~~~~  216 (400)
T 1nxk_A          212 KETTS  216 (400)
T ss_dssp             EECC-
T ss_pred             cccCC
Confidence            97654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.94  E-value=3.5e-26  Score=212.40  Aligned_cols=151  Identities=19%  Similarity=0.339  Sum_probs=132.6

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+......  ..+.+|+.++.++ +|+|++++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            346788999999999999999994 67899999998654332  2478899999999 7999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC-----eEEeccCCcc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-----PKISDFGMAR  394 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~ki~DfGla~  394 (412)
                      ||+ +++|.+++...  ...+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.     +||+|||+++
T Consensus        86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 99999999542  346999999999999999999999987   999999999999988776     9999999999


Q ss_pred             cccCCC
Q 015138          395 LFEMDQ  400 (412)
Q Consensus       395 ~~~~~~  400 (412)
                      .+....
T Consensus       160 ~~~~~~  165 (298)
T 1csn_A          160 FYRDPV  165 (298)
T ss_dssp             ESBCTT
T ss_pred             cccccc
Confidence            876543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.94  E-value=1.3e-26  Score=213.66  Aligned_cols=150  Identities=32%  Similarity=0.523  Sum_probs=131.4

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEec----------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----------  311 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----------  311 (412)
                      .++|+..+.||+|+||.||++... +++.||+|.+.....    .+.+|+.++.+++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            466888999999999999999964 789999999976543    46789999999999999999998864          


Q ss_pred             ------CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCe
Q 015138          312 ------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (412)
Q Consensus       312 ------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~  385 (412)
                            ....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                  34579999999999999998542 2356999999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCcccccCCC
Q 015138          386 KISDFGMARLFEMDQ  400 (412)
Q Consensus       386 ki~DfGla~~~~~~~  400 (412)
                      ||+|||+++.+....
T Consensus       162 kl~Dfg~~~~~~~~~  176 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG  176 (284)
T ss_dssp             EECCCTTCEESSCCS
T ss_pred             EECcchhheeccccc
Confidence            999999999876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=1.6e-26  Score=214.95  Aligned_cols=149  Identities=32%  Similarity=0.532  Sum_probs=131.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEec----------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----------  311 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----------  311 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+... ......+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46788899999999999999995 57899999998643 2334578999999999999999999998865          


Q ss_pred             ---CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEe
Q 015138          312 ---RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       312 ---~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                         ....++||||+++|+|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3567899999999999999954  2345788999999999999999999987   9999999999999999999999


Q ss_pred             ccCCccccc
Q 015138          389 DFGMARLFE  397 (412)
Q Consensus       389 DfGla~~~~  397 (412)
                      |||+++.+.
T Consensus       159 dfg~~~~~~  167 (303)
T 1zy4_A          159 DFGLAKNVH  167 (303)
T ss_dssp             CCCCCSCTT
T ss_pred             eCcchhhcc
Confidence            999998765

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=1.5e-26  Score=229.92  Aligned_cols=152  Identities=30%  Similarity=0.488  Sum_probs=133.8

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      .++|+..++||+|+||.||++.. .+++.||||++.+..  ......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            46788899999999999999995 478999999986532  334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC---CCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD---SEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DfGla~~~  396 (412)
                      ||+++|+|.+++..   ...+++..+..|+.|++.||.|||+.+   |+||||||+|||++   .++.+||+|||+|+.+
T Consensus       101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999988844   356999999999999999999999988   99999999999995   4567999999999977


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ....
T Consensus       175 ~~~~  178 (486)
T 3mwu_A          175 QQNT  178 (486)
T ss_dssp             CCC-
T ss_pred             CCCC
Confidence            5543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.94  E-value=3.5e-26  Score=216.71  Aligned_cols=154  Identities=28%  Similarity=0.397  Sum_probs=133.5

Q ss_pred             hHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHcc--CCCCccceeeEEEecCC
Q 015138          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR--LQHRNLVRLLGFCLERK  313 (412)
Q Consensus       236 ~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~g~~~~~~  313 (412)
                      ........++|...+.||+|+||.||+|.. +++.||||.+...   ....+.+|.+++..  ++||||+++++++....
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            333445567899999999999999999998 4899999998643   33467788888776  79999999999998876


Q ss_pred             ----eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhH--------hCCCCCceecCCCCCCEEECC
Q 015138          314 ----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH--------EDSRLRIIHRDLKASNILLDS  381 (412)
Q Consensus       314 ----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivHrdlk~~Nill~~  381 (412)
                          ..++||||+++|+|.+++..    ..+++..++.++.|++.||.|||        +.+   |+||||||+|||++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK  182 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred             CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence                78999999999999999943    46999999999999999999999        655   999999999999999


Q ss_pred             CCCeEEeccCCcccccCCC
Q 015138          382 EMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       382 ~~~~ki~DfGla~~~~~~~  400 (412)
                      ++++||+|||+++......
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~  201 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSAT  201 (342)
T ss_dssp             TSCEEECCCTTCEEEETTT
T ss_pred             CCCEEEEECCCceeccccc
Confidence            9999999999998876544

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=6.4e-27  Score=235.86  Aligned_cols=150  Identities=21%  Similarity=0.264  Sum_probs=115.8

Q ss_pred             cccccCCeeEEEEE-eCCCCEEEEEEeccCC----------cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEE
Q 015138          251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNS----------KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       251 ~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ..+.|++|.+..+. ...|+.++||.+.+..          .....+|.+|+++|.++ .|+||+++++++.++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45566666666554 4458899999987542          12345699999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||++|++|.++|.+   ...++..   +|+.||+.||.|||+++   ||||||||+||||+.++++||+|||+|+.+..
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999965   3456654   58999999999999998   99999999999999999999999999998765


Q ss_pred             CCccccccccccc
Q 015138          399 DQTHSDTNRVVGT  411 (412)
Q Consensus       399 ~~~~~~~~~~~Gt  411 (412)
                      +.+..  ...+||
T Consensus       392 ~~~~~--~t~vGT  402 (569)
T 4azs_A          392 DCSWP--TNLVQS  402 (569)
T ss_dssp             --CCS--HHHHHH
T ss_pred             CCccc--cCceec
Confidence            54332  235666

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=3.1e-26  Score=214.84  Aligned_cols=148  Identities=26%  Similarity=0.488  Sum_probs=125.1

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEe-----------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL-----------  310 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~-----------  310 (412)
                      .++|+..+.||+|+||.||++... +++.||||++..........+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467888999999999999999964 58999999998776666678999999999999999999999874           


Q ss_pred             ---cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC-CCCCeE
Q 015138          311 ---ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPK  386 (412)
Q Consensus       311 ---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~k  386 (412)
                         +....++||||++ |+|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++ .++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467899999998 69999983    356899999999999999999999988   99999999999997 567999


Q ss_pred             EeccCCcccccC
Q 015138          387 ISDFGMARLFEM  398 (412)
Q Consensus       387 i~DfGla~~~~~  398 (412)
                      |+|||+++....
T Consensus       162 l~Dfg~~~~~~~  173 (320)
T 2i6l_A          162 IGDFGLARIMDP  173 (320)
T ss_dssp             ECCCTTCBCC--
T ss_pred             EccCccccccCC
Confidence            999999997754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.94  E-value=1.7e-26  Score=213.33  Aligned_cols=151  Identities=30%  Similarity=0.478  Sum_probs=133.8

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+....   ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            346788899999999999999996 457889999986532   2234578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           92 MLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            9999999999999854   346899999999999999999999987   9999999999999999999999999997664


Q ss_pred             C
Q 015138          398 M  398 (412)
Q Consensus       398 ~  398 (412)
                      .
T Consensus       166 ~  166 (284)
T 2vgo_A          166 S  166 (284)
T ss_dssp             S
T ss_pred             c
Confidence            3

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.94  E-value=3.9e-26  Score=208.96  Aligned_cols=153  Identities=23%  Similarity=0.363  Sum_probs=133.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC--CeeeE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  317 (412)
                      ..++|+..+.||+|+||.||+|... ++.||||.+....  ......+.+|+.++.+++||||+++++++.+.  ...++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            3467888999999999999999985 8899999997653  33455799999999999999999999999887  77899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+||.|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             eecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999999652 2336999999999999999999999864 459999999999999999999999999876543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.94  E-value=3.6e-26  Score=217.68  Aligned_cols=150  Identities=29%  Similarity=0.577  Sum_probs=129.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecC-------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLER-------  312 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-------  312 (412)
                      .++|+..++||+|+||.||++.. .+++.||||++......  ....+.+|+.++..++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36788899999999999999996 67899999998654322  245678999999999999999999999873       


Q ss_pred             -CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          313 -KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       313 -~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                       +..++||||+++ +|.+.+..  ....+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             468999999985 67666644  2356999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccccC
Q 015138          392 MARLFEM  398 (412)
Q Consensus       392 la~~~~~  398 (412)
                      +|+.+..
T Consensus       170 ~a~~~~~  176 (351)
T 3mi9_A          170 LARAFSL  176 (351)
T ss_dssp             TCEECCC
T ss_pred             hcccccc
Confidence            9997753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=1.2e-26  Score=218.50  Aligned_cols=160  Identities=30%  Similarity=0.492  Sum_probs=135.9

Q ss_pred             cchHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEec
Q 015138          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (412)
Q Consensus       234 ~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  311 (412)
                      +++..+....++|+..+.||+|+||.||+|.. .+++.||||.+..... ....+.+|+.++.++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            44555666778999999999999999999996 5789999999875433 345788999999999 89999999999987


Q ss_pred             ------CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCe
Q 015138          312 ------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (412)
Q Consensus       312 ------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~  385 (412)
                            ....++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  46789999999999999998542 2356899999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCcccccC
Q 015138          386 KISDFGMARLFEM  398 (412)
Q Consensus       386 ki~DfGla~~~~~  398 (412)
                      ||+|||+++.+..
T Consensus       169 kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          169 KLVDFGVSAQLDR  181 (326)
T ss_dssp             EECCCTTTC----
T ss_pred             EEeeCcCceecCc
Confidence            9999999987653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.93  E-value=3.1e-26  Score=214.58  Aligned_cols=151  Identities=29%  Similarity=0.494  Sum_probs=129.7

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ..++|+..+.||+|+||.||+|.. .+|+.||||.+....  ....+.+|+.++.+++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            456788899999999999999996 458999999997643  33568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      |+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+...
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999842  2456899999999999999999999988   999999999999999999999999999877544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.93  E-value=7.6e-27  Score=220.59  Aligned_cols=160  Identities=28%  Similarity=0.403  Sum_probs=137.1

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEe-----
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCL-----  310 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~-----  310 (412)
                      .+.....+|+..++||+|+||.||++.. .+++.||||++..........+.+|+.++.++. ||||+++++++.     
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            3445567889999999999999999995 578999999997776666677899999999996 999999999984     


Q ss_pred             ---cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEE
Q 015138          311 ---ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (412)
Q Consensus       311 ---~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki  387 (412)
                         .....++||||++ |+|.+++........+++..++.|+.|++.||.|||+.+ ++|+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence               3345789999996 799888854334567999999999999999999999874 35999999999999999999999


Q ss_pred             eccCCcccccCC
Q 015138          388 SDFGMARLFEMD  399 (412)
Q Consensus       388 ~DfGla~~~~~~  399 (412)
                      +|||+++.+...
T Consensus       180 ~Dfg~~~~~~~~  191 (337)
T 3ll6_A          180 CDFGSATTISHY  191 (337)
T ss_dssp             CCCTTCBCCSSC
T ss_pred             ecCccceecccc
Confidence            999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.93  E-value=2e-26  Score=214.89  Aligned_cols=149  Identities=28%  Similarity=0.453  Sum_probs=131.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|...+.||+|+||.||++.. .+++.||+|.+..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            45788899999999999999995 47899999999876555556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE---CCCCCeEEeccCCccccc
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFE  397 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~  397 (412)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999998843   356899999999999999999999987   9999999999999   788899999999998654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.93  E-value=3.2e-27  Score=227.24  Aligned_cols=152  Identities=18%  Similarity=0.213  Sum_probs=124.7

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC---CcccHHHHHHHH---HHHccCCCCccceee-------E
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEV---LLLARLQHRNLVRLL-------G  307 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------g  307 (412)
                      ..++|+..+.||+|+||.||+|.. .+|+.||||++...   .......+.+|+   .++++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            356788899999999999999995 67999999999743   333456789999   556666899999998       6


Q ss_pred             EEecCC-----------------eeeEEEecCCCCChhhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCC
Q 015138          308 FCLERK-----------------ERILVYEFVPNASLDHFIFDP----INREHMTWEKRYKIIEGIARGLLYLHEDSRLR  366 (412)
Q Consensus       308 ~~~~~~-----------------~~~lv~Ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~  366 (412)
                      ++...+                 ..+|||||+ +|+|.+++...    .....+++..++.|+.||+.||.|||+.+   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            655443                 278999999 68999998531    11223556888899999999999999998   


Q ss_pred             ceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          367 IIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       367 ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |+||||||+||||+.++.+||+|||+|+...
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~  257 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  257 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence            9999999999999999999999999998643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.93  E-value=1.4e-26  Score=236.72  Aligned_cols=144  Identities=31%  Similarity=0.556  Sum_probs=126.2

Q ss_pred             ccccccCCeeEEEEEe---CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGML---SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~---~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ++||+|+||.||+|.+   ..++.||||+++....  ....++.+|+.++.+++||||+++++++.. +..+|||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999975   3467899999976433  335689999999999999999999999864 558899999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+|.+++..   ...+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+..+.
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            999999953   456999999999999999999999988   9999999999999999999999999999876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.93  E-value=4.4e-26  Score=215.03  Aligned_cols=146  Identities=27%  Similarity=0.467  Sum_probs=130.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEec--CCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLE--RKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~--~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+....   ...+.+|+.++.+++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36788899999999999999984 678999999987533   457899999999997 9999999999987  5678999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~  397 (412)
                      |||+++++|.+++.      .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++ .+||+|||+++.+.
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999883      3889999999999999999999988   99999999999999776 89999999999776


Q ss_pred             CCC
Q 015138          398 MDQ  400 (412)
Q Consensus       398 ~~~  400 (412)
                      ...
T Consensus       183 ~~~  185 (330)
T 3nsz_A          183 PGQ  185 (330)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.93  E-value=3.4e-26  Score=215.72  Aligned_cols=151  Identities=31%  Similarity=0.553  Sum_probs=130.3

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCE--EEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGET--IAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~--vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..+.||+|+||.||++.. .++..  ++||.+.... ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            36788899999999999999995 45654  4999887542 33345689999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          318 VYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      ||||+++|+|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999996532             2346999999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCcccc
Q 015138          385 PKISDFGMARLF  396 (412)
Q Consensus       385 ~ki~DfGla~~~  396 (412)
                      +||+|||+++..
T Consensus       181 ~kL~Dfg~~~~~  192 (327)
T 1fvr_A          181 AKIADFGLSRGQ  192 (327)
T ss_dssp             EEECCTTCEESS
T ss_pred             EEEcccCcCccc
Confidence            999999999854

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.93  E-value=1.8e-26  Score=213.87  Aligned_cols=155  Identities=29%  Similarity=0.534  Sum_probs=131.4

Q ss_pred             HHhhhcCCCccc-cccccCCeeEEEEEe---CCCCEEEEEEeccCCcc--cHHHHHHHHHHHccCCCCccceeeEEEecC
Q 015138          239 IRVATDNFSDAN-KLGQGGFGAVYKGML---SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       239 l~~~~~~~~~~~-~lg~G~fg~V~~~~~---~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  312 (412)
                      +....++|...+ .||+|+||.||+|..   .+++.||||.+......  ...++.+|+.+++.++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            334456777777 999999999999964   34678999999765332  245799999999999999999999999 56


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      +..++||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence            678999999999999999954   356999999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCC
Q 015138          393 ARLFEMDQ  400 (412)
Q Consensus       393 a~~~~~~~  400 (412)
                      ++.+....
T Consensus       164 ~~~~~~~~  171 (291)
T 1xbb_A          164 SKALRADE  171 (291)
T ss_dssp             CEECCTTC
T ss_pred             ceeeccCC
Confidence            99875543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.93  E-value=2.1e-26  Score=220.61  Aligned_cols=148  Identities=30%  Similarity=0.481  Sum_probs=115.9

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC------C
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------K  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~  313 (412)
                      .++|+..+.||+|+||.||+|. ..+|+.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4778899999999999999999 4678999999997542  23455788999999999999999999998754      5


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++|+||+ +++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 789988873    356999999999999999999999988   999999999999999999999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       180 ~~~~~  184 (367)
T 2fst_X          180 RHTAD  184 (367)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=4.7e-26  Score=210.65  Aligned_cols=143  Identities=11%  Similarity=0.052  Sum_probs=126.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+......   ....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            5688889999999999999996 45899999999765432   2357899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ||+++++|.+++..    . ....+...|+.|++.||.|||+++   |+||||||+|||++.++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence            99999999999832    2 355678899999999999999998   9999999999999999999999887653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.93  E-value=4.3e-26  Score=215.05  Aligned_cols=157  Identities=27%  Similarity=0.403  Sum_probs=133.7

Q ss_pred             HHhhhcCCCcc-ccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccC-CCCccceeeEEEecCC
Q 015138          239 IRVATDNFSDA-NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (412)
Q Consensus       239 l~~~~~~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~  313 (412)
                      .....+.|... +.||+|+||.||++.. .+++.||||.+....  ......+.+|+.++.++ +||||+++++++.+..
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            34445566666 8899999999999995 468999999987643  33466789999999999 4699999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC---CCCeEEecc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDF  390 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~Df  390 (412)
                      ..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence            999999999999999998542 3467999999999999999999999988   999999999999998   789999999


Q ss_pred             CCcccccCC
Q 015138          391 GMARLFEMD  399 (412)
Q Consensus       391 Gla~~~~~~  399 (412)
                      |+++.+...
T Consensus       179 g~a~~~~~~  187 (327)
T 3lm5_A          179 GMSRKIGHA  187 (327)
T ss_dssp             GGCEEC---
T ss_pred             ccccccCCc
Confidence            999987544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.93  E-value=4.1e-26  Score=214.62  Aligned_cols=150  Identities=25%  Similarity=0.418  Sum_probs=127.8

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--------ccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      .++|...+.||+|+||.||++.. .+++.||||.+.....        .....+.+|+.++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            46788899999999999999995 5678999999865421        12234889999999999999999999987655


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC---eEEecc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDF  390 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~Df  390 (412)
                       .++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence             8999999999999998853   457999999999999999999999987   999999999999987664   999999


Q ss_pred             CCcccccCC
Q 015138          391 GMARLFEMD  399 (412)
Q Consensus       391 Gla~~~~~~  399 (412)
                      |+++.+...
T Consensus       162 g~~~~~~~~  170 (322)
T 2ycf_A          162 GHSKILGET  170 (322)
T ss_dssp             TTCEECCCC
T ss_pred             ccceecccc
Confidence            999877543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.93  E-value=6.5e-26  Score=209.98  Aligned_cols=152  Identities=30%  Similarity=0.426  Sum_probs=130.2

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec----CCeee
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERI  316 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~  316 (412)
                      ..|...+.||+|+||.||+|.. .++..||+|.+....  ......+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3467778999999999999995 567889999987543  3345678999999999999999999999865    35689


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC-CCCCeEEeccCCccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARL  395 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~  395 (412)
                      +||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999843   356899999999999999999999875 3599999999999998 789999999999986


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      ....
T Consensus       182 ~~~~  185 (290)
T 1t4h_A          182 KRAS  185 (290)
T ss_dssp             CCTT
T ss_pred             cccc
Confidence            5443

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.93  E-value=5.3e-26  Score=211.37  Aligned_cols=150  Identities=31%  Similarity=0.541  Sum_probs=129.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..+.||+|+||.||++.. .+++.||||.+.....  .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            5788899999999999999996 4789999999865432  223568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |++ ++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  155 (299)
T 2r3i_A           83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  155 (299)
T ss_dssp             CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence            997 6999988542 2346899999999999999999999987   99999999999999999999999999987653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=3.4e-26  Score=219.02  Aligned_cols=149  Identities=27%  Similarity=0.476  Sum_probs=130.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecC-----Cee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~  315 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||++..... .....+.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            46788999999999999999995 5688999999975433 3345789999999999999999999998755     368


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||++ |+|.+++.    ...+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 58988884    346999999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      ....
T Consensus       178 ~~~~  181 (364)
T 3qyz_A          178 ADPD  181 (364)
T ss_dssp             CCGG
T ss_pred             cCCC
Confidence            7544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.93  E-value=2.4e-26  Score=211.92  Aligned_cols=153  Identities=28%  Similarity=0.497  Sum_probs=130.6

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCC----CCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      ...++|...+.||+|+||.||+|...+    +..||||.+.... ......+.+|+.++++++||||+++++++.+ +..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            345788889999999999999998532    2359999997653 3345678999999999999999999999765 456


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence            899999999999999854  2345899999999999999999999988   99999999999999999999999999997


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      ....
T Consensus       163 ~~~~  166 (281)
T 3cc6_A          163 IEDE  166 (281)
T ss_dssp             C---
T ss_pred             cccc
Confidence            7543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.93  E-value=4.7e-26  Score=218.58  Aligned_cols=148  Identities=28%  Similarity=0.420  Sum_probs=124.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCC------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  313 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46788999999999999999984 568899999997542  233456889999999999999999999997664      


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++||||+++ +|.+++.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999974 7877773     35899999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      +.....
T Consensus       175 ~~~~~~  180 (371)
T 2xrw_A          175 RTAGTS  180 (371)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            876543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=3.9e-26  Score=235.96  Aligned_cols=148  Identities=23%  Similarity=0.362  Sum_probs=127.9

Q ss_pred             hcCCCccccccccCCeeEEEEEeC--CCCEEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCe-----
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS--NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-----  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-----  314 (412)
                      .++|++.+.||+|+||.||++...  +++.||||.+.... ......+.+|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999964  68899999986543 3344568999999999999999999999987655     


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .+|||||+++++|.+++.     ..+++..++.|+.||+.||.|||+++   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            699999999999988762     26999999999999999999999988   9999999999999886 99999999999


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+...
T Consensus       230 ~~~~~  234 (681)
T 2pzi_A          230 RINSF  234 (681)
T ss_dssp             ETTCC
T ss_pred             hcccC
Confidence            77543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.93  E-value=2.3e-26  Score=218.53  Aligned_cols=150  Identities=20%  Similarity=0.297  Sum_probs=123.7

Q ss_pred             hcCCCccccccccCCeeEEEEEeC----CCCEEEEEEeccCCccc-----------HHHHHHHHHHHccCCCCccceeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNSKQG-----------EIEFKNEVLLLARLQHRNLVRLLG  307 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~l~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~g  307 (412)
                      .++|...+.||+|+||.||+|...    ++..+|||.+.......           ...+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367888999999999999999964    57889999987654221           123667888999999999999999


Q ss_pred             EEec----CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC
Q 015138          308 FCLE----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       308 ~~~~----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~  383 (412)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    77899999999 9999999854   337999999999999999999999987   99999999999999887


Q ss_pred             --CeEEeccCCcccccCC
Q 015138          384 --NPKISDFGMARLFEMD  399 (412)
Q Consensus       384 --~~ki~DfGla~~~~~~  399 (412)
                        .+||+|||+++.+..+
T Consensus       189 ~~~~kL~Dfg~a~~~~~~  206 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPN  206 (345)
T ss_dssp             TTSEEECCCTTCEESSGG
T ss_pred             CCcEEEEeCCCceecccc
Confidence              9999999999987543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=4.8e-26  Score=219.46  Aligned_cols=153  Identities=23%  Similarity=0.408  Sum_probs=126.0

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecC------
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------  312 (412)
                      ....++|+..+.||+|+||.||++.. .+|+.||||++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45567899999999999999999994 67899999998755332    24699999999999999999998543      


Q ss_pred             --------------------------------CeeeEEEecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 015138          313 --------------------------------KERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYL  359 (412)
Q Consensus       313 --------------------------------~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yL  359 (412)
                                                      ...++||||++ |+|.+.+... .....+++..+..++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34789999998 5777666421 2346799999999999999999999


Q ss_pred             HhCCCCCceecCCCCCCEEEC-CCCCeEEeccCCcccccCCC
Q 015138          360 HEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       360 H~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+.+   |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence            9987   99999999999998 68899999999999875544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=1.3e-26  Score=213.22  Aligned_cols=157  Identities=27%  Similarity=0.442  Sum_probs=131.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec--CCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~l  317 (412)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+....  ......+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46788899999999999999995 478999999997543  3345568999999999999999999998854  567899


Q ss_pred             EEecCCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhHhCC--CCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          318 VYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDS--RLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999985421 2345999999999999999999999875  2349999999999999999999999999998


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+...
T Consensus       165 ~~~~~  169 (279)
T 2w5a_A          165 ILNHD  169 (279)
T ss_dssp             HC---
T ss_pred             eeccc
Confidence            76543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.93  E-value=2.1e-26  Score=213.13  Aligned_cols=155  Identities=26%  Similarity=0.369  Sum_probs=122.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc-c-HHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ-G-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ...++|+..+.||+|+||.||++.. .+++.||||++...... . ...+.++...++.++||||+++++++.+.+..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            3457889999999999999999995 67899999999765322 2 2234555566888999999999999999999999


Q ss_pred             EEecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          318 VYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ||||++ |+|.+++... .....+++..+..|+.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            999997 5887776421 1345799999999999999999999997 7   99999999999999999999999999987


Q ss_pred             ccCC
Q 015138          396 FEMD  399 (412)
Q Consensus       396 ~~~~  399 (412)
                      +...
T Consensus       160 ~~~~  163 (290)
T 3fme_A          160 LVDD  163 (290)
T ss_dssp             ----
T ss_pred             cccc
Confidence            6544

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.93  E-value=9.5e-26  Score=216.48  Aligned_cols=147  Identities=29%  Similarity=0.501  Sum_probs=126.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCee----
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER----  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~----  315 (412)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46788899999999999999994 5689999999976432  2345788999999999999999999999877655    


Q ss_pred             --eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          316 --ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       316 --~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                        ++||||++ ++|.+++     ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 6888887     344999999999999999999999997   999999999999999999999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       192 ~~~~~  196 (371)
T 4exu_A          192 RHADA  196 (371)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.93  E-value=3.6e-26  Score=221.12  Aligned_cols=151  Identities=25%  Similarity=0.412  Sum_probs=125.0

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC------eee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------ERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~  316 (412)
                      ..+|+..+.||+|+||.||++....+..||+|++......    ..+|+.+++.++||||+++++++....      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3568889999999999999999877777999988654332    236899999999999999999986543      378


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC-CCCCeEEeccCCccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARL  395 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~  395 (412)
                      +||||++++.+............+++..+..++.|++.||.|||+.+   |+||||||+|||++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655443321123467999999999999999999999988   99999999999999 789999999999998


Q ss_pred             ccCCC
Q 015138          396 FEMDQ  400 (412)
Q Consensus       396 ~~~~~  400 (412)
                      +..+.
T Consensus       192 ~~~~~  196 (394)
T 4e7w_A          192 LIAGE  196 (394)
T ss_dssp             CCTTC
T ss_pred             ccCCC
Confidence            75443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.93  E-value=3.9e-26  Score=210.15  Aligned_cols=151  Identities=27%  Similarity=0.471  Sum_probs=126.0

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecC-CeeeEEE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-KERILVY  319 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lv~  319 (412)
                      ...++|+..+.||+|+||.||++... ++.||||.+....  ....+.+|+.++.+++||||+++++++.+. +..++||
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            34577888999999999999999874 8899999987543  445789999999999999999999997655 4789999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           95 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            999999999998431 1123789999999999999999999987   99999999999999999999999999986643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.93  E-value=4.4e-26  Score=213.55  Aligned_cols=158  Identities=23%  Similarity=0.389  Sum_probs=133.9

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCC--CCccceeeEEEe
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQ--HRNLVRLLGFCL  310 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~  310 (412)
                      .++.+....++|+..+.||+|+||.||++...+++.||||.+....  ......+.+|+.++.+++  |+||+++++++.
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            3344556677899999999999999999998889999999987543  334567899999999997  599999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                      .....++||| +.+++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+||
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Df  170 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF  170 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCC
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeec
Confidence            9999999999 668999999854   356899999999999999999999987   99999999999996 489999999


Q ss_pred             CCcccccCCC
Q 015138          391 GMARLFEMDQ  400 (412)
Q Consensus       391 Gla~~~~~~~  400 (412)
                      |+++.+....
T Consensus       171 g~~~~~~~~~  180 (313)
T 3cek_A          171 GIANQMQPDT  180 (313)
T ss_dssp             SSSCC-----
T ss_pred             cccccccCcc
Confidence            9999876543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.93  E-value=1.7e-25  Score=213.14  Aligned_cols=147  Identities=29%  Similarity=0.498  Sum_probs=127.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCe-----
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-----  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-----  314 (412)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36788899999999999999995 5689999999976432  234568899999999999999999999987654     


Q ss_pred             -eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          315 -RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       315 -~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                       .++||||++ ++|.+++     ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 6888877     235999999999999999999999988   999999999999999999999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       174 ~~~~~  178 (353)
T 3coi_A          174 RHADA  178 (353)
T ss_dssp             TC---
T ss_pred             cCCCC
Confidence            87643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.93  E-value=5.8e-26  Score=221.46  Aligned_cols=149  Identities=28%  Similarity=0.482  Sum_probs=121.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecC------Ceee
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------KERI  316 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~  316 (412)
                      .+|+..+.||+|+||.||+|.. .+++.||||++......    +.+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            4577889999999999999996 46899999998754322    34699999999999999999998542      2367


Q ss_pred             EEEecCCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccCCcc
Q 015138          317 LVYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMAR  394 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfGla~  394 (412)
                      +||||+++ +|.+++.. ......+++..+..++.||+.||.|||+.+   |+||||||+||||+.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 55554421 123467999999999999999999999987   9999999999999965 568999999999


Q ss_pred             cccCCC
Q 015138          395 LFEMDQ  400 (412)
Q Consensus       395 ~~~~~~  400 (412)
                      .+..+.
T Consensus       206 ~~~~~~  211 (420)
T 1j1b_A          206 QLVRGE  211 (420)
T ss_dssp             ECCTTC
T ss_pred             hcccCC
Confidence            875443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.93  E-value=1e-25  Score=231.06  Aligned_cols=155  Identities=22%  Similarity=0.403  Sum_probs=132.6

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCC----CCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      .....++|+..+.||+|+||.||+|....    +..||||.+..... .....+.+|+.++++++||||+++++++. .+
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            34445678888999999999999999632    45799999876433 33467899999999999999999999985 45


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..++||||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            68999999999999999854  2346899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      +.+...
T Consensus       539 ~~~~~~  544 (656)
T 2j0j_A          539 RYMEDS  544 (656)
T ss_dssp             CSCCC-
T ss_pred             eecCCC
Confidence            987544

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.93  E-value=1.1e-25  Score=214.81  Aligned_cols=158  Identities=26%  Similarity=0.339  Sum_probs=118.7

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCe--
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE--  314 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~--  314 (412)
                      ......++|+..+.||+|+||.||+|.. .+++.||||++....... ..+.+|+..+..++||||+++++++.....  
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4455668899999999999999999996 568999999986543322 245678888889999999999999875433  


Q ss_pred             -----eeEEEecCCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHhH--hCCCCCceecCCCCCCEEECC-CCCe
Q 015138          315 -----RILVYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEGIARGLLYLH--EDSRLRIIHRDLKASNILLDS-EMNP  385 (412)
Q Consensus       315 -----~~lv~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~ivHrdlk~~Nill~~-~~~~  385 (412)
                           .++||||++++ |...+.. ......+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                 78999999875 4333221 124567899999999999999999999  766   999999999999997 8999


Q ss_pred             EEeccCCcccccCCC
Q 015138          386 KISDFGMARLFEMDQ  400 (412)
Q Consensus       386 ki~DfGla~~~~~~~  400 (412)
                      ||+|||+++.+....
T Consensus       172 kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE  186 (360)
T ss_dssp             EECCCTTCBCCCTTS
T ss_pred             EEeeCCCceecCCCC
Confidence            999999999876544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.93  E-value=1.3e-25  Score=213.87  Aligned_cols=148  Identities=26%  Similarity=0.474  Sum_probs=130.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecC-----Cee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~  315 (412)
                      .++|+..+.||+|+||.||+|.. .+|+.||||.+..... .....+.+|+.++.+++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            47888999999999999999995 4688999999975432 3345688999999999999999999988754     678


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||++ ++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 689988843    56999999999999999999999987   99999999999999999999999999998


Q ss_pred             ccC
Q 015138          396 FEM  398 (412)
Q Consensus       396 ~~~  398 (412)
                      +..
T Consensus       162 ~~~  164 (353)
T 2b9h_A          162 IDE  164 (353)
T ss_dssp             CC-
T ss_pred             ccc
Confidence            754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.92  E-value=2.1e-25  Score=207.61  Aligned_cols=147  Identities=29%  Similarity=0.362  Sum_probs=126.5

Q ss_pred             cCCCcc-ccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHH-ccCCCCccceeeEEEec----CCeee
Q 015138          244 DNFSDA-NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLL-ARLQHRNLVRLLGFCLE----RKERI  316 (412)
Q Consensus       244 ~~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~g~~~~----~~~~~  316 (412)
                      ++|... +.||+|+||.||++.. .+++.||||.+...     ..+.+|+.++ ..++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456655 7799999999999995 67899999998642     3567788887 55699999999999876    66789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC---CCCeEEeccCCc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMA  393 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla  393 (412)
                      +||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999998652 2346999999999999999999999988   999999999999998   788999999999


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      +.....
T Consensus       168 ~~~~~~  173 (299)
T 3m2w_A          168 KETTGE  173 (299)
T ss_dssp             EECTTC
T ss_pred             cccccc
Confidence            876543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=3.8e-26  Score=217.67  Aligned_cols=147  Identities=19%  Similarity=0.263  Sum_probs=127.1

Q ss_pred             hcCCCccccccccCCeeEEEEEeC---------CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccce---------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS---------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR---------  304 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~---------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  304 (412)
                      .++|...+.||+|+||.||++...         +++.||||.+...     ..+.+|+.++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            468899999999999999999965         3789999998754     25789999999999999988         


Q ss_pred             ------eeEEEec-CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCE
Q 015138          305 ------LLGFCLE-RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (412)
Q Consensus       305 ------l~g~~~~-~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni  377 (412)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.|+.|++.||.|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777766 67889999999 99999999542 2367999999999999999999999997   99999999999


Q ss_pred             EECCCC--CeEEeccCCcccccCC
Q 015138          378 LLDSEM--NPKISDFGMARLFEMD  399 (412)
Q Consensus       378 ll~~~~--~~ki~DfGla~~~~~~  399 (412)
                      |++.++  .+||+|||+++.+...
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGG
T ss_pred             EEcCCCCceEEEecCcceeeccCC
Confidence            999998  9999999999887543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.92  E-value=7.7e-26  Score=209.37  Aligned_cols=153  Identities=33%  Similarity=0.496  Sum_probs=124.5

Q ss_pred             hhcCCCccccccccCCeeEEEEEeC--CCC--EEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLS--NGE--TIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~--~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  314 (412)
                      ..++|+..+.||+|+||.||+|.+.  +++  .||||.+....   ......+.+|+.++.+++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            3467888999999999999999852  333  68999887542   234567899999999999999999999998765 


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            8899999999999999854  2356899999999999999999999987   9999999999999999999999999999


Q ss_pred             cccCCC
Q 015138          395 LFEMDQ  400 (412)
Q Consensus       395 ~~~~~~  400 (412)
                      .+....
T Consensus       170 ~~~~~~  175 (291)
T 1u46_A          170 ALPQND  175 (291)
T ss_dssp             ECCC-C
T ss_pred             cccccc
Confidence            875543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.92  E-value=3.5e-25  Score=204.75  Aligned_cols=154  Identities=31%  Similarity=0.478  Sum_probs=135.2

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ...++|+..+.||+|+||.||++.. .+++.||||.+....  ......+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            3457889999999999999999996 478999999986543  3346678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC---CCeEEeccCCcc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMAR  394 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DfGla~  394 (412)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.+   ..+||+|||+++
T Consensus        99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999988853   346899999999999999999999987   9999999999999764   469999999998


Q ss_pred             cccCCC
Q 015138          395 LFEMDQ  400 (412)
Q Consensus       395 ~~~~~~  400 (412)
                      .+....
T Consensus       173 ~~~~~~  178 (287)
T 2wei_A          173 CFQQNT  178 (287)
T ss_dssp             TBCCCS
T ss_pred             eecCCC
Confidence            775443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.92  E-value=3.5e-25  Score=215.04  Aligned_cols=148  Identities=29%  Similarity=0.468  Sum_probs=114.7

Q ss_pred             CCCc-cccccccCCeeEEEEEeC---CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEec--CCeeeEE
Q 015138          245 NFSD-ANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILV  318 (412)
Q Consensus       245 ~~~~-~~~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv  318 (412)
                      .|+. .++||+|+||.||++...   +++.||||++......  ..+.+|+.++.+++||||+++++++..  ....+||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3444 568999999999999964   5788999999754322  367899999999999999999999954  6789999


Q ss_pred             EecCCCCChhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE----CCCCCeEEe
Q 015138          319 YEFVPNASLDHFIFD------PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKIS  388 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~  388 (412)
                      |||++ |+|.+++..      ......+++..+..|+.||+.||.|||+.+   |+||||||+||||    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99997 577776631      112335999999999999999999999998   9999999999999    777899999


Q ss_pred             ccCCcccccC
Q 015138          389 DFGMARLFEM  398 (412)
Q Consensus       389 DfGla~~~~~  398 (412)
                      |||+|+.+..
T Consensus       175 Dfg~a~~~~~  184 (405)
T 3rgf_A          175 DMGFARLFNS  184 (405)
T ss_dssp             CTTCCC----
T ss_pred             ECCCceecCC
Confidence            9999998754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=7.1e-26  Score=212.53  Aligned_cols=155  Identities=24%  Similarity=0.462  Sum_probs=130.8

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEecC
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  312 (412)
                      ....+....++|+..+.||+|+||.||+|....  .+|+|.+....  ......+.+|+.++.+++||||+++++++.+.
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            344555667889999999999999999999753  59999987542  22234578899999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...++||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence            999999999999999999954  2346899999999999999999999988   99999999999998 67999999999


Q ss_pred             ccccc
Q 015138          393 ARLFE  397 (412)
Q Consensus       393 a~~~~  397 (412)
                      ++...
T Consensus       176 ~~~~~  180 (319)
T 2y4i_B          176 FSISG  180 (319)
T ss_dssp             CC---
T ss_pred             ccccc
Confidence            88653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.92  E-value=4.3e-25  Score=204.78  Aligned_cols=151  Identities=23%  Similarity=0.412  Sum_probs=125.6

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEE-ecCCeeeEEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC-LERKERILVY  319 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~-~~~~~~~lv~  319 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+.......  .+.+|+.++..++|++++..++.+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC--CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch--HHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            357899999999999999999994 678899999876543322  478899999999988877776665 5677889999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE---CCCCCeEEeccCCcccc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLF  396 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~  396 (412)
                      ||+ +++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999999853  2456999999999999999999999998   9999999999999   78899999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ....
T Consensus       159 ~~~~  162 (296)
T 4hgt_A          159 RDAR  162 (296)
T ss_dssp             BCTT
T ss_pred             cCcc
Confidence            6543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.92  E-value=5.9e-25  Score=217.26  Aligned_cols=150  Identities=23%  Similarity=0.400  Sum_probs=129.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC-CccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|++.++||+|+||.||+|.. .+++.||||.+.......  ++..|++++..++| ++|..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC--CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH--HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46789999999999999999994 678999999876544332  47889999999987 556666677778888999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE---CCCCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~  397 (412)
                      |+ +++|.+++..  ....+++..++.|+.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 9999999853  2456999999999999999999999988   9999999999999   688999999999999876


Q ss_pred             CCC
Q 015138          398 MDQ  400 (412)
Q Consensus       398 ~~~  400 (412)
                      ...
T Consensus       158 ~~~  160 (483)
T 3sv0_A          158 DTS  160 (483)
T ss_dssp             CTT
T ss_pred             CCc
Confidence            554

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.92  E-value=2.4e-25  Score=209.52  Aligned_cols=153  Identities=30%  Similarity=0.530  Sum_probs=128.0

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe--CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccC---CCCccceeeEEEe---
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML--SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARL---QHRNLVRLLGFCL---  310 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~g~~~---  310 (412)
                      ...++|+..+.||+|+||.||++..  .+++.||||++.....  .....+.+|+.++..+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3557899999999999999999996  4678999998864322  1122456777776665   8999999999987   


Q ss_pred             --cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEe
Q 015138          311 --ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (412)
Q Consensus       311 --~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~  388 (412)
                        .....++||||++ |+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              5567899999998 6999988542 2345899999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccccC
Q 015138          389 DFGMARLFEM  398 (412)
Q Consensus       389 DfGla~~~~~  398 (412)
                      |||+++.+..
T Consensus       163 Dfg~~~~~~~  172 (326)
T 1blx_A          163 DFGLARIYSF  172 (326)
T ss_dssp             SCCSCCCCCG
T ss_pred             cCcccccccC
Confidence            9999987653

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.92  E-value=6.9e-26  Score=212.04  Aligned_cols=152  Identities=26%  Similarity=0.429  Sum_probs=125.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc------cHHHHHHHHHHHccC----CCCccceeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ------GEIEFKNEVLLLARL----QHRNLVRLLGFCL  310 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~g~~~  310 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+......      ....+.+|+.++.++    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            457799999999999999999985 57889999999765332      122356788888888    8999999999999


Q ss_pred             cCCeeeEEEec-CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC-CCCCeEEe
Q 015138          311 ERKERILVYEF-VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKIS  388 (412)
Q Consensus       311 ~~~~~~lv~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~  388 (412)
                      ..+..++|||| +.+++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++ .++.+||+
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence            99999999999 789999999854   446999999999999999999999987   99999999999999 78999999


Q ss_pred             ccCCcccccCC
Q 015138          389 DFGMARLFEMD  399 (412)
Q Consensus       389 DfGla~~~~~~  399 (412)
                      |||+++.+...
T Consensus       183 dfg~~~~~~~~  193 (312)
T 2iwi_A          183 DFGSGALLHDE  193 (312)
T ss_dssp             CCSSCEECCSS
T ss_pred             EcchhhhcccC
Confidence            99999987644

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.92  E-value=7.2e-25  Score=203.32  Aligned_cols=150  Identities=23%  Similarity=0.412  Sum_probs=129.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEE-ecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC-LERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~-~~~~~~~lv~E  320 (412)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+......  ..+.+|+.++..++|++++..++.+ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            47889999999999999999995 67899999998765433  2588999999999998877666655 56678899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE---CCCCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DfGla~~~~  397 (412)
                      |+ +++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 9999999853  2456999999999999999999999988   9999999999999   488899999999999876


Q ss_pred             CCC
Q 015138          398 MDQ  400 (412)
Q Consensus       398 ~~~  400 (412)
                      ...
T Consensus       160 ~~~  162 (296)
T 3uzp_A          160 DAR  162 (296)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.92  E-value=4.8e-25  Score=215.55  Aligned_cols=150  Identities=24%  Similarity=0.318  Sum_probs=127.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC------CCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL------QHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~g~~~~~~~~  315 (412)
                      ..+|+..++||+|+||.||+|.. .+++.||||++.... .....+.+|+.++..+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            45688899999999999999985 568899999997542 2334567787777766      577999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC--eEEeccCCc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--PKISDFGMA  393 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DfGla  393 (412)
                      ++||||+. ++|.+++... ....+++..+..|+.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||+|
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6898888542 2345999999999999999999999987   999999999999999987  999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       250 ~~~~~  254 (429)
T 3kvw_A          250 CYEHQ  254 (429)
T ss_dssp             EETTC
T ss_pred             eecCC
Confidence            86543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.92  E-value=4.5e-25  Score=207.96  Aligned_cols=155  Identities=26%  Similarity=0.410  Sum_probs=127.5

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHH-HHccCCCCccceeeEEEecCCeeeE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVL-LLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ...++|+..+.||+|+||.||++.. .+++.||||++..... ....++..|+. +++.++||||+++++++...+..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            3457888899999999999999996 5789999999976532 23344555655 7788899999999999999999999


Q ss_pred             EEecCCCCChhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          318 VYEFVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ||||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999985 77777632  11246789999999999999999999997 7   9999999999999999999999999998


Q ss_pred             cccCC
Q 015138          395 LFEMD  399 (412)
Q Consensus       395 ~~~~~  399 (412)
                      .+...
T Consensus       175 ~~~~~  179 (327)
T 3aln_A          175 QLVDS  179 (327)
T ss_dssp             C----
T ss_pred             ecccc
Confidence            77543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=1.3e-25  Score=215.52  Aligned_cols=149  Identities=10%  Similarity=0.067  Sum_probs=111.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc---ccHHHHHHHH---HHHccCCCCccceee-------EE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEV---LLLARLQHRNLVRLL-------GF  308 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~-------g~  308 (412)
                      ..+|...+.||+|+||.||+|.. .+++.||||++.....   .....+.+|+   .+|.. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            45588899999999999999995 5789999999987543   2344577785   45555 799987754       44


Q ss_pred             EecC-----------------CeeeEEEecCCCCChhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHhHhCCCC
Q 015138          309 CLER-----------------KERILVYEFVPNASLDHFIFDPINREHMTWEKR------YKIIEGIARGLLYLHEDSRL  365 (412)
Q Consensus       309 ~~~~-----------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~  365 (412)
                      +...                 ...+|||||++ |+|.+++...  ...+.+..+      +.++.||+.||.|||+++  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            4322                 34799999999 8999998542  223455555      778899999999999988  


Q ss_pred             CceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       366 ~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                       |+||||||+||||+.++.+||+|||+|+....
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~  246 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT  246 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence             99999999999999999999999999997643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.92  E-value=2.1e-25  Score=225.91  Aligned_cols=155  Identities=27%  Similarity=0.425  Sum_probs=132.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEec------CCe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE------RKE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~------~~~  314 (412)
                      .++|+..+.||+|+||.||++.. .+|+.||||.+... .......+.+|+.++.+++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            37899999999999999999995 56899999998764 33345678999999999999999999999765      667


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC---eEEeccC
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFG  391 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DfG  391 (412)
                      .++||||+++|+|.+++........+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555557999999999999999999999987   999999999999997765   9999999


Q ss_pred             CcccccCCC
Q 015138          392 MARLFEMDQ  400 (412)
Q Consensus       392 la~~~~~~~  400 (412)
                      +++.+....
T Consensus       170 ~a~~~~~~~  178 (676)
T 3qa8_A          170 YAKELDQGE  178 (676)
T ss_dssp             CCCBTTSCC
T ss_pred             ccccccccc
Confidence            999875543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.92  E-value=4.7e-25  Score=213.15  Aligned_cols=135  Identities=27%  Similarity=0.372  Sum_probs=113.1

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC--------CCccceeeEEEe---
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ--------HRNLVRLLGFCL---  310 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~g~~~---  310 (412)
                      .++|+..++||+|+||.||++.. .+++.||||++... ......+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47799999999999999999984 56889999999754 233456889999999885        788999999987   


Q ss_pred             -cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCC
Q 015138          311 -ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEM  383 (412)
Q Consensus       311 -~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~  383 (412)
                       .....+|||||+ +++|.+++... ....+++..+..|+.||+.||.|||++ +   |+||||||+||||+.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence             556889999999 55555555331 235699999999999999999999998 7   99999999999999775

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.91  E-value=2.9e-25  Score=217.08  Aligned_cols=152  Identities=26%  Similarity=0.384  Sum_probs=123.5

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeE
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  317 (412)
                      +.....+|...+.||+|+||+|+.....+++.||||++......   .+.+|+.++.++ +||||+++++++.+....+|
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            34455678889999999999976555567899999999765433   246799999999 79999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-----CCCeEEeccCC
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-----EMNPKISDFGM  392 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~ki~DfGl  392 (412)
                      ||||++ |+|.+++...  ...+.+.....++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||+
T Consensus        96 v~E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            999996 6999998653  233444556789999999999999988   999999999999953     33688999999


Q ss_pred             cccccCC
Q 015138          393 ARLFEMD  399 (412)
Q Consensus       393 a~~~~~~  399 (412)
                      |+.+...
T Consensus       170 a~~~~~~  176 (432)
T 3p23_A          170 CKKLAVG  176 (432)
T ss_dssp             EECC---
T ss_pred             eeeccCC
Confidence            9987644

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.91  E-value=2.2e-25  Score=209.57  Aligned_cols=154  Identities=27%  Similarity=0.424  Sum_probs=132.7

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc------cHHHHHHHHHHHccCC--CCccceeeEEEe
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQ--HRNLVRLLGFCL  310 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~g~~~  310 (412)
                      ....++|+..+.||+|+||.||+|.. .+++.||||.+......      ....+.+|+.++.+++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34567899999999999999999984 67889999998764321      1234677999999996  599999999999


Q ss_pred             cCCeeeEEEecCCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC-CCCCeEEe
Q 015138          311 ERKERILVYEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKIS  388 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~  388 (412)
                      ..+..++||||+.+ ++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++ .++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999986 899999854   456899999999999999999999987   99999999999999 77899999


Q ss_pred             ccCCcccccCC
Q 015138          389 DFGMARLFEMD  399 (412)
Q Consensus       389 DfGla~~~~~~  399 (412)
                      |||+++.+...
T Consensus       193 Dfg~~~~~~~~  203 (320)
T 3a99_A          193 DFGSGALLKDT  203 (320)
T ss_dssp             CCTTCEECCSS
T ss_pred             eCccccccccc
Confidence            99999987543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.91  E-value=1.2e-24  Score=205.48  Aligned_cols=150  Identities=24%  Similarity=0.376  Sum_probs=129.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe--CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc------cceeeEEEecCCe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML--SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN------LVRLLGFCLERKE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~g~~~~~~~  314 (412)
                      .++|+..+.||+|+||.||++..  .+++.||||.+.... .....+.+|+.++..++|+|      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46788999999999999999985  467899999986542 33456888999988887654      9999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-------------
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-------------  381 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-------------  381 (412)
                      .++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 89999988542 2346899999999999999999999987   999999999999988             


Q ss_pred             ------CCCeEEeccCCcccccC
Q 015138          382 ------EMNPKISDFGMARLFEM  398 (412)
Q Consensus       382 ------~~~~ki~DfGla~~~~~  398 (412)
                            ++.+||+|||+++....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS
T ss_pred             ccccccCCCceEeeCcccccCcc
Confidence                  66899999999987543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.91  E-value=2e-24  Score=204.40  Aligned_cols=148  Identities=24%  Similarity=0.327  Sum_probs=120.4

Q ss_pred             hcCCCccc-cccccCCeeEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEec----CCeee
Q 015138          243 TDNFSDAN-KLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERI  316 (412)
Q Consensus       243 ~~~~~~~~-~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~  316 (412)
                      .++|...+ .||+|+||.||++... +++.||||++.....    ...+....+..++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46777754 6999999999999964 689999999865321    22223334566799999999999876    44589


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC---CCeEEeccCCc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMA  393 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DfGla  393 (412)
                      +||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.+   +.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999653 2356999999999999999999999998   9999999999999864   45999999999


Q ss_pred             ccccC
Q 015138          394 RLFEM  398 (412)
Q Consensus       394 ~~~~~  398 (412)
                      +....
T Consensus       179 ~~~~~  183 (336)
T 3fhr_A          179 KETTQ  183 (336)
T ss_dssp             EEC--
T ss_pred             eeccc
Confidence            87654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.91  E-value=7.1e-25  Score=214.67  Aligned_cols=148  Identities=26%  Similarity=0.306  Sum_probs=118.8

Q ss_pred             CCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeEEEecCCC
Q 015138          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      |...+.||+|+||+||.+...+|+.||||++....   ...+.+|+.++.++ +||||+++++++.+....+|||||++ 
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            44467899999999987666679999999986532   34578899999876 89999999999999999999999995 


Q ss_pred             CChhhhccCCCCCC----CCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-------------CCeEE
Q 015138          325 ASLDHFIFDPINRE----HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-------------MNPKI  387 (412)
Q Consensus       325 gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-------------~~~ki  387 (412)
                      |+|.+++.......    ..++..++.|+.||+.||.|||+.+   |+||||||+|||++.+             +.+||
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            69999986532111    1133345789999999999999987   9999999999999654             48999


Q ss_pred             eccCCcccccCCC
Q 015138          388 SDFGMARLFEMDQ  400 (412)
Q Consensus       388 ~DfGla~~~~~~~  400 (412)
                      +|||+++.+..+.
T Consensus       170 ~DFG~a~~~~~~~  182 (434)
T 2rio_A          170 SDFGLCKKLDSGQ  182 (434)
T ss_dssp             CCCTTCEECCC--
T ss_pred             cccccceecCCCC
Confidence            9999999876544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.91  E-value=1.5e-24  Score=203.37  Aligned_cols=152  Identities=24%  Similarity=0.397  Sum_probs=116.9

Q ss_pred             hhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc-c-HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ-G-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ..++|+..+.||+|+||.||++.. .+++.||||.+...... . ...+.++..+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            346788899999999999999996 47899999999765432 2 22345555678888999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |||+ ++.+..+...  ....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 4555555422  235689999999999999999999985 6   9999999999999999999999999998765


Q ss_pred             CC
Q 015138          398 MD  399 (412)
Q Consensus       398 ~~  399 (412)
                      ..
T Consensus       177 ~~  178 (318)
T 2dyl_A          177 DD  178 (318)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=1.1e-24  Score=218.48  Aligned_cols=137  Identities=19%  Similarity=0.290  Sum_probs=109.5

Q ss_pred             CccccccccCCeeEEEEEeCCCCEEEEEEeccCCcc--------cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ...+.||+|+||.||++.. .++.+++|+.......        ....+.+|++++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3467899999999999965 4688999986543211        123489999999999999999777777788888999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++++|.+++..           +..|+.|++.||.|||+++   |+||||||+|||++.  ++||+|||+|+.+..
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           4689999999999999988   999999999999998  999999999998865


Q ss_pred             CC
Q 015138          399 DQ  400 (412)
Q Consensus       399 ~~  400 (412)
                      .+
T Consensus       482 ~~  483 (540)
T 3en9_A          482 DE  483 (540)
T ss_dssp             HH
T ss_pred             cc
Confidence            43

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.91  E-value=3.2e-24  Score=206.59  Aligned_cols=157  Identities=27%  Similarity=0.339  Sum_probs=128.9

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CC-----ccceeeEEEe
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HR-----NLVRLLGFCL  310 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~g~~~  310 (412)
                      ......++|+..+.||+|+||.||+|.. .+++.||||++.... ....++..|+.++..++ |+     +|+++++++.
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            3344568899999999999999999995 468899999997432 23446777888888774 44     4999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC--CCCCeEEe
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD--SEMNPKIS  388 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~ki~  388 (412)
                      ..+..+|||||++ |+|.+++... ....+++..+..++.|++.||.|||.+ ..+|+||||||+||||+  .++.+||+
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             cCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            9999999999996 5999988542 234589999999999999999999953 12499999999999995  47789999


Q ss_pred             ccCCcccccC
Q 015138          389 DFGMARLFEM  398 (412)
Q Consensus       389 DfGla~~~~~  398 (412)
                      |||+|+.+..
T Consensus       204 DFG~a~~~~~  213 (382)
T 2vx3_A          204 DFGSSCQLGQ  213 (382)
T ss_dssp             CCTTCEETTC
T ss_pred             eccCceeccc
Confidence            9999987754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.90  E-value=5.6e-24  Score=202.33  Aligned_cols=150  Identities=20%  Similarity=0.348  Sum_probs=126.0

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCC-CEEEEEEeccCCcccHHHHHHHHHHHccCCCCc------cceeeEEEecCCe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNG-ETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN------LVRLLGFCLERKE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~g~~~~~~~  314 (412)
                      .++|+..+.||+|+||.||++.. .++ +.||||.+.... .....+.+|+.++.+++|++      ++.+++++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            46888999999999999999995 344 689999986532 33456788999999887765      8999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEE---------------
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---------------  379 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---------------  379 (412)
                      .++||||+ +++|.+++... ....+++..+..|+.||+.||.|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 56666666432 2346999999999999999999999987   9999999999999               


Q ss_pred             ----CCCCCeEEeccCCcccccC
Q 015138          380 ----DSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       380 ----~~~~~~ki~DfGla~~~~~  398 (412)
                          +.++.+||+|||+++....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS
T ss_pred             cccccCCCcEEEeecCccccccc
Confidence                5678999999999987543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.90  E-value=2.4e-24  Score=206.60  Aligned_cols=151  Identities=24%  Similarity=0.375  Sum_probs=127.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-----------CCccceeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-----------HRNLVRLLGFCL  310 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~g~~~  310 (412)
                      .++|+..+.||+|+||.||++.. .+++.||||.+.... .....+.+|+.++.+++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46788999999999999999995 678999999987532 33456788999988886           899999999988


Q ss_pred             cCC----eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEEC-----
Q 015138          311 ERK----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLD-----  380 (412)
Q Consensus       311 ~~~----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~-----  380 (412)
                      ...    ..++||||+ +++|.+++... ....+++..+..|+.||+.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 89999998542 234599999999999999999999997 7   99999999999994     


Q ss_pred             -CCCCeEEeccCCcccccCC
Q 015138          381 -SEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       381 -~~~~~ki~DfGla~~~~~~  399 (412)
                       ..+.+||+|||+++.+...
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~  191 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH  191 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC
T ss_pred             cCcceEEEcccccccccCCC
Confidence             4458999999999877543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=4.9e-24  Score=196.39  Aligned_cols=143  Identities=17%  Similarity=0.155  Sum_probs=114.8

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCc------------------ccHHHHHHHHHHHccCCCC
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK------------------QGEIEFKNEVLLLARLQHR  300 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~e~~~l~~l~h~  300 (412)
                      +......|+..+.||+|+||.||+|...+|+.||||.+.....                  .....+.+|+.++.+++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344455667799999999999999997799999999865321                  12446899999999999  


Q ss_pred             ccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC
Q 015138          301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD  380 (412)
Q Consensus       301 niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~  380 (412)
                      | +++.+++. .+..++||||+++++|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||++
T Consensus       163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            4 66666543 356799999999999988 411         123479999999999999988   99999999999999


Q ss_pred             CCCCeEEeccCCcccccCC
Q 015138          381 SEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       381 ~~~~~ki~DfGla~~~~~~  399 (412)
                       ++.+||+|||+|+.....
T Consensus       228 -~~~vkl~DFG~a~~~~~~  245 (282)
T 1zar_A          228 -EEGIWIIDFPQSVEVGEE  245 (282)
T ss_dssp             -TTEEEECCCTTCEETTST
T ss_pred             -CCcEEEEECCCCeECCCC
Confidence             999999999999976543

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.88  E-value=7.9e-23  Score=158.50  Aligned_cols=106  Identities=25%  Similarity=0.410  Sum_probs=93.5

Q ss_pred             CCCceEeeccCCcccchHHHHHHHHHHHHHHHHHhhCCCCCCcceeceeeccCcceEEEEecCCCCCChhhHHHHHHHHH
Q 015138           54 NAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTT  133 (412)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~~a~~~~~~~~~~~vy~l~qC~~dls~~~C~~Cl~~~~  133 (412)
                      ++..+..||.++++ +.+.|+.+++.||..|.+.|+.  +..+|+++..+..+.++||||+||++|+++.+|..||..++
T Consensus         3 t~~v~~~Cn~~~~t-~~s~f~~nl~~ll~~L~~~a~~--s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~   79 (108)
T 3a2e_A            3 TAFVSSACNTQKIP-SGSPFNRNLRAMLADLRQNTAF--SGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLV   79 (108)
T ss_dssp             CCEEEEEECSSBCC-TTCTHHHHHHHHHHHHHHHGGG--TTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHH
T ss_pred             cceeeeecCCCccC-CCChHHHHHHHHHHHHHhhCcc--ccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHH
Confidence            34466788988887 6788999999999999988875  34577777766656689999999999999999999999999


Q ss_pred             HhhhhhccCCCCcEEECCcccccccCCcc
Q 015138          134 KLMSKCCDRRQGGRVINPSCSFRYETNKF  162 (412)
Q Consensus       134 ~~~~~~c~~~~gg~v~~~~C~~ry~~~~~  162 (412)
                      ..++++|++++||++++++|++||+.++|
T Consensus        80 ~~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           80 NRIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             TTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            99999999999999999999999999876

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.87  E-value=1.9e-22  Score=196.18  Aligned_cols=152  Identities=20%  Similarity=0.224  Sum_probs=115.7

Q ss_pred             hhcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCC-Ccccee---------eE
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQH-RNLVRL---------LG  307 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h-~niv~l---------~g  307 (412)
                      ...+|...+.||+|+||.||+|. ..+|+.||||++......   ....|.+|+.++..++| +|....         +.
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            34557778899999999999999 567999999998744322   24578999999999987 322111         11


Q ss_pred             E------------Eec-----CCeeeEEEecCCCCChhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCC
Q 015138          308 F------------CLE-----RKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKIIEGIARGLLYLHEDSRLR  366 (412)
Q Consensus       308 ~------------~~~-----~~~~~lv~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~  366 (412)
                      .            ...     ....+++|+++ +++|.+++..    ......+++..++.|+.|++.||.|||+.+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            1            111     12346667654 7899988731    123456888999999999999999999988   


Q ss_pred             ceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          367 IIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       367 ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |+||||||+||||+.++.+||+|||+++...
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~  262 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  262 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecC
Confidence            9999999999999999999999999998654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=8.2e-22  Score=179.27  Aligned_cols=139  Identities=18%  Similarity=0.193  Sum_probs=107.8

Q ss_pred             CCccccccccCCeeEEEEEe-CCCCE--EEEEEeccCCcc------------------------cHHHHHHHHHHHccCC
Q 015138          246 FSDANKLGQGGFGAVYKGML-SNGET--IAVKRLSKNSKQ------------------------GEIEFKNEVLLLARLQ  298 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~e~~~l~~l~  298 (412)
                      |+..+.||+|+||.||+|.. .+|+.  ||||.+......                        ....+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999997 78888  999987543111                        1135788999999998


Q ss_pred             CCcc--ceeeEEEecCCeeeEEEecCCC-C----ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhH-hCCCCCceec
Q 015138          299 HRNL--VRLLGFCLERKERILVYEFVPN-A----SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-EDSRLRIIHR  370 (412)
Q Consensus       299 h~ni--v~l~g~~~~~~~~~lv~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivHr  370 (412)
                      |+++  +.++..    ...+|||||+.+ |    +|.++...      .++.....++.|++.+|.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8764  444442    356899999942 4    66665421      234456789999999999999 877   9999


Q ss_pred             CCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          371 DLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       371 dlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||||+|||++.  .++|+|||+|......
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            99999999998  9999999999876543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=2.1e-18  Score=163.30  Aligned_cols=138  Identities=15%  Similarity=0.169  Sum_probs=98.0

Q ss_pred             CCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCc--------------ccHHHH--------HHHHHHHccCCCCcc
Q 015138          245 NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK--------------QGEIEF--------KNEVLLLARLQHRNL  302 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~--------------~~~~~~--------~~e~~~l~~l~h~ni  302 (412)
                      -|++.+.||+|+||.||+|...+|+.||||.+.....              ......        ..|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3888999999999999999988899999998753210              011112        234455555544333


Q ss_pred             ceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC
Q 015138          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE  382 (412)
Q Consensus       303 v~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~  382 (412)
                      ....-+..  ...+|||||+++++|..+...         .....++.|++.+|.|||+.+   ||||||||.|||++++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence            21111111  223799999999998765421         123467899999999999987   9999999999999887


Q ss_pred             C----------CeEEeccCCcccc
Q 015138          383 M----------NPKISDFGMARLF  396 (412)
Q Consensus       383 ~----------~~ki~DfGla~~~  396 (412)
                      +          .+.|+||+=+...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            7          3899999977643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=1.7e-13  Score=124.40  Aligned_cols=145  Identities=19%  Similarity=0.128  Sum_probs=113.0

Q ss_pred             hhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEe
Q 015138          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       242 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ..+.|.....++.|+.+.||+.... ++.+++|............+.+|..++..+. |.++.+++++....+..++|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3456777778888888999998854 6889999987532222335788999998884 6778899999998889999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC--------------------------------------
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED--------------------------------------  362 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------------------------------------  362 (412)
                      |++|.+|.+.+..        ......++.+++++|..||+.                                      
T Consensus        91 ~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999999876421        112347788999999999981                                      


Q ss_pred             ------------------CCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          363 ------------------SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       363 ------------------~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                                        .+..++|+|++|.|||++.+..+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                              113489999999999998766678999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=1.6e-12  Score=117.55  Aligned_cols=139  Identities=18%  Similarity=0.127  Sum_probs=102.0

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc--cceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++......+.|..+.||+....+|+.+++|......   ...+..|+.++..+.+.+  +.+++++...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3444333333555699999988778889999876542   234678888888886544  56789988887888999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCC--------------------------------------
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS--------------------------------------  363 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------  363 (412)
                      ++|.+|.  ...      .+   ...++.++++.|..||+..                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999884  211      11   2356778888888888643                                      


Q ss_pred             -----------------CCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          364 -----------------RLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       364 -----------------~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                                       +..++|+|++|.|||++.+..++|+|||.+..-
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                             123999999999999988777789999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=3.5e-11  Score=114.28  Aligned_cols=142  Identities=15%  Similarity=0.259  Sum_probs=107.2

Q ss_pred             ccccccccCCeeEEEEEeCCCCEEEEEEec--cCC-cccHHHHHHHHHHHccCC--CCccceeeEEEecC---CeeeEEE
Q 015138          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLS--KNS-KQGEIEFKNEVLLLARLQ--HRNLVRLLGFCLER---KERILVY  319 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~~~~~~vavK~l~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~  319 (412)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|..++..+.  +..+.++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35678999999999988754 678888765  322 122345788999998887  45678999988776   3479999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCC------------------------------------
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS------------------------------------  363 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------  363 (412)
                      ||+++..+.+..     ...++...+..++.++++.|..||...                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998885422     234778888899999999999999731                                    


Q ss_pred             -------------------CCCceecCCCCCCEEECCCCC--eEEeccCCccc
Q 015138          364 -------------------RLRIIHRDLKASNILLDSEMN--PKISDFGMARL  395 (412)
Q Consensus       364 -------------------~~~ivHrdlk~~Nill~~~~~--~ki~DfGla~~  395 (412)
                                         +..++|+|+++.|||++.++.  +.|.||+++..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  69999999874

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.14  E-value=2.5e-11  Score=93.64  Aligned_cols=43  Identities=21%  Similarity=0.538  Sum_probs=41.4

Q ss_pred             CChhhhHHHHHHHHHHHhhcCCCCceeEEEecCCCCcceEEEecCCCC
Q 015138            1 MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDI   48 (412)
Q Consensus         1 ~~~~~C~~C~~~a~~~~~~~C~~~~~a~~~~d~~~~~~C~lrys~~~f   48 (412)
                      +++++|..||+.|++++.+.||++++|+||||     .|+||||+.+|
T Consensus        66 ls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~-----~C~lRY~~~~F  108 (108)
T 3a2e_A           66 ISQSDCTACLSNLVNRIFSICNNAIGARVQLV-----DCFIQYEQRSF  108 (108)
T ss_dssp             SCHHHHHHHHHHHHTTHHHHTTSBSSEEEEET-----TEEEEEESSCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHCCCCceEEEECC-----CEEEEEeCCcC
Confidence            57899999999999999999999999999999     89999999988

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.78  E-value=1.2e-08  Score=94.41  Aligned_cols=137  Identities=20%  Similarity=0.245  Sum_probs=99.4

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCc--cceeeEEEecCC---eeeEEEecC
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRN--LVRLLGFCLERK---ERILVYEFV  322 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lv~Ey~  322 (412)
                      .+.++.|....||+..    ..+++|.....  .....+.+|..++..+. +..  +.++++.....+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568899999999852    56888875432  33456889999998873 333  445555544333   348999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC----------------------------------------
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED----------------------------------------  362 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------  362 (412)
                      +|.+|.....     ..++..++..++.+++..|..||..                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865331     3467777788888888888888851                                        


Q ss_pred             ---------------CCCCceecCCCCCCEEECC--CCCeEEeccCCcccc
Q 015138          363 ---------------SRLRIIHRDLKASNILLDS--EMNPKISDFGMARLF  396 (412)
Q Consensus       363 ---------------~~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~  396 (412)
                                     .++.++|+|++|.|||++.  +..+.|+||+.+..-
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                           1235899999999999998  556899999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=1.8e-07  Score=86.47  Aligned_cols=137  Identities=20%  Similarity=0.171  Sum_probs=95.0

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCC---ccceeeEEEe-cCCeeeEEEecCCC
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR---NLVRLLGFCL-ERKERILVYEFVPN  324 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~Ey~~~  324 (412)
                      .+.++.|....||+.    +..+++|...  .......+..|..+|..+.+.   .+.+.+.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456778888889987    5678888742  222345688999999998653   3567777764 44557899999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC------------------------------------------
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED------------------------------------------  362 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------------------------------------------  362 (412)
                      ..|.+...     ..++......++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88876321     1234455555555566555555542                                          


Q ss_pred             ---------------CCCCceecCCCCCCEEECC---CCC-eEEeccCCcccc
Q 015138          363 ---------------SRLRIIHRDLKASNILLDS---EMN-PKISDFGMARLF  396 (412)
Q Consensus       363 ---------------~~~~ivHrdlk~~Nill~~---~~~-~ki~DfGla~~~  396 (412)
                                     .++.++|+|+++.|||++.   ++. +.|+||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2234699999999999987   355 589999988754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.57  E-value=2.6e-07  Score=83.70  Aligned_cols=136  Identities=17%  Similarity=0.177  Sum_probs=93.5

Q ss_pred             cccccCCe-eEEEEEeC-CCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          251 KLGQGGFG-AVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       251 ~lg~G~fg-~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      .+..|..| .||+-... ++..+.+|+-...   ...++..|...|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445555 68987753 4567888876533   2346788998888774 44477899999999999999999999887


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC---------------------------------------------
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED---------------------------------------------  362 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~---------------------------------------------  362 (412)
                      .+....       .......+..+++..|.-||..                                             
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            664311       0112223444555555555531                                             


Q ss_pred             ----------CCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          363 ----------SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       363 ----------~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                                .++.++|+|+.+.|||++.++.+-|+||+.+..-
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                      1223799999999999998877889999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.51  E-value=1.7e-07  Score=88.51  Aligned_cols=81  Identities=4%  Similarity=-0.012  Sum_probs=55.2

Q ss_pred             cccc-cccCCeeEEEEEeC-------CCCEEEEEEeccCC---cccHHHHHHHHHHHccCCC---CccceeeEEEecC--
Q 015138          249 ANKL-GQGGFGAVYKGMLS-------NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQH---RNLVRLLGFCLER--  312 (412)
Q Consensus       249 ~~~l-g~G~fg~V~~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~g~~~~~--  312 (412)
                      .+.| +.|....+|+....       +++.+++|......   ......+..|..++..+..   -.+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3566 77888899988754       25678888765432   1012346778888877742   3577888887665  


Q ss_pred             -CeeeEEEecCCCCChhh
Q 015138          313 -KERILVYEFVPNASLDH  329 (412)
Q Consensus       313 -~~~~lv~Ey~~~gsL~~  329 (412)
                       ...++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.17  E-value=5.3e-06  Score=79.48  Aligned_cols=75  Identities=15%  Similarity=0.143  Sum_probs=49.0

Q ss_pred             cccccccCCeeEEEEEeC-CCCEEEEEEeccCCc-------ccHHHHHHHHHHHccCCC--C-ccceeeEEEecCCeeeE
Q 015138          249 ANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-------QGEIEFKNEVLLLARLQH--R-NLVRLLGFCLERKERIL  317 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~g~~~~~~~~~l  317 (412)
                      .+.||.|.++.||++... +++.++||.......       .....+..|.+++..+.+  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            567999999999999754 468899997653221       122345678888877632  3 34466654  3445689


Q ss_pred             EEecCCCC
Q 015138          318 VYEFVPNA  325 (412)
Q Consensus       318 v~Ey~~~g  325 (412)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=1.9e-05  Score=73.72  Aligned_cols=141  Identities=16%  Similarity=0.224  Sum_probs=80.0

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC--CccceeeE------EEecCCeeeEEEec
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--RNLVRLLG------FCLERKERILVYEF  321 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~g------~~~~~~~~~lv~Ey  321 (412)
                      +.|+.|..+.||+....+| .+++|+....    ..++..|..++..|..  -.+.+++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4565567889999887654 5888988652    1233344454444421  12344443      12245677899999


Q ss_pred             CCCCChhh-----------h---cc---CCC--C------CCCCCHHHHH------------------------------
Q 015138          322 VPNASLDH-----------F---IF---DPI--N------REHMTWEKRY------------------------------  346 (412)
Q Consensus       322 ~~~gsL~~-----------~---l~---~~~--~------~~~l~~~~~~------------------------------  346 (412)
                      ++|..+..           .   ++   ...  .      .....|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99876531           0   11   000  0      0112343211                              


Q ss_pred             -HHHHHHHHHHHHhHh----------CCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          347 -KIIEGIARGLLYLHE----------DSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       347 -~i~~~i~~~l~yLH~----------~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                       .+..++..++.+|+.          ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             111223446667763          1235699999999999998888999999998863

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.05  E-value=3.7e-05  Score=70.95  Aligned_cols=140  Identities=17%  Similarity=0.164  Sum_probs=93.3

Q ss_pred             CccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC---CCccceeeEEEecCCeeeEEEecCC
Q 015138          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILVYEFVP  323 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lv~Ey~~  323 (412)
                      ...+.|+.|....+|+... ++..+++|.....   ....+..|...|..|.   ...+.+++++....+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456789999999999876 4678888876543   2456788988888874   3568899999888888999999999


Q ss_pred             CCChhhh-----------ccCCCC-------------------CCCCCHHHHH---HHH----------------HHHHH
Q 015138          324 NASLDHF-----------IFDPIN-------------------REHMTWEKRY---KII----------------EGIAR  354 (412)
Q Consensus       324 ~gsL~~~-----------l~~~~~-------------------~~~l~~~~~~---~i~----------------~~i~~  354 (412)
                      +..+..-           |+....                   ...-+|....   ++.                .++..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            8876321           111100                   0012565432   111                11121


Q ss_pred             HH-HHhHh-CCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          355 GL-LYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       355 ~l-~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      .+ ..|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22 23422 2356799999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.00  E-value=1.2e-05  Score=73.35  Aligned_cols=78  Identities=22%  Similarity=0.299  Sum_probs=57.4

Q ss_pred             CCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC---CccceeeEEEecCCeeeEEEecC
Q 015138          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH---RNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      +...+.+|.|..+.||+..+.||+.+.+|+...........|..|...|+.|..   --+.+++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            344678899999999999999999999998765544444457889888887742   2345566542    347899999


Q ss_pred             CCCCh
Q 015138          323 PNASL  327 (412)
Q Consensus       323 ~~gsL  327 (412)
                      +.+..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.82  E-value=7.3e-05  Score=72.09  Aligned_cols=73  Identities=14%  Similarity=0.259  Sum_probs=45.5

Q ss_pred             cccccccCCeeEEEEEeCCCCEEEEEEeccC-----C--c--ccHHHHHHHHHHHc-cCCCCccceeeEEEecCCeeeEE
Q 015138          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKN-----S--K--QGEIEFKNEVLLLA-RLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~-----~--~--~~~~~~~~e~~~l~-~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .+.||.|....||+... +++.++||.....     .  .  .....+..|+..+. ...+..+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            56789999999999865 4678999943211     1  1  12233444443322 22234567777765  4567899


Q ss_pred             EecC-CC
Q 015138          319 YEFV-PN  324 (412)
Q Consensus       319 ~Ey~-~~  324 (412)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.64  E-value=0.00016  Score=66.88  Aligned_cols=143  Identities=14%  Similarity=0.115  Sum_probs=78.6

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc--cceeeEE------EecCCeeeEEEec
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGF------CLERKERILVYEF  321 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~------~~~~~~~~lv~Ey  321 (412)
                      +.|+.|....+|+....+| .+++|........  ..+..|..++..+...+  +.+++..      ....+..++++||
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~--~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCCH--HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4566677788999887655 6778887653111  23455666666653222  3333321      1223567899999


Q ss_pred             CCCCChhhh--------------cc----CCCCC--CC---CCHHHHHH------------HHHHHHHHHHHhHhC----
Q 015138          322 VPNASLDHF--------------IF----DPINR--EH---MTWEKRYK------------IIEGIARGLLYLHED----  362 (412)
Q Consensus       322 ~~~gsL~~~--------------l~----~~~~~--~~---l~~~~~~~------------i~~~i~~~l~yLH~~----  362 (412)
                      ++|..+...              ++    .....  ..   ..|.....            +...+...+.+|+..    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            998765320              11    10000  01   12332111            011234445555531    


Q ss_pred             CCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       363 ~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      .+..++|+|+++.|||++.+..+.|+||+.+..
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            234599999999999998876668999998763

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.57  E-value=0.00027  Score=64.72  Aligned_cols=141  Identities=13%  Similarity=0.117  Sum_probs=75.6

Q ss_pred             CCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEecC-C
Q 015138          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFV-P  323 (412)
Q Consensus       246 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~Ey~-~  323 (412)
                      +...+.|+.|....+|+.     +.+++|......... .+...|..++..+...++ .++++..  .+.-++|+||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            333677888988999998     567888775432211 123457776666643233 4666543  33457899999 6


Q ss_pred             CCChhhh------------------ccCCCC--CCCCCHH-HHHHHHH--------------HHHHHHH----HhHh-CC
Q 015138          324 NASLDHF------------------IFDPIN--REHMTWE-KRYKIIE--------------GIARGLL----YLHE-DS  363 (412)
Q Consensus       324 ~gsL~~~------------------l~~~~~--~~~l~~~-~~~~i~~--------------~i~~~l~----yLH~-~~  363 (412)
                      +.+|..-                  ++....  ....... ....+..              .+...+.    .|.. ..
T Consensus        92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~  171 (301)
T 3dxq_A           92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL  171 (301)
T ss_dssp             CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence            6555320                  111100  0001111 1111100              0111111    1111 22


Q ss_pred             CCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          364 RLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       364 ~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +..++|+|+.+.||| ..++.+.|+||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            345899999999999 5667789999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.54  E-value=0.00088  Score=61.96  Aligned_cols=142  Identities=17%  Similarity=0.165  Sum_probs=80.8

Q ss_pred             ccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCC--ccceeeEE-----EecCCeeeEEEecC
Q 015138          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR--NLVRLLGF-----CLERKERILVYEFV  322 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~g~-----~~~~~~~~lv~Ey~  322 (412)
                      ..++ |....||+....+|+.+++|...... .....+..|..++..+...  .+++++..     ....+..++||||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3455 77788998877777789999886432 1334566777777766422  24445443     11234567899999


Q ss_pred             CCCChhh-----h---------cc----CC--CCCCCCCHHHH----------------------HHHHHHHHHHHHHhH
Q 015138          323 PNASLDH-----F---------IF----DP--INREHMTWEKR----------------------YKIIEGIARGLLYLH  360 (412)
Q Consensus       323 ~~gsL~~-----~---------l~----~~--~~~~~l~~~~~----------------------~~i~~~i~~~l~yLH  360 (412)
                      +|..+..     +         ++    ..  .....+++...                      ...+.+++..+.-+.
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865431     0         00    00  01112232211                      011112222222111


Q ss_pred             h-CCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          361 E-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       361 ~-~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      . ..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1234589999999999999 5 899999988764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.53  E-value=0.00018  Score=69.44  Aligned_cols=73  Identities=18%  Similarity=0.288  Sum_probs=49.4

Q ss_pred             cccccccCCeeEEEEEeCC--------CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEE
Q 015138          249 ANKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVY  319 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~  319 (412)
                      .+.|+.|....+|+....+        ++.+.+|+....  .....+..|..++..+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3567778788999998753        477888877432  112355678888888753344 577776543    3899


Q ss_pred             ecCCCCCh
Q 015138          320 EFVPNASL  327 (412)
Q Consensus       320 Ey~~~gsL  327 (412)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987555

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.50  E-value=0.00053  Score=63.72  Aligned_cols=142  Identities=17%  Similarity=0.113  Sum_probs=72.0

Q ss_pred             ccccccCCee-EEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC--CccceeeEEEecCCeeeEEEecCCCCC
Q 015138          250 NKLGQGGFGA-VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       250 ~~lg~G~fg~-V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      +.|+.|.... +|+....+++.+++|.......   .++..|+.++..+..  -.+.+++.+.....  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4455554433 6676654467777776543321   123445665555532  23567777644333  78999997766


Q ss_pred             hhhhcc---------------------CCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHhH---
Q 015138          327 LDHFIF---------------------DPIN--REHMTWEKRY-------K-------------IIEGIARGLLYLH---  360 (412)
Q Consensus       327 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~~i~~~l~yLH---  360 (412)
                      +.+++.                     ....  ...++.....       .             ....+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            543321                     1000  0111111100       0             0001112222221   


Q ss_pred             hCCCCCceecCCCCCCEEECCC----CCeEEeccCCcccc
Q 015138          361 EDSRLRIIHRDLKASNILLDSE----MNPKISDFGMARLF  396 (412)
Q Consensus       361 ~~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGla~~~  396 (412)
                      ...+..++|+|+.+.|||++.+    ..+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1224469999999999999875    67999999988743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.42  E-value=0.00062  Score=64.44  Aligned_cols=142  Identities=18%  Similarity=0.212  Sum_probs=83.4

Q ss_pred             cccccccCCeeEEEEEeC--------CCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc-cceeeEEEecCCeeeEEE
Q 015138          249 ANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKERILVY  319 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~--------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~  319 (412)
                      .+.|..|-...+|+....        +++.+.+|+.... ......+.+|..+++.+...+ ..++++.+.++    +||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence            345666777889998864        2467888875332 234456678998888774322 35777766542    999


Q ss_pred             ecCCCCChhhh-----------------ccCC--CCCCCC--CHHHHHHHHHHHH-------------------HHHHHh
Q 015138          320 EFVPNASLDHF-----------------IFDP--INREHM--TWEKRYKIIEGIA-------------------RGLLYL  359 (412)
Q Consensus       320 Ey~~~gsL~~~-----------------l~~~--~~~~~l--~~~~~~~i~~~i~-------------------~~l~yL  359 (412)
                      ||++|..|..-                 |+..  ......  -|.+..++..++.                   ..+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998666421                 1111  011112  2444444443332                   122333


Q ss_pred             H----h-CCCCCceecCCCCCCEEECCC----CCeEEeccCCccc
Q 015138          360 H----E-DSRLRIIHRDLKASNILLDSE----MNPKISDFGMARL  395 (412)
Q Consensus       360 H----~-~~~~~ivHrdlk~~Nill~~~----~~~ki~DfGla~~  395 (412)
                      .    . ..+..++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    2 223469999999999999876    6899999998873

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.37  E-value=0.00075  Score=65.59  Aligned_cols=74  Identities=14%  Similarity=0.114  Sum_probs=47.4

Q ss_pred             cccccccCCeeEEEEEeCC-CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEecCCCCC
Q 015138          249 ANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVPNAS  326 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~Ey~~~gs  326 (412)
                      .+.|+.|-...+|+....+ +..+++|+....... ..+...|..++..|...++ .++++.+.  +  .+||||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4567777788999998765 467888876443211 1122578888888865555 57777763  2  25999998765


Q ss_pred             h
Q 015138          327 L  327 (412)
Q Consensus       327 L  327 (412)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.10  E-value=0.0069  Score=56.35  Aligned_cols=32  Identities=28%  Similarity=0.437  Sum_probs=28.1

Q ss_pred             CCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          364 RLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       364 ~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999988764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.0009  Score=63.16  Aligned_cols=74  Identities=11%  Similarity=0.095  Sum_probs=43.4

Q ss_pred             cccccccCCeeEEEEEeCC---------CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc-cceeeEEEecCCeeeEE
Q 015138          249 ANKLGQGGFGAVYKGMLSN---------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKERILV  318 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~---------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~~~~lv  318 (412)
                      .+.|+.|..-.+|+....+         ++.+++|........ ..+...|..++..+...+ ..++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3456777778899988654         267888876543221 112356777777774333 44677654  2  3689


Q ss_pred             EecCCCCCh
Q 015138          319 YEFVPNASL  327 (412)
Q Consensus       319 ~Ey~~~gsL  327 (412)
                      |||+++..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.63  E-value=0.046  Score=52.35  Aligned_cols=141  Identities=17%  Similarity=0.211  Sum_probs=82.1

Q ss_pred             cccccccCCeeEEEEEeCC--------CCEEEEEEeccCCcccHHHHHHHHHHHccCCCCc-cceeeEEEecCCeeeEEE
Q 015138          249 ANKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKERILVY  319 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~  319 (412)
                      .+.+..|-...+|+....+        ++.+++++....... ..+..+|..+++.+...+ ..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3456666677899988753        577888876543321 122356777777774323 356666432    37899


Q ss_pred             ecCCCCChhhh-c----------------cC--------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 015138          320 EFVPNASLDHF-I----------------FD--------PI--NREHMTWEKRYKIIEGI-------------------A  353 (412)
Q Consensus       320 Ey~~~gsL~~~-l----------------~~--------~~--~~~~l~~~~~~~i~~~i-------------------~  353 (412)
                      ||++|..|..- +                +.        ..  ...+.-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998765321 0                10        00  11122244333332221                   2


Q ss_pred             HHHHHhH---------------------hCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          354 RGLLYLH---------------------EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       354 ~~l~yLH---------------------~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ..+.+|.                     ...+..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2233332                     112345899999999999 7888999999998873

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.35  E-value=0.087  Score=50.05  Aligned_cols=30  Identities=27%  Similarity=0.398  Sum_probs=25.3

Q ss_pred             CceecCCCCCCEEE------CCCCCeEEeccCCccc
Q 015138          366 RIIHRDLKASNILL------DSEMNPKISDFGMARL  395 (412)
Q Consensus       366 ~ivHrdlk~~Nill------~~~~~~ki~DfGla~~  395 (412)
                      -++|+|+.+.|||+      +++..++++||-+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998863

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.07  E-value=0.072  Score=32.72  Aligned_cols=29  Identities=17%  Similarity=0.382  Sum_probs=14.1

Q ss_pred             eEEeeehhHHHHHHHHHhhhhheeecccc
Q 015138          190 ILITVIVSVVASVILITGICIFLRVGKLK  218 (412)
Q Consensus       190 iii~v~~~~~~~v~li~~~~~~~~~~~~~  218 (412)
                      +..+++.++++++++++.+++++|+++.+
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            34444444555555555555555554443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.37  E-value=1.3  Score=37.79  Aligned_cols=91  Identities=10%  Similarity=0.033  Sum_probs=64.4

Q ss_pred             CCCCccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HhHhCCCCCceecCCCCC
Q 015138          297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL-YLHEDSRLRIIHRDLKAS  375 (412)
Q Consensus       297 l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~ivHrdlk~~  375 (412)
                      ..||.+  -...-.+.+.+.+.++.-+++.=..-+      ..++...+++++..|+.... +++.     -+|--|+|+
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            357776  333335666777777755333222222      34777888998888887776 5553     578889999


Q ss_pred             CEEECCCCCeEEeccCCcccccCCC
Q 015138          376 NILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       376 Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |++++.++.++|.-.|+-..+.|.+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~lpP~e  138 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESLPPDE  138 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTBSSCS
T ss_pred             eEEEeCCCcEEEEEcCCcccCCCCC
Confidence            9999999999999999988776654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.02  E-value=1.3  Score=37.81  Aligned_cols=92  Identities=11%  Similarity=0.066  Sum_probs=65.8

Q ss_pred             CCCCccceeeEEEecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCC
Q 015138          297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (412)
Q Consensus       297 l~h~niv~l~g~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N  376 (412)
                      ..||+++.. ..-.+.+.+.+.|+.-+.  ...|-    .-..++...+++++..|+....+++.     -+|--|+|.|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcc--cCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            367887755 445556666666664432  22221    12347788899999999888866664     4788899999


Q ss_pred             EEECCCCCeEEeccCCcccccCCC
Q 015138          377 ILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       377 ill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ++++.++.++|.=.|+-..+.|..
T Consensus       110 L~f~~~~~p~i~~RGik~~l~P~~  133 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVDPLP  133 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBSCCC
T ss_pred             EEEcCCCCEEEEEccCccCCCCCC
Confidence            999999999999999977776653

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=87.99  E-value=0.11  Score=31.91  Aligned_cols=29  Identities=24%  Similarity=0.299  Sum_probs=14.3

Q ss_pred             eEEeeehhHHHHHHHHHhhhhheeecccc
Q 015138          190 ILITVIVSVVASVILITGICIFLRVGKLK  218 (412)
Q Consensus       190 iii~v~~~~~~~v~li~~~~~~~~~~~~~  218 (412)
                      +..+++.++++++++++.+++++|+++.+
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            33444444555555555555555554443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.96  E-value=0.064  Score=52.04  Aligned_cols=61  Identities=7%  Similarity=0.074  Sum_probs=18.2

Q ss_pred             CccccccccCCeeEEEEEeCC-CCEEEE------EEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEe
Q 015138          247 SDANKLGQGGFGAVYKGMLSN-GETIAV------KRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCL  310 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~~~-~~~vav------K~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~  310 (412)
                      ...++||   ||.||+|.+.. ..+|||      |......  ......|.+|..++..++|+|+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456676   99999999754 357888      7665432  222346788888999999999999988764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=86.85  E-value=0.14  Score=31.33  Aligned_cols=28  Identities=21%  Similarity=0.374  Sum_probs=14.0

Q ss_pred             EEeeehhHHHHHHHHHhhhhheeecccc
Q 015138          191 LITVIVSVVASVILITGICIFLRVGKLK  218 (412)
Q Consensus       191 ii~v~~~~~~~v~li~~~~~~~~~~~~~  218 (412)
                      +++.++++++++++.+.+.+|.||++.+
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            3334444444455555555566555544

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	412
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-45
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-41
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-40
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-39
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-38
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-32
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-28
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 8e-50
 Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 6/169 (3%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
              +   ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +G+     +  +V ++   +SL H +            K   I    A+G+ YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              IIHRDLK++NI L  ++  KI DFG+A +           ++ G++
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 5e-49
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 7/167 (4%)

Query: 239 IRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K     +G  +A K +    K         E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +        +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            YL    + +I+HRD+K SNIL++S    K+ DFG++        +S
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 9e-47
 Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 7/169 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLV 71

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           RL     + +   ++ E++ N SL  F+  P +   +T  K   +   IA G+ ++ E +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
               IHRDL+A+NIL+   ++ KI+DFG+ARL E ++  +        +
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPI 174

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (403), Expect = 3e-46
 Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 16/174 (9%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQ 298
              FSD  ++G G FGAVY    + N E +A+K++S + KQ      +   EV  L +L+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N ++  G  L      LV E+   ++ D      ++++ +   +   +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           LH      +IHRD+KA NILL      K+ DFG A +       +  N  VGT 
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTP 175

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 7e-46
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 6/164 (3%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            D +    +LG G FG VYK          A K +   S++   ++  E+ +LA   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+LL          ++ EF    ++D  + +      +T  +   + +     L YLH+
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
               +IIHRDLKA NIL   + + K++DFG++          D+
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  157 bits (398), Expect = 1e-45
 Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 19/191 (9%)

Query: 234 FDFETIRVATDNFSDA---------NKLGQGGFGAVYKGML----SNGETIAVKRLSKN- 279
           F FE    A   F+             +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
           +++   +F +E  ++ +  H N++ L G   +    +++ EF+ N SLD F+    N   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            T  +   ++ GIA G+ YL     +  +HRDL A NIL++S +  K+SDFG++R  E D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 400 QTHSDTNRVVG 410
            +       +G
Sbjct: 182 TSDPTYTSALG 192

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-45
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 7/169 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
              +   ++G G FG V+ G   N + +A+K + +     E +F  E  ++ +L H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           +L G CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              +IHRDL A N L+      K+SDFGM R    DQ    +      +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPV 166

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  154 bits (390), Expect = 1e-44
 Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 6/177 (3%)

Query: 233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEV 291
             +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E 
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEA 64

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
            ++  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQ 123

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
           I+  + YL    +   IHRDL A N L+      K++DFG++RL   D   +     
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-44
 Identities = 47/180 (26%), Positives = 87/180 (48%), Gaps = 12/180 (6%)

Query: 239 IRVATDNFSDAN-KLGQGGFGAVYKGML---SNGETIAVKRLSKNSKQGEIE-FKNEVLL 293
           + +  DN   A+ +LG G FG+V +G+         +A+K L + +++ + E    E  +
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           + +L +  +VRL+G C + +  +LV E      L  F+     RE +      +++  ++
Sbjct: 63  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-EMDQTHSDTNRVVGTL 412
            G+ YL        +HRDL A N+LL +    KISDFG+++     D  ++  +     L
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 4e-44
 Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 7/169 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
            + +   +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           +L G C +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
             + +HRDL A N L++ +   K+SDFG++R    D+  S        +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPV 165

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 5e-44
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 17/173 (9%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
            +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67

Query: 311 ER----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED---- 362
           +      +  LV ++  + SL  +    +NR  +T E   K+    A GL +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDY----LNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 363 -SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTL 412
             +  I HRDLK+ NIL+       I+D G+A   +   D      N  VGT 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 6e-44
 Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 8/171 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRN 301
           +++     LG+G +G V   +     E +AVK +         E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+  G   E   + L  E+     L   I        M      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
              + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GTL
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 7e-44
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 8/170 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHR 300
           +++     +G G +G   K    S+G+ +  K L   S  +  +    +EV LL  L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 301 NLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLL 357
           N+VR     ++R    L  V E+     L   I      R+++  E   +++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 358 YLHE--DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             H   D    ++HRDLK +N+ LD + N K+ DFG+AR+   D + +  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-43
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 6/166 (3%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           ++     KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 75

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           +L       +   +V E++   SL  F+      +++   +   +   IA G+ Y+    
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE--- 130

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           R+  +HRDL+A+NIL+   +  K++DFG+ARL E ++  +      
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 2e-42
 Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 10/171 (5%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
              ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V  L   L   E  +V E++   SL     D +    M   +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
               ++IHRD+K+ NILL  + + K++DFG       +Q+   T  +VGT 
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTP 180

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 3e-42
 Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 31/209 (14%)

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKN-SKQGE 284
           L     ++    +N      +G+G FG V++              +AVK L +  S   +
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 285 IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----------- 333
            +F+ E  L+A   + N+V+LLG C   K   L++E++    L+ F+             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 334 ----------PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM 383
                           ++  ++  I   +A G+ YL E    + +HRDL   N L+   M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177

Query: 384 NPKISDFGMARLFEMDQTHSDTNRVVGTL 412
             KI+DFG++R       +         +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPI 206

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 6e-42
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 8/163 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
                   +G+G FG V  G    G  +AVK +  ++      F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLV 63

Query: 304 RLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +LLG  +E K  + +V E++   SL  ++     R  +  +   K    +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                +HRDL A N+L+  +   K+SDFG+ +     Q     
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-41
 Identities = 49/191 (25%), Positives = 74/191 (38%), Gaps = 26/191 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +             T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD---------------PINREHM 340
           L  H N+V LLG C      +++ E+     L +F+                   +   +
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
             E        +A+G+ +L        IHRDL A NILL      KI DFG+AR  + D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 401 THSDTNRVVGT 411
            +         
Sbjct: 200 NYVVKGNARLP 210

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-41
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 14/173 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQH 299
           ++F     LG+G FG VY      +   +A+K L K        E + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            N++RL G+  +     L+ E+ P  ++   +           ++    I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           H     R+IHRD+K  N+LL S    KI+DFG +      +       + GTL
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTL 168

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-40
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 13/171 (7%)

Query: 248 DANKLGQGGFGAVYKGMLSN---GETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNL 302
           +  +LG G FG V KG        +T+AVK L   +    +  E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           VR++G C E +  +LV E      L+ ++       H+  +   +++  ++ G+ YL   
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE-- 124

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN-RVVGTL 412
                +HRDL A N+LL ++   KISDFG+++    D+ +          +
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-40
 Identities = 45/197 (22%), Positives = 74/197 (37%), Gaps = 31/197 (15%)

Query: 244 DNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V                +AVK L + +   E E   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH---------------- 339
           L  H N+V LLG C       L++E+     L +++     +                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 340 ----MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
               +T+E        +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 396 FEMDQTHSDTNRVVGTL 412
              D  +         +
Sbjct: 214 IMSDSNYVVRGNARLPV 230

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-40
 Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 16/171 (9%)

Query: 250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLL 306
            ++G+G F  VYKG+       +A   L     +K     FK E  +L  LQH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 307 GFCLE----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
                    +K  +LV E + + +L  ++      + M  +        I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 363 SRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           +   IIHRDLK  NI +     + KI D G+A L       +    V+GT 
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTP 177

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 52/181 (28%), Positives = 74/181 (40%), Gaps = 13/181 (7%)

Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSK---NSKQGEIEFKNE 290
           T  +   +     KLG G FG V +G          ++AVK L     +  +   +F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
           V  +  L HRNL+RL G  L    ++ V E  P  SL   +    ++ H       +   
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAV 118

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            +A G+ YL      R IHRDL A N+LL +    KI DFG+ R    +  H        
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175

Query: 411 T 411
            
Sbjct: 176 V 176

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-39
 Identities = 39/166 (23%), Positives = 80/166 (48%), Gaps = 5/166 (3%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHR 300
              +++ + +G+G +G V       N   +A+K++S    Q   +    E+ +L R +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N++ +           +   ++    +   ++  +  +H++ +     +  I RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
                 ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+   
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-39
 Identities = 48/175 (27%), Positives = 88/175 (50%), Gaps = 12/175 (6%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARL 297
             F     LG G FG VYKG+ +  GE     +A+K L +  S +   E  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL 357
            + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ 
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 125

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           YL      R++HRDL A N+L+ +  + KI+DFG+A+L   ++           +
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  141 bits (356), Expect = 6e-39
 Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 13/166 (7%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQ- 298
           ++FS    +G+GGFG VY       G+  A+K L K     KQGE    NE ++L+ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 299 --HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V +        +   + + +    L + +         +          I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
            ++H      +++RDLK +NILLD   + +ISD G+A  F   + H
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  140 bits (354), Expect = 8e-39
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 8/170 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D++    +LG G FG V++    + G   A K +    +  +   + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           V L     +  E +++YEF+    L   + D      M+ ++  + +  + +GL ++HE 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142

Query: 363 SRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVG 410
                +H DLK  NI+  ++ +   K+ DFG+    +  Q+   T     
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 45/175 (25%), Positives = 70/175 (40%), Gaps = 10/175 (5%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLA 295
           +   ++F     LG+G F  V     L+     A+K L K     +        E  +++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL H   V+L     + ++      +  N  L  +I                    I   
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSA 120

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VG
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 2e-38
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 12/182 (6%)

Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-----TIAVKRLSKNSKQGE-IEFKNEV 291
           T  +     +    +G G FG VYKGML          +A+K L     + + ++F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
            ++ +  H N++RL G   + K  +++ E++ N +LD F+ +       +  +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRG 118

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT-NRVVG 410
           IA G+ YL     +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T +    
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 411 TL 412
            +
Sbjct: 176 PI 177

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  137 bits (347), Expect = 8e-38
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 8/165 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D +    +LG G FG V++ +  + G     K ++      +   KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           + L     ++ E +L+ EF+    L   I        M+  +    +     GL ++HE 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 363 SRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDT 405
               I+H D+K  NI+ +++     KI DFG+A     D+    T
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-37
 Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 15/176 (8%)

Query: 245 NFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQGEIE-FKNEVLLLARLQH 299
           +F+    +G+G FG VY G L +        AVK L++ +  GE+  F  E +++    H
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 300 RNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
            N++ LLG CL  +    +V  ++ +  L +FI +  +   +     + +          
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR--VVGTL 412
           +   +  + +HRDL A N +LD +   K++DFG+AR     +  S  N+      +
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-37
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 21/178 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGET---IAVKRLSKN-SKQGEIEFKNEVLLLARL-Q 298
           ++    + +G+G FG V K  +         A+KR+ +  SK    +F  E+ +L +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI-------------FDPINREHMTWEKR 345
           H N++ LLG C  R    L  E+ P+ +L  F+                     ++ ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
                 +ARG+ YL +    + IHRDL A NIL+      KI+DFG++R  E+    +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-37
 Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 15/182 (8%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQGEIE-FKN 289
           D+E   +  +       +G+G FG V++G+  +       +A+K     +     E F  
Sbjct: 1   DYE---IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 57

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           E L + +  H ++V+L+G   E     ++ E      L  F+        +         
Sbjct: 58  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYA 114

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             ++  L YL      R +HRD+ A N+L+ S    K+ DFG++R  E    +   ++  
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGK 170

Query: 410 GT 411
             
Sbjct: 171 LP 172

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 8e-37
 Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 25/191 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGM------LSNGETIAVKRLSKNSKQGEIE--FKNEVLLLA 295
           D       LG+G FG V +         +   T+AVK L + +   E         +L+ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 296 RLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIF-------------DPINREHMT 341
              H N+V LLG C +    + ++ EF    +L  ++              + + ++ +T
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
            E        +A+G+ +L      + IHRDL A NILL  +   KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 402 HSDTNRVVGTL 412
           +         L
Sbjct: 190 YVRKGDARLPL 200

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-36
 Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 17/182 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGE-IEFKNEVLLLAR 296
           +  + + +LGQG FG VY+G+            +A+K +++ +   E IEF NE  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------DPINREHMTWEKRYKII 349
               ++VRLLG   + +  +++ E +    L  ++        +       +  K  ++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R       +    + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 410 GT 411
             
Sbjct: 197 LP 198

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-35
 Identities = 35/166 (21%), Positives = 71/166 (42%), Gaps = 9/166 (5%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           + +  A  LG+G FG V++ +  S+ +T   K +       ++  K E+ +L   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           + L       +E ++++EF+    +   I    +   +   +    +  +   L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 363 SRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTN 406
               I H D++  NI+  +  +   KI +FG AR  +         
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 3e-35
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 15/174 (8%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R    +++D   +G G FG VY+  L  +GE +A+K++ ++ +        E+ ++ +L 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLD 71

Query: 299 HRNLVRLLGFCLERKER------ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           H N+VRL  F     E+       LV ++VP             ++ +        +  +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDT 405
            R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  128 bits (323), Expect = 4e-35
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 8/164 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           + +    K+G+G +G VYK   + GET A+K  RL K  +        E+ +L  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L      +K  +LV+E +                 +        +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
               R++HRDLK  N+L++ E   KI+DFG+AR F +       
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  127 bits (320), Expect = 1e-34
 Identities = 42/179 (23%), Positives = 78/179 (43%), Gaps = 20/179 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS---------KQGEIEFKNEVLL 293
           +N+     LG+G    V + +     +  AVK +             ++       EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 294 LARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           L ++  H N+++L           LV++ +    L  ++     +  ++ ++  KI+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
              +  LH+   L I+HRDLK  NILLD +MN K++DFG +   +  +       V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (321), Expect = 2e-34
 Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 10/162 (6%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQH 299
            +F     LG G FG V+      NG   A+K L K      +      +E L+L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
             ++R+ G   + ++  ++ +++    L   +       +   +     +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
                  II+RDLK  NILLD   + KI+DFG A+       
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (313), Expect = 2e-33
 Identities = 35/172 (20%), Positives = 70/172 (40%), Gaps = 8/172 (4%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHR 300
            D +   + LG G F  V         + +A+K ++K + +G+    +NE+ +L +++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N+V L           L+ + V    L   I   + +   T     ++I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           +   +    +        LD +    ISDFG++++ +        +   GT 
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTP 173

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-33
 Identities = 42/192 (21%), Positives = 80/192 (41%), Gaps = 26/192 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGML--------SNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V             +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------------DPINREHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++                   E +
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           + +        +ARG+ YL      + IHRDL A N+L+  +   KI+DFG+AR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 401 THSDTNRVVGTL 412
            +  T      +
Sbjct: 190 YYKKTTNGRLPV 201

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 5e-32
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 8/165 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +  ++        E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N+V+LL       +  LV+EF+          D      +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                R++HRDLK  N+L+++E   K++DFG+AR F +       
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 7e-32
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 14/168 (8%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-----FKNEVLLLARLQHRNLV 303
           + LG+G F  VYK    +  + +A+K++    +    +        E+ LL  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            LL     +    LV++F+             N   +T       +    +GL YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
              I+HRDLK +N+LLD     K++DFG+A+       +      V T
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVT 163

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  120 bits (301), Expect = 7e-32
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 15/178 (8%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L     +AVK L  +  +     + F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 299 HRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH-SDTNRVVGT 411
            L + H+     IIHRD+K +NI++ +    K+ DFG+AR         + T  V+GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 9e-32
 Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 13/173 (7%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN----EVLLLARLQ 298
           ++F     LG+G FG V+        +  A+K L K+    + + +     + +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H  L  +      ++    V E++    L + I    +       +       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           LH      I++RDLK  NILLD + + KI+DFGM +   +    ++T    GT
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 6e-31
 Identities = 42/177 (23%), Positives = 69/177 (38%), Gaps = 12/177 (6%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLA 295
           +V  ++F     LG+G FG V      + G   A+K L K    +K        E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
             +H  L  L            V E+     L   +    +RE +  E+R +     A  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEI 114

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL 412
           +  L       +++RD+K  N++LD + + KI+DFG+ +    D          GT 
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTP 169

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-30
 Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 19/182 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHR 300
             +    K+GQG FG V+K      G+ +A+K++   +++    I    E+ +L  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 301 NLVRLLGFCLERKERI--------LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           N+V L+  C  +            LV++F  +                T  +  ++++ +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQML 126

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVVG 410
             GL Y+H +   +I+HRD+KA+N+L+  +   K++DFG+AR F + +    +     V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 411 TL 412
           TL
Sbjct: 184 TL 185

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 3e-30
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 9/162 (5%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHR 300
             +    K+G+G +G V+K       E +A+KR+    + +        E+ LL  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N+VRL       K+  LV+EF       +F         +  E     +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
                 ++HRDLK  N+L++     K+++FG+AR F +    
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-29
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 16/181 (8%)

Query: 242 ATDNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARL 297
           A   +    ++G+G +G V+K   + + G  +A+KR+   + +    +    EV +L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 298 ---QHRNLVRLLGFCLERKERILVYEFVPNASLDH---FIFDPINREHMTWEKRYKIIEG 351
              +H N+VRL   C   +        +    +D       D +    +  E    ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++           VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 412 L 412
           L
Sbjct: 179 L 179

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (281), Expect = 1e-28
 Identities = 48/193 (24%), Positives = 75/193 (38%), Gaps = 16/193 (8%)

Query: 220 EDENVEETIAKS---LQFDFETIRVAT---DNFSDANKLGQGGFGAVYKGM-LSNGETIA 272
           E E+V+E +AK+       +ET    T   D F     LG G FG V       +G   A
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70

Query: 273 VKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
           +K L K       +     NE  +L  +    LV+L     +     +V E+V    +  
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
            +         +          I     YLH    L +I+RDLK  N+L+D +   +++D
Sbjct: 131 HLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTD 184

Query: 390 FGMARLFEMDQTH 402
           FG A+  +     
Sbjct: 185 FGFAKRVKGRTWT 197

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 18/160 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFC 309
           LG G  G V +       E  A+K L    K      + EV L  R  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVY 74

Query: 310 ----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
                 RK  ++V E +    L   I D  ++   T  +  +I++ I   + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---I 130

Query: 366 RIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTH 402
            I HRD+K  N+L  S+      K++DFG A+      + 
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-28
 Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 19/171 (11%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE------FKNEVLLLARLQ--HRN 301
            LG GGFG+VY G+ +S+   +A+K + K+      E         EV+LL ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++RLL +       +L+ E                R  +  E        +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN 128

Query: 362 DSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
                ++HRD+K  NIL+D +    K+ DFG   L +            GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGT 172

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  111 bits (277), Expect = 2e-28
 Identities = 40/184 (21%), Positives = 74/184 (40%), Gaps = 19/184 (10%)

Query: 239 IRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
           +RV  + +    K+G G FG +Y G  ++ GE +A+K     +K  +     E  +   +
Sbjct: 3   LRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMM 59

Query: 298 QHRNLVRLLGFCLERKER-ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           Q    +  + +C    +  ++V E +  +  D F F        + +    + + +   +
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRI 116

Query: 357 LYLHEDSRLRIIHRDLKASNIL---LDSEMNPKISDFGMARLFEMDQTHSD-----TNRV 408
            Y+H       IHRD+K  N L           I DFG+A+ +   +TH          +
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 409 VGTL 412
            GT 
Sbjct: 174 TGTA 177

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 5e-28
 Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 20/179 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEVLLLAR 296
           D +    +LG G F  V K    S G   A K + K   +         + + EV +L  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+     +E +T E+  + ++ I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGV 126

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGT 411
            YLH    L+I H DLK  NI+L     P    KI DFG+A   +          + GT
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 1e-27
 Identities = 41/168 (24%), Positives = 76/168 (45%), Gaps = 7/168 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHR 300
             + D   +G G +GAV   +    G  +A+K+L +   S+        E+ LL  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 301 NLVRLLGFCLERKERILVYEF-VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N++ LL      +      +F +    +   +   +  E +  ++   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           H      IIHRDLK  N+ ++ +   KI DFG+AR  + + T     R
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 182

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (273), Expect = 1e-27
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 20/173 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRN 301
           D++    KLG+G +  V++ + ++N E + VK L    K+   + K E+ +L  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 302 LVRLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           ++ L     +   R   LV+E V N             + +T       +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 360 HEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           H    + I+HRD+K  N+++D E    ++ D+G+A  +   Q +   N  V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  106 bits (266), Expect = 7e-27
 Identities = 28/173 (16%), Positives = 67/173 (38%), Gaps = 18/173 (10%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           ++G+G FG +++G  L N + +A+K   + S   +   ++E      L     +  + + 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 69

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +     ++   +   SL+  +         + +      + +   +  +HE     +++
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124

Query: 370 RDLKASNILLDSEMNP-----KISDFGMARLFEMDQTHS-----DTNRVVGTL 412
           RD+K  N L+    +       + DFGM + +    T       +   + GT 
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 2e-25
 Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 15/182 (8%)

Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSK----NSK 281
           ++        +V  +NF     LG G +G V+          G+  A+K L K       
Sbjct: 10  RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69

Query: 282 QGEIEFKNEVLLLARLQHR-NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM 340
           +     + E  +L  ++    LV L        +  L+ +++    L   +     RE  
Sbjct: 70  KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERF 126

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           T  +    +  I   L +LH+   L II+RD+K  NILLDS  +  ++DFG+++ F  D+
Sbjct: 127 TEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183

Query: 401 TH 402
           T 
Sbjct: 184 TE 185

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 99.9 bits (248), Expect = 2e-25
 Identities = 31/155 (20%), Positives = 55/155 (35%), Gaps = 20/155 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQ--------GEIEFKNEVLLLARLQH 299
             +G+G   AV+           VK  ++   S +        G++ F    +  AR + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           R L +L G  + +      Y +  NA L   I               ++++ I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +      I+H DL   N+L+  E    I DF  + 
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 2e-24
 Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 27/193 (13%)

Query: 235 DFETIRVATDNFSDANK------LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEI 285
            F ++ V    F+   +      +G G  G V           +A+K+LS+   ++    
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCL------ERKERILVYEFVPNASLDHFIFDPINREH 339
               E++L+  + H+N++ LL          E ++  LV E +              +  
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QME 115

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           +  E+   ++  +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR     
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 400 QTHSDTNRVVGTL 412
                    V T 
Sbjct: 173 FM---MTPYVVTR 182

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 1e-23
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 7/176 (3%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLL 293
           +TI    + + + + +G G +G+V        G  +AVK+LS+   S         E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 294 LARLQHRNLVRLLGFCL-ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           L  ++H N++ LL      R        ++    +   + + +  + +T +    +I  I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR  + + T     R 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.6 bits (218), Expect = 5e-20
 Identities = 31/175 (17%), Positives = 60/175 (34%), Gaps = 18/175 (10%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           KLG G F  V+    + N   +A+K +  +    E   ++E+ LL R+   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78

Query: 310 LERKERILVYEFVPNASLDHFIFDP-------------INREHMTWEKRYKIIEGIARGL 356
                ++L +      +  H +                     +      +I + +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDTNRVVG 410
            Y+H   R  IIH D+K  N+L++       +    +A L             + 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	412
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.98
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.98
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.69
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.21
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.72
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.38
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.85
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.71

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-36  Score=275.82  Aligned_cols=164  Identities=29%  Similarity=0.448  Sum_probs=141.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|+..++||+|+||+||+|.. .+|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..+||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            36788999999999999999995 5789999999976533 234568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++++||+|||+|+.+..+.
T Consensus        84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            9999999999853   457999999999999999999999988   9999999999999999999999999999886555


Q ss_pred             cccccccccccC
Q 015138          401 THSDTNRVVGTL  412 (412)
Q Consensus       401 ~~~~~~~~~Gt~  412 (412)
                      .....+..+||+
T Consensus       158 ~~~~~~~~~GT~  169 (271)
T d1nvra_         158 RERLLNKMCGTL  169 (271)
T ss_dssp             EECCBCCCCSCG
T ss_pred             ccccccceeeCc
Confidence            443344577874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-36  Score=279.45  Aligned_cols=162  Identities=29%  Similarity=0.511  Sum_probs=143.6

Q ss_pred             chHHHHhhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC
Q 015138          235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (412)
Q Consensus       235 ~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  313 (412)
                      .++++++..++|+..++||+|+||.||+|.. .+++.||||+++... ...++|.+|+.+|++++|||||+++|++.+.+
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            3445666778899999999999999999996 458899999987654 34567999999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..+|||||+++|+|.+++... ....+++..++.|+.||+.||.|||+++   |+||||||+||||++++++||+|||+|
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eeEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccce
Confidence            999999999999999998542 3467999999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCc
Q 015138          394 RLFEMDQT  401 (412)
Q Consensus       394 ~~~~~~~~  401 (412)
                      +....+..
T Consensus       163 ~~~~~~~~  170 (287)
T d1opja_         163 RLMTGDTY  170 (287)
T ss_dssp             TTCCSSSS
T ss_pred             eecCCCCc
Confidence            98765543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=273.17  Aligned_cols=160  Identities=27%  Similarity=0.462  Sum_probs=142.8

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      ++|+..++||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            5799999999999999999994 679999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCcc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~  402 (412)
                      ++|+|.+++.    ...+++..+..|+.||+.||.|||+++   |+||||||+|||++.++++||+|||+|+.+..+...
T Consensus       100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            9999999874    346999999999999999999999988   999999999999999999999999999988655433


Q ss_pred             cccccccccC
Q 015138          403 SDTNRVVGTL  412 (412)
Q Consensus       403 ~~~~~~~Gt~  412 (412)
                      .  ...+||+
T Consensus       173 ~--~~~~gt~  180 (293)
T d1yhwa1         173 R--STMVGTP  180 (293)
T ss_dssp             B--CCCCSCG
T ss_pred             c--cccccCC
Confidence            2  2356763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-36  Score=272.24  Aligned_cols=162  Identities=31%  Similarity=0.510  Sum_probs=132.4

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .++|+..++||+|+||.||+|.+.+++.||||++.... ....+|.+|+.++++++||||++++|++...+..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46788899999999999999999888999999997644 34568999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCcc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~  402 (412)
                      ++|+|.+++..  ....++|..++.|+.|++.||.|||+++   |+||||||+||||++++++||+|||+|+.+......
T Consensus        83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999865  3466899999999999999999999987   999999999999999999999999999987654432


Q ss_pred             ccccccccc
Q 015138          403 SDTNRVVGT  411 (412)
Q Consensus       403 ~~~~~~~Gt  411 (412)
                      . .....||
T Consensus       158 ~-~~~~~gt  165 (263)
T d1sm2a_         158 S-STGTKFP  165 (263)
T ss_dssp             --------C
T ss_pred             e-ecceecC
Confidence            2 2234555

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-36  Score=274.37  Aligned_cols=164  Identities=31%  Similarity=0.503  Sum_probs=134.4

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ++..++|+..++||+|+||.||+|++.  ..||||++...  .......|.+|+.++.+++|||||+++|++.+ +..+|
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            445678999999999999999999874  36999998754  33445679999999999999999999998754 56899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++..  ....+++..++.|+.||++||+|||+++   ||||||||+||||+.++++||+|||+|+...
T Consensus        81 v~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            9999999999999864  2456999999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCCccccccccccc
Q 015138          398 MDQTHSDTNRVVGT  411 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt  411 (412)
                      ..........+.||
T Consensus       156 ~~~~~~~~~~~~gt  169 (276)
T d1uwha_         156 RWSGSHQFEQLSGS  169 (276)
T ss_dssp             ----------CCCC
T ss_pred             ccCCcccccccccC
Confidence            54443334446676

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-36  Score=273.28  Aligned_cols=166  Identities=32%  Similarity=0.516  Sum_probs=141.0

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      +++..++|+..++||+|+||.||+|.+++++.||||++.... .....|.+|+.++.+++|||||+++|++.+ +..+||
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            344567888899999999999999999888899999997644 345679999999999999999999998754 567999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++... ....++|..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+|+.+..
T Consensus        86 ~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence            9999999999987442 2335999999999999999999999987   99999999999999999999999999998865


Q ss_pred             CCccccccccccc
Q 015138          399 DQTHSDTNRVVGT  411 (412)
Q Consensus       399 ~~~~~~~~~~~Gt  411 (412)
                      ..... .....||
T Consensus       162 ~~~~~-~~~~~gt  173 (272)
T d1qpca_         162 NEYTA-REGAKFP  173 (272)
T ss_dssp             SCEEC-CTTCCCC
T ss_pred             Ccccc-ccccCCc
Confidence            54332 2234555

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=272.91  Aligned_cols=150  Identities=29%  Similarity=0.434  Sum_probs=136.8

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      +.|++.++||+|+||.||+|.. .+++.||||++..........+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5678899999999999999995 578999999998776666677999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ++|+|.+++.+  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+|+.+..
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            99999998753  2456999999999999999999999998   99999999999999999999999999987643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=260.99  Aligned_cols=153  Identities=27%  Similarity=0.490  Sum_probs=139.3

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      .++|+..++||+|+||+||+|++++++.||||++++... ...+|.+|+.++.+++||||++++|++.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            478999999999999999999998888999999986543 4568999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~  401 (412)
                      ++|+|..++..  ....+++..+.+|+.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            99999999754  3456899999999999999999999987   99999999999999999999999999998765543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=276.97  Aligned_cols=162  Identities=28%  Similarity=0.379  Sum_probs=140.5

Q ss_pred             hhhcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ...++|+..++||+|+||+||+|.. .+|+.||+|++..... .....+.+|+.+|++++|||||++++++.+.+..+||
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4568899999999999999999995 5789999999976533 3345789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-CCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      |||+++|+|.+++.+   ...+++..+..++.|++.||.|||+. +   |+||||||+||||+.++++||+|||+|+.+.
T Consensus        83 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            999999999999854   45699999999999999999999974 6   9999999999999999999999999999875


Q ss_pred             CCCcccccccccccC
Q 015138          398 MDQTHSDTNRVVGTL  412 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt~  412 (412)
                      +...    +..+||+
T Consensus       157 ~~~~----~~~~GT~  167 (322)
T d1s9ja_         157 DSMA----NSFVGTR  167 (322)
T ss_dssp             HHTC-------CCSS
T ss_pred             CCcc----ccccCCc
Confidence            4322    2356773

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.4e-35  Score=268.81  Aligned_cols=154  Identities=32%  Similarity=0.557  Sum_probs=125.8

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCC---EEEEEEeccCC-cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGE---TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~---~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..++||+|+||+||+|... +++   .||||++.... .....+|.+|+.+|++++|||||+++|++.+.+..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            356777889999999999999964 332   58999887643 3445679999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ||||+++|+|.+++..  ....++|.+++.|+.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+.+.
T Consensus       105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999998854  3456999999999999999999999987   9999999999999999999999999999886


Q ss_pred             CCCc
Q 015138          398 MDQT  401 (412)
Q Consensus       398 ~~~~  401 (412)
                      .+..
T Consensus       180 ~~~~  183 (299)
T d1jpaa_         180 DDTS  183 (299)
T ss_dssp             ----
T ss_pred             CCCC
Confidence            5543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-35  Score=268.55  Aligned_cols=163  Identities=28%  Similarity=0.385  Sum_probs=138.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|++.+.||+|+||+||+|.. .+++.||||.+.+..   ......+.+|+.++++++||||+++++++.+.+..+|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            6789999999999999999995 578999999987532   234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998843   467999999999999999999999988   999999999999999999999999999988655


Q ss_pred             CcccccccccccC
Q 015138          400 QTHSDTNRVVGTL  412 (412)
Q Consensus       400 ~~~~~~~~~~Gt~  412 (412)
                      .........+||+
T Consensus       162 ~~~~~~~~~~GT~  174 (288)
T d1uu3a_         162 SKQARANSFVGTA  174 (288)
T ss_dssp             --------CCCCG
T ss_pred             CcccccccccCCc
Confidence            4444444567874

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-35  Score=263.01  Aligned_cols=158  Identities=28%  Similarity=0.449  Sum_probs=138.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|++.+.||+|+||.||+|.. .+++.||||.+.+..   ......+.+|+.++++++||||+++++++.+.+..+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5788899999999999999996 568999999986532   234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|.+++..   ...+++..+..|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....+
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999853   456999999999999999999999988   999999999999999999999999999877544


Q ss_pred             Cccccccccccc
Q 015138          400 QTHSDTNRVVGT  411 (412)
Q Consensus       400 ~~~~~~~~~~Gt  411 (412)
                      ..    ....||
T Consensus       160 ~~----~~~~Gt  167 (263)
T d2j4za1         160 RR----TTLCGT  167 (263)
T ss_dssp             CC----EETTEE
T ss_pred             cc----cccCCC
Confidence            32    235566

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-35  Score=266.65  Aligned_cols=155  Identities=29%  Similarity=0.505  Sum_probs=133.0

Q ss_pred             HhhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       240 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++..++|++.+.||+|+||.||+|...+++.||||++.... .....|.+|+.++++++|||||+++|++.+ ++.++||
T Consensus        13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            34457788999999999999999999888899999997544 345679999999999999999999999854 5689999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|.+++... ....++|..++.|+.||+.||+|||+++   |+||||||+||||+.++++||+|||+|+.+...
T Consensus        91 Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          91 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999999999988542 2346999999999999999999999987   999999999999999999999999999987654


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       167 ~  167 (285)
T d1fmka3         167 E  167 (285)
T ss_dssp             -
T ss_pred             C
Confidence            4

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-35  Score=264.87  Aligned_cols=167  Identities=28%  Similarity=0.437  Sum_probs=128.0

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec--CCeeeEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILV  318 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv  318 (412)
                      ++|+..+.||+|+||.||+|.. .+|+.||||.+....  ......+.+|+.++++++|||||++++++.+  ....+||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6789999999999999999995 678999999997653  2334568999999999999999999999865  4568999


Q ss_pred             EecCCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhHhCC--CCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          319 YEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDS--RLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      |||+++|+|.+++... .....+++..++.++.|++.||.|||+.+  ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998532 12457999999999999999999999854  23599999999999999999999999999998


Q ss_pred             ccCCCcccccccccccC
Q 015138          396 FEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       396 ~~~~~~~~~~~~~~Gt~  412 (412)
                      +..+...  .....||+
T Consensus       164 ~~~~~~~--~~~~~gt~  178 (269)
T d2java1         164 LNHDTSF--AKAFVGTP  178 (269)
T ss_dssp             C-------------CCC
T ss_pred             cccCCCc--cccCCCCc
Confidence            8654432  22366763

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-34  Score=263.16  Aligned_cols=153  Identities=31%  Similarity=0.562  Sum_probs=132.0

Q ss_pred             hhcCCCccc-cccccCCeeEEEEEeC---CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          242 ATDNFSDAN-KLGQGGFGAVYKGMLS---NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       242 ~~~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      ..++|...+ +||+|+||.||+|.+.   ++..||||.++.... ....+|.+|+++|.+++|||||+++|++.. +..+
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            345566666 4999999999999853   345799999976543 345679999999999999999999999865 5689


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      |||||+++|+|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+
T Consensus        85 lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999999744  3457999999999999999999999987   999999999999999999999999999988


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ....
T Consensus       160 ~~~~  163 (285)
T d1u59a_         160 GADD  163 (285)
T ss_dssp             TTCS
T ss_pred             cccc
Confidence            6554

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-34  Score=268.62  Aligned_cols=170  Identities=26%  Similarity=0.381  Sum_probs=139.3

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCC-C-----CEEEEEEeccCC-cccHHHHHHHHHHHccC-CCCccceeeEEEe
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-G-----ETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~-----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~  310 (412)
                      ++...++|+..++||+|+||+||+|+... +     ..||||.+.... ......+.+|+.++.++ +|||||+++|++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            44566789999999999999999999532 2     269999986543 33345789999999998 8999999999999


Q ss_pred             cCCeeeEEEecCCCCChhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceec
Q 015138          311 ERKERILVYEFVPNASLDHFIFDPIN--------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR  370 (412)
Q Consensus       311 ~~~~~~lv~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHr  370 (412)
                      +.+..+|||||+++|+|.++|.....                    ...++|..++.|+.||+.||.|||+++   |+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence            99999999999999999999965321                    235899999999999999999999987   9999


Q ss_pred             CCCCCCEEECCCCCeEEeccCCcccccCCCccccccccccc
Q 015138          371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       371 dlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      ||||+|||++.++++||+|||+|+...............||
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  229 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP  229 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence            99999999999999999999999987665543333335555

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.8e-34  Score=267.55  Aligned_cols=153  Identities=25%  Similarity=0.458  Sum_probs=138.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      ++|++.++||+|+||.||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5789999999999999999995 678999999998776666677999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC--CCCeEEeccCCcccccCCC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DfGla~~~~~~~  400 (412)
                      ++|+|.+++.+  ....+++..+..|+.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+|+.+....
T Consensus       106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999999854  3456999999999999999999999998   999999999999964  5789999999999876554


Q ss_pred             c
Q 015138          401 T  401 (412)
Q Consensus       401 ~  401 (412)
                      .
T Consensus       181 ~  181 (350)
T d1koaa2         181 S  181 (350)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.9e-34  Score=266.65  Aligned_cols=153  Identities=27%  Similarity=0.425  Sum_probs=138.2

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      ++|++.++||+|+||.||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5788999999999999999995 679999999998776666667899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC--CCCCeEEeccCCcccccCCC
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD--SEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~ki~DfGla~~~~~~~  400 (412)
                      ++|+|.+++..  ....+++..+..|+.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+|+.+..+.
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999887743  3456999999999999999999999988   99999999999998  56899999999999887654


Q ss_pred             c
Q 015138          401 T  401 (412)
Q Consensus       401 ~  401 (412)
                      .
T Consensus       184 ~  184 (352)
T d1koba_         184 I  184 (352)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-34  Score=262.21  Aligned_cols=153  Identities=32%  Similarity=0.593  Sum_probs=129.0

Q ss_pred             hcCCCccccccccCCeeEEEEEeCCC-----CEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCCeee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLSNG-----ETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~~~-----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  316 (412)
                      .+.|+..++||+|+||.||+|.+.+.     ..||||++..... ....+|.+|+.++.+++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            45677889999999999999996432     3699999976543 33457899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +||||+.+++|.+++..  ....++|..++.|+.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+|+.+
T Consensus        86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999988754  3467999999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ..+.
T Consensus       161 ~~~~  164 (283)
T d1mqba_         161 EDDP  164 (283)
T ss_dssp             ----
T ss_pred             cCCC
Confidence            6554

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-34  Score=257.13  Aligned_cols=158  Identities=31%  Similarity=0.437  Sum_probs=132.6

Q ss_pred             CccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec----CCeeeEEE
Q 015138          247 SDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERILVY  319 (412)
Q Consensus       247 ~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~lv~  319 (412)
                      +..++||+|+||+||+|.. .+++.||+|++....  ......|.+|+++|++++|||||++++++.+    ....+|||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4566899999999999995 568899999987543  3345578999999999999999999999865    34679999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC-CCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+++ ++|+||||||+||||+ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999853   457999999999999999999999875 4599999999999996 578999999999987544


Q ss_pred             CCcccccccccccC
Q 015138          399 DQTHSDTNRVVGTL  412 (412)
Q Consensus       399 ~~~~~~~~~~~Gt~  412 (412)
                      ...    ...+||+
T Consensus       168 ~~~----~~~~GT~  177 (270)
T d1t4ha_         168 SFA----KAVIGTP  177 (270)
T ss_dssp             TSB----EESCSSC
T ss_pred             Ccc----CCcccCc
Confidence            332    2366774

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-34  Score=263.94  Aligned_cols=172  Identities=26%  Similarity=0.445  Sum_probs=143.0

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEE
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFC  309 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~  309 (412)
                      .+++...++|+..++||+|+||.||+|++.      +++.||||++...... ...+|.+|+.++++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            445667789999999999999999999863      4578999999765433 355799999999999999999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCC---------------------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCce
Q 015138          310 LERKERILVYEFVPNASLDHFIFDP---------------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRII  368 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv  368 (412)
                      ...+..++||||+++|+|.+++...                     .....+++..++.|+.|++.||+|||+++   ||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence            9999999999999999999998531                     12335899999999999999999999987   99


Q ss_pred             ecCCCCCCEEECCCCCeEEeccCCcccccCCCccccccccccc
Q 015138          369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       369 Hrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      ||||||+||||+.++++||+|||+|+.+.+...........||
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~  205 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP  205 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBC
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcC
Confidence            9999999999999999999999999987655433333334454

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-34  Score=265.83  Aligned_cols=162  Identities=26%  Similarity=0.299  Sum_probs=141.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      .++|+..+.||+|+||.||++.. .+|+.||||++.+..   ......+.+|+.+|++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46799999999999999999994 679999999997542   23456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999854   467899999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCcccccccccccC
Q 015138          399 DQTHSDTNRVVGTL  412 (412)
Q Consensus       399 ~~~~~~~~~~~Gt~  412 (412)
                      ....  ....+||+
T Consensus       158 ~~~~--~~~~~GT~  169 (337)
T d1o6la_         158 DGAT--MKTFCGTP  169 (337)
T ss_dssp             TTCC--BCCCEECG
T ss_pred             CCcc--cccceeCH
Confidence            3332  23467773

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.9e-34  Score=262.03  Aligned_cols=149  Identities=34%  Similarity=0.509  Sum_probs=133.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      +.|+..++||+|+||.||+|.. .+++.||||++......   ....+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3488899999999999999994 67889999999765433   2346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+++|+|..++..   ...+++..+..|+.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+....
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            99999999877643   457999999999999999999999998   99999999999999999999999999997654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-33  Score=256.79  Aligned_cols=155  Identities=28%  Similarity=0.494  Sum_probs=127.8

Q ss_pred             ccccccCCeeEEEEEeCC---CCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEecCCC
Q 015138          250 NKLGQGGFGAVYKGMLSN---GETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~---~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey~~~  324 (412)
                      ++||+|+||+||+|.+.+   ++.||||+++....  ....+|.+|+.+|++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   46799999975432  234579999999999999999999999865 467899999999


Q ss_pred             CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCcccc
Q 015138          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (412)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~  404 (412)
                      |+|.+++..   ...++|..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+........
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854   456999999999999999999999987   99999999999999999999999999998765543322


Q ss_pred             -ccccccc
Q 015138          405 -TNRVVGT  411 (412)
Q Consensus       405 -~~~~~Gt  411 (412)
                       .....||
T Consensus       166 ~~~~~~gt  173 (277)
T d1xbba_         166 AQTHGKWP  173 (277)
T ss_dssp             C----CCC
T ss_pred             cccccCCC
Confidence             2234555

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.3e-33  Score=255.64  Aligned_cols=152  Identities=25%  Similarity=0.383  Sum_probs=136.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---------cHHHHHHHHHHHccCC-CCccceeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---------GEIEFKNEVLLLARLQ-HRNLVRLLGFCLE  311 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~g~~~~  311 (412)
                      .++|+..+.||+|+||+||+++. .+|+.||||++.+....         ....+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36788999999999999999995 67899999999765321         1235789999999997 9999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccC
Q 015138          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (412)
Q Consensus       312 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfG  391 (412)
                      ++..+|||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999954   457999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccccCCC
Q 015138          392 MARLFEMDQ  400 (412)
Q Consensus       392 la~~~~~~~  400 (412)
                      +|+.+.++.
T Consensus       156 ~a~~~~~~~  164 (277)
T d1phka_         156 FSCQLDPGE  164 (277)
T ss_dssp             TCEECCTTC
T ss_pred             heeEccCCC
Confidence            999886544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-33  Score=260.31  Aligned_cols=161  Identities=25%  Similarity=0.381  Sum_probs=123.9

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .+.|+..+.||+|+||+||+|.. .+++.||||.+.+.... ....+.+|+.+|++++||||+++++++.+.+..+||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35688899999999999999995 56899999999765432 34468899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEEC---CCCCeEEeccCCccccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD---SEMNPKISDFGMARLFE  397 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DfGla~~~~  397 (412)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+.   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999954   457999999999999999999999988   99999999999995   57899999999999776


Q ss_pred             CCCcccccccccccC
Q 015138          398 MDQTHSDTNRVVGTL  412 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt~  412 (412)
                      .+...   ...+||+
T Consensus       162 ~~~~~---~~~~GT~  173 (307)
T d1a06a_         162 PGSVL---STACGTP  173 (307)
T ss_dssp             --------------C
T ss_pred             CCCee---eeeeeCc
Confidence            54432   2356774

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-33  Score=259.89  Aligned_cols=158  Identities=27%  Similarity=0.379  Sum_probs=138.9

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|++.++||+|+||+||++.. .+|+.||||++.+..   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5788999999999999999995 678999999997542   234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|..++..   ...+++.....++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998853   556888999999999999999999987   999999999999999999999999999987543


Q ss_pred             CcccccccccccC
Q 015138          400 QTHSDTNRVVGTL  412 (412)
Q Consensus       400 ~~~~~~~~~~Gt~  412 (412)
                      ..     ...||+
T Consensus       158 ~~-----~~~Gt~  165 (316)
T d1fota_         158 TY-----TLCGTP  165 (316)
T ss_dssp             BC-----CCCSCT
T ss_pred             cc-----cccCcc
Confidence            22     356764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-33  Score=259.93  Aligned_cols=172  Identities=26%  Similarity=0.452  Sum_probs=144.9

Q ss_pred             HHHHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEE
Q 015138          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFC  309 (412)
Q Consensus       237 ~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~  309 (412)
                      +++++..++|+..++||+|+||.||+|.+.      ++..||||++.+... .....|.+|+.++++++||||++++|++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            455666788899999999999999999863      357899999976533 3345689999999999999999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCC-------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC
Q 015138          310 LERKERILVYEFVPNASLDHFIFDP-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE  382 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~  382 (412)
                      ...+..++||||+++|+|.+++...       .....+++..+..|+.|+++||.|||+++   |+||||||+||||+.+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence            9999999999999999999987431       22345899999999999999999999987   9999999999999999


Q ss_pred             CCeEEeccCCcccccCCCccccccccccc
Q 015138          383 MNPKISDFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       383 ~~~ki~DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      +++||+|||+|+.+.............||
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t  198 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLP  198 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEEC
T ss_pred             ceEEEeecccceeccCCcceeeccceecc
Confidence            99999999999988665544434344555

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-33  Score=259.20  Aligned_cols=176  Identities=28%  Similarity=0.400  Sum_probs=135.5

Q ss_pred             cchHHHHhhhcCCCccccccccCCeeEEEEEeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCcccee
Q 015138          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRL  305 (412)
Q Consensus       234 ~~~~~l~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l  305 (412)
                      ++..++++..++|+..++||+|+||.||+|...      +++.||||++..... .....+.+|+..+.++ +|+||+++
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            455667777789999999999999999999852      346899999976433 3345678888888777 68999999


Q ss_pred             eEEEecC-CeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecC
Q 015138          306 LGFCLER-KERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD  371 (412)
Q Consensus       306 ~g~~~~~-~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrd  371 (412)
                      ++++... ...++||||+++|+|.+++....             ....+++..++.++.||+.||.|||+++   |+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence            9998765 46899999999999999985421             2345899999999999999999999987   99999


Q ss_pred             CCCCCEEECCCCCeEEeccCCcccccCCCcccccccccccC
Q 015138          372 LKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       372 lk~~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      |||+||||++++++||+|||+|+..........+....||+
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~  200 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  200 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence            99999999999999999999999876655444444566773

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.1e-32  Score=253.79  Aligned_cols=152  Identities=31%  Similarity=0.468  Sum_probs=135.6

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC------cccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS------KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      .+.|+..++||+|+||+||+|.. .+|+.||||++.+..      ......+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36789999999999999999995 678999999986542      12356799999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC----CeEEeccC
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DfG  391 (412)
                      +|||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999854   457999999999999999999999988   99999999999998876    49999999


Q ss_pred             CcccccCCC
Q 015138          392 MARLFEMDQ  400 (412)
Q Consensus       392 la~~~~~~~  400 (412)
                      +|+.+....
T Consensus       163 ~a~~~~~~~  171 (293)
T d1jksa_         163 LAHKIDFGN  171 (293)
T ss_dssp             TCEECTTSC
T ss_pred             hhhhcCCCc
Confidence            999876543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.2e-33  Score=258.27  Aligned_cols=163  Identities=29%  Similarity=0.563  Sum_probs=132.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCC----EEEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  317 (412)
                      ++|+..++||+|+||+||+|.+ .+|+    +||||++... +.....+|.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            5688999999999999999995 3444    5899988754 344567899999999999999999999999875 5678


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~  397 (412)
                      ++||+.+|+|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999988754  3567999999999999999999999987   9999999999999999999999999999887


Q ss_pred             CCCcccccccccccC
Q 015138          398 MDQTHSDTNRVVGTL  412 (412)
Q Consensus       398 ~~~~~~~~~~~~Gt~  412 (412)
                      .......+....||+
T Consensus       163 ~~~~~~~~~~~~gt~  177 (317)
T d1xkka_         163 AEEKEYHAEGGKVPI  177 (317)
T ss_dssp             TTCC--------CCT
T ss_pred             cccccccccccccCc
Confidence            655544444455663

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.9e-32  Score=253.75  Aligned_cols=152  Identities=23%  Similarity=0.370  Sum_probs=134.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .++|++.++||+|+||+||+|.. .+++.||||.+..... ....+.+|+.+|+.++||||+++++++.+.+..+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            36788899999999999999995 5688999999976543 334688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC--CCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE--MNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~--~~~ki~DfGla~~~~~~  399 (412)
                      +++|+|.+++..  ....+++.++..|+.||+.||.|||+.+   |+||||||+|||++.+  .++||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999854  2346999999999999999999999988   9999999999999854  48999999999987654


Q ss_pred             C
Q 015138          400 Q  400 (412)
Q Consensus       400 ~  400 (412)
                      .
T Consensus       158 ~  158 (321)
T d1tkia_         158 D  158 (321)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=2.1e-32  Score=257.40  Aligned_cols=149  Identities=26%  Similarity=0.309  Sum_probs=135.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  319 (412)
                      ++|+..++||+|+||.||++.. .+|+.||||++.+..   ......+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6799999999999999999995 579999999986532   233456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      ||+.+|+|.+++..   ...+++..+..|+.||+.||.|||+++   ||||||||+||||+.++++||+|||+|+.+..
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999854   457999999999999999999999988   99999999999999999999999999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=2.4e-32  Score=258.44  Aligned_cols=160  Identities=28%  Similarity=0.341  Sum_probs=135.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHH---HHHHHHccCCCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFK---NEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      .++|++.++||+|+||.||+|.. .+|+.||||.+.+..   ......+.   +|+.+++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            36789999999999999999995 579999999986532   12222333   447778888999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +|||||+++|+|.++|..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999854   456889999999999999999999988   99999999999999999999999999998


Q ss_pred             ccCCCcccccccccccC
Q 015138          396 FEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       396 ~~~~~~~~~~~~~~Gt~  412 (412)
                      +......    ...||+
T Consensus       157 ~~~~~~~----~~~GT~  169 (364)
T d1omwa3         157 FSKKKPH----ASVGTH  169 (364)
T ss_dssp             CSSSCCC----SCCSCG
T ss_pred             cCCCccc----cccccc
Confidence            7654432    345663

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.1e-33  Score=251.76  Aligned_cols=164  Identities=21%  Similarity=0.365  Sum_probs=126.0

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCC----CCEEEEEEeccCCcc-cHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      +..++|+..+.||+|+||.||+|....    +..||||.+...... ....|.+|+.++++++||||++++|++. .+..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            445788899999999999999998632    346899998654433 3557999999999999999999999986 4678


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence            999999999999998754  3457999999999999999999999988   99999999999999999999999999998


Q ss_pred             ccCCCccccccccccc
Q 015138          396 FEMDQTHSDTNRVVGT  411 (412)
Q Consensus       396 ~~~~~~~~~~~~~~Gt  411 (412)
                      +....... +....||
T Consensus       158 ~~~~~~~~-~~~~~gt  172 (273)
T d1mp8a_         158 MEDSTYYK-ASKGKLP  172 (273)
T ss_dssp             --------------CC
T ss_pred             ccCCccee-ccceecC
Confidence            76544322 2234455

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-32  Score=254.38  Aligned_cols=171  Identities=27%  Similarity=0.381  Sum_probs=144.8

Q ss_pred             HHHhhhcCCCccccccccCCeeEEEEEe------CCCCEEEEEEeccCCcc-cHHHHHHHHHHHccC-CCCccceeeEEE
Q 015138          238 TIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARL-QHRNLVRLLGFC  309 (412)
Q Consensus       238 ~l~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~g~~  309 (412)
                      .++...++|+..++||+|+||.||+|++      .+++.||||++...... ...+|.+|+.+++++ +|||||+++|++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            3455668899999999999999999985      34568999999765433 445789999999999 699999999999


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCC
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPI---------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKA  374 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~  374 (412)
                      .+....+|||||+++|+|.+++....               ....+++..++.++.||+.||+|||+++   |+||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence            99999999999999999999985421               2336899999999999999999999998   99999999


Q ss_pred             CCEEECCCCCeEEeccCCcccccCCCccccccccccc
Q 015138          375 SNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       375 ~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      +|||++.++.+||+|||+++...............||
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt  210 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP  210 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccC
Confidence            9999999999999999999988765544444445665

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-32  Score=251.73  Aligned_cols=152  Identities=29%  Similarity=0.490  Sum_probs=130.5

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..++||+|+||+||+|.. .+|+.||||++.....  .....+.+|+.++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6889999999999999999994 6799999999965432  234578999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      |+.++.+......  ....+++..+..++.|++.||.|||+++   ||||||||+|||++.++++||+|||+|+....+.
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9976555444322  3456999999999999999999999988   9999999999999999999999999999875443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.1e-32  Score=252.43  Aligned_cols=160  Identities=28%  Similarity=0.394  Sum_probs=136.4

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC---cccHHHHHHHHHHHc-cCCCCccceeeEEEecCCeeeEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLA-RLQHRNLVRLLGFCLERKERILV  318 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~g~~~~~~~~~lv  318 (412)
                      ++|++.++||+|+||+||+|.. .+++.||||++.+..   ......+..|..++. .++||||+++++++.+++..+||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5788999999999999999995 578999999997542   233445667777665 68999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccC
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~  398 (412)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++++||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999854   456899999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCccccccccccc
Q 015138          399 DQTHSDTNRVVGT  411 (412)
Q Consensus       399 ~~~~~~~~~~~Gt  411 (412)
                      ....  .....||
T Consensus       156 ~~~~--~~~~~gt  166 (320)
T d1xjda_         156 GDAK--TNTFCGT  166 (320)
T ss_dssp             TTCC--BCCCCSC
T ss_pred             cccc--ccccCCC
Confidence            4332  2235666

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.3e-32  Score=250.06  Aligned_cols=147  Identities=29%  Similarity=0.412  Sum_probs=126.2

Q ss_pred             ccccccccCCeeEEEEEe-CCCCEEEEEEeccCCccc-----HHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          248 DANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG-----EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      .+++||+|+||+||+|.. .+|+.||||++.......     ...+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999995 578999999987543221     23588999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      +.++++..++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            99988877663   3566888999999999999999999988   9999999999999999999999999999876544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-32  Score=249.53  Aligned_cols=153  Identities=33%  Similarity=0.489  Sum_probs=124.9

Q ss_pred             hcCCCccccccccCCeeEEEEEeC--CC--CEEEEEEeccCC---cccHHHHHHHHHHHccCCCCccceeeEEEecCCee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS--NG--ETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~--~~--~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  315 (412)
                      .++|+..+.||+|+||.||+|++.  ++  ..||||++.+..   .....+|.+|+.++++++||||++++|++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            467888999999999999999853  23  368999987542   2334579999999999999999999999976 467


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       316 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ++||||+++|+|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            899999999999988754  3456999999999999999999999987   99999999999999999999999999998


Q ss_pred             ccCCCc
Q 015138          396 FEMDQT  401 (412)
Q Consensus       396 ~~~~~~  401 (412)
                      +.....
T Consensus       161 ~~~~~~  166 (273)
T d1u46a_         161 LPQNDD  166 (273)
T ss_dssp             CCC-CC
T ss_pred             cccCCC
Confidence            866544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.9e-32  Score=249.51  Aligned_cols=170  Identities=25%  Similarity=0.386  Sum_probs=137.8

Q ss_pred             HHhhhcCCCccccccccCCeeEEEEEeCC--------CCEEEEEEeccCCc-ccHHHHHHHHHHHccC-CCCccceeeEE
Q 015138          239 IRVATDNFSDANKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGF  308 (412)
Q Consensus       239 l~~~~~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~  308 (412)
                      +.+..++|+..++||+|+||.||+|+...        +..||||++.+... ....++.+|...+.++ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            33456788889999999999999998522        24799999977544 3456788999999888 89999999999


Q ss_pred             EecCCeeeEEEecCCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCC
Q 015138          309 CLERKERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS  375 (412)
Q Consensus       309 ~~~~~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~  375 (412)
                      +.++...++||||+++|+|.++|....             ....+++..++.++.||+.||+|||+.+   ||||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence            999999999999999999999996532             1345899999999999999999999998   999999999


Q ss_pred             CEEECCCCCeEEeccCCcccccCCCccccccccccc
Q 015138          376 NILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT  411 (412)
Q Consensus       376 Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~Gt  411 (412)
                      |||++.++.+||+|||+++..........+....||
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  200 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP  200 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCG
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCC
Confidence            999999999999999999988765544433445554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-31  Score=246.74  Aligned_cols=148  Identities=29%  Similarity=0.514  Sum_probs=128.5

Q ss_pred             cccccccCCeeEEEEEeCCC----CEEEEEEeccC-CcccHHHHHHHHHHHccCCCCccceeeEEEec-CCeeeEEEecC
Q 015138          249 ANKLGQGGFGAVYKGMLSNG----ETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKERILVYEFV  322 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~~----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv~Ey~  322 (412)
                      .++||+|+||+||+|.+.++    ..||||++.+. ......+|.+|+++|++++||||++++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999996432    25899999754 34445679999999999999999999999876 45889999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCCc
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~~  401 (412)
                      ++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++.+.....
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999865  3456888999999999999999999987   99999999999999999999999999998765543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.9e-32  Score=249.82  Aligned_cols=153  Identities=32%  Similarity=0.561  Sum_probs=132.0

Q ss_pred             hcCCCccccccccCCeeEEEEEeC-CCC--EEEEEEeccC-CcccHHHHHHHHHHHccC-CCCccceeeEEEecCCeeeE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGMLS-NGE--TIAVKRLSKN-SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  317 (412)
                      .++|+..++||+|+||.||+|.+. ++.  .||||++... ......+|.+|+++|.++ +|||||+++|++.+.+..++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            367888999999999999999964 344  4788888654 333455799999999999 79999999999999999999


Q ss_pred             EEecCCCCChhhhccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCC
Q 015138          318 VYEFVPNASLDHFIFDP-------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~  384 (412)
                      ||||+++|+|.++|...             .....++|..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            99999999999998653             23467999999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCcccccC
Q 015138          385 PKISDFGMARLFEM  398 (412)
Q Consensus       385 ~ki~DfGla~~~~~  398 (412)
                      +||+|||+|+....
T Consensus       166 ~kl~DfG~a~~~~~  179 (309)
T d1fvra_         166 AKIADFGLSRGQEV  179 (309)
T ss_dssp             EEECCTTCEESSCE
T ss_pred             eEEccccccccccc
Confidence            99999999987653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.5e-32  Score=249.50  Aligned_cols=163  Identities=28%  Similarity=0.377  Sum_probs=130.0

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecCC----eeeEEE
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----ERILVY  319 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~lv~  319 (412)
                      .+|...++||+|+||.||+|++ +|+.||||++...... ...+..|+..+.+++||||++++|++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            3456678999999999999997 5889999998654322 222345666667889999999999998654    578999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC-----CCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-----SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ||+++|+|.++|.+    ..++|..++.++.|++.||.|||+.     +.++|+||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999953    4699999999999999999999974     12459999999999999999999999999999


Q ss_pred             cccCCCccc--ccccccccC
Q 015138          395 LFEMDQTHS--DTNRVVGTL  412 (412)
Q Consensus       395 ~~~~~~~~~--~~~~~~Gt~  412 (412)
                      .+.......  ......||+
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~  176 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTK  176 (303)
T ss_dssp             EEETTTTEECC----CCSCG
T ss_pred             cccCCCcceeccccceeccc
Confidence            886544321  223456663

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=9.6e-32  Score=246.74  Aligned_cols=150  Identities=28%  Similarity=0.492  Sum_probs=135.1

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~Ey  321 (412)
                      ++|+..++||+|+||+||+|...+|+.||||++.....  .....+.+|+.+|++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57888999999999999999988999999999976532  2356789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      +.++.+..+..   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|......
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            99888877763   3567999999999999999999999987   999999999999999999999999999987544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-32  Score=246.80  Aligned_cols=152  Identities=27%  Similarity=0.468  Sum_probs=126.8

Q ss_pred             hhhcCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecC-CeeeEEE
Q 015138          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-KERILVY  319 (412)
Q Consensus       241 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lv~  319 (412)
                      +..++|+..+.||+|+||.||+|.+. |..||||+++...  ..+.|.+|+.++++++||||++++|++.+. +..+|||
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            34567888899999999999999984 7899999996543  345799999999999999999999998654 5689999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCC
Q 015138          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (412)
Q Consensus       320 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~  399 (412)
                      ||+++|+|.++|... ....++|..++.|+.||+.||.|||+.+   |+||||||+|||++.++++||+|||+++.....
T Consensus        81 ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             eccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence            999999999998542 2235899999999999999999999987   999999999999999999999999999976543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=2.4e-31  Score=242.85  Aligned_cols=164  Identities=26%  Similarity=0.385  Sum_probs=132.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc---cHHHHHHHHHHHccCCCCccceeeEEEecCC----e
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERK----E  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~  314 (412)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.+.+....   ....|.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46789999999999999999994 67999999999765332   3456899999999999999999999987654    3


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .+|||||+++++|.+++..   ...+++.+++.|+.||+.||.|||+++   |+||||||+|||++.++..+|+|||+++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998843   457999999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCcc-cccccccccC
Q 015138          395 LFEMDQTH-SDTNRVVGTL  412 (412)
Q Consensus       395 ~~~~~~~~-~~~~~~~Gt~  412 (412)
                      ........ ......+||+
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~  178 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTA  178 (277)
T ss_dssp             ECC----------------
T ss_pred             hhccccccccccccccCcc
Confidence            76443321 2233456663

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.7e-31  Score=245.36  Aligned_cols=157  Identities=28%  Similarity=0.336  Sum_probs=130.2

Q ss_pred             cCCCccc-cccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccC-CCCccceeeEEEec----CCeee
Q 015138          244 DNFSDAN-KLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE----RKERI  316 (412)
Q Consensus       244 ~~~~~~~-~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~----~~~~~  316 (412)
                      ++|.+.. .||+|+||.||+|.. .+++.||||++...     ..+.+|+.++.++ +|||||++++++.+    ....+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5787765 599999999999994 67899999998643     3567899887655 89999999999865    45689


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC---CCCeEEeccCCc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMA  393 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla  393 (412)
                      |||||+++|+|.++|... ....+++..+..|+.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999999652 2356999999999999999999999988   999999999999986   457999999999


Q ss_pred             ccccCCCcccccccccccC
Q 015138          394 RLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       394 ~~~~~~~~~~~~~~~~Gt~  412 (412)
                      +........   ....||+
T Consensus       162 ~~~~~~~~~---~~~~gt~  177 (335)
T d2ozaa1         162 KETTSHNSL---TTPCYTP  177 (335)
T ss_dssp             EECCCCCCC---CCCSCCC
T ss_pred             eeccCCCcc---ccccCCc
Confidence            987654432   2245663

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-30  Score=244.12  Aligned_cols=151  Identities=26%  Similarity=0.461  Sum_probs=127.5

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc-ccHHHHHHHHHHHccCCCCccceeeEEEecCC----eee
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----ERI  316 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~  316 (412)
                      +++|+..++||+|+||+||+|. ..+|+.||||++.+... .....+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            3568899999999999999998 46899999999976543 33456899999999999999999999987653    235


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccc
Q 015138          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (412)
Q Consensus       317 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~  396 (412)
                      +++||+.+|+|.+++.    ...+++..+..++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            5667788999999984    346999999999999999999999998   999999999999999999999999999977


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ....
T Consensus       160 ~~~~  163 (345)
T d1pmea_         160 DPDH  163 (345)
T ss_dssp             CGGG
T ss_pred             cCCC
Confidence            5543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.1e-31  Score=239.94  Aligned_cols=151  Identities=27%  Similarity=0.432  Sum_probs=129.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcc------cHHHHHHHHHHHccCC--CCccceeeEEEecCC
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQ--HRNLVRLLGFCLERK  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~  313 (412)
                      .++|++.++||+|+||.||+|.. .+|+.||||++.+....      ....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            35788899999999999999995 67899999998754211      1223678999999986  899999999999999


Q ss_pred             eeeEEEecCCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCC-CCeEEeccC
Q 015138          314 ERILVYEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFG  391 (412)
Q Consensus       314 ~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DfG  391 (412)
                      ..++||||+.+ +++.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.+ +.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 677777743   457999999999999999999999988   9999999999999855 799999999


Q ss_pred             CcccccCC
Q 015138          392 MARLFEMD  399 (412)
Q Consensus       392 la~~~~~~  399 (412)
                      +|+.....
T Consensus       157 ~a~~~~~~  164 (273)
T d1xwsa_         157 SGALLKDT  164 (273)
T ss_dssp             TCEECCSS
T ss_pred             cceecccc
Confidence            99876543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.7e-30  Score=234.64  Aligned_cols=151  Identities=28%  Similarity=0.458  Sum_probs=135.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCCeeeEEEe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~E  320 (412)
                      ++|+..++||+|+||+||+|+. .+++.||||+++....  .....+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5788899999999999999994 6789999999865432  335678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcccccCCC
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~~~~~~  400 (412)
                      ++.+++|..++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999999888743   567889999999999999999999987   9999999999999999999999999999876543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.9e-30  Score=244.74  Aligned_cols=149  Identities=28%  Similarity=0.471  Sum_probs=124.7

Q ss_pred             CCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccceeeEEEecC------CeeeE
Q 015138          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------KERIL  317 (412)
Q Consensus       245 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~l  317 (412)
                      +|+..++||+|+||+||+|+. .+|+.||||++.+....    +.+|+.+|++++||||+++++++...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            577789999999999999995 57899999999765432    34799999999999999999998543      34789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCcccc
Q 015138          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLF  396 (412)
Q Consensus       318 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~  396 (412)
                      ||||++++.+..+.........+++..+..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755444322234567999999999999999999999987   99999999999999775 8999999999987


Q ss_pred             cCCC
Q 015138          397 EMDQ  400 (412)
Q Consensus       397 ~~~~  400 (412)
                      ...+
T Consensus       174 ~~~~  177 (350)
T d1q5ka_         174 VRGE  177 (350)
T ss_dssp             CTTS
T ss_pred             cCCc
Confidence            6544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=6.1e-30  Score=239.27  Aligned_cols=146  Identities=27%  Similarity=0.475  Sum_probs=128.2

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecC--CeeeEE
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLER--KERILV  318 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~--~~~~lv  318 (412)
                      .++|++.++||+|+||+||+|+. .+|+.||||+++...   ...+.+|+.+|.+++ ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            36799999999999999999995 678999999997543   456889999999995 99999999998743  468999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCC-CeEEeccCCccccc
Q 015138          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFE  397 (412)
Q Consensus       319 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DfGla~~~~  397 (412)
                      |||+++++|..+.      +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus       111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999997764      35899999999999999999999998   99999999999998755 69999999999876


Q ss_pred             CCC
Q 015138          398 MDQ  400 (412)
Q Consensus       398 ~~~  400 (412)
                      ++.
T Consensus       182 ~~~  184 (328)
T d3bqca1         182 PGQ  184 (328)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            554

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.6e-30  Score=239.65  Aligned_cols=149  Identities=28%  Similarity=0.476  Sum_probs=124.4

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecCC------
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  313 (412)
                      .++|+..++||+|+||+||+|.. .+|+.||||++.+...  .....+.+|+.+|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46888999999999999999994 6799999999975432  33456889999999999999999999997654      


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCc
Q 015138          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (412)
Q Consensus       314 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla  393 (412)
                      ..+|||||+ +.+|..++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            569999999 567777763    456999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCC
Q 015138          394 RLFEMD  399 (412)
Q Consensus       394 ~~~~~~  399 (412)
                      +.....
T Consensus       169 ~~~~~~  174 (346)
T d1cm8a_         169 RQADSE  174 (346)
T ss_dssp             EECCSS
T ss_pred             eccCCc
Confidence            987543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-29  Score=234.09  Aligned_cols=151  Identities=28%  Similarity=0.535  Sum_probs=127.6

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccC--CcccHHHHHHHHHHHccCCCCccceeeEEEecC--------
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--------  312 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--------  312 (412)
                      ++|++.++||+|+||+||+|.. .+|+.||||++...  .......+.+|+.+|++++||||+++++.+...        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788999999999999999995 67999999998654  233345688999999999999999999998653        


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCC
Q 015138          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (412)
Q Consensus       313 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGl  392 (412)
                      ...++||||++++.+..+..   ....++......|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            45789999999888776652   3556889999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCC
Q 015138          393 ARLFEMDQ  400 (412)
Q Consensus       393 a~~~~~~~  400 (412)
                      ++.+....
T Consensus       164 ~~~~~~~~  171 (318)
T d3blha1         164 ARAFSLAK  171 (318)
T ss_dssp             CEECCC--
T ss_pred             eeeccccc
Confidence            98876544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.8e-30  Score=237.27  Aligned_cols=151  Identities=28%  Similarity=0.373  Sum_probs=132.4

Q ss_pred             cCCCccccccccCCeeEEEEEe----CCCCEEEEEEeccCC----cccHHHHHHHHHHHccCCC-CccceeeEEEecCCe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKE  314 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~  314 (412)
                      ++|+..++||+|+||+||+|..    .+|+.||||.+.+..    ......+.+|+.++.+++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999984    247899999986542    1233457899999999966 899999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .+++|||+.+|+|.+++..   ...+.......++.|++.||.|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999854   456778888999999999999999988   9999999999999999999999999999


Q ss_pred             cccCCC
Q 015138          395 LFEMDQ  400 (412)
Q Consensus       395 ~~~~~~  400 (412)
                      .+....
T Consensus       178 ~~~~~~  183 (322)
T d1vzoa_         178 EFVADE  183 (322)
T ss_dssp             ECCGGG
T ss_pred             hhcccc
Confidence            875444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.95  E-value=1.4e-28  Score=226.00  Aligned_cols=162  Identities=20%  Similarity=0.346  Sum_probs=134.5

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC-CccceeeEEEecCCeeeEEEe
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKERILVYE  320 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~E  320 (412)
                      .++|++.++||+|+||.||+|+. .+|+.||||.+......  ..+.+|++.+..++| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            36788999999999999999994 57899999988654332  246788888988865 899999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC-----CCCeEEeccCCccc
Q 015138          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-----EMNPKISDFGMARL  395 (412)
Q Consensus       321 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~ki~DfGla~~  395 (412)
                      |+ +++|.+++..  ....+++.....++.|++.||.|||+.+   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 6899888754  3456999999999999999999999988   999999999999975     56799999999998


Q ss_pred             ccCCCcc-----cccccccccC
Q 015138          396 FEMDQTH-----SDTNRVVGTL  412 (412)
Q Consensus       396 ~~~~~~~-----~~~~~~~Gt~  412 (412)
                      +......     .....++||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~  177 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTA  177 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCT
T ss_pred             cccCccccceeecccCceEEch
Confidence            7644322     1233467874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6e-29  Score=230.11  Aligned_cols=162  Identities=30%  Similarity=0.480  Sum_probs=128.7

Q ss_pred             hcCCCccccccccCCeeEEEEEe-CC-CCEEEEEEeccCCc--ccHHHHHHHHHHHccC---CCCccceeeEEEec----
Q 015138          243 TDNFSDANKLGQGGFGAVYKGML-SN-GETIAVKRLSKNSK--QGEIEFKNEVLLLARL---QHRNLVRLLGFCLE----  311 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~~-~~-~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~----  311 (412)
                      .++|++.++||+|+||+||+|.. .+ ++.||||++.....  .....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999995 44 56799999865322  1222456677766655   89999999999853    


Q ss_pred             -CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEecc
Q 015138          312 -RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (412)
Q Consensus       312 -~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~Df  390 (412)
                       ....+++|||+.++++......  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             3467899999999887655432  4566899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccccCCCcccccccccccC
Q 015138          391 GMARLFEMDQTHSDTNRVVGTL  412 (412)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~Gt~  412 (412)
                      |+++.......   .....||+
T Consensus       161 g~~~~~~~~~~---~~~~~gT~  179 (305)
T d1blxa_         161 GLARIYSFQMA---LTSVVVTL  179 (305)
T ss_dssp             CSCCCCCGGGG---GCCCCCCC
T ss_pred             hhhhhhccccc---CCCcccCh
Confidence            99987654332   22356663

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-28  Score=232.40  Aligned_cols=148  Identities=29%  Similarity=0.479  Sum_probs=126.2

Q ss_pred             hcCCCccccccccCCeeEEEEE-eCCCCEEEEEEeccCCc--ccHHHHHHHHHHHccCCCCccceeeEEEecC-----Ce
Q 015138          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KE  314 (412)
Q Consensus       243 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~  314 (412)
                      .++|+..++||+|+||+||+|. ..+|+.||||++.+...  .....+.+|+.+|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4679999999999999999999 46799999999976532  3345688999999999999999999998643     34


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++++||+.+|+|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+|.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            577788899999999983    356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccc
Q 015138          395 LFE  397 (412)
Q Consensus       395 ~~~  397 (412)
                      ...
T Consensus       170 ~~~  172 (348)
T d2gfsa1         170 HTD  172 (348)
T ss_dssp             CCT
T ss_pred             ccC
Confidence            654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=6.6e-28  Score=222.36  Aligned_cols=161  Identities=23%  Similarity=0.371  Sum_probs=128.1

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCcccee-eEEEecCCeeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL-LGFCLERKERILVYEF  321 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~g~~~~~~~~~lv~Ey  321 (412)
                      ++|++.++||+|+||.||+|.. .+|+.||||.+......  .++..|+++++.++|+|++.+ .++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5689999999999999999995 67899999988765433  247889999999987765554 5556777888999999


Q ss_pred             CCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECC---CCCeEEeccCCcccccC
Q 015138          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEM  398 (412)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DfGla~~~~~  398 (412)
                      +. ++|.+.+..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+|+.+..
T Consensus        85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            94 556555432  3457999999999999999999999998   999999999999864   45799999999998865


Q ss_pred             CCccc-----ccccccccC
Q 015138          399 DQTHS-----DTNRVVGTL  412 (412)
Q Consensus       399 ~~~~~-----~~~~~~Gt~  412 (412)
                      .....     ....+.||+
T Consensus       159 ~~~~~~~~~~~~~~~~gt~  177 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTA  177 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCS
T ss_pred             cccccceeccccCCcCCCc
Confidence            54321     223466774

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.2e-28  Score=227.80  Aligned_cols=148  Identities=26%  Similarity=0.388  Sum_probs=121.0

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCC--cccHHHHHHHHHHHccCCCCccceeeEEEec------CCe
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE------RKE  314 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~------~~~  314 (412)
                      ++|++.++||+|+||+||+|.. .+|+.||||++.+..  ......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6788999999999999999995 579999999997543  2334568899999999999999999999864      367


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       315 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      .++||||+.++.+..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999776655442      45899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCC
Q 015138          395 LFEMDQ  400 (412)
Q Consensus       395 ~~~~~~  400 (412)
                      ......
T Consensus       168 ~~~~~~  173 (355)
T d2b1pa1         168 TAGTSF  173 (355)
T ss_dssp             ------
T ss_pred             cccccc
Confidence            765433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=8.8e-24  Score=181.34  Aligned_cols=134  Identities=19%  Similarity=0.200  Sum_probs=105.8

Q ss_pred             ccccccccCCeeEEEEEeCCCCEEEEEEeccCCcc------------------cHHHHHHHHHHHccCCCCccceeeEEE
Q 015138          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ------------------GEIEFKNEVLLLARLQHRNLVRLLGFC  309 (412)
Q Consensus       248 ~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~l~g~~  309 (412)
                      +.++||+|+||.||+|...+|+.||||.+......                  .......|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            46899999999999999888999999986532110                  012345688889999999999887653


Q ss_pred             ecCCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhCCCCCceecCCCCCCEEECCCCCeEEec
Q 015138          310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (412)
Q Consensus       310 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D  389 (412)
                          ..+|+|||+++..+.++          ++.....++.|++.+|.|||+.+   |+||||||+|||++++ .++|+|
T Consensus        84 ----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 ----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred             ----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence                23799999988766443          22334678999999999999988   9999999999999865 589999


Q ss_pred             cCCcccccCC
Q 015138          390 FGMARLFEMD  399 (412)
Q Consensus       390 fGla~~~~~~  399 (412)
                      ||+|+....+
T Consensus       146 FG~a~~~~~~  155 (191)
T d1zara2         146 FPQSVEVGEE  155 (191)
T ss_dssp             CTTCEETTST
T ss_pred             CCCcccCCCC
Confidence            9999876543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.88  E-value=2.7e-23  Score=196.35  Aligned_cols=151  Identities=23%  Similarity=0.286  Sum_probs=119.3

Q ss_pred             cCCCccccccccCCeeEEEEEe-CCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-----------CCccceeeEEEec
Q 015138          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-----------HRNLVRLLGFCLE  311 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~g~~~~  311 (412)
                      .+|++.++||+|+||+||+|+. .+|+.||||++.+... ....+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3488999999999999999995 6799999999976432 2346778888887775           5789999988764


Q ss_pred             --CCeeeEEEecCCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHh-CCCCCceecCCCCCCEEECCCCC----
Q 015138          312 --RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMN----  384 (412)
Q Consensus       312 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~----  384 (412)
                        ....++++++...+..............+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence              34667777777665443333223345678899999999999999999998 55   999999999999987654    


Q ss_pred             --eEEeccCCcccccC
Q 015138          385 --PKISDFGMARLFEM  398 (412)
Q Consensus       385 --~ki~DfGla~~~~~  398 (412)
                        +||+|||.|+....
T Consensus       169 ~~~kl~dfg~s~~~~~  184 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE  184 (362)
T ss_dssp             EEEEECCCTTCEETTB
T ss_pred             ceeeEeeccccccccc
Confidence              99999999987643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.69  E-value=4.5e-08  Score=86.10  Aligned_cols=143  Identities=19%  Similarity=0.143  Sum_probs=95.5

Q ss_pred             cCCCccccccccCCeeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCC-CCccceeeEEEecCCeeeEEEecC
Q 015138          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFV  322 (412)
Q Consensus       244 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~Ey~  322 (412)
                      ..|+..+..+-++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+....+..++|||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            4455444433334468998765 45677888876654444445677888776663 444678888888888899999999


Q ss_pred             CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhHhC----------------------------------------
Q 015138          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED----------------------------------------  362 (412)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------  362 (412)
                      ++..+.+....     ...   ...++.++++.|..||+.                                        
T Consensus        93 ~G~~~~~~~~~-----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          93 DGVLCSEEYED-----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SSEEHHHHTTT-----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             ccccccccccc-----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            99888654421     111   122344455555555531                                        


Q ss_pred             ----------------CCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          363 ----------------SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       363 ----------------~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                                      .+..++|+|+.|.|||++++..+.|.||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                            112279999999999999877778999998874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.21  E-value=6.8e-06  Score=71.26  Aligned_cols=131  Identities=18%  Similarity=0.158  Sum_probs=85.6

Q ss_pred             cccccCC-eeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCC--CccceeeEEEecCCeeeEEEecCCCCCh
Q 015138          251 KLGQGGF-GAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERKERILVYEFVPNASL  327 (412)
Q Consensus       251 ~lg~G~f-g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~~~~lv~Ey~~~gsL  327 (412)
                      .+..|.. ..||+....++..+.+|........   .+..|...+..+..  -.+.+++++..+.+..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444543 5789998877888888876554333   35667777766633  3467888888888889999999998776


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHH---------------------------------------------------H
Q 015138          328 DHFIFDPINREHMTWEKRYKIIEGIARG---------------------------------------------------L  356 (412)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~---------------------------------------------------l  356 (412)
                      .+..        +...   .++.++++.                                                   +
T Consensus        94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4421        0000   111122222                                                   2


Q ss_pred             HHhHhC----CCCCceecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          357 LYLHED----SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       357 ~yLH~~----~~~~ivHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      ..+...    .++.++|+|+.|.|||++.+..+.|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            222221    122379999999999999887788999998865

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.72  E-value=5.6e-05  Score=69.89  Aligned_cols=77  Identities=14%  Similarity=0.146  Sum_probs=47.3

Q ss_pred             cccccccCCeeEEEEEeCC-CCEEEEEEeccC-------CcccHHHHHHHHHHHccCC-C--CccceeeEEEecCCeeeE
Q 015138          249 ANKLGQGGFGAVYKGMLSN-GETIAVKRLSKN-------SKQGEIEFKNEVLLLARLQ-H--RNLVRLLGFCLERKERIL  317 (412)
Q Consensus       249 ~~~lg~G~fg~V~~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~g~~~~~~~~~l  317 (412)
                      .+.||.|..-.||+....+ ++.++||.-...       ..........|.+.|..+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999998644 678899864321       1112223445776666552 2  345666655  4455689


Q ss_pred             EEecCCCCCh
Q 015138          318 VYEFVPNASL  327 (412)
Q Consensus       318 v~Ey~~~gsL  327 (412)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999986543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.38  E-value=0.00036  Score=62.47  Aligned_cols=135  Identities=17%  Similarity=0.121  Sum_probs=77.6

Q ss_pred             eeEEEEEeCCCCEEEEEEeccCCcccHHHHHHHHHHHccCCCCccc--eeeE-----EEecCCeeeEEEecCCCCChhhh
Q 015138          258 GAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV--RLLG-----FCLERKERILVYEFVPNASLDHF  330 (412)
Q Consensus       258 g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~g-----~~~~~~~~~lv~Ey~~~gsL~~~  330 (412)
                      =.||+....+|+.+++|....... ...++..|+..+..|...++.  ..+.     ........+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            379999999999999998765432 345677888887776433221  1111     12345567889999987554211


Q ss_pred             -----------c-------c--CCCCCCCCCHH----------------------HHHHHHHHHHHHHHHh-HhCCCCCc
Q 015138          331 -----------I-------F--DPINREHMTWE----------------------KRYKIIEGIARGLLYL-HEDSRLRI  367 (412)
Q Consensus       331 -----------l-------~--~~~~~~~l~~~----------------------~~~~i~~~i~~~l~yL-H~~~~~~i  367 (412)
                                 +       .  ....+..+++.                      ....++.++...+.-+ .+..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                       0       0  00111112211                      1112233333333222 12233458


Q ss_pred             eecCCCCCCEEECCCCCeEEeccCCccc
Q 015138          368 IHRDLKASNILLDSEMNPKISDFGMARL  395 (412)
Q Consensus       368 vHrdlk~~Nill~~~~~~ki~DfGla~~  395 (412)
                      +|+|+.+.|||++.+  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  46899998863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.85  E-value=0.0013  Score=60.35  Aligned_cols=72  Identities=19%  Similarity=0.308  Sum_probs=47.3

Q ss_pred             ccccccCCeeEEEEEeCCC--------CEEEEEEeccCCcccHHHHHHHHHHHccCCCCcc-ceeeEEEecCCeeeEEEe
Q 015138          250 NKLGQGGFGAVYKGMLSNG--------ETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYE  320 (412)
Q Consensus       250 ~~lg~G~fg~V~~~~~~~~--------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E  320 (412)
                      +.|+-|--=.+|+....++        +.|.++... .. .......+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4676666678999886543        445555544 32 334456788888888753344 478887653    68999


Q ss_pred             cCCCCCh
Q 015138          321 FVPNASL  327 (412)
Q Consensus       321 y~~~gsL  327 (412)
                      |+++..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.71  E-value=0.027  Score=49.29  Aligned_cols=30  Identities=27%  Similarity=0.344  Sum_probs=27.0

Q ss_pred             CCceecCCCCCCEEECCCCCeEEeccCCcc
Q 015138          365 LRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (412)
Q Consensus       365 ~~ivHrdlk~~Nill~~~~~~ki~DfGla~  394 (412)
                      ..+||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            359999999999999988878999999876